PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rona, RJ; Hooper, R; Jones, M; Hull, L; Browne, T; Horn, O; Murphy, D; Hotopf, M; Wessely, S				Rona, Roberto J.; Hooper, Richard; Jones, Margaret; Hull, Lisa; Browne, Tess; Horn, Oded; Murphy, Dominic; Hotopf, Matthew; Wessely, Simon			Mental health screening in armed forces before the Iraq war and prevention of subsequent psychological morbidity: follow-up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILITARY; ILLNESS; PTSD; QUESTIONNAIRE; PREDICTORS; SERVICE; TRAUMA	Objective To assess whether screening for mental disorder before the start of the 2003 Iraq war would have predicted subsequent mental disorders. Design Longitudinal cohort study of the United Kingdom armed forces. Participants 2820 of 2873 personnel of the three services who completed an initial questionnaire in 2002 were asked to complete a second questionnaire between June 2004 and 2 March 2006. Setting Regiments, air stations, bases, ships, and homes for those who had left the services. Main outcome measures Positive and negative likelihood ratios, and positive and negative predictive value of first assessment compared with assessment two to three years later of post-traumatic stress disorder, general health questionnaire, physical symptoms, self 0 perception of health, and alcohol misuse for the entire group and for those deployed to die Iraq war. Results The response rate to the follow-up questionnaire was 69%, adjusted for return to senders. The positive likelihood ratio of post-traumatic stress disorder was high (13.1, 95% confidence interval 7.2 to 23.8). but the negative likelihood ratio was close to 1 (0.78, 0.67 to 0.91). The positive predictive values were low because of the low prevalence of post-traumatic stress disorder in the period before the Iraq war. The positive likelihood ratios for the other psychological assessments varied between 2.7 and 5.6, and the negative likelihood ratios were slightly lower than for post-traumatic stress disorder, indicating that these were not good candidates for screening. Results were the same for the analyses restricted to those who were deployed. Conclusions Screening for common mental disorders before deployment in this cohort would not have reduced Subsequent morbidity or predicted post-traumatic stress disorder, but this may change if there is a considerable increase in the prevalence of die disorder.	Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England; Natl Heart & Lung Inst, Imperial Coll London, London SW3 6LR, England	University of London; King's College London; Imperial College London	Rona, RJ (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England.	Roberto.rona@iop.kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Wessely, Simon C/A-8713-2008	Rona, Roberto/0000-0003-3739-5571; Hooper, Richard/0000-0002-1063-0917; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929				AITA JA, 1949, ARCH NEURO PSYCHIATR, V61, P170, DOI 10.1001/archneurpsyc.1949.02310080074005; APPEL JW, 1946, AM J PSYCHIAT, V103, P196, DOI 10.1176/ajp.103.2.196; Barbor T. F., 2001, ALCOHOL USE DISORDER; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese P. D., 2006, NOVEL APPROACHES DIA, P78; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BRILL NQ, 1952, AM J PSYCHIAT, V109, P401, DOI 10.1176/ajp.109.6.401; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; *DOD, 1997, 64903 DOD; EGAN JR, 1951, JAMA-J AM MED ASSOC, V145, P466, DOI 10.1001/jama.1951.02920250018004; *GAO, GAO06397; *GAO, GAO06397 DOD; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; JACOBSEN BK, 1995, PSYCHOL MED, V25, P957, DOI 10.1017/S0033291700037442; Jones E, 2003, J MED SCREEN, V10, P40, DOI 10.1258/096914103321610798; LUDWIG A O, 1947, Mil Surg, V100, P51; NORRIS RL, 2005, STRESS TRAUMA CRISIS, V8, P1; Orr DW, 1941, B MENNINGER CLIN, V5, P131; Orr JW, 2001, CURR OPIN OBSTET GYN, V13, P1, DOI 10.1097/00001703-200102000-00001; PLESSET MR, 1946, AM J PSYCHIAT, V103, P87, DOI 10.1176/ajp.103.1.87; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Rona RJ, 2004, J MED SCREEN, V11, P158, DOI 10.1258/0969141041732210; Rona RJ, 2004, J MED SCREEN, V11, P148, DOI 10.1258/0969141041732193; SALMON T, 1917, MENT HYG, V1, P529; SCHNURR PP, 1993, AM J PSYCHIAT, V150, P479; SHARP WL, 1950, AM J PSYCHIAT, V106, P801, DOI 10.1176/ajp.106.11.801; Shephard Ben, 2000, WAR NERVES SOLDIERS; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Sutton DG, 1939, PSYCHIATR, V2, P1; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Ware J. E., 1993, SF36 HLTH SURVEY MAN; Wright KM, 2002, MIL MED, V167, P853, DOI 10.1093/milmed/167.10.853	37	68	69	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2006	333	7576					991	994A		10.1136/BMJ.38985.610949.55	http://dx.doi.org/10.1136/BMJ.38985.610949.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108GX	17023434	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000242229400014
J	Ranen, MC; Jacobsen, SB				Ranen, Michael C.; Jacobsen, Stein B.			Barium isotopes in chondritic meteorites: Implications for planetary reservoir models	SCIENCE			English	Article							EARLY SOLAR-SYSTEM; MURCHISON METEORITE; EARTHS MANTLE; NEUTRON BURST; DIFFERENTIATION; MOLYBDENUM; SM-146; BA	High-precision barium isotope measurements yielded differences of up to 25 parts per million in the Ba-137/Ba-136 ratio and 60 parts per million in the Ba-138/Ba-136 ratio between chondrites and Earth. These differences probably arose from incomplete mixing of nucleosynthetic material in the solar nebula. Chondritic meteorites have a slight excess of supernova-derived material as compared to Earth, demonstrating that the solar nebula was not perfectly homogenized upon formation.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Ranen, MC (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ranen@fas.harvard.edu	Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	Jacobsen, Stein/0000-0003-2164-0720				BORG LE, 2006, LUNAR PLANET SCI, V37, pA1154; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CAMERON AGW, 1963, ICARUS, V1, P339, DOI 10.1016/0019-1035(62)90033-7; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; CASSEN P, 1997, AIP C P, V402, P697; CLAYTON RN, 1976, EARTH PLANET SC LETT, V30, P10, DOI 10.1016/0012-821X(76)90003-0; CLAYTON RN, 2003, TREATISE GEOCHEMISTR, V1, pCH6; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HARPER CL, 1993, LUNAR PLANET SCI, V24, pA607; Hidaka H, 2003, EARTH PLANET SC LETT, V214, P455, DOI 10.1016/S0012-821X(03)00393-5; Hidaka H, 2001, EARTH PLANET SC LETT, V193, P459, DOI 10.1016/S0012-821X(01)00513-1; HOWARD WM, 1992, METEORITICS, V27, P404, DOI 10.1111/j.1945-5100.1992.tb00222.x; HUSS GR, 1997, AIP C P, V402, P721; Jacobsen SB, 1996, GEOCHIM COSMOCHIM AC, V60, P3747, DOI 10.1016/0016-7037(96)00217-7; JACOBSEN SB, 2006, LUNAR PLANET SCI, V37, pA2241; MCCULLOCH MT, 1978, ASTROPHYS J, V220, pL15, DOI 10.1086/182628; Meyer BS, 2000, ASTROPHYS J, V540, pL49, DOI 10.1086/312865; OTT U, 1988, NATURE, V332, P700, DOI 10.1038/332700a0; PELLIN MJ, 2000, LUNAR PLANET SCI, V31, pA1917; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Yin QZ, 2002, NATURE, V415, P881, DOI 10.1038/415881a; YIN QZ, 2001, LUNAR PLANET SCI, V32, pA2128; ZINNER E, 1991, ASTROPHYS J, V382, pL47, DOI 10.1086/186210	24	75	77	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					809	812		10.1126/science.1132595	http://dx.doi.org/10.1126/science.1132595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17023611				2022-12-28	WOS:000241729800044
J	Ahmed, AR; Spigelman, Z; Cavacini, LA; Posner, MR				Ahmed, A. Razzaque; Spigelman, Zachary; Cavacini, Lisa A.; Posner, Marshall R.			Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY RITUXIMAB; ADJUVANT THERAPY; IMMUNOGLOBULIN; REMISSION; RECALCITRANT; DISEASES; IGG	BACKGROUND: Pemphigus vulgaris is a potentially fatal autoimmune mucocutaneous blistering disease. Conventional therapy consists of high-dose corticosteroids, immunosuppressive agents, and intravenous immune globulin. METHODS: We studied patients with refractory pemphigus vulgaris involving 30% or more of their body-surface area, three or more mucosal sites, or both who had inadequate responses to conventional therapy and intravenous immune globulin. We treated the patients with two cycles of rituximab (375 mg per square meter of body-surface area) once weekly for 3 weeks and intravenous immune globulin (2 g per kilogram of body weight) in the fourth week. This induction therapy was followed by a monthly infusion of rituximab and intravenous immune globulin for 4 consecutive months. Titers of serum antibodies against keratinocytes and numbers of peripheral-blood B cells were monitored. RESULTS: Of 11 patients, 9 had rapid resolution of lesions and a clinical remission lasting 22 to 37 months (mean, 31.1). All immunosuppressive therapy, including prednisone, could be discontinued before ending rituximab treatment in all patients. Two patients were treated with rituximab only during recurrences and had sustained remissions. Titers of IgG4 antikeratinocyte antibodies correlated with disease activity. Peripheral-blood B cells became undetectable shortly after initiating rituximab therapy but subsequently returned to normal values. Side effects that have been associated with rituximab were not observed, nor were infections. CONCLUSIONS: The combination of rituximab and intravenous immune globulin is effective in patients with refractory pemphigus vulgaris.	New England Baptist Hosp, Ctr Blistering Dis, Boston, MA 02120 USA; New England Baptist Hosp, Parker Hill Oncol & Hematol, Boston, MA 02120 USA; New England Baptist Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; Waltham Canc Ctr, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Beth Israel Deaconess Med Ctr, Human Monoclonal Antibody Lab, Boston, MA 02215 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	New England Baptist Hospital; New England Baptist Hospital; New England Baptist Hospital; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute	Ahmed, AR (corresponding author), New England Baptist Hosp, Ctr Blistering Dis, 70 Parker Hill Ave,Suite 208, Boston, MA 02120 USA.							Ahmed AR, 2004, EXPERT OPIN INV DRUG, V13, P1019, DOI 10.1517/13543784.13.8.1019; Ahmed AR, 2003, ARCH DERMATOL, V139, P1051, DOI 10.1001/archderm.139.8.1051; AHMED AR, 1980, ANN INTERN MED, V92, P396, DOI 10.7326/0003-4819-92-3-396; Arin MJ, 2005, BRIT J DERMATOL, V153, P620, DOI 10.1111/j.1365-2133.2005.06651.x; BHOL K, 1994, DERMATOLOGY, V189, P85, DOI 10.1159/000246938; BHOL K, 1995, P NATL ACAD SCI USA, V92, P5239, DOI 10.1073/pnas.92.11.5239; Bystryn JC, 1996, ARCH DERMATOL, V132, P203, DOI 10.1001/archderm.132.2.203; CAVACINI LA, 1994, J IMMUNOL, V152, P2538; Cooper HL, 2003, CLIN EXP DERMATOL, V28, P366, DOI 10.1046/j.1365-2230.2003.01283.x; Dupuy A, 2004, ARCH DERMATOL, V140, P91, DOI 10.1001/archderm.140.1.91; Espana A, 2004, J AM ACAD DERMATOL, V50, P974, DOI 10.1016/j.jaad.2003.08.021; Hacker MK, 2002, CLIN IMMUNOL, V105, P64, DOI 10.1006/clim.2002.5259; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Kimby E, 2005, CANCER TREAT REV, V31, P456, DOI 10.1016/j.ctrv.2005.05.007; Kong HH, 2005, PEDIATR DERMATOL, V22, P461, DOI 10.1111/j.1525-1470.2005.00118.x; Lehrnbecher T, 2001, KLIN PADIATR, V213, pA103, DOI 10.1055/s-2001-17506; Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849; Looney R. John, 2005, V8, P193; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Morrison LH, 2004, J AM ACAD DERMATOL, V51, P817, DOI 10.1016/j.jaad.2004.06.007; Narat S, 2005, HAEMATOLOGICA, V90, P1273; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Quartier P, 2001, LANCET, V358, P1511, DOI 10.1016/S0140-6736(01)06573-4; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; Salopek TG, 2002, J AM ACAD DERMATOL, V47, P785, DOI 10.1067/mjd.2002.126273; Sapir T, 2005, ANN NY ACAD SCI, V1051, P743, DOI 10.1196/annals.1361.118; Schmidt E, 2005, BRIT J DERMATOL, V153, P449, DOI 10.1111/j.1365-2133.2005.06740.x; Sieb JP, 2005, CURR OPIN PHARMACOL, V5, P303, DOI 10.1016/j.coph.2005.01.010; Sokos DR, 2002, BIOL BLOOD MARROW TR, V8, P117, DOI 10.1053/bbmt.2002.v8.pm11939601; Specks U, 2001, ARTHRITIS RHEUM, V44, P2836, DOI 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W; Stasi R, 2002, BLOOD, V99, P3872, DOI 10.1182/blood-2002-02-0392; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; TRUHAN AP, 1989, ANN ALLERGY, V62, P375; Virgolini Luigi, 2003, Haematologica, V88, pELT24; Winkler U, 1999, BLOOD, V94, P2217, DOI 10.1182/blood.V94.7.2217.419k02_2217_2224; Yassa SK, 2005, CLIN TRANSPLANT, V19, P423, DOI 10.1111/j.1399-0012.2005.00334.x; Yeh SW, 2006, CLIN IMMUNOL, V120, P68, DOI 10.1016/j.clim.2006.03.006; Yeh SW, 2005, AM J CLIN DERMATOL, V6, P327, DOI 10.2165/00128071-200506050-00006; Zaja F, 2002, ARTHRITIS RHEUM-US, V46, P2252, DOI 10.1002/art.10345	39	341	371	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1772	1779		10.1056/NEJMoa062930	http://dx.doi.org/10.1056/NEJMoa062930			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065638				2022-12-28	WOS:000241512500005
J	Straus, SE; Thorpe, KE; Holroyd-Leduc, J				Straus, Sharon E.; Thorpe, Kevin E.; Holroyd-Leduc, Jayna			How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; BLIND CLINICAL-TRIAL; CEREBROSPINAL-FLUID; DIFFERENTIAL-DIAGNOSIS; ATRAUMATIC NEEDLE; BED REST; MULTIVARIATE APPROACH; COMPUTED-TOMOGRAPHY; POSTDURAL PUNCTURE; AMERICAN-ACADEMY	Context Diagnostic lumbar punctures (LPs), commonly used to rule out meningitis, are associated with adverse events. Objective To systematically review the evidence about diagnostic LP techniques that may decrease the risk of adverse events and the evidence about test accuracy of cerebrospinal fluid (CSF) analysis in adult patients with suspected bacterial meningitis. Data Sources We searched the Cochrane Library, MEDLINE ( using Ovid and PubMed) from 1966 to January 2006 and EMBASE from 1980 to January 2006 without language restrictions to identify relevant studies and identified others from the bibliographies of retrieved articles. Study Selection We included randomized trials of patients aged 18 years or older undergoing interventions to facilitate a successful diagnostic LP or to potentially reduce adverse events. Studies assessing the accuracy of biochemical analysis of the CSF for possible bacterial meningitis were also identified. Data Extraction Two investigators independently appraised study quality and extracted relevant data. For studies of the LP technique, data on the intervention and the outcome were extracted. For studies of the laboratory diagnosis of bacterial meningitis, data on the reference standard and test accuracy were extracted. Data Synthesis We found 15 randomized trials. A random-effects model was used for quantitative synthesis. Five studies of 587 patients compared atraumatic needles with standard needles and found a nonsignificant decrease in the odds of headache with an atraumatic needle ( absolute risk reduction [ARR], 12.3%; 95% confidence interval [CI], - 1.72% to 26.2%). Reinsertion of the stylet before needle removal decreased the risk of headache ( ARR, 11.3%; 95% CI, 6.50%-16.2%). The combined results from 4 studies of 717 patients showed a nonsignificant decrease in headache in patients who were mobilized after LP ( ARR, 2.9%; 95% CI, - 3.4 to 9.3%). Four studies on the accuracy of biochemical analysis of CSF in patients with suspected meningitis met inclusion criteria. A CSF - blood glucose ratio of 0.4 or less ( likelihood ratio [LR], 18; 95% CI, 12- 27]), CSF white blood cell count of 500/mu L or higher ( LR, 15; 95% CI, 10-22), and CSF lactate level of 31.53 mg/dL or more ( >= 3.5 mmol/L; LR, 21; 95% CI, 14-32) accurately diagnosed bacterial meningitis. Conclusions These data suggest that small-gauge, atraumatic needles may decrease the risk of headache after diagnostic LP. Reinsertion of the stylet before needle removal should occur and patients do not require bed rest after the procedure. Future research should focus on evaluating interventions to optimize the success of a diagnostic LP and to enhance training in procedural skills.	Univ Calgary, Div Gen Internal Med, Calgary, AB T2N 1N4, Canada; Univ Toronto, St Michaels Hosp, Knowledge Translat Program, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada	University of Calgary; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Straus, SE (corresponding author), Foothills Med Ctr, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	sharon.straus@utoronto.ca		Thorpe, Kevin/0000-0002-7586-3893				Aamodt A, 2001, ACTA NEUROL SCAND, V103, P396, DOI 10.1034/j.1600-0404.2001.103006396.x; Abbrescia KL, 2001, ACAD EMERG MED, V8, P8, DOI 10.1111/j.1553-2712.2001.tb00538.x; Armon C, 2005, NEUROLOGY, V65, P510, DOI 10.1212/01.wnl.0000173034.96211.1b; Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Baty V, 2000, EUR J CLIN MICROBIOL, V19, P422, DOI 10.1007/s100960000287; Bier A., 1899, DTSCH Z CHIR, V51, P361, DOI 10.1007/BF02792160; Birnbach DJ, 2001, HEADACHE, V41, P385, DOI 10.1046/j.1526-4610.2001.111006385.x; Boon JM, 2004, CLIN ANAT, V17, P544, DOI 10.1002/ca.10250; BRAUNE HJ, 1992, ACTA NEUROL SCAND, V86, P50, DOI 10.1111/j.1600-0404.1992.tb08053.x; BRIEM H, 1983, SCAND J INFECT DIS, V15, P277, DOI 10.3109/inf.1983.15.issue-3.08; Brivet FG, 2005, INTENS CARE MED, V31, P1654, DOI 10.1007/s00134-005-2811-1; CARBAAT PAT, 1981, LANCET, V2, P1133; CLOUGH C, 1980, BRIT MED J, V280, P297, DOI 10.1136/bmj.280.6210.297; CONLY JM, 1983, AM J MED, V75, P102, DOI 10.1016/0002-9343(83)90080-3; DAUBE JR, 1993, NEUROLOGY, V43, P625; DELIYANNAKIS E, 1971, MIL MED, V136, P370, DOI 10.1093/milmed/136.4.370; DIETERICH M, 1988, EUR ARCH PSY CLIN N, V237, P194, DOI 10.1007/BF00449906; DIETERICH M, 1985, EUR ARCH PSY CLIN N, V235, P71, DOI 10.1007/BF00633475; Dunbar SA, 1998, J CLIN MICROBIOL, V36, P1617, DOI 10.1128/JCM.36.6.1617-1620.1998; ENGELHARDT A, 1992, CEPHALALGIA, V12, P259, DOI 10.1046/j.1468-2982.1992.1204259.x; Eskey CJ, 2001, AM J NEURORADIOL, V22, P571; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; Evans RW, 2000, NEUROLOGY, V55, P909, DOI 10.1212/WNL.55.7.909; Flaatten H, 1998, ACTA NEUROL SCAND, V98, P445, DOI 10.1111/j.1600-0404.1998.tb07328.x; Gopal AK, 1999, ARCH INTERN MED, V159, P2681, DOI 10.1001/archinte.159.22.2681; Gorman P, 2000, Stud Health Technol Inform, V70, P106; HANDLER CE, 1982, J ROY SOC MED, V75, P404; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Hicks CM, 2000, J GEN INTERN MED, V15, P716, DOI 10.1046/j.1525-1497.2000.91104.x; HILTONJONES D, 1982, J NEUROL NEUROSUR PS, V45, P743, DOI 10.1136/jnnp.45.8.743; HINDLEY NJ, 1995, ACTA NEUROL SCAND, V91, P405, DOI 10.1111/j.1600-0404.1995.tb07029.x; HOEN B, 1995, EUR J CLIN MICROBIOL, V14, P267, DOI 10.1007/BF02116518; JOHANNSSON G, 1992, LAKARTIDNINGEN, V98, P4030; Kiefe CI, 1998, INT J QUAL HEALTH C, V10, P443, DOI 10.1093/intqhc/10.5.443; Kleyweg RP, 1998, CEPHALALGIA, V18, P635, DOI 10.1046/j.1468-2982.1998.1809635.x; KOMOROWSKI RA, 1986, J CLIN MICROBIOL, V24, P982, DOI 10.1128/JCM.24.6.982-985.1986; KOVANEN J, 1986, HEADACHE, V26, P224, DOI 10.1111/j.1526-4610.1986.hed2605224.x; KUNTZ KM, 1992, NEUROLOGY, V42, P1884, DOI 10.1212/WNL.42.10.1884; LANNIGAN R, 1980, J CLIN MICROBIOL, V11, P324, DOI 10.1128/JCM.11.4.324-327.1980; Leblebicioglu H, 1996, EUR J CLIN MICROBIOL, V15, P252, DOI 10.1007/BF01591365; LENAERTS M, 1993, CEPHALALGIA, V13, P296, DOI 10.1046/j.1468-2982.1993.1304296.x; LINDQUIST L, 1988, EUR J CLIN MICROBIOL, V7, P374, DOI 10.1007/BF01962340; LOMAN J, 1934, ARCH NEUROL PSYCH, P1279; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; MCKINNEY WP, 1994, J GEN INTERN MED, V9, P8, DOI 10.1007/BF02599135; Moorthy K, 2003, ST HEAL T, V94, P219; MULLER B, 1994, J NEUROL, V241, P376, DOI 10.1007/BF02033354; Queckenstedt, 1916, DEUTSCH Z NERVENHEIL, V55, P325, DOI [10.1007/BF01733057, DOI 10.1007/BF01733057]; Quincke H, 1891, VERH C INN MED, V10, P321; RUFF RL, 1981, STROKE, V12, P879, DOI 10.1161/01.STR.12.6.879; Sandoval Marcelo, 2004, Emerg Radiol, V10, P179, DOI 10.1007/s10140-003-0286-3; Serpell MG, 1998, BRIT MED J, V316, P1709, DOI 10.1136/bmj.316.7146.1709; Shah KH, 2003, ACAD EMERG MED, V10, P151, DOI 10.1111/j.1553-2712.2003.tb00033.x; SMITH FR, 1980, LANCET, V1, P1245; SMITH IK, 1994, IEE ENERGY S, V7, P32; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; SPRIGGS DA, 1992, POSTGRAD MED J, V68, P581, DOI 10.1136/pgmj.68.801.581; STEELE RW, 1986, J CLIN MICROBIOL, V23, P965, DOI 10.1128/JCM.23.5.965-966.1986; STERNBACH G, 1985, Journal of Emergency Medicine, V2, P199, DOI 10.1016/0736-4679(85)90397-X; Strupp M, 1998, J NEUROL, V245, P589, DOI 10.1007/s004150050250; Strupp M, 1997, NEW ENGL J MED, V336, P1190, DOI 10.1056/NEJM199704173361616; Strupp M, 2001, NEUROLOGY, V57, P2310, DOI 10.1212/WNL.57.12.2310; SUDLOW C, 2005, POSTURE FLUIDS PREVE; Thomas SR, 2000, BRIT MED J, V321, P986, DOI 10.1136/bmj.321.7267.986; Tohmo H, 1998, ANAESTHESIA, V53, P299, DOI 10.1046/j.1365-2044.1998.00326.x; TOURTELLOTTE WW, 1972, HEADACHE, V12, P73, DOI 10.1111/j.1526-4610.1972.hed1202073.x; Vavricka SR, 2003, ANN HEMATOL, V82, P570, DOI 10.1007/s00277-003-0707-0; VILMING ST, 1988, CEPHALALGIA, V8, P75, DOI 10.1046/j.1468-2982.1988.0802075.x; Vimala J, 1998, J Assoc Physicians India, V46, P930; Waldman W, 1999, NEUROLOGY, V52, P1296, DOI 10.1212/WNL.52.6.1296; WASILAUSKAS BL, 1982, J CLIN MICROBIOL, V16, P531, DOI 10.1128/JCM.16.3.531-535.1982; WHITE LJ, 1986, ANN INTERN MED, V104, P880, DOI 10.7326/0003-4819-104-6-880; WILLIAMS C, 1994, LANCET, V344, P1086, DOI 10.1016/S0140-6736(94)91742-6; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	74	90	91	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					2012	2022		10.1001/jama.296.16.2012	http://dx.doi.org/10.1001/jama.296.16.2012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062865	Bronze			2022-12-28	WOS:000241495300024
J	Borghi, J; Ensor, T; Somanathan, A; Lissner, C; Mills, A				Borghi, Jo; Ensor, Tim; Somanathan, Aparnaa; Lissner, Craig; Mills, Anne		Lancet Maternal Survival Series St	Maternal survival 4 - Mobilising financial resources for maternal health	LANCET			English	Article							COMMUNITY LOAN FUNDS; REMOVING USER FEES; OBSTETRIC EMERGENCIES; COST-EFFECTIVENESS; DEVELOPING-COUNTRIES; INSURANCE SCHEME; INCOME COUNTRIES; CHILD SURVIVAL; CARE; SERVICES	Coverage of cost-effective maternal health services remains poor due to insufficient supply and inadequate demand for these services among the poorest groups. Households pay too great a share of the costs of maternal health services, or do not seek care because they cannot afford the costs. Available evidence creates a strong case for removal of user fees and provision of universal coverage for pregnant women, particularly for delivery care. To be successful, governments must also replenish the income lost through the abolition of user fees. Where insurance schemes exist, maternal health care needs to be included in the benefits package, and careful design is needed to ensure uptake by the poorest people. Voucher schemes should be tested in low-income settings, and their costs and relative cost-effectiveness assessed. Further research is needed on methods to target financial assistance for transport and time costs. Current investment in maternal health is insufficient to meet the fifth Millennium Development Goal (MDG), and much greater resources are needed to scale up coverage of maternal health services and create demand. Existing global estimates are too crude to be of use for domestic planning, since resource requirements will vary; budgets need first to be developed at country-level. Donors need to increase financial contributions for maternal health in low-income countries to help fill the resource gap. Resource tracking at country and donor levels will help hold countries and donors to account for their commitments to achieving the maternal health MDG.	Univ London London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, London WC1E 7HT, England; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland; Inst Child Hlth, London, England; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen; University of London; University College London; World Health Organization	Mills, A (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, Keppel St, London WC1E 7HT, England.	anne.mills@lshtm.ac.uk	Ensor, Tim/ABD-5899-2020	Ensor, Tim/0000-0003-0279-9576; Borghi, Josephine/0000-0002-0482-5451; Mills, Anne/0000-0001-9863-9950				Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Afsana K, 2004, REPROD HEALTH MATTER, V12, P171, DOI 10.1016/S0968-8080(04)24142-8; Akashi H, 2004, SOC SCI MED, V58, P553, DOI 10.1016/S0277-9536(03)00240-5; AMOAKO N, 2002, HLTH FINANCING GHANA; BLOCK MAG, 1994, HEALTH POLICY PLANN, V9, P204, DOI 10.1093/heapol/9.2.204; Borghi J, 2006, TROP MED INT HEALTH, V11, P228, DOI 10.1111/j.1365-3156.2005.01546.x; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; BORGHI J, IN PRESS J HLTH POPU; Borghi J., 2004, COPING BURDEN COSTS; CESAR CLG, 1986, ANN TROP PAEDIATR, V6, P167, DOI 10.1080/02724936.1986.11748432; Chiwuzie J, 1997, INT J GYNECOL OBSTET, V59, pS231, DOI 10.1016/S0020-7292(97)00170-7; Conteh L, 2001, COSTS SCALING PRIORI; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Criel B, 2003, SOC SCI MED, V57, P1205, DOI 10.1016/S0277-9536(02)00495-1; Criel B, 1999, SOC SCI MED, V48, P897, DOI 10.1016/S0277-9536(98)00391-8; Daponte A, 2000, INT J GYNECOL OBSTET, V71, P127, DOI 10.1016/S0020-7292(00)00266-6; DEBOER CN, 1989, SOC SCI MED, V28, P1007, DOI 10.1016/0277-9536(89)90383-3; DMYTRACZENKO T, 1998, EVALUACION SEGURO NA; Ensor T, 2005, HEALTH POLICY, V75, P49, DOI 10.1016/j.healthpol.2005.02.002; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; ENSOR T, 2005, NOTE COMP HLTH FINAN; Essien E, 1997, INT J GYNECOL OBSTET, V59, pS237, DOI 10.1016/S0020-7292(97)00171-9; Fofana P, 1997, INT J GYNECOL OBSTET, V59, pS225, DOI 10.1016/S0020-7292(97)00169-0; Fox-Rushby Julia A., 1995, World Health Statistics Quarterly, V48, P23; FRASER A, 2004, 52 OXF; Gertler P., 2001, EXPT INCENTIVE BASED; *GHAN MIN HLTH, 2004, GUID DEL EX POL MAT; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Gohou V, 2004, TROP MED INT HEALTH, V9, P406, DOI 10.1111/j.1365-3156.2004.01204.x; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; GRAHAM WJ, 2002, MATERNAL MORBIDITY M, P3; *HLTH EC FIN UN, 2003, PUBL EXP REV HLTH SE; *HLTH EC FIN UN, 2004, PROP PUBL FIN ALL US; Jahan R, 2004, LANCET, V364, P742, DOI 10.1016/S0140-6736(04)16954-7; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Khan MM, 2001, HEALTH POLICY PLANN, V16, P264, DOI 10.1093/heapol/16.3.264; Kowalewski Marga, 2002, Afr J Reprod Health, V6, P65, DOI 10.2307/3583147; Kunst A. E., 2001, STUDIES HLTH SERV OR, V17, P297; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Macintyre K, 1999, SOC SCI MED, V49, P1473, DOI 10.1016/S0277-9536(99)00201-4; Macq J, 2001, HUM RESOUR HEALTH, V5, P17; Mason E, 2005, LANCET, V365, P1286, DOI 10.1016/S0140-6736(05)61005-7; MBUGUA JK, 1995, SOC SCI MED, V41, P829, DOI 10.1016/0277-9536(94)00400-N; MILLS A, 1983, EC HLTH DEV COUNTRIE, P64; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Murray SF, 1997, BIRTH-ISS PERINAT C, V24, P258, DOI 10.1111/j.1523-536X.1997.tb00600.x; NABYONGA J, HLTH POLICY PLAN, V20, P100; Nahar S, 1998, HEALTH POLICY PLANN, V13, P417, DOI 10.1093/heapol/13.4.417; NEUPANE BD, 2003, PERFORMANCE MANAGEME; OWA JA, 1995, TROP GEOGR MED, V47, P86; OWA JA, 1992, LANCET, V340, P732, DOI 10.1016/0140-6736(92)92273-I; *OXF, 2004, UND TEACH IMF POL SQ; Parkhurst JO, 2005, BMJ-BRIT MED J, V331, P510, DOI 10.1136/bmj.331.7515.510; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Pokhrel S, 2005, B WORLD HEALTH ORGAN, V83, P338; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Sandiford P, 2002, PUBLIC POLICY PRIVAT; SCHNEIDER H, 2000, REPROD HEALTH MATTER, V8, P55; Schneider P, 2006, HEALTH ECON, V15, P19, DOI 10.1002/hec.1014; SCHNEIDER P, 2001, PARTNERSHIPS HLTH RE; Shaw RP, 2002, TANZANIAS COMMUNITY; Shehu D, 1997, INT J GYNECOL OBSTET, V59, pS173, DOI 10.1016/S0020-7292(97)00163-X; SOMANATHAN A, 2003, SURVEY GROWTH DEV PR; SOMANATHAN A, 2005, CRITICAL ASSESSMENT; SOMANATHAN A, 2004, REV COSTS FINANCING; Soucat A, 1997, INT J HEALTH PLAN M, V12, pS81, DOI 10.1002/(SICI)1099-1751(199706)12:1+<S81::AID-HPM467>3.3.CO;2-X; Taylor C, 1993, World Health Stat Q, V46, P242; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations, 2002, REP INT C FIN DEV MO; WHO, 2005, MAK EV MOTH CHILD CO; Wilkinson D, 2001, B WORLD HEALTH ORGAN, V79, P665; *WORLD BANK, 1987, FIN HLTH SERV DEV CO; *WORLD BANK, 2006, POVERTYNET HOM; Xu Lingzhong, 2002, Aust Health Rev, V25, P15	76	171	171	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1457	1465		10.1016/S0140-6736(06)69383-5	http://dx.doi.org/10.1016/S0140-6736(06)69383-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	097PA	17055948				2022-12-28	WOS:000241459100034
J	Obermeyer, CM				Obermeyer, Carla Makhlouf			FHV in the Middle East	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV-INFECTION; SAUDI-ARABIA; PREVALENCE; HIV/AIDS; AIDS; EPIDEMIOLOGY; IRAN		WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	World Health Organization	Obermeyer, CM (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	obermeyerc@who.int						Al-Mazrou Y, 2005, ANN SAUDI MED, V25, P100, DOI 10.5144/0256-4947.2005.100; Ali S, 1996, AIDS STD Health Promot Exch, P13; Chemtob D, 2005, PUBLIC HEALTH, V119, P138, DOI 10.1016/j.puhe.2004.02.011; DeJong J, 2005, REPROD HEALTH MATTER, V13, P49, DOI 10.1016/S0968-8080(05)25181-9; El Feki S, 2006, LANCET, V367, P975, DOI 10.1016/S0140-6736(06)68409-2; Elmir E, 2002, INT J STD AIDS, V13, P839, DOI 10.1258/095646202321020125; ERSILIA F, 2002, MED LAW, V21, P381; Gheiratmand R, 2005, SEX TRANSM INFECT, V81, P279, DOI 10.1136/sti.2004.012880; Gray PB, 2004, SOC SCI MED, V58, P1751, DOI 10.1016/S0277-9536(03)00367-8; Hashim MSK, 1997, AIDS PATIENT CARE ST, V11, P331, DOI 10.1089/apc.1997.11.331; Heikel J, 1999, EUR J EPIDEMIOL, V15, P711, DOI 10.1023/A:1007639928462; Jahani MR, 2005, SEX TRANSM INFECT, V81, P185, DOI 10.1136/sti.2004.011114; Jenkins C, 2003, OVERVIEW HIV AIDS SI; Jurjus A R, 1998, J Med Liban, V46, P285; KALLAJIEH W, 2000, INT J INFECT DIS, V4, P209; KANDELA P, 1993, LANCET, V341, P298, DOI 10.1016/0140-6736(93)92637-9; KELLEY L, 2005, VEIL PUBLIC HLTH CRI; KHATTAB H, 2005, UNAIDS REG M WOM GIR; Lenton C, 1997, LANCET, V349, P1005, DOI 10.1016/S0140-6736(05)62906-6; Petro-Nustas Wasileh, 2002, J Transcult Nurs, V13, P118, DOI 10.1177/104365960201300204; Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17; *UNAIDS JOINT UN P, 2006, AIDS EP UPD 2006; Yassin K, 2001, AIDS, V15, P936, DOI 10.1097/00002030-200105040-00016; Zawawi TH, 1997, INFECT CONT HOSP EP, V18, P158	24	71	73	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					851	854		10.1136/bmj.38994.400370.7C	http://dx.doi.org/10.1136/bmj.38994.400370.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053246	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000241678500024
J	Elliott, T; Neefjes, J				Elliott, Tim; Neefjes, Jacques			The complex route to MHC class I-peptide complexes	CELL			English	Editorial Material								The loading of peptides into the groove of MHC class I molecules prior to antigen presentation is a complex process. In this issue of Cell, Park et al. (2006) show that peptide loading gets a helping hand from a resident ER enzyme called protein disulfide isomerase, a chaperone that has oxidoreductase activity.	Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England; Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	University of Southampton; Netherlands Cancer Institute	Elliott, T (corresponding author), Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England.	t.j.elliott@soton.ac.uk; j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Elliott, Tim/0000-0003-1097-0222				Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	6	9	9	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					249	251		10.1016/j.cell.2006.10.001	http://dx.doi.org/10.1016/j.cell.2006.10.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055423	Bronze			2022-12-28	WOS:000241827100009
J	Deng, M; Hochstrasser, M				Deng, Min; Hochstrasser, Mark			Spatially regulated ubiquitin ligation by an ER/nuclear membrane ligase	NATURE			English	Article							NUCLEAR-PORE COMPLEX; MAT-ALPHA-2 REPRESSOR; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; YEAST; RETICULUM; TRANSPORT; ARCHITECTURE; SYSTEM; ACTIN	The ubiquitin system targets many cellular proteins. Doa10 ( also known as Ssm4), a yeast transmembrane ubiquitin ligase (E3), resides in the endoplasmic reticulum ( ER), but it attaches ubiquitin to soluble proteins that concentrate in the nucleus. A central question is how nuclear substrates gain access to an enzyme in the ER. Here we show that Doa10 reaches the inner nuclear membrane. A subcomplex of nuclear pore subunits is important for this transport. Notably, another ER transmembrane E3, Hrd1 ( also known as Der3), cannot localize efficiently to the inner nuclear membrane. Tethering Doa10 at the cell periphery inhibits degradation of soluble nuclear substrates but not cytoplasmic ones. If Doa10 is released from these peripheral sites, localization of Doa10 to the nuclear envelope and degradation of its nuclear substrates are restored in parallel. Thus, localization of Doa10 to the inner nuclear membrane is necessary for nuclear substrate degradation. These data indicate that different membrane ubiquitin ligases are spatially sorted within the ER - nuclear envelope membrane system and that this differential localization contributes to their specificity.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484				Andrulis ED, 1998, NATURE, V395, P525, DOI 10.1038/26795; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Isaac C, 2001, J CELL SCI, V114, P4253; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101	34	128	130	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					827	831		10.1038/nature05170	http://dx.doi.org/10.1038/nature05170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051211				2022-12-28	WOS:000241362700044
J	Salgado, E				Salgado, Elena			WHO Director-General election: an agenda for the future	LANCET			English	Editorial Material									Minist Hlth & Consumer Affairs Spain, Madrid 28071, Spain		Salgado, E (corresponding author), Minist Hlth & Consumer Affairs Spain, Madrid 28071, Spain.	smsc@msc.es						*MIN SAND CONS, PROYECT ESTHER; *WHO, 2006, COMM SOC DET HLTH	2	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1311	1313		10.1016/S0140-6736(06)69535-4	http://dx.doi.org/10.1016/S0140-6736(06)69535-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046448				2022-12-28	WOS:000241388100009
J	Di Paolo, G; De Camilli, P				Di Paolo, Gilbert; De Camilli, Pietro			Phosphoinositides in cell regulation and membrane dynamics	NATURE			English	Review							PLECKSTRIN HOMOLOGY DOMAIN; BINDING; YEAST; KINASE; PTDINS(4,5)P-2; METABOLISM; PHOSPHATASES; RECOGNITION; MUTATIONS; MECHANISM		Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci,Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol,Program Cellular Neurosci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Pathol & Cell Biol, New York, NY 10032 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Columbia University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci,Howard Hughes Med Inst, New Haven, CT 06510 USA.	gd2175@columbia.edu; pietro.decamilli@yale.edu			NIDA NIH HHS [P30 DA018343] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Botelho RJ, 2004, CURR TOP MICROBIOL, V282, P1; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hammond G, 2004, CURR TOP MICROBIOL, V282, P177; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li SL, 2005, AM J HUM GENET, V77, P54, DOI 10.1086/431346; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ma L, 1998, J CELL BIOL, V140, P1125; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; MARTONE AL, 1964, J PROSTHET DENT, V14, P231, DOI 10.1016/0022-3913(64)90084-8; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MICHELL RH, 2005, TRENDS BIOCHEM SCI, P52; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Rothman JE, 1996, PROTEIN SCI, V5, P185; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	75	1952	1998	3	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					651	657		10.1038/nature05185	http://dx.doi.org/10.1038/nature05185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035995				2022-12-28	WOS:000241160500037
J	Herz, AVM; Gollisch, T; Machens, CK; Jaeger, D				Herz, Andreas V. M.; Gollisch, Tim; Machens, Christian K.; Jaeger, Dieter			Modeling single-neuron dynamics and computations: A balance of detail and abstraction	SCIENCE			English	Review							EARLY VISUAL-SYSTEM; RECEPTIVE-FIELDS; COINCIDENCE DETECTION; PYRAMIDAL NEURON; SPIKING NEURONS; GANGLION-CELL; PURKINJE-CELL; RELAY CELLS; INFORMATION; CORTEX	The fundamental building block of every nervous system is the single neuron. Understanding how these exquisitely structured elements operate is an integral part of the quest to solve the mysteries of the brain. Quantitative mathematical models have proved to be an indispensable tool in pursuing this goal. We review recent advances and examine how single-cell models on five levels of complexity, from black-box approaches to detailed compartmental simulations, address key questions about neural dynamics and signal processing.	Bernstein Ctr Computat Neurosci Berlin, D-10099 Berlin, Germany; Humboldt Univ, D-10099 Berlin, Germany; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Humboldt University of Berlin; Harvard University; Cold Spring Harbor Laboratory; Emory University	Herz, AVM (corresponding author), Bernstein Ctr Computat Neurosci Berlin, D-10099 Berlin, Germany.	a.herz@biologie.hu-berlin.de		Gollisch, Tim/0000-0003-3998-533X; Jaeger, Dieter/0000-0002-5122-1319; Machens, Christian/0000-0003-1717-1562				Adelman TL, 2003, NEURON, V40, P823, DOI 10.1016/S0896-6273(03)00680-9; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Aldworth ZN, 2005, J NEUROSCI, V25, P5323, DOI 10.1523/JNEUROSCI.0359-05.2005; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brecht M, 2004, J NEUROSCI, V24, P9223, DOI 10.1523/JNEUROSCI.3344-04.2004; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FISHER ME, 1983, LECT NOTES PHYS, V186, P1; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; GERSTNER W, 1992, NETWORK-COMP NEURAL, V3, P139, DOI 10.1088/0954-898X/3/2/004; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gollisch T, 2005, PLOS BIOL, V3, P144, DOI 10.1371/journal.pbio.0030008; Gollisch T, 2006, NETWORK-COMP NEURAL, V17, P103, DOI 10.1080/09548980600569670; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kepecs A, 2002, J NEUROSCI, V22, P9053; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Koch C., 1998, BIOPHYSICS COMPUTATI; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Kuznetsov AS, 2006, J NEUROPHYSIOL, V95, P932, DOI 10.1152/jn.00691.2004; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Machens CK, 2005, NEURON, V47, P447, DOI 10.1016/j.neuron.2005.06.015; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rainer G, 1999, J NEUROSCI, V19, P5493; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; Rall W, 1964, NEURAL THEORY MODELI, P73; Rhodes PA, 2005, J PHYSIOL-LONDON, V565, P765, DOI 10.1113/jphysiol.2004.070888; Rinzel J., 1989, METHODS NEURONAL MOD, P135; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Santamaria F, 2005, J NEUROPHYSIOL, V93, P237, DOI 10.1152/jn.00458.2004; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vervaeke K, 2006, NEURON, V49, P257, DOI 10.1016/j.neuron.2005.12.022; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	84	287	294	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					80	85		10.1126/science.1127240	http://dx.doi.org/10.1126/science.1127240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023649				2022-12-28	WOS:000241031200039
J	Kim, SV; Mehal, WZ; Dong, XM; Heinrich, V; Pypaert, M; Mellman, I; Dembo, M; Mooseker, MS; Wu, DQ; Flavell, RA				Kim, Sangwon V.; Mehal, Wajahat Z.; Dong, Xuemei; Heinrich, Volkmar; Pypaert, Marc; Mellman, Ira; Dembo, Micah; Mooseker, Mark S.; Wu, Dianqing; Flavell, Richard A.			Modulation of cell adhesion and motility in the immune system by Myo1f	SCIENCE			English	Article							MYOSIN-I; ENDOCYTOSIS; MIGRATION; MOVEMENT; STRATEGY; MUTANTS; GENE	Although class I myosins are known to play a wide range of roles, the physiological function of long-tailed class I myosins in vertebrates remains elusive. We demonstrated that one of these proteins, Myo1f, is expressed predominantly in the mammalian immune system. Cells from Myo1f-deficient mice exhibited abnormally increased adhesion and reduced motility, resulting from augmented exocytosis of beta 2 integrin - containing granules. Also, the cortical actin that co-localizes with Myo1f was reduced in Myo1f-deficient cells. In vivo, Myo1f-deficient mice showed increased susceptibility to infection by Listeria monocytogenes and an impaired neutrophil response. Thus, Myo1f directs immune cell motility and innate host defense against infection.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, New Haven, CT 06520 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Yale Univ, Dept Pathol, New Haven, CT 06511 USA; Yale Univ, Dept Mol Biol, New Haven, CT 06511 USA; Yale Univ, Dept Cellular Biol, New Haven, CT 06511 USA; Yale Univ, Dept Dev Biol, New Haven, CT 06511 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Ludwig Institute for Cancer Research; Yale University; University of Connecticut; Boston University; Yale University; Yale University; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Dembo, Micah/C-2755-2013; Mellman, Ira/ABG-5896-2020; Heinrich, Volkmar/D-1169-2009; Kim, Sangwon V./S-1166-2016	Heinrich, Volkmar/0000-0002-4932-5012; Kim, Sangwon V./0000-0001-8453-7080	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025387, K08DK002965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM072002, R01GM073823] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080706, R01 HL080706-10, R01 HL080706-11] Funding Source: Medline; NIDDK NIH HHS [R01 DK25387, K08 DK02965] Funding Source: Medline; NIGMS NIH HHS [R01 GM72002, R01 GM054597, R01 GM073823] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen AH, 2001, ARCH OTOLARYNGOL, V127, P921, DOI 10.1001/archotol.127.8.921; CONLAN JW, 1991, J EXP MED, V174, P741, DOI 10.1084/jem.174.3.741; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Redowicz MJ, 2002, ACTA BIOCHIM POL, V49, P789; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rogers HW, 1996, J IMMUNOL, V156, P679; SMITH CW, 2001, CLIN IMMUNOLOGY  PRI; STOFFLER HE, 1995, J CELL BIOL, V129, P819, DOI 10.1083/jcb.129.3.819; Swanson JA, 1999, J CELL SCI, V112, P307; Taki T, 2005, ONCOGENE, V24, P5191, DOI 10.1038/sj.onc.1208711; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Titus MA, 2000, J EUKARYOT MICROBIOL, V47, P191, DOI 10.1111/j.1550-7408.2000.tb00038.x; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406	27	82	83	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					136	139		10.1126/science.1131920	http://dx.doi.org/10.1126/science.1131920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023661				2022-12-28	WOS:000241031200054
J	Stanley, JR; Amagai, M				Stanley, John R.; Amagai, Masayuki			Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPIDERMOLYTIC TOXIN-A; REGULATORY T-CELLS; DESMOGLEIN 3; EXFOLIATIVE TOXIN; VULGARIS-IGG; CULTURED KERATINOCYTES; PLASMINOGEN-ACTIVATOR; IMMUNOELECTRON MICROSCOPY; PATHOGENIC AUTOANTIBODIES; FOLIACEUS AUTOANTIBODIES		Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan	University of Pennsylvania; Keio University	Stanley, JR (corresponding author), Univ Penn, Sch Med, Dept Dermatol, 211 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.		Li, Chia Cheng/D-9906-2015; Amagai, Masayuki/K-5325-2013	Amagai, Masayuki/0000-0003-3314-7052	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052672] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR052672] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; AMAGAI M, 1995, J INVEST DERMATOL, V104, P895, DOI 10.1111/1523-1747.ep12606168; Amagai M, 2000, J CLIN INVEST, V105, P625, DOI 10.1172/JCI8748; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Amagai M, 1999, BRIT J DERMATOL, V140, P351; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Aoki-Ota M, 2006, J INVEST DERMATOL, V126, P105, DOI 10.1038/sj.jid.5700016; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Arin MJ, 2005, BRIT J DERMATOL, V153, P620, DOI 10.1111/j.1365-2133.2005.06651.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Cavarelli J, 1997, STRUCTURE, V5, P813, DOI 10.1016/S0969-2126(97)00235-9; Cheng SW, 2002, BRIT J DERMATOL, V147, P261, DOI 10.1046/j.1365-2133.2002.04838.x; CRIBIER B, 1994, J AM ACAD DERMATOL, V30, P319, DOI 10.1016/S0190-9622(94)70032-X; DANCER SJ, 1990, FEBS LETT, V268, P129, DOI 10.1016/0014-5793(90)80990-Z; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; GORBSKY G, 1981, J CELL BIOL, V90, P243, DOI 10.1083/jcb.90.1.243; Hanakawa Y, 2004, J BIOL CHEM, V279, P5268, DOI 10.1074/jbc.M311087200; Hanakawa Y, 2003, J INVEST DERMATOL, V121, P383, DOI 10.1046/j.1523-1747.2003.12362.x; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; HASHIMOTO K, 1983, J EXP MED, V157, P259, DOI 10.1084/jem.157.1.259; Hertl M, 1998, J INVEST DERMATOL, V110, P388, DOI 10.1046/j.1523-1747.1998.00156.x; Hertl M, 1998, J INVEST DERMATOL, V110, P62, DOI 10.1046/j.1523-1747.1998.00086.x; Ishii K, 1997, J IMMUNOL, V159, P2010; Ito Yoichiro, 2002, Journal of Infection and Chemotherapy, V8, P256, DOI 10.1007/s10156-002-0175-9; KAPOSI M, 1887, PATHOLOGIE THERPIE H; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; KOUHI L, 1984, J EXP MED, V160, P1509; Ladhani S, 2001, CLIN MICROBIOL INFEC, V7, P301, DOI 10.1046/j.1198-743x.2001.00258.x; LEE CY, 1987, J BACTERIOL, V169, P3904, DOI 10.1128/jb.169.9.3904-3909.1987; Lin MS, 1997, J CLIN INVEST, V99, P31, DOI 10.1172/JCI119130; Mahoney MG, 1999, J INVEST DERMATOL, V113, P22, DOI 10.1046/j.1523-1747.1999.00632.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mascaro JM, 1997, CLIN IMMUNOL IMMUNOP, V85, P90, DOI 10.1006/clin.1997.4408; MELISH ME, 1972, J INFECT DIS, V125, P129, DOI 10.1093/infdis/125.2.129; MELISH ME, 1970, NEW ENGL J MED, V282, P1114, DOI 10.1056/NEJM197005142822002; MORIOKA S, 1987, J INVEST DERMATOL, V89, P474, DOI 10.1111/1523-1747.ep12460937; Nagasaka T, 2004, J CLIN INVEST, V114, P1484, DOI 10.1172/JCI200420480; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; OSIANDER FB, 1794, DENKWURDKEITEN HEILK; OTOOLE PW, 1987, J BACTERIOL, V169, P3910, DOI 10.1128/jb.169.9.3910-3915.1987; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; ROCK B, 1990, J CLIN INVEST, V85, P296, DOI 10.1172/JCI114426; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAMS WM, 1971, BRIT J DERMATOL, V84, P7; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Schmidt E, 2005, BRIT J DERMATOL, V153, P449, DOI 10.1111/j.1365-2133.2005.06740.x; Shirakata Y, 1998, J INVEST DERMATOL, V110, P76, DOI 10.1046/j.1523-1747.1998.00085.x; Shu E, 2005, J DERMATOL SCI, V40, P209, DOI 10.1016/j.jdermsci.2005.09.001; STANLEY JR, 2003, FITZPATRICKS DERMATO, P558; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Tsunoda K, 2002, EUR J IMMUNOL, V32, P627, DOI 10.1002/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Veldman C, 2004, J IMMUNOL, V172, P6468, DOI 10.4049/jimmunol.172.10.6468; Veldman CM, 2004, J IMMUNOL, V172, P3883, DOI 10.4049/jimmunol.172.6.3883; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Wu H, 2000, NEW ENGL J MED, V343, P31, DOI 10.1056/NEJM200007063430105; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935; Yamaguchi T, 2002, J INFECT DIS, V185, P1511, DOI 10.1086/340212	76	292	302	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1800	1810		10.1056/NEJMra061111	http://dx.doi.org/10.1056/NEJMra061111			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065642				2022-12-28	WOS:000241512500009
J	Pearson, J				Pearson, Joanna			The thought of a book	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												joanna_pearson@jhmi.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1943	1944		10.1001/jama.296.16.1943	http://dx.doi.org/10.1001/jama.296.16.1943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062850				2022-12-28	WOS:000241495300001
J	Hawkesworth, CJ; Kemp, AIS				Hawkesworth, C. J.; Kemp, A. I. S.			Evolution of the continental crust	NATURE			English	Review							HF-ISOTOPE EVIDENCE; U-PB; DETRITAL ZIRCONS; OXYGEN ISOTOPES; DEPLETED MANTLE; GROWTH; HAFNIUM; ND; CONSTRAINTS; SUBDUCTION	The continental crust covers nearly a third of the Earth's surface. It is buoyant - being less dense than the crust under the surrounding oceans - and is compositionally evolved, dominating the Earth's budget for those elements that preferentially partition into silicate liquid during mantle melting. Models for the differentiation of the continental crust can provide insights into how and when it was formed, and can be used to show that the composition of the basaltic protolith to the continental crust is similar to that of the average lower crust. From the late Archaean to late Proterozoic eras ( some 3 - 1 billion years ago), much of the continental crust appears to have been generated in pulses of relatively rapid growth. Reconciling the sedimentary and igneous records for crustal evolution indicates that it may take up to one billion years for new crust to dominate the sedimentary record. Combining models for the differentiation of the crust and the residence time of elements in the upper crust indicates that the average rate of crust formation is some 2 - 3 times higher than most previous estimates.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; James Cook Univ N Queensland, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	University of Bristol; James Cook University	Hawkesworth, CJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	c.j.hawkesworth@bristol.ac.uk	Facility, Edinburgh Ion Microprobe/AAD-8512-2020; Kemp, Anthony/H-5179-2014	Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657; Kemp, Anthony/0000-0003-1642-0360				Albarede F, 1998, TECTONOPHYSICS, V296, P1, DOI 10.1016/S0040-1951(98)00133-4; ALBAREDE F, 1987, EARTH PLANET SC LETT, V82, P25, DOI 10.1016/0012-821X(87)90104-X; ALLEGRE CJ, 1984, EARTH PLANET SC LETT, V67, P19, DOI 10.1016/0012-821X(84)90035-9; ALLEGRE CJ, 1989, EARTH PLANET SC LETT, V96, P61, DOI 10.1016/0012-821X(89)90124-6; Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; Annen C, 2002, EARTH PLANET SC LETT, V203, P937, DOI 10.1016/S0012-821X(02)00929-9; Arculus R.J., 1999, J P ROYAL SOC NEW S, V132, P83; ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; ARNDT NT, 1989, TECTONOPHYSICS, V161, P201, DOI 10.1016/0040-1951(89)90154-6; Barth MG, 2000, CHEM GEOL, V165, P197, DOI 10.1016/S0009-2541(99)00173-4; Bergaruz G. W., 1994, MAGMATIC SYSTEMS, V57, P291; Blichert-Toft J, 1999, GEOCHIM COSMOCHIM AC, V63, P3901, DOI 10.1016/S0016-7037(99)00183-0; Bodet F, 2000, GEOCHIM COSMOCHIM AC, V64, P2067, DOI 10.1016/S0016-7037(00)00352-5; BOHER M, 1992, J GEOPHYS RES-SOL EA, V97, P345, DOI 10.1029/91JB01640; BOWRING SA, 1995, SCIENCE, V269, P1535, DOI 10.1126/science.7667634; Clift P, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000127; Collerson KD, 1999, SCIENCE, V283, P1519, DOI 10.1126/science.283.5407.1519; Condie K.C, 1994, ARCHEAN CRUSTAL EVOL, V11, P85, DOI DOI 10.1016/S0166-2635(08)70221-4; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Condie KC, 2005, PRECAMBRIAN RES, V139, P42, DOI 10.1016/j.precamres.2005.04.006; DAVIES G, 1985, EARTH PLANET SC LETT, V75, P1, DOI 10.1016/0012-821X(85)90045-7; Davies GF, 1995, EARTH PLANET SC LETT, V136, P363, DOI 10.1016/0012-821X(95)00167-B; ELLAM RM, 1988, GEOLOGY, V16, P314, DOI 10.1130/0091-7613(1988)016<0314:IACCGA>2.3.CO;2; Elliott T, 2004, EARTH PLANET SC LETT, V220, P231, DOI 10.1016/S0012-821X(04)00096-2; FYFE WS, 1978, CHEM GEOL, V23, P89, DOI 10.1016/0009-2541(78)90068-2; Griffin WL, 2004, PRECAMBRIAN RES, V131, P231, DOI 10.1016/j.precamres.2003.12.011; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; Hawkesworth CJ, 2006, CHEM GEOL, V226, P144, DOI 10.1016/j.chemgeo.2005.09.018; Hawkesworth CJ, 2006, CHEM GEOL, V226, P134, DOI 10.1016/j.chemgeo.2005.09.017; Hawkesworth CJ, 1997, SCIENCE, V276, P551, DOI 10.1126/science.276.5312.551; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HURLEY PM, 1969, SCIENCE, V164, P1229, DOI 10.1126/science.164.3885.1229; Ireland TR, 2003, REV MINERAL GEOCHEM, V53, P215, DOI 10.2113/0530215; JACOBSEN SB, 1979, J GEOPHYS RES, V84, P7411, DOI 10.1029/JB084iB13p07411; Jaupart C., 2003, TREATISE GEOCHEMISTR, V3, P65, DOI [10.1016/B0-08-043751-6/03020-6, DOI 10.1016/B0-08-043751-6/03020-6, DOI 10.1016/B0-08-043751-6/03017-6]; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; KAY RW, 1991, GEOL RUNDSCH, V80, P259, DOI 10.1007/BF01829365; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Kemp A.I.S., 2003, TREATISE GEOCHEM, V3.11, P349, DOI 10.1016/B0-08-043751-6/03027-9; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; Knudsen TL, 2001, CONTRIB MINERAL PETR, V141, P83, DOI 10.1007/s004100000220; Kramers JD, 2002, GEOL SOC SPEC PUBL, V199, P259, DOI 10.1144/GSL.SP.2002.199.01.13; Kramers JD, 1997, CHEM GEOL, V139, P75, DOI 10.1016/S0009-2541(97)00027-2; Lowe DR, 2004, GEOLOGY, V32, P493, DOI 10.1130/G20342.1; Martin H., 1994, ARCHEAN CRUSTAL EVOL, V11, P205, DOI DOI 10.1016/S0166-2635(08)70224-X; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P4717, DOI 10.1016/0016-7037(94)90203-8; McLennan SM, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000gc000109; MOORBATH S, 1978, PHILOS T R SOC A, V288, P401, DOI 10.1098/rsta.1978.0024; Moorbath S, 1997, CHEM GEOL, V135, P213, DOI 10.1016/S0009-2541(96)00117-9; Moore VM, 2004, TECTONICS, V23, DOI 10.1029/2002TC001430; ONIONS RK, 1983, EARTH PLANET SC LETT, V63, P229, DOI 10.1016/0012-821X(83)90039-0; ONIONS RK, 1979, J GEOPHYS RES, V84, P6091, DOI 10.1029/JB084iB11p06091; PATCHETT PJ, 1981, CONTRIB MINERAL PETR, V78, P279; Petford N, 1996, J PETROL, V37, P1491, DOI 10.1093/petrology/37.6.1491; Plank T, 2005, J PETROL, V46, P921, DOI 10.1093/petrology/egi005; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; RAPP RP, 1995, J PETROL, V36, P891, DOI 10.1093/petrology/36.4.891; REYMER A, 1984, TECTONICS, V3, P63, DOI 10.1029/TC003i001p00063; RUDNICK R, 1990, NATURE, V347, P711, DOI 10.1038/347711a0; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; STEIN M, 1994, NATURE, V372, P63, DOI 10.1038/372063a0; Storey CD, 2006, CHEM GEOL, V227, P37, DOI 10.1016/j.chemgeo.2005.09.003; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; Taylor S.R., 1985, CONTINENTAL CRUST IT; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Turner SP, 2000, PHILOS T ROY SOC A, V358, P1443, DOI 10.1098/rsta.2000.0598; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; VALLEY JW, 1994, EARTH PLANET SC LETT, V126, P187, DOI 10.1016/0012-821X(94)90106-6; Vervoort JD, 1996, GEOCHIM COSMOCHIM AC, V60, P3717, DOI 10.1016/0016-7037(96)00201-3; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Vervoort JD, 1996, NATURE, V379, P624, DOI 10.1038/379624a0; Vervoort JD, 2000, EARTH PLANET SC LETT, V181, P115, DOI 10.1016/S0012-821X(00)00170-9; VONHUENE R, 1991, REV GEOPHYS, V29, P279, DOI 10.1029/91RG00969; VOSHAGE H, 1990, NATURE, V347, P731, DOI 10.1038/347731a0; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Zandt G, 2004, NATURE, V431, P41, DOI 10.1038/nature02847	78	461	497	3	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					811	817		10.1038/nature05191	http://dx.doi.org/10.1038/nature05191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051208				2022-12-28	WOS:000241362700041
J	Roberts, LM; Pattison, H; Roalfe, A; Franklyn, J; Wilson, S; Hobbs, R; Parle, JV				Roberts, Lesley M.; Pattison, Helen; Roalfe, Andrea; Franklyn, Jayne; Wilson, Sue; Hobbs, Richard; Parle, James V.			Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?	ANNALS OF INTERNAL MEDICINE			English	Article							L-THYROXINE TREATMENT; MINI-MENTAL STATE; MAJOR DEPRESSION; HOSPITAL ANXIETY; HYPOTHYROIDISM; POPULATION; SYMPTOMS; DISEASE; ADULTS; MANAGEMENT	Background: Widespread use of automated sensitive assays for thyroid hormones and thyroid-stimulating hormone (TSH) has increased identification of mild thyroid dysfunction, especially in elderly patents. The clinical significance of this dysfunction, however, remains uncertain, and associations with cognitive impairment, depression, and anxiety are unconfirmed. Objective: To determine the association between mild thyroid dysfunction and cognition, depression, and anxiety in elderly persons. Design: Cross-sectional study. Associations were explored through mixed-model analyses. Setting: Primary care practices in central England. Patients: 5865 patients 65 years of age or older with no known thyroid disease who were recruited from primary care registers. Measurements: Serum TSH and free thyroxine (T-4) were measured. Depression and anxiety were assessed by using the Hospital Anxiety and Depression Scale (HADS), and cognitive functioning was established by using the Middlesex Elderly Assessment of Mental State and the Folstein Mini-Mental State Examination. Comorbid conditions, medication use, and sociodemographic profiles were recorded. Results: 295 patients met the criteria for subclinical thyroid dysfunction (127 were hyperthyroid, and 168 were hypothyroid). After confounding variables were controlled for, statistically significant associations were seen between anxiety (HADS score) and TSH level (P = 0.013) and between cognition and both TSH and free T-4 levels. The magnitude of these associations lacked clinical relevance: A 50-mlU/L increase in the TSH level was associated with a 1-point reduction in the HADS anxiety score, and a 1-point increase in the Mini-Mental State Examination score was associated with an increase of 50 mlU/L in the TSH level or 25 pmol/L in the free T-4 level. Limitations: Because of the low participation rate, low prevalence of subclinical thyroid dysfunction, and other unidentified recruitment biases, participants may not be representative of the elderly population. Conclusions: After the confounding effects of comorbid conditions and use of medication were controlled for, subclinical thyroid dysfunction was not associated with depression, anxiety, or cognition.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Roberts, LM (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	l.m.roberts@bham.ac.uk	Pattison, Helen/D-2702-2009	Pattison, Helen/0000-0002-9483-4342; hobbs, richard/0000-0001-7976-7172				Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Bono G, 2004, ACTA NEUROL SCAND, V110, P59, DOI 10.1111/j.1600-0404.2004.00262.x; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brown ES, 1998, HARVARD REV PSYCHIAT, V5, P239, DOI 10.3109/10673229809000307; Efron B., 1994, MONOGRAPHS STAT APPL; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gharib H, 2005, THYROID, V15, P24, DOI 10.1089/thy.2005.15.24; GIFT AG, 1989, INT J NURS STUD, V26, P281, DOI 10.1016/0020-7489(89)90009-6; Golding E., 1989, MIDDLESEX ELDERLY AS; Gonen MS, 2004, ENDOCR J, V51, P311, DOI 10.1507/endocrj.51.311; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; HAGGERTY JJ, 1993, AM J PSYCHIAT, V150, P508; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; Lloyd, 2004, ENGLISH INDICES DEPR; Luboshitzky R, 1996, ISRAEL J MED SCI, V32, P60; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; *OFF NAT STAT, 2001, CENS NAT REP ENG WAL; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Patten SB, 2005, CAN J PSYCHIAT, V50, P195, DOI 10.1177/070674370505000402; Ringel MD, 2005, J CLIN ENDOCR METAB, V90, P588, DOI 10.1210/jc.2004-2173; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stern RA, 1995, COMPREHENSIVE TXB PS, P241; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; van Boxtel MPJ, 2004, PSYCHONEUROENDOCRINO, V29, P891, DOI 10.1016/j.psyneuen.2003.08.002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	174	179	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					573	581		10.7326/0003-4819-145-8-200610170-00006	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	095NX	17043339				2022-12-28	WOS:000241315700003
J	Monneuse, O; Al-Ahmadi, K; Ahmed, N				Monneuse, Olivier; Al-Ahmadi, Kalhed; Ahmed, Najma			The case of a migrating bullet	LANCET			English	Editorial Material									Univ Toronto, St Michaels Hosp, Dept Gen Surg, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Trauma Program, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ahmed, N (corresponding author), Univ Toronto, St Michaels Hosp, Dept Gen Surg, 30 Bond St 3Q-073, Toronto, ON M5B 1W8, Canada.	AhmedN@smh.toronto.on.ca						Bertoldo U, 2004, J TRAUMA, V57, P187, DOI 10.1097/01.TA.0000135490.10227.5C; Bett N, 2004, Heart, V90, P1298, DOI 10.1136/hrt.2004.037804; Kalimi R, 2002, J TRAUMA, V52, P772, DOI 10.1097/00005373-200204000-00030; Ronsivalle J, 2005, MIL MED, V170, P1044, DOI 10.7205/MILMED.170.12.1044	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1392	1392		10.1016/S0140-6736(06)69563-9	http://dx.doi.org/10.1016/S0140-6736(06)69563-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046472				2022-12-28	WOS:000241388100036
J	Clary, DC				Clary, David C.			Quantum chemistry of complex systems	SCIENCE			English	Editorial Material							DENSITY FITTING APPROXIMATIONS; 1ST-PRINCIPLES CALCULATIONS; CONICAL INTERSECTION; AMMONIA-SYNTHESIS; SCATTERING		Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England	University of Oxford	Clary, DC (corresponding author), Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England.	david.clary@chem.ox.ac.uk	Clary, David C/AAC-3903-2019	Clary, David C/0000-0003-4439-741X				Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Boggio-Pasqua M, 2005, J PHYS CHEM A, V109, P8849, DOI 10.1021/jp053354r; Dirac PAM, 1929, P R SOC LOND A-CONTA, V123, P714, DOI 10.1098/rspa.1929.0094; Gomez I, 2006, J PHYS CHEM A, V110, P3986, DOI 10.1021/jp056208u; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Hellman A, 2006, J PHYS CHEM B, V110, P17719, DOI 10.1021/jp056982h; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Hrenar T, 2006, J PHYS CHEM A, V110, P2060, DOI 10.1021/jp055578f; Kerkeni BN, 2006, PHYS CHEM CHEM PHYS, V8, P917, DOI 10.1039/b514563p; Philipsen PHT, 2006, J PHYS CHEM B, V110, P12470, DOI 10.1021/jp060886e; Schrodinger E, 1926, ANN PHYS-BERLIN, V79, P361, DOI 10.1002/andp.19263840404; Schutz M, 2004, J CHEM PHYS, V121, P737, DOI 10.1063/1.1760747; Werner HJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2150817; 2006, S 1 EUR CHEM C BUD H	14	15	15	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					265	266		10.1126/science.1133434	http://dx.doi.org/10.1126/science.1133434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038614				2022-12-28	WOS:000241194100031
J	van Dam, JA; Aziz, HA; Sierra, MAA; Hilgen, FJ; Ostende, LWVDH; Lourens, LJ; Mein, P; van der Meulen, AJ; Pelaez-Campomanes, P				van Dam, Jan A.; Abdul Aziz, Hayfaa; Sierra, M. Angeles Alvarez; Hilgen, Frederik J.; Ostende, Lars W. van den Hoek; Lourens, Lucas J.; Mein, Pierre; van der Meulen, Albert J.; Pelaez-Campomanes, Pablo			Long-period astronomical forcing of mammal turnover	NATURE			English	Article							LATE MIOCENE; CONTINENTAL SEQUENCES; MIDDLE MIOCENE; CLIMATE; STRATIGRAPHY; EVOLUTION; RECORD	Mammals are among the fastest-radiating groups, being characterized by a mean species lifespan of the order of 2.5 million years (Myr)(1,2). The basis for this characteristic timescale of origination, extinction and turnover is not well understood. Various studies have invoked climate change to explain mammalian species turnover(3,4), but other studies have either challenged or only partly confirmed the climate-turnover hypothesis(5-7). Here we use an exceptionally long (24.5-2.5 Myr ago), dense, and well-dated terrestrial record of rodent lineages from central Spain, and show the existence of turnover cycles with periods of 2.4-2.5 and 1.0 Myr. We link these cycles to low-frequency modulations of Milankovitch oscillations(8), and show that pulses of turnover occur at minima of the 2.37-Myr eccentricity cycle and nodes of the 1.2-Myr obliquity cycle. Because obliquity nodes and eccentricity minima are associated with ice sheet expansion and cooling and affect regional precipitation, we infer that long-period astronomical climate forcing is a major determinant of species turnover in small mammals and probably other groups as well.	Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Univ Complutense, Fac Geol, Dept Palaeontol, E-28040 Madrid, Spain; Natl Museum Nat Hist, NL-2333 CR Leiden, Netherlands; Univ Lyon 1, Fac Earth Sci, F-69622 Villeurbanne, France; CSIC, Natl Museum Nat Hist, E-28006 Madrid, Spain	Utrecht University; Complutense University of Madrid; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consejo Superior de Investigaciones Cientificas (CSIC)	van Dam, JA (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	jdam@geo.uu.nl	Peláez-Campomanes, Pablo/G-4561-2010; van Dam, Jan/B-9420-2012; van den Hoek Ostende, Lars W./E-7054-2010	Peláez-Campomanes, Pablo/0000-0002-6551-1026; van Dam, Jan/0000-0002-2748-3722; Hilgen, Frits/0000-0002-5683-259X				Abels HA, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001129; Alonso-Zarza AM, 2000, PALAEOGEOGR PALAEOCL, V160, P1, DOI 10.1016/S0031-0182(00)00041-9; Alroy J, 2000, PALEOBIOLOGY, V26, P259, DOI 10.1666/0094-8373(2000)26[259:GCCANA]2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Aziz HA, 2004, EARTH PLANET SC LETT, V222, P243, DOI 10.1016/j.epsl.2004.02.018; Aziz HA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001818; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Bennett, 1997, EVOLUTION ECOLOGY PA; Daams R, 1999, NEWSL STRATIGR, V37, P103; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Heslop D, 2002, PHYS EARTH PLANET IN, V130, P103, DOI 10.1016/S0031-9201(01)00310-7; Hilgen FJ, 2003, PALAEOGEOGR PALAEOCL, V199, P229, DOI 10.1016/S0031-0182(03)00505-4; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LEROY S, 1994, PALAEOGEOGR PALAEOCL, V109, P295, DOI 10.1016/0031-0182(94)90181-3; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Lourens LJ, 1997, QUATERN INT, V40, P43, DOI 10.1016/S1040-6182(96)00060-2; Mein P., 1990, PALEONTOL EVOLUCIO, V23, P121; Prothero DR, 1996, PALAEOGEOGR PALAEOCL, V127, P257, DOI 10.1016/S0031-0182(96)00099-5; Sheldon PR, 1996, PALAEOGEOGR PALAEOCL, V127, P209, DOI 10.1016/S0031-0182(96)00096-X; Tuenter E., 2004, THESIS UTRECHT U; Turco E, 2001, PALEOCEANOGRAPHY, V16, P405, DOI 10.1029/2000PA000509; van Dam JA, 1999, PALAEOGEOGR PALAEOCL, V151, P267, DOI 10.1016/S0031-0182(99)00015-2; van Dam JA, 2004, J PALEONTOL, V78, P741, DOI 10.1666/0022-3360(2004)078<0741:AMSFTM>2.0.CO;2; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Vrba ES, 2004, PHILOS T R SOC B, V359, P285, DOI 10.1098/rstb.2003.1397; Wade BS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001042; Westerhold T, 2005, PALAEOGEOGR PALAEOCL, V217, P205, DOI 10.1016/j.palaeo.2004.12.001; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	30	198	204	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					687	691		10.1038/nature05163	http://dx.doi.org/10.1038/nature05163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036002	Green Accepted			2022-12-28	WOS:000241160500045
J	Garcia-Moreno, C; Jansen, HAFM; Ellsberg, M; Heise, L; Watts, CH				Garcia-Moreno, Claudia; Jansen, Henrica A. F. M.; Ellsberg, Mary; Heise, Lori; Watts, Charlotte H.		WHO Multi-Country Study Wo	Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence	LANCET			English	Article							CONFLICT; ABUSE	Background Violence against women is a serious human rights abuse and public health issue. Despite growing evidence Of the size of the problem, current evidence comes largely from industrialised settings, and methodological differences limit the extent to which comparisons can be made between studies. We aimed to estimate the extent of physical and sexual intimate partner violence against women in 15 sites in ten countries: Bangladesh, Brazil, Ethiopia, Japan, Namibia, Peru, Samoa, Serbia and Montenegro, Thailand, and the United Republic of Tanzania. Methods Standardised population-based household surveys were done between 2000 and 2003. Women aged 15-49 years were interviewed and those who had ever had a male partner were asked in private about their experiences of physically and sexually violent and emotionally abusive acts. Findings 24097 women completed interviews, with around 1500 interviews per site. The reported lifetime prevalence of physical or sexual partner violence, or both, varied from 15% to 71%, with two sites having a prevalence of less than 25%, seven between 25% and 50%, and six between 50% and 75%. Between 4% and 54% of respondents reported physical or sexual partner violence, or both, in the past year. Men who were more controlling were more likely to be violent against their partners. In all but one setting women were at far greater risk of physical or sexual violence by a partner than from violence by other people. interpretation The findings confirm that physical and sexual partner violence against women is widespread. The variation in prevalence within and between settings highlights that this violence in not inevitable, and must be addressed.	WHO, Dept Gender Women & Hlth, CH-1211 Geneva 27, Switzerland; Path, Washington, DC USA; London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Garcia-Moreno, C (corresponding author), WHO, Dept Gender Women & Hlth, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	garciamorenoc@who.int	Heise, LORI/AAI-6251-2020; Franca-Junior, Ivan/C-4110-2012	Franca-Junior, Ivan/0000-0002-7004-7301				Alvazzi del Frate Anna, 1998, UN INTERREGIONAL CRI, V57; [Anonymous], 1995, 4 WORLD C WOM BEIJ C; [Anonymous], 1999, ENDING VIOLENCE WOME; Archer J, 2006, PERS SOC PSYCHOL REV, V10, P133, DOI 10.1207/s15327957pspr1002_3; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Campbell J., 2002, LANCET, V359, P1509; Canadian Centre for Justice Statistics, 2005, FAM VIOL CAN STAT PR; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; DEAN A, 1995, EPI INFO VERSION 6 W; Ellsberg M, 2000, SOC SCI MED, V51, P1595, DOI 10.1016/S0277-9536(00)00056-3; Ellsberg M, 2002, LANCET, V359, P1599, DOI 10.1016/S0140-6736(02)08521-5; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Ellsberg MC, 1999, AM J PUBLIC HEALTH, V89, P241, DOI 10.2105/AJPH.89.2.241; Fanslow Janet, 2004, N Z Med J, V117, pU1173; Garcia -Moreno C, 2003, HLTH HUMAN RIGHTS J, V6, P112; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; HAKIMI M, 2002, SILENCE SAKE HARMONY; Hassan Fatma, 2004, Inj Control Saf Promot, V11, P111, DOI 10.1080/15660970412331292333; Heise L., 2002, WORLD REPORT VIOLENC; Heise LL, 1996, SAGE VIOL WOMEN, V3, P7; Jansen HAFM, 2004, VIOLENCE AGAINST WOM, V10, P831, DOI 10.1177/1077801204265554; Joachim Jutta, 1999, GENDER POLITICS GLOB, P142; Johnson H., 1996, DANGEROUS DOMAINS VI; JOHNSON MP, 2000, COUPLES CONFLICT; Jones AS, 1999, WOMEN HEALTH ISS, V9, P295; Kishor S., 2004, PROFILING DOMESTIC V; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Tjaden P, 2000, EXTENT NATURE CONSEQ; *TOK SUR KENK, 1999, RES REP GEN SER, V83; Walby S., 2004, HOME OFFICE RES STUD; Watts C., 2002, HLTH POLICY GLOBALIS, P159; World Health Organization, 2001, WHOFCHGWH011; World Health Organization (WHO), 2004, WHO MULT STUD WOM HL	34	1899	1956	5	346	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1260	1269		10.1016/S0140-6736(06)69523-8	http://dx.doi.org/10.1016/S0140-6736(06)69523-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091WF	17027732				2022-12-28	WOS:000241058300033
J	Cui, LB; Jeong, H; Borovecki, F; Parkhurst, CN; Tanese, N; Krainc, D				Cui, Libin; Jeong, Hyunkyung; Borovecki, Fran; Parkhurst, Christopher N.; Tanese, Naoko; Krainc, Dimitri			Transcriptional repression of PGC-alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration	CELL			English	Article							ENERGY-METABOLISM; MOUSE MODEL; STRIATAL NEURONS; DISEASE; EXPRESSION; DEFECTS; SUSCEPTIBILITY; COACTIVATOR; PGC-1-ALPHA; DISRUPTION	Huntington's disease (HID) is an inherited neurodegenerative disease caused by a glutamine repeat expansion in huntingtin protein. Transcriptional deregulation and altered energy metabolism have been implicated in HID pathogenesis. We report here that mutant huntingtin causes disruption of mitochondrial function by inhibiting expression of PGC-1 alpha, a transcriptional coactivator that regulates several metabolic processes, including mitochondrial biogenesis and respiration. Mutant huntingtin represses PGC-1 alpha gene transcription by associating with the promoter and interfering with the CREB/TAF4-dependent transcriptional pathway critical for the regulation of PGC-1 alpha gene expression. Crossbreeding of PGC-1 alpha knockout (KO) mice with HID knockin (KI) mice leads to increased neurodegeneration of striatal neurons and motor abnormalities in the HID mice. Importantly, expression of PGC-1 alpha partially reverses the toxic effects of mutant huntingtin in cultured striatal neurons. Moreover, lentiviral-mediated delivery of PGC-1 alpha in the striatum provides neuroprotection in the transgenic HID mice. These studies suggest a key role for PGC-1 alpha in the control of energy metabolism in the early stages of HID pathogenesis.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; New York University	Cui, LB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu		Tanese, Naoko/0000-0002-1946-3211	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050352, P01NS045242] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS050352, P01NS045242] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Furukawa T, 2000, J BIOL CHEM, V275, P29847, DOI 10.1074/jbc.M002989200; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Koroshetz WJ, 1997, ANN NEUROL, V41, P160, DOI 10.1002/ana.410410206; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; SANDOVAL J, 2004, NUCLEIC ACIDS RES, V32, P1; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Takahashi Y, 2000, GENE DEV, V14, P804; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	42	787	798	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					59	69		10.1016/j.cell.2006.09.015	http://dx.doi.org/10.1016/j.cell.2006.09.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018277	Bronze			2022-12-28	WOS:000241445800014
J	Lin, JN				Lin, Jil-Nong			Yellow palms and soles in diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Paochien Hosp, Pingtung 900, Taiwan		Lin, JN (corresponding author), Paochien Hosp, Pingtung 900, Taiwan.	jiunong.lin@msa.hinet.net							0	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1486	1486		10.1056/NEJMicm050780	http://dx.doi.org/10.1056/NEJMicm050780			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021324				2022-12-28	WOS:000240976200010
J	Hwang, HY				Hwang, Harold Y.			Tuning interface states	SCIENCE			English	Editorial Material									Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; Univ Tokyo, Dept Appl Phys, Chiba 2778561, Japan	University of Tokyo; University of Tokyo	Hwang, HY (corresponding author), Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan.	hyhwang@k.u-tokyo.ac.jp	Hwang, Harold Y/I-6943-2012					BARAFF GA, 1977, PHYS REV LETT, V38, P237, DOI 10.1103/PhysRevLett.38.237; HARRISON WA, 1978, PHYS REV B, V18, P4402, DOI 10.1103/PhysRevB.18.4402; Huijben M, 2006, NAT MATER, V5, P556, DOI 10.1038/nmat1675; KALABUKHOV AS, ORGCONDMAT0603501; KROEMER H, 1987, J CRYST GROWTH, V81, P193, DOI 10.1016/0022-0248(87)90391-5; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; SIEMONS W, ORGCONDMAT0603598; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867	10	72	74	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1895	1896		10.1126/science.1133138	http://dx.doi.org/10.1126/science.1133138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008513				2022-12-28	WOS:000240832200031
J	Kraft, ML; Weber, PK; Longo, ML; Hutcheon, ID; Boxer, SG				Kraft, Mary L.; Weber, Peter K.; Longo, Marjorie L.; Hutcheon, Ian D.; Boxer, Steven G.			Phase separation of lipid membranes analyzed with high-resolution secondary ion mass spectrometry	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; DOMAIN FORMATION; CHOLESTEROL; BILAYERS; RAFTS; CELL; PHOSPHOLIPIDS; TRANSITIONS; MIXTURES	Lateral variations in membrane composition are postulated to play a central role in many cellular events, but it has been difficult to probe membrane composition and organization on length scales of tens to hundreds of nanometers. We present a high-resolution imaging secondary ion mass spectrometry technique to reveal the lipid distribution within a phase-separated membrane with a lateral resolution of similar to 100 nanometers. Quantitative information about the chemical composition within small lipid domains was obtained with the use of isotopic labels to identify each molecular species. Composition variations were detected within some domains.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; Lawrence Livermore Natl Lab, Biosecur & Nanosci Lab, Livermore, CA 94551 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050; Boxer, Steven/0000-0001-9167-4286	NIGMS NIH HHS [GM06930] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchette CD, 2006, BIOPHYS J, V90, P4466, DOI 10.1529/biophysj.105.072744; Bourdos N, 2000, BIOPHYS J, V79, P357, DOI 10.1016/S0006-3495(00)76297-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Burns AR, 2003, LANGMUIR, V19, P8358, DOI 10.1021/la030175x; Drees Frauke, 2004, V294, P303; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Frolov VAJ, 2006, BIOPHYS J, V91, P189, DOI 10.1529/biophysj.105.068502; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; IPSEN JH, 1988, BIOCHIM BIOPHYS ACTA, V944, P121, DOI 10.1016/0005-2736(88)90425-7; JACOBS RE, 1977, BIOCHEMISTRY-US, V16, P4349, DOI 10.1021/bi00639a004; Kahya N, 2004, J STRUCT BIOL, V147, P77, DOI 10.1016/j.jsb.2003.09.021; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Lin WC, 2006, BIOPHYS J, V90, P228, DOI 10.1529/biophysj.105.067066; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Marxer CG, 2005, BIOPHYS J, V88, P2965, DOI 10.1529/biophysj.104.057257; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Pacholski ML, 1999, J AM CHEM SOC, V121, P4716, DOI 10.1021/ja983022i; Perez JB, 2006, ADV FUNCT MATER, V16, P306, DOI 10.1002/adfm.200500236; Peteranderl R, 2004, J AM SOC MASS SPECTR, V15, P478, DOI 10.1016/j.jasms.2003.11.019; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Ratto TV, 2002, BIOPHYS J, V83, P3380, DOI 10.1016/S0006-3495(02)75338-1; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sostarecz AG, 2004, J AM CHEM SOC, V126, P13882, DOI 10.1021/ja0472127; Stottrup BL, 2005, BIOPHYS J, V88, P269, DOI 10.1529/biophysj.104.049439; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3	35	215	222	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1948	1951		10.1126/science.1130279	http://dx.doi.org/10.1126/science.1130279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008528	Green Submitted			2022-12-28	WOS:000240832200047
J	McGuire, JA; Shen, YR				McGuire, John A.; Shen, Y. Ron			Ultrafast vibrational dynamics at water interfaces	SCIENCE			English	Article							TEMPERATURE-DEPENDENCE; REVERSE MICELLES; PHOTON-ECHO; ENERGY; SPECTROSCOPY; RELAXATION; SURFACES; SPECTRA	Time-resolved sum-frequency vibrational spectroscopy permits the study of hitherto neglected ultrafast vibrational dynamics of neat water interfaces. Measurements on interfacial bonded OH stretch modes revealed relaxation behavior on sub-picosecond time scales in close resemblance to that of bulk water. Vibrational excitation is followed by spectral diffusion, vibrational relaxation, and thermalization in the hydrogen-bonding network. Dephasing of the excitation occurs in <= 100 femtoseconds. Population relaxation of the dangling OH stretch was found to have a time constant of 1.3 picoseconds, the same as that for excitation transfer between hydrogen-bonded and unbonded OH stretches of water molecules surrounded by acetone.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Shen, YR (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	yrshen@calmail.berkeley.edu	McGuire, John A/C-3380-2015	McGuire, John A/0000-0002-0682-0953				Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z; CONBOY JC, 1994, J PHYS CHEM-US, V98, P9688, DOI 10.1021/j100090a600; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; DU Q, 1994, PHYS REV LETT, V72, P238, DOI 10.1103/PhysRevLett.72.238; DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313; Franks F., 1972, WATER COMPREHENSIVE; Garrett BC, 2004, SCIENCE, V303, P1146, DOI 10.1126/science.1089801; Gilijamse JJ, 2005, P NATL ACAD SCI USA, V102, P3202, DOI 10.1073/pnas.0404916102; GUYOTSIONNEST P, 1991, PHYS REV LETT, V66, P1489, DOI 10.1103/PhysRevLett.66.1489; Harpham MR, 2004, J CHEM PHYS, V121, P7855, DOI 10.1063/1.1792592; Huse N, 2005, CHEM PHYS LETT, V404, P389, DOI 10.1016/j.cplett.2005.02.007; Lawrence CP, 2003, J CHEM PHYS, V118, P264, DOI 10.1063/1.1525802; Lock AJ, 2002, J CHEM PHYS, V117, P1708, DOI 10.1063/1.1485966; Lock AJ, 2001, J PHYS CHEM A, V105, P1238, DOI 10.1021/jp003158e; Moller KB, 2004, J PHYS CHEM A, V108, P1275, DOI 10.1021/jp035935r; Ostroverkhov V, 2004, CHEM PHYS LETT, V386, P144, DOI 10.1016/j.cplett.2004.01.047; Poulsen JA, 2003, J PHYS CHEM A, V107, P8420, DOI 10.1021/jp0225469; Shen Y. R., 1994, P INT SCH PHYS, P139; Steinel T, 2004, J PHYS CHEM A, V108, P10957, DOI 10.1021/jp046711r; Stenger J, 2002, J PHYS CHEM A, V106, P2341, DOI 10.1021/jp013104k; Tan HS, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1883605; Woutersen S, 1998, PHYS REV LETT, V81, P1106, DOI 10.1103/PhysRevLett.81.1106; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	24	209	209	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1945	1948		10.1126/science.1131536	http://dx.doi.org/10.1126/science.1131536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008527				2022-12-28	WOS:000240832200046
J	Fox, KAA; Dabbous, OH; Goldberg, RJ; Pieper, KS; Eagle, KA; Van de Werf, F; Avezum, A; Goodman, SG; Flather, MD; Anderson, FA; Granger, CB				Fox, Keith A. A.; Dabbous, Omar H.; Goldberg, Robert J.; Pieper, Karen S.; Eagle, Kim A.; Van de Werf, Frans; Avezum, Alvaro; Goodman, Shaun G.; Flather, Marcus D.; Anderson, Frederick A., Jr.; Granger, Christopher B.		GRACE Investigators	Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ST-SEGMENT-ELEVATION; GLOBAL REGISTRY; DOCTORS	Objective To develop a clinical risk prediction tool for estimating the cumulative six month risk of death and death or myocardial infarction to facilitate triage and management of patients with acute coronary syndrome. Design Prospective multinational observational study in which we used multivariable regression to develop a final predictive model, with prospective and external validation. Setting Ninety four hospitals in 14 countries in Europe, North and South America, Australia, and New Zealand. Population 43 810 patients (21688 derivation set; 22 122 in validation set) presenting with acute coronary syndrome with or without ST segment elevation enrolled in the global registry of acute coronary events (GRACE) study between April 1999 and September 2005. Main outcome measures Death and myocardial infarction. Results 1989 patients died in hospital, 1466 died between discharge and six month follow-up, and 2793 sustained a new non-fatal myocardial infarction. Nine factors independently predicted death and the combined end point of death or myocardial infarction in the period from admission to six months after discharge: age, development (or history) of heart failure, peripheral vascular disease, systolic blood pressure, Killip class, initial serum creatinine concentration, elevated initial cardiac markers, cardiac arrest on admission, and ST segment deviation. The simplified model was robust, with prospectively validated C-statistics of 0.81 for predicting death and 0.73 for death or myocardial infarction from admission to six months after discharge. The external applicability of the model was validated in the dataset from GUSTO IIb (global use of strategies to open occluded coronary arteries). Conclusions This risk prediction tool uses readily identifiable variables to provide robust prediction of the cumulative six month risk of death or myocardial infarction. It is a rapid and widely applicable method for assessing cardiovascular risk to complement clinical assessment and can guide patient triage and management across the spectrum of patients with acute coronary syndrome.	Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH16 4SB, Midlothian, Scotland; Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; Duke Clin Res Inst, Durham, NC 27705 USA; Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Dante Pazzanese Inst Cardiol, BR-04012909 Sao Paulo, Brazil; St Michaels Hosp, Terrence Donnelly Heart Ctr, Div Cardiol, Toronto, ON M5B 1W8, Canada; Royal Brompton Hosp, Royal Brompton & Harefield NHS Trust, London SW3 6NP, England	Royal Infirmary of Edinburgh; University of Edinburgh; University of Massachusetts System; University of Massachusetts Worcester; Duke University; University of Michigan System; University of Michigan; KU Leuven; University Hospital Leuven; Instituto Dante Pazzanese de Cardiologia; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Fox, KAA (corresponding author), Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh EH16 4SB, Midlothian, Scotland.	k.a.a.fox@ed.ac.uk	Granger, Christopher B/D-3458-2014; Fox, keith A A/I-3742-2013; Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020	Granger, Christopher B/0000-0002-0045-3291; Avezum, Alvaro AA/0000-0002-3073-6890; Fox, Keith/0000-0002-0140-2752; Van de Werf, Frans/0000-0001-9479-7767	NCATS NIH HHS [UL1 TR002003] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; McManus RJ, 2002, BMJ-BRIT MED J, V324, P459, DOI 10.1136/bmj.324.7335.459; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; 2001, HEART, V85, P133	12	950	1005	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2006	333	7578					1091	1094		10.1136/bmj.38985.646481.55	http://dx.doi.org/10.1136/bmj.38985.646481.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17032691	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000242520200014
J	Hallan, SI; Dahl, K; Oien, CM; Grootendorst, DC; Aasberg, A; Holmen, J; Dekker, FW				Hallan, Stein I.; Dahl, Ketil; Oien, Cecilia M.; Grootendorst, Diana C.; Aasberg, Arne; Holmen, Jostein; Dekker, Friedo W.			Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To find an effective screening strategy for detecting patients with chronic kidney disease and to describe the natural course of the disease. Design Eight year follow-up of a cross sectional health survey (the HUNT II study). Setting Nord-Trondelag County, Norway Participants 65 604 people (70.6% of 0 adults aged >= 20 in the county). Main outcome measures Incident end stage renal disease (ESRD) and cardiovascular mortality monitored by individual linkage to central registries. Results 3069/65 604 (4.7%) people had chronic kidney disease (estimated glomerular filtration rate < 60 ml/min/1.73 m(2)), so we would need to screen 20.6 people (95% confidence interval 20.0 to 21.2) to identify one case. Restriction of screening to those with hypertension, diabetes, or age > 55 would identify 93.2% (92.4% to 94.0%) of patients with chronic kidney disease, with a number needed to screen of 8.7 (8.5 to 9.0). Restriction of screening according to guidelines of the United States kidney disease outcomes quality initiative (US KDOQI) gave similar results, but restriction according to the United Kingdom's chronic kidney disease guidelines detected only 51.6% (49.6% to 53.4%) of cases. Screening only people with previously known diabetes or hypertension detected 44.2% (42.7% to 45.7%) of all cases, with a number needed to screen of six. During the eight year follow-up only 38 of the 3069 people with chronic kidney disease progressed to end stage renal disease, and the risk was especially low in people without diabetes or hypertension, women, and those aged >= 70 or with a glomerular filtration rate 45-59 ml/min/1.73 m(2) at screeiting. In contrast, there was a high cardiovascular mortality: 3.5, 7.4, and 10.1 deaths per 100 person years among people with a glomerular filtration rate 45-59, 30-44, and < 30 ml/min/1.73 m(2), respectively. Conclusion Screening people with hypertension, diabetes mellitus, or age > 55 was the most effective strategy to detect patients with chronic kidney disease, but the risk of end stage renal disease among those detected was low.	Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Biol, N-7006 Trondheim, Norway; St Olavs Univ Hosp, Dept Med, Div Nephrol, N-7006 Trondheim, Norway; Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 Leiden, Netherlands; St Olaf Univ Hosp, Dept Clin Biochem, N-7006 Trondheim, Norway; Norwegian Univ Sci & Technol, Fac Med, HUNT Res Ctr, N-7650 Verdal, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Norwegian University of Science & Technology (NTNU)	Hallan, SI (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Biol, N-7006 Trondheim, Norway.	stein.hallan@ntnu.no	Dekker, Friedo W/B-6452-2011	Dekker, Friedo W/0000-0002-2433-2494				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 2005, ISN NEWS, V13, P3; BOULWARE LE, 2003, JAMA-J AM MED ASSOC, V17, P3101; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; de Jong PE, 2004, KIDNEY INT, V66, P2109, DOI 10.1111/j.1523-1755.2004.66001.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Holmen JM K., 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.1093/eurheartj/eht019]; McClellan WM, 2003, J AM SOC NEPHROL, V14, pS81, DOI 10.1097/01.ASN.0000070144.86024.04; Nahas ME, 2005, KIDNEY INT, V68, P2918, DOI 10.1111/j.1523-1755.2005.00774.x; Remuzzi G, 2005, LANCET, V365, P556; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634	11	223	236	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1047	1050		10.1136/bmj.39001.657755.BE	http://dx.doi.org/10.1136/bmj.39001.657755.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108HB	17062598	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000242229800016
J	Wen, LX				Wen, Lianxing			Localized temporal change of the earth's inner core boundary	SCIENCE			English	Article							TELESEISMIC DOUBLETS; DIFFERENTIAL ROTATION; EARTHQUAKE DOUBLETS; VELOCITY VARIATIONS; OUTER CORE; EXISTENCE; CONVECTION	Compressional waves of an earthquake doublet ( two events occurring in the South Sandwich Islands on 1 December 1993 and 6 September 2003), recorded at three seismic stations in Russia and Kyrgyzstan and reflected off Earth's inner core boundary, arrived at least from 39 to 70 milliseconds earlier in the 2003 event than in the 1993 event. Such changes indicate that Earth's inner core radius enlarged locally beneath middle Africa by 0.98 to 1.75 kilometers between the times of these two events. Changes of the inner core radius may be explained by either a differential motion of the inner core, assuming that irregularities are present at the inner core boundary and fixed to the inner core, or a rapid growth of the inner core by this amount.	SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wen, LX (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	Lianxing.Wen@sunysb.edu		Wen, Lianxing/0000-0002-5344-6212				BLOXHAM J, 1989, PHILOS T R SOC A, V329, P415, DOI 10.1098/rsta.1989.0087; BRAGINSKII SI, 1963, DOKL AKAD NAUK SSSR+, V149, P1311; Buffett BA, 2000, GEOPHYS MONOGR SER, V117, P37; Creager KC, 1997, SCIENCE, V278, P1284, DOI 10.1126/science.278.5341.1284; Davies G. F., 1979, 17 GEN ASS IUGG CANB; FEARN DR, 1981, NATURE, V292, P232, DOI 10.1038/292232a0; GUBBINS D, 1977, J GEOPHYS, V43, P423; Hulot G, 2002, NATURE, V416, P620, DOI 10.1038/416620a; JACOBS JA, 1953, NATURE, V172, P297, DOI 10.1038/172297a0; Li AY, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000379; LOPER DE, 1978, GEOPHYS J ROY ASTR S, V54, P389, DOI 10.1111/j.1365-246X.1978.tb04265.x; LOPER DE, 1981, PHYS EARTH PLANET IN, V24, P302, DOI 10.1016/0031-9201(81)90117-5; Poupinet G, 2000, PHYS EARTH PLANET IN, V118, P77, DOI 10.1016/S0031-9201(99)00129-6; POUPINET G, 1984, J GEOPHYS RES, V89, P5719, DOI 10.1029/JB089iB07p05719; Poupinet G, 2001, PHYS EARTH PLANET IN, V124, P275, DOI 10.1016/S0031-9201(01)00206-0; Schaff DP, 2004, SCIENCE, V303, P1176, DOI 10.1126/science.1093422; Song XD, 2001, PHYS EARTH PLANET IN, V124, P269, DOI 10.1016/S0031-9201(01)00182-0; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; STEVENSON DJ, 1987, GEOPHYS J INT, V88, P311, DOI 10.1111/j.1365-246X.1987.tb01383.x; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; Sumita I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000548; Vidale JE, 2000, NATURE, V405, P445, DOI 10.1038/35013039; WORSTER MG, 1992, J FLUID MECH, V237, P649, DOI 10.1017/S0022112092003562; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Zhang J, 2005, SCIENCE, V309, P1357, DOI 10.1126/science.1113193	25	63	66	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					967	970		10.1126/science.1131692	http://dx.doi.org/10.1126/science.1131692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17008488				2022-12-28	WOS:000241896000045
J	Yang, ZL; Camp, NJ; Sun, H; Tong, ZZ; Gibbs, D; Cameron, DJ; Chen, HY; Zhao, Y; Pearson, E; Li, X; Chien, J; DeWan, A; Harmon, J; Bernstein, PS; Shridhar, V; Zabriskie, NA; Hoh, J; Howes, K; Zhang, K				Yang, Zhenglin; Camp, Nicola J.; Sun, Hui; Tong, Zongzhong; Gibbs, Daniel; Cameron, D. Joshua; Chen, Haoyu; Zhao, Yu; Pearson, Erik; Li, Xi; Chien, Jeremy; DeWan, Andrew; Harmon, Jennifer; Bernstein, Paul S.; Shridhar, Viji; Zabriskie, Norman A.; Hoh, Josephine; Howes, Kimberly; Zhang, Kang			A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration	SCIENCE			English	Article							COMPLEMENT FACTOR-H; CIGARETTE-SMOKING; RISK; POLYMORPHISM; CFH; ASSOCIATION; MACULOPATHY; LOC387715; DISEASE	Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a strong genetic predisposition. A locus at human chromosome 10q26 affects the risk of AMD, but the precise gene(s) have not been identified. We genotyped 581 AMD cases and 309 normal controls in a Caucasian cohort in Utah. We demonstrate that a single-nucleotide polymorphism, rs11200638, in the promoter region of HTRA1 is the most likely causal variant for AMD at 10q26 and is estimated to confer a population attributable risk of 49.3%. The HTRA1 gene encodes a secreted serine protease. Preliminary analysis of lymphocytes and retinal pigment epithelium from four AMD patients revealed that the risk allele was associated with elevated expression levels of HTRA1 mRNA and protein. We also found that drusen in the eyes of AMD patients were strongly immunolabeled with HTRA1 antibody. Together, these findings support a key role for HTRA1 in AMD susceptibility and identify a potential new pathway for AMD pathogenesis.	Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Eccles Inst Human Genet, Program Human Mol Biol & Genet, Salt Lake City, UT 84132 USA; Sichuan Prov Peoples Hosp, Chengdu 610071, Sichuan, Peoples R China; Univ Utah, Sch Med, Dept Biomed Informat, Div Genet Epidemiol, Salt Lake City, UT 84108 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Mayo Clin, Coll Med, Dept Lab Med & Expt Pathol, Rochester, MN 55905 USA; Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mayo Clinic; Yale University	Zhang, K (corresponding author), Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.	kzhang@hmbg.utah.edu	Seal, Sudipta/A-7698-2012; Chien, Jeremy/AID-8939-2022; Zhang, Kang/Y-2740-2019; Chu, Kai On/E-2325-2016; Chen, Haoyu/A-7432-2013	Zhang, Kang/0000-0002-4549-1697; Chen, Haoyu/0000-0003-0676-4610; Chien, Jeremy/0000-0003-4744-8374; DeWan, Andrew/0000-0002-7679-8704	NATIONAL CANCER INSTITUTE [K07CA098364] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014448, P30EY014800, R01EY015771, R01EY014428] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141	18	610	655	8	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					992	993		10.1126/science.1133811	http://dx.doi.org/10.1126/science.1133811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17053109				2022-12-28	WOS:000241896000053
J	Malin, G				Malin, Gill			Oceans - New pieces for the marine sulfur cycle jigsaw	SCIENCE			English	Editorial Material							DMSP; CLIMATE; ALGAE		Univ E Anglia, Sch Environm Sci, Lab Global Marine & Atmospher Chem, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Malin, G (corresponding author), Univ E Anglia, Sch Environm Sci, Lab Global Marine & Atmospher Chem, Norwich NR4 7TJ, Norfolk, England.	g.malin@uea.ac.uk	Malin, Gill/C-6985-2009	Malin, Gill/0000-0002-3639-9215	Natural Environment Research Council [NE/B501039/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; *U E ANGL, 2006, 4 INT S BIOL ENV CHE; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043	11	19	20	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					607	608		10.1126/science.1133279	http://dx.doi.org/10.1126/science.1133279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068252				2022-12-28	WOS:000241557800034
J	Matear, RJ; McNeil, BI				Matear, Richard J.; McNeil, Ben I.			Comment on "Preindustrial to modern interdecadal variability in coral reef pH"	SCIENCE			English	Editorial Material							GREAT-BARRIER-REEF; CARBON BUDGET; CO2		Commonwealth Sci & Ind Res Org Marine & Atmospher, Hobart, Tas, Australia; Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; Univ New S Wales, Sch Math, Climate & Environm Dynam Lab, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of New South Wales Sydney	Matear, RJ (corresponding author), Commonwealth Sci & Ind Res Org Marine & Atmospher, Hobart, Tas, Australia.	Richard.Matear@csiro.au	matear, richard J/C-5133-2011	matear, richard J/0000-0002-3225-0800; McNeil, Ben/0000-0001-5765-7087				Kawahata H, 2000, MAR CHEM, V72, P257, DOI 10.1016/S0304-4203(00)00085-2; Kawahata H, 1999, J OCEANOGR, V55, P731, DOI DOI 10.1023/A:1007872314591; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.1034/j.1600-0889.2003.01442.x; Suzuki A, 2001, GEOPHYS RES LETT, V28, P1243, DOI 10.1029/2000GL011875; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	8	8	10	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					595	595		10.1126/science.1128198	http://dx.doi.org/10.1126/science.1128198			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068245				2022-12-28	WOS:000241557800024
J	Hill, AG; Clark, CJ; Lubbad, I; Bruderlein, C				Hill, Allan G.; Clark, Cari Jo; Lubbad, Ismail; Bruderlein, Claude			Hope and despair over health in Gaza	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Ctr Populat & Dev, Cambridge, MA 02138 USA; Harvard Univ, Program Humanitarian Policy & Conflict Res, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hill, AG (corresponding author), Harvard Univ, Ctr Populat & Dev, 9 Bow St, Cambridge, MA 02138 USA.	ahill@hsph.harvard.edu		Hill, Allan/0000-0002-4418-0379				*HUM POL CONFL RES, 2006, POP PROJ SOC DEV GAZ; Keating M., 2005, AID DIPLOMACY FACTS; *UN OFF COORD HUM, GAZ STRIP SIT REP	3	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 21	2006	333	7573					845	846		10.1136/bmj.38993.390822.68	http://dx.doi.org/10.1136/bmj.38993.390822.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053241	Green Published, Bronze			2022-12-28	WOS:000241678500019
J	Thwaites, CL; Yen, LM; Loan, HT; Thuy, TTD; Thwaites, GE; Stepniewska, K; Soni, N; White, NJ; Farrar, JJ				Thwaites, C. L.; Yen, L. M.; Loan, H. T.; Thuy, T. T. D.; Thwaites, G. E.; Stepniewska, K.; Soni, N.; White, N. J.; Farrar, J. J.			Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial	LANCET			English	Article							SYMPATHETIC OVERACTIVITY; MANAGEMENT; INSTABILITY; MORPHINE	Background The most common cause of death in individuals with severe tetanus in the absence of mechanical ventilation is spasm-related respiratory failure, whereas in ventilated patients it is tetanus-associated autonomic dysfunction. Our aim was to determine whether continuous magnesium sulphate infusion reduces the need for mechanical ventilation and improves control of muscle spasms and autonomic instability. Methods We did a randomised, double blind, placebo controlled trial in 256 Vietnamese patients over age 15 years with severe tetanus admitted to the Hospital for Tropical Medicine, Ho Chi Minh City, Vietnam. Participants were randomly assigned magnesium sulphate (n=97) or placebo solution (n=98) intravenously for 7 days. The primary outcomes were requirement of assisted ventilation and of drugs to control muscle spasms and cardiovascular instability within the 7-day study period. Analyses were done by intention to treat. This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN74651862. Findings No patients were lost to follow-up. There was no difference in requirement for mechanical ventilation between individuals treated with magnesium and those receiving placebo (odds ratio 0.71, 95% CI 0.36-1.40; p=0.324); survival was also much the same in the two groups. However, compared with the placebo group, patients ;receiving magnesium required significantly less midazolam (7.1 mg/kg per day [0.1-47.9] vs 1.4 mg/kg per day [0.0-17.3]; p=0.026) and pipecuronium (2.3 mg/kg per day [0.0-33.0] vs 0.0 mg/kg per day [0.0-14.8]; p=0.005) to control muscle spasms and associated tachycardia. Individuals receiving magnesium were 4.7 (1.4-15.9) times less likely to require verapamil to treat cardiovascular instability than those in the placebo group. The incidence of adverse events was not different between the groups. Interpretation Magnesium infusion does not reduce the need for mechanical ventilation in adults with severe tetanus but does reduce the requirement for other drugs to control muscle spasms and cardiovascular instability.	Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England; Chelsea & Westminster Hosp, Magill Dept Anaesthesia, London, England	University of Oxford; University of Oxford; Imperial College London	Thwaites, CL (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 190 Ben Ham Tu,Dist 5, Ho Chi Minh City, Vietnam.	louise.thwaites@btinternet.com	Farrar, Jeremy J./HGA-7610-2022; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Thwaites, Guy E/R-4993-2019	White, Nick/0000-0002-1897-1978; Thwaites, Guy E/0000-0002-2858-2087; Farrar, Jeremy/0000-0002-2700-623X; Stepniewska, Kasia/0000-0002-1713-6209	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ablett J., 1967, S TETANUS GREAT BRIT, P1; AHMADSYAH I, 1985, BRIT MED J, V291, P648, DOI 10.1136/bmj.291.6496.648; ALTURA BM, 1981, FED PROC, V40, P2672; Attygalle D, 2002, ANAESTHESIA, V57, P811; Attygalle D, 1997, ANAESTHESIA, V52, P956, DOI 10.1111/j.1365-2044.1997.206-az0340.x; Attygalle Deepthi, 2004, Expert Rev Anti Infect Ther, V2, P73, DOI 10.1586/14787210.2.1.73; Bhagwanjee S, 1999, CRIT CARE MED, V27, P1721, DOI 10.1097/00003246-199909000-00004; Blake JA, 1906, SURG GYNECOL OBSTET, V2, P541; BUCHANAN N, 1979, INTENS CARE MED, V5, P65, DOI 10.1007/BF01686048; Cassell OCS, 2002, BRIT MED J, V324, P1442, DOI 10.1136/bmj.324.7351.1442; Cook TM, 2001, BRIT J ANAESTH, V87, P477, DOI 10.1093/bja/87.3.477; Gregorakos L, 1997, INTENS CARE MED, V23, P893, DOI 10.1007/s001340050428; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Ismoedijanto, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P175; JAMES MFM, 1985, INTENS CARE MED, V11, P5; KING WW, 1991, AM J MED, V91, P425, DOI 10.1016/0002-9343(91)90162-Q; Okoromah CN, 2004, COCHRANE DB SYST REV, V1; PHILLIPS LA, 1967, LANCET, V1, P1216; POWLES AB, 1985, ANAESTHESIA, V40, P879, DOI 10.1111/j.1365-2044.1985.tb11050.x; QUINTERO MLM, 1987, CRIT CARE MED, V15, P801, DOI 10.1097/00003246-198708000-00022; ROCKE DA, 1986, S AFR MED J, V70, P666; Rukshin Vladimir, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P193, DOI 10.1177/107424840300800304; Tawaites CL, 2003, ANAESTHESIA, V58, P286, DOI 10.1046/j.1365-2044.2003.30568.x; Thwaites CL, 2006, TROP MED INT HEALTH, V11, P279, DOI 10.1111/j.1365-3156.2006.01562.x; Thwaites CL, 2004, T ROY SOC TROP MED H, V98, P671, DOI 10.1016/j.trstmh.2004.01.008; Thwaites CL, 2003, BMJ-BRIT MED J, V326, P117, DOI 10.1136/bmj.326.7381.117; Thwaites CL, 2005, CURR ANAESTH CRIT CA, V16, P50; Udwadia F.E., 1994, TETANUS; VAKIL BJ, 1975, P 4 INT C TET DAK, P3349; von Euler U S, 1973, Acta Physiol Scand, V89, P415; Yen LM, 1997, S ANT RES SO VIET NA	31	83	93	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1436	1443		10.1016/S0140-6736(06)69444-0	http://dx.doi.org/10.1016/S0140-6736(06)69444-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055945				2022-12-28	WOS:000241459100031
J	Kodadek, T; Sikder, D; Nalley, K				Kodadek, Thomas; Sikder, Devanjan; Nalley, Kip			Keeping transcriptional activators under control	CELL			English	Review							GENE-EXPRESSION; IN-VIVO; UBIQUITIN; TURNOVER; DOMAIN; DYNAMICS; ALPHA	Transcriptional activators need to be modulated and eventually switched off after the initial event that triggers their activation. Here, we discuss how ubiquitination of activators and their proteasome-mediated turnover are crucial steps in this process.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	thomas.kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28185] Funding Source: Medline; NIGMS NIH HHS [GM-71833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brady KL, 2005, J BIOL CHEM, V280, P26743, DOI 10.1074/jbc.M502677200; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	17	92	95	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					261	264		10.1016/j.cell.2006.10.002	http://dx.doi.org/10.1016/j.cell.2006.10.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055428	Bronze			2022-12-28	WOS:000241827100014
J	Sternberg, EM; Wilson, MA				Sternberg, Esther M.; Wilson, Matthew A.			Neuroscience and architecture: Seeking common ground	CELL			English	Editorial Material							MEMORY; HIPPOCAMPUS; CELLS	As these paired Commentaries discuss, neuroscientists and architects are just beginning to collaborate, each bringing what they know about their respective fields to the task of improving the environment of research buildings and laboratories.	NIMH, Integrat Neural Immune Program, NIH, Bethesda, MD 20892 USA; MIT, Picower Inst Learning & Mem, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sternberg, EM (corresponding author), NIMH, Integrat Neural Immune Program, NIH, Bethesda, MD 20892 USA.	sternbee@mail.nih.gov; mwilson@mit.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002585, ZIAMH002585] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bailey KR, 2006, ILAR J, V47, P124, DOI 10.1093/ilar.47.2.124; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Jeffery KJ, 2004, REV NEUROSCIENCE, V15, P309; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mormede P, 2002, PSYCHONEUROENDOCRINO, V27, P563, DOI 10.1016/S0306-4530(01)00093-2; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Schimanski LA, 2004, NEUROSCI BIOBEHAV R, V28, P463, DOI 10.1016/j.neubiorev.2004.04.002; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5	9	39	40	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					239	242		10.1016/j.cell.2006.10.012	http://dx.doi.org/10.1016/j.cell.2006.10.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055420	Bronze			2022-12-28	WOS:000241827100006
J	Milstein, A; Smith, M				Milstein, Arnold; Smith, Mark			America's new refugees - Seeking affordable surgery offshore.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mercer Hlth & Benefits, San Francisco, CA USA; Pacific Business Grp Hlth, San Francisco, CA USA; Calif HealthCare Fdn, Oakland, CA USA		Milstein, A (corresponding author), Mercer Hlth & Benefits, San Francisco, CA USA.							*CAL HEALTHC FDN, 2005, HLTH INS CAN CAL AFF; Kher Unmesh, 2006, Time, V167, P44; Mattoo A, 2006, HEALTH AFFAIR, V25, P358, DOI 10.1377/hlthaff.25.2.358; Wachter RM, 2006, NEW ENGL J MED, V354, P661, DOI 10.1056/NEJMp058258	4	77	78	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1637	1640		10.1056/NEJMp068190	http://dx.doi.org/10.1056/NEJMp068190			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050886				2022-12-28	WOS:000241357300003
J	Vora, A; Mitchell, CD; Lennard, L; Eden, TOB; Kinsey, SE; Lilleyman, J; Richards, SM				Vora, Ajay; Mitchell, Chris D.; Lennard, Lynne; Eden, T. O. B.; Kinsey, Sally E.; Lilleyman, John; Richards, Sue M.		Med Res Council Natl Canc Res	Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial	LANCET			English	Article							VENO-OCCLUSIVE DISEASE; HEPATIC VENOOCCLUSIVE DISEASE; BONE-MARROW TRANSPLANTATION; CHILDRENS-CANCER-GROUP; MAINTENANCE THERAPY; LIVER; MERCAPTOPURINE; THIOGUANINE; DEXAMETHASONE; CHEMOTHERAPY	Background 6-mercaptopurine has been a standard component of long-term continuing treatment for childhood lymphoblastic leukaemia, whereas 6-thioguanine has been mainly used for intensification courses. Since preliminary data have shown that 6-thioguanine is more effective than 6-mercaptopurine, we compared the efficacy and toxicity of the two drugs for childhood lymphoblastic leukaemia. Methods Consecutive children with lymphoblastic leukaemia diagnosed in the UK and Ireland between April, 1997, and June, 2002, were randomly assigned either 6-thioguanine (750 patients) or 6-mercaptopurine (748 patients) during interim maintenance and continuing therapy. All patients received 6-thioguanine during intensification courses. We analysed event-free and overall survival on an intention-to-treat basis. We obtained toxicity data using an adverse-event reporting system, with follow-up questionnaires to seek detailed information for specific toxicities. This trial is registered with the International Standard Randomised Controlled Number 26727615 with the name ALL97. Findings After a median follow up of 6 years, there was no difference in event-free or overall survival between the two treatment groups. Although 6-thioguanine conferred a significantly lower risk of isolated CNS relapse than did 6-mercaptopurine (odds ratio [OR] 0.53, 95% CI 0.30-0.92, p=0.02), the benefit was offset by an increased risk of death in remission (2.22, 1.20-4.14, p=0.01), mainly due to infections during continuing therapy. Additionally, 95 patients developed veno-occlusive disease of the liver. Of these, 82 were randomly assigned 6-thioguanine, representing 11% of all 6-thioguanine recipients. On long-term follow-up, about 5% of 6-thioguanine recipients have evidence of non-cirrhotic portal hypertension due to periportal liver fibrosis or nodular regenerative hyperplasia. Interpretation Compared with 6-mercaptopurine, 6-thioguanine causes excess toxicity without an overall benefit. 6-mercaptopurine should remain the thiopurine of choice for continuing therapy of childhood lymphoblastic leukaemia.	Sheffield Childrens Hosp, Dept Paediat Haematol, Sheffield S10 2TH, S Yorkshire, England; John Radcliffe Hosp, Oxford OX3 9DU, England; Univ Sheffield, Div Clin Sci, Sheffield S10 2TN, S Yorkshire, England; Manchester Childrens Univ Hosp, Manchester, Lancs, England; Cent Manchester Hosp, Manchester, Lancs, England; Christie Hosp, Manchester, Lancs, England; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; Royal London Hosp, London E1 1BB, England; Clin Trial Serv Unit, Oxford, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Oxford; University of Sheffield; Christie NHS Foundation Trust; Christie Hospital; Saint James's University Hospital; Barts Health NHS Trust; Royal London Hospital; University of Oxford	Vora, A (corresponding author), Sheffield Childrens Hosp, Dept Paediat Haematol, Sheffield S10 2TH, S Yorkshire, England.	ajay.vora@sch.nhs.uk	Lennard, Lynne/E-1131-2011		Medical Research Council [G0300130] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADAMSON PC, 1994, LEUKEMIA RES, V18, P805, DOI 10.1016/0145-2126(94)90159-7; Bairey O, 2002, AM J HEMATOL, V69, P281, DOI 10.1002/ajh.10072; Bisogno G, 1997, MED PEDIATR ONCOL, V29, P245, DOI 10.1002/(SICI)1096-911X(199710)29:4<245::AID-MPO2>3.3.CO;2-X; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Boula AM, 2005, AM J HEMATOL, V79, P216, DOI 10.1002/ajh.20338; BROX LW, 1981, CANCER CHEMOTH PHARM, V6, P35; Broxson EH, 2005, PEDIATR BLOOD CANCER, V44, P226, DOI 10.1002/pbc.20202; BURCHENAL JH, 1953, BLOOD, V8, P965, DOI 10.1182/blood.V8.11.965.965; Chessells JM, 2002, BRIT J HAEMATOL, V118, P445, DOI 10.1046/j.1365-2141.2002.03647.x; CHESSELLS JM, 1995, BRIT J HAEMATOL, V89, P364, DOI 10.1111/j.1365-2141.1995.tb03313.x; DCRUZ CA, 1983, CANCER-AM CANCER SOC, V52, P1803, DOI 10.1002/1097-0142(19831115)52:10<1803::AID-CNCR2820521007>3.0.CO;2-D; De Bruyne R, 2006, J HEPATOL, V44, P407, DOI 10.1016/j.jhep.2005.06.020; Dubinsky MC, 2003, GASTROENTEROLOGY, V125, P298, DOI 10.1016/S0016-5085(03)00938-7; Eden OB, 2000, LEUKEMIA, V14, P2307, DOI 10.1038/sj.leu.2401962; ESSELL JH, 1992, BLOOD, V79, P2784; EVANS WE, 1994, LEUKEMIA RES, V18, P811, DOI 10.1016/0145-2126(94)90160-0; GILL RA, 1982, ANN INTERN MED, V96, P58, DOI 10.7326/0003-4819-96-1-58; GRINER PF, 1976, ANN INTERN MED, V85, P578, DOI 10.7326/0003-4819-85-5-578; Guilland JC, 2003, PATHOL BIOL, V51, P101, DOI 10.1016/S0369-8114(03)00104-4; Hann I, 2001, BRIT J HAEMATOL, V113, P103, DOI 10.1046/j.1365-2141.2001.02668.x; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; HENZE G, 1991, BLOOD, V78, P1166; Holtmann M, 2003, DIGEST DIS SCI, V48, P1503, DOI 10.1023/A:1024755521423; KAO NL, 1993, J AM ACAD DERMATOL, V28, P1017, DOI 10.1016/S0190-9622(08)80659-7; Kinsey S, 2002, BLOOD, V100, p763A; KRIVOY N, 1982, ANN INTERN MED, V96, P788, DOI 10.7326/0003-4819-96-6-788_1; LARREY D, 1988, GUT, V29, P1265, DOI 10.1136/gut.29.9.1265; LENNARD L, 1993, BRIT J CANCER, V68, P186, DOI 10.1038/bjc.1993.311; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Merino JM, 2000, PEDIATR HEMAT ONCOL, V17, P429, DOI 10.1080/08880010050034391; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; MURPHY ML, 1955, P AM ASSOC CANC RES, V2, P36; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Nelson J. Arly, 1992, Cancer Bulletin (Houston), V44, P470; Park YD, 1997, BONE MARROW TRANSPL, V19, P915, DOI 10.1038/sj.bmt.1700760; Rozman C, 1996, BONE MARROW TRANSPL, V17, P75; Stoneham S, 2003, BRIT J HAEMATOL, V123, P100, DOI 10.1046/j.1365-2141.2003.04578.x; STORK LC, 2002, COMP MERCAPTOPURINE; TUBERGEN DG, 1993, J CLIN ONCOL, V11, P527, DOI 10.1200/JCO.1993.11.3.527	39	134	142	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1339	1348		10.1016/S0140-6736(06)69558-5	http://dx.doi.org/10.1016/S0140-6736(06)69558-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046466				2022-12-28	WOS:000241388100030
J	Stafford, N				Stafford, Ned			Hell on no wheels	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					621	621		10.1038/443621a	http://dx.doi.org/10.1038/443621a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035970				2022-12-28	WOS:000241160500013
J	Chen, ZY; Jing, DQ; Bath, KG; Ieraci, A; Khan, T; Siao, CJ; Herrera, DG; Toth, M; Yang, C; McEwen, BS; Hempstead, BL; Lee, FS				Chen, Zhe-Yu; Jing, Deqiang; Bath, Kevin G.; Ieraci, Alessandro; Khan, Tanvir; Siao, Chia-Jen; Herrera, Daniel G.; Toth, Miklos; Yang, Chingwen; McEwen, Bruce S.; Hempstead, Barbara L.; Lee, Francis S.			Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior	SCIENCE			English	Article							ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; HIPPOCAMPAL FUNCTION; ANIMAL-MODELS; HUMAN-MEMORY; BRAIN; DEPRESSION; MICE; NEURONS; TRAITS	A common single-nucleotide polymorphism in the brain-derived neurotrophic factor ( BDNF) gene, a methionine ( Met) substitution for valine (Val) at codon 66 (Val66Met), is associated with alterations in brain anatomy and memory, but its relevance to clinical disorders is unclear. We generated a variant BDNF mouse (BDNF(Met/Met)) that reproduces the phenotypic hallmarks in humans with the variant allele. BDNF(Met) was expressed in brain at normal levels, but its secretion from neurons was defective. When placed in stressful settings, BDNF(Met/Met) mice exhibited increased anxiety-related behaviors that were not normalized by the antidepressant, fluoxetine. A variant BDNF may thus play a key role in genetic predispositions to anxiety and depressive disorders.	Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China; Rockefeller Univ, Gene Targeting Facil, New York, NY 10021 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Shandong University; Rockefeller University; Rockefeller University	Chen, ZY (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA.	zheyuchen@sdu.edu.cn; fslee@med.cornell.edu	Toth, Miklos/O-3343-2017; McEwen, Bruce/Z-1630-2019; Ieraci, Alessandro/AAA-8738-2020	Ieraci, Alessandro/0000-0001-6737-7695	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060478, K08MH068850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS052819] Funding Source: NIH RePORTER; NIMH NIH HHS [MH068850, MH060478] Funding Source: Medline; NINDS NIH HHS [R01 NS052819, NS30687, NS052819] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CASERTA F, 1995, J NEUROSCI METH, V56, P133, DOI 10.1016/0165-0270(94)00115-W; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hensler JG, 2003, J NEUROCHEM, V85, P1139, DOI 10.1046/j.1471-4159.2003.01748.x; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Rios M, 2006, J NEUROBIOL, V66, P408, DOI 10.1002/neu.20233; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; SURTEES PG, 2006, IN PRESS J PSYCHIAT, DOI DOI 10.1016/J.JPSYCHIRES.2006.05.015; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656	28	983	1012	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					140	143		10.1126/science.1129663	http://dx.doi.org/10.1126/science.1129663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023662	Green Accepted			2022-12-28	WOS:000241031200055
J	Fukui, Y; Yamamoto, H; Fujishita, M; Kudo, N; Torii, K; Nozawa, S; Takahashi, K; Matsumoto, R; Machida, M; Kawamura, A; Yonekura, Y; Mizuno, N; Onishi, T; Mizuno, A				Fukui, Yasuo; Yamamoto, Hiroaki; Fujishita, Motosuji; Kudo, Natsuko; Torii, Kazufumi; Nozawa, Satoshi; Takahashi, Kunio; Matsumoto, Ryoji; Machida, Mami; Kawamura, Akiko; Yonekura, Yoshinori; Mizuno, Norikazu; Onishi, Toshikazu; Mizuno, Akira			Molecular loops in the galactic center: Evidence for magnetic flotation	SCIENCE			English	Article							NONUNIFORM GRAVITATIONAL-FIELDS; SCALE CO SURVEY; PARKER INSTABILITY; CENTER REGION; CLOUDS; NANTEN; GALAXY; EMISSION; GAS	The central few hundred parsecs of the Milky Way host a massive black hole and exhibit very violent gas motion and high temperatures in molecular gas. The origin of these properties has been a mystery for the past four decades. Wide-field imaging of the (12)CO ( rotational quantum number J = 1 to 0) 2.6-millimeter spectrum has revealed huge loops of dense molecular gas with strong velocity dispersions in the galactic center. We present a magnetic flotation model to explain that the formation of the loops is due to magnetic buoyancy caused by the Parker instability. The model has the potential to offer a coherent explanation for the origin of the violent motion and extensive heating of the molecular gas in the galactic center.	Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Ibaraki Univ, Dept Sci, Mito, Ibaraki 3108512, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Grad Univ Adv Studies, Kanagawa 2400193, Japan; Chiba Univ, Fac Sci, Dept Phys, Inage Ku, Chiba 2638522, Japan; Osaka Prefecture Univ, Dept Phys Sci, Osaka 5998531, Japan; Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Ibaraki University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Chiba University; Osaka Metropolitan University; Nagoya University	Fukui, Y (corresponding author), Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	fukui@a.phys.nagoya-u.ac.jp	Matsumoto, Ryoji/G-3668-2017	Matsumoto, Ryoji/0000-0002-9500-384X; Machida, Mami/0000-0001-6353-7639; TORII, KAZUFUMI/0000-0003-2450-1611; Fukui, Yasuo/0000-0002-8966-9856				BALLY J, 1988, ASTROPHYS J, V324, P223, DOI 10.1086/165891; BANIA TM, 1977, ASTROPHYS J, V216, P381, DOI 10.1086/155478; Bitran M, 1997, ASTRON ASTROPHYS SUP, V125, P99, DOI 10.1051/aas:1997214; BURTON WB, 1978, ASTROPHYS J, V225, P815, DOI 10.1086/156547; Chuss DT, 2003, ASTROPHYS J, V599, P1116, DOI 10.1086/379538; Fukui Y, 1999, PUBL ASTRON SOC JPN, V51, P751, DOI 10.1093/pasj/51.6.751; GUSTEN R, 2004, P 4 COL BONN ZERM S, P253; HARRIS IA, 1985, ASTROPHYS J, V294, pL93; HORIUCHI T, 1988, PUBL ASTRON SOC JPN, V40, P147; LaRosa TN, 2005, ASTROPHYS J, V626, pL23, DOI 10.1086/431647; Machida M., 2000, APJ, V532, P67; MATSUMOTO R, 1988, PUBL ASTRON SOC JPN, V40, P171; Matsunaga K, 2001, PUBL ASTRON SOC JPN, V53, P1003, DOI 10.1093/pasj/53.6.1003; Mizuno A, 2004, ASTR SOC P, V317, P59; MORRIS M, 1992, ASTROPHYS J, V399, pL63, DOI 10.1086/186607; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Nozawa S, 2005, PUBL ASTRON SOC JPN, V57, P995, DOI 10.1093/pasj/57.6.995; Oka T, 2005, ASTROPHYS J, V632, P882, DOI 10.1086/432679; Oka T, 1998, ASTROPHYS J SUPPL S, V118, P455, DOI 10.1086/313138; PARKER EN, 1966, ASTROPHYS J, V145, P811, DOI 10.1086/148828; Rodriguez-Fernandez NJ, 2001, ASTRON ASTROPHYS, V365, P174, DOI 10.1051/0004-6361:20000020; SHIBATA K, 1991, NATURE, V353, P633, DOI 10.1038/353633a0; Tsuboi M, 1999, ASTROPHYS J SUPPL S, V120, P1, DOI 10.1086/313165; UCHIDA KI, 1995, ASTRON ASTROPHYS, V298, P473; YUSEFZADEH F, 1984, NATURE, V310, P557, DOI 10.1038/310557a0	25	73	74	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					106	109		10.1126/science.1130425	http://dx.doi.org/10.1126/science.1130425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023654				2022-12-28	WOS:000241031200045
J	Morris, M				Morris, Mark			Galactic prominences on the rise	SCIENCE			English	Editorial Material							GAS		Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Morris, M (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	morris@astro.ucla.edu		Morris, Mark/0000-0002-6753-2066				ELMEGREEN BG, 1982, ASTROPHYS J, V253, P634, DOI 10.1086/159665; Fukui Y, 2006, SCIENCE, V314, P106, DOI 10.1126/science.1130425; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Novak G, 2003, ASTROPHYS J, V583, pL83, DOI 10.1086/368156; PARKER EN, 1966, ASTROPHYS J, V145, P811, DOI 10.1086/148828; Yusef-Zadeh F, 2004, ASTROPHYS J SUPPL S, V155, P421, DOI 10.1086/425257	6	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					70	71		10.1126/science.1133500	http://dx.doi.org/10.1126/science.1133500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023643				2022-12-28	WOS:000241031200034
J	Park, CY; Dolmetsch, R				Park, Chan Young; Dolmetsch, Richard			The double life of a transcription factor takes it outside the nucleus	SCIENCE			English	Editorial Material							BRUTONS TYROSINE KINASE; TFII-I; WILLIAMS-SYNDROME; EXPRESSION; CHANNELS; DISORDER; ENTRY; BRAIN; TRPC		Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Park, CY (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bird GS, 2004, CURR MOL MED, V4, P291, DOI 10.2174/1566524043360681; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Danoff SK, 2004, NEUROSCIENCE, V123, P931, DOI 10.1016/j.neuroscience.2003.08.038; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Franke Y, 1999, CYTOGENET CELL GENET, V86, P296, DOI 10.1159/000015322; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604	16	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					64	65		10.1126/science.1133757	http://dx.doi.org/10.1126/science.1133757			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023638				2022-12-28	WOS:000241031200029
J	Drake, JF; Swisdak, M; Che, H; Shay, MA				Drake, J. F.; Swisdak, M.; Che, H.; Shay, M. A.			Electron acceleration from contracting magnetic islands during reconnection	NATURE			English	Article							PARTICLE-ACCELERATION; MAGNETOTAIL; ORBITS	A long-standing problem in the study of space and astrophysical plasmas is to explain the production of energetic electrons as magnetic fields 'reconnect' and release energy. In the Earth's magnetosphere, electron energies reach hundreds of thousands of electron volts (refs 1 - 3), whereas the typical electron energies associated with large-scale reconnection-driven flows are just a few electron volts. Recent observations further suggest that these energetic particles are produced in the region where the magnetic field reconnects(4). In solar flares, upwards of 50 per cent of the energy released can appear as energetic electrons(5,6). Here we show that electrons gain kinetic energy by reflecting from the ends of the contracting 'magnetic islands' that form as reconnection proceeds. The mechanism is analogous to the increase of energy of a ball reflecting between two converging walls - the ball gains energy with each bounce. The repetitive interaction of electrons with many islands allows large numbers to be efficiently accelerated to high energy. The back pressure of the energetic electrons throttles reconnection so that the electron energy gain is a large fraction of the released magnetic energy. The resultant energy spectra of electrons take the form of power laws with spectral indices that match the magnetospheric observations.	Univ Maryland, College Pk, MD 20742 USA; USN, Res Lab, Div Plasma Phys, Washington, DC 20375 USA; Univ Delaware, Newark, DE 19716 USA	University System of Maryland; University of Maryland College Park; United States Department of Defense; United States Navy; Naval Research Laboratory; University of Delaware	Drake, JF (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	drake@plasma.umd.edu	Shay, Michael A/G-5476-2013; Swisdak, Michael/R-1352-2017; Che, Haihong/AAX-9286-2021; Drake, James/P-9477-2017	Swisdak, Michael/0000-0002-5435-3544; Drake, James/0000-0002-9150-1841				BAKER DN, 1976, GEOPHYS RES LETT, V3, P557, DOI 10.1029/GL003i009p00557; Birn J, 2004, PHYS PLASMAS, V11, P1825, DOI 10.1063/1.1704641; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Drake JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025957; Drake JF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.095001; GALEEV AA, 1986, SPACE SCI REV, V44, P1, DOI 10.1007/BF00227227; Holman GD, 2005, ADV SPACE RES, V35, P1669, DOI 10.1016/j.asr.2004.11.022; Imada S, 2005, Frontiers in Magnetospheric Plasma Physics: Celebrating 10 Years of Geotail Operation, P34; JOKIPII JR, 1969, ASTROPHYS J, V155, P777, DOI 10.1086/149909; KLIEM B, 1994, ASTROPHYS J SUPPL S, V90, P719, DOI 10.1086/191896; Lin J, 2005, ASTROPHYS J, V622, P1251, DOI 10.1086/428110; Lin RP, 2003, ASTROPHYS J, V595, pL69, DOI 10.1086/378932; LIN RP, 1971, SOL PHYS, V17, P412, DOI 10.1007/BF00150045; MATTHAEUS WH, 1984, PHYS REV LETT, V53, P1449, DOI 10.1103/PhysRevLett.53.1449; MENG CI, 1981, J GEOPHYS RES-SPACE, V86, P5682, DOI 10.1029/JA086iA07p05682; Miller JA, 1997, J GEOPHYS RES-SPACE, V102, P14631, DOI 10.1029/97JA00976; Oieroset M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195001; Pritchett PL, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA009999; Shibata K, 2001, EARTH PLANETS SPACE, V53, P473, DOI 10.1186/BF03353258; TERASAWA T, 1976, PLANET SPACE SCI, V24, P855, DOI 10.1016/0032-0633(76)90076-3; Zeiler A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000287; Zelenyi L, 1991, ADV SPACE RES, V11, P177, DOI [10.1016/0273-1177(91)90030-N, DOI 10.1016/0273-1177(91)90030-N]	22	684	693	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					553	556		10.1038/nature05116	http://dx.doi.org/10.1038/nature05116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024088				2022-12-28	WOS:000240988200038
J	Laureys, M				Laureys, Marc			Arteriovenous fistula on CT angiography	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Laureys, M (corresponding author), Free Univ Brussels, Hop Erasme, 808 Route Lennik, B-1070 Brussels, Belgium.	marc.laureys@ulb.ac.be							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					E15	E15		10.1056/NEJMicm050326	http://dx.doi.org/10.1056/NEJMicm050326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021314				2022-12-28	WOS:000240976200011
J	Scannell, K				Scannell, Kate			An aging un-American	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Dept Med Eth, Oakland, CA USA	University of California System; University of California San Francisco; Kaiser Permanente	Scannell, K (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.								0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1415	1417		10.1056/NEJMp068068	http://dx.doi.org/10.1056/NEJMp068068			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	090UA	17021317				2022-12-28	WOS:000240976200003
J	Wall, LL				Wall, L. Lewis			Obstetric vesicovaginal fistula as an international public-health problem	LANCET			English	Review							RESIDUAL URINARY-INCONTINENCE; SAFE MOTHERHOOD; SURGICAL-MANAGEMENT; SUCCESSFUL REPAIR; OBSTRUCTED LABOR; NORTHERN NIGERIA; VAGINAL FISTULAS; GENITOURINARY; EXPERIENCE; CLASSIFICATION	Vesicovaginal fistula is a devastating injury in which an abnormal opening forms between a woman's bladder and vagina, resulting in urinary incontinence. This condition is rare in developed countries, but in developing countries it is a common complication of childbirth resulting from prolonged obstructed labour. Estimates suggest that at least 3 million women in poor countries have unrepaired vesicovaginal fistulas, and that 30 000-130 000 new cases develop each year in Africa alone. The general public and the world medical community remain largely unaware of this problem. In this article I review the pathophysiology of vesicovaginal fistula in obstructed labour and describe the effect of this condition on the lives of women in developing countries. Policy recommendations to combat this problem include enhancing public awareness, raising the priority of women's reproductive health for developing countries and aid agencies, expanding access to emergency obstetric services, and creation of fistula repair centres.	Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anthropol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wall, LL (corresponding author), Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO 63110 USA.	walll@wustl.edu						Abitbol MM., 1996, BIRTH HUMAN EVOLUTIO; ABOUZAHR C, 1998, HLTH DIMENSIONS SEX, P243; Arrowsmith S, 1996, Obstet Gynecol Surv, V51, P568, DOI 10.1097/00006254-199609000-00024; ARROWSMITH SD, 1994, J UROLOGY, V152, P403, DOI 10.1016/S0022-5347(17)32749-0; Browning A, 2006, BJOG-INT J OBSTET GY, V113, P482, DOI 10.1111/j.1471-0528.2006.00875.x; Browning A, 2006, BJOG-INT J OBSTET GY, V113, P475, DOI 10.1111/j.1471-0528.2006.00847.x; Browning A, 2004, BJOG-INT J OBSTET GY, V111, P357, DOI 10.1111/j.1471-0528.2004.00080.x; Carey MP, 2002, AM J OBSTET GYNECOL, V186, P948, DOI 10.1067/mob.2002.122247; Cockshott W P, 1973, Clin Radiol, V24, P241, DOI 10.1016/S0009-9260(73)80091-1; Danso K A, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P117, DOI 10.1007/BF01894198; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; ELKINS TE, 1990, OBSTET GYNECOL, V75, P727; ELKINS TE, 1994, AM J OBSTET GYNECOL, V170, P1108, DOI 10.1016/S0002-9378(94)70105-9; ELKINS TE, 1996, J PELVIC SURG, V2, P182; EMEMBOLU J, 1992, INT J GYNECOL OBSTET, V39, P205, DOI 10.1016/0020-7292(92)90658-6; EngenderHealth, 2003, OBST FIST NEEDS ASS; FORTNEY JA, 1996, BASE ICEBERG PREVALE; Gessessew A, 2003, ETHIOPIAN MED J, V41, P123; Goh JTW, 2005, BJOG-INT J OBSTET GY, V112, P1328, DOI 10.1111/j.1471-0528.2005.00712.x; Goh JTW, 2004, AUST NZ J OBSTET GYN, V44, P502, DOI 10.1111/j.1479-828X.2004.00315.x; GOODWIN WE, 1980, J UROLOGY, V123, P370, DOI 10.1016/S0022-5347(17)55941-8; Graham W, 1998, BRIT J OBSTET GYNAEC, V105, P375, DOI 10.1111/j.1471-0528.1998.tb10116.x; Hamlin Catherine, 2001, HOSP RIVER STORY HOP; HAMLIN RHJ, 1969, BMJ-BRIT MED J, V2, P147, DOI 10.1136/bmj.2.5650.147; Harrison K A, 1997, Afr J Reprod Health, V1, P7, DOI 10.2307/3583270; HASSIM AM, 1974, BRIT J SURG, V61, P461, DOI 10.1002/bjs.1800610612; Hilton P, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P189, DOI 10.1007/BF01901602; HUDSON CN, 1975, BRIT J OBSTET GYNAEC, V82, P501, DOI 10.1111/j.1471-0528.1975.tb00676.x; Islam A I, 1992, Bangladesh Med Res Counc Bull, V18, P82; KELLY J, 1993, INT UROGYNECOL J PEL, V4, P278; KOLAWOLE TM, 1978, CLIN RADIOL, V29, P85, DOI 10.1016/S0009-9260(78)80172-X; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; LAGUNDOYE SB, 1976, CLIN RADIOL, V27, P531, DOI 10.1016/S0009-9260(76)80122-5; Lancet, 1994, LANCET, p[1994, 1399]; Langkilde NC, 1999, SCAND J UROL NEPHROL, V33, P100; Loudon Irvine, 1993, DEATH CHILDBIRTH INT; Mahfouz NP, 1938, J OBSTET GYN BR COMM, V45, P405; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; Maine D., 1999, SAFE MOTHERHOOD INIT, P175; MARGOLIS T, 1994, OBSTET GYNECOL, V84, P148; MCCONNACHIE ELF, 1958, S AFR MED J, V32, P524; MOERMAN ML, 1982, AM J OBSTET GYNECOL, V143, P528, DOI 10.1016/0002-9378(82)90542-7; Muleta M, 2004, ETHIOPIAN MED J, V42, P9; Muleta M, 1999, LANCET, V354, P2051, DOI 10.1016/S0140-6736(99)05161-2; MURPHY M, 1981, J BIOSOC SCI, V13, P139, DOI 10.1017/S0021932000013304; Murray C, 2002, BJOG-INT J OBSTET GY, V109, P828, DOI 10.1111/j.1471-0528.2002.00124.x; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; NORDBERG EM, 1984, BRIT MED J, V289, P92, DOI 10.1136/bmj.289.6437.92; Rangnekar NP, 2000, J AM COLL SURGEONS, V191, P259, DOI 10.1016/S1072-7515(00)00351-3; Saint George J, 1969, J Obstet Gynaecol Br Commonw, V76, P741; Seim AR, 2005, B WORLD HEALTH ORGAN, V83, P392; Shiffman J, 2004, HEALTH POLICY PLANN, V19, P380, DOI 10.1093/heapol/czh053; Shiffman J, 2003, SOC SCI MED, V56, P1197, DOI 10.1016/S0277-9536(02)00119-3; Sims JM., 1852, AM J MED SCI, V23, P59, DOI [10.1097/00000441-185201000-00004, DOI 10.1097/00000441-185201000-00004]; TAHZIB F, 1983, BRIT J OBSTET GYNAEC, V90, P387, DOI 10.1111/j.1471-0528.1983.tb08933.x; TAHZIB F, 1985, LANCET, V2, P1291; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Vangeenderhuysen C, 2001, INT J GYNECOL OBSTET, V73, P65, DOI 10.1016/S0020-7292(00)00374-X; Waaldijk K, 2004, AM J OBSTET GYNECOL, V191, P795, DOI 10.1016/j.ajog.2004.02.020; Waaldijk K, 1997, TROP DOCT, V27, P227, DOI 10.1177/004947559702700414; WAALDIJK K, 1994, INT J GYNECOL OBSTET, V45, P11, DOI 10.1016/0020-7292(94)90759-5; WAALDIJK K, 1995, INT J GYNECOL OBSTET, V49, P161, DOI 10.1016/0020-7292(95)02350-L; Waaldijk K, 1994, STEP BY STEP SURG VE; Waaldijk K., 1993, INT UROGYNECOL J, V4, P126, DOI [10.1007/BF00376428, DOI 10.1007/BF00376428]; Wall LL, 2006, INT UROGYNECOL J, V17, P559, DOI 10.1007/s00192-005-0056-8; Wall LL, 2005, J WOMENS HEALTH, V14, P863, DOI 10.1089/jwh.2005.14.863; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; Wall LL, 2002, OBSTET GYNECOL, V100, P1328, DOI 10.1016/S0029-7844(02)02498-5; Wall LL, 1998, STUD FAMILY PLANN, V29, P341, DOI 10.2307/172248; WALL LL, 2005, OBSTET GYNECOL SU S1, V60, P51; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; WHO, 1991, ESS EL OBST CAR 1 RE; WHO, 2004, MAT MORT 2000 EST DE; Zacharin RF, 2000, AUST NZ J SURG, V70, P851, DOI 10.1046/j.1440-1622.2000.01990.x	74	262	265	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1201	1209		10.1016/S0140-6736(06)69476-2	http://dx.doi.org/10.1016/S0140-6736(06)69476-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089XU	17011947				2022-12-28	WOS:000240916000032
J	Scheeres, DJ; Fahnestock, EG; Ostro, SJ; Margot, JL; Benner, LAM; Broschart, SB; Bellerose, J; Giorgini, JD; Nolan, MC; Magri, C; Pravec, P; Scheirich, P; Rose, R; Jurgens, RF; De Jong, EM; Suzuki, S				Scheeres, D. J.; Fahnestock, E. G.; Ostro, S. J.; Margot, J. -L.; Benner, L. A. M.; Broschart, S. B.; Bellerose, J.; Giorgini, J. D.; Nolan, M. C.; Magri, C.; Pravec, P.; Scheirich, P.; Rose, R.; Jurgens, R. F.; De Jong, E. M.; Suzuki, S.			Dynamical configuration of binary near-Earth asteroid (66391) 1999 KW4	SCIENCE			English	Article							RIGID BODIES; ASTEROIDS; MOTION; MODEL	Dynamical simulations of the coupled rotational and orbital dynamics of binary near-Earth asteroid 66391 ( 1999 KW4) suggest that it is excited as a result of perturbations from the Sun during perihelion passages. Excitation of the mutual orbit will stimulate complex fluctuations in the orbit and rotation of both components, inducing the attitude of the smaller component to have large variation within some orbits and to hardly vary within others. The primary's proximity to its rotational stability limit suggests an origin from spin-up and disruption of a loosely bound precursor within the past million years.	Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arecibo Observ, Arecibo, PR 00612 USA; Univ Maine, Dept Nat Sci, Farmington, ME 04938 USA; Acad Sci Czech Republ, Astron Inst, CZ-25165 Ondrejov, Czech Republic	University of Michigan System; University of Michigan; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; National Aeronautics & Space Administration (NASA); University of Maine System; University of Maine Farmington; University of Maine Orono; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences	Scheeres, DJ (corresponding author), Univ Michigan, Dept Aerosp Engn, 1320 Beal Ave, Ann Arbor, MI 48109 USA.	scheeres@umich.edu	Pravec, Petr/G-9037-2014; Pravec, Petr/AAE-2695-2019; Nolan, Michael C/H-4980-2012; Margot, Jean-Luc/A-6154-2012; Scheirich, Peter/H-4331-2014	Pravec, Petr/0000-0001-8434-9776; Nolan, Michael C/0000-0001-8316-0680; Margot, Jean-Luc/0000-0001-9798-1797; Scheirich, Peter/0000-0001-8518-9532; SCHEERES, DANIEL/0000-0003-0558-3842				Bottke WF, 1996, ICARUS, V124, P372, DOI 10.1006/icar.1996.0215; BOTTKE WF, 2002, ASTEROIDS, V3, P405; BURNS JA, 1973, MON NOT R ASTRON SOC, V165, P403, DOI 10.1093/mnras/165.4.403; COLOMBO G, 1966, ASTRON J, V71, P891, DOI 10.1086/109983; Cuk M, 2005, ICARUS, V176, P418, DOI 10.1016/j.icarus.2005.02.001; FAHNESTOCK EG, IN PRESS CELESTRIAL; FARINELLA P, 1992, ICARUS, V96, P284, DOI 10.1016/0019-1035(92)90081-H; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Guibout V, 2003, CELEST MECH DYN ASTR, V87, P263, DOI 10.1023/B:CELE.0000005720.09027.ee; HE HL, 1994, INT J ROCK MECH MIN, V31, P525; KINOSHITA H, 1972, PUBL ASTRON SOC JPN, V24, P423; Korycansky DG, 2004, ASTROPHYS SPACE SCI, V291, P57, DOI 10.1023/B:ASTR.0000029954.42344.cf; Maciejewski AJ, 1995, CELEST MECH DYN ASTR, V63, P1, DOI 10.1007/BF00691912; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; Miller JK, 2002, ICARUS, V155, P3, DOI 10.1006/icar.2001.6753; MURRAY CD, 1999, SOLAR SYSTEM DYNAMIC, P160; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; Pravec P, 2006, ICARUS, V181, P63, DOI 10.1016/j.icarus.2005.10.014; Richardson DC, 2006, ANNU REV EARTH PL SC, V34, P47, DOI 10.1146/annurev.earth.32.101802.120208; Roig F, 2003, ICARUS, V165, P355, DOI 10.1016/S0019-1035(03)00216-1; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Scheeres DJ, 2005, DYNAM SYST, V20, P23, DOI 10.1080/1468936042000281321; SCHEERES DJ, 2006, 37 LUN PLAN SCI C LE; Walsh KJ, 2006, ICARUS, V180, P201, DOI 10.1016/j.icarus.2005.08.015; Werner RA, 2005, CELEST MECH DYN ASTR, V91, P337, DOI 10.1007/s10569-004-4621-0	25	108	109	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1280	1283		10.1126/science.1133599	http://dx.doi.org/10.1126/science.1133599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17038588				2022-12-28	WOS:000242215800037
J	Janssen, BJC; Christodoulidou, A; McCarthy, A; Lambris, JD; Gros, P				Janssen, Bert J. C.; Christodoulidou, Agni; McCarthy, Andrew; Lambris, John D.; Gros, Piet			Structure of C3b reveals conformational changes that underlie complement activity	NATURE			English	Article							3RD COMPONENT; FACTOR-H; BINDING-SITE; RECEPTOR 2; IMMUNITY; CR-1; C-3; IDENTIFICATION; PATHOGENS; RESIDUES	Resistance to infection and clearance of cell debris in mammals depend on the activation of the complement system, which is an important component of innate and adaptive immunity(1,2). Central to the complement system is the activated form of C3, called C3b, which attaches covalently to target surfaces(3) to amplify complement response, label cells for phagocytosis and stimulate the adaptive immune response. C3b consists of 1,560 amino-acid residues and has 12 domains. It binds various proteins and receptors to effect its functions(4). However, it is not known how C3 changes its conformation into C3b and thereby exposes its many binding sites. Here we present the crystal structure at 4-angstrom resolution of the activated complement protein C3b and describe the conformational rearrangements of the 12 domains that take place upon proteolytic activation. In the activated form the thioester is fully exposed for covalent attachment to target surfaces and is more than 85 angstrom away from the buried site in native C3 (ref. 5). Marked domain rearrangements in the alpha-chain present an altered molecular surface, exposing hidden and cryptic sites that are consistent with known putative binding sites of factor B and several complement regulators. The structural data indicate that the large conformational changes in the proteolytic activation and regulation of C3 take place mainly in the first conversion step, from C3 to C3b. These insights are important for the development of strategies to treat immune disorders that involve complement-mediated inflammation.	Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Utrecht University; University of Pennsylvania; European Molecular Biology Laboratory (EMBL)	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016; Janssen, Bert/I-3338-2016; McCarthy, Andrew A/A-5926-2013; Lambris, John/Q-5633-2018	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; McCarthy, Andrew A/0000-0003-4478-0136; Lambris, John/0000-0002-9370-5776				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Inal JM, 2002, J IMMUNOL, V168, P5213, DOI 10.4049/jimmunol.168.10.5213; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kolln J, 2004, J IMMUNOL, V173, P5540, DOI 10.4049/jimmunol.173.9.5540; LAMBRIS JD, 1988, IMMUNOL TODAY, V9, P387, DOI 10.1016/0167-5699(88)91240-6; LAMBRIS JD, 1988, J BIOL CHEM, V263, P12147; LAMBRIS JD, 1980, J EXP MED, V152, P1625, DOI 10.1084/jem.152.6.1625; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; OKEEFE MC, 1988, J BIOL CHEM, V263, P12690; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; ROSS GD, 1982, J IMMUNOL, V129, P2051; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; [No title captured]	30	278	294	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					213	216		10.1038/nature05172	http://dx.doi.org/10.1038/nature05172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051160	Green Published			2022-12-28	WOS:000241867200042
J	Bourlat, SJ; Juliusdottir, T; Lowe, CJ; Freeman, R; Aronowicz, J; Kirschner, M; Lander, ES; Thorndyke, M; Nakano, H; Kohn, AB; Heyland, A; Moroz, LL; Copley, RR; Telford, MJ				Bourlat, Sarah J.; Juliusdottir, Thorhildur; Lowe, Christopher J.; Freeman, Robert; Aronowicz, Jochanan; Kirschner, Mark; Lander, Eric S.; Thorndyke, Michael; Nakano, Hiroaki; Kohn, Andrea B.; Heyland, Andreas; Moroz, Leonid L.; Copley, Richard R.; Telford, Maximilian J.			Deuterostome phylogeny reveals monophyletic chordates and the new phylum Xenoturbellida	NATURE			English	Article							EVOLUTION; ANIMALS; PLATYHELMINTHES; ENTEROPNEUSTA; UROCHORDATE; CHARACTERS; FLATWORMS; EPIDERMIS; COLLAGEN; SYSTEMS	Deuterostomes comprise vertebrates, the related invertebrate chordates (tunicates and cephalochordates) and three other invertebrate taxa: hemichordates, echinoderms and Xenoturbella(1). The relationships between invertebrate and vertebrate deuterostomes are clearly important for understanding our own distant origins. Recent phylogenetic studies of chordate classes and a sea urchin have indicated that urochordates might be the closest invertebrate sister group of vertebrates, rather than cephalochordates, as traditionally believed(2-5). More remarkable is the suggestion that cephalochordates are closer to echinoderms than to vertebrates and urochordates, meaning that chordates are paraphyletic(2). To study the relationships among all deuterostome groups, we have assembled an alignment of more than 35,000 homologous amino acids, including new data from a hemichordate, starfish and Xenoturbella. We have also sequenced the mitochondrial genome of Xenoturbella. We support the clades Olfactores ( urochordates and vertebrates) and Ambulacraria ( hemichordates and echinoderms(6)). Analyses using our new data, however, do not support a cephalochordate and echinoderm grouping and we conclude that chordates are monophyletic. Finally, nuclear and mitochondrial data place Xenoturbella as the sister group of the two ambulacrarian phyla(1). As such, Xenoturbella is shown to be an independent phylum, Xenoturbellida, bringing the number of living deuterostome phyla to four.	UCL, Dept Biol, London WC1E 6BT, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Royal Swedish Acad Sci, Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA	University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of Chicago; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Royal Swedish Academy of Sciences; State University System of Florida; University of Florida	Telford, MJ (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Bourlat, Sarah/A-5232-2009; Telford, Maximilian J/B-7178-2008; Bourlat, Sarah/AAR-2251-2020	Bourlat, Sarah/0000-0003-0218-0298; Telford, Maximilian J/0000-0002-3749-5620; Moroz, Leonid/0000-0002-1333-3176; Freeman, Robert/0000-0003-1463-9748; Heyland, Andreas/0000-0002-7592-4473; Lowe, Christopher/0000-0002-7789-8643	Biotechnology and Biological Sciences Research Council [BB/C509866/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aguinaldo AMA, 1998, AM ZOOL, V38, P878; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; JEFFERIES RPS, 1991, CIBA F SYMP, V162, P94; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; JOBB G, 2006, TREEFINDER VERSION M; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Oda H, 2002, EVOL DEV, V4, P426, DOI 10.1046/j.1525-142X.2002.02031.x; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; PEDERSEN KJ, 1988, ACTA ZOOL-STOCKHOLM, V69, P231, DOI 10.1111/j.1463-6395.1988.tb00920.x; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; PHILLIPE H, IN PRESS TRENDS ECOL; Raikova OI, 2000, ZOOMORPHOLOGY, V120, P107, DOI 10.1007/s004350000028; REISINGER ERICH, 1960, ZEITSCHR WISS ZOOL, V164, P188; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Stach T, 2005, J MAR BIOL ASSOC UK, V85, P1519, DOI 10.1017/S0025315405012725; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; WEICHERT CK, 1965, ANATOMY CHORDATES; Westblad E., 1949, ARK ZOOL, V1, P3; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9	30	399	412	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					85	88		10.1038/nature05241	http://dx.doi.org/10.1038/nature05241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17051155				2022-12-28	WOS:000241701500050
J	Lagage, PO; Doucet, C; Pantin, E; Habart, E; Duchene, G; Menard, F; Pinte, C; Charnoz, S; Pel, JW				Lagage, Pierre-Olivier; Doucet, Coralie; Pantin, Eric; Habart, Emilie; Duchene, Gaspard; Menard, Francois; Pinte, Christophe; Charnoz, Sebastien; Pel, Jan-Willem			Anatomy of a flaring proto-planetary disk around a young intermediate-mass star	SCIENCE			English	Article							HERBIG AE/BE STARS; ISO SPECTROSCOPY; PLANET FORMATION; BETA-PICTORIS; DUST; SYSTEMS; DISTRIBUTIONS; EMISSION; NEBULA; GAS	Although planets are being discovered around stars more massive than the Sun, information about the proto-planetary disks where such planets have built up is sparse. We have imaged mid-infrared emission from polycyclic aromatic hydrocarbons at the surface of the disk surrounding the young intermediate-mass star HD 97048 and characterized the disk. The disk is in an early stage of evolution, as indicated by its large content of dust and its hydrostatic flared geometry, indicative of the presence of a large amount of gas that is well mixed with dust and gravitationally stable. The disk is a precursor of debris disks found around more-evolved A stars such as beta-Pictoris and provides the rare opportunity to witness the conditions prevailing before ( or during) planet formation.	Univ Paris 07, CEA Saclay,CNRS,Unite Mixte Rech 7158, Lab Astrophys Interact Multiechelles,Direct Sci M, Lab Rech Lois Fondamentales,Univers DAPNIA,Serv A, F-91191 Gif Sur Yvette, France; Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Grenoble 1, CNRS, Unite Mixte Rech 5571, F-38041 Grenoble, France; Univ Groningen, Groningen, Netherlands; Netherlands Fdn Res Astron, NL-7990 AA Dwingeloo, Netherlands	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Groningen	Lagage, PO (corresponding author), Univ Paris 07, CEA Saclay,CNRS,Unite Mixte Rech 7158, Lab Astrophys Interact Multiechelles,Direct Sci M, Lab Rech Lois Fondamentales,Univers DAPNIA,Serv A, F-91191 Gif Sur Yvette, France.	Pierre-Olivier.Lagage@cea.fr		Duchene, Gaspard/0000-0002-5092-6464				Acke B, 2004, ASTRON ASTROPHYS, V426, P151, DOI 10.1051/0004-6361:20040400; Artymowicz P, 1997, ANNU REV EARTH PL SC, V25, P175, DOI 10.1146/annurev.earth.25.1.175; Chiang EI, 2001, ASTROPHYS J, V547, P1077, DOI 10.1086/318427; DURISEN RH, 2006, PROTOSTARS PLANETS, V5; Goldreich P, 2004, ASTROPHYS J, V614, P497, DOI 10.1086/423612; Grady CA, 2005, ASTROPHYS J, V630, P958, DOI 10.1086/430731; Greaves JS, 2005, SCIENCE, V307, P68, DOI 10.1126/science.1101979; Henning T, 1998, ASTRON ASTROPHYS, V336, P565; Ida S, 2004, ASTROPHYS J, V604, P388, DOI 10.1086/381724; Kuchner MJ, 2004, ASTROPHYS J, V612, P1147, DOI 10.1086/422577; Lagage P. O., 2004, MESSENGER, V117, P12; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Mannings V, 2000, ASTROPHYS J, V529, P391, DOI 10.1086/308253; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476, DOI 10.1051/0004-6361:20000144; ODell CR, 1997, SCIENCE, V276, P1355, DOI 10.1126/science.276.5317.1355; OSSENKOPF V, 1994, ASTRON ASTROPHYS, V291, P943; PRUSTI T, 1994, ASTRON ASTROPHYS, V292, P593; PUGET JL, 1989, ANNU REV ASTRON ASTR, V27, P161; Setiawan J, 2005, ASTRON ASTROPHYS, V437, pL31, DOI 10.1051/0004-6361:200500133; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Takeuchi T, 2005, ASTROPHYS J, V627, P286, DOI 10.1086/430393; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; van Boekel R, 2004, ASTRON ASTROPHYS, V418, P177, DOI 10.1051/0004-6361:20034331; van den Ancker ME, 1998, ASTRON ASTROPHYS, V330, P145; Van Kerckhoven C, 2002, ASTRON ASTROPHYS, V384, P568, DOI 10.1051/0004-6361:20011814; WEIDENSCHILLING SJ, 1977, ASTROPHYS SPACE SCI, V51, P153, DOI 10.1007/BF00642464; WEINTRAUB JS, 2006, P PROT PLAN 5 C WAIK, P8197	27	74	74	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					621	623		10.1126/science.1131436	http://dx.doi.org/10.1126/science.1131436			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17008490				2022-12-28	WOS:000241557800038
J	Chiappe, LM; Bertelli, S				Chiappe, Luis M.; Bertelli, Sara			Skull morphology of giant terror birds	NATURE			English	Article									Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA		Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA.	chiappe@nhm.org		Chiappe, Luis/0000-0001-9661-0601				Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; ALVARENGA HMF, 1982, AN ACAD BRAS CIENC, V54, P697; AMEGHINO F, 1895, B I GEOGRAFICO ARGEN, V15, P501; Andrews C.W., 1901, T ZOOLOGICAL SOC LON, V15, P55; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Gould Gina C., 2005, Bulletin of the Florida Museum of Natural History, V45, P201; Kraglievich L., 1932, Anales de Museo Montevideo (2), V3, P323; Livezey BC, 1998, PHILOS T R SOC B, V353, P2077, DOI 10.1098/rstb.1998.0353; MARSHALL LG, 1994, SCI AM, V270, P90, DOI 10.1038/scientificamerican0294-90; Patterson B., 1960, Publ Mus Cienc nat Mar del Plata, V1, P1; SINCLAIR WJ, 1932, REPORTS PRINCETON U, P157; Tambussi C. P, 1996, CONTRIBUTIONS SO S A, p[245, 30]; TONNI EP, 1980, NATURAL HIST MUSEUM, V330, P105	13	8	10	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					929	929		10.1038/443929a	http://dx.doi.org/10.1038/443929a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066027	Bronze			2022-12-28	WOS:000241523400041
J	Henschke, CI; Yankelevitz, DF; Libby, DM; Pasmantier, MW; Smith, JP; Miettinen, OS				Henschke, Claudia I.; Yankelevitz, David F.; Libby, Daniel M.; Pasmantier, Mark W.; Smith, James P.; Miettinen, Olli S.		Int Early Lung Canc Action Program	Survival of patients with stage I lung cancer detected on CT screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COST-EFFECTIVENESS; ACTION PROJECT; FOLLOW-UP; NODULES; SIZE; TIME		Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, New York, NY 10021 USA; McGill Univ, Montreal, PQ, Canada	Cornell University; NewYork-Presbyterian Hospital; McGill University	Henschke, CI (corresponding author), Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, 525 E 168th St, New York, NY 10021 USA.	chensch@med.cornell.edu	Zulueta, Javier J/H-5127-2011	Zulueta, Javier J/0000-0003-3182-3555; Sullivan, Francis J./0000-0001-5111-5383	NCI NIH HHS [R01-CA-78905, R01-CA-633931] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078905] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG HLTH CAR POL R, 1994, AG HLTH CAR POL RES, P82; Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; *AM CANC SOC, 2005, CANC FACTS FIG STAT; Buell P E, 1971, J Surg Oncol, V3, P539, DOI 10.1002/jso.2930030509; Chirikos TN, 2002, CHEST, V121, P1507, DOI 10.1378/chest.121.5.1507; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2006, ARCH INTERN MED, V166, P321, DOI 10.1001/archinte.166.3.321; Henschke CI, 2004, CLIN IMAG, V28, P317, DOI 10.1016/j.clinimag.2004.05.001; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2003, LUNG CANCER-J IASLC, V39, P327, DOI 10.1016/S0169-5002(02)00503-2; Henschke CI, 2002, LUNG CANCER-J IASLC, V35, P143, DOI 10.1016/S0169-5002(01)00416-0; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; HENSCHKE CI, 2002, PROGR ONCOLOGY 2002; International Early Lung Cancer Action Program Investigators, INT EARL LUNG CANC A; Kostis WJ, 2004, RADIOLOGY, V231, P446, DOI 10.1148/radiol.2312030553; Libby DM, 2006, CHEST, V129, P1039, DOI 10.1378/chest.129.4.1039; LINDFORS KK, 1995, JAMA-J AM MED ASSOC, V274, P881, DOI 10.1001/jama.274.11.881; Lindfors KK, 1996, JAMA-J AM MED ASSOC, V275, P112; Marshall D, 2001, LUNG CANCER, V32, P227, DOI 10.1016/S0169-5002(00)00239-7; Marshall D, 2001, EUR J CANCER, V37, P1759, DOI 10.1016/S0959-8049(01)00205-2; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Miettinen OS, 2000, CAN MED ASSOC J, V162, P1431; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; REEVES AP, 2001, 87 ANN M RAD SOC N A; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Rosenquist CJ, 1998, CANCER, V82, P2235, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2235::AID-CNCR19>3.0.CO;2-V; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Travis W, 2004, WHO CLASSIFICATION T; Vazquez M, 2003, LUNG CANCER-J IASLC, V39, P231, DOI 10.1016/S0169-5002(02)00452-X; Wisnivesky JP, 2003, CHEST, V124, P614, DOI 10.1378/chest.124.2.614	31	1253	1314	5	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1763	1771						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065637				2022-12-28	WOS:000241512500004
J	Das, P				Das, Pam			Lunch with The Lancet Richard Gere	LANCET			English	Editorial Material												pamela.das@lancet.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1413	1413		10.1016/S0140-6736(06)69592-5	http://dx.doi.org/10.1016/S0140-6736(06)69592-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055931				2022-12-28	WOS:000241459100015
J	van de Pas, R				van de Pas, Remco			Darfur-dependent population at risk of another catastrophe	BRITISH MEDICAL JOURNAL			English	Editorial Material											van de Pas, R (corresponding author), Margrietstr 8, NL-5056 HL Berkel Enschot, Netherlands.	R.vandepas@gmx.net						Petersen Andreas, 2006, SCORCHED EARTH DARFU; *UN OFF COORD HUM, SUD BRIEF J EG SECR; *UN OFF COORD HUM, 2006, SUD NCOS UN COV PER	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 21	2006	333	7573					846	847		10.1136/bmj.38986.426354.68	http://dx.doi.org/10.1136/bmj.38986.426354.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053242	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000241678500020
J	Goley, ED; Ohkawa, T; Mancuso, J; Woodruff, JB; D'Alessio, JA; Cande, WZ; Volkman, LE; Welch, MD				Goley, Erin D.; Ohkawa, Taro; Mancuso, Joel; Woodruff, Jeffrey B.; D'Alessio, Joseph A.; Cande, W. Zacheus; Volkman, Loy E.; Welch, Matthew D.			Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like protein	SCIENCE			English	Article							WASP/SCAR PROTEINS; CYTOCHALASIN-D; CELLS; NUCLEOPOLYHEDROVIRUS	Diverse bacterial and viral pathogens induce actin polymerization in the cytoplasm of host cells to facilitate infection. Here, we describe a pathogenic mechanism for promoting dynamic actin assembly in the nucleus to enable viral replication. The baculovirus Autographa californica multiple nucleopolyhedrovirus induced nuclear actin polymerization by translocating the host actin-nucleating Arp2/3 complex into the nucleus, where it was activated by p78/83, a viral Wiskott-Aldrich syndrome protein (WASP)-like protein. Nuclear actin assembly by p78/83 and Arp2/3 complex was essential for viral progeny production. Recompartmentalizing dynamic host actin may represent a conserved mode of pathogenesis and reflect viral manipulation of normal functions of nuclear actin.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu		Goley, Erin/0000-0002-8518-2303	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054693] Funding Source: Medline; NIGMS NIH HHS [GM59609, R01 GM059609, R01 GM059609-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357; CHARLTON CA, 1993, VIROLOGY, V197, P245, DOI 10.1006/viro.1993.1585; CHARLTON CA, 1991, J VIROL, V65, P1219, DOI 10.1128/JVI.65.3.1219-1227.1991; Feierbach B, 2006, PLOS PATHOG, V2, P763, DOI 10.1371/journal.ppat.0020085; HESS RT, 1989, J INVERTEBR PATHOL, V53, P169, DOI 10.1016/0022-2011(89)90005-0; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Nie YC, 2006, VIRUS RES, V116, P129, DOI 10.1016/j.virusres.2005.09.007; Ohkawa T, 2002, J VIROL, V76, P12281, DOI 10.1128/JVI.76.23.12281-12289.2002; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; POSSEE RD, 1991, VIROLOGY, V185, P229, DOI 10.1016/0042-6822(91)90770-C; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; VOLKMAN LE, 1987, VIROLOGY, V156, P32, DOI 10.1016/0042-6822(87)90433-8; VOLKMAN LE, 1988, VIROLOGY, V163, P547, DOI 10.1016/0042-6822(88)90295-4; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	18	139	157	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					464	467		10.1126/science.1133348	http://dx.doi.org/10.1126/science.1133348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053146				2022-12-28	WOS:000241382500042
J	Morello, R; Bertin, TK; Chen, YQ; Hicks, J; Tonachini, L; Monticone, M; Castagnola, P; Rauch, F; Glorieux, FH; Vranka, J; Bachinger, HP; Pace, JM; Schwarze, U; Byers, PH; Weis, M; Fernandes, RJ; Eyre, DR; Yao, ZQ; Boyce, BF; Lee, B				Morello, Roy; Bertin, Terry K.; Chen, Yuqing; Hicks, John; Tonachini, Laura; Monticone, Massimiliano; Castagnola, Patrizio; Rauch, Frank; Glorieux, Francis H.; Vranka, Janice; Bachinger, Hans Peter; Pace, James M.; Schwarze, Ulrike; Byers, Peter H.; Weis, MaryAnn; Fernandes, Russell J.; Eyre, David R.; Yao, Zhenqing; Boyce, Brendan F.; Lee, Brendan			CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta	CELL			English	Article							CARTILAGE ASSOCIATED PROTEIN; BASEMENT-MEMBRANE COLLAGEN; BONE HISTOMORPHOMETRY; CDNA CLONING; TRIPLE-HELIX; I COLLAGEN; FORM; GENE; PROCOLLAGEN; EXPRESSION	Prolyl hydroxylation is a critical posttranslational modification that affects structure, function, and turnover of target proteins. Prolyl 3-hydroxylation occurs at only one position in the triple-helical domain of fibrillar collagen chains, and its biological significance is unknown. CRTAP shares homology with a family of putative prolyl 3-hydroxylases (P3Hs), but it does not contain their common dioxygenase domain. Loss of Crtap in mice causes an osteo-chondrodysplasia characterized by severe osteoporosis and decreased osteoid production. CRTAP can form a complex with P3H1 and cyclophilin B (CYPB), and Crtap(-/-) bone and cartilage collagens show decreased prolyl 3-hydroxylation. Moreover, mutant collagen shows evidence of overmodification, and collagen fibrils in mutant skin have increased diameter consistent with altered fibrillogenesis. In humans, CRTAP mutations are associated with the clinical spectrum of recessive osteogenesis imperfecta, including the type II and VII forms. Hence, dysregulation of prolyl 3-hydroxylation is a mechanism for connective tissue disease.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Texas Childrens Hosp, Houston, TX 77030 USA; Ist Nazl Ric Canc, I-16132 Genoa, Italy; Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Shriners Hosp Children, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14627 USA; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Genoa; IRCCS AOU San Martino IST; McGill University; McGill University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; Howard Hughes Medical Institute	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu	Rauch, Frank/D-1554-2009; Castagnola, Patrizio/H-2029-2012	Castagnola, Patrizio/0000-0003-2008-9199; Byers, Peter H./0000-0001-7786-7030; Rauch, Frank/0000-0002-6261-0360	NIAMS NIH HHS [AR43510, AR41223, AR37318, R37 AR037318, R01 AR036794, R03 AR052896, AR051459] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; NIDCR NIH HHS [DE01771] Funding Source: Medline; NIEHS NIH HHS [ES11253] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR051459, R01AR036794, R37AR037318, R01AR041223, R01AR037318, R01AR043510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Aravind L, 2001, GENOME BIOL, V2; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Byers P.H., 2002, CONNECTIVE TISSUE HE, P285; Castagnola P, 1997, J CELL SCI, V110, P1351; COHN DH, 1990, AM J HUM GENET, V46, P591; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dreyer SD, 1998, CLIN GENET, V54, P464; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Kuznetsova NV, 2004, MATRIX BIOL, V23, P101, DOI 10.1016/j.matbio.2004.03.002; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MAJAMAA K, 1981, BIOCHEM J, V196, P203, DOI 10.1042/bj1960203; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 2001, NAT GENET, V27, P205, DOI 10.1038/84853; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pepin M, 1997, PRENATAL DIAG, V17, P559, DOI 10.1002/(SICI)1097-0223(199706)17:6<559::AID-PD111>3.3.CO;2-7; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Tonachini L, 2004, J CELL PHYSIOL, V201, P470, DOI 10.1002/jcp.20126; Tonachini L, 1999, CYTOGENET CELL GENET, V87, P191, DOI 10.1159/000015463; TRYGGVASON K, 1979, BIOCHEM J, V178, P127, DOI 10.1042/bj1780127; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200	44	367	385	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					291	304		10.1016/j.cell.2006.08.039	http://dx.doi.org/10.1016/j.cell.2006.08.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055431	Bronze			2022-12-28	WOS:000241827100017
J	Loose, C; Jensen, K; Rigoutsos, I; Stephanopoulos, G				Loose, Christopher; Jensen, Kyle; Rigoutsos, Isidore; Stephanopoulos, Gregory			A linguistic model for the rational design of antimicrobial peptides	NATURE			English	Article							SEQUENCES; MEMBRANE; DATABASE	Antimicrobial peptides (AmPs) are small proteins that are used by the innate immune system to combat bacterial infection in multicellular eukaryotes(1). There is mounting evidence that these peptides are less susceptible to bacterial resistance than traditional antibiotics and could form the basis for a new class of therapeutic agents(2). Here we report the rational design of new AmPs that show limited homology to naturally occurring proteins but have strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis. These peptides were designed using a linguistic model of natural AmPs: we treated the amino-acid sequences of natural AmPs as a formal language and built a set of regular grammars to describe this language. We used this set of grammars to create new, unnatural AmP sequences. Our peptides conform to the formal syntax of natural antimicrobial peptides but populate a previously unexplored region of protein sequence space.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Agrivida, Cambridge, MA 02139 USA; IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Massachusetts Institute of Technology (MIT); Harvard University; International Business Machines (IBM)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Rigoutsos, Isidore/C-5381-2012	Rigoutsos, Isidore/0000-0003-1529-8631				Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Jurafsky Daniel, 2000, SPEECH LANGUAGE PROC, V1st; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; MAIZEL JV, 1981, P NATL ACAD SCI-BIOL, V78, P7665, DOI 10.1073/pnas.78.12.7665; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	168	185	7	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					867	869		10.1038/nature05233	http://dx.doi.org/10.1038/nature05233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051220				2022-12-28	WOS:000241362700054
J	Okie, S				Okie, Susan			Stem-cell politics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Abbott A, 2006, NATURE, V443, P12, DOI 10.1038/443012a; KLIMANSKAYA I, HUMAN EMBRYONIC STEM	2	10	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1633	1635		10.1056/NEJMp068206	http://dx.doi.org/10.1056/NEJMp068206			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096DN	17050884				2022-12-28	WOS:000241357300001
J	Yelin, D; Rizvi, I; White, WM; Motz, JT; Hasan, T; Bouma, BE; Tearney, GJ				Yelin, D.; Rizvi, I.; White, W. M.; Motz, J. T.; Hasan, T.; Bouma, B. E.; Tearney, G. J.			Three-dimensional miniature endoscopy	NATURE			English	Article							INTRADUCTAL LESIONS; DIAGNOSIS; BREAST		Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Yelin, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	gtearney@partners.org	Rizvi, Imran/A-3889-2019; Rizvi, Imran/E-5049-2013	Rizvi, Imran/0000-0001-9673-4700; Rizvi, Imran/0000-0001-9673-4700; Hasan, Tayyaba/0000-0003-0871-6057				HIRSCHOWITZ B, 1961, LANCET, V1, P1074; ISHIBASHI F, 2006, INTERVEN CARDIOL, V19, P17; Jacobs VR, 2005, J MINIM INVAS GYN L, V12, P359, DOI 10.1016/j.jmig.2005.04.004; Matsunaga T, 2004, CANCER-AM CANCER SOC, V101, P2164, DOI 10.1002/cncr.20657; Molpus KL, 1996, INT J CANCER, V68, P588; Motz JT, 2005, OPT LETT, V30, P2760, DOI 10.1364/OL.30.002760; Reece EA, 1999, SEMIN PERINATOL, V23, P424; Shi KB, 2004, OPT EXPRESS, V12, P2096, DOI 10.1364/OPEX.12.002096; Tearney GJ, 2002, OPT LETT, V27, P412, DOI 10.1364/OL.27.000412; Yelin D, 2005, OPT LETT, V30, P1794, DOI 10.1364/OL.30.001794	10	110	138	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					765	765		10.1038/443765a	http://dx.doi.org/10.1038/443765a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051200	Bronze			2022-12-28	WOS:000241362700033
J	Budnitz, DS; Pollock, DA; Weidenbach, KN; Mendelsohn, AB; Schroeder, TJ; Annest, JL				Budnitz, Daniel S.; Pollock, Daniel A.; Weidenbach, Kelly N.; Mendelsohn, Aaron B.; Schroeder, Thomas J.; Annest, Joseph L.			National surveillance of emergency department visits for outpatient adverse drug events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC-VARIATION; MYOCARDIAL-INFARCTION; AMBULATORY-CARE; SAFETY; INJURIES; ERRORS	Context Adverse drug events are common and often preventable causes of medical injuries. However, timely, nationally representative information on outpatient adverse drug events is limited. Objective To describe the frequency and characteristics of adverse drug events that lead to emergency department visits in the United States. Design, Setting, and Participants Active surveillance from January 1, 2004, through December 31, 2005, through the National Electronic Injury Surveillance System Cooperative Adverse Drug Event Surveillance project. Main Outcome Measures National estimates of the numbers, population rates, and severity (measured by hospitalization) of individuals with adverse drug events treated in emergency departments. Results Over the 2-year study period, 21 298 adverse drug event cases were reported, producing weighted annual estimates of 701 547 individuals (95% confidence interval [CI], 509 642-893 452) or 2.4 individuals per 1000 population(95% CI, 1.7-3.0) treated in emergency departments. Of these cases, 3487 individuals required hospitalization (annual estimate, 117 318 [16.7%]; 95% CI, 13.1%-20.3%). Adverse drug events accounted for 2.5% (95% CI, 2.0%-3.1%) of estimated emergency department visits for all unintentional injuries and 6.7% (95% CI, 4.7%-8.7%) of those leading to hospitalization and accounted for 0.6% of estimated emergency department visits for all causes. Individuals aged 65 years or older were more likely than younger individuals to sustain adverse drug events (annual estimate, 4.9 vs 2.0 per 1000; rate ratio [RR], 2.4; 95% CI, 1.8-3.0) and more likely to require hospitalization (annual estimate, 1.6 vs 0.23 per 1000; RR, 6.8; 95% CI, 4.3-9.2). Drugs for which regular outpatient monitoring is used to prevent acute toxicity accounted for 41.5% of estimated hospitalizations overall (1381 cases; 95% CI, 30.9%-52.1%) and 54.4% of estimated hospitalizations among individuals aged 65 years or older (829 cases; 95% CI, 45.0%-63.7%). Conclusions Adverse drug events among outpatients that lead to emergency department visits are an important cause of morbidity in the United States, particularly among individuals aged 65 years or older. Ongoing, population-based surveillance can help monitor these events and target prevention strategies.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; US Consumer Prod Safety Commiss, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Budnitz, DS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Coordinating Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.	dbudnitz@cdc.gov		Mendelsohn, Aaron/0000-0002-0560-1177; Budnitz, Daniel/0000-0002-0136-2623				Ahmad SR, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P135; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Budnitz DS, 2007, PHARMACOEPIDEM DR S, V16, P160, DOI 10.1002/pds.1242; Budnitz DS, 2005, ANN EMERG MED, V45, P197, DOI 10.1016/j.annemergmed.2004.09.020; Carter JS, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P116; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P380; Classen D, 2003, JAMA-J AM MED ASSOC, V289, P1154, DOI 10.1001/jama.289.9.1154; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; *CTR MED MED SERV, TOOLK HLTH CAR PROF; Dubois RW, 2002, HEALTH AFFAIR, V21, P240, DOI 10.1377/hlthaff.21.1.240; *FDA, 2005, EL OR BOOK; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gandhi TK, 2005, J GEN INTERN MED, V20, P837, DOI 10.1111/j.1525-1497.2005.0194.x; General Accounting Office, 2000, ADV DRUG EV MAGN HLT; Graham JD, 1997, JAMA-J AM MED ASSOC, V278, P1418, DOI 10.1001/jama.278.17.1418; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hafner JW, 2002, ANN EMERG MED, V39, P258, DOI 10.1067/mem.2002.121401; Havranek EP, 2004, ARCH INTERN MED, V164, P1186, DOI 10.1001/archinte.164.11.1186; *ICH POINTS CONS W, 2003, MED DRA TERM SEL POI; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Layde PM, 2002, JAMA-J AM MED ASSOC, V287, P1993, DOI 10.1001/jama.287.15.1993; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lopez J, 2004, AM J HYPERTENS, V17, P1095, DOI 10.1016/j.amjhyper.2004.07.015; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Raebel MA, 2006, AM J MANAG CARE, V12, P268; Richter ED, 2006, ANNU REV PUBL HEALTH, V27, P125, DOI 10.1146/annurev.publhealth.27.021405.102225; Rodgers GB, 1996, JAMA-J AM MED ASSOC, V275, P1661, DOI 10.1001/jama.275.21.1661; Schroeder T, 2001, NATL ELECT INJURY SU; SHOJANIA KG, 2001, EVID REP TECHNOL ASS, V43, P87; *SLON EP CTR, 2004, PATT MED US US 2004; Strom BL, 2003, PHARMACOEPIDEM DR S, V12, P653, DOI 10.1002/pds.859; Tierney WM, 2003, NEW ENGL J MED, V348, P1587, DOI 10.1056/NEJMe030026; Trim JC, 2003, J HOSP INFECT, V53, P237, DOI 10.1053/jhin.2002.1378; *US BUR CENS, 2000, ANN EST POP SEX 5 YE; *US BUR CENS, 2000, ANN EST POP SEL AG G; *US CONS PROD SAF, 2002, NAT EL INJ SURV SYST; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Vervloet D, 1998, BRIT MED J, V316, P1511, DOI 10.1136/bmj.316.7143.1511; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234; Zed PJ, 2005, J PHARM PRACT, V18, P329, DOI 10.1177/0897190005280049; Zhan CL, 2005, JT COMM J QUAL PATIE, V31, P372, DOI 10.1016/S1553-7250(05)31050-6	46	598	616	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1858	1866		10.1001/jama.296.15.1858	http://dx.doi.org/10.1001/jama.296.15.1858			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	095ST	17047216				2022-12-28	WOS:000241329300028
J	Joensuu, H				Joensuu, Heikki			Sunitinib for imatinib-resistant GIST	LANCET			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; EFFICACY; MESYLATE; SAFETY; KIT		Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00014 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4, FIN-00014 Helsinki, Finland.	heikki.joensuu@hus.fi		Joensuu, Heikki/0000-0003-0281-2507				Bono P, 2004, BLOOD, V103, P2929, DOI 10.1182/blood-2003-10-3443; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; DEMETRI GD, LANCET; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211	7	46	48	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1303	1304		10.1016/S0140-6736(06)69489-0	http://dx.doi.org/10.1016/S0140-6736(06)69489-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046443				2022-12-28	WOS:000241388100004
J	Kilgore, DB				Kilgore, David B.			The imaginary safety net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												david.kilgore@multicare.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1701	1702		10.1001/jama.296.14.1701	http://dx.doi.org/10.1001/jama.296.14.1701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032975				2022-12-28	WOS:000241103400001
J	Armstrong, N; Jasti, J; Beich-Frandsen, M; Gouaux, E				Armstrong, Neali; Jasti, Jaysankar; Beich-Frandsen, Mads; Gouaux, Eric			Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor	CELL			English	Article							LIGAND-BINDING CORE; CRYSTAL-STRUCTURES; ION-CHANNEL; KINETIC-PROPERTIES; POINT MUTATION; AMPA; CYCLOTHIAZIDE; GLUR2; ACTIVATION; SITE	The canonical conformational states occupied by most ligand-gated ion channels, and many cell-surface receptors, are the resting, activated, and desensitized states. While the resting and activated states of multiple receptors are well characterized, elaboration of the structural properties of the desensitized state, a state that is by definition inactive, has proven difficult. Here we use electrical, chemical, and crystallographic experiments on the AMPA-sensitive GluR2 receptor, defining the conformational rearrangements of the agonist binding cores that occur upon desensitization of this ligand-gated ion channel. These studies demonstrate that desensitization involves the rupture of an extensive interface between domain 1 of 2-fold related glutamate-binding core subunits, compensating for the ca. 21 degrees of domain closure induced by glutamate binding. The rupture of the domain 1 interface allows the ion channel to close and thereby provides a simple explanation to the long-standing question of how agonist binding is decoupled from ion channel gating upon receptor desensitization.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Armstrong, N (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Beich-Frandsen, Mads/H-7689-2014	Gouaux, Eric/0000-0002-8549-2360; Beich-Frandsen, Mads/0000-0002-9573-5119				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOWIE D, 1993, BRIT J PHARMACOL, V109, P779, DOI 10.1111/j.1476-5381.1993.tb13642.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dingledine R, 1999, PHARMACOL REV, V51, P7; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; HALL RA, 1993, BRAIN RES, V628, P345, DOI 10.1016/0006-8993(93)90978-V; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kessler M, 1996, MOL PHARMACOL, V49, P123; Koike M, 2000, J NEUROSCI, V20, P2166; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	41	176	179	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					85	97		10.1016/j.cell.2006.08.037	http://dx.doi.org/10.1016/j.cell.2006.08.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018279	Bronze			2022-12-28	WOS:000241445800016
J	Caraveo, G; van Rossum, DB; Patterson, RL; Snyder, SH; Desiderio, S				Caraveo, Gabriela; van Rossum, Damian B.; Patterson, Randen L.; Snyder, Solomon H.; Desiderio, Stephen			Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry	SCIENCE			English	Article							BRUTONS TYROSINE KINASE; CELL-RECEPTOR ENGAGEMENT; PHOSPHOLIPASE-C-GAMMA; INDUCED CA2+ ENTRY; ACTIVATION; EXPRESSION; GENE; IDENTIFICATION; RECOGNITION; CHANNELS	TFII-I is a transcription factor and a target of phosphorylation by Bruton's tyrosine kinase. In humans, deletions spanning the TFII-I locus are associated with a cognitive defect, the Williams-Beuren cognitive profile. We report an unanticipated role of TFII-I outside the nucleus as a negative regulator of agonist-induced calcium entry (ACE) that suppresses surface accumulation of TRPC3 ( transient receptor potential C3) channels. Inhibition of ACE by TFII-I requires phosphotyrosine residues that engage the SH2 (Src-homology 2) domains of phospholipase C - gamma (PLC-gamma) and an interrupted, pleckstrin homology (PH) - like domain that binds the split PH domain of PLC-gamma. Our observations suggest a model in which TFII-I suppresses ACE by competing with TRPC3 for binding to PLC-gamma.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu		van Rossum, Damian/0000-0003-1011-2586				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bussolino DF, 2001, FASEB J, V15, P556; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Danoff SK, 2004, NEUROSCIENCE, V123, P931, DOI 10.1016/j.neuroscience.2003.08.038; Egloff AM, 2001, J BIOL CHEM, V276, P27806, DOI 10.1074/jbc.M103692200; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Peppiatt CM, 2004, BIOCHEM J, V381, P929, DOI 10.1042/BJ20040097; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Utzny C, 2005, BIOPHYS J, V88, P1, DOI 10.1529/biophysj.103.038216; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a	30	69	69	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					122	125		10.1126/science.1127815	http://dx.doi.org/10.1126/science.1127815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023658				2022-12-28	WOS:000241031200050
J	Chien, YC; Kim, S; Bumeister, R; Loo, YM; Kwon, SW; Johnson, CL; Balakireva, MG; Romeo, Y; Kopelovich, L; Gale, M; Yeaman, C; Camonis, JH; Zhao, YM; White, MA				Chien, Yuchen; Kim, Sungchan; Bumeister, Ron; Loo, Yueh-Ming; Kwon, Sung Won; Johnson, Cynthia L.; Balakireva, Mirey G.; Romeo, Yves; Kopelovich, Levy; Gale, Michael, Jr.; Yeaman, Charles; Camonis, Jacques H.; Zhao, Yingming; White, Michael A.			RaIB GTPase-mediated activation of the I kappa B family kinase TBK1 couples innate immune signaling to tumor cell survival	CELL			English	Article							DOUBLE-STRANDED-RNA; RAL-GTPASES; REGULATORY FACTOR-3; IKK-EPSILON; EXOCYST; MEMBRANE; IDENTIFICATION; PROLIFERATION; EFFECTOR; REQUIREMENTS	The monomeric RaIGTPases, RaIA and RalB are recognized as components of a regulatory framework supporting tumorigenic transformation. Specifically, RaIB is required to suppress apoptotic checkpoint activation, the mechanistic basis of which is unknown. Reported effector proteins of RaIB include the Sec5 component of the exocyst, an octameric protein complex implicated in tethering of vesicles to membranes. Surprisingly, we find that the RaIB/Sec5 effector complex directly recruits and activates the atypical I kappa B kinase family member TBK1. In cancer cells, constitutive engagement of this pathway, via chronic RalB activation, restricts initiation of apoptotic programs typically engaged in the context of oncogenic stress. Although dispensable for survival in a nontumorigenic context, this pathway helps mount an innate immune response to virus exposure. These observations define the mechanistic contribution of RaIGTPases to cancer cell survival and reveal the RaIB/Sec5 effector complex as a component of TBK1-dependent innate immune signaling.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Inst Curie, INSERM, U548, Paris, France; NCI, Div Canc Prevent, NIH, Bethesda, MD 20892 USA; Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa	Chien, YC (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Yeaman, Charles A/A-1624-2009; Romeo, Yves/AAC-1669-2021	Loo, Yueh-Ming/0000-0001-6294-7273; Monaco, Cynthia/0000-0003-3093-5563; Gale, Michael/0000-0002-6332-7436; Yeaman, Charles/0000-0001-6149-628X	NATIONAL CANCER INSTITUTE [R01CA071443, R21CA107943, R33CA107943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002] Funding Source: NIH RePORTER; NCI NIH HHS [CA107943, CA71443, R01 CA071443, CN35132] Funding Source: Medline; NIGMS NIH HHS [R01 GM067002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hiscott J, 2004, NAT STRUCT MOL BIOL, V11, P1028, DOI 10.1038/nsmb1104-1028; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; MITLN N, 2005, CURR BIOL, V15, pR563; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Park SH, 1995, ONCOGENE, V11, P2349; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	51	276	293	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					157	170		10.1016/j.cell.2006.08.034	http://dx.doi.org/10.1016/j.cell.2006.08.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018283	Bronze			2022-12-28	WOS:000241445800021
J	Marder, TB				Marder, Todd B.			Boron goes on the attack	SCIENCE			English	Editorial Material							TRANSITION-METAL-BORYL; CHEMISTRY; COMPLEXES		Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University	Marder, TB (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.	todd.marder@durham.ac.uk	Marder, Todd B./R-6017-2019	Marder, Todd/0000-0002-9990-0169				Aldridge S, 2004, COORDIN CHEM REV, V248, P535, DOI 10.1016/j.ccr.2003.12.003; Arduengo AJ, 1999, TETRAHEDRON, V55, P14523, DOI 10.1016/S0040-4020(99)00927-8; Bell NJ, 2004, CHEM COMMUN, P1854, DOI 10.1039/b406052k; Braunschweig H, 2005, ANGEW CHEM INT EDIT, V44, P7826, DOI 10.1002/anie.200503703; Braunschweig H, 2006, ANGEW CHEM INT EDIT, V45, P5254, DOI 10.1002/anie.200600506; BROTHERTON RJ, 1960, J AM CHEM SOC, V82, P6242, DOI 10.1021/ja01509a009; Brown H. C., 1972, BORANES ORGANIC CHEM; Irvine GJ, 1998, CHEM REV, V98, P2685, DOI 10.1021/cr9500085; Ishiyama T, 2000, J ORGANOMET CHEM, V611, P392, DOI 10.1016/S0022-328X(00)00470-8; Lusch M. J., 1990, ORG SYNTH C, V7, P346; Marder TB, 1998, TOP CATAL, V5, P63, DOI 10.1023/A:1019145818515; MARDER TB, 2005, PRODUCT SUBCLASS 3 D, V6, P117; Segawa Y, 2006, SCIENCE, V314, P113, DOI 10.1126/science.1131914; Smith MR, 1999, PROG INORG CHEM, V48, P505, DOI 10.1002/9780470166499.ch6; ZAIDLEWICZ M, 2001, ORGANIC SYNTHESES VI, V2	15	77	77	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					69	70		10.1126/science.1133326	http://dx.doi.org/10.1126/science.1133326			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023642				2022-12-28	WOS:000241031200033
J	Dobscha, SK; Corson, K; Hickam, DH; Perrin, NA; Kraemer, DF; Gerrity, MS				Dobscha, Steven K.; Corson, Kathryn; Hickam, David H.; Perrin, Nancy A.; Kraemer, Dale F.; Gerrity, Martha S.			Depression decision support in primary care - A cluster randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBID MEDICAL ILLNESS; IMPROVING PRIMARY-CARE; MANAGED PRIMARY-CARE; COLLABORATIVE CARE; MAJOR DEPRESSION; TREATMENT GUIDELINES; OUTCOMES; DISORDERS; EDUCATION; IMPACT	Background: Intensive collaborative interventions improve depression outcomes, but the benefit of less intensive interventions is not clear. Objective: To determine whether decision support improves outcomes for patients with depression. Design: Clinician-level, cluster randomized, controlled trial. Setting: 5 primary care clinics of 1 Veterans Affairs medical center. Participants: 41 primary care clinicians, and 375 patients with depression (Patient Health Questionnaire [PHQ-9] depression scores of 10 to 25 or Hopkins Symptom Checklist-20 [SCL-20] scores >= 1.0). Measurements: The primary outcome was change in depression score (SCL-20) at 6 and 12 months. Secondary outcomes were health-related quality-of-life (36-item Short Form for Veterans [SF-36V] score), patient satisfaction, antidepressant use, and health care utilization. Intervention: Clinicians received depression education and were randomly assigned to depression decision support or usual care. The depression decision support team, which consisted of a psychiatrist and nurse, provided 1 early patient educational contact and depression monitoring with feedback to clinicians over 12 months. Results: Although SCL-20 depression scores improved in both groups, the intervention had no effect compared with usual care. The difference in slopes comparing intervention and control over 12 months was 0.20 (95% Cl, -0.37 to 0.78; P = 0.49), which was neither clinically nor statistically significant. Changes in SF-36V scores also did not differ between groups. At 12 months, intervention patients reported greater satisfaction (P = 0.002) and were more likely to have had at least 1 mental health specialty appointment (41.1 % vs. 27.2%; P = 0.025), to have received any antidepressant (79.3% vs. 69.3%; P = 0.041), and to have received antidepressants for 90 days or more (76.2% vs. 61.6%; P 0.008). Limitations: Usual care clinicians received depression education and had on-site mental health support, which may have mitigated intervention effectiveness. Conclusions: Decision support improved processes of care but not depression outcomes. More intensive care management or specialty treatment may be needed to improve depression outcomes.	Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97207 USA; Oregon State Univ, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; Oregon State University	Dobscha, SK (corresponding author), Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, POB 1034 P3MHDC, Portland, OR 97207 USA.	steven.dobscha@va.gov		Gerrity, Martha/0000-0002-8772-4591; Hickman, Heather/0000-0003-4168-4894				*AHCPR, 1993, AHCPR PUBL; *AM BOARD INT MED, 1989, FIN REP PAT SAT QUES, V2; [Anonymous], 1997, COMP INT DIAGN INT C; Babor TF., 1989, ALCOHOL USE DISORDER, V1, P45; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cole S, 2000, GEN HOSP PSYCHIAT, V22, P299, DOI 10.1016/S0163-8343(00)80007-9; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Dietrich A J, 2000, Eff Clin Pract, V3, P191; Dobscha SK, 2003, GEN HOSP PSYCHIAT, V25, P230, DOI 10.1016/S0163-8343(03)00020-3; Gerrity MS, 1999, J FAM PRACTICE, V48, P949; Gerrity MS, 2004, J GEN INTERN MED, V19, P166; Gerrity MS, 2001, MED CARE, V39, P856, DOI 10.1097/00005650-200108000-00011; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Hasin DS, 1996, J AFFECT DISORDERS, V41, P63, DOI 10.1016/0165-0327(96)00068-7; HAYS RD, 1995, MR162RC RAND, P23; Hedrick SC, 2003, J GEN INTERN MED, V18, P9, DOI 10.1046/j.1525-1497.2003.11109.x; Holtzheimer PE, 2005, AM J PSYCHIAT, V162, P970, DOI 10.1176/appi.ajp.162.5.970; Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700; Iosifescu DV, 2004, PSYCHOSOMATICS, V45, P419, DOI 10.1176/appi.psy.45.5.419; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kazis L. E., 2000, MED OUTCOMES TRUST M, V5, P1; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kobak KA, 1997, JAMA-J AM MED ASSOC, V278, P905, DOI 10.1001/jama.278.11.905; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; ORMEL J, 1991, ARCH GEN PSYCHIAT, V48, P700; Raudenbush S. W., 2001, HIERARCHICAL LINEAR, V2nd; RICHARDSON C, 2003, VETERANS 2000 CENSUS; Rollman BL, 2002, J GEN INTERN MED, V17, P493, DOI 10.1046/j.1525-1497.2002.10421.x; Rost K, 2000, ARCH FAM MED, V9, P150, DOI 10.1001/archfami.9.2.150; Rubenstein LV, 1999, HEALTH AFFAIR, V18, P89, DOI 10.1377/hlthaff.18.5.89; Saint S, 2003, J GEN INTERN MED, V18, P725, DOI 10.1046/j.1525-1497.2003.20637.x; Schectman G, 2005, AM J MED, V118, P393, DOI 10.1016/j.amjmed.2005.01.003; SIMON G, 1995, AM J PSYCHIAT, V152, P352; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 2005, PSYCHOL MED, V35, P271, DOI 10.1017/S0033291704003071; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Sloan KL, 2003, MED CARE, V41, P761, DOI 10.1097/00005650-200306000-00009; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Walker EA, 2000, J GEN INTERN MED, V15, P859, DOI 10.1046/j.1525-1497.2000.91142.x; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607	64	58	59	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					477	487		10.7326/0003-4819-145-7-200610030-00005	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092JX	17015865				2022-12-28	WOS:000241093900001
J	Ronsmans, C; Graham, WJ				Ronsmans, Carine; Graham, Wendy J.		Lancet Maternal Survival Series	Maternal survival 1 - Maternal mortality: who, when, where, and why	LANCET			English	Article							SAFE MOTHERHOOD; HIV-INFECTION; SEASONAL-VARIATION; VERBAL AUTOPSY; PREGNANCY; DEATH; COMMUNITY; RISK; WOMEN; EMERGENCE	The risk of a woman dying as a result of pregnancy or childbirth during her lifetime is about one in six in the poorest parts of the world compared with about one in 30 000 in Northern Europe. Such a discrepancy poses a huge challenge to meeting the fifth Millennium Development Goal to reduce maternal mortality by 75% between 1990 and 2015. Some developed and transitional countries have managed to reduce their maternal mortality during the past 25 years. Few of these, however, began with the very high rates that are now estimated for the poorest countries-in which further progress is jeopardised by weak health systems, continuing high fertility, and poor availability of data. Maternal deaths are clustered around labour, delivery, and the immediate postpartum period, with obstetric haemorrhage being the main medical cause of death. Local variation can be important, with unsafe abortion carrying huge risk in some populations, and HIV/AIDS becoming a leading cause of death where HIV-related mortaliy rates are high. Inequalities in the risk of maternal death exist everywhere. Targeting of interventions to the most vulnerable-rural populations and poor people-is essential if substantial progress is to be achieved by 2015.	London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen	Ronsmans, C (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	carine.ronsmans@lshtm.ac.uk		Graham, Wendy/0000-0003-1473-5342				AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; Alliegro MB, 1997, ARCH INTERN MED, V157, P2585, DOI 10.1001/archinte.157.22.2585; Anya SE, 2004, AM J TROP MED HYG, V70, P510, DOI 10.4269/ajtmh.2004.70.510; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; BASHIR A, 1995, INT J GYNECOL OBSTET, V50, pS93, DOI 10.1016/0020-7292(95)02494-W; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; BJORKLUND K, 2005, ACTA OBSTET GYNECOL, V84, P927; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; BRETTLE RP, 1995, AIDS, V9, P1177, DOI 10.1097/00002030-199510000-00010; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; CAMPBELL OMR, 1990, MATERNAL CHILD EPIDE, V2; DEBROUWERE V, 1998, BESOINS OBSTET NONCO; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; DIELTIENS G, 2005, PREGNANCY RELATED MO; Etard JF, 2003, AM J TROP MED HYG, V68, P503, DOI 10.4269/ajtmh.2003.68.503; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; FAUVEAU V, 1988, B WORLD HEALTH ORGAN, V66, P643; FAUVEAU V, 1989, SOC SCI MED, V29, P1121, DOI 10.1016/0277-9536(89)90025-7; Fawcus S, 1997, TROP DOCT, V27, P159, DOI 10.1177/004947559702700314; Fawcus SR, 2005, BJOG-INT J OBSTET GY, V112, P1257, DOI 10.1111/j.1471-0528.2005.00601.x; FORTNEY J, 1997, ACTES SEMINAIRE SAN, V1, P85; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; GRAHAM WJ, 2002, MATERNAL MORBIDITY M, P3; GRAHAM WJ, IN PRESS INT J GYNAE; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Harrison K A, 1997, Afr J Reprod Health, V1, P7, DOI 10.2307/3583270; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hoj L, 1999, INT J EPIDEMIOL, V28, P70, DOI 10.1093/ije/28.1.70; Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7; HORD C, 1991, STUD FAMILY PLANN, V22, P231, DOI 10.2307/1966479; Hoyert DL, 2000, BIRTH-ISS PERINAT C, V27, P4, DOI 10.1046/j.1523-536x.2000.00004.x; HURT LS, 2002, BRIT SOC POP STUD DE; Ibison JM, 1996, BRIT J OBSTET GYNAEC, V103, P973, DOI 10.1111/j.1471-0528.1996.tb09546.x; JOHANSSON C, 2002, 1 UNDP HUM DEV REP O; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Kodio B, 2002, TROP MED INT HEALTH, V7, P499, DOI 10.1046/j.1365-3156.2002.00892.x; Kunst A. E., 2001, STUDIES HLTH SERV OR, V17, P297; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Liljestrand J, 2004, J PUBLIC HEALTH POL, V25, P299, DOI 10.1057/palgrave.jphp.3190030; Loudon I., 1992, DEATH CHILDBIRTH INT; MACFARLANE A, 2001, WHY MOTHERS DIE 1997, P346; MAHLER H, 1987, LANCET, V1, P668; Maiques-Montesinos V, 1999, ACTA OBSTET GYN SCAN, V78, P789, DOI 10.1034/j.1600-0412.1999.780909.x; MAKUBALO L, 1999, SAVING MOTHERS REPOR; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; McIntyre JA, 2005, LANCET, V366, P1141, DOI 10.1016/S0140-6736(05)67458-2; MEASURE DHS, DEMOGRAPHIC HLTH SUR; *MIN HLTH EG, 1994, NAT MAT MORT STUD FI; *MIN HLTH POP EG, 2001, EG NAT MAT MORT STUD; Mswia R, 2003, B WORLD HEALTH ORGAN, V81, P87; Mungra A, 1999, BRIT J OBSTET GYNAEC, V106, P55, DOI 10.1111/j.1471-0528.1999.tb08085.x; Olsen BE, 2002, ACTA OBSTET GYN SCAN, V81, P301, DOI 10.1034/j.1600-0412.2002.810404.x; Pradhan EK, 2002, B WORLD HEALTH ORGAN, V80, P887; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Ronsmans C, 1999, LANCET, V354, P1448, DOI 10.1016/S0140-6736(99)03222-5; RONSMANS C, 2004, WHY MOTHERS DIE 2000, P272; Ronsmans C, 2004, NUMBERS REV MATERNAL; Rutgers S, 2001, Cent Afr J Med, V47, P39; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Seneviratne HR, 2000, INT J GYNECOL OBSTET, V70, P113, DOI 10.1016/S0020-7292(00)00223-X; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Shiffman J, 2004, HEALTH POLICY PLANN, V19, P380, DOI 10.1093/heapol/czh053; Songane FF, 2002, SOC SCI MED, V54, P23, DOI 10.1016/S0277-9536(01)00004-1; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; THONNEAU P, 2002, NEW ENGL J MED, V347, P24; *UN SECR DEP EC SO, 2004, WORLD POP PROSP 2004; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, V17, P7; VANDERPAAL LVF, 2002, 14 INT AIDS C BARC S; *WHO, 2005, MAT MORT VIET NAM 20; *WHO UNICEF UN POP, 2004, MAT MORT 2000 EST DE; *WORLD BANK GROUP, WDI DAT QUER; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	82	1094	1124	0	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1189	1200		10.1016/S0140-6736(06)69380-X	http://dx.doi.org/10.1016/S0140-6736(06)69380-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089XU	17011946				2022-12-28	WOS:000240916000031
J	Bloche, MG				Bloche, M. Gregg			Consumer-directed health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Washington, DC 20057 USA; Brookings Inst, Washington, DC 20036 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Brookings Institution; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Washington, DC 20057 USA.							CLAXTON G, 2006, HLTH BENEFITS 2006 P; Newhouse JP, 2004, HEALTH AFFAIR, V23, P107, DOI 10.1377/hlthaff.23.6.107; Remler DK, 2006, HEALTH AFFAIR, V25, P1070, DOI 10.1377/hlthaff.25.4.1070; Scandlen G, 2005, HEALTH AFFAIR, V24, P1554, DOI 10.1377/hlthaff.24.6.1554	4	31	31	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1756	1759		10.1056/NEJMp068127	http://dx.doi.org/10.1056/NEJMp068127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098HV	17065635	Green Submitted			2022-12-28	WOS:000241512500002
J	Cooper, TA				Cooper, Thomas A.			A reversal of misfortune for myotonic dystrophy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.							Harper PS, 2001, MYOTONIC DYSTROPHY; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014	4	16	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1825	1827		10.1056/NEJMcibr064708	http://dx.doi.org/10.1056/NEJMcibr064708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065646				2022-12-28	WOS:000241512500016
J	Tomita, K; Ishitani, R; Fukai, S; Nureki, O				Tomita, Kozo; Ishitani, Ryuichiro; Fukai, Shuya; Nureki, Osamu			Complete crystallographic analysis of the dynamics of CCA sequence addition	NATURE			English	Article							ADDING ENZYME; TRANSFER-RNA; STRUCTURAL BASIS; MECHANISM; NUCLEOTIDYLTRANSFERASE; POLYMERIZATION	CCA-adding polymerase matures the essential 39-CCA terminus of transfer RNA without any nucleic-acid template. However, it remains unclear how the correct nucleotide triphosphate is selected in each reaction step and how the polymerization is driven by the protein and RNA dynamics. Here we present complete sequential snapshots of six complex structures of CCA-adding enzyme and four distinct RNA substrates with and without CTP ( cytosine triphosphate) or ATP ( adenosine triphosphate). The CCA-lacking RNA stem extends by one base pair to force the discriminator nucleoside into the active-site pocket, and then tracks back after incorporation of the first cytosine monophosphate (CMP). Accommodation of the second CTP clamps the catalytic cleft, inducing a reorientation of the beta-turn, which flips C74 to allow CMP to be accepted. In contrast, after the second CMP is added, the polymerase and RNA primer are locked in the closed state, which directs the subsequent A addition. Between the CTP- and ATP-binding stages, the side-chain conformation of Arg 224 changes markedly; this is controlled by the global motion of the enzyme and position of the primer terminus, and is likely to achieve the CTP/ATP discrimination, depending on the polymerization stage. Throughout the CCA-adding reaction, the enzyme tail domain firmly anchors the TYC-loop of the tRNA, which ensures accurate polymerization and termination.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058565, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Kanagawa 2258501, Japan; JST, SORST, Kawaguchi, Saitama 3320012, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Tomita, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	kozo-tomita@aist.go.jp; nureki@bio.titech.ac.jp	Tomita, Kozo/J-5746-2013; Tomita, Kozo/E-9390-2017; Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014	Tomita, Kozo/0000-0002-7374-3898; Fukai, Shuya/0000-0002-1241-1443; 				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Matsumoto A, 1999, EUR BIOPHYS J BIOPHY, V28, P369, DOI 10.1007/s002490050221; NAKAMURA S, 1994, NUCLEIC ACIDS RES, V22, P514, DOI 10.1093/nar/22.3.514; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	23	60	61	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					956	960		10.1038/nature05204	http://dx.doi.org/10.1038/nature05204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17051158				2022-12-28	WOS:000241523400046
J	Staessen, JA; Li, Y; Richart, T				Staessen, Jan A.; Li, Yan; Richart, Tom			Oral renin inhibitors	LANCET			English	Review							ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; RO 42-5892; ANTIHYPERTENSIVE EFFICACY; ESSENTIAL-HYPERTENSION; TRANSITION-STATE; ALISKIREN; RESPONSES; REMIKIREN; RO-42-5892	Use of drugs that inhibit the renin-angiotensin system is an effective way to intervene in the pathogenesis of cardiovascular and renal disorders. The idea of blocking the renin system at its origin by inhibition of renin has existed for more than 30 years. Renin inhibition suppresses the generation of the active peptide angiotensin II. The first generation of orally active renin inhibitors were never used clinically because of low bioavailability and weak blood-pressure-lowering activity. At present, aliskiren is the first non-peptide orally active renin inhibitor to progress to phase-III clinical trials. It might become the first renin inhibitor with indications for the treatment of hypertension and cardiovascular and renal disorders. Novel compounds with improved oral bioavailability, specificity, and efficacy are now in preclinical development. This Review summarises the development of oral renin inhibitors and their pharmacokinetic and pharmacodynamic properties, with a focus on aliskiren.	Univ Leuven, Studies Coorfinating Ctr, Lab Hypertens,Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Campus Gasthuisberg,Herestr 49,Box 702, B-3000 Louvain, Belgium; Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China	KU Leuven; Shanghai Jiao Tong University	Staessen, JA (corresponding author), Univ Leuven, Studies Coorfinating Ctr, Lab Hypertens,Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Campus Gasthuisberg,Herestr 49,Box 702, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637				Allikmets Kristina, 2002, Curr Opin Investig Drugs, V3, P1479; Anan F, 2005, EUR J CLIN PHARMACOL, V61, P353, DOI 10.1007/s00228-005-0931-8; Azizi M, 2004, J AM SOC NEPHROL, V15, P3126, DOI 10.1097/01.ASN.0000146686.35541.29; BOGER J, 1985, J MED CHEM, V28, P1779, DOI 10.1021/jm00150a007; BOLIS G, 1987, J MED CHEM, V30, P1729, DOI 10.1021/jm00393a008; BRUNNER HR, 1974, CIRC RES, V34, pI35; BUHLER FR, 1972, NEW ENGL J MED, V287, P1209, DOI 10.1056/NEJM197212142872401; CAMENZIND E, 1991, J CARDIOVASC PHARM, V18, P299, DOI 10.1097/00005344-199109000-00001; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; CLOZEL JP, 1994, LIFE SCI, V54, pPL87, DOI 10.1016/0024-3205(94)00706-3; Clozel JP, 1999, J CARDIOVASC PHARM, V34, P674, DOI 10.1097/00005344-199911000-00008; CLOZEL JP, 1993, HYPERTENSION, V22, P9, DOI 10.1161/01.HYP.22.1.9; CORDERO P, 1991, HYPERTENSION, V17, P510, DOI 10.1161/01.HYP.17.4.510; CUMIN F, 1985, J BIOL CHEM, V260, P9154; DEGASPARO M, 1989, BRIT J CLIN PHARMACO, V27, P587; DELABAYS A, 1989, HYPERTENSION, V13, P941, DOI 10.1161/01.HYP.13.6.941; DEODHAR SD, 1964, J EXP MED, V119, P425, DOI 10.1084/jem.119.3.425; DERKX FHM, 1991, AM J HYPERTENS, V4, P602, DOI 10.1093/ajh/4.7.602; Dieterle W, 2005, INT J CLIN PHARM TH, V43, P527; Dieterle W, 2004, BRIT J CLIN PHARMACO, V58, P433, DOI 10.1111/j.1365-2125.2004.02160.x; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; ELAMRANI AIK, 1993, J CARDIOVASC PHARM, V22, P231, DOI 10.1097/00005344-199308000-00010; FISCHLI W, 1991, HYPERTENSION, V18, P22, DOI 10.1161/01.HYP.18.1.22; FISHER NDL, 1994, HYPERTENSION, V23, P44, DOI 10.1161/01.HYP.23.1.44; FISHER NDL, 1995, CLIN PHARMACOL THER, V57, P342, DOI 10.1016/0009-9236(95)90160-4; Fisher NDL, 2005, J AM SOC NEPHROL, V16, P592, DOI 10.1681/ASN.2004100874; FITZPATRICK MA, 1992, J CARDIOVASC PHARM, V19, P169, DOI 10.1097/00005344-199202000-00003; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; GROSS F, 1972, SCIENCE, V175, P656, DOI 10.1126/science.175.4022.656; HERSHEY JC, 2005, DRUG DISCOV TODAY, V2, P181; Himmelmann A, 1996, AM J HYPERTENS, V9, P517, DOI 10.1016/0895-7061(95)00340-1; Hollenberg NK, 1998, HYPERTENSION, V32, P387, DOI 10.1161/01.HYP.32.3.387; HUI KY, 1987, J MED CHEM, V30, P1287, DOI 10.1021/jm00391a005; JEUNEMAITRE X, 1989, AM J HYPERTENS, V2, P819, DOI 10.1093/ajh/2.11.819; Kim S, 2000, PHARMACOL REV, V52, P11; KIOWSKI W, 1994, CIRCULATION, V90, P2748, DOI 10.1161/01.CIR.90.6.2748; KLEINBLOESEM CH, 1993, CLIN PHARMACOL THER, V53, P585, DOI 10.1038/clpt.1993.74; KLEINERT HD, 1988, HYPERTENSION, V11, P613, DOI 10.1161/01.HYP.11.6.613; KOBRIN I, 1993, AM J HYPERTENS, V6, P349, DOI 10.1093/ajh/6.5.349; Lefevre G, 2000, J IMMUNOASSAY, V21, P65, DOI 10.1080/01971520009349500; MACFADYEN RJ, 1995, J CARDIOVASC PHARM, V25, P347, DOI 10.1097/00005344-199503000-00001; Maibaum J, 2003, EXPERT OPIN THER PAT, V13, P589, DOI 10.1517/eotp.13.5.589.23031; Marki HP, 2001, FARMACO, V56, P21, DOI 10.1016/S0014-827X(01)01004-7; MENARD J, 1995, CIRCULATION, V91, P330, DOI 10.1161/01.CIR.91.2.330; MENTO PF, 1993, J CARDIOVASC PHARM, V21, P791, DOI 10.1097/00005344-199305000-00016; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; MIYAZAKI M, 1989, J HYPERTENS, V7, pS25, DOI 10.1097/00004872-198904002-00006; NEUBERG GW, 1991, AM J CARDIOL, V67, P63, DOI 10.1016/0002-9149(91)90101-P; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; Pilz B, 2005, HYPERTENSION, V46, P569, DOI 10.1161/01.HYP.0000179573.91016.3f; Richter WF, 1996, XENOBIOTICA, V26, P243, DOI 10.3109/00498259609046705; RONGEN GA, 1995, CLIN PHARMACOKINET, V29, P6, DOI 10.2165/00003088-199529010-00002; RONGEN GA, 1993, CLIN PHARMACOL THER, V54, P567, DOI 10.1038/clpt.1993.189; SAITO H, 1989, HYPERTENSION, V13, P749, DOI 10.1161/01.HYP.13.6.749; SKEGGS LT, 1957, J EXP MED, V106, P439, DOI 10.1084/jem.106.3.439; Staessen JA, 2005, HYPERTENS RES, V28, P385, DOI 10.1291/hypres.28.385; Stanton A, 2003, HYPERTENSION, V42, P1137, DOI 10.1161/01.HYP.0000101688.17370.87; SWEET CS, 1984, AM J MED, V77, P7, DOI 10.1016/S0002-9343(84)80052-2; Tenenbaum A, 2000, AM J HYPERTENS, V13, P776, DOI 10.1016/S0895-7061(00)00268-5; Tree M, 1983, J Hypertens, V1, P399, DOI 10.1097/00004872-198312000-00013; van Paassen P, 2000, NEPHROL DIAL TRANSPL, V15, P637, DOI 10.1093/ndt/15.5.637; VANDENMEIRACKER AH, 1993, J HYPERTENS, V11, P831, DOI 10.1097/00004872-199308000-00010; VANPAASSEN P, 1995, J CARDIOVASC PHARM, V26, P39; VERBURG KM, 1990, J PHARMACOL EXP THER, V252, P449; VERBURG KM, 1989, HYPERTENSION, V13, P262, DOI 10.1161/01.HYP.13.3.262; Vinson GP, 1997, HUM REPROD, V12, P651, DOI 10.1093/humrep/12.4.651; VISKOPER RJ, 1994, J HUM HYPERTENS, V8, P133; WAKERLIN GE, 1958, CIRCULATION, V17, P653, DOI 10.1161/01.CIR.17.4.653; Wang JG, 2005, HYPERTENSION, V45, P907, DOI 10.1161/01.HYP.0000165020.14745.79; WANG JG, STROKE          0608, DOI DOI 10.1161/01.STR.0000227223.902.39.13; WEBB DJ, 1985, J HYPERTENS, V3, P653, DOI 10.1097/00004872-198512000-00013; Wood JM, 2003, BIOCHEM BIOPH RES CO, V308, P698, DOI 10.1016/S0006-291X(03)01451-7; WOOD JM, 1994, PHARMACOL THERAPEUT, V61, P325, DOI 10.1016/0163-7258(94)90015-9; WOOD JM, 1989, J CARDIOVASC PHARM, V14, P221, DOI 10.1097/00005344-198908000-00006; Wood JM, 2005, J HYPERTENS, V23, P417, DOI 10.1097/00004872-200502000-00025; WOOD JM, 1985, HYPERTENSION, V7, P797, DOI 10.1161/01.HYP.7.5.797; Zhang Q, 1997, Am J Ther, V4, P199, DOI 10.1097/00045391-199705000-00006	79	203	217	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1449	1456		10.1016/S0140-6736(06)69442-7	http://dx.doi.org/10.1016/S0140-6736(06)69442-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055947				2022-12-28	WOS:000241459100033
J	Kundig, P				Kuendig, Peter			Chemistry: The future of organic synthesis	SCIENCE			English	Editorial Material							CATALYSIS		Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland	University of Geneva	Kundig, P (corresponding author), Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland.	peter.kundig@chiorg.unige.ch						Anastas PT, 2002, ACCOUNTS CHEM RES, V35, P686, DOI 10.1021/ar010065m; Arp FO, 2005, J AM CHEM SOC, V127, P10482, DOI 10.1021/ja053751f; Baxendale IR, 2006, CHEM COMMUN, P2566, DOI 10.1039/b600382f; Baxendale IR, 2006, SYNLETT, P427, DOI 10.1055/S-2006-926244; Belder D, 2006, ANGEW CHEM INT EDIT, V45, P2463, DOI 10.1002/anie.200504205; de Bruin B, 2006, ANGEW CHEM INT EDIT, V45, P2660, DOI 10.1002/anie.200504480; Dijk EW, 2004, TETRAHEDRON, V60, P9687, DOI 10.1016/j.tet.2004.06.148; Doi T, 2006, CHEM-ASIAN J, V1, P370, DOI 10.1002/asia.200600156; GUENARD D, 1993, ACCOUNTS CHEM RES, V26, P160, DOI 10.1021/ar00028a005; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Marko IE, 2001, SCIENCE, V294, P1842, DOI 10.1126/science.1067545; Martin-Matute B, 2006, CHEM-EUR J, V12, P6053, DOI 10.1002/chem.200600257; Noyori R, 2005, PHILOS T ROY SOC A, V363, P901, DOI 10.1098/rsta.2004.1536; Shibasaki M, 2006, CHEM SOC REV, V35, P269, DOI 10.1039/b506346a; Solinas M, 2005, ANGEW CHEM INT EDIT, V44, P2291, DOI 10.1002/anie.200461768; Webb PB, 2004, CHEM COMMUN, P612, DOI 10.1039/b316311c; Zard SZ, 2006, ANGEW CHEM INT EDIT, V45, P2496, DOI 10.1002/anie.200600811; 2006, 1 EUR CHEM C 27 31 A	18	22	22	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					430	431		10.1126/science.1134084	http://dx.doi.org/10.1126/science.1134084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053137				2022-12-28	WOS:000241382500029
J	Lin, LH; Wang, PL; Rumble, D; Lippmann-Pipke, J; Boice, E; Pratt, LM; Lollar, BS; Brodie, EL; Hazen, TC; Andersen, GL; DeSantis, TZ; Moser, DP; Kershaw, D; Onstott, TC				Lin, Li-Hung; Wang, Pei-Ling; Rumble, Douglas; Lippmann-Pipke, Johanna; Boice, Erik; Pratt, Lisa M.; Sherwood Lollar, Barbara; Brodie, Eoin L.; Hazen, Terry C.; Andersen, Gary L.; DeSantis, Todd Z.; Moser, Duane P.; Kershaw, Dave; Onstott, T. C.			Long-term sustainability of a high-energy, low-diversity crustal biome	SCIENCE			English	Article							WITWATERSRAND BASIN; DEEP; SULFATE; SUBSURFACE; FLUIDS; GEOCHEMISTRY; WATERS; SEA	Geochemical, microbiological, and molecular analyses of alkaline saline groundwater at 2.8 kilometers depth in Archaean metabasalt revealed a microbial biome dominated by a single phylotype affiliated with thermophilic sulfate reducers belonging to Firmicutes. These sulfate reducers were sustained by geologically produced sulfate and hydrogen at concentrations sufficient to maintain activities for millions of years with no apparent reliance on photosynthetically derived substrates.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan; Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; Univ Toronto, Dept Geol, Toronto, ON, Canada; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV USA; Anglo Gold, Mponeng Mine, Johannesburg, South Africa	Princeton University; National Taiwan University; National Taiwan University; Carnegie Institution for Science; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Indiana University System; Indiana University Bloomington; University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Lin, LH (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	lhlin@ntu.edu.tw	Andersen, Gary/G-2792-2015; Lin, Li-Hung/K-8091-2012; Lippmann-Pipke, Johanna/D-7987-2011; Brodie, Eoin L/A-7853-2008; Rumble, Douglas/AAU-3930-2020; Hazen, Terry C/C-1076-2012	Andersen, Gary/0000-0002-1618-9827; Lippmann-Pipke, Johanna/0000-0002-9765-3803; Brodie, Eoin L/0000-0002-8453-8435; Rumble, Douglas/0000-0002-7440-9189; Hazen, Terry C/0000-0002-2536-9993; WANG, PEI-LING/0000-0002-4392-3935; Onstott, Tullis/0000-0002-2898-3374; Lin, Li-Hung/0000-0002-0985-1464				BADZIONG W, 1978, ARCH MICROBIOL, V117, P209, DOI 10.1007/BF00402310; Campbell L. L., 1986, BERGEYS MANUAL SYSTE, V2, P1200; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Drennan GR, 1999, MINER PETROL, V66, P83, DOI 10.1007/BF01161723; Frimmel HE, 1999, MINER PETROL, V66, P55, DOI 10.1007/BF01161722; JONES MQW, 1988, J GEOPHYS RES-SOLID, V93, P3243, DOI 10.1029/JB093iB04p03243; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Lin LH, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000907; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Liu YT, 1997, INT J SYST BACTERIOL, V47, P615, DOI 10.1099/00207713-47-3-615; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; MURPHY EM, 1992, WATER RESOUR RES, V28, P723, DOI 10.1029/91WR02678; Nakagawa T, 2002, FEMS MICROBIOL ECOL, V41, P199, DOI 10.1111/j.1574-6941.2002.tb00981.x; NAZINA T N, 1988, Mikrobiologiya, V57, P823; Omar GI, 2003, GEOFLUIDS, V3, P69, DOI 10.1046/j.1468-8123.2003.00050.x; Onstott TC, 1999, ENIGMATIC MICROORGAN, P489; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Sass H, 2004, SYST APPL MICROBIOL, V27, P541, DOI 10.1078/0723202041748181; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tardy-Jacquenod C, 1998, INT J SYST BACTERIOL, V48, P333, DOI 10.1099/00207713-48-2-333; ZHAO B, 2004, GEOSCIENCE AFRICA, V2, P732	29	252	273	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					479	482		10.1126/science.1127376	http://dx.doi.org/10.1126/science.1127376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053150	Green Submitted, Green Published			2022-12-28	WOS:000241382500046
J	Kienast, M; Kienast, SS; Calvert, SE; Eglinton, TI; Mollenhauer, G; Francois, R; Mix, AC				Kienast, Markus; Kienast, Stephanie S.; Calvert, Stephen E.; Eglinton, Timothy I.; Mollenhauer, Gesine; Francois, Roger; Mix, Alan C.			Eastern Pacific cooling and Atlantic overturning circulation during the last deglaciation	NATURE			English	Article							CLIMATE-CHANGE; EQUATORIAL PACIFIC; SEA; TEMPERATURES; COLLAPSE; RECORD; OCEAN	Surface ocean conditions in the equatorial Pacific Ocean could hold the clue to whether millennial-scale global climate change during glacial times was initiated through tropical ocean - atmosphere feedbacks or by changes in the Atlantic thermohaline circulation(1). North Atlantic cold periods during Heinrich events and millennial-scale cold events (stadials) have been linked with climatic changes in the tropical Atlantic Ocean and South America(2-4), as well as the Indian and East Asian monsoon systems(5,6), but not with tropical Pacific sea surface temperatures(7). Here we present a high-resolution record of sea surface temperatures in the eastern tropical Pacific derived from alkenone unsaturation measurements. Our data show a temperature drop of 1 degrees C, synchronous ( within dating uncertainties) with the shutdown of the Atlantic meridional overturning circulation during Heinrich event 1, and a smaller temperature drop of 0.5 degrees C synchronous with the smaller reduction in the overturning circulation during the Younger Dryas event. Both cold events coincide with maxima in surface ocean productivity as inferred from Th-230-normalized carbon burial fluxes, suggesting increased upwelling at the time. From the concurrence of equatorial Pacific cooling with the two North Atlantic cold periods during deglaciation, we conclude that these millennial-scale climate changes were probably driven by a reorganization of the oceans' thermohaline circulation, although possibly amplified by tropical ocean - atmosphere interaction as suggested before(8).	Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Dalhousie University; University of British Columbia; Woods Hole Oceanographic Institution; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Oregon State University	Kienast, M (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada.	markus.kienast@dal.ca	Mollenhauer, Gesine/AAD-8167-2019; Mollenhauer, Gesine/B-5190-2015	Mollenhauer, Gesine/0000-0001-5138-564X; Mollenhauer, Gesine/0000-0001-5138-564X; Kienast, Stephanie/0000-0003-3867-4919; Eglinton, Timothy/0000-0001-5060-2155				Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Clement AC, 2001, J CLIMATE, V14, P2369, DOI 10.1175/1520-0442(2001)014<2369:AODTSF>2.0.CO;2; Feldberg MJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000740; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Higginson MJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020511; Huang Chin-Chien, 2002, Western Pacific Earth Sciences, V2, P1; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Koutavas A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000894; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Kucera M, 2005, QUATERNARY SCI REV, V24, P951, DOI 10.1016/j.quascirev.2004.07.014; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lyle M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001019; LYLE MW, 1992, NATURE, V355, P812, DOI 10.1038/355812a0; Martinez I, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000877; McIntyre A, 1996, SCIENCE, V274, P1867, DOI 10.1126/science.274.5294.1867; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MIX AC, 2003, P ODP IN REP 202; MOORE TC, 1973, J GEOL, V81, P458, DOI 10.1086/627884; Ohkouchi N, 2002, SCIENCE, V298, P1224, DOI 10.1126/science.1075287; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Schmittner A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000591; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Timmermann A, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001090; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	32	117	121	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					846	849		10.1038/nature05222	http://dx.doi.org/10.1038/nature05222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051216				2022-12-28	WOS:000241362700049
J	Shojania, KG; Fletcher, KE; Saint, S				Shojania, Kaveh G.; Fletcher, Kathlyn E.; Saint, Sanjay			Graduate medical education and patient safety: A busy-and occasionally hazardous-intersection	ANNALS OF INTERNAL MEDICINE			English	Article							RESIDENT WORK HOURS; JULY PHENOMENON; COMMUNICATION FAILURES; SIGN-OUT; ERRORS; CARE; MORTALITY; MANAGEMENT; HOSPITALS; ADMISSION	A patient admitted to a teaching hospital with a mild episode of acute pancreatitis initially improved, but then her condition deteriorated and she subsequently died. The initial deterioration probably reflected bowel obstruction, as shown on an abdominal radiograph that an on-call intern forgot to review. This diagnostic delay was compounded by poor communication that resulted in a medical student inserting a feeding tube-rather than a nasogastric tube-to decompress the bowel, followed by failure to recognize how ill the patient had become. The case highlights the hazards of patient handoffs as well as the importance of clear communication techniques and knowing when to ask for help. The discussion also shows the vicious circle that results when attending physicians fail to provide effective supervision: Not only is safety compromised but trainees lose the experience of being supervised. Consequently, trainees have no models of effective supervision on which to draw when they become supervisors. They then fall into the same trap as those who taught them, busying themselves with direct patient care and providing supervision only as time allows.	Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; Clement J Zablocki VA Med Ctr, Milwaukee, WI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Ann Arbor VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Ottawa; Ottawa Hospital Research Institute; Medical College of Wisconsin; University of Michigan System; University of Michigan	Shojania, KG (corresponding author), Ottawa Civic Hosp, Civ Campus,1053 Carling Ave,Room C403,Box 693, Ottawa, ON K1Y 4E9, Canada.	kshojania@ohri.ca	Saint, Sanjay/AAF-5126-2019		NIDDK NIH HHS [DK67451] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067451] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; ASTION M, 2005, LAB ERRORS PATIENT S, V1, P2; Barenfanger J, 2004, AM J CLIN PATHOL, V121, P801, DOI 10.1309/9DYM6ROTM830U95Q; Barry WA, 2003, J GEN INTERN MED, V18, P639, DOI 10.1046/j.1525-1497.2003.20605.x; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Borenstein SH, 2004, J SURG RES, V122, P162, DOI 10.1016/j.jss.2004.05.014; BUCHWALD D, 1989, ARCH INTERN MED, V149, P765, DOI 10.1001/archinte.149.4.765; Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; Claridge JA, 2001, SURGERY, V130, P346, DOI 10.1067/msy.2001.116670; Cleary PD, 2003, ANN INTERN MED, V138, P33, DOI 10.7326/0003-4819-138-1-200301070-00009; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Flynn T., 2005, ACGME B, P15; Haig KM, 2006, JT COMM J QUAL PATIE, V32, P167, DOI 10.1016/S1553-7250(06)32022-3; Hobgood C, 2005, ACAD MED, V80, P758, DOI 10.1097/00001888-200508000-00012; Hofer TP, 2002, ANN INTERN MED, V137, P327, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00008; *JOINT COMM ACCR H, 2006, GOAL 2 COMM; Kachalia Allen, 2003, Jt Comm J Qual Saf, V29, P503; Kilminster SM, 2000, MED EDUC, V34, P827, DOI 10.1046/j.1365-2923.2000.00758.x; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Leach DC, 2005, ACGME B, P2; Ofri D, 2004, NEW ENGL J MED, V351, P1824, DOI 10.1056/NEJMp038251; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Phy MP, 2004, MAYO CLIN PROC, V79, P332, DOI 10.4065/79.3.332; Pierluissi E, 2003, JAMA-J AM MED ASSOC, V290, P2838, DOI 10.1001/jama.290.21.2838; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Redelmeier DA, 2005, ANN INTERN MED, V142, P115, DOI 10.7326/0003-4819-142-2-200501180-00010; Ryan J, 2005, ANN INTERN MED, V143, P917, DOI 10.7326/0003-4819-143-12-200512200-00016; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Shojania KG, 2002, MED CLIN N AM, V86, P847, DOI 10.1016/S0025-7125(02)00016-0; Shulkin D J, 1995, Am J Med Qual, V10, P14, DOI 10.1177/0885713X9501000104; SMITH L, 2005, AHRQ WEB M M SERIAL; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Zare SM, 2005, SURGERY, V138, P150, DOI 10.1016/j.surg.2005.05.011	41	56	56	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					592	598		10.7326/0003-4819-145-8-200610170-00008	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043341				2022-12-28	WOS:000241315700005
J	Tfelt-Hansen, P; Olesen, J				Tfelt-Hansen, Peer; Olesen, Jes			Increasing the effect of triptans in migraine	LANCET			English	Editorial Material							EFFERVESCENT ASPIRIN; DOUBLE-BLIND; TRIMEBUTINE; METOCLOPRAMIDE; ABSORPTION; PLACEBO; ATTACKS		Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark	University of Copenhagen	Tfelt-Hansen, P (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark.	tfelt@inet.uni2.dk		Olesen, Jes/0000-0002-6712-2702				Delvaux M, 1997, J INT MED RES, V25, P225, DOI 10.1177/030006059702500501; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Kaufman J., 1936, RADIOLOGY, V27, P301; Krymchantowski AV, 2006, CEPHALALGIA, V26, P871, DOI 10.1111/j.1468-2982.2006.01136.x; Saivin S, 2000, ARZNEIMITTEL-FORSCH, V50, P717; Tfelt-Hansen P, 2006, HEADACHES, P505; TFELTHANSEN P, 1995, LANCET, V346, P923, DOI 10.1016/S0140-6736(95)91554-0; TFELTHANSEN P, 1984, CEPHALALGIA, V4, P107, DOI 10.1046/j.1468-2982.1984.0402107.x; Thomsen LL, 1996, CEPHALALGIA, V16, P270, DOI 10.1046/j.1468-2982.1996.1604270.x; VOLANS GN, 1974, BRIT MED J, V4, P265, DOI 10.1136/bmj.4.5939.265; VOLANS GN, 1975, BRIT J CLIN PHARMACO, V2, P57, DOI 10.1111/j.1365-2125.1975.tb00472.x; Wang HY, 2002, J CHROMATOGR B, V779, P173, DOI 10.1016/S1570-0232(02)00369-0; WILKINSON M, 1976, HEADACHE, V15, P291, DOI 10.1111/j.1526-4610.1976.hed1504291.x	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1313	1314		10.1016/S0140-6736(06)69536-6	http://dx.doi.org/10.1016/S0140-6736(06)69536-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046449				2022-12-28	WOS:000241388100010
J	Sudarsan, N; Hammond, MC; Block, KF; Welz, R; Barrick, JE; Roth, A; Breaker, RR				Sudarsan, Narasimhan; Hammond, Ming C.; Block, Kirsten F.; Welz, Ruediger; Barrick, Jeffrey E.; Roth, Adam; Breaker, Ronald R.			Tandem riboswitch architectures exhibit complex gene control functions	SCIENCE			English	Article							INTRINSIC TRANSCRIPTION TERMINATION; GRAM-POSITIVE BACTERIA; S-ADENOSYLMETHIONINE; MESSENGER-RNA; METHIONINE SYNTHASE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; LIGAND-BINDING; METE GENE; EXPRESSION	Riboswitches are structured RNAs typically located in the 5' untranslated regions of bacterial mRNAs that bind metabolites and control gene expression. Most riboswitches sense one metabolite and function as simple genetic switches. However, we found that the 5' region of the Bacillus clausii metE messenger RNA includes two riboswitches that respond to S-adenosylmethionine and coenzyme B-12. This tandem arrangement yields a composite gene control system that functions as a two-input Boolean NOR logic gate. These findings and the discovery of additional tandem riboswitch architectures reveal how simple RNA elements can be assembled to make sophisticated genetic decisions without involving protein factors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012; Block, Kirsten/F-1600-2010	Barrick, Jeffrey/0000-0003-0888-7358; Block, Kirsten/0000-0003-4401-3754; Breaker, Ronald/0000-0002-2165-536X	NIGMS NIH HHS [GM 068819, R01 GM068819, GM 07223-31] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068819] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P11101, DOI 10.1021/bi00502a013; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; GREGG JR, 1998, UNDERSTANDING SCI TE, P77; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gutierrez-Preciado A, 2005, TRENDS GENET, V21, P432, DOI 10.1016/j.tig.2005.06.001; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; PTASHNE M, 2002, GENES SIGNALS; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup JK, 2004, CURR OPIN STRUC BIOL, V14, P344, DOI 10.1016/j.sbi.2004.04.007; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; WU WF, 1992, J BACTERIOL, V174, P4833, DOI 10.1128/JB.174.14.4833-4837.1992; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yocum RR, 1996, J BACTERIOL, V178, P4604, DOI 10.1128/jb.178.15.4604-4610.1996	36	185	207	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					300	304		10.1126/science.1130716	http://dx.doi.org/10.1126/science.1130716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038623				2022-12-28	WOS:000241194100042
J	Peppiatt, CM; Howarth, C; Mobbs, P; Attwell, D				Peppiatt, Claire M.; Howarth, Clare; Mobbs, Peter; Attwell, David			Bidirectional control of CNS capillary diameter by pericytes	NATURE			English	Article							RAT RETINA; CONTAINING MICROVASCULATURE; BLOOD-FLOW; IN-VIVO; BRAIN; CALCIUM; MUSCLE; CORTEX; CELLS	Neural activity increases local blood flow in the central nervous system (CNS), which is the basis of BOLD (blood oxygen level dependent) and PET (positron emission tomography) functional imaging techniques(1-3). Blood flow is assumed to be regulated by precapillary arterioles, because capillaries lack smooth muscle. However, most (65%) noradrenergic innervation of CNS blood vessels terminates near capillaries rather than arterioles(4), and in muscle and brain a dilatory signal propagates from vessels near metabolically active cells to precapillary arterioles(5,6), suggesting that blood flow control is initiated in capillaries. Pericytes, which are apposed to CNS capillaries and contain contractile proteins(7), could initiate such signalling. Here we show that pericytes can control capillary diameter in whole retina and cerebellar slices. Electrical stimulation of retinal pericytes evoked a localized capillary constriction, which propagated at similar to 2 mu m s(-1) to constrict distant pericytes. Superfused ATP in retina or noradrenaline in cerebellum resulted in constriction of capillaries by pericytes, and glutamate reversed the constriction produced by noradrenaline. Electrical stimulation or puffing GABA (gamma-amino butyric acid) receptor blockers in the inner retina also evoked pericyte constriction. In simulated ischaemia, some pericytes constricted capillaries. Pericytes are probably modulators of blood flow in response to changes in neural activity, which may contribute to functional imaging signals and to CNS vascular disease.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	D.Attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020	Peppiatt-Wildman, Claire/0000-0002-4406-8571; Howarth, Clare/0000-0002-6660-9770	Wellcome Trust [017948, 075232] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Berg BR, 1997, AM J PHYSIOL-HEART C, V272, pH2693, DOI 10.1152/ajpheart.1997.272.6.H2693; BUTRYN RK, 1995, MICROVASC RES, V50, P80, DOI 10.1006/mvre.1995.1040; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; DUFFY S, 1995, J NEUROSCI, V15, P5535; HAEFLIGER IO, 1994, INVEST OPHTH VIS SCI, V35, P991; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Kawamura H, 2004, J PHYSIOL-LONDON, V561, P671, DOI 10.1113/jphysiol.2004.073098; Kawamura H, 2003, J PHYSIOL-LONDON, V551, P787, DOI 10.1113/jphsiol.2003.047977; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266, DOI 10.1152/ajpheart.1989.257.1.H266; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Roy C S, 1890, J Physiol, V11, P85; Rucker HK, 2000, BRAIN RES BULL, V51, P363, DOI 10.1016/S0361-9230(99)00260-9; Sakagami K, 2001, MICROVASC RES, V62, P196, DOI 10.1006/mvre.2001.2343; Schonfelder U, 1998, MICROVASC RES, V56, P22, DOI 10.1006/mvre.1998.2086; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	30	748	777	6	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					700	704		10.1038/nature05193	http://dx.doi.org/10.1038/nature05193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036005	Green Accepted			2022-12-28	WOS:000241160500048
J	Pisansky, TM				Pisansky, Thomas M.			External-beam radiotherapy for localized prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							3-DIMENSIONAL CONFORMAL RADIOTHERAPY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; RADIATION-THERAPY; DOSE-ESCALATION; RADICAL PROSTATECTOMY; HORMONAL-THERAPY; PSA ERA; 70 GY; BRACHYTHERAPY		Mayo Clin & Mayo Fdn, Dept Radiat Oncol, Rochester, MN 55905 USA	Mayo Clinic	Pisansky, TM (corresponding author), Mayo Clin & Mayo Fdn, Dept Radiat Oncol, 200 1st St SW, Rochester, MN 55905 USA.							Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Beckendorf V, 2004, INT J RADIAT ONCOL, V60, P1056, DOI 10.1016/j.ijrobp.2004.05.033; Bey P, 2000, INT J RADIAT ONCOL, V48, P513, DOI 10.1016/S0360-3016(00)00691-X; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Chon BH, 2002, ONCOLOGIST, V7, P136, DOI 10.1634/theoncologist.7-2-136; Coleman CN, 2001, INT J RADIAT ONCOL, V49, P301, DOI 10.1016/S0360-3016(00)01521-2; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Demanes DJ, 2005, INT J RADIAT ONCOL, V61, P1306, DOI 10.1016/j.ijrobp.2004.08.014; Gonzalgo ML, 2003, J UROLOGY, V170, P2444, DOI 10.1097/01.ju.0000085381.20139.b6; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Herman MG, 2003, INT J RADIAT ONCOL, V57, P1131, DOI 10.1016/S0360-3016(03)00766-1; Horwitz EM, 2001, CANCER, V92, P1281, DOI 10.1002/1097-0142(20010901)92:5<1281::AID-CNCR1449>3.0.CO;2-9; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Jacob R, 2004, CANCER-AM CANCER SOC, V100, P538, DOI 10.1002/cncr.11927; Jani AB, 2003, LANCET, V361, P1045, DOI 10.1016/S0140-6736(03)12833-4; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kattan MW, 2000, J CLIN ONCOL, V18, P3352, DOI 10.1200/JCO.2000.18.19.3352; Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1; Kupelian P, 2005, INT J RADIAT ONCOL, V61, P415, DOI 10.1016/j.ijrobp.2004.05.018; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1463, DOI 10.1016/j.ijrobp.2005.05.054; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; Leibel SA, 2003, SEMIN ONCOL, V30, P596, DOI 10.1016/S0093-7754(03)00354-3; Liu M, 2005, RADIOTHER ONCOL, V74, P197, DOI 10.1016/j.radonc.2004.09.016; *MEM SLOAN KETT CA, 2006, PROST NOM; Miller DC, 2005, J CLIN ONCOL, V23, P2772, DOI 10.1200/JCO.2005.07.116; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; *NAT COMPR CANC NE, 2006, PROST CANC; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Pisansky TM, 2005, MAYO CLIN PROC, V80, P883, DOI 10.4065/80.7.883; Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; *RAD THER ONC GROU, 2006, GEN CANC PROT; Roach M, 2000, INT J RADIAT ONCOL, V47, P617, DOI 10.1016/S0360-3016(00)00577-0; Roach M, 2000, INT J RADIAT ONCOL, V48, P313; Roach M, 2004, INT J RADIAT ONCOL, V60, P1351, DOI 10.1016/j.ijrobp.2004.05.026; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7; Symon Z, 2003, INT J RADIAT ONCOL, V57, P384, DOI 10.1016/S0360-3016(03)00569-8; Teh BS, 2004, CANCER INVEST, V22, P913, DOI 10.1081/CNV-200039674; Valicenti R, 2000, J CLIN ONCOL, V18, P2740, DOI 10.1200/JCO.2000.18.14.2740; Zelefsky MJ, 2005, J CLIN ONCOL, V23, P826, DOI 10.1200/JCO.2005.02.111; Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7; Zelefsky MJ, 2001, J UROLOGY, V166, P1839; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	51	39	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1583	1591		10.1056/NEJMct055263	http://dx.doi.org/10.1056/NEJMct055263			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035651				2022-12-28	WOS:000241160400009
J	O'Reilly, RC				O'Reilly, Randall C.			Biologically based computational models of high-level cognition	SCIENCE			English	Review							PREFRONTAL CORTEX; WORKING-MEMORY; NETWORK MODEL; TASK; MECHANISMS; ATTENTION; SELECTION; BEHAVIOR; RULES; BRAIN	Computer models based on the detailed biology of the brain can help us understand the myriad complexities of human cognition and intelligence. Here, we review models of the higher level aspects of human intelligence, which depend critically on the prefrontal cortex and associated subcortical areas. The picture emerging from a convergence of detailed mechanistic models and more abstract functional models represents a synthesis between analog and digital forms of computation. Specifically, the need for robust active maintenance and rapid updating of information in the prefrontal cortex appears to be satisfied by bistable activation states and dynamic gating mechanisms. These mechanisms are fundamental to digital computers and may be critical for the distinctive aspects of human intelligence.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	O'Reilly, RC (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80309 USA.	oreilly@psych.colorado.edu	O'Reilly, Randall/A-5819-2008		NIMH NIH HHS [MH069597, MH64445] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445, R01MH069597] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; ANDERSON JR, 2006, CAN HUMAN MIND OCCUR; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Diamond A, 1998, DEVELOPMENTAL SCI, V1, P185, DOI 10.1111/1467-7687.00022; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Fuster J., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Hazy TE, 2006, NEUROSCIENCE, V139, P105, DOI 10.1016/j.neuroscience.2005.04.067; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; KRAIN AL, 2006, CLIN PSYCHOL REV; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Morton JB, 2002, DEVELOPMENTAL SCI, V5, P435; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Stedron JM, 2005, J COGNITIVE NEUROSCI, V17, P623, DOI 10.1162/0898929053467622; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; TOMASELLO M., 2001, CULTURAL ORIGINS HUM; van der Velde F, 2006, BEHAV BRAIN SCI, V29, P37, DOI 10.1017/S0140525X06009022; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 1999, J NEUROSCI, V19, P9587; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zipser D, 1991, NEURAL COMPUT, V3, P179, DOI 10.1162/neco.1991.3.2.179	40	292	300	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					91	94		10.1126/science.1127242	http://dx.doi.org/10.1126/science.1127242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023651				2022-12-28	WOS:000241031200041
J	Yusupova, G; Jenner, L; Rees, B; Moras, D; Yusupov, M				Yusupova, Gulnara; Jenner, Lasse; Rees, Bernard; Moras, Dino; Yusupov, Marat			Structural basis for messenger RNA movement on the ribosome	NATURE			English	Article							ANGSTROM RESOLUTION; ESCHERICHIA-COLI; TRANSLATION INITIATION; CRYSTAL-STRUCTURES; BINDING SITE; SUBUNIT; SEQUENCES; CODON	Translation initiation is a major determinant of the overall expression level of a gene(1 - 3). The translation of functionally active protein requires the messenger RNA to be positioned on the ribosome such that the start/ initiation codon will be read first and in the correct frame. Little is known about the molecular basis for the interaction of mRNA with the ribosome at different states of translation. Recent crystal structures of the ribosomal subunits(4 - 8), the empty 70S ribosome(9) and the 70S ribosome containing functional ligands(10 - 13) have provided information about the general organization of the ribosome and its functional centres. Here we compare the X- ray structures of eight ribosome complexes modelling the translation initiation, post- initiation and elongation states. In the initiation and post- initiation complexes, the presence of the Shine - Dalgarno ( SD) duplex causes strong anchoring of the 5' end of mRNA onto the platform of the 30S subunit, with numerous interactions between mRNA and the ribosome. Conversely, the 5' end of the ' elongator' mRNA lacking SD interactions is flexible, suggesting a different exit path for mRNA during elongation. After the initiation of translation, but while an SD interaction is still present, mRNA moves in the 3' -->5' direction with simultaneous clockwise rotation and lengthening of the SD duplex, bringing it into contact with ribosomal protein S2.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Yusupov, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	marat@titus.u-strasbg.fr	Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANONACO MA, 1989, EUR J BIOCHEM, V182, P501, DOI 10.1111/j.1432-1033.1989.tb14856.x; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; DeLano W.L, PYMOL MOL GRAPHICS S; DRAPER DE, 1996, ESCHERICHIA COLI SAL, P902; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; LATEANA A, 1995, RNA, V1, P772; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rees B, 2005, ACTA CRYSTALLOGR D, V61, P1299, DOI [10.1107/S0907444905019591, 10.1107/S0904777905019591]; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHURR T, 1993, NUCLEIC ACIDS RES, V21, P4019, DOI 10.1093/nar/21.17.4019; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	25	203	210	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					391	394		10.1038/nature05281	http://dx.doi.org/10.1038/nature05281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17051149				2022-12-28	WOS:000242018300054
J	Asaria, P; MacMahon, E				Asaria, Perviz; MacMahon, Eithne			Measles in the United Kingdom: can we eradicate it by 2010?	BRITISH MEDICAL JOURNAL			English	Review							HERD-IMMUNITY; YOUNG-ADULTS; VITAMIN-A; CHILDREN; HEPATITIS; VIRUS; ENGLAND; STATES; WALES; MUMPS	Measles has reappeared in the United Kingdom, with 449 confirmed cases to the end of May 2006 compared with 77 in 2005, and the first death since 1992.(1) (2) Cases are occurring in inadequately vaccinated children and in young adults, leading to concerns that endemic measles could re-emerge. But, as with smallpox, measles could be eradicated. It has been eliminated in the Americas since 2002. The World Health Organization has set 2010 as the target for elimination in the European region, where 29 000 cases were reported in 2004.(3) Much ground will have to be regained in the United Kingdom if the 2010 target is to be met. We review the uptake of the combined measles, mumps, and rubella (MMR) vaccine in the United Kingdom and Europe, and identify susceptible groups. As clinical experience of measles has declined, doctors in the United Kingdom may not consider the diagnosis nor recognise a case. We also therefore consider the diagnosis, management, and control of measles infection.	St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, Infect & Immunol Delivery Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	MacMahon, E (corresponding author), St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, Infect & Immunol Delivery Unit, London SE1 7EH, England.	eithne.macmahon@gsu.nhs.uk						ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A; [Anonymous], 2006, IMM INF DIS, P1; [Anonymous], 2005, IMM INF DIS, P1; BROWN DWG, 1994, BRIT MED J, V308, P1015, DOI 10.1136/bmj.308.6935.1015; BUTLER JC, 1993, PEDIATRICS, V91, P1176; *CDC, 2006, EP PREV VACC PREV DI, P125; CHERRY JD, 2004, TXB PEDIAT INFECT DI, P2283; de Quadros CA, 2003, J INFECT DIS, V187, pS102, DOI 10.1086/368032; Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X; FOSTER A, 1987, BRIT J OPHTHALMOL, V71, P331, DOI 10.1136/bjo.71.5.331; GAVISH D, 1983, ARCH INTERN MED, V143, P674, DOI 10.1001/archinte.143.4.674; GAY N, 2004, POTENTIAL MEASLES TR, P1; Gershon AA, 2005, MANDELL DOUGLAS BENN, P2031; GRIFFIN DE, 2001, FIELDS VIROLOGY, V1, P1401; HANNINEN P, 1980, J CLIN MICROBIOL, V11, P610; Health Protection Agency, 2006, COMMUN DIS REP WKLY, V16, P3; HUSSEY GD, 1990, NEW ENGL J MED, V323, P160, DOI 10.1056/NEJM199007193230304; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; KAPLAN LJ, 1992, JAMA-J AM MED ASSOC, V267, P1237, DOI 10.1001/jama.267.9.1237; Kidd IM, 2003, LANCET, V362, P832, DOI 10.1016/S0140-6736(03)14256-0; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; Moss WJ, 2002, CLIN INFECT DIS, V35, P189, DOI 10.1086/341248; MOUALLEM M, 1987, ARCH INTERN MED, V147, P1111, DOI 10.1001/archinte.147.6.1111; Okada H, 2000, ARCH VIROL, V145, P905, DOI 10.1007/s007050050683; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; Pertinhez TA, 2004, SPECTROSC-INT J, V18, P1; Ramsay ME, 2003, J INFECT DIS, V187, pS198, DOI 10.1086/368024; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; SHALEVZIMELS H, 1988, HEPATOLOGY, V8, P1138, DOI 10.1002/hep.1840080529; SHNEIDERSCHAULI.S, 2004, PRINCIPLES PRACTICE, P399; SIEGEL M, 1973, JAMA-J AM MED ASSOC, V226, P1521, DOI 10.1001/jama.226.13.1521; Vyse AJ, 2002, EPIDEMIOL REV, V24, P125, DOI 10.1093/epirev/mxf002; Wharton M, 1990, MMWR Recomm Rep, V39, P1; WHITE DO, 1994, MED VIROLOGY, P256; WHO, 2005, ECOSYSTEMS HUMAN WEL, P1; *WHO, 2003, WHO REC SURV STAND M; *WHO, WHO UNICEF EST MCV C; *WHO MED CTR, FACT SHEET 286 REV M	39	39	43	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2006	333	7574					890	895		10.1136/bmj.38989.445845.7C	http://dx.doi.org/10.1136/bmj.38989.445845.7C			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	101WT	17068034	Green Published			2022-12-28	WOS:000241772600016
J	Patel, PR; Larson, AK; Castel, AD; Ganova-Raeva, LM; Myers, RA; Roup, BJ; Farrell, KP; Edwards, L; Nainan, O; Krick, JP; Blythe, D; Fiore, AE; Roche, JC				Patel, Priti R.; Larson, A. Kirsten; Castel, Amanda D.; Ganova-Raeva, Lilia M.; Myers, Robert A.; Roup, Brenda J.; Farrell, Katherine P.; Edwards, Leslie; Nainan, Omana; Krick, John P.; Blythe, David; Fiore, Anthony E.; Roche, Jeffrey C.			Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NOSOCOMIAL TRANSMISSION; COMPOUNDING PHARMACY; UNITED-STATES; OUTBREAK; PREVALENCE; WARD; HCV	Context Nuclear pharmacies prepare radiopharmaceutical products for use in common diagnostic procedures, including myocardial perfusion studies. Hepatitis C virus (HCV) transmission has not been reported previously in the setting of nuclear imaging studies. Objective To investigate an outbreak of acute HCV infection identified among patients who underwent myocardial perfusion studies on October 15, 2004, using an injected radiopharmaceutical. Design, Setting, and Patients Outbreak investigation including molecular epidemiology and pharmacy site investigation at outpatient cardiology clinics and a nuclear pharmacy in Maryland. Ninety patients who received injections drawn from select radiopharmaceutical vials prepared on October 14-15, 2004, at a single nuclear pharmacy were offered testing for bloodborne pathogens. Pharmacy procedures were reviewed and HCV quasi species analysis was performed. Main Outcome Measures Hepatitis C virus infection and quasispecies sequence similarity. Results Sixteen patients with acute HCV infection were identified from 3 separate clinics. All patients received radiopharmaceutical injections drawn from a single pharmacy vial ( vial 1). None of the 59 tested patients who received doses from 6 other vials had acute HCV infection. Blood from a potential source patient with HCV and human immunodeficiency virus (HIV) infection was processed for a radiolabeled white blood cell study in the pharmacy 12 hours before vial 1 was prepared. The HCV quasispecies sequences from this potential source patient were nearly identical to those from cases (97.8%-98.5% similarity). No acute HIV infections were identified. Pharmacy practices that could have led to blood cross-contamination included reuse of needles and syringes during dilutions and use of common flow hoods for some steps in the preparation of sterile and blood-derived products. Conclusions Sixteen persons acquired HCV infection from a blood-contaminated radiopharmaceutical. The source and practices that could have facilitated breaks in aseptic technique were identified at the pharmacy. Nuclear pharmacies that handle biological products should follow appropriate aseptic technique to prevent contamination of sterile radiopharmaceuticals.	Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; Anne Arundel Cty Dept Hlth, Annapolis, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene	Patel, PR (corresponding author), Ctr Dis Control & Prevent, Off Workforce & Career Dev, 1600 Clifton Rd,MS A-31, Atlanta, GA 30333 USA.	ppatel@cdc.gov	Fiore, Anthony/AAO-8956-2020					Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; *AM PHARM ASS SECT, NUCL PHARM COMP GUID; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P269; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Callahan RJ, 1996, SEMIN NUCL MED, V26, P85, DOI 10.1016/S0001-2998(96)80029-8; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1109; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P901; Ciesielski Carol A., 1997, American Journal of Medicine, V102, P115, DOI 10.1016/S0002-9343(97)00076-4; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; Comstock RD, 2004, INFECT CONT HOSP EP, V25, P576, DOI 10.1086/502442; de Oliveira AM, 2005, ANN INTERN MED, V142, P898, DOI 10.7326/0003-4819-142-11-200506070-00007; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Forns X, 2005, HEPATOLOGY, V41, P115, DOI 10.1002/hep.20515; Furusyo N, 2004, INFECT CONT HOSP EP, V25, P584, DOI 10.1086/502443; Held MR, 2006, PEDIATRICS, V118, pE212, DOI 10.1542/peds.2005-2617; Janowski MC, 2005, INF DIS SOC AM 43 AN; Kastango Eric S Mba Rph Fashp, 2002, Int J Pharm Compd, V6, P404; Kastango ES, 2004, AM J HEALTH-SYST PH, V61, P1928, DOI 10.1093/ajhp/61.18.1928; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; KRAWCZYNSKI K, 2003, 54 ANN M AM SOC STUD; Lagging LM, 2002, SCAND J INFECT DIS, V34, P580, DOI 10.1080/00365540110080926; Massari M, 2001, J CLIN MICROBIOL, V39, P2860, DOI 10.1128/JCM.39.8.2860-2863.2001; *MED INF DIV IMV, 2005 NUCL MED MARK S; Morris AM, 2003, AM J HEALTH-SYST PH, V60, P2567, DOI 10.1093/ajhp/60.24.2567; National Association of Boards of Pharmacy, MOD STAT PHARM ACT M; Newton DW, 2003, AM J PHARM EDUC, V67, P12; Pegues DA, 2006, CLIN INFECT DIS, V43, P838, DOI 10.1086/507341; Perz JF, 2005, J CLIN MICROBIOL, V43, P5316, DOI 10.1128/JCM.43.10.5316-5318.2005; *PURD U DIV NUCL P, LIST NUCL PHARM US; Ridzon R, 1997, NEW ENGL J MED, V336, P919, DOI 10.1056/NEJM199703273361304; Sabra K, 2003, AM J HEALTH-SYST PH, V60, P1593, DOI 10.1093/ajhp/60.15.1593; Silini E, 2002, HAEMATOLOGICA, V87, P1200; SUNENSHINE RH, 2005, INF DIS SOC AM 43 AN; Trissel LA, 2003, AM J HEALTH-SYST PH, V60, P432, DOI 10.1093/ajhp/60.5.432; United States Pharmacopeia Inc, 2004, PHARM COMP STER PREP, P2461; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; Young D, 2003, AM J HEALTH-SYST PH, V60, P2402, DOI 10.1093/ajhp/60.23.2402; Young D, 2002, AM J HEALTH-SYST PH, V59, P2261, DOI 10.1093/ajhp/59.23.2261	41	45	48	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					2005	2011		10.1001/jama.296.16.2005	http://dx.doi.org/10.1001/jama.296.16.2005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062864				2022-12-28	WOS:000241495300023
J	Halme, DG; Kessler, DA				Halme, Dina Gould; Kessler, David A.			FDA regulation of stem-cell-based therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; FEEDERS; LINES		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Halme, DG (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BACH FH, 1968, LANCET, V2, P1364; *DEP HLTH HUM SERV, MED PRIV NAT STAND P; Food and Drug Administration, 2003, GUID REV INSTR TEMPL; *FOOD DRUG ADM, 2006, INDS APPR COMPL CGMP; *FOOD DRUG ADM, 2001, PHS GUID INF DIS ISS; *FOOD DRUG ADM, 1993, FED RED, V58, P53248; *FOOD DRUG ADM, 2004, GUID IND EL DET DON; GATTI RA, 1968, LANCET, V2, P1366; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Holden C, 2002, SCIENCE, V297, P1647; KESSLER DA, 1993, NEW ENGL J MED, V329, P1169, DOI 10.1056/NEJM199310143291607; Lanza R., 2004, HDB STEM CELLS 2 VOL, V2; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lo B, 2005, STEM CELLS, V23, P1454, DOI 10.1634/stemcells.2005-ed.4; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; NIH, 2001, STEM CELLS SCI PROGR; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Thomson JA, 1998, SCIENCE, V282, P1827; U.S. FOOD & DRUG ADMIN, 1997, PROPOSED APPROACH RE, P19	22	276	296	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1730	1735		10.1056/NEJMhpr063086	http://dx.doi.org/10.1056/NEJMhpr063086			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096DN	17050899				2022-12-28	WOS:000241357300017
J	Okie, S				Okie, Susan			Single-cell storm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		MANNIES J, 2006, ST LOUIS POST D 0907, pD3; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391	2	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1634	1637		10.1056/NEJMp068224	http://dx.doi.org/10.1056/NEJMp068224			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050885				2022-12-28	WOS:000241357300002
J	Huang, HJ; Regan, KM; Lou, ZK; Chen, JJ; Tindall, DJ				Huang, Haojie; Regan, Kevin M.; Lou, Zhenkun; Chen, Junjie; Tindall, Donald J.			CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage	SCIENCE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CELL-CYCLE REGULATION; PROSTATE-CANCER; CHECKPOINT; INSTABILITY; ACTIVATION; EXPRESSION; SURVIVAL; KINASE; LIGAND	The function of cyclin-dependent kinase 2 (CDK2) is often abolished after DNA damage. The inhibition of CDK2 plays a central role in DNA damage - induced cell cycle arrest and DNA repair. However, whether CDK2 also influences the survival of cells under genotoxic stress is unknown. Forkhead box O (FOXO) transcription factors are emerging as key regulators of cell survival. CDK2 specifically phosphorylated FOXO1 at serine-249 (Ser(249)) in vitro and in vivo. Phosphorylation of Ser249 resulted in cytoplasmic localization and inhibition of FOXO1. This phosphorylation was abrogated upon DNA damage through the cell cycle checkpoint pathway that is dependent on the protein kinases Chk1 and Chk2. Moreover, silencing of FOXO1 by small interfering RNA diminished DNA damage - induced death in both p53-deficient and p53-proficient cells. This effect was reversed by restored expression of FOXO1 in a manner depending on phosphorylation of Ser249. Functional interaction between CDK2 and FOXO1 provides a mechanism that regulates apoptotic cell death after DNA strand breakage.	Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Urol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Tindall, DJ (corresponding author), Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	tindall.donald@mayo.edu			NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060920, R01DK065236] Funding Source: NIH RePORTER; NCI NIH HHS [CA91956] Funding Source: Medline; NIDDK NIH HHS [DK65236, DK60920] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chatterjee D, 2001, CANCER RES, V61, P7148; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Paquet C, 2004, APOPTOSIS, V9, P815, DOI 10.1023/B:APPT.0000045791.55282.91; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836	20	265	273	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					294	297		10.1126/science.1130512	http://dx.doi.org/10.1126/science.1130512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038621				2022-12-28	WOS:000241194100040
J	Goldblatt, C; Lenton, TM; Watson, AJ				Goldblatt, Colin; Lenton, Timothy M.; Watson, Andrew J.			Bistability of atmospheric oxygen and the Great Oxidation	NATURE			English	Article							MOLECULAR FOSSILS; LIFE DETECTION; METHANE; RISE; CYCLE	The history of the Earth has been characterized by a series of major transitions separated by long periods of relative stability(1). The largest chemical transition was the 'Great Oxidation', approximately 2.4 billion years ago, when atmospheric oxygen concentrations rose from less than 10(-5) of the present atmospheric level (PAL) to more than 0.01 PAL, and possibly(2) to more than 0.1 PAL. This transition took place long after oxygenic photosynthesis is thought to have evolved(3-5), but the causes of this delay and of the Great Oxidation itself remain uncertain(6-11). Here we show that the origin of oxygenic photosynthesis gave rise to two simultaneously stable steady states for atmospheric oxygen. The existence of a low-oxygen (less than 10(-5) PAL) steady state explains how a reducing atmosphere persisted for at least 300 million years after the onset of oxygenic photosynthesis. The Great Oxidation can be understood as a switch to the high-oxygen (more than 5 x 10(-3) PAL) steady state. The bistability arises because ultraviolet shielding of the troposphere by ozone becomes effective once oxygen levels exceed 10(-5) PAL, causing a nonlinear increase in the lifetime of atmospheric oxygen. Our results indicate that the existence of oxygenic photosynthesis is not a sufficient condition for either an oxygen-rich atmosphere or the presence of an ozone layer, which has implications for detecting life on other planets using atmospheric analysis(12,13) and for the evolution of multicellular life.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Ctr Ecol & Hydrol, Edinburgh Res Stn, Penicuik EH26 0QB, Midlothian, Scotland	University of East Anglia; UK Centre for Ecology & Hydrology (UKCEH)	Goldblatt, C (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	c.goldblatt@uea.ac.uk		Watson, Andrew/0000-0002-9654-8147	Natural Environment Research Council [ceh010024] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4321, DOI 10.1016/S0016-7037(03)00209-6; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Holland HD, 2003, GEOCHIM COSMOCHIM AC, V67, P787, DOI 10.1016/S0016-7037(00)01178-X; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Kasting JF, 2005, PRECAMBRIAN RES, V137, P119, DOI 10.1016/j.precamres.2005.03.002; KASTING JF, 1979, J GEOPHYS RES-OCEANS, V84, P3097, DOI 10.1029/JC084iC06p03097; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; KASTING JF, 1980, J GEOPHYS RES-OCEANS, V85, P3255, DOI 10.1029/JC085iC06p03255; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; LENTON T, 2004, DAHLEM WORKSHOP REPO, V91, P29; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; LOVELOCK JE, 1965, NATURE, V207, P568, DOI 10.1038/207568a0; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Ren T, 1997, CAN J MICROBIOL, V43, P925, DOI 10.1139/m97-133; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005	30	184	191	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					683	686		10.1038/nature05169	http://dx.doi.org/10.1038/nature05169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036001				2022-12-28	WOS:000241160500044
J	Chait, BT				Chait, Brian T.			Mass spectrometry: Bottom-up or top-down?	SCIENCE			English	Editorial Material							PROTEIN		Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University	Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA.	chait@rockefeller.edu						Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; Han XM, 2006, SCIENCE, V314, P109, DOI 10.1126/science.1128868; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Sowell RA, 2004, J AM SOC MASS SPECTR, V15, P1341, DOI 10.1016/j.jasms.2004.06.014; WOZNIAK RW, 1994, J CELL BIOL, V125, P31, DOI 10.1083/jcb.125.1.31; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	8	284	299	12	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					65	66		10.1126/science.1133987	http://dx.doi.org/10.1126/science.1133987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023639				2022-12-28	WOS:000241031200030
J	Hatziioannou, T; Princiotta, M; Piatak, M; Yuan, F; Zhang, FW; Lifson, JD; Bieniasz, PD				Hatziioannou, Theodora; Princiotta, Michael; Piatak, Michael, Jr.; Yuan, Fang; Zhang, Fengwen; Lifson, Jeffrey D.; Bieniasz, Paul D.			Generation of simian-tropic HIV-1 by restriction factor evasion	SCIENCE			English	Article							INFECTION; VIF		Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Rockefeller Univ, New York, NY 10016 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bieniasz, PD (corresponding author), Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org	Liu, FL/D-1795-2009					Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343	4	128	133	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					95	95		10.1126/science.1130994	http://dx.doi.org/10.1126/science.1130994			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023652				2022-12-28	WOS:000241031200042
J	Singh, S				Singh, Seema			Indian science in transition	CELL			English	Editorial Material								India is a country in transition, and so is its science. Scientific institutions, researchers, regulatory agencies, and government policies are in a state of flux as changes are instigated to overcome the bureaucracy and inertia that are characteristic of a populous developing nation.											0	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					23	25		10.1016/j.cell.2006.09.020	http://dx.doi.org/10.1016/j.cell.2006.09.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018269	Bronze			2022-12-28	WOS:000241445800006
J	Schillinger, D				Schillinger, Dean			Patagonia pastorale	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dschillinger@medsfgh.ucsf.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1567	1568		10.1001/jama.296.13.1567	http://dx.doi.org/10.1001/jama.296.13.1567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090JS	17018793				2022-12-28	WOS:000240948200001
J	Ule, J; Stefani, G; Mele, A; Ruggiu, M; Wang, XN; Taneri, B; Gaasterland, T; Blencowe, BJ; Darnell, RB				Ule, Jernej; Stefani, Giovanni; Mele, Aldo; Ruggiu, Matteo; Wang, Xuning; Taneri, Bahar; Gaasterland, Terry; Blencowe, Benjamin J.; Darnell, Robert B.			An RNA map predicting Nova-dependent splicing regulation	NATURE			English	Article							TRACT-BINDING-PROTEIN; PRE-MESSENGER-RNA; RICH ELEMENTS; HNRNP A1; U1 SNRNP; IN-VIVO; IDENTIFICATION; EXON; ENHANCER; COMPLEX	Nova proteins are neuron-specific alternative splicing factors. We have combined bioinformatics, biochemistry and genetics to derive an RNA map describing the rules by which Nova proteins regulate alternative splicing. This map revealed that the position of Nova binding sites (YCAY clusters) in a pre-messenger RNA determines the outcome of splicing. The map correctly predicted Nova's effect to inhibit or enhance exon inclusion, which led us to examine the relationship between the map and Nova's mechanism of action. Nova binding to an exonic YCAY cluster changed the protein complexes assembled on pre-mRNA, blocking U1 snRNP ( small nuclear ribonucleoprotein) binding and exon inclusion, whereas Nova binding to an intronic YCAY cluster enhanced spliceosome assembly and exon inclusion. Assays of splicing intermediates of Nova-regulated transcripts in mouse brain revealed that Nova preferentially regulates removal of introns harbouring ( or closest to) YCAY clusters. These results define a genome-wide map relating the position of a cis-acting element to its regulation by an RNA binding protein, namely that Nova binding to YCAY clusters results in a local and asymmetric action to regulate spliceosome assembly and alternative splicing in neurons.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University; University of Toronto	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Ule, Jernej/C-6315-2013; Stefani, Giovanni/P-6179-2015	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Stefani, Giovanni/0000-0002-8782-6811; Ruggiu, Matteo/0000-0002-6404-1210	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BARABINO SML, 1990, CELL, V63, P293, DOI 10.1016/0092-8674(90)90162-8; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Carlo T, 1996, RNA, V2, P342; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gee SL, 2000, BLOOD, V95, P692, DOI 10.1182/blood.V95.2.692; Gersappe A, 1999, MOL CELL BIOL, V19, P364; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; TARN WY, 1994, GENE DEV, V8, P2704, DOI 10.1101/gad.8.22.2704; TSAI MJ, 1980, CELL, V22, P219, DOI 10.1016/0092-8674(80)90170-1; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	50	390	397	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					580	586		10.1038/nature05304	http://dx.doi.org/10.1038/nature05304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17065982				2022-12-28	WOS:000242377600040
J	Ajees, AA; Gunasekaran, K; Volanakis, JE; Narayana, SVL; Kotwal, GJ; Murthy, HMK				Ajees, A. Abdul; Gunasekaran, K.; Volanakis, John E.; Narayana, Sthanam. V. L.; Kotwal, Girish J.; Krishna Murthy, H. M.			RETRACTED: The structure of complement C3b provides insights into complement activation and regulation (Retracted article. See vol. 532,2016)	NATURE			English	Article; Retracted Publication							FACTOR-H; CRYSTAL-STRUCTURE; CONTROL PROTEIN; 3RD COMPONENT; X-RAY; BINDING-SITE; CR-1; IDENTIFICATION; RESIDUES; HEPARIN	The human complement system is an important component of innate immunity. Complement-derived products mediate functions contributing to pathogen killing and elimination(1). However, inappropriate activation of the system contributes to the pathogenesis of immunological and inflammatory diseases(1). Complement component 3 (C3) occupies a central position because of the manifold biological activities of its activation fragments, including the major fragment, C3b, which anchors the assembly of convertases effecting C3 and C5 activation. C3 is converted to C3b by proteolysis of its anaphylatoxin domain(2), by either of two C3 convertases. This activates a stable thioester bond, leading to the covalent attachment of C3b to cell-surface or protein-surface hydroxyl groups through transesterification(3). The cleavage and activation of C3 exposes binding sites for factors B, H and I, properdin, decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35) and viral molecules such as vaccinia virus complement-control protein(4). C3b associates with these molecules in different configurations and forms complexes mediating the activation, amplification and regulation of the complement response(1,4). Structures of C3 and C3c, a fragment derived from the proteolysis of C3b, have revealed a domain configuration, including six macroglobulin domains (MG1 - MG6; nomenclature follows ref. 5) arranged in a ring, termed the beta-ring(5). However, because neither C3 nor C3c is active in complement activation and regulation, questions about function can be answered only through direct observations on C3b. Here we present a structure of C3b that reveals a marked loss of secondary structure in the CUB ( for 'complement C1r/C1s, Uegf, Bmp1') domain, which together with the resulting translocation of the thioester domain provides a molecular basis for conformational changes accompanying the conversion of C3 to C3b. The total conformational changes make many proposed ligand-binding sites more accessible and create a cavity that shields target peptide bonds from access by factor I. A covalently bound N-acetyl-L-threonine residue demonstrates the geometry of C3b attachment to surface hydroxyl groups.	Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Cape Town, HSC, Div Med Virol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Cape Town	Murthy, HMK (corresponding author), Univ Alabama Birmingham, Ctr Biophys Sci & Engn, 1530 3rd Ave S, Birmingham, AL 35294 USA.	murthy@cbse.uab.edu			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; *CCP4, 1993, ACTA CRYSTALLOGR D, V50, P760; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Ganesh VK, 2004, P NATL ACAD SCI USA, V101, P8924, DOI 10.1073/pnas.0400744101; GETTINS PGW, 1995, BIOCHEMISTRY-US, V34, P12233, DOI 10.1021/bi00038a018; HIGGINS JMG, 1995, J IMMUNOL, V155, P5777; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; LAMBRIS JD, 1988, IMMUNOL TODAY, V9, P387, DOI 10.1016/0167-5699(88)91240-6; LAMBRIS JD, 1988, J BIOL CHEM, V263, P12147; Law SKA, 1997, PROTEIN SCI, V6, P263; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; OKEEFE MC, 1988, J BIOL CHEM, V263, P12690; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puliti R, 2000, ACTA CRYSTALLOGR C, V56, P496; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Smith SA, 2003, BBA-PROTEINS PROTEOM, V1650, P30, DOI 10.1016/S1570-9639(03)00189-4; Tsiftsoglou SA, 2005, BIOCHEMISTRY-US, V44, P6239, DOI 10.1021/bi047680t; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x; Zanotti G, 2000, BBA-PROTEIN STRUCT M, V1478, P232, DOI 10.1016/S0167-4838(00)00040-6	30	57	60	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					221	225		10.1038/nature05258	http://dx.doi.org/10.1038/nature05258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051152				2022-12-28	WOS:000241867200044
J	Kirwan, JF; Cousens, S; Venter, L; Cook, C; Stulting, A; Roux, P; Murdoch, I				Kirwan, James F.; Cousens, Simon; Venter, Lynette; Cook, Colin; Stulting, Andries; Roux, Paul; Murdoch, Ian			Effect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; VISUAL-ACUITY; TRABECULECTOMY; IRRADIATION; ADJUNCT; EYE	Objective To evaluate whether beta radiation may offer a practical method of improving surgical success for glaucoma drainage surgery in South Africa. Design Double blind, randomised controlled trial. Setting Three public hospitals in South Africa. Participants 450 black Africans with primary glaucoma. Interventions Trabeculectomy with 1000 cGy beta radiation or standard trabeculectomy without beta radiation (placebo). Main outcome measures Primary outcome measure was surgical failure within 12 months (intraocular pressure > 21 mm Hg while receiving no treatment for ocular hypotension). Secondary outcomes were visual acuity, surgical reintervention for cataract, and intraoperative and postoperative complications. Results 320 people were recruited. beta radiation was given to 164; 20 (6%) were not seen again after surgery. One year after surgery the estimated risk of surgical failure was 30% (95% confidence interval 22% to 38%) in the placebo arm compared with 5% (2% to 10%) in the radiation arm. The radiation group experienced a higher incidence of operable cataract (18 participants) than the placebo group (five participants; P = 0.01). At two years the estimated risks with placebo and beta radiation were, respectively, 2.8% (0.9% to 8.3%) and 16.7% (10.0% to 27.3%). Conclusion beta radiation substantially reduced the risk of surgical failure after glaucoma surgery. Some evidence was, however, found of an increased risk for cataract surgery (a known complication of trabeculectomy) in the beta radiation arm during the two years after surgery.	UCL, Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England; London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; Natl Hosp, Dept Ophthalmol, Bloemfontein, South Africa; Groote Schuur Hosp, Dept Ophthalmol, ZA-7925 Cape Town, South Africa; Pretoria Acad Hosp, Dept Ophthalmol, Pretoria, South Africa	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Pretoria	Murdoch, I (corresponding author), UCL, Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England.	i.murdoch@ucl.ac.uk	Murdoch, Ian/Z-2527-2019		Wellcome Trust [056045, 068244] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barnes RM, 2000, CLIN EXP OPHTHALMOL, V28, P259, DOI 10.1046/j.1442-9071.2000.00317.x; BROADWAY D, 1994, BRIT J OPHTHALMOL, V78, P466, DOI 10.1136/bjo.78.6.466; Chen PP, 1998, OPHTHALMOLOGY, V105, P1928, DOI 10.1016/S0161-6420(98)91044-2; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COSTA VP, 1993, OPHTHALMOLOGY, V100, P599; Derbolav A, 2002, J CATARACT REFR SURG, V28, P425, DOI 10.1016/S0886-3350(01)01189-0; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Edmunds B, 2002, EYE, V16, P297, DOI 10.1038/sj.eye.6700148; Gleckler M, 1998, MED PHYS, V25, P29, DOI 10.1118/1.598434; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kirwan JF, 2003, EYE, V17, P207, DOI 10.1038/sj.eye.6700306; LAI J, 1994, INVEST OPHTH VIS SCI, V34, P1432; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; MILLER MH, 1991, BRIT J OPHTHALMOL, V75, P584, DOI 10.1136/bjo.75.10.584; POPOVIC V, 1991, ACTA OPHTHALMOL, V69, P299; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2000, BRIT J OPHTHALMOL, V84, P860, DOI 10.1136/bjo.84.8.860; Rehman SU, 2002, OPHTHALMOLOGY, V109, P302, DOI 10.1016/S0161-6420(01)00885-5; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; RITCH R, 1996, GLAUCOMAS, V3; Rosser DA, 2001, BRIT J OPHTHALMOL, V85, P432, DOI 10.1136/bjo.85.4.432; THOMAS CI, 1962, RADIOLOGY, V79, P588, DOI 10.1148/79.4.588; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; TORNQVIST G, 1991, ACTA OPHTHALMOL, V69, P450; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vesti E, 1997, OPHTHALMIC SURG LAS, V28, P128; Wilkins M, 2001, COCHRANE DB SYST REV; Wormald R, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001132; Yalvac IS, 2004, J CATARACT REFR SURG, V30, P2050, DOI 10.1016/j.jcrs.2004.02.073	30	30	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2006	333	7575					942	994A		10.1136/bmj.38971.395301.7C	http://dx.doi.org/10.1136/bmj.38971.395301.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17023435	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-28	WOS:000242157900015
J	Berkefeld, H; Sailer, CA; Bildl, W; Rohde, V; Thumfart, JO; Eble, S; Klugbauer, N; Reisinger, E; Bischofberger, J; Oliver, D; Knaus, HG; Schulte, U; Fakler, B				Berkefeld, Henrike; Sailer, Claudia A.; Bildl, Wolfgang; Rohde, Volker; Thumfart, Joerg-Oliver; Eble, Silke; Klugbauer, Norbert; Reisinger, Ellen; Bischofberger, Josef; Oliver, Dominik; Knaus, Hans-Guenther; Schulte, Uwe; Fakler, Bernd			BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; RAT CHROMAFFIN CELLS; CA2+ CHANNELS; CALCIUM-CHANNELS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; SPIKE REPOLARIZATION; PYRAMIDAL NEURONS	Large-conductance calcium- and voltage-activated potassium channels (BKCa) are dually activated by membrane depolarization and elevation of cytosolic calcium ions (Ca2+). Under normal cellular conditions, BKCa channel activation requires Ca2+ concentrations that typically occur in close proximity to Ca2+ sources. We show that BKCa channels affinity-purified from rat brain are assembled into macromolecular complexes with the voltage-gated calcium channels Cav1.2 (L-type), Cav2.1 (P/Q-type), and Cav2.2 (N-type). Heterologously expressed BKCa-Cav complexes reconstitute a functional "Ca2+ nanodomain" where Ca2+ influx through the Cav channel activates BKCa in the physiological voltage range with submillisecond kinetics. Complex formation with distinct Cav channels enables BKCa-mediated membrane hyperpolarization that controls neuronal firing pattern and release of hormones and transmitters in the central nervous system.	Logopharm GmbH, D-79104 Freiburg, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; Univ Freiburg, Inst Pharmacol & Toxicol, D-79104 Freiburg, Germany	University of Freiburg; Medical University of Innsbruck; University of Freiburg	Fakler, B (corresponding author), Logopharm GmbH, Hermann Herder Str 7, D-79104 Freiburg, Germany.	u.schulte@logopharm.com; bernd.fakler@physiologie.uni-freiburg.de	Thumfart, Joerg O/F-9741-2013; Oliver, Dominik/F-5845-2013	Thumfart, Joerg O/0000-0001-7647-9888; Oliver, Dominik/0000-0002-8368-0923; Reisinger, Ellen/0000-0003-3739-7569; Bischofberger, Josef/0000-0002-4006-1663				ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavelier P, 2003, CEREBELLUM, V2, P196, DOI 10.1080/14734220310016141; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Davies PJ, 1999, J NEUROPHYSIOL, V82, P818, DOI 10.1152/jn.1999.82.2.818; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Knaus HG, 1996, J NEUROSCI, V16, P955; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; Lingle C J, 1996, Ion Channels, V4, P261; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Prakriya M, 1999, J NEUROPHYSIOL, V81, P2267, DOI 10.1152/jn.1999.81.5.2267; Prakriya M, 2000, J NEUROPHYSIOL, V84, P1123, DOI 10.1152/jn.2000.84.3.1123; Protti DA, 1997, PFLUG ARCH EUR J PHY, V434, P406, DOI 10.1007/s004240050414; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SAKURAI T, 1995, J BIOL CHEM, V270, P21234, DOI 10.1074/jbc.270.36.21234; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Sun XL, 2003, J NEUROSCI, V23, P3639; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wanner SG, 1999, BIOCHEMISTRY-US, V38, P5392, DOI 10.1021/bi983040c; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Xie C, 2005, J GEN PHYSIOL, V126, P205, DOI 10.1085/jgp.200509293; Yazejian B, 1997, J NEUROSCI, V17, P2990	42	279	284	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					615	620		10.1126/science.1132915	http://dx.doi.org/10.1126/science.1132915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068255				2022-12-28	WOS:000241557800037
J	Glabe, C				Glabe, Charles			Biomedicine - Avoiding collateral damage in Alzheimer's disease treatment	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; GENERATION; BACE1; CLEAVAGE		Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Glabe, C (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341	11	1	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					602	603		10.1126/science.1135043	http://dx.doi.org/10.1126/science.1135043			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098XT	17068248				2022-12-28	WOS:000241557800030
J	Wang, DJ; Mookherjee, M; Xu, YS; Karato, S				Wang, Duojun; Mookherjee, Mainak; Xu, Yousheng; Karato, Shun-ichiro			The effect of water on the electrical conductivity of olivine	NATURE			English	Article							MANTLE; HYDROGEN; WADSLEYITE; ANISOTROPY; DIFFUSION; PRESSURE; CREEP	It is well known that water ( as a source of hydrogen) affects the physical and chemical properties of minerals - for example, plastic deformation(1-3) and melting temperature(4) - and accordingly plays an important role in the dynamics and geochemical evolution of the Earth. Estimating the water content of the Earth's mantle by direct sampling provides only a limited data set from shallow regions (<200 km depth)(5). Geophysical observations such as electrical conductivity are considered to be sensitive to water content(6), but there has been no experimental study to determine the effect of water on the electrical conductivity of olivine, the most abundant mineral in the Earth's mantle. Here we report a laboratory study of the dependence of the electrical conductivity of olivine aggregates on water content at high temperature and pressure. The electrical conductivity of synthetic polycrystalline olivine was determined from a. c. impedance measurements at a pressure of 4 GPa for a temperature range of 873 - 1,273K for water contents of 0.01 - 0.08 wt%. The results show that the electrical conductivity is strongly dependent on water content but depends only modestly on temperature. The water content dependence of conductivity is best explained by a model in which electrical conduction is due to the motion of free protons. A comparison of the laboratory data with geophysical observations 7 - 10 suggests that the typical oceanic asthenosphere contains similar to 10(-2) wt% water, whereas the water content in the continental upper mantle is less than similar to 10(-3) wt%.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Chinese Acad Sci, Inst Geochem, Guiyang 550002, Peoples R China; China Earthquake Adv, Inst Geol, Beijing 100029, Peoples R China; Univ Connecticut, Dept Math, Storrs, CT 06269 USA	Yale University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; University of Connecticut	Karato, S (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	shun-ichiro.karato@yale.edu	Mookherjee, Mainak/F-7949-2010	Mookherjee, Mainak/0000-0002-0605-5964				Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; Bolfan-Casanova N, 2005, MINERAL MAG, V69, P229, DOI 10.1180/0026461056930248; CONSTABLE S, 1992, J GEOPHYS RES-SOL EA, V97, P3397, DOI 10.1029/91JB02453; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Gatzemeier A, 2005, PHYS EARTH PLANET IN, V149, P225, DOI 10.1016/j.pepi.2004.10.004; HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579; Hier-Majumder S, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003292; Hirth G., 2000, GEOCHEM GEOPHY GEOSY, V1, DOI [10.1029/2000GC000048, DOI 10.1029/2000GC000048]; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Ichiki M, 2001, GEOPHYS RES LETT, V28, P3773, DOI 10.1029/2001GL012983; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; KARATO S, 1974, THESIS U TOKYO; Karato SI, 2003, PHILOS MAG, V83, P401, DOI 10.1080/0141861021000025829; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; Kohlstedt DL, 1998, Z PHYS CHEM, V207, P147, DOI 10.1524/zpch.1998.207.Part_1_2.147; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; KUSHIRO I, 1968, J GEOPHYS RES, V73, P6023, DOI 10.1029/JB073i018p06023; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; Olsen N, 1999, GEOPHYS J INT, V138, P179, DOI 10.1046/j.1365-246x.1999.00854.x; PATERSON MS, 1982, B MINERAL, V105, P20; SCHOCK RN, 1989, J GEOPHYS RES-SOLID, V94, P5829, DOI 10.1029/JB094iB05p05829; Simpson F, 2005, GEOPHYS J INT, V160, P1092, DOI 10.1111/j.1365-246X.2005.02563.x; Simpson F, 2002, EARTH PLANET SC LETT, V203, P535, DOI 10.1016/S0012-821X(02)00862-2; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2609, DOI 10.1016/0016-7037(82)90381-7; Tarits P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019277; WANG D, 2004, THESIS CHINESE ACAD; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1	30	299	337	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					977	980		10.1038/nature05256	http://dx.doi.org/10.1038/nature05256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066032				2022-12-28	WOS:000241523400051
J	Liu, JH; Zingmond, DS; McGory, ML; SooHoo, NF; Ettner, SL; Brook, RH; Ko, CY				Liu, Jerome H.; Zingmond, David S.; McGory, Marcia L.; SooHoo, Nelson F.; Ettner, Susan L.; Brook, Robert H.; Ko, Clifford Y.			Disparities in the utilization of high-volume hospitals for complex surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSLUMINAL CORONARY ANGIOPLASTY; OPERATIVE MORTALITY; SURGICAL MORTALITY; UNINSURED ADULTS; OUTCOMES; ASSOCIATION; HEALTH; RACE; QUALITY; GENDER	Context Referral to high-volume hospitals has been recommended for operations with a demonstrated volume-outcome relationship. The characteristics of patients who receive care at low-volume hospitals may be different from those of patients who receive care at high-volume hospitals. These differences may limit their ability to access or receive care at a high-volume hospital. Objective To identify patient characteristics associated with the use of high-volume hospitals, using California's Office of Statewide Health Planning and Development patient discharge database. Design, Setting, and Participants Retrospective study of Californians receiving the following inpatient operations from 2000 through 2004: elective abdominal aortic aneurysm repair, coronary artery bypass grafting, carotid endarterectomy, esophageal cancer resection, hip fracture repair, lung cancer resection, cardiac valve replacement, coronary angioplasty, pancreatic cancer resection, and total knee replacement. Main Outcome Measures Patient race/ethnicity and insurance status in high-volume ( highest 20% of patients by mean annual volume) and in low-volume ( lowest 20%) hospitals. Results A total of 719 608 patients received 1 of the 10 operations. Overall, non-whites, Medicaid patients, and uninsured patients were less likely to receive care at high-volume hospitals and more likely to receive care at low-volume hospitals when controlling for other patient-level characteristics. Blacks were significantly ( P <. 05) less likely than whites to receive care at high-volume hospitals for 6 of the 10 operations ( relative risk [RR] range, 0.40-0.72), while Asians and Hispanics were significantly less likely to receive care at high-volume hospitals for 5 ( RR range, 0.60-0.91) and 9 ( RR range, 0.46-0.88), respectively. Medicaid patients were significantly less likely than Medicare patients to receive care at high-volume hospitals for 7 of the operations ( RR range, 0.22-0.66), while uninsured patients were less likely to be treated at high-volume hospitals for 9 ( RR range, 0.20-0.81). Conclusions There are substantial disparities in the characteristics of patients receiving care at high-volume hospitals. The interest in selective referral to high-volume hospitals should include explicit efforts to identify the patient and system factors required to reduce current inequities regarding their use.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Ctr Surg Outcomes & Qual, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA; RAND Corp, Santa Monica, CA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Ko, CY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Ctr Surg Outcomes & Qual, 10833 Le Conte Ave,72-215 CHS,Box 956904, Los Angeles, CA 90095 USA.	cko@mednet.ucla.edu			NATIONAL INSTITUTE ON AGING [K08AG023024] Funding Source: NIH RePORTER; NIA NIH HHS [1K08AG023024] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Epstein AM, 2003, MED CARE, V41, P1240, DOI 10.1097/01.MLR.0000093423.38746.8C; Glance LG, 2003, ANN THORAC SURG, V76, P1155, DOI 10.1016/S0003-4975(03)00114-0; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; HUGHES RG, 1988, MED CARE, V26, P1057, DOI 10.1097/00005650-198811000-00004; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; *KAIS FAM FDN, US HLTH COV UN; Kansagra SM, 2004, JAMA-J AM MED ASSOC, V292, P1717, DOI 10.1001/jama.292.14.1717; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; LILLIEBLANTON M, KEY FACTS RACE ETHNI; Little R. J. A., 1987, STAT ANAL MISSING DA; Liu JH, 2003, J SURG RES, V113, P96, DOI 10.1016/S0022-4804(03)00145-8; Long S. J., 1997, REGRESSION MODELS CA, V7; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; LUFT HS, 1995, BRIT MED J, V311, P1304, DOI 10.1136/bmj.311.7015.1304b; Okoro CA, 2005, J HEALTH CARE POOR U, V16, P453, DOI 10.1353/hpu.2005.0058; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Peck C, 2001, AM J SURG, V181, P450, DOI 10.1016/S0002-9610(01)00614-6; PHILLIPS KA, 1995, MED CARE, V33, P502, DOI 10.1097/00005650-199505000-00005; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785; Taylor A K, 2001, Health Serv Res, V36, P16; van Lanschot JJB, 2001, CANCER-AM CANCER SOC, V91, P1574, DOI 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2	33	384	384	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1973	1980		10.1001/jama.296.16.1973	http://dx.doi.org/10.1001/jama.296.16.1973			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062860				2022-12-28	WOS:000241495300019
J	Kramer, MS; Rouleau, J; Baskett, TF; Joseph, KS				Kramer, Michael S.; Rouleau, Jocelyn; Baskett, Thomas F.; Joseph, K. S.		Maternal Hlth Study Grp Canadian P	Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study	LANCET			English	Article							UNITED-STATES; MORTALITY	Background Amniotic-fluid embolism is a rare, but serious and often fatal maternal complication of delivery, of which the cause is unknown. We undertook an epidemiological study to investigate the association between amniotic-fluid embolism and medical induction of labour. Methods We used a population-based cohort of 3 million hospital deliveries in Canada between 1991 and 2002 to assess the associations between overall and fatal rates of amniotic-fluid embolism and medical and surgical induction, maternal age, fetal presentation, mode of delivery, and pregnancy and labour complications. Findings Total rate of amniotic-fluid embolism was 14.8 per 100000 multiple-birth deliveries and 6.0 per 100 000 singleton deliveries (odds ratio 2.5 [95% CI 0.9-6.2]). Of the 180 cases of amniotic-fluid embolism in women with singleton deliveries during the study period, 24 (13%) were fatal. We saw no significant temporal increase in occurrence of amniotic-fluid embolism for total or fatal cases. Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism (adjusted odds ratio 1.8 [1.3-2.7]), and the association was stronger for fatal cases (crude odds ratio 3.5 [1.5-8.4]). Maternal age of 35 years or older, Caesarean or instrumental vaginal delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption, eclampsia, and fetal distress were also associated with an increased risk. Interpretation Medical induction of labour seems to increase the risk of amniotic-fluid embolism. Although the absolute excess risk is low, women and physicians should be aware of this risk when making decisions about elective labour induction.	Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; McGill Univ, Fac Med, Dept Paediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Publ Hlth Agcy Canada, Infant Hlth Sect, Div Surveillance & Epidemiol, Ottawa, ON, Canada; Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada; Dalhousie Univ, Dept Paediat, Halifax, NS, Canada	McGill University; McGill University; McGill University; Public Health Agency of Canada; Dalhousie University; Dalhousie University; Dalhousie University	Kramer, MS (corresponding author), Montreal Childrens Hosp, 2300 Tupper St Les Tourelles, Montreal, PQ H3H 1P3, Canada.	michael.kramer@mcgill.ca		Joseph, K.S./0000-0003-2317-5607				ATRASH HK, 1990, OBSTET GYNECOL, V76, P1055; Benson MD, 1996, AM J OBSTET GYNECOL, V175, P737; BURROWS A, 1995, AUST NZ J OBSTET GYN, V35, P245, DOI 10.1111/j.1479-828X.1995.tb01973.x; Clark S L, 1990, Obstet Gynecol Surv, V45, P360, DOI 10.1097/00006254-199006000-00003; CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1159; GEOGHEGAN FJ, 1964, J OBSTET GYN BR COMM, V71, P673; Gilbert WM, 1999, OBSTET GYNECOL, V93, P973, DOI 10.1016/S0029-7844(99)00004-6; GREGORY MG, 1973, OBSTET GYNECOL, V42, P236; HANKINS GDV, 1993, AM J OBSTET GYNECOL, V168, P1113, DOI 10.1016/0002-9378(93)90355-M; Health Canada, 2004, SPEC REP MAT MORT SE; HOGBERG U, 1985, GYNECOL OBSTET INVES, V20, P130; Kirby RS, 2004, BIRTH-ISS PERINAT C, V31, P148, DOI 10.1111/j.0730-7659.2004.00294.x; LEWIS G, 2004, WHY MOTHERS DIE 2000, P96; MORGAN M, 1979, ANAESTHESIA, V34, P20, DOI 10.1111/j.1365-2044.1979.tb04862.x; Robillard J, 2005, AM J OBSTET GYNECOL, V193, P1508, DOI 10.1016/j.ajog.2005.03.022; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P1625, DOI 10.1111/j.1471-0528.2005.00770.x; Turner Linda A, 2002, Chronic Dis Can, V23, P22; Turner Linda A, 2002, Chronic Dis Can, V23, P31; Wagner M, 2005, PAEDIATR PERINAT EP, V19, P173, DOI 10.1111/j.1365-3016.2005.00630.x; Weiwen Y, 2000, OBSTET GYNECOL, V95, p38S; Wen S W, 1997, Chronic Dis Can, V18, P113; Wen S W, 2001, Chronic Dis Can, V22, P1	22	117	125	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1444	1448		10.1016/S0140-6736(06)69607-4	http://dx.doi.org/10.1016/S0140-6736(06)69607-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055946				2022-12-28	WOS:000241459100032
J	Wakabayashi, H; Otani, T; Yachida, S; Okano, K; Izuishi, K; Suzuki, Y				Wakabayashi, Hisao; Otani, Tsuyoshi; Yachida, Shinichi; Okano, Keiichi; Izuishi, Kunihiko; Suzuki, Yasuyuki			Central venous catheter-related infection diagnosed by CT	LANCET			English	Editorial Material							COMPLICATIONS; THROMBOSIS		Kagawa Univ, Fac Med, Dept Surg Gastroenterol, Miki, Kagawa 7610793, Japan	Kagawa University	Wakabayashi, H (corresponding author), Kagawa Univ, Fac Med, Dept Surg Gastroenterol, Miki, Kagawa 7610793, Japan.	hisao-w@med.kagawa-u.ac.jp						Cheng TY, 2006, ANN SURG ONCOL, V13, P66, DOI 10.1245/ASO.2006.02.003; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; van Rooden CJ, 2005, J CLIN ONCOL, V23, P2655, DOI 10.1200/JCO.2005.05.002; Wilkin TD, 2003, RADIOLOGY, V228, P697, DOI 10.1148/radiol.2283020681	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1466	1466		10.1016/S0140-6736(06)69608-6	http://dx.doi.org/10.1016/S0140-6736(06)69608-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055949				2022-12-28	WOS:000241459100035
J	Driehuys, B				Driehuys, Bastiaan			Chemistry: Toward molecular imaging with xenon MRI	SCIENCE			English	Editorial Material									Duke Univ, Med Ctr, Ctr In Vivo Microscopy, Dept Radiol, Durham, NC 27710 USA	Duke University	Driehuys, B (corresponding author), Duke Univ, Med Ctr, Ctr In Vivo Microscopy, Dept Radiol, Durham, NC 27710 USA.	driehuys@orion.duhs.duke.edu						ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; DRIEHUYS B, IN PRESS P NATL ACAD; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Ruset IC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053002; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847	6	11	12	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					432	433		10.1126/science.1134532	http://dx.doi.org/10.1126/science.1134532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053138				2022-12-28	WOS:000241382500030
J	Roberts, WM				Roberts, William M.			Snaring otoferlin's role in deafness	CELL			English	Editorial Material								Mutations in the gene encoding otoferlin are known to cause deafness, but the mechanism is unclear. In this issue, Roux et al. (2006) demonstrate that otoferlin interacts with SNARE molecules at the afferent synapses of cochlear inner hair cells to trigger exocytosis of neurotransmitter.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Roberts, WM (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	roberts@uoneuro.uoregon.edu		Roberts, William/0000-0001-9762-4255				Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; MerchanPerez A, 1996, J COMP NEUROL, V371, P208, DOI 10.1002/(SICI)1096-9861(19960722)371:2<208::AID-CNE2>3.0.CO;2-6; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	4	3	9	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					258	260		10.1016/j.cell.2006.10.010	http://dx.doi.org/10.1016/j.cell.2006.10.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055427	Bronze			2022-12-28	WOS:000241827100013
J	Xing, Y; Xu, YH; Chen, Y; Jeffrey, PD; Chao, Y; Lin, Z; Li, Z; Strack, S; Stock, JB; Shi, YG				Xing, Yongna; Xu, Yanhui; Chen, Yu; Jeffrey, Philip D.; Chao, Yang; Lin, Zheng; Li, Zhu; Strack, Stefan; Stock, Jeffry B.; Shi, Yigong			Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins	CELL			English	Article							SMALL-T-ANTIGEN; REGULATORY-A-SUBUNIT; PP2A CATALYTIC SUBUNIT; MOLECULAR-CLONING; TRUNCATED ISOFORM; CRYSTAL-STRUCTURE; SIMIAN VIRUS-40; ALPHA SUBUNIT; SERINE/THREONINE PHOSPHATASES; CARBOXYL METHYLATION	The serine/threonine phosphatase protein phosphatase 2A (PP2A) plays an essential role in many aspects of cellular functions and has been shown to be an important tumor suppressor. The core enzyme of PP2A comprises a 65 kDa scaffolding subunit and a 36 kDa catalytic subunit. Here we report the crystal structures of the PP2A core enzyme bound to two of its inhibitors, the tumor-inducing agents okadaic acid and microcystin-LR, at 2.6 and 2.8 angstrom resolution, respectively. The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15. Formation of the core enzyme forces the scaffolding subunit to undergo pronounced structural rearrangement. The scaffolding subunit exhibits considerable conformational flexibility, which is proposed to play an essential role in PP2A function. These structures, together with biochemical analyses, reveal significant insights into PP2A function and serve as a framework for deciphering the diverse roles of PP2A in cellular physiology.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	Princeton University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Xu, Yanhui/D-5119-2019	Shi, Yigong/0000-0003-2030-168X; Strack, Stefan/0000-0002-6175-7280; Jeffrey, Philip/0000-0002-4351-5341; Li, Zhu/0000-0003-1536-9401				Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harada Ken-Ichi, 1996, Natural Toxins, V4, P277; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ito A, 2003, AM J PATHOL, V162, P81, DOI 10.1016/S0002-9440(10)63800-X; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHI B, 1990, J VIROL, V64, P5649, DOI 10.1128/JVI.64.11.5649-5651.1990; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Suzuki K, 2003, INT J ONCOL, V23, P1263; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; TAKATA K, 2000, BREED RES, V2, P11; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	59	251	276	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					341	353		10.1016/j.cell.2006.09.025	http://dx.doi.org/10.1016/j.cell.2006.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055435	Bronze			2022-12-28	WOS:000241827100021
J	Pimentel, M; Park, S; Mirocha, J; Kane, SV; Kong, Y				Pimentel, Mark; Park, Sandy; Mirocha, James; Kane, Sunanda V.; Kong, Yuthana			The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							INTESTINAL BACTERIAL OVERGROWTH; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; IN-VITRO; PREVALENCE; CONSTIPATION; IMPROVEMENT; TEGASEROD; ALOSETRON; COMMUNITY	Background: Alterations in gut flora may be important in the pathophysiology of the irritable bowel syndrome (IBS). Objective: To determine whether the nonabsorbed antibiotic rifaximin is more effective than placebo in reducing symptoms in adults with IBS. Design: Double-blind, randomized, placebo-controlled study. Setting: 2 tertiary care medical centers. Participants: 87 patients who met Rome I criteria for IBS and were enrolled from December 2003 to March 2005. Interventions: Participants who met enrollment criteria were randomly assigned to receive 400 mg of rifaximin 3 times daily for 10 days (n = 43) or placebo (n = 44). Eighty participants completed rifaximin therapy or placebo, and follow-up data were available for at least 34 participants per study group at any time point thereafter. Measurements: A questionnaire was administered before treatment and 7 days after treatment. The primary outcome was global improvement in IBS. Patients were then asked to keep a weekly symptom diary for 10 weeks. Results: Over the 10 weeks of follow-up, rifaximin resulted in greater improvement in IBS symptoms (P = 0.020). In addition, rifaximin recipients had a lower bloating score after treatment. Limitations: The major limitations of the study were its modest sample size and short duration and that most patients were from 1 center. Conclusions: Rifaximin improves IBS symptoms for up to 10 weeks after the discontinuation of therapy.	Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA 90024 USA; Univ Chicago, Chicago, IL 60637 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Pimentel, M (corresponding author), Cedars Sinai Med Ctr, Burns & Allen Res Inst, 8730 Alden Dr,Suite 225E, Los Angeles, CA 90048 USA.	pimentelm@cshs.org	Pimentel, Mark/AAH-7073-2021	Pimentel, Mark/0000-0002-0619-5115				AGREUS L, 1995, GASTROENTEROLOGY, V109, P671, DOI 10.1016/0016-5085(95)90373-9; Attar A, 1999, GASTROENTEROLOGY, V117, P794, DOI 10.1016/S0016-5085(99)70336-7; BALSARI A, 1982, MICROBIOLOGICA, V5, P185; Bardhan KD, 2000, ALIMENT PHARM THERAP, V14, P23; Bommelaer G, 2004, GASTROEN CLIN BIOL, V28, P554, DOI 10.1016/S0399-8320(04)95011-7; Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149; Cuoco L, 2006, Minerva Gastroenterol Dietol, V52, P89; Di Stefano M, 2000, ALIMENT PHARM THERAP, V14, P551; Drossman DA, 1994, FUNCTIONAL GASTROINT; DuPont HL, 2005, ANN INTERN MED, V142, P805, DOI 10.7326/0003-4819-142-10-200505170-00005; El-Serag Hashem B, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS3; Fiorucci S, 2002, DIGESTION, V66, P246, DOI 10.1159/000068362; Gionchetti P, 2005, CHEMOTHERAPY, V51, P96, DOI 10.1159/000081995; Gwee KA, 2004, AM J GASTROENTEROL, V99, P924, DOI 10.1111/j.1572-0241.2004.04161.x; Hungin APS, 2003, ALIMENT PHARM THER, V17, P643, DOI 10.1046/j.1365-2036.2003.01456.x; Jiang ZD, 2005, CHEMOTHERAPY, V51, P67, DOI 10.1159/000081991; Lauritano EC, 2005, ALIMENT PHARM THER, V22, P31, DOI 10.1111/j.1365-2036.2005.02516.x; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Marchese A, 2000, CHEMOTHERAPY, V46, P253, DOI 10.1159/000007297; Mas A, 2003, J HEPATOL, V38, P51, DOI 10.1016/S0168-8278(02)00350-1; Muller-Lissner SA, 2001, ALIMENT PHARM THER, V15, P1655, DOI 10.1046/j.1365-2036.2001.01094.x; Novick J, 2002, ALIMENT PHARM THER, V16, P1877, DOI 10.1046/j.1365-2036.2002.01372.x; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Sharara AI, 2006, AM J GASTROENTEROL, V101, P326, DOI 10.1111/j.1572-0241.2006.00458.x; VANZANTEN VSJ, 1999, GUT, V45, pII69; Wilson S, 2004, BRIT J GEN PRACT, V54, P495	28	335	355	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					557	563		10.7326/0003-4819-145-8-200610170-00004	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043337				2022-12-28	WOS:000241315700001
J	Edozien, LC				Edozien, Leroy C.			Controversy - NHS maternity units should not encourage commercial banking of umbilical cord blood	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BACKTRACKING LEUKEMIA; TRANSPLANTATION		St Marys Hosp, Manchester M13 0JH, Lancs, England	University of Manchester	Edozien, LC (corresponding author), St Marys Hosp, Manchester M13 0JH, Lancs, England.	Leroy.Edozien@cmmc.nhs.uk		Edozien, Leroy/0000-0002-1815-7300				*AM COLL OBST GYN, 1997, INT J GYNECOL OBSTET, V58, P257; [Anonymous], 2002, RCM Midwives, V5, P422; [Anonymous], 1999, Pediatrics, V104, P116; Armson BA, 2005, J OBSTET GYNAECOL CA, V27, P263; *CELLS LTD, 2005, INF BOOKL; DERBYSHIRE D, 2004, DAILY TELEGRAPH 0217; Ecker JL, 2005, OBSTET GYNECOL, V105, P1282, DOI 10.1097/01.AOG.0000166162.45300.6a; *EUR GROUP ETH SCI, 2004, ETH ASP UMB CORD BLO; Fisk NM, 2005, PLOS MED, V2, P87, DOI 10.1371/journal.pmed.0020044; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Johnson FL, 1997, J PEDIAT HEMATOL ONC, V19, P183, DOI 10.1097/00043426-199705000-00001; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Munzer SR, 2001, J PEDIAT HEMATOL ONC, V23, P203, DOI 10.1097/00043426-200105000-00004; Nakagawa R, 2004, TRANSFUSION, V44, P262, DOI 10.1111/j.1537-2995.2004.00645.x; *NAT CONS ETH COMM, 2002, OP NUMB 74 UMB CORD; Pafumi C, 2002, GYNECOL OBSTET INVES, V54, P73, DOI 10.1159/000067714; Rabe H, 2004, COCHRANE DB SYST REV, V18, DOI [DOI 10.1002/14651858.CD003248.PUB2, 10.1002/14651858.CD003248.pub2]; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rogers I, 2004, BEST PRACT RES CL OB, V18, P893, DOI 10.1016/j.bpobgyn.2004.06.004; Rowley JD, 1998, NAT MED, V4, P150, DOI 10.1038/nm0298-150; Royal College of Obstetricians and Gynaecologists, 2006, 2 ROYAL COLL OBST GY; Solves P, 2003, ACTA OBSTET GYN SCAN, V82, P439; Warwick R, 2004, BEST PRACT RES CL OB, V18, P995, DOI 10.1016/j.bpobgyn.2004.07.003	23	20	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2006	333	7572					801	804		10.1136/bmj.38950.628519.68	http://dx.doi.org/10.1136/bmj.38950.628519.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038739	Green Published			2022-12-28	WOS:000241566000019
J	Nelson, CM; VanDuijn, MM; Inman, JL; Fletcher, DA; Bissell, MJ				Nelson, Celeste M.; VanDuijn, Martijn M.; Inman, Jamie L.; Fletcher, Daniel A.; Bissell, Mina J.			Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures	SCIENCE			English	Article							GROWTH-FACTOR-BETA; GLAND; MOUSE; FORM; BUD; PROLIFERATION; TGF-BETA-1; MODEL	The treelike structures of many organs, including the mammary gland, are generated by branching morphogenesis, a reiterative process of branch initiation and invasion from a preexisting epithelium. Using a micropatterning approach to control the initial three-dimensional structure of mouse mammary epithelial tubules in culture, combined with an algorithm to quantify the extent of branching, we found that the geometry of tubules dictates the position of branches. We predicted numerically and confirm experimentally that branches initiate at sites with a local minimum in the concentration of autocrine inhibitory morphogens, such as transforming growth factor - beta. These results reveal that tissue geometry can control organ morphogenesis by defining the local cellular microenvironment, a finding that has relevance to control of invasion and metastasis.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	cmnelson@lbl.gov; mjbissell@lbl.gov	Nelson, Celeste/AAT-7612-2021	Nelson, Celeste/0000-0001-9973-8870; van Duijn, Martijn/0000-0002-6654-994X	NATIONAL CANCER INSTITUTE [R01CA064786, R01CA057621, R37CA064786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072736] Funding Source: NIH RePORTER; NCI NIH HHS [CA64786, R37 CA064786, R01 CA057621, R01 CA064786-10, CA57621, R01 CA057621-10, R01 CA064786] Funding Source: Medline; NIGMS NIH HHS [GM72736, R01 GM072736, R01 GM072736-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Chen C., UNPUB; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; FAULKIN LJ, 1960, J NATL CANCER I, V24, P953; Gilles C, 1999, J CELL SCI, V112, P4615; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Ingber DE, 2005, P NATL ACAD SCI USA, V102, P11571, DOI 10.1073/pnas.0505939102; LAWRENCE DA, 1984, J CELL PHYSIOL, V121, P184, DOI 10.1002/jcp.1041210123; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RITVOS O, 1995, MECH DEVELOP, V50, P229, DOI 10.1016/0925-4773(94)00342-K; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SERRA R, 1994, DEVELOPMENT, V120, P2153; SILBERSTEIN GB, 1987, SCIENCE, V237, P291, DOI 10.1126/science.3474783; Simian M, 2001, DEVELOPMENT, V128, P3117; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Weaver M, 2000, DEVELOPMENT, V127, P2695; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	30	461	472	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					298	300		10.1126/science.1131000	http://dx.doi.org/10.1126/science.1131000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038622	Green Accepted, Green Submitted			2022-12-28	WOS:000241194100041
J	Aoki, T; Dayan, B; Wilcut, E; Bowen, WP; Parkins, AS; Kippenberg, TJ; Vahala, KJ; Kimble, HJ				Aoki, Takao; Dayan, Barak; Wilcut, E.; Bowen, W. P.; Parkins, A. S.; Kippenberg, T. J.; Vahala, K. J.; Kimble, H. J.			Observation of strong coupling between one atom and a monolithic microresonator	NATURE			English	Article							SINGLE PHOTONS; QUANTUM; DYNAMICS; CAVITY; GENERATION	Over the past decade, strong interactions of light and matter at the single-photon level have enabled a wide set of scientific advances in quantum optics and quantum information science. This work has been performed principally within the setting of cavity quantum electrodynamics(1-4) with diverse physical systems(5), including single atoms in Fabry-Perot resonators(1,6), quantum dots coupled to micropillars and photonic bandgap cavities(7,8) and Cooper pairs interacting with superconducting resonators(9,10). Experiments with single, localized atoms have been at the forefront of these advances(11-15) with the use of optical resonators in high-finesse Fabry-Perot configurations(16). As a result of the extreme technical challenges involved in further improving the multilayer dielectric mirror coatings(17) of these resonators and in scaling to large numbers of devices, there has been increased interest in the development of alternative microcavity systems(5). Here we show strong coupling between individual caesium atoms and the fields of a high-quality toroidal microresonator. From observations of transit events for single atoms falling through the resonator's evanescent field, we determine the coherent coupling rate for interactions near the surface of the resonator. We develop a theoretical model to quantify our observations, demonstrating that strong coupling is achieved, with the rate of coherent coupling exceeding the dissipative rates of the atom and the cavity. Our work opens the way for investigations of optical processes with single atoms and photons in lithographically fabricated microresonators. Applications include the implementation of quantum networks(18,19), scalable quantum logic with photons(20), and quantum information processing on atom chips(21).	CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; CALTECH, TJ Watson Lab Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Bowen, Warwick P/A-7630-2010; Dayan, Barak/Q-7480-2017; Kippenberg, T. J./B-3133-2013	Bowen, Warwick P/0000-0001-8127-1715; Dayan, Barak/0000-0001-8592-8550; Kippenberg, T. J./0000-0002-3408-886X; Parkins, Andrew/0000-0002-5922-4506				Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Badolato A, 2005, SCIENCE, V308, P1158, DOI 10.1126/science.1109815; Berman P., 1994, CAVITY QUANTUM ELECT; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; BRAGINSKY VB, 1989, PHYS LETT A, V137, P393, DOI 10.1016/0375-9601(89)90912-2; Briegel HJ, 2000, PHYSICS OF QUANTUM INFORMATION, P191; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Courtois JY, 1996, PHYS REV A, V53, P1862, DOI 10.1103/PhysRevA.53.1862; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Hood CJ, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033804; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kippenberg TJ, 2004, APPL PHYS LETT, V85, P6113, DOI 10.1063/1.1833556; Legero T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070503; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; McKeever J, 2003, NATURE, V425, P268, DOI 10.1038/nature01974; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Nussmann S, 2005, NAT PHYS, V1, P122, DOI 10.1038/nphys120; Raimond JM, 2005, J PHYS B-AT MOL OPT, V38, pS535, DOI 10.1088/0953-4075/38/9/006; REMPE G, 1992, OPT LETT, V17, P363, DOI 10.1364/OL.17.000363; Spillane SM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.013817; TREUTLEIN P, 2006, ARXIVORGABSQUANTPH06; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Vernooy DW, 1998, PHYS REV A, V57, pR2293, DOI 10.1103/PhysRevA.57.R2293; Vernooy DW, 1998, OPT LETT, V23, P247, DOI 10.1364/OL.23.000247; Vernooy DW, 1997, PHYS REV A, V55, P1239, DOI 10.1103/PhysRevA.55.1239; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walther H, 2004, FORTSCHR PHYS, V52, P1154, DOI 10.1002/prop.200410185	30	611	683	6	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					671	674		10.1038/nature05147	http://dx.doi.org/10.1038/nature05147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035998	Green Accepted, Green Submitted			2022-12-28	WOS:000241160500041
J	ten Cate, O				ten Cate, Olle			Medical education - Trust competence, and the supervisor's role in postgraduate training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Med Ctr Utrecht, Ctr Res & Dev Educ, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	ten Cate, O (corresponding author), Univ Med Ctr Utrecht, Ctr Res & Dev Educ, POB 85500, NL-3508 GA Utrecht, Netherlands.	t.j.tencate@umcutrecht.nl	Cate, Olle Th.J. ten/W-8382-2018	Cate, Olle Th.J. ten/0000-0002-6379-8780				Accreditation Council for Graduate Medical Education, OUTC PROJ; Armstrong M., 2010, PERFORMANCE MANAGEME; *AUSTR MED ASS, AMA POS STAT PREV ME; BLEKER OP, 2004, DUTCH J MED ED, V23, P4; Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Charlin B, 2000, TEACH LEARN MED, V12, P189, DOI 10.1207/S15328015TLM1204_5; Elstein AS, 1978, MED PROBLEM SOLVING; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; *GEN MED COUNC, PRINC GOOD MED ED TR; Grant J, 1999, ADV HEALTH SCI EDUC, V4, P271, DOI 10.1023/A:1009845202352; Harvey R. J., 1991, HDB IND ORG PSYCHOL, V2, P71; Jonassen D. H., 1999, TASK ANAL METHODS IN; Long DM, 2000, ACAD MED, V75, P1178, DOI 10.1097/00001888-200012000-00009; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Rethans JJ, 2002, MED EDUC, V36, P901, DOI 10.1046/j.1365-2923.2002.01316.x; *ROYAL COLL PHYS S, 2005, SKILLS NEW MILL REP; Schuwirth LWT, 2006, MED EDUC, V40, P296, DOI 10.1111/j.1365-2929.2006.02405.x; STEWART A, 2005, PRACTICAL GUIDE MED, P186; WIJNENMEIJER M, 2006, COMPETENCY BASED CUR	20	129	132	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					748	751		10.1136/bmj.38938.407569.94	http://dx.doi.org/10.1136/bmj.38938.407569.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	17023469	Green Submitted, Green Published			2022-12-28	WOS:000241248600024
J	Destexhe, A; Contreras, D				Destexhe, Alain; Contreras, Diego			Neuronal computations with stochastic network states	SCIENCE			English	Review							DEPENDENT MODULATION; SYNCHRONOUS SPIKING; SYNAPTIC ACTIVITY; CEREBRAL-CORTEX; DYNAMICS; PROPAGATION; SLEEP; RESPONSIVENESS; OSCILLATIONS; RESONANCE	Neuronal networks in vivo are characterized by considerable spontaneous activity, which is highly complex and intrinsically generated by a combination of single-cell electrophysiological properties and recurrent circuits. As seen, for example, during waking compared with being asleep or under anesthesia, neuronal responsiveness differs, concomitant with the pattern of spontaneous brain activity. This pattern, which defines the state of the network, has a dramatic influence on how local networks are engaged by inputs and, therefore, on how information is represented. We review here experimental and theoretical evidence of the decisive role played by stochastic network states in sensory responsiveness with emphasis on activated states such as waking. From single cells to networks, experiments and computational models have addressed the relation between neuronal responsiveness and the complex spatiotemporal patterns of network activity. The understanding of the relation between network state dynamics and information representation is a major challenge that will require developing, in conjunction, specific experimental paradigms and theoretical frameworks.	CNRS, Integrat & Computat Neurosci Unit UNIC, Gif Sur Yvette, France; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Pennsylvania	Destexhe, A (corresponding author), CNRS, Integrat & Computat Neurosci Unit UNIC, Gif Sur Yvette, France.	Destexhe@iaf.cnrs-gif.fr		Destexhe, Alain/0000-0001-7405-0455				Alvarez FP, 2004, NEUROCOMPUTING, V58, P285, DOI 10.1016/j.neucom.2004.01.057; Amit DJ, 1989, MODELING BRAIN FUNCT; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BELL CC, 1993, P NATL ACAD SCI USA, V90, P4650, DOI 10.1073/pnas.90.10.4650; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Conner CE, 1997, J NEUROSCI, V17, P3201; Contreras D, 1997, NEUROSCIENCE, V76, P11; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DESTEXHE A, 1994, PHYS REV E, V50, P1594, DOI 10.1103/PhysRevE.50.1594; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; FREGNAC Y, 2006, COS COMP SYST NEUR 2; FUNKE K, 1992, BRAIN RES, V573, P217, DOI 10.1016/0006-8993(92)90766-3; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; Kisley MA, 1999, J NEUROSCI, V19, P10451; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Li B, 1999, J PHYSIOL-LONDON, V514, P857, DOI 10.1111/j.1469-7793.1999.857ad.x; Litvak V, 2003, J NEUROSCI, V23, P3006; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Maass W, 2002, NEURAL NETWORKS, V15, P155, DOI 10.1016/S0893-6080(01)00144-7; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; MORROW TJ, 1992, J NEUROPHYSIOL, V67, P305, DOI 10.1152/jn.1992.67.2.305; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Pope S. B, 2001, TURBULENT FLOWS; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Rudolph M, 2003, J NEUROSCI, V23, P2466; Shu YS, 2003, J NEUROSCI, V23, P10388; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; STERIADE M, 1969, J NEUROPHYSIOL, V32, P251, DOI 10.1152/jn.1969.32.2.251; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1974, J NEUROPHYSIOL, V37, P1065, DOI 10.1152/jn.1974.37.5.1065; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1969, ELECTROEN CLIN NEURO, V27, P678; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Steriade M., 1997, THALAMUS; Steriade M., 2003, NEURONAL SUBSTRATES; Stocks NG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.030902; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	71	174	178	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					85	90		10.1126/science.1127241	http://dx.doi.org/10.1126/science.1127241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023650				2022-12-28	WOS:000241031200040
J	Lemons, D; McGinnis, W				Lemons, Derek; McGinnis, William			Genomic evolution of Hox gene clusters	SCIENCE			English	Review							DROSOPHILA BITHORAX COMPLEX; ABDOMINAL-A; BODY PLAN; EXPRESSION; TRANSCRIPTION; RNA; DIVERSIFICATION; ULTRABITHORAX; SEGMENTATION; MELANOGASTER	The family of Hox genes, which number 4 to 48 per genome depending on the animal, control morphologies on the main body axis of nearly all metazoans. The conventional wisdom is that Hox genes are arranged in chromosomal clusters in colinear order with their expression patterns on the body axis. However, recent evidence has shown that Hox gene clusters are fragmented, reduced, or expanded in many animals - findings that correlate with interesting morphological changes in evolution. Hox gene clusters also contain many noncoding RNAs, such as intergenic regulatory transcripts and evolutionarily conserved microRNAs, some of whose developmental functions have recently been explored.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu			NICHD NIH HHS [R37 HD028315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aboobaker A, 2003, CURR OPIN GENET DEV, V13, P593, DOI 10.1016/j.gde.2003.10.009; Ahringer J, 1996, GENE DEV, V10, P1120, DOI 10.1101/gad.10.9.1120; Akbari OS, 2006, DEV BIOL, V293, P294, DOI 10.1016/j.ydbio.2006.02.015; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Blin M, 2003, DEV GENES EVOL, V213, P90, DOI 10.1007/s00427-003-0294-z; Brena C, 2006, EVOL DEV, V8, P252, DOI 10.1111/j.1525-142X.2006.00096.x; Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Carroll SB., 2005, DNA DIVERSITY; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; Enright AJ, 2004, GENOME BIOL, V5; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hsia CC, 2003, CURR OPIN GENET DEV, V13, P199, DOI 10.1016/S0959-437X(03)00017-0; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Minguillon C, 2005, INT J BIOL SCI, V1, P19; Ohno S., 1970, EVOLUTION GENE DUPLI; Pierce RJ, 2005, MOL BIOL EVOL, V22, P2491, DOI 10.1093/molbev/msi239; REGULSKI M, 1985, CELL, V43, P71, DOI 10.1016/0092-8674(85)90013-3; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Shankland M, 2000, P NATL ACAD SCI USA, V97, P4434, DOI 10.1073/pnas.97.9.4434; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	50	241	249	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1918	1922		10.1126/science.1132040	http://dx.doi.org/10.1126/science.1132040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008523				2022-12-28	WOS:000240832200040
J	Vrabioiu, AM; Mitchison, TJ				Vrabioiu, Alina M.; Mitchison, Timothy J.			Structural insights into yeast septin organization from polarized fluorescence microscopy	NATURE			English	Article							BUDDING YEAST; CELL CORTEX; PROTEIN; CYTOKINESIS; MEMBRANE; RING; ORIENTATION; DYNAMICS; ACTIN; CYCLE	Septins are polymerizing GTPases(1) that function in cortical organization and cell division(2-4). In Saccharomyces cerevisiae they localize at the isthmus between the mother and the daughter cells, where they undergo a transition from a non-dynamic hourglass-shaped assembly(5) to two separate rings, at the onset of cytokinesis(6,7). Septins form filaments as pure protein(8) and in vivo(9), but the filament organization within the hourglass and ring structures is controversial(9,10). Here, we use polarized fluorescence microscopy(11) of orientationally constrained green fluorescent protein to determine septin filament organization and dynamics in living yeast. We found that the hourglass is made of filaments aligned along the yeast bud neck. During the transition from hourglass to rings the filaments rotate through 90 degrees in the membrane plane and become circumferential. These data resolve a long-standing controversy in the field and provide strong evidence that septins have a mechanical function in cell division.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Vrabioiu, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	alina_vrabioiu@student.hms.harvard.edu						AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; BURGHARDT TP, 1984, BIOPOLYMERS, V23, P2383; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dale RE, 1999, BIOPHYS J, V76, P1606, DOI 10.1016/S0006-3495(99)77320-0; DESPER CR, 1967, J APPL PHYS, V38, P4225, DOI 10.1063/1.1709109; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Inoue S, 2002, P NATL ACAD SCI USA, V99, P4272, DOI 10.1073/pnas.062065199; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lippincott J, 2001, J CELL SCI, V114, P1379; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Picart C, 1999, BIOPHYS J, V77, P865, DOI 10.1016/S0006-3495(99)76938-9; Rocheleau JV, 2003, BIOPHYS J, V84, P4078, DOI 10.1016/S0006-3495(03)75133-9; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Schmidt M, 2002, J CELL SCI, V115, P293; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	29	155	157	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					466	469		10.1038/nature05109	http://dx.doi.org/10.1038/nature05109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006515				2022-12-28	WOS:000240798800048
J	Villamor, E; Cnattingius, S				Villamor, Eduardo; Cnattingius, Sven			Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study	LANCET			English	Article							PREPREGNANCY WEIGHT; PHYSICAL-ACTIVITY; MATERNAL OBESITY; OVERWEIGHT; COMPLICATIONS; TRENDS; PREVALENCE; WOMEN; DIET	Background Maternal obesity has been positively associated with risk of adverse pregnancy outcomes, but evidence of a causal relation is scarce. Causality would be lent support if temporal changes in weight affected risk of adverse pregnancy outcomes. Methods We examined the associations between change in prepregnancy body-mass index (BMI) from the first to the second pregnancies, and the risk of adverse outcomes during the second pregnancy in a nationwide Swedish study of 151025 women who had their first two consecutive singleton births between 1992 and 2001. Findings Compared with women whose BMI changed between -1.0 and 0.9 units, the adjusted odds ratios for adverse pregnancy outcomes for those who gained 3 or more units during an average 2 years were: pre-eclampsia, 1.78 (95% CI 1.52-2.08); gestational hypertension 1.76 (1.39-2.23); gestational diabetes 2.09 (1.68-2.61); Caesarean delivery 1.32 (1.22-1.44); stillbirth 1.63 (1.20-2.21); and large-for-gestational-age birth 1.87 (1.72-2.04). The associations were linearly related to the amount of weight change and were also noted in women who had a healthy prepregnancy BMI for both pregnancies. Interpretation These findings lend support to a causal relation between being overweight or obese and risks of adverse pregnancy outcomes. Additionally they suggest that modest increases in BMI before pregnancy could result in perinatal complications, even if a woman does not become overweight. Our results provide robust epidemiological evidence for advocating weight loss in overweight and obese women who are planning to become pregnant and, to prevent weight gain before pregnancy in women with healthy BMIs.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet	Villamor, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	evillamo@hsph.harvard.edu						Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Delvaux T, 2001, AM J PREV MED, V21, P52, DOI 10.1016/S0749-3797(01)00315-4; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Jeffery RW, 2003, AM J CLIN NUTR, V78, P684, DOI 10.1093/ajcn/78.4.684; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Lindmark G, 1991, Acta Obstet Gynecol Scand, V70, P105, DOI 10.3109/00016349109006190; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; *NAT BOARD HLTH WE, EV SWED MED BIRTH RE; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; O'Toole ML, 2003, J WOMENS HEALTH, V12, P991, DOI 10.1089/154099903322643910; ODELL LD, 1945, JAMA-J AM MED ASSOC, V128, P87, DOI 10.1001/jama.1945.02860190023006; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Rosenberg TJ, 2003, OBSTET GYNECOL, V102, P1022, DOI [10.1016/j.obstetgynecol.2003.07.005, 10.1016/S0029-7844(03)00878-0]; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 1995, PHYS STAT US INT ANT	29	518	540	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1164	1170		10.1016/S0140-6736(06)69473-7	http://dx.doi.org/10.1016/S0140-6736(06)69473-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011943				2022-12-28	WOS:000240916000028
J	Pichlmair, A; Schulz, O; Tan, CP; Naslund, TI; Liljestrom, P; Weber, F; Sousa, CRE				Pichlmair, Andreas; Schulz, Oliver; Tan, Choon Ping; Naslund, Tanja I.; Liljestrom, Peter; Weber, Friedemann; Sousa, Caetano Reis E.			RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 '-phosphates	SCIENCE			English	Article							NS1 PROTEIN; VIRAL-INFECTION; INNATE; INTERFERON; DNA; RECOGNITION; INDUCTION; IMMUNITY; VIRUSES; REPLICATION	Double-stranded RNA ( dsRNA) produced during viral replication is believed to be the critical trigger for activation of antiviral immunity mediated by the RNA helicase enzymes retinoic acid inducible gene I (RIG-I) and melanoma differentiation - associated gene 5 (MDA5). We showed that influenza A virus infection does not generate dsRNA and that RIG-I is activated by viral genomic single-stranded RNA (ssRNA) bearing 5'-phosphates. This is blocked by the influenza protein nonstructured protein 1 (NS1), which is found in a complex with RIG-I in infected cells. These results identify RIG-I as a ssRNA sensor and potential target of viral immune evasion and suggest that its ability to sense 5'-phosphorylated RNA evolved in the innate immune system as a means of discriminating between self and nonself.	London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England; Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany	Cancer Research UK; Karolinska Institutet; University of Freiburg	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England.	caetano@cancer.org.uk	Weber, Friedemann/AAB-3425-2019; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Weber, Friedemann/0000-0001-9737-337X; Liljestrom, Peter/0000-0002-2132-0981; Schulz, Oliver/0000-0002-1493-3341				Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Knipe D.M., 2001, FIELDS VIROLOGY; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	23	1675	1776	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					997	1001		10.1126/science.1132998	http://dx.doi.org/10.1126/science.1132998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17038589				2022-12-28	WOS:000241896000055
J	Knoch, D; Pascual-Leone, A; Meyer, K; Treyer, V; Fehr, E				Knoch, Daria; Pascual-Leone, Alvaro; Meyer, Kaspar; Treyer, Valerie; Fehr, Ernst			Diminishing reciprocal fairness by disrupting the right prefrontal cortex	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ULTIMATUM GAME; INHIBITION; COGNITION	Humans restrain self-interest with moral and social values. They are the only species known to exhibit reciprocal fairness, which implies the punishment of other individuals' unfair behaviors, even if it hurts the punisher's economic self-interest. Reciprocal fairness has been demonstrated in the Ultimatum Game, where players often reject their bargaining partner's unfair offers. Despite progress in recent years, however, little is known about how the human brain limits the impact of selfish motives and implements fair behavior. Here we show that disruption of the right, but not the left, dorsolateral prefrontal cortex (DLPFC) by low-frequency repetitive transcranial magnetic stimulation substantially reduces subjects' willingness to reject their partners' intentionally unfair offers, which suggests that subjects are less able to resist the economic temptation to accept these offers. Importantly, however, subjects still judge such offers as very unfair, which indicates that the right DLPFC plays a key role in the implementation of fairness-related behaviors.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland; Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; Harvard Univ, Sch Med, Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Univ Zurich Hosp, Dept Radiol, PET Ctr, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Zurich; University Zurich Hospital	Knoch, D (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.	dknoch@iew.unizh.ch; efehr@iew.unizh.ch	Treyer, Valerie/G-6986-2018; Pascual-Leone, Alvaro/AAC-5101-2019; Knoch, Daria/H-7324-2012; Pascual-Leone, Alvaro/G-6566-2011	Treyer, Valerie/0000-0002-4584-3031; Pascual-Leone, Alvaro/0000-0001-8975-0382; 	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR018875] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Boyd R, 2005, ORIGIN EVOLUTION CUL; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Damasio A, 1995, DESCARTES ERROR EMOT; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Freud S., 1962, EGO ID; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; OEWENSTEIN GF, 2004, ANIMAL SPIRITS AFFEC; Perugini M, 2003, EUR J PERSONALITY, V17, P251, DOI 10.1002/per.474; RABIN M, 1993, AM ECON REV, V83, P1281; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; [No title captured]	28	650	679	4	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					829	832		10.1126/science.1129156	http://dx.doi.org/10.1126/science.1129156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17023614	Green Published			2022-12-28	WOS:000241729800050
J	Han, Y; Alsayed, AM; Nobili, M; Zhang, J; Lubensky, TC; Yodh, AG				Han, Y.; Alsayed, A. M.; Nobili, M.; Zhang, J.; Lubensky, T. C.; Yodh, A. G.			Brownian motion of an ellipsoid	SCIENCE			English	Article							DIFFUSION; DEPOLARIZATION; COEFFICIENTS; RELAXATION; PARTICLES; MOLECULES; MOVEMENT	We studied the Brownian motion of isolated ellipsoidal particles in water confined to two dimensions and elucidated the effects of coupling between rotational and translational motion. By using digital video microscopy, we quantified the crossover from short-time anisotropic to longtime isotropic diffusion and directly measured probability distributions functions for displacements. We confirmed and interpreted our measurements by using Langevin theory and numerical simulations. Our theory and observations provide insights into fundamental diffusive processes, which are potentially useful for understanding transport in membranes and for understanding the motions of anisotropic macromolecules.	Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Univ Montpellier 2, CNRS, Lab Colloides Verres & Nanomat, F-34090 Montpellier, France	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Lubensky, TC (corresponding author), Univ Penn, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	tom@physics.upenn.edu						Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bhattacharya S, 2005, J FLUID MECH, V541, P263, DOI 10.1017/S0022112005005938; Coffey W.T., 2004, LANGEVIN EQUATION AP, DOI 10.1142/5343; DIEKMANN S, 1982, BIOPHYS CHEM, V15, P263, DOI 10.1016/0301-4622(82)80009-4; DOI M, 1986, THEORY POLYM DYNAMIC, P300; EIMER W, 1990, BIOCHEMISTRY-US, V29, P799, DOI 10.1021/bi00455a030; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Einstein A, 1906, ANN PHYS-BERLIN, V19, P289, DOI 10.1002/andp.19063240204; HAGERMAN PJ, 1981, BIOPOLYMERS, V20, P1503, DOI 10.1002/bip.1981.360200710; Happel J, 1991, LOW REYNOLDS NUMBER; Hartshorne NH., 1970, CRYSTALS POLARISING, V4th; HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391; HU CM, 1974, J CHEM PHYS, V60, P4354, DOI 10.1063/1.1680910; Nelson E., 1972, DYNAMICAL THEORIES B; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; PRAGER S, 1955, J CHEM PHYS, V23, P2404, DOI 10.1063/1.1741890; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SCHAEFER DW, 1971, J CHEM PHYS, V55, P3884, DOI 10.1063/1.1676675; TAO T, 1969, BIOPOLYMERS, V8, P609, DOI 10.1002/bip.1969.360080505; Vasanthi R, 2001, J CHEM PHYS, V114, P7989, DOI 10.1063/1.1363674	21	383	392	6	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					626	630		10.1126/science.1130146	http://dx.doi.org/10.1126/science.1130146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068256				2022-12-28	WOS:000241557800040
J	Hansma, PK; Schitter, G; Fantner, GE; Prater, C				Hansma, Paul K.; Schitter, Georg; Fantner, Georg E.; Prater, Craig			Applied physics - High-speed atomic force microscopy	SCIENCE			English	Editorial Material							CANTILEVERS		Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Veeco Instruments Inc, Goleta, CA 93117 USA	University of California System; University of California Santa Barbara	Hansma, PK (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	prasant@physics.ucsb.edu	Schitter, Georg/G-1764-2012; Fantner, Georg/F-7392-2011	Schitter, Georg/0000-0002-8746-5892; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065354] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 65354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; BARRETT RC, 1991, J VAC SCI TECHNOL B, V9, P302, DOI 10.1116/1.585610; Chand A, 2000, J MICROELECTROMECH S, V9, P112, DOI 10.1109/84.825785; Croft D, 2001, J DYN SYST-T ASME, V123, P35, DOI 10.1115/1.1341197; Fantner GE, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1850651; Fantner GE, 2006, ULTRAMICROSCOPY, V106, P881, DOI 10.1016/j.ultramic.2006.01.015; Humphris ADL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1855407; Humphris ADL, 2003, APPL PHYS LETT, V83, P6, DOI 10.1063/1.1590737; Kodera N, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1903123; Schaffer TE, 1997, P SOC PHOTO-OPT INS, V3009, P48, DOI 10.1117/12.271228; Schitter G, 2004, NANOTECHNOLOGY, V15, P108, DOI 10.1088/0957-4484/15/1/021; Schitter G, 2006, P AMER CONTR CONF, V1-12, P502, DOI 10.1109/ACC.2006.1655406; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177; Walters DA, 1997, P SOC PHOTO-OPT INS, V3009, P43, DOI 10.1117/12.271227	16	144	151	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					601	602		10.1126/science.1133497	http://dx.doi.org/10.1126/science.1133497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068247				2022-12-28	WOS:000241557800029
J	Backhus, LM; Bremner, RM				Backhus, Leah M.; Bremner, Ross M.			Intrathoracic splenosis after remote trauma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ So Calif, Los Angeles, CA 90033 USA	University of Southern California	Backhus, LM (corresponding author), Univ So Calif, Los Angeles, CA 90033 USA.	backhus@usc.edu		Backhus, Leah/0000-0002-4553-1003					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1811	1811		10.1056/NEJMicm050481	http://dx.doi.org/10.1056/NEJMicm050481			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065643				2022-12-28	WOS:000241512500011
J	Cardinale, BJ; Srivastava, DS; Duffy, JE; Wright, JP; Downing, AL; Sankaran, M; Jouseau, C				Cardinale, Bradley J.; Srivastava, Diane S.; Duffy, J. Emmett; Wright, Justin P.; Downing, Amy L.; Sankaran, Mahesh; Jouseau, Claire			Effects of biodiversity on the functioning of trophic groups and ecosystems	NATURE			English	Article							SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; RICHNESS; ECOLOGY; FUTURE; ALTERS	Over the past decade, accelerating rates of species extinction have prompted an increasing number of studies to reduce species diversity experimentally and examine how this alters the efficiency by which communities capture resources and convert those into biomass(1,2). So far, the generality of patterns and processes observed in individual studies have been the subjects of considerable debate(3-7). Here we present a formal meta-analysis of studies that have experimentally manipulated species diversity to examine how it affects the functioning of numerous trophic groups in multiple types of ecosystem. We show that the average effect of decreasing species richness is to decrease the abundance or biomass of the focal trophic group, leading to less complete depletion of resources used by that group. At the same time, analyses reveal that the standing stock of, and resource depletion by, the most species-rich polyculture tends to be no different from that of the single most productive species used in an experiment. Of the known mechanisms that might explain these trends, results are most consistent with what is called the 'sampling effect', which occurs when diverse communities are more likely to contain and become dominated by the most productive species. Whether this mechanism is widespread in natural communities is currently controversial. Patterns we report are remarkably consistent for four different trophic groups ( producers, herbivores, detritivores and predators) and two major ecosystem types ( aquatic and terrestrial). Collectively, our analyses suggest that the average species loss does indeed affect the functioning of a wide variety of organisms and ecosystems, but the magnitude of these effects is ultimately determined by the identity of species that are going extinct.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Ohio Wesleyan Univ, Dept Zool, Delaware, OH 43015 USA; Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	University of California System; University of California Santa Barbara; University of British Columbia; William & Mary; Virginia Institute of Marine Science; Duke University; Ohio Wesleyan University; University of Leeds; Columbia University	Cardinale, BJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	cardinale@lifesci.ucsb.edu	Wright, Justin/AAG-6461-2019; Duffy, J. Emmett/ABF-9200-2020; Cardinale, Bradley J/I-7076-2013	Wright, Justin/0000-0002-9102-5347; Duffy, J. Emmett/0000-0001-8595-6391; 				Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gause G.F., 1936, STRUGGLE EXISTENCE; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Raffaelli D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P147; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010	30	1240	1331	27	1154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					989	992		10.1038/nature05202	http://dx.doi.org/10.1038/nature05202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066035				2022-12-28	WOS:000241523400054
J	Palareti, G; Cosmi, B; Legnani, C; Tosetto, A; Brusi, C; Iorio, A; Pengo, V; Ghirarduzzi, A; Pattacini, C; Testa, S; Lensing, AWA; Tripodi, A				Palareti, Gualtiero; Cosmi, Benilde; Legnani, Cristina; Tosetto, Alberto; Brusi, Carlotta; Iorio, Alfonso; Pengo, Vittorio; Ghirarduzzi, Angelo; Pattacini, Corrado; Testa, Sophie; Lensing, Anthonie W. A.; Tripodi, Armando		PROLONG Investigators	D-dimer testing to determine the duration of anticoagulation therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; RECURRENT VENOUS THROMBOEMBOLISM; NEGATIVE PREDICTIVE VALUE; PULMONARY-EMBOLISM; ORAL ANTICOAGULATION; LABORATORY DIAGNOSIS; FIRST EPISODE; RISK; COHORT	BACKGROUND: The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation. METHODS: We performed D-dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years. RESULTS: The D-dimer assay was abnormal in 223 of 608 patients (36.7%). A total of 18 events occurred among the 120 patients who stopped anticoagulation (15.0%), as compared with 3 events among the 103 patients who resumed anticoagulation (2.9%), for an adjusted hazard ratio of 4.26 (95% confidence interval [CI], 1.23 to 14.6; P=0.02). Thromboembolism recurred in 24 of 385 patients with a normal D-dimer level (6.2%). Among patients who stopped anticoagulation, the adjusted hazard ratio for recurrent thromboembolism among those with an abnormal D-dimer level, as compared with those with a normal D-dimer level, was 2.27 (95% CI, 1.15 to 4.46; P=0.02). CONCLUSIONS: Patients with an abnormal D-dimer level 1 month after the discontinuation of anticoagulation have a significant incidence of recurrent venous thromboembolism, which is reduced by the resumption of anticoagulation. The optimal course of anticoagulation in patients with a normal D-dimer level has not been clearly established.	S Orsola Malpighi Univ Hosp, Dept Angiol & Blood Coagulat, I-40138 Bologna, Italy; San Bortolo Hosp, Vicenza, Italy; Univ Perugia, I-06100 Perugia, Italy; Univ Hosp, Padua, Italy; Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; Gen Hosp, Parma, Italy; Gen Hosp, Cremona, Italy; Maggiore Hosp, Ist Ricovero & Cura Carattere Sci, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	IRCCS Azienda Ospedaliero-Universitaria di Bologna; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Perugia; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Arcispedale S. Maria Nuova; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Amsterdam; Academic Medical Center Amsterdam	Palareti, G (corresponding author), S Orsola Malpighi Univ Hosp, Dept Angiol & Blood Coagulat, Via Albertoni 15, I-40138 Bologna, Italy.	palareti@tin.it	Pengo, Vittorio/GSE-5972-2022; Pengo, Vittorio/AAV-9491-2020; Iorio, Alfonso/B-9478-2013; Tosetto, Alberto/AAB-9320-2022; Cosmi, Benilde/K-9459-2016; Tosetto, Alberto/AAM-3200-2020	Pengo, Vittorio/0000-0003-2064-6071; Pengo, Vittorio/0000-0003-2064-6071; Iorio, Alfonso/0000-0002-3331-8766; Cosmi, Benilde/0000-0003-0606-6038; Tosetto, Alberto/0000-0002-0119-5204; LEGNANI, CRISTINA/0000-0003-1999-7800; Alatri, Adriano/0000-0001-7116-1846				Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Fattorini A, 2002, THROMB HAEMOSTASIS, V88, P162; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; HAGER K, 1995, GERONTOLOGY, V41, P159; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kottke-Marchant K, 2002, ARCH PATHOL LAB MED, V126, P1326; Kuruvilla J, 2003, THROMB HAEMOSTASIS, V89, P284, DOI 10.1055/s-0037-1613444; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Pinede L, 2001, CIRCULATION, V103, P2453; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Wisloff F, 2002, THROMB RES, V108, P263, DOI 10.1016/S0049-3848(02)00400-0	22	486	546	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1780	1789		10.1056/NEJMoa054444	http://dx.doi.org/10.1056/NEJMoa054444			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065639				2022-12-28	WOS:000241512500006
J	Al-Gazali, L; Hamamy, H; Al-Arrayad, S				Al-Gazali, Lihadh; Hamamy, Hanan; Al-Arrayad, Shaikha			Genetic dilsorders in the Arab world	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; ATTITUDES; COMMUNITY		United Arab Emirates Univ, Dept Paediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; Minist Hlth, Bahrain, Bahrain	United Arab Emirates University; Ministry of Health - Bahrain	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Dept Paediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	algazali@hotmail.com						Abu Shahla ANK, 2004, J TROP PEDIATRICS, V50, P101, DOI 10.1093/tropej/50.2.101; Ahmed S, 2002, NEW ENGL J MED, V347, P1162, DOI 10.1056/NEJMsa013234; Al Arrayed S, 2005, COMMUNITY GENET, V8, P52, DOI 10.1159/000083340; Al-Gazali LI, 2005, COMMUNITY GENET, V8, P186, DOI 10.1159/000086764; Al-Gazali LI, 2005, COMMUNITY GENET, V8, P48, DOI 10.1159/000083339; Al-Odaib AN, 2003, SAUDI MED J, V24, P1168; ALNUAIM A, 1992, ANN SAUDI MED, V12, P129, DOI 10.5144/0256-4947.1992.129; Alwan A, 1997, EMRO TECHNICAL PUBLI; Carmi R, 1998, SCI CONTEXT, V11, P391, DOI 10.1017/S0269889700003094; CHAABOUNI H, 2005, GENETIC COUNSELLING; Christianson A., 2006, GLOBAL REPORT BIRTH; El-Hazmi MAF, 2004, SAUDI MED J, V25, P1549; FARAG T, 2001, AMBASSADORS ONLINE M, V4; Hamamy H, 2003, AMBASSADORS ONLINE M, V6; HAMAMY H, IN PRESS COMMUNITY G; HELLANI A, 2004, PRENAT DIAGN, V24, P93; *INT CTR BIRTH DEF, ANN REP; NIAZI MA, 1995, HUM HERED, V45, P65, DOI 10.1159/000154261; Rajab A, 1999, Community Genet, V2, P23, DOI 10.1159/000016179; Raz AE, 2004, J FAM PLAN REPROD H, V30, P49, DOI 10.1783/147118904322701992; Samavat A, 2004, BMJ-BRIT MED J, V329, P1134, DOI 10.1136/bmj.329.7475.1134; Stoltenberg C, 1999, AM J MED GENET, V82, P423, DOI 10.1002/(SICI)1096-8628(19990219)82:5<423::AID-AJMG12>3.3.CO;2-3; Teebi A, 1997, OXFORD MONOGRAPHS ME, V30; Wahab AA, 2006, CLIN GENET, V69, P360, DOI 10.1111/j.1399-0004.2006.00593.x	24	197	199	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					831	834B		10.1136/bmj.38982.704931.AE	http://dx.doi.org/10.1136/bmj.38982.704931.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ON	17053236	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000241678500015
J	Bromberg, ME				Bromberg, Michael E.			Focus on research: Immune thrombocytopenic purpura - The changing therapeutic landscape	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Bromberg, ME (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.							Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x; Vesely SK, 2004, ANN INTERN MED, V140, P112, DOI 10.7326/0003-4819-140-3-200402030-00012	3	42	46	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1643	1645		10.1056/NEJMp068169	http://dx.doi.org/10.1056/NEJMp068169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050888				2022-12-28	WOS:000241357300005
J	Eichacker, PQ; Natanson, C; Danner, RL				Eichacker, Peter Q.; Natanson, Charles; Danner, Robert L.			Surviving sepsis - Practice guidelines, marketing campaign, and Eli Lilly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Eichacker, PQ (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.				CLINICAL CENTER [ZIACL008060, Z01CL008060] Funding Source: NIH RePORTER	CLINICAL CENTER		Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Levy M, 2004, CRIT CARE MED, V32, P2002, DOI 10.1097/01.CCM.0000142729.07050.C9; LILLY E, SURVIVING SEPSIS CAS; *NIH, ONL ANN BIBL SURV SE; REGALADO R, 2003, WALL STREET J   0918, pA1	6	148	154	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1640	1642		10.1056/NEJMp068197	http://dx.doi.org/10.1056/NEJMp068197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050887				2022-12-28	WOS:000241357300004
J	Russell, AG; Charette, JM; Spencer, DF; Gray, MW				Russell, Anthony G.; Charette, J. Michael; Spencer, David F.; Gray, Michael W.			An early evolutionary origin for the minor spliceosome	NATURE			English	Article							MESSENGER-RNA INTRONS; AT-AC INTRON; U12-DEPENDENT INTRONS; U12 SNRNA; U12-TYPE SPLICEOSOME; IN-VIVO; IDENTIFICATION; CONSERVATION; GENOME; VERTEBRATES	The minor spliceosome is a ribonucleoprotein complex that catalyses the removal of an atypical class of spliceosomal introns (U12-type) from eukaryotic messenger RNAs1,2. It was first identified and characterized in animals, where it was found to contain several unique RNA constituents that share structural similarity with and seem to be functionally analogous to the small nuclear RNAs (snRNAs) contained in the major spliceosome(3-8). Subsequently, minor spliceosomal components and U12-type introns have been found in plants(9-12) but not in fungi. Unlike that of the major spliceosome, which arose early in the eukaryotic lineage(13,14), the evolutionary history of the minor spliceosome is unclear because there is evidence of it in so few organisms. Here we report the identification of homologues of minor-spliceosome-specific proteins and snRNAs, and U12-type introns, in distantly related eukaryotic microbes (protists) and in a fungus ( Rhizopus oryzae). Cumulatively, our results indicate that the minor spliceosome had an early origin: several of its characteristic constituents are present in representative organisms from all eukaryotic supergroups for which there is any substantial genome sequence information. In addition, our results reveal marked evolutionary conservation of functionally important sequence elements contained within U12-type introns and snRNAs.	Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Gray, MW (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5850 Coll St, Halifax, NS B3H 1X5, Canada.	m.w.gray@dal.ca		Gray, Michael/0000-0001-7125-2625				Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dietrich RC, 2005, RNA, V11, P1430, DOI 10.1261/rna.7206305; Dietrich RC, 2001, MOL CELL BIOL, V21, P1942, DOI 10.1128/MCB.21.6.1942-1952.2001; Dietrich RC, 1997, MOL CELL, V1, P151, DOI 10.1016/S1097-2765(00)80016-7; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kolossova I, 1997, RNA, V3, P227; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Russell AG, 2006, J MOL BIOL, V357, P1548, DOI 10.1016/j.jmb.2006.01.063; Schneider C, 2004, P NATL ACAD SCI USA, V101, P9584, DOI 10.1073/pnas.0403400101; Shukla GC, 1999, RNA, V5, P525, DOI 10.1017/S1355838299982213; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; TARN WY, 1995, RNA, V1, P644; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; Yu YT, 1997, P NATL ACAD SCI USA, V94, P6030, DOI 10.1073/pnas.94.12.6030; Zhu W, 2003, NUCLEIC ACIDS RES, V31, P4561, DOI 10.1093/nar/gkg492	30	84	85	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					863	866		10.1038/nature05228	http://dx.doi.org/10.1038/nature05228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051219				2022-12-28	WOS:000241362700053
J	Chong, YS; Su, LL				Chong, Yap-Seng; Su, Lin-Lin			Misoprostol for preventing PPH: some lessons learned	LANCET			English	Editorial Material							POSTPARTUM HEMORRHAGE; 3RD STAGE		Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; Natl Univ Singapore Hosp, Singapore 119074, Singapore	National University of Singapore; National University of Singapore	Chong, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore.	obgcys@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473				Chong Yap Seng, 1997, Obstetrics and Gynecology, V90, P703, DOI 10.1016/S0029-7844(97)00275-5; Chong YS, 2004, EUR J OBSTET GYN R B, V113, P191, DOI 10.1016/j.ejogrb.2003.09.011; COELHO HLL, 1993, LANCET, V341, P1261, DOI 10.1016/0140-6736(93)91157-H; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; El-ReFaey H, 2002, LANCET, V359, P707, DOI 10.1016/S0140-6736(02)07787-5; ElRefaey H, 1996, LANCET, V347, P1257, DOI 10.1016/S0140-6736(96)90771-0; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Gulmezoglu AM, 2004, COCHRANE DB SYST REV, V1; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Int Confederation Midwives, 2004, J MIDWIFERY WOM HEAL, V49, P76; Joy SD, 2003, INT J GYNECOL OBSTET, V82, P143, DOI 10.1016/S0020-7292(03)00146-2; Langenbach C, 2006, INT J GYNECOL OBSTET, V92, P10, DOI 10.1016/j.ijgo.2005.10.001; Potts M, 2004, LANCET, V364, P1110, DOI 10.1016/S0140-6736(04)17120-1	13	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1216	1218		10.1016/S0140-6736(06)69497-X	http://dx.doi.org/10.1016/S0140-6736(06)69497-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027709				2022-12-28	WOS:000241058300006
J	Di Ventura, B; Lemerle, C; Michalodimitrakis, K; Serrano, L				Di Ventura, Barbara; Lemerle, Caroline; Michalodimitrakis, Konstantinos; Serrano, Luis			From in vivo to in silico biology and back	NATURE			English	Review							STOCHASTIC CHEMICAL-KINETICS; ENGINEERED GENE NETWORKS; CELL-CELL COMMUNICATION; ESCHERICHIA-COLI; METABOLIC NETWORKS; SELF-ORGANIZATION; PATTERN-FORMATION; SYSTEMS BIOLOGY; TOGGLE SWITCH; SIMULATION	The massive acquisition of data in molecular and cellular biology has led to the renaissance of an old topic: simulations of biological systems. Simulations, increasingly paired with experiments, are being successfully and routinely used by computational biologists to understand and predict the quantitative behaviour of complex systems, and to drive new experiments. Nevertheless, many experimentalists still consider simulations an esoteric discipline only for initiates. Suspicion towards simulations should dissipate as the limitations and advantages of their application are better appreciated, opening the door to their permanent adoption in everyday research.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Serrano, L (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	serrano@embl.de	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392				Abouhamad WN, 1998, J BACTERIOL, V180, P3757, DOI 10.1128/JB.180.15.3757-3764.1998; Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; ALFONSI A, 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Ander M., 2004, Systems Biology, V1, P129, DOI 10.1049/sb:20045017; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Batt G, 2005, BIOINFORMATICS, V21, pI19, DOI 10.1093/bioinformatics/bti1048; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BEZRUKOV SM, 2003, P SPIE, V5110; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Chang Phei Lang, 2005, Chang Gung Med J, V28, P201; CLARKE BL, 1981, J CHEM PHYS, V75, P4970, DOI 10.1063/1.441885; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P303, DOI 10.1016/j.ijfoodmicro.2004.11.016; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Errampalli DD, 2004, OMICS, V8, P370, DOI 10.1089/omi.2004.8.370; Fall CP., 2002, COMPUTATIONAL CELL B; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hardy Simon, 2004, J Bioinform Comput Biol, V2, P595; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jaenecke S, 1996, MOL MICROBIOL, V21, P293, DOI 10.1046/j.1365-2958.1996.6411358.x; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; KANT I, CRITIQUE PURE REAS 2, P45; KERCKHOFFS R, 2005, AM J PHYSIOL-HEART C, V5, pH1889; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; KUIPERS B, 1989, READINGS QUALITATIVE, P257; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lemerle C, 2005, FEBS LETT, V579, P1789, DOI 10.1016/j.febslet.2005.02.009; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liu Q, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041907; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; LOUIS M, 2002, SCI STKE, V143, pPE33, DOI DOI 10.1126/STKE.2002.143.PE33; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SAVAGEAU MA, 1991, J THEOR BIOL, V151, P509, DOI 10.1016/S0022-5193(05)80367-4; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schoning JC, 2005, FEBS LETT, V579, P3246, DOI 10.1016/j.febslet.2005.03.028; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stundzia AB, 1996, J COMPUT PHYS, V127, P196, DOI 10.1006/jcph.1996.0168; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Wu D, 2005, BIOPHYS CHEM, V115, P37, DOI 10.1016/j.bpc.2004.12.047; Yarmush ML, 2003, ANNU REV BIOMED ENG, V5, P349, DOI 10.1146/annurev.bioeng.5.031003.163247; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	77	200	204	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					527	533		10.1038/nature05127	http://dx.doi.org/10.1038/nature05127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024084				2022-12-28	WOS:000240988200034
J	Sherson, JF; Krauter, H; Olsson, RK; Julsgaard, B; Hammerer, K; Cirac, I; Polzik, ES				Sherson, Jacob F.; Krauter, Hanna; Olsson, Rasmus K.; Julsgaard, Brian; Hammerer, Klemens; Cirac, Ignacio; Polzik, Eugene S.			Quantum teleportation between light and matter	NATURE			English	Article							SINGLE PHOTONS; STATE; STORAGE	Quantum teleportation(1) is an important ingredient in distributed quantum networks(2), and can also serve as an elementary operation in quantum computers(3). Teleportation was first demonstrated as a transfer of a quantum state of light onto another light beam(4-6); later developments used optical relays(7) and demonstrated entanglement swapping for continuous variables(8). The teleportation of a quantum state between two single material particles ( trapped ions) has now also been achieved(9,10). Here we demonstrate teleportation between objects of a different nature - light and matter, which respectively represent 'flying' and 'stationary' media. A quantum state encoded in a light pulse is teleported onto a macroscopic object (an atomic ensemble containing 10(12) caesium atoms). Deterministic teleportation is achieved for sets of coherent states with mean photon number (n) up to a few hundred. The fidelities are 0.58 +/- 0.02 for n = 20 and 0.60 +/- 0.02 for n = 5 5 - higher than any classical state transfer can possibly achieve(11). Besides being of fundamental interest, teleportation using a macroscopic atomic ensemble is relevant for the practical implementation of a quantum repeater(2). An important factor for the implementation of quantum networks is the teleportation distance between transmitter and receiver; this is 0.5 metres in the present experiment. As our experiment uses propagating light to achieve the entanglement of light and atoms required for teleportation, the present approach should be scalable to longer distances.	Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen O, Denmark; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark	University of Copenhagen; Niels Bohr Institute; Max Planck Society; Aarhus University	Polzik, ES (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	polzik@nbi.dk	Hammerer, Klemens/C-3538-2008; Cirac, J. Ignacio/A-9105-2017; Polzik, Eugene/M-4724-2014	Hammerer, Klemens/0000-0002-7179-0666; Cirac, J. Ignacio/0000-0003-3359-1743; Polzik, Eugene/0000-0001-9859-6591				BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Hammerer K, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052313; Hammerer K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150503; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Julsgaard B, 2004, J OPT B-QUANTUM S O, V6, P5, DOI 10.1088/1464-4266/6/1/002; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Julsgaard B, 2003, QUANTUM INF COMPUT, V3, P518; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; POLZIK ES, 1992, PHYS REV LETT, V68, P3020, DOI 10.1103/PhysRevLett.68.3020; SHERSON J, 2006, IN PRESS ADV AT MOL; Takei N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220502; VAIDMAN L, 1994, PHYS REV A, V49, P1473, DOI 10.1103/PhysRevA.49.1473	25	488	492	6	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					557	560		10.1038/nature05136	http://dx.doi.org/10.1038/nature05136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024089	Green Submitted			2022-12-28	WOS:000240988200039
J	Harris, KM; Sponsel, A; Hutter, AM; Maron, BJ				Harris, Kevin M.; Sponsel, Austin; Hutter, Adolph M., Jr.; Maron, Barry J.			Cardiovascular screening practices of major North American professional sports teams	ANNALS OF INTERNAL MEDICINE			English	Article							SUDDEN CARDIAC DEATH; LEAGUE BASEBALL TEAM; HIGH-SCHOOL; HYPERTROPHIC CARDIOMYOPATHY; HEART-ASSOCIATION; FOOTBALL PLAYERS; YOUNG; DISEASE; RECOMMENDATIONS; REHABILITATION	Background: Customary preparticipation screening strategies to detect heart disease in professional athletes have not been examined systematically. Objective: To describe the current preparticipation cardiovascular screening process for professional athletes. Design: Screening practices surveyed by questionnaire. Setting: The 122 major professional sports teams in North America. Participants: Athletic trainers and team physicians. Measurements: League recommendations for history taking and physical examination and noninvasive testing were compared with screening recommendations from an American Heart Association consensus panel. Results: All 122 teams have team physicians perform annual screening, including family and personal history taking (100%), physical examination (100%), and lipid panels (108 of 122 [89%]). Diagnostic testing by using electrocardiography was substantially more common (112 of 122 [92%]) than exercise testing and stress echocardiography (21 of 122 [17%]) or echocardiography (16 of 122 [13%]). League recommendations for history taking and physical examination were most complete for Major League Baseball and the National Hockey League, meeting 10 of 12 and 8 of 12 American Heart Association recommendations, respectively. The most comprehensive cardiovascular screening using echocardiography is confined to selected, elite professional basketball players. Limitations: Data were self-reported by team representatives. Conclusions: A variety of nonstandardized preparticipation screening strategies for the detection of cardiovascular disease, varying considerably in scope, constitute customary practice among professional sports teams.	Minnesota Heart Inst Fdn, Minneapolis, MN 55407 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Minneapolis Heart Institute Foundation; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Harris, KM (corresponding author), Minnesota Heart Inst Fdn, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.	kharris@mplsheart.com						Abernethy WB, 2003, J AM COLL CARDIOL, V41, P280, DOI 10.1016/S0735-1097(02)02633-5; BROWN C, 2005, NY TIMES        0907, pD2; Cantwell JD, 2003, AM J CARDIOL, V92, P467, DOI 10.1016/S0002-9149(03)00670-2; Cantwell JD, 2002, AM J CARDIOL, V90, P1395, DOI 10.1016/S0002-9149(02)02882-5; CHENGELIS AS, 2006, DETROIT DAILY N 0404, pD4; Choo JK, 2002, AM J CARDIOL, V90, P198, DOI 10.1016/S0002-9149(02)02454-2; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; HELLER D, 1993, WASHINGTON TIMES; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; Maron BJ, 2005, EUR HEART J, V26, P428, DOI 10.1093/eurheartj/ehi154; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 2001, CIRCULATION, V103, P327; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; NANCE R, 2005, USA TODAY       1019, pC6; Paterick TE, 2005, JAMA-J AM MED ASSOC, V294, P3011, DOI 10.1001/jama.294.23.3011; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; SNOW C, 2004, MINNEAPOLIS STA 1104, pC1; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; YOUNGBLOOD D, 2005, MINNEAPOLIS STA 1218, pC13	28	41	41	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					507	511		10.7326/0003-4819-145-7-200610030-00008	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015868				2022-12-28	WOS:000241093900004
J	Schwartz, LM; Woloshin, S; Dvorin, EL; Welch, HG				Schwartz, Lisa M.; Woloshin, Steven; Dvorin, Evan L.; Welch, H. Gilbert			Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks	BMJ-BRITISH MEDICAL JOURNAL			English	Review								Objective To examine the accessibility of absolute risk in articles reporting ratio measures in leading medical journals. Design Structured review of abstracts presenting ratio measures. Setting Articles published between 1 June 2003 and 1 May 2004 in Annals of Internal Medicine, BMJ, Journal of the American Medical Association,journal of the National Cancer Institute, Lancet, and New England Journal of Medicine. Participants 222 articles based on study designs in which absolute risks were directly calculable (61 randomised trials, 161 cohort studies). Main outcome measure Accessibility of the absolute risks underlying the first ratio measure in the abstract. Results 68% of articles (150/222) failed to report the underlying absolute risks for the first ratio measure in the abstract (range 55 - 81% across the journals). Among these articles, about half did report the underlying absolute risks elsewhere in the article (text, table, or figure) but half did not report them anywhere. Absolute risks were more likely to be reported in the abstract for randomised trials compared with cohort studies (62% v 21%; relative risk 3.0, 95% confidence interval 2.1 to 4.2) and for studies reporting crude compared with adjusted ratio measures (62% v 2 11%; relative risk 3.0, 2.1 to 4.3). Conclusion Absolute risks are often not easily accessible in articles reporting ratio measures and sometimes are missing altogether-this lack of accessibility can easily exaggerate readers' perceptions of benefit or harm.	Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA		Woloshin, S (corresponding author), Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA.	steven.woloshin@dartmouth.edu		Dvorin, Evan/0000-0001-5037-2783	NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA104721] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*CONSORT GROUP, CONS STAT; FAHEY T, 1995, BRIT MED J, V311, P1056, DOI 10.1136/bmj.311.7012.1056; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Yueh B, 1999, J CLIN EPIDEMIOL, V52, P13, DOI 10.1016/S0895-4356(98)00133-4; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; 2005, STATA 9 REFERENCE MA, P392	12	81	82	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2006	333	7581					1248	1250A		10.1136/bmj.38985.564317.7C	http://dx.doi.org/10.1136/bmj.38985.564317.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17060338	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000243197000017
J	Finfer, S; Bellomo, R				Finfer, Simon; Bellomo, Rinaldo		Saline Versus Albumin	Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED-TRIALS	Objective To determine whether outcomes of resuscitation with albumin or saline in the intensive care unit depend on patients' baseline serum albumin concentration. Design Analysis of data from a double blind, randomised controlled trial. Setting Intensive care units of 16 hospitals in Australia and New Zealand. Participants 6045 participants in the saline versus albumin fluid evaluation (SAFE) study. Interventions Fluid resuscitation with 4% albumin or saline in patients with a baseline serum albumin concentration of 25 g/l or less or more than 25 g/l. Main outcome measures Primary outcome was all cause mortality at 28 days. Secondary outcomes were length of stay in the intensive care unit, length of stay in hospital, duration of renal replacement therapy, and duration of mechanical ventilation. Main results The odds ratios for death for albumin compared with saline for patients with a baseline serum albumin concentration of 25 g/l or less and more than 25 g/l were 0.87 and 1.09, respectively (ratio of odds ratios 0.80, 95% confidence interval 0.63 to 1.02); P = 0.08 for heterogeneity. No significant interaction was found between baseline serum albumin concentration as a continuous variable and the effect of albumin and saline on mortality. No consistent interaction was found between baseline serum albumin concentration and treatment effects on length of stay in the intensive care unit, length of hospital stay, duration of renal replacement therapy, or duration of mechanical ventilation. Conclusion The outcomes of resuscitation with albumin and saline are similar irrespective of patients' baseline serum albumin concentration.	Australian & New Zealand Intens Care Soc, Clin Trials Grp, Carlton, Vic 3053, Australia		Finfer, S (corresponding author), Australian & New Zealand Intens Care Soc, Clin Trials Grp, Carlton, Vic 3053, Australia.	sfinfer@george.org.au	Joyce, Christopher/B-7437-2013; Carroll, Rosemary/W-5427-2018; Cooper, D. James/G-7961-2013; ODonnell, Jane/GEX-9181-2022; Higgins, Alisa/AAM-8088-2020	Carroll, Rosemary/0000-0002-2162-2744; Cooper, D. James/0000-0002-5872-9051; ODonnell, Jane/0000-0002-9554-5497; Higgins, Alisa/0000-0001-8295-7559; MacMahon, Stephen/0000-0003-2064-7699; Stephens, Dianne/0000-0002-3785-6828; Neal, Bruce/0000-0002-0490-7465; Woodward, Mark/0000-0001-9800-5296; Bellomo, Rinaldo/0000-0002-1650-8939; French, Craig/0000-0003-1363-9711; Bates, Samantha Jean/0000-0002-8613-1946; Myburgh, John/0000-0003-4088-7016; McEvoy, Suzanne/0000-0002-9804-4276; Finfer, Simon/0000-0002-2785-5864				*ANZICS CLIN TRIAL, SAL VS ALB FLUID EV; Cook D, 2004, NEW ENGL J MED, V350, P2294, DOI 10.1056/NEJMe048095; Finfer S, 2004, NEW ENGL J MED, V350, P2247; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; 2004, COCHRANE DATABASE SY	8	141	154	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 18	2006	333	7577					1044	1046		10.1136/bmj.38985.398704.7C	http://dx.doi.org/10.1136/bmj.38985.398704.7C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108HB	17040925	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000242229800015
J	Wang, YC; Zhang, YJ; Ha, Y				Wang, Yongcheng; Zhang, Yingjiu; Ha, Ya			Crystal structure of a rhomboid family intramembrane protease	NATURE			English	Article							CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; DROSOPHILA RHOMBOID-1; SIGNAL PEPTIDASE; TNF-ALPHA; PROTEOLYSIS; CLEAVAGE; MECHANISM; REVEALS; SERINE	Escherichia coli GlpG is an integral membrane protein that belongs to the widespread rhomboid protease family. Rhomboid proteases, like site-2 protease (S2P) and gamma-secretase, are unique in that they cleave the transmembrane domain of other membrane proteins. Here we describe the 2.1 angstrom resolution crystal structure of the GlpG core domain. This structure contains six transmembrane segments. Residues previously shown to be involved in catalysis, including a Ser-His dyad, and several water molecules are found at the protein interior at a depth below the membrane surface. This putative active site is accessible by substrate through a large 'V-shaped' opening that faces laterally towards the lipid, but is blocked by a half-submerged loop structure. These observations indicate that, in intramembrane proteolysis, the scission of peptide bonds takes place within the hydrophobic environment of the membrane bilayer. The crystal structure also suggests a gating mechanism for GlpG that controls substrate access to its hydrophilic active site.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DE SB, 1999, NATURE, V398, P518; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koonin E.V., 2003, GENOME BIOL, V4, P19, DOI 10.1186/gb-2003-4-3-r19; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LI X, 1996, NEURON, V17; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Tjalsma H, 2000, J BIOL CHEM, V275, P25102, DOI 10.1074/jbc.M002676200; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wasserman JD, 2000, GENE DEV, V14, P1651; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	49	282	291	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					179	183		10.1038/nature05255	http://dx.doi.org/10.1038/nature05255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051161				2022-12-28	WOS:000241867200034
J	He, LM; Wu, XS; Mohan, R; Wu, LG				He, Liming; Wu, Xin-Sheng; Mohan, Raja; Wu, Ling-Gang			Two modes of fusion pore opening revealed by cell-attached recordings at a synapse	NATURE			English	Article							TRANSMITTER RELEASE; VESICLES; CAPACITANCE; SINGLE; ENDOCYTOSIS; MEMBRANE; MODULATION; EXOCYTOSIS; DIFFUSION; PROTEINS	Fusion of a vesicle with the cell membrane opens a pore that releases transmitter to the extracellular space(1-3). The pore can either dilate fully so that the vesicle collapses completely, or close rapidly to generate 'kiss-and-run' fusion(1,2,4-7). The size of the pore determines the release rate(2). At synapses, the size of the fusion pore is unclear, 'kiss-and-run' remains controversial(8-15), and the ability of 'kiss-and-run' fusion to generate rapid synaptic currents(16,17) is questionable(18). Here, by recording fusion pore kinetics during single vesicle fusion, we found both full collapse and 'kiss-and-run' fusion at calyx-type synapses. For full collapse, the initial fusion pore conductance (G(p)) was usually > 375 pS and increased rapidly at >= 299 pS ms(-1). 'Kiss-and-run' fusion was seen as a brief capacitance flicker (< 2 s) with G(p) > 288 pS for most flickers, but within 15 - 288 pS for the remaining flickers. Large G(p) (> 288 pS) might discharge transmitter rapidly and thereby cause rapid synaptic currents, whereas small Gp might generate slow and small synaptic currents. These results show that 'kiss-and-run' fusion occurs at synapses and that it can generate rapid postsynaptic currents, and suggest that various fusion pore sizes help to control the kinetics and amplitude of synaptic currents.	NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Room 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003009, ZIANS003009] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALMERS W, 1991, ANN NY ACAD SCI, V635, P318, DOI 10.1111/j.1749-6632.1991.tb36502.x; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Satzler K, 2002, J NEUROSCI, V22, P10567; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stiles JR, 2001, SYNAPSES, P681; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	30	154	162	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					102	105		10.1038/nature05250	http://dx.doi.org/10.1038/nature05250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17065984				2022-12-28	WOS:000241701500054
J	Telesco, C				Telesco, Charles			Astronomy - Born with flare	SCIENCE			English	Editorial Material									Univ Florida, Dept Astron, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Telesco, C (corresponding author), Univ Florida, Dept Astron, Gainesville, FL 32611 USA.	telesco@astro.ufl.edu						Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Lagage PO, 2006, SCIENCE, V314, P621, DOI 10.1126/science.1131436; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Marcy G, 2005, PROG THEOR PHYS SUPP, P24, DOI 10.1143/PTPS.158.24; McCaughrean M. J., 2000, Protostars and planets 4, P485	5	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					605	606		10.1126/science.1133759	http://dx.doi.org/10.1126/science.1133759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068250				2022-12-28	WOS:000241557800032
J	Gess, RW; Coates, MI; Rubidge, BS				Gess, Robert W.; Coates, Michael I.; Rubidge, Bruce S.			A lamprey from the Devonian period of South Africa	NATURE			English	Article							VERTEBRATES; ORIGIN	Lampreys are the most scientifically accessible of the remaining jawless vertebrates, but their evolutionary history is obscure. In contrast to the rich fossil record of armoured jawless fishes, all of which date from the Devonian period and earlier(1-3), only two Palaeozoic lampreys have been recorded, both from the Carboniferous period(1). In addition to these, the recent report of an exquisitely preserved Lower Cretaceous example(4) demonstrates that anatomically modern lampreys were present by the late Mesozoic era. Here we report a marine/ estuarine fossil lamprey from the Famennian ( Late Devonian) of South Africa(5,6), the identity of which is established easily because many of the key specializations of modern forms are already in place. These specializations include the first evidence of a large oral disc, the first direct evidence of circumoral teeth and a well preserved branchial basket. This small agnathan, Priscomyzon riniensis gen. et sp. nov., is not only more conventionally lamprey-like than other Palaeozoic examples(7,8), but is also some 35 million years older. This finding is evidence that agnathans close to modern lampreys had evolved before the end of the Devonian period. In this light, lampreys as a whole appear all the more remarkable: ancient specialists that have persisted as such and survived a subsequent 360 million years.	Univ Witwatersrand, Sch Geosci, Bernard Price Inst Palaeontol, ZA-2050 Johannesburg, South Africa; Univ Chicago, Dept Organismal Biol, Chicago, IL 60637 USA	University of Witwatersrand; University of Chicago	Gess, RW (corresponding author), Univ Witwatersrand, Sch Geosci, Bernard Price Inst Palaeontol, ZA-2050 Johannesburg, South Africa.	robg@imaginet.co.za	Coates, Michael/AAO-3810-2020; Rubidge, Bruce/AAE-7021-2019	Coates, Michael/0000-0003-2843-1075; Rubidge, Bruce/0000-0003-2477-1873				ANDERSON HM, 1995, BOT J LINN SOC, V117, P305, DOI 10.1006/bojl.1995.0021; BARDACK D, 1968, SCIENCE, V162, P1265, DOI 10.1126/science.162.3859.1265; BARDACK D, 1971, FIELDIANA GEOLOGY, V33, P489; Bardack D., 1971, BIOL LAMPREYS, V1, P67; Chang MM, 2006, NATURE, V441, P972, DOI 10.1038/nature04730; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Eldredge N., 1984, P272; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Hardisty M.W, 1971, P127; HARDISTY MW, 1981, BIOL LAMPREYS, V3, P333; Hiller N., 1992, S AFR J GEOL, V95, P203; Hubbs CL, 1971, BIOLOGY LAMPREYS, V1, P1; Janvier P, 2006, NATURE, V440, P1183, DOI 10.1038/nature04471; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 2002, NATURE, V417, P609, DOI 10.1038/417609a; JANVIER P, 1983, Journal of Vertebrate Paleontology, V2, P407; Janvier P., 1996, EARLY VERTEBRATES; Janvier P., 2004, RECENT ADV ORIGIN EA, P29; LUND R, 1986, GEOBIOS-LYON, V19, P647, DOI 10.1016/S0016-6995(86)80061-4; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Swofford D.L., 2003, PAUP VERSION 40 B10; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; YALDEN DW, 1985, ZOOL J LINN SOC-LOND, V84, P291, DOI 10.1111/j.1096-3642.1985.tb01802.x	28	179	186	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					981	984		10.1038/nature05150	http://dx.doi.org/10.1038/nature05150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066033				2022-12-28	WOS:000241523400052
J	Goldstein, RN				Goldstein, Roger N.			Architectural design and the collaborative research environment	CELL			English	Editorial Material								Given that science is a collaborative endeavor, architects are striving to design new research buildings that not only provide a more pleasant work space but also facilitate interactions among researchers.	Goody Clancy, Boston, MA 02116 USA		Goldstein, RN (corresponding author), Goody Clancy, Boston, MA 02116 USA.	roger.goldstein@goodyclancy.com							0	9	10	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					243	246		10.1016/j.cell.2006.10.007	http://dx.doi.org/10.1016/j.cell.2006.10.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055421	Bronze			2022-12-28	WOS:000241827100007
J	Block, DL; Bournaud, F; Combes, F; Groess, R; Barmby, P; Ashby, MLN; Fazio, GG; Pahre, MA; Willner, SP				Block, D. L.; Bournaud, F.; Combes, F.; Groess, R.; Barmby, P.; Ashby, M. L. N.; Fazio, G. G.; Pahre, M. A.; Willner, S. P.			An almost head-on collision as the origin of two off-centre rings in the Andromeda galaxy	NATURE			English	Article							IONIZED-GAS; MODEL; M31	The unusual morphology of the Andromeda galaxy ( Messier 31, the closest spiral galaxy to the Milky Way) has long been an enigma. Although regarded for decades as showing little evidence of a violent history, M31 has a well-known(1-7) outer ring of star formation at a radius of ten kiloparsecs whose centre is offset from the galaxy nucleus. In addition, the outer galaxy disk is warped, as seen at both optical(8) and radio(9) wavelengths. The halo contains numerous loops and ripples. Here we report the presence of a second, inner dust ring with projected dimensions of 1.5 x 1 kiloparsecs and offset by about half a kiloparsec from the centre of the galaxy (based upon an analysis of previously-obtained data(10)). The two rings appear to be density waves propagating in the disk. Numerical simulations indicate that both rings result from a companion galaxy plunging through the centre of the disk of M31. The most likely interloper is M32. Head-on collisions between galaxies are rare, but it appears nonetheless that one took place 210 million years ago in our Local Group of galaxies.	Univ Witwatersrand, Sch Computat & Appl Math, Anglo Amer Cosm Dust Lab, ZA-2050 Johannesburg, South Africa; Observ Paris, LERMA, F-75014 Paris, France; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of Witwatersrand; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Block, DL (corresponding author), Univ Witwatersrand, Sch Computat & Appl Math, Anglo Amer Cosm Dust Lab, Private Bag 3, ZA-2050 Johannesburg, South Africa.	block@cam.wits.ac.za	Bournaud, Frederic/K-1263-2013; Combes, Francoise/F-6046-2011; Barmby, Pauline/I-7194-2016	Combes, Francoise/0000-0003-2658-7893; Barmby, Pauline/0000-0003-2767-0090				Appleton P. N., 1996, Fundamentals of Cosmic Physics, V16, P111; BAADE W, 1963, EVOLUTION STARS GALA, P56; BARMBY P, IN PRESS ASTROPHYS J; BEATON RL, UNPUB ASTROPHYS J LE; Beck R, 1998, ASTRON ASTROPHYS SUP, V129, P329, DOI 10.1051/aas:1998187; Block DL, 2001, ASTRON ASTROPHYS, V375, P761, DOI 10.1051/0004-6361:20010775; Bournaud F, 2003, ASTRON ASTROPHYS, V401, P817, DOI 10.1051/0004-6361:20030150; BRAUN R, 1991, ASTROPHYS J, V372, P54, DOI 10.1086/169954; Brinks E., 1984, Astronomy & Astrophysics Supplement Series, V55, P179; BUTA R, 1995, ASTROPHYS J SUPPL S, V96, P39, DOI 10.1086/192113; CIARDULLO R, 1988, ASTRON J, V95, P438, DOI 10.1086/114645; DAME TM, 1993, ASTROPHYS J, V418, P730, DOI 10.1086/173430; Elmegreen DM, 2005, ASTROPHYS J, V631, P85, DOI 10.1086/432502; Gerber RA, 1996, MON NOT R ASTRON SOC, V278, P345; Gordon KD, 2006, ASTROPHYS J, V638, pL87, DOI 10.1086/501046; Haas M, 1998, ASTRON ASTROPHYS, V338, pL33; Horellou C, 2001, ASTROPHYS SPACE SCI, V276, P1141, DOI 10.1023/A:1017524632342; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; JACOBY GH, 1985, ASTROPHYS J, V290, P136, DOI 10.1086/162968; Lavery RJ, 2004, ASTROPHYS J, V612, P679, DOI 10.1086/422420; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; Nieten C, 2006, ASTRON ASTROPHYS, V453, P459, DOI 10.1051/0004-6361:20035672; Pellet A., 1978, Astronomy and Astrophysics Supplement Series, V31, P439; SHU FH, 1973, ASTROPHYS J, V183, P819, DOI 10.1086/152270; Stanek KZ, 1998, ASTROPHYS J, V503, pL131, DOI 10.1086/311539; STRUCKMARCELL C, 1993, ASTROPHYS J, V411, P108, DOI 10.1086/172811; UNWIN SC, 1983, MON NOT R ASTRON SOC, V205, P773, DOI 10.1093/mnras/205.3.773; Welch GA, 2001, ASTROPHYS J, V557, P671, DOI 10.1086/322266; WILLAIME MC, 2001, ESA, P519	30	93	94	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					832	834		10.1038/nature05184	http://dx.doi.org/10.1038/nature05184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051212	Green Submitted			2022-12-28	WOS:000241362700045
J	Hauptman, PJ; Schnitzler, MA; Swindle, J; Burroughs, TE				Hauptman, Paul J.; Schnitzler, Mark A.; Swindle, Jason; Burroughs, Thomas E.			Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; NATRIURETIC PEPTIDE; TEMPORAL TRENDS; DOBUTAMINE; IMPACT; PHARMACOTHERAPIES; MANAGEMENT; PHYSICIANS; MILRINONE	Context The rate of adoption of new therapies for cardiovascular diseases following the publication of favorable clinical trial results has been studied; however, less is known about the rates of de-adoption of a drug when negative studies are published. Objective To evaluate the use of nesiritide before and after March and April 2005 publications in 2 high-impact journals that suggested an increased risk of renal failure and mortality with intravenous nesiritide for acute decompensated heart failure. Design, Setting, and Patients Analysis of a large prospective hospital database, developed for quality and utilization benchmarking, of 491 acute care US hospitals at which 385 627 inpatient admissions occurred with a primary International Classification of Diseases, Ninth Revision (ICD-9) code for heart failure between January and August 2001 (prior to nesiritide release) and January 2004 to December 2005 (before and after publication periods). In addition, any patient admitted who received nesiritide in the absence of a primary or secondary heart failure code was evaluated for potential off-label use of the drug. Main Outcome Measure Use of nesiritide and other intravenous vasoactive therapy among patients admitted with heart failure. Results Nesiritide use decreased from a peak of 16.6% (2351 of 14 167 admissions) in March 2005 to 5.6% (611 of 10 822 admissions) in December 2005 (P < .001). Among those patients treated with nesiritide, the mean duration of treatment changed minimally, from 2.3 to 2.1 days. Although the use of inotropes also decreased during the period under study, the changes were more modest; furthermore, of those patients who were prescribed intravenous vasoactive therapy, a higher percentage were prescribed inotropes after publication (3272 [ 21.5%] of 15 193 patients from January-April 2005 vs 5750 [29.6%] of 19 445 patients from May-December 2005, P < .001). The use of nesiritide, in the absence of an ICD-9 heart failure code, was small. Conclusions Rapid de-adoption of nesiritide occurred following 2 publications suggesting risk with the drug. Further analyses are required to evaluate the consequences of these changes on patient outcomes and to anticipate how publications of adverse findings can influence practice.	St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA; St Louis Univ, Sch Med, Ctr Outcomes Res, St Louis, MO USA; St Louis Univ, Sch Med, Dept Med, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University; Saint Louis University	Hauptman, PJ (corresponding author), St Louis Univ Hosp, Div Cardiol, FDT-15,3635 Vista Ave, St Louis, MO 63110 USA.	hauptmpj@slu.edu			NIA NIH HHS [R01 AG021515, R01 AG021515-04] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021515] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM COLL CARD AM H, ACC AHA 2005 GUID UP; Bayram M, 2005, AM J CARDIOL, V96, p47G, DOI 10.1016/j.amjcard.2005.07.021; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Burger AJ, 2002, AM HEART J, V144, P1102, DOI 10.1067/mhj.2002.125620; Col NF, 1996, ARCH INTERN MED, V156, P54, DOI 10.1001/archinte.156.1.54; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Ewy GA, 1999, J AM COLL CARDIOL, V33, P572; Felker GM, 2001, AM HEART J, V142, P932, DOI 10.1067/mhj.2001.119611; FRIEDMAN L, 1983, CONTROL CLIN TRIALS, V4, P513, DOI 10.1016/0197-2456(83)90032-6; Gambassi G, 2000, AM HEART J, V139, P85, DOI 10.1016/S0002-8703(00)90313-2; Hamann J, 2004, AM J PSYCHIAT, V161, P1301, DOI 10.1176/appi.ajp.161.7.1301; HENSLEY SJ, 2006, WALL STREET J   0125, pA3; HORTON DP, 2005, COMMUNICATION   0713; Hussain Z, 2006, J CARD FAIL, V12, P343, DOI 10.1016/j.cardfail.2006.02.005; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kesselhelm AS, 2006, HEALTH AFFAIR, V25, P1095, DOI 10.1377/hlthaff.25.4.1095; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kizer JR, 1999, AM HEART J, V137, P79, DOI 10.1016/S0002-8703(99)70462-X; Kozyrskyj AL, 2004, CAN MED ASSOC J, V171, P139, DOI 10.1503/cmaj.1031629; LAMAS GA, 1992, NEW ENGL J MED, V327, P241, DOI 10.1056/NEJM199207233270405; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; McDermontt MM, 1997, AM HEART J, V134, P901, DOI 10.1016/S0002-8703(97)80013-0; O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4; Oliva F, 1999, AM HEART J, V138, P247, DOI 10.1016/S0002-8703(99)70108-0; PACKER M, 1993, J AM COLL CARDIOL, V22, pA119, DOI 10.1016/0735-1097(93)90474-F; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rich MW, 1998, AM HEART J, V135, P367, DOI 10.1016/S0002-8703(98)70309-6; Roumie CL, 2005, AM J MED, V118, P641, DOI 10.1016/j.amjmed.2005.02.013; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Shaya Fadia T, 2005, Manag Care Interface, V18, P27; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Topol EJ, 2005, NEW ENGL J MED, V353, P113, DOI 10.1056/NEJMp058139; Tu K, 2003, CAN MED ASSOC J, V168, P553; *US DEP HHS, 2001, CARD REN DRUGS ADV C; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Young JB, 2005, J AM COLL CARDIOL, V46, P505, DOI 10.1016/j.jacc.2005.05.014; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	45	43	46	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1877	1884		10.1001/jama.296.15.1877	http://dx.doi.org/10.1001/jama.296.15.1877			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047218	Bronze, Green Accepted			2022-12-28	WOS:000241329300030
J	Haydon, DT; Randall, DA; Matthews, L; Knobel, DL; Tallents, LA; Gravenor, MB; Williams, SD; Pollinger, JP; Cleaveland, S; Woolhouse, MEJ; Sillero-Zubiri, C; Marino, J; Macdonald, DW; Laurenson, MK				Haydon, D. T.; Randall, D. A.; Matthews, L.; Knobel, D. L.; Tallents, L. A.; Gravenor, M. B.; Williams, S. D.; Pollinger, J. P.; Cleaveland, S.; Woolhouse, M. E. J.; Sillero-Zubiri, C.; Marino, J.; Macdonald, D. W.; Laurenson, M. K.			Low-coverage vaccination strategies for the conservation of endangered species	NATURE			English	Article							ORAL RABIES VACCINE; ETHIOPIAN WOLVES; MOUTH EPIDEMIC; DYNAMICS; DISEASE; FOOT; DOGS; POPULATION; MANAGEMENT; WILDLIFE	The conventional objective of vaccination programmes is to eliminate infection by reducing the reproduction number of an infectious agent to less than one(1), which generally requires vaccination of the majority of individuals. In populations of endangered wildlife, the intervention required to deliver such coverage can be undesirable and impractical(2); however, endangered populations are increasingly threatened by outbreaks of infectious disease for which effective vaccines exist(3,4). As an alternative, wildlife epidemiologists could adopt a vaccination strategy that protects a population from the consequences of only the largest outbreaks of disease. Here we provide a successful example of this strategy in the Ethiopian wolf, the world's rarest canid(5), which persists in small subpopulations threatened by repeated outbreaks of rabies introduced by domestic dogs(6). On the basis of data from past outbreaks, we propose an approach that controls the spread of disease through habitat corridors between subpopulations and that requires only low vaccination coverage. This approach reduces the extent of rabies outbreaks and should significantly enhance the long-term persistence of the population. Our study shows that vaccination used to enhance metapopulation persistence through elimination of the largest outbreaks of disease requires lower coverage than the conventional objective of reducing the reproduction number of an infectious agent to less than one(1).	Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Oxford, Wildlife Conservat Res Unit, Oxford OX13 5QL, England; Ethiopian Wolf Conservat Programme, Robe, Bale, Ethiopia; Univ Edinburgh, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Wildlife & Emerging Dis Sect, Roslin EH25 9RG, Midlothian, Scotland; Swansea Univ, Sch Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; Univ Calif Los Angeles, Conservat Genet Resource Ctr, Los Angeles, CA 90095 USA; Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh EH9 3JF, Midlothian, Scotland; Frankfurt Zool Soc, Arusha, Tanzania	University of Glasgow; University of Oxford; University of Edinburgh; Swansea University; University of California System; University of California Los Angeles; University of Edinburgh	Haydon, DT (corresponding author), Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	D.Haydon@bio.gla.ac.uk	Matthews, Louise/E-2913-2013; Knobel, Darryn/O-7057-2014	Matthews, Louise/0000-0003-4420-8367; Knobel, Darryn/0000-0002-0425-3799; Haydon, Daniel/0000-0002-1240-1886; Tallents, Lucy/0000-0001-5601-0468				ANDERSON R M, 1991; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Ball FG, 2002, MATH BIOSCI, V177, P333, DOI 10.1016/S0025-5564(01)00095-5; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Farry SC, 1998, J WILDLIFE DIS, V34, P23, DOI 10.7589/0090-3558-34.1.23; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Foggin, 1988, THESIS U ZIMBABWE; Haydon DT, 2002, CONSERV BIOL, V16, P1372, DOI 10.1046/j.1523-1739.2002.00559.x; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HETHCOTE HW, 1978, THEOR POPUL BIOL, V14, P338, DOI 10.1016/0040-5809(78)90011-4; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Knobel DL, 2003, ONDERSTEPOORT J VET, V70, P73; Knobel DL, 2002, J WILDLIFE DIS, V38, P352, DOI 10.7589/0090-3558-38.2.352; Laurenson K, 1998, ANIM CONSERV, V1, P273, DOI 10.1111/j.1469-1795.1998.tb00038.x; Marino J, 2006, ANIM CONSERV, V9, P49, DOI 10.1111/j.1469-1795.2005.00011.x; Marino J, 2003, ORYX, V37, P62, DOI 10.1017/S0030605303000139; MORELL V, 1995, SCIENCE, V270, P1302, DOI 10.1126/science.270.5240.1302; Morris W. F., 2002, QUANTITATIVE CONSERV; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Randall DA, 2004, EMERG INFECT DIS, V10, P2214, DOI 10.3201/eid1012.040080; Sillero-Zubiri C., 2004, CANIDS FOXES WOLVES, P167; SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80; Steelman HG, 1998, J WILDLIFE DIS, V34, P764, DOI 10.7589/0090-3558-34.4.764; Vial F, 2006, BIOL CONSERV, V131, P180, DOI 10.1016/j.biocon.2006.04.005; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123; Woodroffe R, 2001, ORYX, V35, P234, DOI 10.1017/S0030605300031902	28	136	137	0	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					692	695		10.1038/nature05177	http://dx.doi.org/10.1038/nature05177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036003				2022-12-28	WOS:000241160500046
J	Mathura, JR; Jampol, LM				Mathura, Jeevan R., Jr.; Jampol, Lee M.			Medical mystery - Visual-field defect	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Mathura, JR (corresponding author), Northwestern Univ, Chicago, IL 60611 USA.	j-mathura@northwestern.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1592	1592		10.1056/NEJMicm040399	http://dx.doi.org/10.1056/NEJMicm040399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035652				2022-12-28	WOS:000241160400011
J	Nowak, D				Nowak, Dennis			Doctors on strike - The crisis in German health care delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Munich, Inst & Outpatient Clin Occupat & Environm Med, Munich, Germany; Tech Univ, Munich, Germany	University of Munich; Technical University of Munich	Nowak, D (corresponding author), Univ Munich, Inst & Outpatient Clin Occupat & Environm Med, Munich, Germany.							BRAMLEYHARKER E, 2004, COMP PHYS EARNINGS C; KASSIRER JP, 1995, NEW ENGL J MED, V333, P50, DOI 10.1056/NEJM199507063330110	2	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1520	1522		10.1056/NEJMp068148	http://dx.doi.org/10.1056/NEJMp068148			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035645				2022-12-28	WOS:000241160400002
J	Kouyialis, AT; Sakas, DE				Kouyialis, Andreas T.; Sakas, Darnianos E.			Benign intraspinal tumour misdiagnosed as mechanical low back pain	LANCET			English	Editorial Material									Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens 10676, Greece	Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Kouyialis, AT (corresponding author), Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens 10676, Greece.	kouyialis@hotmail.com						CERVONI L, 1994, ACTA NEUROCHIR, V127, P199, DOI 10.1007/BF01808766; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Sonel B, 2002, RHEUMATOL INT, V21, P253, DOI 10.1007/s00296-002-0177-z; Tolias CM, 1997, NEURORADIOLOGY, V39, P276, DOI 10.1007/s002340050408	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1300	1300		10.1016/S0140-6736(06)69526-3	http://dx.doi.org/10.1016/S0140-6736(06)69526-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027736				2022-12-28	WOS:000241058300037
J	He, X				He, Xi			Unwinding a path to nuclear beta-catenin	CELL			English	Editorial Material							AXIN	In this issue of Cell, Yang et al. (2006b) show that PDGF, a growth factor that induces the transition of epithelial cells to mesenchymal cells, stimulates the c-Abl kinase-dependent phosphorylation of p68 RNA helicase. Phosphorylated p68 dissociates beta-catenin from the Axin destruction complex, thereby promoting nuclear beta-catenin signaling independent of Wnt activation.	Harvard Univ, Childrens Hosp, Sch Med, Program Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	He, X (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Program Neurobiol, 300 Longwood Ave, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu						Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022	10	32	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					40	42		10.1016/j.cell.2006.09.016	http://dx.doi.org/10.1016/j.cell.2006.09.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018273	Bronze			2022-12-28	WOS:000241445800010
J	Offenhauser, N; Castelletti, D; Mapelli, L; Soppo, BE; Regondi, MC; Rossi, P; D'Angelo, E; Frassoni, C; Amadeo, A; Tocchetti, A; Pozzi, B; Disanza, A; Guarnieri, D; Betsholtz, C; Scita, G; Helberlein, U; Di Fiore, PP				Offenhauser, Nina; Castelletti, Daniela; Mapelli, Lisa; Soppo, Blanche Ekalle; Regondi, Maria Cristina; Rossi, Paola; D'Angelo, Egidio; Frassoni, Carolina; Amadeo, Alida; Tocchetti, Arianna; Pozzi, Benedetta; Disanza, Andrea; Guarnieri, Douglas; Betsholtz, Christer; Scita, Giorgio; Helberlein, Ulrike; Di Fiore, Pier Paolo			Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics	CELL			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; DENDRITIC SPINES; GLUTAMATE RECEPTORS; NMDA RECEPTORS; IN-VITRO; ALCOHOL; REORGANIZATION; PLASTICITY; TRANSMISSION	Dynamic modulation of the actin cytoskeleton is critical for synaptic plasticity, abnormalities of which are thought to contribute to mental illness and addiction. Here we report that mice lacking Eps8, a regulator of actin dynamics, are resistant to some acute intoxicating effects of ethanol and show increased ethanol consumption. In the brain, the N-methyl-D-aspartate (NMDA) receptor is a major target of ethanol. We show that Eps8 is localized to postsynaptic structures and is part of the NMDA receptor complex. Moreover, in Eps8 null mice, NMDA receptor currents and their sensitivity to inhibition by ethanol are abnormal. In addition, Eps8 null neurons are resistant to the actin-remodeling activities of NMDA and ethanol. We propose that proper regulation of the actin cytoskeleton is a key determinant of cellular and behavioral responses to ethanol.	Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; Univ Pavia, Dipartimento Sci Fisiol & Farmacol Cellulari & Mo, I-27100 Pavia, Italy; Ist Nazl Neurol, Dipartimento Epilettol Clin & Neurofisiol Sperime, I-20133 Milan, Italy; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; Ist Europeo Oncol, Dipartimento Oncol Sperimentale, I-20141 Milan, Italy; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Pavia; University of Milan; IRCCS European Institute of Oncology (IEO); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; University of Milan	Offenhauser, N (corresponding author), Fdn Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	nina.offenhauser@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Amadeo, Alida/C-3158-2016; AMADEO, ALIDA/AAG-5110-2020; Mapelli, Lisa/GSI-4507-2022; Mapelli, Lisa/J-9802-2019; Frassoni, Carolina CF/J-8337-2016; Di Fiore, Pier Paolo/K-2130-2012; Regondi, Maria Cristina/AAJ-5601-2021; Scita, Giorgio/J-9670-2012; D'Angelo, Egidio/AAC-3846-2022	Amadeo, Alida/0000-0002-7581-8339; AMADEO, ALIDA/0000-0002-7581-8339; Mapelli, Lisa/0000-0002-5048-0458; Frassoni, Carolina CF/0000-0002-9300-5139; Di Fiore, Pier Paolo/0000-0002-2252-0950; Regondi, Maria Cristina/0000-0002-1398-7591; D'Angelo, Egidio/0000-0002-6007-7187; Scita, Giorgio/0000-0001-7984-1889; Offenhauser, Nina/0000-0002-3316-3047; ROSSI, Paola/0000-0002-1134-4111; Tocchetti, Arianna/0000-0001-7004-7582; Disanza, Andrea/0000-0001-5101-2907	NIAAA NIH HHS [AA10035, AA13105] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013105, R01AA010035] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Bachmanov AA, 1996, BEHAV GENET, V26, P563, DOI 10.1007/BF02361229; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Berry RB, 2004, ALCOHOL, V32, P9, DOI 10.1016/j.alcohol.2003.09.005; BLITZER RD, 1990, BRAIN RES, V537, P203, DOI 10.1016/0006-8993(90)90359-J; Bowers BJ, 2000, ALCOHOL RES HEALTH, V24, P175; Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Halpain S, 1998, J NEUROSCI, V18, P9835; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hoffman PL, 2003, INT REV NEUROBIOL, V56, P35, DOI 10.1016/S0074-7742(03)56002-0; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Honse Y, 2004, NEUROPHARMACOLOGY, V46, P647, DOI 10.1016/j.neuropharm.2003.11.006; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kampov-Polevoy AB, 1999, ALCOHOL ALCOHOLISM, V34, P386, DOI 10.1093/alcalc/34.3.386; Krazem A, 2003, BEHAV BRAIN RES, V147, P17, DOI 10.1016/S0166-4328(03)00113-X; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rossi P, 2002, J NEUROSCI, V22, P9687; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Rustay NR, 2003, P NATL ACAD SCI USA, V100, P2917, DOI 10.1073/pnas.0437273100; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schuckit MA, 2000, J STUD ALCOHOL, V61, P827, DOI 10.15288/jsa.2000.61.827; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shiraishi Y, 2003, J NEUROCHEM, V87, P364, DOI 10.1046/j.1471-4159.2003.02003.x; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Tabakoff B, 2003, J NEUROSCI, V23, P4491; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Woodward JJ, 2000, CRIT REV NEUROBIOL, V14, P69; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yamada K, 2001, EUR J NEUROSCI, V13, P2025, DOI 10.1046/j.0953-816x.2001.01580.x; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	64	91	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					213	226		10.1016/j.cell.2006.09.011	http://dx.doi.org/10.1016/j.cell.2006.09.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018287	Bronze			2022-12-28	WOS:000241445800025
J	Gandhi, TK; Kachalia, A; Thomas, EJ; Puopolo, AL; Yoon, C; Brennan, TA; Studdert, DM				Gandhi, Tejal K.; Kachalia, Allen; Thomas, Eric J.; Puopolo, Ann Louise; Yoon, Catherine; Brennan, Troyen A.; Studdert, David M.			Missed and delayed diagnoses in the ambulatory setting: A study of closed malpractice claims	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE EVENTS; DECISION-SUPPORT; NEGLIGENT CARE; ERRORS; CHOLECYSTECTOMY; WOMEN; UTAH	Background: Although missed and delayed diagnoses have become an important patient safety concern, they remain largely unstudied, especially in the outpatient setting. Objective: To develop a framework for investigating missed and delayed diagnoses, advance understanding of their causes, and identify opportunities for prevention. Design: Retrospective review of 307 closed malpractice claims in which patients alleged a missed or delayed diagnosis in the ambulatory setting. Setting: 4 malpractice insurance companies. Measurements: Diagnostic errors associated with adverse outcomes for patients, process breakdowns, and contributing factors. Results: A total of 181 claims (59%) involved diagnostic errors that harmed patients. Fifty-nine percent (106 of 181) of these errors were associated with serious harm, and 30% (55 of 181) resulted in death. For 59% (106 of 181) of the errors, cancer was the diagnosis involved, chiefly breast (44 claims [24%]) and colorectal (13 claims [7%]) cancer. The most common breakdowns in the diagnostic process were failure to order an appropriate diagnostic test (100 of 181 [55%]), failure to create a proper follow-up plan (81 of 181 [45%]), failure to obtain an adequate history or perform an adequate physical examination (76 of 181 [42%]), and incorrect interpretation of diagnostic tests (67 of 181 [37%]). The leading factors that contributed to the errors were failures in judgment (143 of 181 [791%]), vigilance or memory (106 of 181 [59%]), knowledge (86 of 181 [48%]), patient-related factors (84 of 181 [46%]), and handoffs (36 of 181 [20%]). The median number of process breakdowns and contributing factors per error was 3 for both (interquartile range, 2 to 4). Limitations: Reviewers were not blinded to the litigation outcomes, and the reliability of the error determination was moderate. Conclusions: Diagnostic errors that harm patients are typically the result of multiple breakdowns and individual and system factors. Awareness of the most common types of breakdowns and factors could help efforts to identify and prioritize strategies to prevent diagnostic errors.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	studdert@hsph.harvard.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537	AHRQ HHS [HS011886-03, KO2HS11285] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS011285, U18HS011886] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2005, NEW ENGL J MED, V353, P1405, DOI 10.1056/NEJMsb051157; BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P1697, DOI 10.1001/jama.270.14.1697; CHANDRA A, 2005, HLTH AFF MILLWOOD, pW5240; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Friedman CP, 2005, J GEN INTERN MED, V20, P334, DOI 10.1111/j.1525-1497.2005.30145.x; Gandhi TK, 2005, ANN INTERN MED, V142, P352, DOI 10.7326/0003-4819-142-5-200503010-00010; Graber M, 2002, ACAD MED, V77, P981, DOI 10.1097/00001888-200210000-00009; Haas JS, 2000, J GEN INTERN MED, V15, P321, DOI 10.1046/j.1525-1497.2000.08030.x; Joint Commission on Accreditation of Healthcare Organizations, NAT PAT SAF GOALS; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kern KA, 1997, ARCH SURG-CHICAGO, V132, P392; KERN KA, 1994, AM J SURG, V168, P217, DOI 10.1016/S0002-9610(05)80189-8; KOHN LT, 1999, ERR HUMAN BUILDING S; KRAVITZ RL, 1991, JAMA-J AM MED ASSOC, V266, P2087, DOI 10.1001/jama.266.15.2087; LaBine SJ, 1996, LAW HUMAN BEHAV, V20, P501, DOI 10.1007/BF01499038; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; MARCUS AC, 1992, MED CARE, V30, P216, DOI 10.1097/00005650-199203000-00004; Margo CE, 2003, QUAL SAF HEALTH CARE, V12, P416, DOI 10.1136/qhc.12.6.416; Phillips RL, 2004, QUAL SAF HEALTH CARE, V13, P121, DOI 10.1136/qshc.2003.008029; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Reason J., 1997, MANAGING RISK ORG AC; Schoen C, 2004, HEALTH AFFAIR, V23, pW4487, DOI 10.1377/hlthaff.W4.487; Sowka M., 1980, MALPRACTICE CLAIMS F; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002; STUDDERT DM, 2000, INDIANA LAW REV, V33, P1643; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Weiler PC, 1993, MEASURE MALPRACTICE	33	444	446	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					488	496		10.7326/0003-4819-145-7-200610030-00006	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015866				2022-12-28	WOS:000241093900002
J	Lamb, J; Crawford, ED; Peck, D; Modell, JW; Blat, IC; Wrobel, MJ; Lerner, J; Brunet, JP; Subramanian, A; Ross, KN; Reich, M; Hieronymus, H; Wei, G; Armstrong, SA; Haggarty, SJ; Clemons, PA; Wei, R; Carr, SA; Lander, ES; Golub, TR				Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.			The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER-CELLS; CELLULAR-DRUG RESISTANCE; ALZHEIMERS-DISEASE; IN-VITRO; CHAPERONE HEAT-SHOCK-PROTEIN-90; MICROARRAY ANALYSIS; INHIBITORS; TOXICITY; ESTROGEN	To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this "Connectivity Map'' resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02144 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	justin@broad.mit.edu; golub@broad.harvard.edu	Crawford, Emily/AAA-9674-2019; Crawford, Emily/AAP-9565-2020; Haggarty, Stephen J/M-9495-2016; Carr, Steven A./AAH-8366-2019	Crawford, Emily/0000-0003-4182-2337; Crawford, Emily/0000-0003-4182-2337; Haggarty, Stephen J/0000-0002-7872-168X; Reich, Michael/0000-0003-4735-5514				Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EDWARDS DP, 1980, ENDOCRINOLOGY, V107, P884, DOI 10.1210/endo-107-4-884; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Glaser KB, 2003, MOL CANCER THER, V2, P151; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Hennessy EJ, 2005, J ORG CHEM, V70, P7371, DOI 10.1021/jo051096o; HIERONYMUS H, IN PRESS CANC RES; Hollander M, 1999, NONPARAMETRIC STAT M, P178; Hongo T, 1997, BLOOD, V89, P2959, DOI 10.1182/blood.V89.8.2959; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Kubota T, 1998, CANCER RES, V58, P3344; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lopez IP, 2003, OBES RES, V11, P188, DOI 10.1038/oby.2003.30; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MYLARI BL, 1990, J MED CHEM, V33, P2019, DOI 10.1021/jm00169a035; Natsoulis G, 2005, GENOME RES, V15, P724, DOI 10.1101/gr.2807605; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDERHOEK JY, 1979, MOL PHARMACOL, V16, P171; WAKELING AE, 1991, CANCER RES, V51, P3867; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; WEI G, IN PRESS CANC CELL; Yao Q, 2003, CLIN CANCER RES, V9, P4483	41	3283	3413	24	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1929	1935		10.1126/science.1132939	http://dx.doi.org/10.1126/science.1132939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008526				2022-12-28	WOS:000240832200043
J	Lowenstein, TK; Demicco, RV				Lowenstein, Tim K.; Demicco, Robert V.			Elevated eocene atmospheric CO2 and its subsequent decline	SCIENCE			English	Article							CARBON-DIOXIDE CONCENTRATIONS		SUNY Binghamton, Dept Geol Sci & Environm Studies, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Lowenstein, TK (corresponding author), SUNY Binghamton, Dept Geol Sci & Environm Studies, Binghamton, NY 13902 USA.	lowenst@binghamton.edu						Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; EUGSTER HP, 1966, J GEOPHYS RES, V71, P3369, DOI 10.1029/JZ071i014p03369; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Yapp CJ, 2004, GEOCHIM COSMOCHIM AC, V68, P935, DOI 10.1016/j.gca.2003.09.002; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	8	118	135	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1928	1928		10.1126/science.1129555	http://dx.doi.org/10.1126/science.1129555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008525				2022-12-28	WOS:000240832200042
J	Majumdar, SR; McAlister, FA; T Enrich, D; Padwal, RS; Marrie, TJ				Majumdar, Sumit R.; McAlister, Finlay A.; T Enrich, Dean; Padwal, Raj S.; Marrie, Thomas J.			Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THERAPY; RISK; MORTALITY; TRIALS; SEPSIS	Objectives To determine whether statins reduce mortality or need for admission to intensive care in patients admitted to hospital with community acquired pneumonia, and to assess whether previously reported improvements in sepsis related outcomes were a result of the healthy user effect. Design Population based prospective cohort study. Setting Six hospitals in Capital Health, Edmonton, Alberta, Canada. Participants Adults admitted to hospital with pneumonia and categorised according to use of statins for at least one week before admission and during hospital stay. Main outcome measures Composite of in-hospital mortality or admission to an intensive care unit. Results Of 3415 patients with pneumonia admitted to hospital.. 624 (18%) died or were admitted to an intensive care unit. Statin users were less likely to die or be admitted to an intensive care unit than non-users (50/325 (15%) v 574/3090 (19%), odds ratio 0.80, P = 0.15). After more complete adjustment for confounding, however, the odds ratios changed from potential benefit (0.78, adjusted for age and sex) to potential harm (1.10, fully adjusted including propensity scores. 95% confidence interval 0.76 to 1.60). Conclusions Statins are not associated with reduced mortality or need for admission to an intensive care unit in patients with pneumonia; reports of benefit in the setting of sepsis may be a result of confounding.	Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2B7, Canada	University of Alberta	Majumdar, SR (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, 2E3-07 Walter Mackenzie Hlth Sci Ctr,8440-112th S, Edmonton, AB T6G 2B7, Canada.		McAlister, Finlay/C-4151-2013; Padwal, Raj/G-6903-2016	McAlister, Finlay/0000-0001-7435-3341; Padwal, Raj/0000-0003-3541-2817				Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Basi SK, 2004, AM J MED, V117, P305, DOI 10.1016/j.amjmed.2004.03.029; Col NF, 2003, ANN INTERN MED, V139, P923, DOI 10.7326/0003-4819-139-11-200312020-00011; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hosmer DW, 1989, APPL LOGISTIC REGRES, P140; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Marrie TJ, 2005, CHEST, V127, P1260, DOI 10.1378/chest.127.4.1260; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Petitti DB, 1998, JAMA-J AM MED ASSOC, V280, P650, DOI 10.1001/jama.280.7.650; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Thomsen RW, 2005, BRIT J CLIN PHARMACO, V60, P534, DOI 10.1111/j.1365-2125.2005.02494.x; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	30	205	214	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2006	333	7576					999	1001		10.1136/BMJ.38992.565972.7C	http://dx.doi.org/10.1136/BMJ.38992.565972.7C			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17060337	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000242229400016
J	Kral, JG				Kral, John G.			ABC of obesity - Management: Part III - Surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material								Although surgery can be-a potentially life extending treatment for obesity, most patients and doctors reject surgical intervention. Moreover, no national health budget or insurance can afford surgery on a very large scale. However, obesity surgery is a successful, validated, legitimate treatment and needs to be considered in some circumstances.	SUNY Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Kral, JG (corresponding author), SUNY Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA.							Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Kral JG, 2004, OBES RES, V12, P1539, DOI 10.1038/oby.2004.193; Livingston EH, 2005, SURG CLIN N AM, V85, P665; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 2006, OBESITY REV S2, V7, P27; Sugerman HJ, 2005, INT J OBESITY, V29, P735, DOI 10.1038/sj.ijo.0802930	6	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2006	333	7574					900	903		10.1136/bmj.333.7574.900	http://dx.doi.org/10.1136/bmj.333.7574.900			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	101WT	17068036	Green Published			2022-12-28	WOS:000241772600020
J	Anderson, R; Moore, T				Anderson, Ross; Moore, Tyler			The economics of information security	SCIENCE			English	Review							MARKET	The economics of information security has recently become a thriving and fast-moving discipline. As distributed systems are assembled from machines belonging to principals with divergent interests, we find that incentives are becoming as important as technical design in achieving dependability. The new field provides valuable insights not just into "security" topics ( such as bugs, spam, phishing, and law enforcement strategy) but into more general areas such as the design of peer-to-peer systems, the optimal balance of effort by programmers and testers, why privacy gets eroded, and the politics of digital rights management.	Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England	University of Cambridge	Anderson, R (corresponding author), Univ Cambridge, Comp Lab, 15 JJ Thomson Ave, Cambridge CB3 0FD, England.	ross.anderson@cl.cam.ac.uk						Acquisti A, 2005, MARKET SCI, V24, P367, DOI 10.1287/mksc.1040.0103; Acquisti A., 2006, 5 WORKSH EC INF SEC; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ANDERSON RJ, 1994, COMMUN ACM, V37, P32, DOI 10.1145/188280.188291; ANDERSON RJ, 2001, 17 ANN COMP SEC APPL; ARORA A, 2004, 3 WORKSH EC INF SEC; Bohme R, 2006, LECT NOTES COMPUT SC, V3995, P298; Bohme R., 2006, 5 WORKSH EC INF SEC; Campbell K., 2003, Journal of Computer Security, V11, P431; Danezis G, 2005, IEEE SECUR PRIV, V3, P45, DOI 10.1109/MSP.2005.29; DINGLEDINE R, 2006, 5 WORKSH EC INF SEC; EDELMAN B, 2006, 5 WORKSH EC INF SEC; Goodhart D., 2004, PROSPECT FEB; KANNAN K, 2004, 3 WORKSH EC INF SEC; KATZ ML, 1985, AM ECON REV, V75, P424; Kunreuther H, 2003, J RISK UNCERTAINTY, V26, P231, DOI 10.1023/A:1024119208153; MOORE T, 2005, 4 WORKSH EC INF SEC; NAGARAJA S, 2006, 5 WORKSH EC INF SEC; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Odlyzko A., 2003, P 5 INT C EL COMM, P355, DOI [10.1145/948005.948051, DOI 10.1145/948005.948051]; OGUT H, 2005, 4 WORKSH EC INF SEC; OZMENT A, 2006, 5 WORKSH EC INF SEC; OZMENT A, 2005, 4 WORKSH EC INF SEC; OZMENT A, 2006, 15 USENIX SEC S VANC; Ozment A., 2004, 3 WORKSH EC INF SEC; PIN management requirements, 2004, PIN MANAGEMENT REQUI; RESCORLA E, 2004, 3 WORKSH EC INF SEC; SCHECHTER SE, 2004, THESIS HARVARD U; Varian H, 2004, ADV INF SEC, V12, P1; VARIAN H, 2000, NY TIMES        0601; VARIAN H, 2005, 3 DIG RIGHTS MAN C B	32	314	321	5	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					610	613		10.1126/science.1130992	http://dx.doi.org/10.1126/science.1130992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098XT	17068253				2022-12-28	WOS:000241557800035
J	Butcher, J				Butcher, James			On reflection - Paul Allen 1, Bill Gates 0	LANCET			English	Editorial Material												james.butcher@lancet.com		Butcher, James/0000-0001-8546-6093					0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1413	1413		10.1016/S0140-6736(06)69591-3	http://dx.doi.org/10.1016/S0140-6736(06)69591-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055930				2022-12-28	WOS:000241459100014
J	Dar-Nimrod, I; Heine, SJ				Dar-Nimrod, Ilan; Heine, Steven J.			Exposure to scientific theories affects women's math performance	SCIENCE			English	Article							STEREOTYPE THREAT		Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Heine, SJ (corresponding author), Univ British Columbia, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	heine@psych.ubc.ca	Heine, Steven/C-6975-2011; Dar Nimrod, Ilan/C-9746-2011; Dar-Nimrod, Ilan/AAX-2441-2020	Dar-Nimrod, Ilan/0000-0003-2308-3673	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060155] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH60155-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Monterosso J, 2005, ETHICS BEHAV, V15, P139, DOI 10.1207/s15327019eb1502_4; Prentice DA, 2006, PSYCHOL SCI, V17, P129, DOI 10.1111/j.1467-9280.2006.01675.x; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; SUMMERS LH, 2005, NBER C DIV SCI ENG W	6	180	181	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					435	435		10.1126/science.1131100	http://dx.doi.org/10.1126/science.1131100			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	096MW	17053140				2022-12-28	WOS:000241382500032
J	Park, B; Lee, S; Kim, E; Cho, K; Riddell, SR; Cho, S; Ahn, K				Park, Boyoun; Lee, Sungwook; Kim, Eunkyung; Cho, Kwangmin; Riddell, Stanley R.; Cho, Sunglim; Ahn, Kwangseog			Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing	CELL			English	Article							PROTEIN DISULFIDE-ISOMERASE; TAP-TRANSLOCATED PEPTIDES; ENDOPLASMIC-RETICULUM; LOADING COMPLEX; OXIDOREDUCTASE ERP57; BOND FORMATION; HLA-DM; MOLECULES; OPTIMIZATION; DEGRADATION	Activated CD8(+) T cells discriminate infected and tumor cells from normal self by recognizing MHC class I-bound peptides on the surface of antigen-presenting cells. The mechanism by which MHC class I molecules select optimal peptides against a background of prevailing suboptimal peptides and in a considerably proteolytic ER environment remained unknown. Here, we identify protein disulfide isomerase (PDI), an enzyme critical to the formation of correct disulfide bonds in proteins, as a component of the peptide-loading complex. We show that PDI stabilizes a peptide-receptive site by regulating the oxidation state of the disulfide bond in the MHC peptide-binding groove, a function that is essential for selecting optimal peptides. Furthermore, we demonstrate that human cytomegalovirus US3 protein inhibits CD8(+) T cell recognition by mediating PDI degradation, verifying the functional relevance of PDI-catalyzed peptide editing in controlling intracellular pathogens. These results establish a link between thiol-based redox regulation and antigen processing.	Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Ctr Antigen Presentat, Seoul 151747, South Korea; Korea Univ, Coll Life Sci, Seoul 136701, South Korea; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Res Ctr Funct Cellulom, Seoul 151747, South Korea	Seoul National University (SNU); Korea University; Fred Hutchinson Cancer Center	Ahn, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Ctr Antigen Presentat, Seoul 151747, South Korea.	ksahn@snu.ac.kr	Lee, Sungwook/K-3697-2013	CHO, KWANGMIN/0000-0001-6764-1425				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Lehner PJ, 2003, IMMUNITY, V18, P315, DOI 10.1016/S1074-7613(03)00061-X; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Montoya M, 1999, J IMMUNOL, V163, P1914; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; PIMESKOSKI A, 2004, J BIOL CHEM, V279, P10374; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; WARBURTON RJ, 1994, HUM IMMUNOL, V39, P261, DOI 10.1016/0198-8859(94)90269-0; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	43	137	147	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					369	382		10.1016/j.cell.2006.08.041	http://dx.doi.org/10.1016/j.cell.2006.08.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055437	Bronze			2022-12-28	WOS:000241827100023
J	Striano, P; Zara, F; Minetti, C; Striano, S				Striano, Pasquale; Zara, Federico; Minetti, Carlo; Striano, Salvatore			Epileptic seizures can follow high doses of oral vardenafil	BRITISH MEDICAL JOURNAL			English	Article							NITRIC-OXIDE; SILDENAFIL; MICE		Univ Naples Federico II, Dept Neurol Sci, I-80131 Naples, Italy; Univ Genoa, Inst G Gaslini, Muscular & Neurodegenerat Dis Unit, Genoa, Italy	University of Naples Federico II; University of Genoa; IRCCS Istituto Giannina Gaslini	Striano, S (corresponding author), Univ Naples Federico II, Dept Neurol Sci, Via Pansini, I-80131 Naples, Italy.	sstriano@libero.it	Zara, Federico/U-3477-2017; Minetti, Carlo/K-4666-2018; Striano, Pasquale/F-9117-2014	Zara, Federico/0000-0001-9744-5222; Minetti, Carlo/0000-0002-0640-1804; Striano, Pasquale/0000-0002-6065-1476				Gilad R, 2002, BRIT MED J, V325, P869, DOI 10.1136/bmj.325.7369.869; Hatzichristou D, 2004, EUR UROL, V45, P634, DOI 10.1016/j.eururo.2004.01.014; Keating GM, 2003, DRUGS, V63, P2673, DOI 10.2165/00003495-200363230-00010; Koussa S, 2006, REV NEUROL-FRANCE, V162, P651, DOI 10.1016/S0035-3787(06)75062-7; Przegalinski E, 1996, NEUROSCI LETT, V217, P145, DOI 10.1016/S0304-3940(96)13085-8; Riazi K, 2006, BRIT J PHARMACOL, V147, P935, DOI 10.1038/sj.bjp.0706680	6	16	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 14	2006	333	7572					785	785		10.1136/sbmj.38953.758565.79	http://dx.doi.org/10.1136/sbmj.38953.758565.79			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038735	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000241566000015
J	Nakabachi, A; Yamashita, A; Toh, H; Ishikawa, H; Dunbar, HE; Moran, NA; Hattori, M				Nakabachi, Atsushi; Yamashita, Atsushi; Toh, Hidehiro; Ishikawa, Hajime; Dunbar, Helen E.; Moran, Nancy A.; Hattori, Masahira			The 160-kilobase genome of the bacterial endosymbiont Carsonella	SCIENCE			English	Article									RIKEN, Environm Mol Biol Lab, Wako, Saitama 3510198, Japan; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan; Kitasato Inst, Ctr Basic Res, Minato Ku, Tokyo 1088641, Japan; Univ Air, Sch Gen Educ, Chiba 2618586, Japan; Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; RIKEN, Genom Sci Ctr, Genome Core Technol Facil, Kanagawa 2300045, Japan	RIKEN; University of Arizona; Kitasato University; University of Tokyo; RIKEN	Nakabachi, A (corresponding author), RIKEN, Environm Mol Biol Lab, Wako, Saitama 3510198, Japan.	bachi@email.arizona.edu; hattori@k.u-tokyo.ac.jp	Puigbò, Pere/A-2214-2008; Nakabachi, Atsushi/H-1661-2011; Moran, Nancy A/G-1591-2010; Hattori, Masahira/AAD-3785-2019	Nakabachi, Atsushi/0000-0003-0281-1723; 					0	380	430	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					267	267		10.1126/science.1134196	http://dx.doi.org/10.1126/science.1134196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038615				2022-12-28	WOS:000241194100032
J	Stengel, M; Spaldin, NA				Stengel, Massimiliano; Spaldin, Nicola A.			Origin of the dielectric dead layer in nanoscale capacitors	NATURE			English	Article							THIN-FILMS; THICKNESS; CONSTANT; SIZE; FERROELECTRICITY	Capacitors are a mainstay of electronic integrated circuits and devices, where they perform essential functions such as storing electrical charge, and blocking direct current while allowing alternating currents to propagate. Because they are often the largest components in circuits, extensive efforts are directed at reducing their size through the use of high-permittivity insulators such as perovskite-structure SrTiO3 (refs 1, 2), which should provide more capacitance per unit area of device. Unfortunately, most experiments on thin-film SrTiO3 capacitors have yielded capacitance values that are orders of magnitude smaller than expected(3). The microscopic origin of this reduced capacitance, which is often discussed in terms of a low-permittivity interfacial 'dead layer'(4), is not well understood. Whether such a dead layer exists at all, and if so, whether it is an intrinsic property of an ideal metal-insulator interface or a result of processing issues such as defects and strains, are controversial questions. Here we present fully ab initio calculations of the dielectric properties of realistic SrRuO3/SrTiO3/SrRuO3 nanocapacitors, and show that the observed dramatic capacitance reduction is indeed an intrinsic effect. We demonstrate the existence of a dielectric dead layer by calculating the dielectric profile across the interface and analyse its origin by extracting the ionic and electronic contributions to the electrostatic screening. We establish a correspondence between the dead layer and the hardening of the collective SrTiO3 zone-centre polar modes, and determine the influence of the electrode by repeating our calculations for Pt/SrTiO3/Pt capacitors. Our results provide practical guidelines for minimizing the deleterious effects of the dielectric dead layer in nanoscale devices.	Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Stengel, M (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	stengel@mrl.ucsb.edu	Spaldin, Nicola A/A-1017-2010; Stengel, Massimiliano/E-2934-2010	Spaldin, Nicola A/0000-0003-0709-9499; Stengel, Massimiliano/0000-0003-4175-3888				Antons A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024102; BALDERESCHI A, 1988, PHYS REV LETT, V61, P734, DOI 10.1103/PhysRevLett.61.734; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Black CT, 1999, IEEE T ELECTRON DEV, V46, P776, DOI 10.1109/16.753713; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Dawber M, 2002, JPN J APPL PHYS 1, V41, P6848, DOI 10.1143/JJAP.41.6848; Finnis MW, 1996, J PHYS-CONDENS MAT, V8, P5811, DOI 10.1088/0953-8984/8/32/003; Gerra G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107603; Ghosez P., 2006, HDB THEORETICAL COMP; Giustino F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.144104; Hwang CS, 2002, J APPL PHYS, V92, P432, DOI 10.1063/1.1483105; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Junquera J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155327; Kim DJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237602; MEAD CA, 1961, PHYS REV LETT, V6, P545, DOI 10.1103/PhysRevLett.6.545; Nagaraj B, 1999, APPL PHYS LETT, V74, P3194, DOI 10.1063/1.124104; Natori K, 1998, APPL PHYS LETT, V73, P632, DOI 10.1063/1.121930; Plonka R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931063; Saad MM, 2004, J PHYS-CONDENS MAT, V16, pL451, DOI 10.1088/0953-8984/16/41/L04; Sai N, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.020101; Scott JF, 1998, ANNU REV MATER SCI, V28, P79, DOI 10.1146/annurev.matsci.28.1.79; Sinnamon LJ, 2002, APPL PHYS LETT, V81, P703, DOI 10.1063/1.1494837; Sinnamon LJ, 2001, APPL PHYS LETT, V78, P1724, DOI 10.1063/1.1356731; Sirenko AA, 2000, NATURE, V404, P373, DOI 10.1038/35006023; Spaldin NA, 2004, SCIENCE, V304, P1606, DOI 10.1126/science.1099822; STENGEL M, 2005, ARXIVORGCONDMAT05110; Vendik OG, 1998, APPL PHYS LETT, V73, P37, DOI 10.1063/1.121715; Zhou C, 1997, J APPL PHYS, V82, P3081, DOI 10.1063/1.366147	29	430	435	9	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					679	682		10.1038/nature05148	http://dx.doi.org/10.1038/nature05148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036000				2022-12-28	WOS:000241160500043
J	Horton, R				Horton, Richard			The next Director-General of WHO	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							Horton R, 2006, LANCET, V367, P1793, DOI 10.1016/S0140-6736(06)68779-5	1	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1213	1214		10.1016/S0140-6736(06)69496-8	http://dx.doi.org/10.1016/S0140-6736(06)69496-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027707				2022-12-28	WOS:000241058300004
J	Lin, PW; Stoll, BJ				Lin, Patricia W.; Stoll, Barbara J.			Necrotising enterocolitis	LANCET			English	Review							BIRTH-WEIGHT INFANTS; NECROSIS-FACTOR-ALPHA; PORTAL VENOUS GAS; NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; NEONATAL RESEARCH NETWORK; DUODENAL MOTOR-RESPONSES; CRITICALLY-ILL INFANTS; DONOR HUMAN-MILK; INNATE IMMUNITY	Necrotising enterocolitis is one of the most common gastrointestinal emergencies in newborn infants. Here we review the epidemiology, clinical presentation, and pathophysiology of the disease, as well as strategies for diagnosis, management, and prevention. Necrotising enterocolitis is one of the most devastating and unpredictable diseases affecting premature infants. Despite decades of research, its pathogenesis remains unclear; diagnosis can be difficult; and treatment is challenging. We will need to improve our understanding of intestinal defences in premature infants, dietary and bacterial factors, and genetic effects that could predispose infants to necrotising enterocolitis before we can develop new strategies for prevention and treatment.	Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA	Emory University	Lin, PW (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA.	patricia_lin@oz.ped.emory.edu	lin, patricia/GYJ-2688-2022; Denning, Patricia W/G-4485-2011					Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adesanya Olubukunola A, 2005, J Perinatol, V25, P583, DOI 10.1038/sj.jp.7211360; Ahrens P, 2004, PEDIATR RES, V55, P652, DOI 10.1203/01.PDR.0000112100.61253.85; Akisu M, 2002, BIOL NEONATE, V81, P260, DOI 10.1159/000056757; AlTawil Y, 1996, J PEDIATR-US, V129, P374, DOI 10.1016/S0022-3476(96)70069-0; Amin HJ, 2002, J PEDIATR-US, V140, P425, DOI 10.1067/mpd.2002.123289; ANDREWS DA, 1990, AM J SURG, V159, P507, DOI 10.1016/S0002-9610(05)81257-7; Avivi-Green C, 2000, ONCOL RES, V12, P83, DOI 10.3727/096504001108747558; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bartholome AL, 2004, JPEN-PARENTER ENTER, V28, P210, DOI 10.1177/0148607104028004210; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; BELL MJ, 1978, NEW ENGL J MED, V298, P281; BERSETH CL, 1992, PEDIATRICS, V90, P669; BERSETH CL, 1990, J PEDIATR-US, V117, P777, DOI 10.1016/S0022-3476(05)83343-8; Berseth CL, 2005, CURR OPIN PEDIATR, V17, P170, DOI 10.1097/01.mop.0000150566.50580.26; BERSETH CL, 1989, J PEDIATR-US, V115, P646, DOI 10.1016/S0022-3476(89)80302-6; BERSETH CL, 1992, J PEDIATR GASTR NUTR, V14, P182, DOI 10.1097/00005176-199202000-00011; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Boccia D, 2001, EUR J PEDIATR, V160, P385, DOI 10.1007/s004310100749; Bolisetty S, 2000, ACTA PAEDIATR, V89, P1226, DOI 10.1080/080352500750027619; BOMELBURG T, 1992, EUR J RADIOL, V15, P149, DOI 10.1016/0720-048X(92)90143-W; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Buonomo C, 1999, RADIOL CLIN N AM, V37, P1187, DOI 10.1016/S0033-8389(05)70256-6; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; Chen HQ, 2006, PEPTIDES, V27, P931, DOI 10.1016/j.peptides.2005.08.018; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHUN K, 1992, J PEDIATR SURG, V27, P322, DOI 10.1016/0022-3468(92)90855-2; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Collier-Hyams LS, 2005, J IMMUNOL, V175, P4194, DOI 10.4049/jimmunol.175.7.4194; Collier-Hyams LS, 2005, CELL MOL LIFE SCI, V62, P1339, DOI 10.1007/s00018-005-5038-y; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; COVERT RF, 1989, AM J PERINAT, V6, P455, DOI 10.1055/s-2007-999639; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; DECURTIS M, 1987, EUR J PEDIATR, V146, P398, DOI 10.1007/BF00444947; DILORENZO M, 1995, J PEDIATR SURG, V30, P1138, DOI 10.1016/0022-3468(95)90006-3; DILORENZO M, 1995, J PEDIATR SURG, V30, P235, DOI 10.1016/0022-3468(95)90567-7; Dimmitt RA, 2000, J PEDIATR SURG, V35, P856, DOI 10.1053/jpsu.2000.6865; Eckmann L, 2005, CURR OPIN GASTROEN, V21, P147, DOI 10.1097/01.mog.0000153311.97832.8c; Eckmann L, 2004, CURR OPIN GASTROEN, V20, P82, DOI 10.1097/00001574-200403000-00006; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; EGAN EA, 1977, J PEDIATR-US, V90, P331, DOI 10.1016/S0022-3476(77)80683-5; Ehrlich PF, 2001, AM SURGEON, V67, P752; EIBL MM, 1988, NEW ENGL J MED, V319, P1, DOI 10.1056/NEJM198807073190101; Faingold R, 2005, RADIOLOGY, V235, P587, DOI 10.1148/radiol.2352031718; Fanaro S, 2005, ACTA PAEDIATR, V94, P22, DOI 10.1080/08035320510043538; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Foster J, 2004, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD001816.pub2, DOI 10.1002/14651858.CD001816.PUB2]; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GERBER AR, 1985, PEDIATR INFECT DIS J, V4, P246, DOI 10.1097/00006454-198505000-00008; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GOSCHE JR, 1993, AM J PHYSIOL, V264, pG447, DOI 10.1152/ajpgi.1993.264.3.G447; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hall NJ, 2005, ARCH SURG-CHICAGO, V140, P1149, DOI 10.1001/archsurg.140.12.1149; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Henry Marion C W, 2005, Semin Pediatr Surg, V14, P181, DOI 10.1053/j.sempedsurg.2005.05.007; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; HOLMAN RC, IN PRESS PAEDIAT PER; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HORWITZ JR, 1995, J PEDIATR SURG, V30, P994, DOI 10.1016/0022-3468(95)90328-3; Hoy CM, 2000, J CLIN MICROBIOL, V38, P4539, DOI 10.1128/JCM.38.12.4539-4547.2000; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; HUTTER JJ, 1976, J PEDIATR-US, V88, P1026, DOI 10.1016/S0022-3476(76)81069-4; ITTMANN PI, 1992, DIGEST DIS SCI, V37, P14, DOI 10.1007/BF01308336; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; JOHNSON JF, 1988, PEDIATR RADIOL, V19, P25, DOI 10.1007/BF02388403; Kanauchi O, 1999, J GASTROEN HEPATOL, V14, P1173, DOI 10.1046/j.1440-1746.1999.02025.x; KANTO WP, 1994, CLIN PERINATOL, V21, P335, DOI 10.1016/S0095-5108(18)30349-X; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim WY, 2005, PEDIATR RADIOL, V35, P1056, DOI 10.1007/s00247-005-1533-4; KIRKS DR, 1974, AM J ROENTGENOL, V122, P153, DOI 10.2214/ajr.122.1.153; KLIEGMAN RM, 1990, J PEDIATR-US, V117, pS2, DOI 10.1016/S0022-3476(05)81123-0; Kliegman RM, 2005, PEDIATRICS, V115, P171, DOI 10.1542/peds.2004-2271; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; KOSLOSKE AM, 1994, J PEDIATR SURG, V29, P663, DOI 10.1016/0022-3468(94)90736-6; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lebenthal A, 1999, JPEN-PARENTER ENTER, V23, pS3, DOI 10.1177/014860719902300502; Ledbetter DJ, 2000, J PEDIATR SURG, V35, P178, DOI 10.1016/S0022-3468(00)90006-X; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lencer WI, 1997, P NATL ACAD SCI USA, V94, P8585, DOI 10.1073/pnas.94.16.8585; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin J, 2004, MED HYPOTHESES, V62, P291, DOI 10.1016/S0306-9877(03)00333-5; Lin PW, 2004, J BIOL CHEM, V279, P19902, DOI 10.1074/jbc.M311821200; Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304; Llanos AR, 2002, PAEDIATR PERINAT EP, V16, P342, DOI 10.1046/j.1365-3016.2002.00445.x; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Luig M, 2005, J PAEDIATR CHILD H, V41, P169, DOI 10.1111/j.1440-1754.2005.00582.x; Maayan-Metzger Ayala, 2004, J Perinatol, V24, P494, DOI 10.1038/sj.jp.7211135; MADARA JL, 1990, AM J PATHOL, V137, P1273; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Mallow EB, 1996, J BIOL CHEM, V271, P4038; McClure RJ, 2001, ACTA PAEDIATR, V90, P19, DOI 10.1080/08035250151085313; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; McElhinney DB, 2000, PEDIATRICS, V106, P1080, DOI 10.1542/peds.106.5.1080; McGuire W, 2003, ARCH DIS CHILD-FETAL, V88, P11; Mentschel J, 2003, METABOLISM, V52, P1400, DOI 10.1016/S0026-0495(03)00318-4; Merlin D, 2001, AM J PHYSIOL-CELL PH, V280, pC296, DOI 10.1152/ajpcell.2001.280.2.C296; MERRITT CRB, 1984, AM J ROENTGENOL, V143, P1059, DOI 10.2214/ajr.143.5.1059; MILLER MJS, 1990, DIGEST DIS SCI, V35, P1257, DOI 10.1007/BF01536416; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Neish AS, 2004, IMMUNOL RES, V29, P175, DOI 10.1385/IR:29:1-3:175; Neish AS, 2004, INFLAMM BOWEL DIS, V10, P159, DOI 10.1097/00054725-200403000-00015; Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Neu J, 2005, BIOL NEONATE, V87, P97, DOI 10.1159/000081898; Newell SJ, 2000, CLIN PERINATOL, V27, P221, DOI 10.1016/S0095-5108(05)70015-4; Ng S, 2001, J PAEDIATR CHILD H, V37, P1, DOI 10.1046/j.1440-1754.2001.00584.x; NOWICKI PT, 1994, CLIN PERINATOL, V21, P219, DOI 10.1016/S0095-5108(18)30342-7; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ostlie DJ, 2003, J PEDIATR SURG, V38, P1039, DOI 10.1016/S0022-3468(03)00187-8; Otte JM, 2003, J GASTROENTEROL, V38, P717, DOI 10.1007/s00535-003-1136-5; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; Ouwehand AC, 2005, CURR OPIN BIOTECH, V16, P212, DOI 10.1016/j.copbio.2005.01.007; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Patole S, 2005, J MATERN-FETAL NEO M, V18, P67, DOI 10.1080/14767050500127724; Petty John K, 2005, Semin Pediatr Surg, V14, P191, DOI 10.1053/j.sempedsurg.2005.05.009; PIAZZA AJ, IN PRESS NELSONS TXB; POLAKCHARCON S, 1980, J NATL CANCER I, V65, P53; Potoka DA, 2002, WORLD J SURG, V26, P806, DOI 10.1007/s00268-002-4056-2; Pourcyrous M, 2005, PEDIATRICS, V116, P1064, DOI 10.1542/peds.2004-1806; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reber KM, 2002, CLIN PERINATOL, V29, P23, DOI 10.1016/S0095-5108(03)00063-0; Rumbo M, 2005, CELL MOL LIFE SCI, V62, P1288, DOI 10.1007/s00018-005-5033-3; Salhab Walid A, 2004, J Perinatol, V24, P534, DOI 10.1038/sj.jp.7211165; Salzman NH, 1998, PEDIATR RES, V44, P20, DOI 10.1203/00006450-199807000-00003; Sankaran K, 2004, J PEDIATR GASTR NUTR, V39, P366, DOI 10.1097/00005176-200410000-00012; Sase M, 2005, AM J OBSTET GYNECOL, V193, P1000, DOI 10.1016/j.ajog.2005.05.044; Sase M, 2005, J MATERN-FETAL NEO M, V17, P213, DOI 10.1080/14767050500073340; Sase M, 2001, J SURG RES, V99, P347, DOI 10.1006/jsre.2001.6189; Sase M, 2001, J SURG RES, V101, P68, DOI 10.1006/jsre.2001.6254; Schanler RJ, 2005, PEDIATRICS, V116, P400, DOI 10.1542/peds.2004-1974; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Seitz G, 2005, J PEDIATR SURG, V40, P1440, DOI 10.1016/j.jpedsurg.2005.05.043; SHAH P, 2004, COCHRANE DB SYST REV, V4; Sharma R, 2005, J PEDIATR SURG, V40, P371, DOI 10.1016/j.jpedsurg.2004.10.022; Siu YK, 1998, ARCH DIS CHILD-FETAL, V79, pF105, DOI 10.1136/fn.79.2.F105; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; STOLL BJ, 1980, J PEDIATR-US, V96, P447; STOLL BJ, 1994, CLIN PERINATOL, V21, P205, DOI 10.1016/S0095-5108(18)30341-5; Stoll BJ, 1996, J PEDIATR-US, V129, P72, DOI 10.1016/S0022-3476(96)70192-0; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; Treszl A, 2003, J PEDIATR SURG, V38, P1374, DOI 10.1016/S0022-3468(03)00399-3; Treszl A, 2001, ACTA PAEDIATR, V90, P1182, DOI 10.1080/080352501317061611; Tsukahara T, 2003, J NUTR SCI VITAMINOL, V49, P414, DOI 10.3177/jnsv.49.414; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; Venkatraman A, 2003, AM J PHYSIOL-GASTR L, V285, pG177, DOI 10.1152/ajpgi.00307.2002; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wallace TD, 2003, J FOOD PROTECT, V66, P466, DOI 10.4315/0362-028X-66.3.466; WILSON R, 1982, PEDIATR RES, V16, P82; WILSON R, 1983, PEDIATRICS, V71, P19; WISWELL TE, 1988, AM J DIS CHILD, V142, P532, DOI 10.1001/archpedi.1988.02150050070034; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Young AN, 2003, AM J SURG PATHOL, V27, P199, DOI 10.1097/00000478-200302000-00008; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zouali H, 2005, DIGEST DIS SCI, V50, P1684, DOI 10.1007/s10620-005-2915-z	181	629	670	1	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1271	1283		10.1016/S0140-6736(06)69525-1	http://dx.doi.org/10.1016/S0140-6736(06)69525-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027734				2022-12-28	WOS:000241058300035
J	Nandakumar, J; Shuman, S; Lima, CD				Nandakumar, Jayakrishnan; Shuman, Stewart; Lima, Christopher D.			RNA ligase structures reveal the basis for RNA specificity and conformational changes that drive ligation forward	CELL			English	Article							DNA-LIGASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; MUTATIONAL ANALYSIS; MECHANISM; NICK; ASSOCIATION; ENZYME	T4 RNA ligase 2 (Rnl2) and kinetoplastid RNA editing ligases exemplify a family of RNA repair enzymes that seal 3'OH/5'PO4 nicks in duplex RNAs via ligase adenylylation (step 1), AMP transfer to the nick 5'PO4 (step 2), and attack by the nick 3'OH on the 5'-adenylylated strand to form a phosphodiester (step 3). Crystal structures are reported for Rnl2 at discrete steps along this pathway: the covalent Rnl2-AMP intermediate; Rnl2 bound to an adenylylated nicked duplex, captured immediately following step 2; and Rnl2 at an adenylylated nick in a state poised for step 3. These structures illuminate the stereochemistry of nucleotidyl transfer and reveal how remodeling of active-site contacts and conformational changes propel the ligation reaction forward. Mutational analysis and comparison of nick-bound structures of Rnl2 and human DNA ligase I highlight common and divergent themes of substrate recognition that can explain their specialization for RNA versus DNA repair.	Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Sloan Kettering Inst, Training Program Chem Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nandakumar, J (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA.	limac@mskcc.edu		Nandakumar, Jayakrishnan/0000-0001-9146-2785; Lima, Christopher/0000-0002-9163-6092	NCRR NIH HHS [RR-15301] Funding Source: Medline; NIGMS NIH HHS [GM63611, GM61906] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611, R01GM061906] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc V, 1999, J BIOL CHEM, V274, P24289, DOI 10.1074/jbc.274.34.24289; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUPTA G, 1985, J MOL BIOL, V186, P463, DOI 10.1016/0022-2836(85)90118-4; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEHMAN IR, 1974, SCIENCE, V186, P790; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MODRICH P, 1972, J BIOL CHEM, V247, P6370; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nandakumar J, 2005, J BIOL CHEM, V280, P23484, DOI 10.1074/jbc.M500831200; Nandakumar J, 2004, MOL CELL, V16, P211, DOI 10.1016/j.molcel.2004.09.022; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo SS, 2003, MOL BIOCHEM PARASIT, V127, P161, DOI 10.1016/S0166-6851(02)00333-X; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SILBER R, 1972, P NATL ACAD SCI USA, V69, P3009, DOI 10.1073/pnas.69.10.3009; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Uhlenbeck O.C., 1982, ENZYMES, V15, P31, DOI [10.1016/s1874-6047(08)60274-7, DOI 10.1016/S1874-6047(08)60274-7]; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; YANG SW, 1992, J BIOL CHEM, V267, P8117; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200	47	68	70	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					71	84		10.1016/j.cell.2006.08.038	http://dx.doi.org/10.1016/j.cell.2006.08.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018278	Bronze			2022-12-28	WOS:000241445800015
J	Rothenfluh, A; Threlkeld, RJ; Bainton, RJ; Tsai, LTY; Lasek, AW; Heberlein, U				Rothenfluh, Adrian; Threlkeld, Robert J.; Bainton, Roland J.; Tsai, Linus T. -Y.; Lasek, Amy W.; Heberlein, Ulrike			Distinct behavioral responses to ethanol are regulated by alternate RhoGAP18B lsoforms	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; RHO-GTPASES; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; NERVOUS-SYSTEM; NEUROPEPTIDE-Y; KNOCKOUT MICE; P190 RHOGAP; ALCOHOLISM; RECEPTOR	In most organisms, low ethanol doses induce increased activity, while high doses are sedating. To investigate the underlying mechanisms, we isolated Drosophila mutants with altered ethanol responsiveness. Mutations in white rabbit (whir), disrupting RhoGAP18B, are strongly resistant to the sedating effects of ethanol. This resistance can be suppressed by reducing the levels of Rho1 or Rac, implicating these GTPases in the behavioral response to ethanol. Indeed, expression of constitutively active forms of Rho1 or Rac1 in adult flies results in ethanol resistance similar to that observed in whir mutants. The whir locus produces several transcripts, RA-RD, which are predicted to encode three distinct RhoGAPs that share only the GAP domain. The RC transcript mediates the sedating effects of ethanol, while the RA transcript regulates its stimulant effects. Thus, distinct RhoGAPs, encoded by the same gene, regulate different manifestations of acute ethanol intoxication.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Rothenfluh, A (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	adrian.rothenfluh@ucsf.edu; ulrike.heberlein@ucsf.edu	Lasek, Amy/AAV-7606-2020	Lasek, Amy/0000-0002-7099-2442; Tsai, Linus/0000-0002-0134-6949; Rothenfluh, Adrian/0000-0002-3813-5723	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, R01AA013105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014809] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA10035, AA13105] Funding Source: Medline; NIDA NIH HHS [DA14809] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Enoch MA, 1999, PSYCHIAT CLIN N AM, V22, P289, DOI 10.1016/S0193-953X(05)70077-0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Humeau Y, 2002, J NEUROSCI, V22, P7968; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Parr J, 2001, J NEUROSCI METH, V107, P93, DOI 10.1016/S0165-0270(01)00357-0; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schuckit MA, 2000, AM J ADDICTION, V9, P103, DOI 10.1080/10550490050173172; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Scott EK, 2003, J NEUROSCI, V23, P3118; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Thiele TE, 2004, NEUROPEPTIDES, V38, P235, DOI 10.1016/j.npep.2004.04.005; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wolf FW, 2002, J NEUROSCI, V22, P11035	60	97	97	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					199	211		10.1016/j.cell.2006.09.010	http://dx.doi.org/10.1016/j.cell.2006.09.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018286	Bronze			2022-12-28	WOS:000241445800024
J	Sordella, R; Van Aelst, L				Sordella, Raffaella; Van Aelst, Linda			Driving actin dynamics under the influence of alcohol	CELL			English	Editorial Material								The actin cytoskeleton plays a pivotal role in regulating neuronal development and activity, and dysregulation of actin dynamics has been linked to impaired cognitive function. In this issue of Cell, Rothenfluh et al. (2006) and Offenhauser et al. (2006) show that actin dynamics can also affect the cellular and behavioral responses of flies and mice to alcohol.	Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Massachusetts General Hospital; Harvard University; Cold Spring Harbor Laboratory	Sordella, R (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, 13th St, Charlestown, MA 02129 USA.	vanaelst@cshl.edu						Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Dick Danielle M, 2006, Curr Psychiatry Rep, V8, P151, DOI 10.1007/s11920-006-0015-1; Enoch MA, 1999, PSYCHIAT CLIN N AM, V22, P289, DOI 10.1016/S0193-953X(05)70077-0; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Wernicke C, 2003, BIOL PSYCHIAT, V54, P922, DOI 10.1016/S0006-3223(03)00072-6	7	11	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					37	39		10.1016/j.cell.2006.09.017	http://dx.doi.org/10.1016/j.cell.2006.09.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018272	Bronze			2022-12-28	WOS:000241445800009
J	Paton, AW; Beddoe, T; Thorpe, CM; Whisstock, JC; Wilce, MCJ; Rossjohn, J; Talbot, UM; Paton, JC				Paton, Adrienne W.; Beddoe, Travis; Thorpe, Cheleste M.; Whisstock, James C.; Wilce, Matthew C. J.; Rossjohn, Jamie; Talbot, Ursula M.; Paton, James C.			AB(5) subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP	NATURE			English	Article							TOXIGENIC ESCHERICHIA-COLI; CELL-DEATH PROGRAM; ER CHAPERONE; SHIGA TOXIN; STRESS; PROTEINS; REGULATOR; STRAINS; FAMILY	AB(5) toxins are produced by pathogenic bacteria and consist of enzymatic A subunits that corrupt essential eukaryotic cell functions, and pentameric B subunits that mediate uptake into the target cell. AB(5) toxins include the Shiga, cholera and pertussis toxins and a recently discovered fourth family, subtilase cytotoxin, which is produced by certain Shiga toxigenic strains of Escherichia coli. Here we show that the extreme cytotoxicity of this toxin for eukaryotic cells is due to a specific single-site cleavage of the essential endoplasmic reticulum chaperone BiP/GRP78. The A subunit is a subtilase-like serine protease; structural studies revealed an unusually deep active-site cleft, which accounts for its exquisite substrate specificity. A single amino-acid substitution in the BiP target site prevented cleavage, and coexpression of this resistant protein protected transfected cells against the toxin. BiP is a master regulator of endoplasmic reticulum function, and its cleavage by subtilase cytotoxin represents a previously unknown trigger for cell death.	Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; Monash Univ, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	University of Adelaide; Monash University; Monash University; Tufts Medical Center; Tufts University	Paton, AW (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	adrienne.paton@adelaide.edu.au; james.paton@adelaide.edu.au	Beddoe, Travis/F-3415-2014; Paton, James C/A-9920-2008; Rossjohn, Jamie/F-9032-2013	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Whisstock, James/0000-0003-4200-5611				Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; KOZUTSUMI Y, 1989, J CELL SCI, P115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Maniatis T., 1982, MOL CLONING; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	24	284	287	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					548	552		10.1038/nature05124	http://dx.doi.org/10.1038/nature05124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024087				2022-12-28	WOS:000240988200037
J	Solomon, JH; Hartmann, MJ				Solomon, Joseph H.; Hartmann, Mitra J.			Robotic whiskers used to sense features	NATURE			English	Article							CONTACT		Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Solomon, JH (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	m-hartmann@northwestern.edu	Hartmann, Mitra/B-6766-2009; Hartmann, Mitra/A-8150-2008					Clements TN, 2006, IEEE T ROBOT, V22, P844, DOI 10.1109/TRO.2006.878950; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Kaneko M, 1998, IEEE T ROBOTIC AUTOM, V14, P278, DOI 10.1109/70.681246; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Neimark MA, 2003, J NEUROSCI, V23, P6499; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005	7	106	112	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					525	525		10.1038/443525a	http://dx.doi.org/10.1038/443525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024083	Bronze			2022-12-28	WOS:000240988200032
J	Corrado, D; Basso, C; Pavei, A; Michieli, P; Schiavon, M; Thiene, G				Corrado, Domenico; Basso, Cristina; Pavei, Andrea; Michieli, Pierantonio; Schiavon, Maurizio; Thiene, Gaetano			Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	78th Annual Scientific Session of the American-Heart-Association	NOV 13-16, 2005	Dallas, TX	Amer Heart Assoc			RIGHT-VENTRICULAR CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC DEATH; OF-CARDIOLOGY; HIGH-SCHOOL; ADULTS; HEART; DISEASE; PEOPLE; ABNORMALITIES	Context A nationwide systematic preparticipation athletic screening was introduced in Italy in 1982. The impact of such a program on prevention of sudden cardiovascular death in the athlete remains to be determined. Objective To analyze trends in incidence rates and cardiovascular causes of sudden death in young competitive athletes in relation to preparticipation screening. Design, Setting, and Participants A population-based study of trends in sudden cardiovascular death in athletic and nonathletic populations aged 12 to 35 years in the Veneto region of Italy between 1979 and 2004. A parallel study examined trends in cardiovascular causes of disqualification from competitive sports in 42 386 athletes undergoing preparticipation screening at the Center for Sports Medicine in Padua ( 22 312 in the early screening period [1982-1992] and 20 074 in the late screening period [1993-2004]). Main Outcome Measures Incidence trends of total cardiovascular and cause-specific sudden death in screened athletes and unscreened nonathletes of the same age range over a 26-year period. Results During the study period, 55 sudden cardiovascular deaths occurred in screened athletes (1.9 deaths/100 000 person-years) and 265 sudden deaths in unscreened nonathletes (0.79 deaths/100 000 person-years). The annual incidence of sudden cardiovascular death in athletes decreased by 89% ( from 3.6/100 000 person-years in 19791980 to 0.4/100 000 person-years in 2003-2004; P for trend <. 001), whereas the incidence of sudden death among the unscreened nonathletic population did not change significantly. The mortality decline started after mandatory screening was implemented and persisted to the late screening period. Compared with the prescreening period ( 19791981), the relative risk of sudden cardiovascular death in athletes was 0.56 in the early screening period (95% CI, 0.29-1.15; P=. 04) and 0.21 in the late screening period ( 95% CI, 0.09-0.48; P=. 001). Most of the reduced mortality was due to fewer cases of sudden death from cardiomyopathies ( from 1.50/100 000 person-years in the prescreening period to 0.15/100 000 person-years in the late screening period; P for trend=.002). During the study period, 879 athletes (2.0%) were disqualified from competition due to cardiovascular causes at the Center for Sports Medicine: 455 ( 2.0%) in the early screening period and 424 (2.1%) in the late screening period. The proportion of athletes who were disqualified for cardiomyopathies increased from 20 (4.4%) of 455 in the early screening period to 40 (9.4%) of 424 in the late screening period ( P=. 005). Conclusions The incidence of sudden cardiovascular death in young competitive athletes has substantially declined in the Veneto region of Italy since the introduction of a nationwide systematic screening. Mortality reduction was predominantly due to a lower incidence of sudden death from cardiomyopathies that paralleled the increasing identification of athletes with cardiomyopathies at preparticipation screening.	Univ Padua, Sch Med, Inst Pathol Anat, I-35121 Padua, Italy; Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, I-35121 Padua, Italy; Ctr Sports Med & Phys Act, Padua, Italy	University of Padua; University of Padua	Thiene, G (corresponding author), Univ Padua, Sch Med, Inst Pathol Anat, Via A Gabelli 61, I-35121 Padua, Italy.	gaetano.thiene@unipd.it	Schiavon, Maurizio/AAU-9558-2021; Fahimifar, Sepideh/M-5303-2019	basso, cristina/0000-0002-0195-9753; CORRADO, DOMENICO/0000-0003-1487-0392				[Anonymous], 1994, J Am Coll Cardiol, V24, P845; BASSO C, 1995, HUM PATHOL, V26, P1065, DOI 10.1016/0046-8177(95)90267-8; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; Basso C, 2001, CIRCULATION, V103, P269; Basso C, 2001, CARDIOVASC RES, V50, P290, DOI 10.1016/S0008-6363(01)00261-9; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Comitato Organizzativo Cardiologico per l'Idoneita Allo Sport (COCIS), 1989, G ITAL CARDIOL, V19, P250; Corrado D, 2005, LANCET, V366, pS47, DOI 10.1016/S0140-6736(05)67847-6; CORRADO D, 1994, CIRCULATION, V90, P2315, DOI 10.1161/01.CIR.90.5.2315; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; CORRADO D, 1992, BRIT HEART J, V68, P601; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Corrado D, 2001, CIRCULATION, V103, P710; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; MARON BJ, 1985, J AM COLL CARDIOL, V6, P1189; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; Nistri S, 2003, AM J CARDIOL, V91, P1021, DOI 10.1016/S0002-9149(03)00132-2; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Selvin S, 1995, PRACTICAL BIOSTATIST, P455; TEARE D, 1958, BRIT HEART J, V20, P1; THIENE G, 1983, HUM PATHOL, V14, P704, DOI 10.1016/S0046-8177(83)80143-9; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; 1982, GAZZETTA UFFICI 0305, P63; 1971, GAZZETTA UFFICI 1223, P8162	40	994	1038	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1593	1601		10.1001/jama.296.13.1593	http://dx.doi.org/10.1001/jama.296.13.1593			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	090JS	17018804	Bronze			2022-12-28	WOS:000240948200019
J	Starrs, AM				Starrs, Ann M.			Safe motherhood initiative: 20 years and counting	LANCET			English	Editorial Material									Family Care Int, New York, NY 10012 USA		Starrs, AM (corresponding author), Family Care Int, New York, NY 10012 USA.	astarrs@familycareintl.org						[Anonymous], 1994, INT C POP DEV PROGR; FATHALLA M, 1987, PEOPLE, V14, P8; Otsea K., 1992, PROGR PROSPECTS SAFE; ROSENFIELD A, 1985, LANCET, V2, P83; STARRS A, 1987, PREVENTING TRAGEDY M; STARRS A, 1998, SAFE MOTHERHOOD ACTI; UNDP, MDGS BAS WHAT AR MIL	7	138	141	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2006	368	9542					1130	1132		10.1016/S0140-6736(06)69385-9	http://dx.doi.org/10.1016/S0140-6736(06)69385-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011924				2022-12-28	WOS:000240916000005
J	Psaty, BM; Burke, SP				Psaty, Bruce M.; Burke, Sheila P.			Protecting the health of the public - Institute of medicine recommendations on drug safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Smithsonian Inst, Washington, DC 20560 USA; Natl Acad Sci, Inst Med, Comm Assessment US Drug Safety Syst, Washington, DC 20418 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Smithsonian Institution; National Academies of Sciences, Engineering & Medicine	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.							BACIU A, 2006, FUTURE DRUG SAFETY P; Department of Health and Human Services, 2003, DEP HLTH HUM SERV PU; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; U.S. GOV'T ACCOUNTABILITY OFFICE, 2006, GAO06402	4	62	65	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1753	1755		10.1056/NEJMp068228	http://dx.doi.org/10.1056/NEJMp068228			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098HV	17030843				2022-12-28	WOS:000241512500001
J	Einfeld, SL; Piccinin, AM; Mackinnon, A; Hofer, SM; Taffe, J; Gray, KM; Bontempo, DE; Hoffman, LR; Parmenter, T; Tonge, BJ				Einfeld, Stewart L.; Piccinin, Andrea M.; Mackinnon, Andrew; Hofer, Scott M.; Taffe, John; Gray, Kylie M.; Bontempo, Daniel E.; Hoffman, Lesa R.; Parmenter, Trevor; Tonge, Bruce J.			Psychopathology in young people with intellectual disability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEVELOPMENTAL BEHAVIOR CHECKLIST; EMOTIONAL DISTURBANCE; MENTAL-HEALTH; POPULATION PREVALENCE; LONGITUDINAL DATA; CHILDREN; ADOLESCENTS; INDIVIDUALS; RETARDATION; MOTHERS	Context Comorbid severe mental health problems complicating intellectual disability are a common and costly public health problem. Although these problems are known to begin in early childhood, little is known of how they evolve over time or whether they continue into adulthood. Objective To study the course of psychopathology in a representative population of children and adolescents with intellectual disability. Design, Setting, and Participants The participants of the Australian Child to Adult Development Study, an epidemiological cohort of 578 children and adolescents recruited in 1991 from health, education, and family agencies that provided services to children with intellectual disability aged 5 to 19.5 years in 6 rural and urban census regions in Australia, were followed up for 14 years with 4 time waves of data collection. Data were obtained from 507 participants, with 84% of wave 1 (1991-1992) participants being followed up at wave 4 (2002-2003). Main Outcome Measures The Developmental Behaviour Checklist (DBC), a validated measure of psychopathology in young people with intellectual disability, completed by parents or other caregivers. Changes over time in the Total Behaviour Problem Score and 5 subscale scores of the DBC scores were modeled using growth curve analysis. Results High initial levels of behavioral and emotional disturbance decreased only slowly over time, remaining high into young adulthood, declining by 1.05 per year on the DBC Total Behaviour Problem Score. Overall severity of psychopathology was similar across mild to severe ranges of intellectual disability ( with mean Total Behaviour Problem Scores of approximately 44). Psychopathology decreased more in boys than girls over time ( boys starting with scores 2.61 points higher at baseline and ending with scores 2.57 points lower at wave 4), and more so in participants with mild intellectual disability compared with those with severe or profound intellectual disability who diverged from having scores 0.53 points lower at study commencement increasing to a difference of 6.98 points below severely affected children by wave 4. This trend was observed in each of the subscales, except the social-relating disturbance subscale, which increased over time. Prevalence of participants meeting criteria for major psychopathology or definite psychiatric disorder decreased from 41% at wave 1 to 31% at wave 4. Few of the participants (10%) with psychopathology received mental health interventions during the study period. Conclusion These results provide evidence that the problem of psychopathology comorbid with intellectual disability is both substantial and persistent and suggest the need for effective mental health interventions.	Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; Monash Univ, Ctr Dev Psychiat & Psychol, Sch Psychol Psychiat & Psychol Med, Melbourne, Vic 3004, Australia; Univ Sydney, Fac Med, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Australian National University; Monash University; University of Sydney	Einfeld, SL (corresponding author), Brain & Mind Res Inst, 100 Mallett St, Camperdown, NSW 2050, Australia.	s.einfeld@fhs.usyd.edu.au	Mackinnon, Andrew J/A-4901-2008; Tonge, Bruce J/T-8036-2018; Gray, Kylie/H-3345-2014; Hofer, Scott M/D-9090-2014	Tonge, Bruce J/0000-0002-4236-9688; Gray, Kylie/0000-0001-6518-4240; Hofer, Scott M/0000-0001-8923-4337; Piccinin, Andrea/0000-0001-5538-7028; Mackinnon, Andrew/0000-0003-0831-9801; Parmenter, Trevor/0000-0002-8297-8488	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061809] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH061809, R01 MH061809-06, MH61809-02] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSON DJ, 1992, AM J MENT RETARD, V96, P488; [Anonymous], 22 YEARS CAUSES CONS; [Anonymous], 1991, MANUAL CHILD BEHAV C; *AUSTR BUR STAT, 2006, MENT HLTH AUSTR SNAP; BRUININKS R, 1988, MENTAL RETARDATION M; Chadwick O, 2005, PSYCHOL MED, V35, P751, DOI 10.1017/S0033291704003733; CHESS S, 1977, J AM ACAD CHILD PSY, V16, P5; Clarke AR, 2003, J INTELL DISABIL RES, V47, P210, DOI 10.1046/j.1365-2788.2003.00470.x; Cox A., 1985, CHILD ADOLESCENT PSY, V2nd edn., P233; Dekker MC, 2003, J AM ACAD CHILD PSY, V42, P923, DOI 10.1097/01.CHI.0000046891.27264.C1; Dekker MC, 2002, J CHILD PSYCHOL PSYC, V43, P1087, DOI 10.1111/1469-7610.00235; Einfeld S. L., 2002, MANUAL DEV BEHAV CHE; EINFELD SL, 1994, AM J MED GENET, V51, P386, DOI 10.1002/ajmg.1320510417; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Einfeld SL, 1996, J INTELL DISABIL RES, V40, P99, DOI 10.1111/j.1365-2788.1996.tb00611.x; Einfeld SL, 1997, AM J MENT RETARD, V102, P45, DOI 10.1352/0895-8017(1997)102<0045:BAEDII>2.0.CO;2; Einfeld SL, 1996, J INTELL DISABIL RES, V40, P91, DOI 10.1111/j.1365-2788.1996.tb00610.x; Emerson E, 2003, J INTELL DISABIL RES, V47, P51, DOI 10.1046/j.1365-2788.2003.00464.x; Fotheringham JB, 1999, CAN J PSYCHIAT, V44, P589, DOI 10.1177/070674379904400608; Gustafsson C, 2004, SOC PSYCH PSYCH EPID, V39, P448, DOI 10.1007/s00127-004-0774-0; Hastings RP, 2003, J INTELL DISABIL RES, V47, P231, DOI 10.1046/j.1365-2788.2003.00485.x; Hastings RP, 2002, J INTELLECT DEV DIS, V27, P149, DOI 10.1080/1366825021000008657; Hodapp Robert M., 1996, P362; Koskentausta T, 2004, RES DEV DISABIL, V25, P341, DOI 10.1016/j.ridd.2003.12.001; Linna SL, 1999, EUR CHILD ADOLES PSY, V8, P77; *NIH WORKSH, 2001, EM BEH HLTH PERS MEN; Parmenter TR, 1998, J INTELLECT DEV DIS, V23, P71, DOI 10.1080/13668259800033591; Quine L., 1989, STRESS COPING FAMILI; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Roberts RE, 1998, AM J PSYCHIAT, V155, P715; Rutter M., 1970, ED HLTH BEHAV; Singer J.D., 2003, APPL LONGITUDINAL DA; US Department of Health and Human Services, 2002, REP SURG GEN C HLTH; Wallander JL, 2003, INT REV RES MENT RET, V26, P93, DOI 10.1016/S0074-7750(03)01003-6; WALLANDER JL, 2001, P 34 ANN GATL C CHAR	38	221	223	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1981	1989		10.1001/jama.296.16.1981	http://dx.doi.org/10.1001/jama.296.16.1981			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098BL	17062861	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000241495300020
J	Gillies, R; von Schoen-Angerer, T; 't Hoen, E				Gillies, Rowan; von Schoen-Angerer, Tido; 't Hoen, Ellen			Historic opportunity for WHO to re-assert leadership	LANCET			English	Editorial Material									MSF Campaign Access Essential Med, CH-1211 Geneva, Switzerland; Med Sans Frontieres, Geneva, Switzerland; MSF Campaign Access Essential Med, Paris, France	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	von Schoen-Angerer, T (corresponding author), MSF Campaign Access Essential Med, CH-1211 Geneva, Switzerland.	tido.von.schoen-angerer@msf.org		't Hoen, Ellen/0000-0003-4477-6866; von Schoen-Angerer, Tido/0000-0003-3601-7480				[Anonymous], 2006, Lancet, V368, P964; [Anonymous], 2004, GENEVA DECLARATION F; BARRACLOUGH E, 2006, MANAGING INTELL 0926; *COMM INT PROP INN, 2006, PUBL HLTH INN INT PR; MSF, 2006, UNT WEB PRIC RED PRI; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; THOEN E, 2006, ACCESS MED WHY ITS T; UNICEF World Health Organization, 2005, WORLD MAL REP 2005; WILLIAMS DC, 2006, ASIA TIMES      0619; World Trade Organisation, 1999, LEG TEXTS RES UR ROU; 2006, LANCET, V368, P1063	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1405	1406		10.1016/S0140-6736(06)69584-6	http://dx.doi.org/10.1016/S0140-6736(06)69584-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055929				2022-12-28	WOS:000241459100010
J	Rovers, MM; Glasziou, P; Appelman, CL; Burke, P; McCormick, DP; Damoiseaux, RA; Gaboury, I; Little, P; Hoes, AW				Rovers, Maroeska M.; Glasziou, Paul; Appelman, Cees L.; Burke, Peter; McCormick, David P.; Damoiseaux, Roger A.; Gaboury, Isabelle; Little, Paul; Hoes, Arno W.			Antibiotics for acute otitis media: a meta-analysis with individual patient data	LANCET			English	Article							DOUBLE-BLIND; GENERAL-PRACTICE; CONTROLLED-TRIAL; PLACEBO; AMOXICILLIN; CHILDREN; MYRINGOTOMY; PENICILLIN	Background Individual trials to test effectiveness of antibiotics in children with acute otitis media have been too small for valid subgroup analyses. We aimed to identify subgroups of children who would and would not benefit more than others from treatment with antibiotics. Methods We did a meta-analysis of data from six randomised trials of the effects of antibiotics in children with acute otitis media. Individual patient data from 1643 children aged from 6 months to 12 years were validated and re-analysed. We defined the primary outcome as an extended course of acute otitis media, consisting of pain, fever, or both at 3-7 days. Findings Significant effect modifications were noted for otorrhoea, and for age and bilateral acute otitis media. In children younger than 2 years of age with bilateral acute otitis media, 55% of controls and 30% on antibiotics still had pain, fever, or both at 3-7 days, with a rate difference between these groups of -25% (95% CI -36% to -14%), resulting in a number-needed-to-treat (NNT) of four children. We identified no significant differences for age alone. In children with otorrhoea the rate difference and NNT, respectively, were -36% (-53% to -19%) and three, whereas in children without otorrhoea the equivalent values were -14% (-23% to -5%) and eight. Interpretation Antibiotics seem to be most beneficial in children younger than 2 years of age with bilateral acute otitis media, and in children with both acute otitis media and otorrhoea. For most other children with mild disease an observational policy seems justified.	Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Otolaryngol, NL-3508 AB Utrecht, Netherlands; Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford, England; Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA; Childrens Hosp Eastern Ontario, Ontario Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; Univ Southampton, Aldermoor Hlth Ctr, Community Clin Sci Div, Southampton, Hants, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Oxford; University of Texas System; University of Texas Medical Branch Galveston; University of Ottawa; Children's Hospital of Eastern Ontario; University of Southampton	Rovers, MM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 7-109,POB 85060, NL-3508 AB Utrecht, Netherlands.	M.Rovers@umcutrecht.nl	Gaboury, Isabelle/B-6868-2011; Glasziou, Paul/A-7832-2008; Rovers, Maroeska/F-2969-2014	Glasziou, Paul/0000-0001-7564-073X; Rovers, Maroeska/0000-0002-3095-170X; Damoiseaux, Roger/0000-0001-8052-0302; Little, Paul/0000-0003-3664-1873				APPELMAN CL, 1999, HUISARTS WET, V42, P362; APPELMAN CLM, 1991, BMJ-BRIT MED J, V303, P1450, DOI 10.1136/bmj.303.6815.1450; Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Brookes S T, 2001, Health Technol Assess, V5, P1; BURKE P, 1991, BRIT MED J, V303, P558, DOI 10.1136/bmj.303.6802.558; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; ENGELHARD D, 1989, LANCET, V2, P141; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; HALSTED C, 1968, AM J DIS CHILD, V115, P542, DOI 10.1001/archpedi.1968.02100010544003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOWIE VM, 1972, CLIN PEDIATR, V11, P205, DOI 10.1177/000992287201100407; KALEIDA PH, 1991, PEDIATRICS, V87, P466; LAXDAL OE, 1970, CAN MED ASSOC J, V102, P263; Le Saux N, 2005, CAN MED ASSOC J, V172, P335, DOI 10.1503/cmaj.1040771; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Marcy M, 2001, 15 AG HEALTHC RES QU; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; MYGIND N, 1981, CLIN OTOLARYNGOL, V6, P5, DOI 10.1111/j.1365-2273.1981.tb01781.x; Ostfeld E, 1987, REC ADV OT MED P 4 I, P235; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; RUDBERG R. D., 1954, ACTA OTO LARYNGOL, V113, P1; Ruohola A, 2003, PEDIATRICS, V111, P1061, DOI 10.1542/peds.111.5.1061; SAINTONGE DMD, 1982, BMJ-BRIT MED J, V284, P1078; Scottish Intercollegiate Guidelines Network, 2003, DIAGN MAN CHILDH OT; Thalin A, 1985, P INT C AC SECR OT 1, P441; *UK DEP HLTH, 2004, PRODIGY GUID OT MED; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033, DOI 10.1136/bmj.290.6474.1033; VANBUCHEM FL, 1981, LANCET, V2, P883; Venekamp RP, 2015, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000219.PUB4, 10.1002/14651858.CD000219.pub4]; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116	34	183	186	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1429	1435		10.1016/S0140-6736(06)69606-2	http://dx.doi.org/10.1016/S0140-6736(06)69606-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055944				2022-12-28	WOS:000241459100030
J	Floto, RA; MacAry, PA; Boname, JM; Mien, TS; Kampmann, B; Hair, JR; Huey, OS; Houben, ENG; Pieters, J; Day, C; Oehlmann, W; Singh, M; Smith, KGC; Lehner, PJ				Floto, R. Andres; MacAry, Paul A.; Boname, Jessica M.; Mien, Tan Suet; Kampmann, Beate; Hair, James R.; Huey, Oh Seen; Houben, Edith N. G.; Pieters, Jean; Day, Cheryl; Oehlmann, Wulf; Singh, Mahavir; Smith, Kenneth G. C.; Lehner, Paul J.			Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5	SCIENCE			English	Article							T-CELLS; CHEMOKINES; CCR5-DELTA-32; TUBERCULOSIS; IMMUNITY	An effective host immune response to mycobacterial infection must control pathogen dissemination without inducing immunopathology. Constitutive overexpression of mycobacterial heat shock protein (myHsp70) is associated with impaired bacterial persistence, but the immune-mediated mechanisms are unknown. We found that myHsp70, in addition to enhancing antigen delivery to human dendritic cells, signaled through the CCR5 chemokine receptor, promoting dendritic cell aggregation, immune synapse formation between dendritic cells and T cells, and the generation of effector immune responses. Thus, CCR5 acts as a pattern-recognition receptor for myHsp70, which may have implications for both the pathophysiology of tuberculosis and the use of myHsps in tumor-directed immunotherapy.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 XY, England; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Immunol, Singapore 117597, Singapore; Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, Singapore, Singapore; Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London SW7 2AZ, England; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Nuffield Dept Med, Oxford OX1 3SY, England; Lionex Diagnost & Therapeut GmbH, D-38124 Braunschweig, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Imperial College London; University of Basel; University of Oxford; Lionex Diagnostics & Therapeutics GmbH	Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 XY, England.	pjl30@cam.ac.uk	Houben, Edith N.G./B-2110-2015; Tan, Suet/A-2224-2011; Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Houben, Edith N.G./0000-0002-8805-2002; Day, Cheryl L/0000-0002-6497-4846; Smith, Kenneth/0000-0003-3829-4326; Tan, Suet-Mien/0000-0003-2371-8739; MacAry, Paul/0000-0002-1139-8996; Lehner, Paul Joseph/0000-0001-9383-1054; Pieters, Jean/0000-0002-5284-9757; Boname, Jessica/0000-0002-5149-5934	MRC [G108/485, G9800943] Funding Source: UKRI; Medical Research Council [G9800943, G0600823, G108/485] Funding Source: Medline; Wellcome Trust [077273] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422	20	127	137	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					454	458		10.1126/science.1133515	http://dx.doi.org/10.1126/science.1133515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053144				2022-12-28	WOS:000241382500039
J	Corma, A; Diaz-Cabanas, MJ; Jorda, JL; Martinez, C; Moliner, M				Corma, Avelino; Diaz-Cabanas, Maria J.; Luis Jorda, Jose; Martinez, Cristina; Moliner, Manuel			High-throughput synthesis and catalytic properties of a molecular sieve with 18-and 10-member rings	NATURE			English	Article							POWDER DIFFRACTION DATA; LARGE-PORE ZEOLITES; RATIONAL DESIGN; HIGH-SILICA; TOPOLOGY; CHANNELS; SYSTEM; ITQ-7; FCC	Crystalline molecular sieves with large pores and high adsorption capacities have many potential applications(1-4). Of these materials, zeolites are of particular interest owing to their stability in a wide range of experimental conditions. An aluminophosphate with very large circular channels(5) containing 18 oxygen atoms (18-ring channels) has been synthesized, but in the search for large-pore zeolites, most of the materials which have been synthesized up to now contain only 14-ring channels; the synthesis of zeolites with larger ring structures has been believed to be hindered by the low Si-O-Si bond angles available. A silicogaloaluminate (ECR-34) with unidirectional 18-ring channels(12) was recently reported, but exhibited low micropore volume, thus rendering the material less attractive for catalytic applications. Here we report the structure and catalytic activity of the silicogermanate zeolite ITQ-33; this material exhibits straight large pore channels with circular openings of 18-rings along the c axis interconnected by a bidirectional system of 10-ring channels, yielding a structure with very large micropore volume. The conditions for synthesis are easily accessible, but are not typical, and were identified using high-throughput techniques.	Univ Politecn Valencia, UPV CSIC, Inst Tecnol Quim, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, UPV CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	CANOS, AVELINO CORMA/A-3040-2013; MOLINER, MANUEL/D-4404-2013; Jorda, Jose L./D-1334-2009; Martínez, Cristina/H-5915-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; MOLINER, MANUEL/0000-0002-5440-716X; Jorda, Jose L./0000-0002-0304-5680; Martínez, Cristina/0000-0002-4415-084X				ANNEN MJ, 1991, J CHEM SOC CHEM COMM, P1175, DOI 10.1039/c39910001175; Blasco T, 2002, J PHYS CHEM B, V106, P2634, DOI 10.1021/jp013302b; BRUNNER GO, 1989, NATURE, V337, P146, DOI 10.1038/337146a0; Burton A, 2003, CHEM-EUR J, V9, P5737, DOI 10.1002/chem.200305238; Cantin A, 2006, J AM CHEM SOC, V128, P4216, DOI 10.1021/ja0603599; Cejka J, 2002, CATAL REV, V44, P375, DOI 10.1081/CR-120005741; CHEETHAM T, 2001, STUD SURF SCI CATAL, V135, P788; Corma A, 2004, NATURE, V431, P287, DOI 10.1038/nature02909; Corma A, 2004, CHEM COMMUN, P1356, DOI 10.1039/b406572g; Corma A, 2002, NATURE, V418, P514, DOI 10.1038/nature00924; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; Corma A, 1997, J CATAL, V165, P102, DOI 10.1006/jcat.1997.1474; Corma A, 2001, CHEM COMMUN, P1486, DOI 10.1039/b104114m; Corma A, 2001, J CATAL, V197, P151, DOI 10.1006/jcat.2000.3065; Correll S, 2003, ANGEW CHEM INT EDIT, V42, P3549, DOI 10.1002/anie.200351372; DAVIS ME, 1988, NATURE, V331, P698, DOI 10.1038/331698a0; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Ferey G, 2001, SCIENCE, V291, P994, DOI 10.1126/science.1059200; Freyhardt CC, 1996, NATURE, V381, P295, DOI 10.1038/381295a0; Grosse-Kunstleve RW, 1999, J APPL CRYSTALLOGR, V32, P536, DOI 10.1107/S0021889899003453; Grosse-Kunstleve RW, 1997, J APPL CRYSTALLOGR, V30, P985, DOI 10.1107/S0021889897005013; Jager R, 2004, CHEM-EUR J, V10, P247, DOI 10.1002/chem.200305474; LAWTON SL, 1990, SCIENCE, V247, P1319, DOI 10.1126/science.247.4948.1319; Paillaud JL, 2004, SCIENCE, V304, P990, DOI 10.1126/science.1098242; RODRIGUEZCARVAJ.J, 2005, FULLPROF VERSION 3 3; Strohmaier KG, 2003, J AM CHEM SOC, V125, P16035, DOI 10.1021/ja0371653; Treacy MMJ, 2004, MICROPOR MESOPOR MAT, V74, P121, DOI 10.1016/j.micromeso.2004.06.013; Wang YX, 2003, SOLID STATE SCI, V5, P1421, DOI 10.1016/j.solidstatesciences.2003.09.003; Yoshikawa M, 1998, J PHYS CHEM B, V102, P7139, DOI 10.1021/jp982169t; Zheng NF, 2005, ANGEW CHEM, V117, P5433	30	383	396	10	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					842	845		10.1038/nature05238	http://dx.doi.org/10.1038/nature05238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051215				2022-12-28	WOS:000241362700048
J	Cripe, LD				Cripe, Larry D.			Hope is the thing with feathers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lcripe@iupui.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1815	1816		10.1001/jama.296.15.1815	http://dx.doi.org/10.1001/jama.296.15.1815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047201				2022-12-28	WOS:000241329300001
J	Galloway, MJ; Smellie, WSA				Galloway, Michael J.; Smellie, W. Stuart A.			Cases in primary care laboratory medicine - Investigating iron status in microcytic anaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFICIENCY ANEMIA; DIAGNOSIS		Sunderland Royal Hosp, City Hosp Sunderland NHS Fdn Trust, Sunderland SR4 7TP, England; Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England	Sunderland Royal Hospital	Galloway, MJ (corresponding author), Sunderland Royal Hosp, City Hosp Sunderland NHS Fdn Trust, Sunderland SR4 7TP, England.	mike.galloway@chs.northy.nhs.uk						*BRIT COL MED ASS, 2004, INV MAN IR DEF; CASH JM, 1989, AM J MED, V87, P638; Goddard AF, 2000, GUT, V46, pIV1; GRINER PF, 1999, DIAGNOSTIC STRATEGIE, P575; GUYATT GH, 1990, AM J MED, V88, P205, DOI 10.1016/0002-9343(90)90143-2; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Smellie WSA, 2006, J CLIN PATHOL, V59, P781, DOI 10.1136/jcp.200X.033944; Thomas RE, 2006, LANCET, V367, P1990, DOI 10.1016/S0140-6736(06)68888-0	8	25	25	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 14	2006	333	7572					791	793		10.1136/bmj.38979.358032.BE	http://dx.doi.org/10.1136/bmj.38979.358032.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038737	Green Published			2022-12-28	WOS:000241566000017
J	Koblinsky, M; Matthews, Z; Hussein, J; Mavalankar, D; Mridha, MK; Anwar, I; Achadi, E; Adjei, S; Padmanabhan, P; van Lerberghe, W				Koblinsky, Marge; Matthews, Zoe; Hussein, Julia; Mavalankar, Dileep; Mridha, Malay K.; Anwar, Iqbal; Achadi, Endang; Adjei, Sam; Padmanabhan, P.; van Lerberghe, Wim		Lancet Maternal Survival Series	Maternal Survival 3 - Going to scale with professional skilled care	LANCET			English	Article							CONTINUING MEDICAL-EDUCATION; CESAREAN-SECTION; HUMAN-RESOURCES; HEALTH; DELIVERY; BIRTH; PERFORMANCE; PHYSICIAN; NEEDS	Because most women prefer professionally provided maternity care when they have access to it, and since the needed clinical interventions are well known, we discuss in their paper what is needed to move forward from apparent global stagnation in provision and use of maternal health care where maternal mortality is high. The main obstacles to the expansion of care are the dire scarcity of skilled providers and health-system infrastructure, substandard quality of care, and women's reluctance to use maternity care where there are high costs and poorly attuned services. To increase the supply of professional skilled birthing care, strategic decisions must be made in three areas: training, deployment, and retention of health workers. Based on results from simulations, teams of midwives and midwife assistants working in facilities could increase coverage of maternity care by up to 40% by 2015. Teams of providers are the efficient option, creating the possibility of scaling up as much as 10 times more quickly than would be the case with deployment of solo health workers in home deliveries with dedicated or multipurpose workers.	ICDDR B, Ctr Hlth & Populat Res, Div Publ Hlth Sci, Reprod Hlth Unit, Dhaka, Bangladesh; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Southampton, Div Social Stat, Southampton, Hants, England; IMMPACT Univ Aberdeen, Aberdeen, Scotland; Indian Inst Management, Publ Syst Grp, Ahmadabad 380015, Gujarat, India; Univ Indonesia, Ctr Family Welf, Depok, W Java, Indonesia; Govt Ghana, Gen Hlth, Accra, Ghana; Govt India, Publ Hlth & Prevent Med, Madras, Tamil Nadu, India; WHO, Dept Hlth Financing & Stewardship, CH-1211 Geneva, Switzerland	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Southampton; University of Aberdeen; Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad; University of Indonesia; Ministry of Earth Sciences (MoES) - India; National Institute of Ocean Technology (NIOT); World Health Organization	Koblinsky, M (corresponding author), ICDDR B, Ctr Hlth & Populat Res, Div Publ Hlth Sci, Reprod Hlth Unit, Dhaka, Bangladesh.	margek@icddrb.org	Mridha, Malay Kanti/AAJ-5539-2020; Matthews, Zoe/HGD-0506-2022; Mavalankar, Dileep/AAX-6931-2020	Mridha, Malay Kanti/0000-0001-9226-457X; Mavalankar, Dileep/0000-0003-0498-3799; Van Lerberghe, Wim/0000-0001-9966-6563; Matthews, Zoe/0000-0003-1533-6618				Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Afsana K, 2001, REPROD HEALTH MATTER, V9, P79, DOI 10.1016/S0968-8080(01)90094-1; *AMDD WORK GROUP I, 2002, INT J GYNECOL OBSTET, V7, P277; AMDD Working Group on Indicators, 2004, Int J Gynaecol Obstet, V86, P110, DOI 10.1016/j.ijgo.2004.04.034; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; *AV MAT DEATH DIS, 2002, INT J GYNECOL OBSTET, V80, P222; Bailey P, 2005, INT J GYNECOL OBSTET, V89, P221, DOI 10.1016/j.ijgo.2004.12.045; Bankana B, 2003, INT J GYNECOL OBSTET, V83, P112, DOI 10.1016/S0020-7292(03)00187-5; Belghiti A, 1998, TROP MED INT HEALTH, V3, P584; Blum LS, 2006, REPROD HEALTH MATTER, V14, P51, DOI 10.1016/S0968-8080(06)27234-3; BORGHI J, IN PRESS J HLTH POPU; Boucar M, 2004, SAFE MOTHERHOOD STUD; Bradby B., 1998, Reproductive Health Matters, V6, P50, DOI 10.1016/S0968-8080(98)90007-6; BUCHAN, 2004, GLOBAL SHORTAGE REGI; *CHART I PERS DEV, 2002, SUST SUCC DIFF TIM R; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Clarke H F, 2001, Hosp Q, V4, P50; d'Oliveira AFPL, 2002, LANCET, V359, P1681, DOI 10.1016/S0140-6736(02)08592-6; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DELVAUX T, 2005, QUALITY MATERNITY SE; *DG HLTH SERV MIN, 2005, MAN INF SYST HLTH HU; Dieleman Marjolein, 2006, Hum Resour Health, V4, P2, DOI 10.1186/1478-4491-4-2; *DIR GEN HLTH FAM, 2004, HLTH INF IND; Flamm BL, 1998, BIRTH-ISS PERINAT C, V25, P117, DOI 10.1046/j.1523-536x.1998.00117.x; Fullerton J, 2003, MIDWIFERY, V19, P174, DOI 10.1016/S0266-6138(03)00032-9; GAY J, 2000, WHAT WORKS POLICY PR; GBANGBADE S, 2003, SAFE MOTHERHOOD STUD; *GLOB HLTH TRUST, 2004, JLI STRAT REP HUM RE; Gohou V, 2004, TROP MED INT HEALTH, V9, P406, DOI 10.1111/j.1365-3156.2004.01204.x; GWATKIN D, 2000, INITIAL COUNTRY LEVE; HARGADON J, 2004, COMPLEXITY HLTH WORK, P1; Harvey S, 2005, 104 ANN M AM ANTHR A; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; JAFFRE Y, 2004, MED INHOSPITALIERE D; Jahn A, 2001, STUD HLTH SERV ORGAN, V17, P229; JENNING L, 2005, COMP 2 DATA COLLECTI; Kabakian-Khasholian T, 2000, SOC SCI MED, V51, P103, DOI 10.1016/S0277-9536(99)00443-8; Khawaja M, 2004, HEALTH POLICY, V69, P273, DOI 10.1016/j.healthpol.2004.05.006; KOBLINSKY M, 2003, REDUCING MATERNAL MO, V1; Krasovec K, 2004, INT J GYNECOL OBSTET, V85, pS14, DOI 10.1016/ijgo.2004.02.007; KURESHY N, 2000, REV SELECT FAMILY CO; *MAL MIN HLTH POP, 1999, MIN HLTH POP GOV MAL; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; McCaw-Binns A, 2004, SAFE MOTHERHOOD STUD; MCCAWBINNS A, 2003, REDUCING MATERNAL MO, V1; Miller S, 2003, INT J GYNECOL OBSTET, V82, P89, DOI 10.1016/S0020-7292(03)00148-6; Moore M., 2002, BEHAV CHANGE APPROAC; Murray SF, 2001, HEALTH POLICY PLANN, V16, P353, DOI 10.1093/heapol/16.4.353; NACHBAR N, 1996, REPORT USE COMMUNITY; *NAT COMM MACR HLT, 2005, REP NAT COMM MACR HL, P99; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; NOTZON FC, 1994, AM J OBSTET GYNECOL, V170, P495, DOI 10.1016/S0002-9378(94)70217-9; Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155; Ronsmans C, 2004, BJOG-INT J OBSTET GY, V111, P1027, DOI 10.1111/j.1471-0528.2004.00247.x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sloan NL, 2000, INT J GYNECOL OBSTET, V69, P229, DOI 10.1016/S0020-7292(00)00192-2; SOMANATHAN A, 2005, 9 EQUITAP; STANTON C, 2006, J BIOSOC SCI, P1; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; TAWFIK L, 2001, IMPACT HIV AIDS HLTH; United Nations, 2004, WORLD POP PROSP 2004; VANLERBERGHE W, 1992, TYPOLIGIE PERFORMANC; Vaz F, 1999, B WORLD HEALTH ORGAN, V77, P688; *WHO UNICEF UNFPA, 1997, GUID MON AV US OBST; *WORLD BANK, POV HLTH TABL FIG; World Health Organisation, 2005, WORLD HLTH REP MAK E; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2006, WORLD HLTH REP WORK	71	328	329	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1377	1386		10.1016/S0140-6736(06)69382-3	http://dx.doi.org/10.1016/S0140-6736(06)69382-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096PA	17046470				2022-12-28	WOS:000241388100034
J	Lean, M; Finer, N				Lean, Mike; Finer, Nick			ABC of obesity - Management: Part II - Drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORLISTAT		Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; Addenbrookes Hosp, Wellcome Clin Res Facil, Cambridge, England	University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lean, M (corresponding author), Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland.		Finer, Nicholas/B-9981-2009	Finer, Nicholas/0000-0003-2468-6804				Curran MP, 2004, DRUGS, V64, P2845, DOI 10.2165/00003495-200464240-00010; Finer N, 2005, EUR HEART J SUPPL, V7, pL32, DOI 10.1093/eurheartj/sui084; Greenway Frank L, 2005, Expert Opin Drug Saf, V4, P1083, DOI 10.1517/14740338.4.6.1083; Pagotto U, 2005, ANN MED, V37, P270, DOI 10.1080/07853890510037419; Rissanen A, 2003, INT J OBESITY, V27, P103, DOI 10.1038/sj.ijo.0802165; Small Caroline J, 2005, Curr Opin Investig Drugs, V6, P369	6	23	25	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 14	2006	333	7572					794	797		10.1136/bmj.333.7572.794	http://dx.doi.org/10.1136/bmj.333.7572.794			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038738	Green Published			2022-12-28	WOS:000241566000018
J	Bartek, J; Lukas, J				Bartek, Jiri; Lukas, Jiri			Balancing life-or-death decisions	SCIENCE			English	Editorial Material							DOUBLE-STRAND BREAKS; DNA-DAMAGE; CELL-CYCLE; CHECKPOINT; ATM		Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513	11	10	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					261	262		10.1126/science.1133758	http://dx.doi.org/10.1126/science.1133758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093TV	17038611				2022-12-28	WOS:000241194100028
J	Heinrich, CA				Heinrich, Christoph A.			How fast does gold trickle out of volcanoes?	SCIENCE			English	Editorial Material									Swiss Fed Inst Technol, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Zurich, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Heinrich, CA (corresponding author), Swiss Fed Inst Technol, Dept Earth Sci, Clausiusstr 25, CH-8092 Zurich, Switzerland.	heinrich@erdw.ethz.ch	Heinrich, Christoph A/D-3921-2014	Heinrich, Christoph A/0000-0001-5838-4607				Carman G.D., 2003, SOC EC GEOLOGISTS SP, P247; GIGGENBACH WF, 1992, ECON GEOL BULL SOC, V87, P1927; Haneberg W. C., 2005, P INT C LANDSL RISK; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; Heinrich CA, 2004, GEOLOGY, V32, P761, DOI 10.1130/G20629.1; Heinrich CA, 1999, GEOLOGY, V27, P755, DOI 10.1130/0091-7613(1999)027<0755:MFBMBA>2.3.CO;2; Simmons SF, 2006, SCIENCE, V314, P288, DOI 10.1126/science.1132866	7	16	16	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					263	264		10.1126/science.1134456	http://dx.doi.org/10.1126/science.1134456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038612				2022-12-28	WOS:000241194100029
J	Borchelt, DR				Borchelt, David R.			Amyotrophic lateral sclerosis - Are microglia killing motor neurons?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Florida, Dept Neurosci, McKnight Brain Inst, SantaFe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, SantaFe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA.							Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019	4	21	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1611	1613		10.1056/NEJMcibr064358	http://dx.doi.org/10.1056/NEJMcibr064358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035656				2022-12-28	WOS:000241160400016
J	Omer, SB; Pan, WKY; Halsey, NA; Stokley, S; Moulton, LH; Navar, AM; Pierce, M; Salmon, DA				Omer, Saad B.; Pan, William K. Y.; Halsey, Neal A.; Stokley, Shannon; Moulton, Lawrence H.; Navar, Ann Marie; Pierce, Mathew; Salmon, Daniel A.			Nonmedical exemptions to school immunization requirements - Secular trends and association of state policies with pertussis incidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SAMPLE-SIZE; PHILOSOPHICAL EXEMPTIONS; MEASLES; VACCINES; CHILDREN	Context School immunization requirements have played a major role in controlling vaccine-preventable diseases in the United States. Most states offer nonmedical exemptions to school requirements (religious or personal belief). Exemptors are at increased risk of acquiring and transmitting disease. The role of exemption policies may be especially important for pertussis, which is endemic in the United States. Objective To determine if (1) the rates of nonmedical exemptions differ and have been increasing in states that offer only religious vs personal belief exemptions; (2) the rates of nonmedical exemptions differ and have been increasing in states that have easy vs medium and easy vs difficult processes for obtaining exemptions; and (3) pertussis incidence is associated with policies of granting personal belief exemptions, ease of obtaining exemptions, and acceptance of parental signature as sufficient proof of compliance with school immunization requirements. Design, Setting, and Participants We analyzed 1991 through 2004 state-level rates of nonmedical exemptions at school entry and 1986 through 2004 pertussis incidence data for individuals aged 18 years or younger. Main Outcome Measures State-level exemption rates and pertussis incidence. Results From 2001 through 2004, states that permitted personal belief exemptions had higher nonmedical exemption rates than states that offered only religious exemptions, and states that easily granted exemptions had higher nonmedical exemption rates in 2002 through 2003 compared with states with medium and difficult exemption processes. The mean exemption rate increased an average of 6% per year, from 0.99% in 1991 to 2.54% in 2004, among states that offered personal belief exemptions. In states that easily granted exemptions, the rate increased 5% per year, from 1.26% in 1991 to 2.51% in 2004. No statistically significant change was seen in states that offered only religious exemptions or that had medium and difficult exemption processes. In multivariate analyses adjusting for demographics, easier granting of exemptions (incidence rate ratio = 1.53; 95% confidence interval, 1.10-2.14) and availability of personal belief exemptions (incidence rate ratio = 1.48; 95% confidence interval, 1.03-2.13) were associated with increased pertussis incidence. Conclusions Permitting personal belief exemptions and easily granting exemptions are associated with higher and increasing nonmedical US exemption rates. State policies granting personal belief exemptions and states that easily grant exemptions are associated with increased pertussis incidence. States should examine their exemption policies to ensure control of pertussis and other vaccine-preventable diseases.	Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL 32608 USA; Duke Univ, Sch Med, Durham, NC USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Vaccine Safety, Baltimore, MD USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	State University System of Florida; University of Florida; Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Salmon, DA (corresponding author), Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, 1329 SW 16th St,Room 5239,POB 100177, Gainesville, FL 32608 USA.	das@ehpr.ufl.edu	Petri, William/AAL-3642-2020; Omer, Saad B/K-1182-2012	Petri, William/0000-0002-7268-1218; Omer, Saad B/0000-0002-5383-3474; Pan, William/0000-0002-7407-7399; Moulton, Lawrence/0000-0001-7041-7387; salmon, daniel/0000-0002-1035-4422	PHS HHS [UIP000032A] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDC, 2005, MMWR-MORBID MORTAL W, V52, P1; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Immunization Action Coalition, STAT MAND IMM VACC P; *J HOPK BLOOMB SCH, VACC EX; McNeil Jr. D. G., 2002, NY TIMES        1130; *NAT NETW IMM INF, VACC INF; Orenstein WA, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00290-X; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Plotkin S.L., 2004, VACCINES-BASEL, V5, P1; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; ROBISON G, 2003, 37 NAT IMM C MARC 18; Rota JS, 2001, AM J PUBLIC HEALTH, V91, P645, DOI 10.2105/AJPH.91.4.645; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Salmon DA, 2001, PUBLIC HEALTH REP, V116, P289, DOI 10.1016/S0033-3549(04)50050-X; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; U.S. Census Bureau, POP EST PROGR; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Willis Bayo C., 2005, Morbidity and Mortality Weekly Report, V54, P1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	289	292	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1757	1763		10.1001/jama.296.14.1757	http://dx.doi.org/10.1001/jama.296.14.1757			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032989	Bronze			2022-12-28	WOS:000241103400024
J	Derman, RJ; Kodkany, BS; Goudar, SS; Geller, SE; Naik, VA; Bellad, MB; Patted, SS; Patel, A; Edlavitch, SA; Hartwell, T; Chakraborty, H; Moss, N				Derman, Richard J.; Kodkany, Bhalchandra S.; Goudar, Shivaprasad S.; Geller, Stacie E.; Naik, Vijaya A.; Bellad, M. B.; Patted, Shobhana S.; Patel, Ashlesha; Edlavitch, Stanley A.; Hartwell, Tyler; Chakraborty, Hrishikesh; Moss, Nancy			Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial	LANCET			English	Article							3RD STAGE; LABOR; MANAGEMENT; OXYTOCIN; 3RD-STAGE; DELIVERY; HEALTH	Background Postpartum haemorrhage is a major cause of maternal mortality in the developing world. Although effective methods for prevention and treatment of such haemorrhage exist-such as the uterotonic drug oxytocin - most are not feasible in resource-poor settings where many births occur at home. We aimed to investigate whether oral misoprostol, a potential alternative to oxytocin, could prevent postpartum haemorrhage in a community home-birth setting. Methods In a placebo-controlled trial undertaken between September, 2002, and December, 2005, 1620 women in rural India were randomised to receive oral misoprostol (n=812) or placebo (n=808) after delivery. 25 auxiliary nurse midwives undertook the deliveries, administered the study drug, and measured blood loss. The primary outcome was the incidence of acute postpartum haemorrhage (defined as >= 500 mL bleeding) within 2 h of delivery. Analysis was by intention-to-treat. The trial was registered with the US clinical trials database (http://www.clinicaltrials.gov) as number NCT00097123. Findings Oral misoprostol was associated with a significant reduction in the rate of acute postpartum haemorrhage (12.0% to 6.4%, p < 0.0001; relative risk 0.53 [95% CI 0.39-0.74]) and acute severe postpartum haemorrhage (1.2% to 0.2%, p < 0.0001; 0.20 [0.04-0.91]. One case of postpartum haemorrhage was prevented for every 18 women treated. Misoprostol was also associated with a decrease in mean postpartum blood loss (262.3 mL to 214.3 mL, p < 0.0001). Postpartum haemorrhage rates fell over time in both groups but remained significantly higher in the placebo group. Women taking misoprostol. had a higher rate of transitory symptoms of chills and fever than the control. Interpretation Oral misoprostol was associated with significant decreases in the rate of acute postpartum haemorrhage and mean blood loss. The drug's low cost, ease of administration, stability, and a positive safety profile make it a good option in resource-poor settings.	Univ Illinois, Coll Med, Dept Obstet & Gynecol MC 808, Chicago, IL 60612 USA; Univ Missouri, Sch Med, Kansas City, MO 64108 USA; Jawaharlal Nehru Med Coll, Belgaum, Karnataka, India; John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA; NICHHD, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Missouri System; University of Missouri Kansas City; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Geller, SE (corresponding author), Univ Illinois, Coll Med, Dept Obstet & Gynecol MC 808, 820 S Wood St, Chicago, IL 60612 USA.	SGeller@uic.edu	GOUDAR, SHIVAPRASAD S/S-1217-2019; Patted, Shobhana/AAC-7879-2021; Bellad, Mrutyunjaya/R-6494-2019	GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; Patted, Shobhana/0000-0001-5085-1768; Bellad, Mrutyunjaya/0000-0003-0460-1439; Chakraborty, Hrishikesh/0000-0001-9078-845X; Derman, Richard/0000-0003-1148-1594	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD042372] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Bugalho A, 2001, INT J GYNECOL OBSTET, V73, P1, DOI 10.1016/S0020-7292(01)00346-0; Caliskan E, 2003, OBSTET GYNECOL, V101, P921, DOI 10.1016/S0029-7844(03)00077-2; Chandhiok N, 2006, INT J GYNECOL OBSTET, V92, P170, DOI 10.1016/j.ijgo.2005.10.019; DALY SA, 1999, J AM OBSTET GYNE S1, V180, P68; Darney PD, 2001, LANCET, V358, P682, DOI 10.1016/S0140-6736(01)05846-9; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; El-Refaey H, 2000, BRIT J OBSTET GYNAEC, V107, P1104, DOI 10.1111/j.1471-0528.2000.tb11108.x; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; Geller SE, 2004, INT J GYNECOL OBSTET, V87, P267, DOI 10.1016/j.ijgo.2004.08.019; GIBBS RS, 1980, OBSTET GYNECOL, V55, pS178, DOI 10.1097/00006250-198003001-00045; GREENSFELDER L, 2006, OLD DRUGS NEW USE WI; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hofmeyr GJ, 2001, S AFR MED J, V91, P432; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Kodkany BS, 2004, INT J FERTIL WOMEN M, V49, P91; Kundodyiwa TW, 2001, INT J GYNECOL OBSTET, V75, P235, DOI 10.1016/S0020-7292(01)00498-2; Langenbach C, 2006, INT J GYNECOL OBSTET, V92, P10, DOI 10.1016/j.ijgo.2005.10.001; Lumbiganon P, 2002, BJOG-INT J OBSTET GY, V109, P1222, DOI 10.1016/S1470-0328(02)02919-1; *MAT NEON HLTH, 2004, PREV POSTP HEM COMM; Miller S, 2004, J MIDWIFERY WOM HEAL, V49, P283, DOI 10.1016/j.jmwh.2004.04.001; *MIN HLTH FAM WELF, 2005, GUID ANT CAR SKILL A; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Ng PS, 2001, HUM REPROD, V16, P31, DOI 10.1093/humrep/16.1.31; Nordstrom L, 1997, BRIT J OBSTET GYNAEC, V104, P781, DOI 10.1111/j.1471-0528.1997.tb12020.x; Oboro V O, 2003, J Obstet Gynaecol, V23, P13, DOI 10.1080/0144361021000043146; Patel A, 2006, INT J GYNECOL OBSTET, V93, P220, DOI 10.1016/j.ijgo.2006.02.014; PRITCHARD JA, 1962, AM J OBSTET GYNECOL, V84, P1271; Ray A, 2001, J OBSTET GYNAECOL IN, V51, P53; *REG GEN IND, 2000, SRS B, V33, P6; Selo-Ojeme D O, 2002, J Obstet Gynaecol, V22, P463; Walley RL, 2000, BRIT J OBSTET GYNAEC, V107, P1111, DOI 10.1111/j.1471-0528.2000.tb11109.x; Walraven G, 2005, BJOG-INT J OBSTET GY, V112, P1277, DOI 10.1111/j.1471-0528.2005.00711.x; WHO, 2004, MAT MORT 2000 EST DE; WHO, 2005, MAK EV MOTH CHILD CO; *WHO UNFPA UNICEF, 1999, WORLD BANK RED MAT M; Zachariah ES, 2006, INT J GYNECOL OBSTET, V92, P23, DOI 10.1016/j.ijgo.2005.08.026; ZHAR CA, 1991, MATERNAL MORTALITY; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7	41	222	224	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1248	1253		10.1016/S0140-6736(06)69522-6	http://dx.doi.org/10.1016/S0140-6736(06)69522-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027730				2022-12-28	WOS:000241058300031
J	Jablonski, D; Roy, K; Valentine, JW				Jablonski, David; Roy, Kaustuv; Valentine, James W.			Out of the tropics: Evolutionary dynamics of the latitudinal diversity gradient	SCIENCE			English	Article							GLOBAL BIODIVERSITY; SPECIES-DIVERSITY; EXTINCTION RATES; FOSSIL RECORD; MARINE REALM; PATTERNS; SCALE; ENERGY; HISTORY; WATER	The evolutionary dynamics underlying the latitudinal gradient in biodiversity have been controversial for over a century. Using a spatially explicit approach that incorporates not only origination and extinction but immigration, a global analysis of genera and subgenera of marine bivalves over the past 11 million years supports an "out of the tropics'' model, in which taxa preferentially originate in the tropics and expand toward the poles without losing their tropical presence. The tropics are thus both a cradle and a museum of biodversity, contrary to the conceptual dichotomy dominant since 1974; a tropical diversity crisis would thus have profound evolutionary effects at all latitudes.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California San Diego; University of California System; University of California Berkeley	Jablonski, D (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	djablons@uchicago.edu						Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; [Anonymous], 1878, TROPICAL NATURE OTHE; Beu A.G., 2005, Scripta Geologica (Leiden), V130, P1; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Brown JM, 2005, EVOLUTION, V59, P238; CAMPBELL C A, 1977, Paleobiology, V3, P49; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Cecca F, 2005, J BIOGEOGR, V32, P535, DOI 10.1111/j.1365-2699.2005.01176.x; Cecca F., 2002, PALAEOBIOGEOGRAPHY M, P273; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Cooper RA, 2006, GEOLOGY, V34, P241, DOI 10.1130/G22206.1; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; DARLINGTON PJ, 1959, EVOLUTION, V13, P488, DOI 10.2307/2406131; Ferraz E, 1998, DIS AQUAT ORGAN, V33, P43, DOI 10.3354/dao033043; Ferrero Elena, 1992, Bollettino Malacologico, V28, P101; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 1996, P ROY SOC B-BIOL SCI, V263, P63, DOI 10.1098/rspb.1996.0011; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Hawkins BA, 2005, J BIOGEOGR, V32, P1035, DOI 10.1111/j.1365-2699.2004.01238.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; HECHT AD, 1972, SYST ZOOL, V21, P308, DOI 10.2307/2412169; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; JABLONSKI D, 1993, NATURE, V364, P142, DOI 10.1038/364142a0; Jablonski David, 2003, P368; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Judd WS, 1994, HARVARD PAPERS BOTAN, V1, P1; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Leighton LR, 2005, EVOL ECOL, V19, P563, DOI 10.1007/s10682-005-1021-1; LEWIN R, 1989, SCIENCE, V244, P527, DOI 10.1126/science.244.4904.527; Martin PR, 2004, EVOLUTION, V58, P938; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Paradis E, 2004, J THEOR BIOL, V229, P19, DOI 10.1016/j.jtbi.2004.02.018; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pavia G., 1976, B SOC PALEONTOLOGICA, V14, P99; Pawar SS, 2005, EVOLUTION, V59, P234; Ree RH, 2005, EVOLUTION, V59, P2299; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs Robert E., 1993, P350; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P151; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; SCHEMSKE DW, 2002, FDN TROPICAL FOREST, P163; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shen SZ, 2004, PALAEOGEOGR PALAEOCL, V208, P235, DOI 10.1016/j.palaeo.2004.03.009; STANLEY SM, 1980, GEOLOGY, V8, P422, DOI 10.1130/0091-7613(1980)8<422:LCIPPA>2.0.CO;2; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; STENSETH NC, 1984, OIKOS, V43, P417, DOI 10.2307/3544168; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; Valentine James W., 1993, P341; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WOOD SLB, 2006, THESIS VIRGINIA POLY; Wright SD, 2003, EVOLUTION, V57, P2893	72	576	596	11	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					102	106		10.1126/science.1130880	http://dx.doi.org/10.1126/science.1130880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023653				2022-12-28	WOS:000241031200044
J	Schlessinger, J; Lemmon, MA				Schlessinger, Joseph; Lemmon, Mark A.			Nuclear signaling by receptor tyrosine kinases: The first robin of spring	CELL			English	Review							CLEAVAGE; ERBB-4; LOCALIZATION; PROTEIN; DOMAIN	The role of receptor tyrosine kinases (RTKs) in transmembrane signaling is well established. Recently, ligand-dependent translocation of RTKs to the nucleus has been reported, but the functional importance of this process remains unclear. In this issue, Sardi et al. (2006) provide evidence for direct signaling in the nucleus by an intracellular ErbB4 receptor fragment that is released upon receptor activation by ligand. The fragment forms a complex with the adaptor TAB2 and the corepressor N-CoR and transits to the nucleus, where it represses transcription of genes that promote the formation of astrocytes.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania	Schlessinger, J (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu; mlemmon@mail.med.upenn.edu		Lemmon, Mark/0000-0002-3379-5319	NATIONAL CANCER INSTITUTE [R01CA079992, R01CA096768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA096768, R01-CA079992] Funding Source: Medline; NIAMS NIH HHS [R01-AR051889, R01-AR051448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; GOLDSTEIN, 2006, CELL, V124, P35; Krolewski JJ, 2005, J CELL BIOCHEM, V95, P478, DOI 10.1002/jcb.20451; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0	18	75	80	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					45	48		10.1016/j.cell.2006.09.013	http://dx.doi.org/10.1016/j.cell.2006.09.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018275	Bronze			2022-12-28	WOS:000241445800012
J	Kalus, RM; Shojania, KG; Amory, JK; Saint, S				Kalus, Robert M.; Shojania, Kaveh G.; Amory, John K.; Saint, Sanjay			Lost in transcription	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIAN ORDER ENTRY; ERRORS; SYSTEMS; SAFETY		Univ Washington, Dept Internal Med, Div Gen Internal Med, Seattle, WA 98104 USA; Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Washington; University of Washington Seattle; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Michigan System; University of Michigan	Kalus, RM (corresponding author), Univ Washington, Dept Internal Med, Div Gen Internal Med, Box 359702, Seattle, WA 98104 USA.	rkalus@u.washington.edu	Saint, Sanjay/AAF-5126-2019	Amory, John/0000-0002-7419-435X	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD045386] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Grove ML, 2003, BMJ-BRIT MED J, V326, P1145, DOI 10.1136/bmj.326.7399.1145-b; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; LOMAESTRO BM, 1992, JAMA-J AM MED ASSOC, V268, P2031, DOI 10.1001/jama.1992.03490150083021; Moore TJ, 2004, AM J HEALTH-SYST PH, V61, P1380, DOI 10.1093/ajhp/61.13.1380; Shojania KG, 2002, MED CLIN N AM, V86, P847, DOI 10.1016/S0025-7125(02)00016-0	9	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1487	1491		10.1056/NEJMcps054086	http://dx.doi.org/10.1056/NEJMcps054086			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021325				2022-12-28	WOS:000240976200012
J	Olson, EN				Olson, Eric N.			Gene regulatory networks in the evolution and development of the heart	SCIENCE			English	Review							BHLH TRANSCRIPTION FACTOR; T-BOX GENES; CARDIAC MORPHOGENESIS; CIONA-INTESTINALIS; VERTEBRATE HEART; HOMEOBOX GENE; DROSOPHILA; CELLS; TINMAN; DIFFERENTIATION	The heart, an ancient organ and the first to form and function during embryogenesis, evolved by the addition of new structures and functions to a primitive pump. Heart development is controlled by an evolutionarily conserved network of transcription factors that connect signaling pathways with genes for muscle growth, patterning, and contractility. During evolution, this ancestral gene network was expanded through gene duplication and co-option of additional networks. Mutations in components of the cardiac gene network cause congenital heart disease, the most common human birth defect. The consequences of such mutations reveal the logic of organogenesis and the evolutionary origins of morphological complexity.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, P01HL049953, R01HL053351] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL077439, P01 HL049953, R01 HL053351] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; AVERY L, 1997, NEMATODE C ELEGANS, V2, P679; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bishopric NH, 2005, ANN NY ACAD SCI, V1047, P13, DOI 10.1196/annals.1341.002; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BODMER R, 1993, DEVELOPMENT, V118, P719; BODMER R, 1995, TRENDS CARDIOVAS MED, V5, P21, DOI 10.1016/1050-1738(94)00032-Q; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen JN, 1996, DEVELOPMENT, V122, P3809; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; Cripps RM, 1998, DEV BIOL, V203, P106, DOI 10.1006/dbio.1998.9040; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson E. H., 2001, DEV EVOLUTION; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Fishman MC, 1997, CELL, V91, P153, DOI 10.1016/S0092-8674(00)80397-9; Fu YC, 1998, DEVELOPMENT, V125, P4439; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Holland ND, 2003, DEV BIOL, V255, P128, DOI 10.1016/S0012-1606(02)00050-7; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kolsch V, 2002, DEV GENES EVOL, V212, P473, DOI 10.1007/s00427-002-0268-6; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Miskolczi-McCallum CM, 2005, DEV BIOL, V278, P459, DOI 10.1016/j.ydbio.2004.11.026; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Riley PR, 2000, DEV BIOL, V227, P156, DOI 10.1006/dbio.2000.9864; ROMER AS, 1967, SCIENCE, V158, P1629, DOI 10.1126/science.158.3809.1629; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Simoes-Costa MS, 2005, DEV BIOL, V277, P1, DOI 10.1016/j.ydbio.2004.09.026; Sorrentino RP, 2005, SEMIN CELL DEV BIOL, V16, P107, DOI 10.1016/j.semcdb.2004.10.005; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	52	723	767	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1922	1927		10.1126/science.1132292	http://dx.doi.org/10.1126/science.1132292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008524	Green Accepted			2022-12-28	WOS:000240832200041
J	Rosato, M; Mwansambo, CW; Kazembe, PN; Phiri, T; Soko, QS; Lewycka, S; Kunyenge, BE; Vergnano, S; Osrin, D; Newell, ML; Costello, AMD				Rosato, Mikey; Mwansambo, Charles W.; Kazembe, Peter N.; Phiri, Tambosi; Soko, Queen S.; Lewycka, Sonia; Kunyenge, Beata E.; Vergnano, Stefania; Osrin, David; Newell, Marie-Louise; Costello, Anthony M. de L.			Women's groups' perceptions of maternal health issues in rural Malawi	LANCET			English	Article							NEONATAL-MORTALITY; CARE; INTERVENTIONS; DISTRICT; CONTEXT; TRIAL	Background Improvements in preventive and care-seeking behaviours to reduce maternal mortality in rural Africa depend on the knowledge and attitudes of women and communities. Surveys have indicated a poor awareness of maternal health problems by individual women. We report the perceptions of women's groups to such issues in the rural Mchinji district of Malawi. Methods Participatory women's groups in the Mchinji district identified maternal health problems (172 groups, 3171 women) and prioritised problems they considered most important (171 groups, 2833 women). In-depth qualitative data was obtained through six focus-group discussions with the women's groups, three with women's group facilitators, and four interviews with facilitator supervisors. Findings The maternal health problems most commonly identified by more than half the groups were anaemia (87%), malaria (80%), retained placenta (77%), obstructed labour (76%), malpresentation (71%), antepartum and postpartum haemorrhage (70% each), and pre-eclampsia (56%). The five problems prioritised as most important were anaemia (sum of rank score 304), malpresentation (295), retained placenta (277), obstructed labour (276). and postpartum haemorrhage (275). HIV/AIDS and sepsis were identified or prioritised much less because complexity and contextual factors hindered their consideration. Interpretation Rural Malawian women meeting in participatory groups showed a developed awareness of maternal health problems and the concern and motivation to address them. Community mobilisation strategies, such as women's groups, might be effective at reducing maternal mortality because they can draw on the collective capacity in communities to solve problems and make women's voices heard by decision-makers.	MaiMwana Project, Mchinji, Malawi; UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1E 6BT, England; Kamuzu Cent Hosp, Dept Paediat, Lilongwe, Malawi; Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkbele, South Africa	University of London; University College London; University of Kwazulu Natal	Rosato, M (corresponding author), MaiMwana Project, Box 2, Mchinji, Malawi.	m.rosato@ich.ucl.ac.uk	Newell, Marie-Louise/AAE-8222-2019; Lewycka, Sonia/J-1234-2019; Lewycka, Sonia/G-4698-2012; Vergnano, Stefi/AAR-3647-2020	Newell, Marie-Louise/0000-0002-1074-7699; Lewycka, Sonia/0000-0002-5923-9468; Osrin, David/0000-0001-9691-9684				ABOUZAHR C, 2003, MATERNAL MORTALITY 2; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; CHISALE CB, 2002, GOSPEL SEED CULTURE; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; ERICKSON N, 1995, WHAT HLTH CARE LIT R; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Freda M C, 1991, J Obstet Gynecol Neonatal Nurs, V20, P140, DOI 10.1111/j.1552-6909.1991.tb01686.x; Hasan I J, 2002, J Pak Med Assoc, V52, P148; Heggenhougen H. K., 2003, BEHAV SOCIAL ASPECTS; Helitzer-Allen DL, 1993, RES SOCIOL HLTH CARE, V10, P269; HOWARDGRABMAN L, 2002, WARMI PROJECT PARTIC; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kumbani L, 2002, Curationis, V25, P43; LEMA VM, 2005, E AFR MED J, V82, P1; Lofland J., 2006, ANAL SOCIAL SETTINGS; MACCORMACK C, 1992, SOC SCI MED, V35, P831, DOI 10.1016/0277-9536(92)90083-3; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McCoy D., 2004, REPORT COMMISSIONED; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; Mubyazi G, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-31; MWANSAMBO CW, 2006, REPR HLTH C AS MOTH; National Statistical Office Malawi and ORC Macro, 2005, MAL DEM HLTH SURV 20; Soltani M S, 1999, Sante Publique, V11, P203; Tadesse E, 2004, Cent Afr J Med, V50, P29; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Van Breugel J. W. M., 2001, KACHERE MONOGRAPH, V13; Waltensperger K., 2001, CULTURAL BELIEFS SOC; WONG GC, 1995, SOC SCI MED, V41, P1147, DOI 10.1016/0277-9536(94)00430-2	29	54	55	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1180	1188		10.1016/S0140-6736(06)69475-0	http://dx.doi.org/10.1016/S0140-6736(06)69475-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089XU	17011945				2022-12-28	WOS:000240916000030
J	Sirtori, CR; Calabresi, L				Sirtori, Cesare R.; Calabresi, Laura			Japan: are statins still good for everybody?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; RISK; SIMVASTATIN; TRIAL		Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Osped Niguarda Ca Granda, Univ Ctr Dyslipidaemias, I-20133 Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Sirtori, CR (corresponding author), Osped Niguarda Ca Granda, Univ Ctr Dyslipidaemias, I-20133 Milan, Italy.	cesare.sirtori@unimi.it	Sirtori, Cesare/F-4658-2012	Calabresi, Laura/0000-0001-5042-9532				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2004, LANCET, V363, P757; Howard BV, 2006, DIABETES CARE, V29, P391, DOI 10.2337/diacare.29.02.06.dc05-1299; Iwata H, 2006, CANCER SCI, V97, P133, DOI 10.1111/j.1349-7006.2006.00153.x; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Opie LH, 2006, LANCET, V367, P69, DOI 10.1016/S0140-6736(06)67927-0; PEDERSEN TR, 1994, LANCET, V344, P1383; Sirtori CR, 2006, LANCET, V367, P1141, DOI 10.1016/S0140-6736(06)68500-0; Sirtori CR, 2000, ATHEROSCLEROSIS, V152, P1, DOI 10.1016/S0021-9150(00)00551-7; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243	12	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1135	1136		10.1016/S0140-6736(06)69450-6	http://dx.doi.org/10.1016/S0140-6736(06)69450-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011926				2022-12-28	WOS:000240916000007
J	Mattila, PS				Mattila, Petri S.			Antibiotics in childhood acute otitis media	LANCET			English	Editorial Material									Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, FIN-00290 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Mattila, PS (corresponding author), Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, FIN-00290 Helsinki, Finland.	petri.mattila@hus.fi		Mattila, Petri/0000-0003-1911-1811				APPELMAN CLM, 1993, BRIT MED J, V306, P895, DOI 10.1136/bmj.306.6882.895; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Freid V M, 1998, Vital Health Stat 13, P1; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Venekamp RP, 2015, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000219.PUB4, 10.1002/14651858.CD000219.pub4]	7	4	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1397	1398		10.1016/S0140-6736(06)69580-9	http://dx.doi.org/10.1016/S0140-6736(06)69580-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055924				2022-12-28	WOS:000241459100005
J	Amenomori, M; Ayabe, S; Bi, XJ; Chen, D; Cui, SW; Danzengluobu; Ding, LK; Ding, XH; Feng, CF; Feng, ZY; Feng, ZY; Gao, XY; Geng, QX; Guo, HW; He, HH; He, M; Hibino, K; Hotta, N; Hu, HB; Hu, HB; Huang, J; Huang, Q; Jia, HY; Kajino, F; Kasahara, K; Katayose, Y; Kato, C; Kawata, K; Labaciren; Le, GM; Li, AF; Li, JY; Lou, YQ; Lu, H; Lu, SL; Meng, XR; Mizutani, K; Mu, J; Munakata, K; Nagai, A; Nanjo, H; Nishizawa, M; Ohnishi, M; Ohta, I; Onuma, H; Ouchi, T; Ozawa, S; Ren, JR; Saito, T; Saito, TY; Sakata, M; Sako, TK; Sasaki, T; Shibata, M; Shiomi, A; Shirai, T; Sugimoto, H; Takita, M; Tan, YH; Tateyama, N; Torii, S; Tsuchiya, H; Udo, S; Wang, B; Wang, H; Wang, X; Wang, YG; Wu, HR; Xue, L; Yamamoto, Y; Yan, CT; Yang, XC; Yasue, S; Ye, ZH; Yu, GC; Yuan, AF; Yuda, T; Zhang, HM; Zhang, JL; Zhang, NJ; Zhang, XY; Zhang, Y; Zhang, Y; Zhaxisangzhu; Zhou, XX				Amenomori, M.; Ayabe, S.; Bi, X. J.; Chen, D.; Cui, S. W.; Danzengluobu; Ding, L. K.; Ding, X. H.; Feng, C. F.; Feng, Zhaoyang; Feng, Z. Y.; Gao, X. Y.; Geng, Q. X.; Guo, H. W.; He, H. H.; He, M.; Hibino, K.; Hotta, N.; Hu, Haibing; Hu, H. B.; Huang, J.; Huang, Q.; Jia, H. Y.; Kajino, F.; Kasahara, K.; Katayose, Y.; Kato, C.; Kawata, K.; Labaciren; Le, G. M.; Li, A. F.; Li, J. Y.; Lou, Y. -Q.; Lu, H.; Lu, S. L.; Meng, X. R.; Mizutani, K.; Mu, J.; Munakata, K.; Nagai, A.; Nanjo, H.; Nishizawa, M.; Ohnishi, M.; Ohta, I.; Onuma, H.; Ouchi, T.; Ozawa, S.; Ren, J. R.; Saito, T.; Saito, T. Y.; Sakata, M.; Sako, T. K.; Sasaki, T.; Shibata, M.; Shiomi, A.; Shirai, T.; Sugimoto, H.; Takita, M.; Tan, Y. H.; Tateyama, N.; Torii, S.; Tsuchiya, H.; Udo, S.; Wang, B.; Wang, H.; Wang, X.; Wang, Y. G.; Wu, H. R.; Xue, L.; Yamamoto, Y.; Yan, C. T.; Yang, X. C.; Yasue, S.; Ye, Z. H.; Yu, G. C.; Yuan, A. F.; Yuda, T.; Zhang, H. M.; Zhang, J. L.; Zhang, N. J.; Zhang, X. Y.; Zhang, Y.; Zhang, Yi; Zhaxisangzhu; Zhou, X. X.		Tibet AS Collaboration	Anisotropy and corotation of Galactic cosmic rays	SCIENCE			English	Article							AIR-SHOWER ARRAY; SIDEREAL ANISOTROPIES; ENERGY REGION; POINT SOURCES; ORIGIN; PERFORMANCE; INTENSITY; EMISSION; SEARCH; GAS	The intensity of Galactic cosmic rays is nearly isotropic because of the influence of magnetic fields in the Milky Way. Here, we present two-dimensional high-precision anisotropy measurement for energies from a few to several hundred teraelectronvolts (TeV), using the large data sample of the Tibet Air Shower Arrays. Besides revealing finer details of the known anisotropies, a new component of Galactic cosmic ray anisotropy in sidereal time is uncovered around the Cygnus region direction. For cosmic-ray energies up to a few hundred TeV, all components of anisotropies fade away, showing a corotation of Galactic cosmic rays with the local Galactic magnetic environment. These results have broad implications for a comprehensive understanding of cosmic rays, supernovae, magnetic fields, and heliospheric and Galactic dynamic environments.	Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing 100049, Peoples R China; Hirosaki Univ, Dept Phys, Hirosaki, Aomori 0368561, Japan; Saitama Univ, Dept Phys, Saitama 3388570, Japan; Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; Hebei Normal Univ, Dept Phys, Shijiazhuang 050016, Peoples R China; Tibet Univ, Dept Math & Phys, Lhasa 850000, Peoples R China; Shandong Univ, Dept Phys, Jinan 250100, Peoples R China; SW Jiaotong Univ, Inst Modern Phys, Chengdu 610031, Peoples R China; Yunnan Univ, Dept Phys, Kunming 650091, Peoples R China; Kanagawa Univ, Fac Engn, Yokohama, Kanagawa 2218686, Japan; Utsunomiya Univ, Fac Educ, Utsunomiya, Tochigi 3218505, Japan; Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; Konan Univ, Dept Phys, Kobe, Hyogo 6588501, Japan; Shibaura Inst Technol, Fac Syst Engn, Saitama 3378570, Japan; Shinshu Univ, Dept Phys, Matsumoto, Nagano 3908621, Japan; Chinese Acad Sci, Ctr Space Sci & Applicat Res, Beijing 100080, Peoples R China; Tsing Hua Univ, Dept Phys, Beijing 100084, Peoples R China; Tsing Hua Univ, Tsinghua Ctr Astrophys, Beijing 100084, Peoples R China; Waseda Univ, Adv Res Inst Sci & Engn, Tokyo 1698555, Japan; Utsunomiya Univ, Adv Media Newtork Ctr, Utsunomiya, Tochigi 3218585, Japan; Natl Inst Informat, Tokyo 1018430, Japan; Univ Air, Tochigi Study Ctr, Utsunomiya, Tochigi 3210943, Japan; Tokyo Metropolitan Coll Ind Technol, Tokyo 1168523, Japan; Shonan Inst Technol, Fujisawa, Kanagawa 2518511, Japan; RIKEN, Wako, Saitama 3510198, Japan; Shinshu Univ, Sch Gen Educ, Matsumoto, Nagano 3908621, Japan	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Hirosaki University; Saitama University; Yokohama National University; Hebei Normal University; Tibet University; Shandong University; Chinese Academy of Sciences; Southwest Jiaotong University; Yunnan University; Kanagawa University; Utsunomiya University; University of Tokyo; Konan University; Shibaura Institute of Technology; Shinshu University; Chinese Academy of Sciences; Tsinghua University; Tsinghua University; Waseda University; Utsunomiya University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; RIKEN; Shinshu University	Zhang, Y (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing 100049, Peoples R China.	zhangyi@mail.ihep.ac.cn	Tsuchiya, Harufumi/H-4145-2019; Tsuchiya, Harufumi/F-5232-2019; Torii, Shoji/AAF-5199-2021	Tsuchiya, Harufumi/0000-0002-5581-0006; Zhang, Yi/0000-0001-6223-4724; Sako, T. K./0000-0002-7003-6493; Yan, Chi-Tau/0000-0002-9668-9740; KATAYOSE, Yusaku/0000-0003-4836-7621				Aglietta M, 2003, P 28 INT COSM RAY C, P183; Aharonian F, 2002, ASTRON ASTROPHYS, V393, pL37, DOI 10.1051/0004-6361:20021171; Ambrosio M, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.042002; Amenomori M, 2005, ASTROPHYS J, V633, P1005, DOI 10.1086/491612; Amenomori M, 2005, ASTROPHYS J, V626, pL29, DOI 10.1086/431582; Amenomori M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.061101; AMENOMORI M, 1990, NUCL INSTRUM METH A, V288, P619, DOI 10.1016/0168-9002(90)90161-X; Amenomori M, 2003, ASTROPHYS J, V598, P242, DOI 10.1086/378350; Amenomori M, 2001, AIP CONF PROC, V558, P557, DOI 10.1063/1.1370823; AMENOMORI M, 1993, PHYS REV D, V47, P2675, DOI 10.1103/PhysRevD.47.2675; AMENOMORI M, 1992, PHYS REV LETT, V69, P2468, DOI 10.1103/PhysRevLett.69.2468; AMENOMORI M, 2002, P 27 INT COSM RAY C, V2, P573; Antoni T, 2004, ASTROPHYS J, V604, P687, DOI 10.1086/382039; Atkins R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.251103; BERGAMASCO L, 1990, P 21 INT COSM RAY C, V6, P372; Compton AH, 1935, PHYS REV, V47, P0817, DOI 10.1103/PhysRev.47.817; CUTLER DJ, 1986, NATURE, V322, P434, DOI 10.1038/322434a0; Dar A, 2005, NUOVO CIMENTO B, V120, P767, DOI 10.1393/ncb/i2005-10119-y; Duldig ML, 2001, PUBL ASTRON SOC AUST, V18, P12, DOI 10.1071/AS01003; Erlykin AD, 2006, ASTROPART PHYS, V25, P183, DOI 10.1016/j.astropartphys.2006.01.003; Fan ZH, 1996, NATURE, V383, P800, DOI 10.1038/383800a0; GUILLIAN G, IN PRESS PHYS REV D; Hall DL, 1999, J GEOPHYS RES-SPACE, V104, P6737, DOI 10.1029/1998JA900107; Hall DL, 1998, J GEOPHYS RES-SPACE, V103, P367, DOI 10.1029/97JA02520; HEBER B, 2002, P 27 INT COSM RAY C, P118; Hunter SD, 1997, ASTROPHYS J, V481, P205, DOI 10.1086/304012; Krymsky G F., 1964, GEOMAGN AERON, V977, P763; Lou YQ, 2003, MON NOT R ASTRON SOC, V341, P909, DOI 10.1046/j.1365-8711.2003.06461.x; LOU YQ, 1994, ASTROPHYS J, V428, pL21, DOI 10.1086/187383; LOU YQ, 2006, IN PRESS MON NOT R A; Munakata K, 1997, PHYS REV D, V56, P23, DOI 10.1103/PhysRevD.56.23; Nagashima K, 1998, J GEOPHYS RES-SPACE, V103, P17429, DOI 10.1029/98JA01105; Nagashima K., 1976, P INT COSM RAY S HIG, P326; PARKER EN, 1965, PLANET SPACE SCI, V13, P9, DOI 10.1016/0032-0633(65)90131-5; PARKER EN, 1966, ASTROPHYS J, V145, P811, DOI 10.1086/148828; VOELK HJ, 2003, FRONTIERS COSMIC RAY, P29; Walker G, 2004, ASTROPHYS J, V614, pL93, DOI 10.1086/425863; Yu C, 2006, MON NOT R ASTRON SOC, V370, P121, DOI 10.1111/j.1365-2966.2006.10432.x	38	184	193	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					439	443		10.1126/science.1131702	http://dx.doi.org/10.1126/science.1131702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053141	Green Submitted			2022-12-28	WOS:000241382500034
J	Mahata, B; Mukherjee, S; Mishra, S; Bandyopadhyay, A; Adhya, S				Mahata, Bidesh; Mukherjee, Saikat; Mishra, Sumita; Bandyopadhyay, Arun; Adhya, Samit			Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells	SCIENCE			English	Article							LEISHMANIA-MITOCHONDRIA; ALZHEIMER-DISEASE; MERRF-SYNDROME; DNA; MUTATION; IMPORT; ENDOCYTOSIS; TRNA(LYS); DELETIONS; MEMBRANE	Many maternally inherited and incurable neuromyopathies are caused by mutations in mitochondrial (mt) transfer RNA ( tRNA) genes. Kinetoplastid protozoa, including Leishmania, have evolved specialized systems for importing nucleus-encoded tRNAs into mitochondria. We found that the Leishmania RNA import complex (RIC) could enter human cells by a caveolin-1-dependent pathway, where it induced import of endogenous cytosolic tRNAs, including tRNALys, and restored mitochondrial function in a cybrid harboring a mutant mt tRNALys (MT-TK) gene. The use of protein complexes to modulate mitochondrial function may help in the management of such genetic disorders.	Indian Inst Chem Biol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adhya, S (corresponding author), Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	sadhya@iicb.res.in	MUKHERJEE, SAIKAT/ABF-1050-2021	Mahata, Bidesh/0000-0002-4506-0184; Mishra, Sumita/0000-0002-6455-4075				Bhattacharyya SN, 2003, MOL CELL BIOL, V23, P5217, DOI 10.1128/MCB.23.15.5217-5224.2003; Bhattacharyya Suvendra Nath, 2004, RNA Biol, V1, P84, DOI 10.4161/rna.1.2.1180; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; Goswami S, 2003, NUCLEIC ACIDS RES, V31, P5552, DOI 10.1093/nar/gkg773; Goswami S, 2006, P NATL ACAD SCI USA, V103, P8354, DOI 10.1073/pnas.0510869103; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GOTO Y, 1995, MUSCLE NERVE, pS107; HAUSER R, 1995, EMBO J, V14, P4212, DOI 10.1002/j.1460-2075.1995.tb00095.x; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	23	77	80	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					471	474		10.1126/science.1129754	http://dx.doi.org/10.1126/science.1129754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053148				2022-12-28	WOS:000241382500044
J	Fraser, IP; Cserti, CM; Dzik, WH; Pasternack, MS; Harris, NL				Fraser, Iain P.; Cserti, Christine M.; Dzik, Walter H.; Pasternack, Mark S.; Harris, Nancy Lee			A 3-year-old girl with fever after a visit to Africa - Severe Plasmodium falciparum malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXCHANGE-TRANSFUSION; TRAVELERS; CYTOADHERENCE; ERYTHROCYTES; DIAGNOSIS; PROGNOSIS; SPECTRUM; CHILDREN; ADJUNCT; DISEASE		Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Fraser, IP (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.		Cserti-Gazdewich, Christine/AAK-7413-2021	Cserti-Gazdewich, Christine/0000-0002-5297-6406				Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Burchard GD, 1997, TROP MED INT HEALTH, V2, P733, DOI 10.1046/j.1365-3156.1997.d01-375.x; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Franco-Paredes C, 2006, LANCET INFECT DIS, V6, P139, DOI 10.1016/S1473-3099(06)70410-8; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; GARCIA LS, 2001, DIAGNOSTIC MED PARAS, P159; Hanscheid T, 1999, CLIN LAB HAEMATOL, V21, P235, DOI 10.1046/j.1365-2257.1999.00220.x; Hill DR, 2006, NEW ENGL J MED, V354, P115, DOI 10.1056/NEJMp058292; Hoontrakoon S, 1998, TROP MED INT HEALTH, V3, P156, DOI 10.1111/j.1365-3156.1998.00198.x; Lyke KE, 2003, AM J TROP MED HYG, V69, P253, DOI 10.4269/ajtmh.2003.69.253; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; Riddle MS, 2002, CLIN INFECT DIS, V34, P1192, DOI 10.1086/339810; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SOWUNMI A, 1992, ANN TROP PAEDIATR, V12, P155, DOI 10.1080/02724936.1992.11747561; Stauffer W, 2003, CLIN INFECT DIS, V37, P1340, DOI 10.1086/379074; WATT G, 1992, T ROY SOC TROP MED H, V86, P359, DOI 10.1016/0035-9203(92)90217-Z; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; WHO UNICEF, 2005, WORLD MALARIA REPORT; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298	22	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1715	1722		10.1056/NEJMcpc069022	http://dx.doi.org/10.1056/NEJMcpc069022			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050896				2022-12-28	WOS:000241357300014
J	Lin, MT; Beal, MF				Lin, Michael T.; Beal, M. Flint			Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases	NATURE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; SYNUCLEIN TRANSGENIC MICE; SUBSTANTIA-NIGRA NEURONS; ONSET PARKINSONS-DISEASE; PROLYL ISOMERASE PIN1; CYTOCHROME-C RELEASE; DEPENDENT CELL-DEATH; MTDNA CONTROL-REGION; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE	Many lines of evidence suggest that mitochondria have a central role in ageing-related neurodegenerative diseases. Mitochondria are critical regulators of cell death, a key feature of neurodegeneration. Mutations in mitochondrial DNA and oxidative stress both contribute to ageing, which is the greatest risk factor for neurodegenerative diseases. In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis. Moreover, an impressive number of disease-specific proteins interact with mitochondria. Thus, therapies targeting basic mitochondrial processes, such as energy metabolism or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Beal, MF (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Room F-160,525 E 68th St, New York, NY 10021 USA.	fbeal@med.cornell.edu						Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kong JM, 1998, J NEUROSCI, V18, P3241; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lovell MA, 2004, J ALZHEIMERS DIS, V6, P659; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Meulener MC, 2005, J NEUROCHEM, V93, P1524, DOI 10.1111/j.1471-4159.2005.03145.x; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Ohyagi Y, 2000, NEUROREPORT, V11, P167, DOI 10.1097/00001756-200001170-00033; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Rathke-Hartlieb S, 2002, EXP NEUROL, V175, P87, DOI 10.1006/exnr.2002.7868; Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X; Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787; Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Sun JT, 2002, GENETICS, V161, P661; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tanasichuk RW, 2002, FISH OCEANOGR, V11, P18, DOI 10.1046/j.1365-2419.2002.00185.x; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	100	4285	4440	28	1035	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					787	795		10.1038/nature05292	http://dx.doi.org/10.1038/nature05292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051205				2022-12-28	WOS:000241362700038
J	Schaeffer, AJ				Schaeffer, Anthony J.			Chronic prostatitis and the chronic pelvic pain syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC BACTERIAL PROSTATITIS; PLACEBO-CONTROLLED MULTICENTER; CHRONIC ABACTERIAL PROSTATITIS; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; NATIONAL-INSTITUTES; FOLLOW-UP; INTRAVENOUS UROGRAPHY; SYMPTOM INDEX; MEN		Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Schaeffer, AJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA.	ajschaeffer@northwestern.edu			NIDDK NIH HHS [U01 DK65277-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK065277] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; Anderson RU, 2005, J UROLOGY, V174, P155, DOI 10.1097/01.ju.0000161609.31185.d5; Andrews SJ, 2002, BRIT MED J, V324, P454, DOI 10.1136/bmj.324.7335.454; Barbalias GA, 1998, J UROLOGY, V159, P883, DOI 10.1016/S0022-5347(01)63761-3; Bates S, 2000, SEX TRANSM INFECT, V76, P398, DOI 10.1136/sti.76.5.398; Bundrick W, 2003, UROLOGY, V62, P537, DOI 10.1016/S0090-4295(03)00565-X; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Cheah PY, 2003, J UROLOGY, V169, P592, DOI 10.1016/S0022-5347(05)63960-2; Cheah PY, 2003, UROLOGY, V61, P60, DOI 10.1016/S0090-4295(02)02081-2; Chen R, 2003, UROLOGY, V61, P1156, DOI 10.1016/S0090-4295(03)00141-9; Collins MM, 2000, ANN INTERN MED, V133, P367, DOI 10.7326/0003-4819-133-5-200009050-00013; Collins MM, 2000, UROLOGY, V55, P403, DOI 10.1016/S0090-4295(99)00536-1; Collins MM, 2001, J UROLOGY, V166, P1800, DOI 10.1016/S0022-5347(05)65678-9; Collins MM, 2001, J GEN INTERN MED, V16, P656; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; De Rose AF, 2004, UROLOGY, V63, P13, DOI 10.1016/j.urology.2003.08.006; DELAROSETTE JJMCH, 1993, UROLOGY, V41, P301, DOI 10.1016/0090-4295(93)90584-W; DOBLE A, 1991, UROLOGY, V38, P247, DOI 10.1016/S0090-4295(91)80355-B; Engeler DS, 2003, EUR UROL, V44, P546, DOI 10.1016/S0302-2838(03)00370-1; Evliyaoglu Yalcin, 2002, International Urology and Nephrology, V34, P351, DOI 10.1023/A:1024487604631; FELICIANO AE, 1999, TXB PROSTATITIS, P311; GOLZ R, 1991, MYCOSES, V34, P381, DOI 10.1111/j.1439-0507.1991.tb00799.x; HANUS PM, 1984, CLIN PHARMACY, V3, P49; Hu WL, 2002, ASIAN J ANDROL, V4, P163; Kaplan SA, 1996, UROLOGY, V47, P836, DOI 10.1016/S0090-4295(96)00038-6; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, J UROLOGY, V167, P2574, DOI 10.1016/S0022-5347(05)65041-0; Little MA, 2000, NEPHROL DIAL TRANSPL, V15, P200, DOI 10.1093/ndt/15.2.200; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; MEARES EM, 1968, INVEST UROL, V5, P492; Mehik A, 2003, UROLOGY, V62, P425, DOI 10.1016/S0090-4295(03)00466-7; Motrich RD, 2005, HUM REPROD, V20, P2567, DOI 10.1093/humrep/dei073; Naber KG, 2002, INT J ANTIMICROB AG, V20, P18, DOI 10.1016/S0924-8579(02)00067-5; Naber KG, 2000, INT J ANTIMICROB AG, V14, P143, DOI 10.1016/S0924-8579(99)00142-9; Nadler RB, 2006, UROLOGY, V67, P337, DOI 10.1016/j.urology.2005.08.031; Nadler RB, 2002, UROLOGY, V60, P42, DOI 10.1016/S0090-4295(02)02390-7; Nadler RB, 2001, J UROLOGY, V166, P2293, DOI 10.1016/S0022-5347(05)65554-1; Nickel J C, 1997, Tech Urol, V3, P38; Nickel JC, 2005, J UROLOGY, V173, P1252, DOI 10.1097/01.ju.0000159198.83103.01; Nickel JC, 2004, BJU INT, V93, P991, DOI 10.1111/j.1464-410X.2003.04766.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nickel JC, 2003, UROLOGY, V62, P614, DOI 10.1016/S0090-4295(03)00583-1; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Pontari MA, 2003, DRUG AGING, V20, P1111, DOI 10.2165/00002512-200320150-00004; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; SCHAEFFER AJ, 1990, J UROLOGY, V144, P690, DOI 10.1016/S0022-5347(17)39556-3; Schneider H, 2004, UROLOGY, V63, P1027, DOI 10.1016/j.urology.2004.02.002; Shoskes DA, 2002, UROLOGY, V60, P35, DOI 10.1016/S0090-4295(02)02383-X; WEIDNER W, 1991, INFECTION, V19, pS119, DOI 10.1007/BF01643680; WEIDNER W, 1991, J UROLOGY, V146, P350, DOI 10.1016/S0022-5347(17)37791-1; WEIDNER W, 1994, PROSTATITIS ETIOPATH, P158	51	144	159	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1690	1698		10.1056/NEJMcp060423	http://dx.doi.org/10.1056/NEJMcp060423			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050893				2022-12-28	WOS:000241357300010
J	Brown, P; Brunnhuber, K; Chalkidou, K; Chalmers, I; Clarke, M; Fenton, M; Forbes, C; Glanville, J; Hicks, NJ; Moody, J; Twaddle, S; Timimi, H; Young, P				Brown, P.; Brunnhuber, K.; Chalkidou, K.; Chalmers, I.; Clarke, M.; Fenton, M.; Forbes, C.; Glanville, J.; Hicks, N. J.; Moody, J.; Twaddle, S.; Timimi, H.; Young, P.			Health research - How to formulate research recommendations	BRITISH MEDICAL JOURNAL			English	Editorial Material							STROKE; TRIAL		BMJ Publishing Grp, London WC1H 9JR, England; Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England; James Lind Initiat, Jamse Lind Alliance Secretariat, Database Uncertainties Effects Treatments, Oxford OX2 7LG, England; UK Cochrane Ctr, Oxford OX2 7LG, England; Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Southampton, Natl Coordinating Ctr Hlth Technol Assessment, Southampton SO16 7PX, Hants, England; Scottish Intercollegiate Guidelines Network, Edinburgh EH2 1EN, Midlothian, Scotland; Update Software, Oxford OX2 7LG, England	BMJ Publishing Group Ltd; National Institute for Health & Care Excellence; Cochrane Centre; University of York - UK; University of Southampton	Brown, P (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.	pbrown@bmjgroup.com	Glanville, Julie May/C-2358-2008	Glanville, Julie May/0000-0002-1253-8524				CANNON M, 1996, J NEUROL NEUROSUR PS, V61, P604; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; LIP GYH, 2006, CLIN EVIDENCE, V15, P52; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mant J, 2006, BMJ-BRIT MED J, V332, P635, DOI 10.1136/bmj.38758.600116.AE; McIntosh AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003442.pub2; O'Donnell C, 2003, BMJ-BRIT MED J, V327, P834, DOI 10.1136/bmj.327.7419.834; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Richardson W S, 1995, ACP J Club, V123, pA12; WARBURTON E, 2006, CLIN EVIDENCE, V15, P49	10	207	208	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 14	2006	333	7572					804	806		10.1136/bmj.38987.492014.94	http://dx.doi.org/10.1136/bmj.38987.492014.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038740	Green Published			2022-12-28	WOS:000241566000020
J	Sussman, BJ; Townsend, D; Ivanov, MY; Stolow, A				Sussman, Benjamin J.; Townsend, Dave; Ivanov, Misha Yu.; Stolow, Albert			Dynamic stark control of photochemical processes	SCIENCE			English	Article							MULTIELECTRON DISSOCIATIVE IONIZATION; LASER-PULSES; IBR; PHOTODISSOCIATION; FIELD; PREDISSOCIATION; TRANSITIONS; CHEMISTRY; OZONE; MODEL	A method is presented for controlling the outcome of photochemical reactions by using the dynamic Stark effect due to a strong, nonresonant infrared field. The application of a precisely timed infrared laser pulse reversibly modifies potential energy barriers during a chemical reaction without inducing any real electronic transitions. Dynamic Stark control (DSC) is experimentally demonstrated for a nonadiabatic photochemical reaction, showing substantial modification of reaction channel probabilities in the dissociation of IBr. The DSC process is nonperturbative and insensitive to laser frequency and affects all polarizable molecules, suggesting broad applicability.	Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada	National Research Council Canada; Queens University - Canada	Stolow, A (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	albert.stolow@nrc.ca	Ivanov, Mikhail/AAG-1727-2021; Townsend, Dave/K-3461-2015; Stolow, Albert/AAN-5609-2020					Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bandrauk A.D., 1994, MOL LASER FIELDS; Brumer P., 2003, PRINCIPLES QUANTUM C; CHAN CK, 1991, J CHEM PHYS, V94, P2688, DOI 10.1063/1.459843; CHILD MS, 1976, MOL PHYS, V32, P1495, DOI 10.1080/00268977600102861; CORNAGGIA C, 1990, PHYS REV A, V42, P5464, DOI 10.1103/PhysRevA.42.5464; Domcke W., 2004, CONICAL INTERSECTION, VVol. 15; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; FRASINSKI LJ, 1987, PHYS REV LETT, V58, P2424, DOI 10.1103/PhysRevLett.58.2424; GARCIA RR, 1994, J GEOPHYS RES-ATMOS, V99, P12937, DOI 10.1029/94JD00725; GEORGE TF, 1977, FARADAY DISCUSS, V62, P246, DOI 10.1039/dc9776200246; GROSS P, 1994, CHEM PHYS LETT, V223, P263, DOI 10.1016/0009-2614(94)00447-1; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Lezius M, 2001, PHYS REV LETT, V86, P51, DOI 10.1103/PhysRevLett.86.51; Niikura H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.203601; Patchkovskii S, 2006, PHYS CHEM CHEM PHYS, V8, P926, DOI 10.1039/b515192a; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Rabitz H, 2003, SCIENCE, V299, P525, DOI 10.1126/science.1080683; Rice S. A., 2000, OPTICAL CONTROL MOL; SHAPIRO M, 1986, J CHEM PHYS, V85, P6449, DOI 10.1063/1.451474; SHAPIRO M, 1985, J CHEM PHYS, V83, P1588, DOI 10.1063/1.449395; SHORE BK, 1990, THEORY COHERENT ATOM; Shore BW., 1990, THEORY COHERENT ATOM; Sussman BJ, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.053403; Sussman BJ, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.051401; Vardi A, 1998, PHYS REV A, V58, P1352, DOI 10.1103/PhysRevA.58.1352; Vogt R, 1999, J ATMOS CHEM, V32, P375, DOI 10.1023/A:1006179901037; Wrede E, 2001, J CHEM PHYS, V114, P2629, DOI 10.1063/1.1337049; Zhu CY, 2001, ADV CHEM PHYS, V117, P127, DOI 10.1002/9780470141779.ch2	30	300	300	0	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					278	281		10.1126/science.1132289	http://dx.doi.org/10.1126/science.1132289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038617				2022-12-28	WOS:000241194100035
J	Zelhof, AC; Hardy, RW; Becker, A; Zuker, CS				Zelhof, Andrew C.; Hardy, Robert W.; Becker, Ann; Zuker, Charles S.			Transforming the architecture of compound eyes	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENE-FUNCTION; MORPHOGENESIS; CHAOPTIN; PHOTORECEPTORS; DEGENERATION; GLYCOPROTEIN; PROMININ; MUTANTS	Eyes differ markedly in the animal kingdom, and are an extreme example of the evolution of multiple anatomical solutions to light detection and image formation. A salient feature of all photoreceptor cells is the presence of a specialized compartment ( disc outer segments in vertebrates, and microvillar rhabdomeres in insects), whose primary role is to accommodate the millions of light receptor molecules required for efficient photon collection. In insects, compound eyes can have very different inner architectures(1-3). Fruitflies and houseflies have an open rhabdom system, in which the seven rhabdomeres of each ommatidium are separated from each other and function as independent light guides. In contrast, bees and various mosquitoes and beetle species have a closed system, in which rhabdomeres within each ommatidium are fused to each other, thus sharing the same visual axis. To understand the transition between open and closed rhabdom systems, we isolated and characterized the role of Drosophila genes involved in rhabdomere assembly. Here we show that Spacemaker, a secreted protein expressed only in the eyes of insects with open rhabdom systems, acts together with Prominin and the cell adhesion molecule Chaoptin to choreograph the partitioning of rhabdomeres into an open system. Furthermore, the complete loss of spacemaker (spam) converts an open rhabdom system to a closed one, whereas its targeted expression to photoreceptors of a closed system markedly reorganizes the architecture of the compound eyes to resemble an open system. Our results provide a molecular atlas for the construction of microvillar assemblies and illustrate the critical effect of differences in a single structural protein in morphogenesis.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	azelhof@flyeye.ucsd.edu; charles@flyeye.ucsd.edu		Zelhof, Andrew/0000-0001-7085-822X	NEI NIH HHS [R01 EY006979, R01 EY006979-17] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006979] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Franceschini N., 1972, INFORMATION PROCESSI, P75; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Land M.F., 1989, P90; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Nilsson D.-E., 1989, P30; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Shaw S.R., 1989, P186; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; Yoon CS, 1996, CELL TISSUE RES, V284, P77, DOI 10.1007/s004410050568; Zelhof AC, 2004, J CELL BIOL, V164, P417, DOI 10.1083/jcb.200307048; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	21	125	128	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					696	699		10.1038/nature05128	http://dx.doi.org/10.1038/nature05128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036004				2022-12-28	WOS:000241160500047
J	Kim, H; Lim, SW; Kim, S; Kim, JW; Chang, YH; Carroll, BJ; Kim, DK				Kim, Hyeran; Lim, Shinn-Won; Kim, Seonwoo; Kim, Jong-Won; Chang, Yun Hee; Carroll, Bernard J.; Kim, Doh Kwan			Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; HUMAN NOREPINEPHRINE TRANSPORTER; RECURRENT MAJOR DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; ALLELIC VARIATION; ASSOCIATION; PROMOTER; EFFICACY; DISORDER; VARIANTS	Context Polymorphisms in the serotonin transporter gene (5-HTT) may influence antidepressant response to selective serotonin reuptake inhibitors (SSRIs). The norepinephrine transporter ( NET) is the analogous target for norepinephrine reuptake inhibitors (NRIs). Objective To determine whether antidepressant responses to SSRIs or NRIs are associated with genetic polymorphisms of the corresponding monoamine transporters. Design, Setting, and Patients A 6-week naturalistic treatment study with blinded outcome evaluation of 241 Korean inpatients and outpatients with major depression at an academic psychiatry service. Patients were recruited to the study from March 1998 through February 2003. Interventions Treatment with an SSRI (fluoxetine or sertraline; n=136) or an NRI ( nortriptyline; n=105) antidepressant. Adherence was assessed by measuring plasma concentration at 4 weeks. Patients were genotyped for s/l polymorphisms in 5-HTT promoter region (5-HTTLPR), 5-HTT intron 2 s/l variation, and NET G1287A variation of exon 9. Main Outcome Measures An SSRI and NRI response ( defined as >= 50% decrease in Hamilton Rating Scale for Depression score at 6 weeks). Results NRI response was associated with the NET G1287A polymorphism ( odds ratio [ OR], 7.54; 95% confidence interval [CI], 2.53-22.49; P <. 001). An SSRI response was associated with the 5-HTT intron 2 s/l variation ( OR, 20.11; 95% CI, 4.27-94.74; P <. 001). The 5-HTTLPR was also associated with an SSRI response ( OR, 3.34; 95% CI, 1.41-7.91; P=. 006). In contrast to studies in white patients, the favorable allele for SSRI response was S 5-HTTLPR. The S 5-HTTLPR was associated also with NRI response ( OR, 3.73; 95% CI, 1.32-10.53; P=. 01). The NET polymorphism was not associated with an SSRI response. The NET G1287A GG genotype (56% of the population) was associated with better response to the NRI (83.3% [35/42]) than to SSRI ( 58.7% [44/75]) ( OR, 3.52; 95% CI, 1.39-8.95; P=. 006). Some genotype combinations were associated with high rates of antidepressant response and others with low rates of response. Conclusions Monoamine transporter gene polymorphisms were associated with response to antidepressants with homologous monoamine transporter targets. Combinations of polymorphisms were informative for response and nonresponse. Confirmation of these preliminary findings would permit refined pharmacogenetic selection of antidepressant treatment.	Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Genet, Seoul 135710, South Korea; Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; Samsung Biomed Res Inst, Biostat Unit, Seoul, South Korea; Myongji Univ, Dept Food & Nutr, Yongin, South Korea; Pacific Behav Res Fdn, Carmel, CA USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Myongji University	Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 135710, South Korea.	paulkim@smc.samsung.co.kr	Kim, Doh Kwan/F-4616-2014; Kim, Jong Won/C-9615-2011	Kim, Doh Kwan/0000-0002-2302-6153; 				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Arias B, 2003, J CLIN PSYCHOPHARM, V23, P563, DOI 10.1097/01.jcp.0000095350.32154.73; Bellivier F, 1998, NEUROSCI LETT, V255, P143, DOI 10.1016/S0304-3940(98)00677-6; Benedetti F, 2003, BIOL PSYCHIAT, V54, P687, DOI 10.1016/S0006-3223(02)01894-2; DELGADO PL, 1993, PSYCHOPHARMACOL BULL, V29, P389; DELGADO PL, 1991, PSYCHOPHARMACOL BULL, V27, P321; Driscoll HC, 2005, INT J GERIATR PSYCH, V20, P661, DOI 10.1002/gps.1334; Durham LK, 2004, PSYCHOPHARMACOLOGY, V174, P525, DOI 10.1007/s00213-003-1562-3; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; First M. B., 1997, STRUCTURED CLIN INTE; Fredman SJ, 2000, J CLIN PSYCHIAT, V61, P403, DOI 10.4088/JCP.v61n0602; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Golimbet V. E., 2002, Genetika, V38, P671; Hachisu Mitsugu, 2000, Folia Pharmacologica Japonica, V115, P271, DOI 10.1254/fpj.115.271; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Jonsson EG, 1998, PSYCHIAT RES, V79, P1, DOI 10.1016/S0165-1781(98)00027-4; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Koch S, 2002, NEUROPSYCHOPHARMACOL, V27, P949, DOI 10.1016/S0893-133X(02)00377-9; Kollroser M, 2002, THER DRUG MONIT, V24, P537, DOI 10.1097/00007691-200208000-00013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Leszczynska-Rodziewicz A, 2002, NEUROPSYCHOBIOLOGY, V45, P182, DOI 10.1159/000063668; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; McGue M, 1997, J ABNORM PSYCHOL, V106, P439, DOI 10.1037/0021-843X.106.3.439; Minov C, 2001, NEUROSCI LETT, V303, P119, DOI 10.1016/S0304-3940(01)01704-9; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Ng CH, 2006, INT CLIN PSYCHOPHARM, V21, P87, DOI 10.1097/01.yic.0000188214.46667.3f; NYSTROM C, 1985, ACTA PSYCHIAT SCAND, V72, P6, DOI 10.1111/j.1600-0447.1985.tb02563.x; ORSULAK PJ, 2001, CLIN TOXICOLOGY LAB; Owen D, 1999, PSYCHIAT RES, V87, P1, DOI 10.1016/S0165-1781(99)00050-5; Perlis RH, 2003, BIOL PSYCHIAT, V54, P879, DOI 10.1016/S0006-3223(03)00424-4; Pollock BG, 2000, NEUROPSYCHOPHARMACOL, V23, P587, DOI 10.1016/S0893-133X(00)00132-9; Rausch JL, 2002, BIOL PSYCHIAT, V51, P723, DOI 10.1016/S0006-3223(01)01283-5; Reynolds CF, 1996, AM J PSYCHIAT, V153, P1288; Reynolds CF, 1998, AM J PSYCHIAT, V155, P795; Runkel F, 2000, PHARMACOGENETICS, V10, P397, DOI 10.1097/00008571-200007000-00003; Samochowiec J, 2002, PSYCHIAT RES, V111, P229, DOI 10.1016/S0165-1781(02)00145-2; Sand PG, 2002, NEUROSCI LETT, V333, P41, DOI 10.1016/S0304-3940(02)00984-9; Serretti A, 2005, PHARMACOGENET GENOM, V15, P61, DOI 10.1097/01213011-200502000-00001; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Srisurapanont Manit, 1998, Journal of the Medical Association of Thailand, V81, P387; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P185, DOI 10.1176/appi.ajgp.10.2.185; Stober G, 1999, AM J MED GENET, V88, P158, DOI 10.1002/(SICI)1096-8628(19990416)88:2<158::AID-AJMG12>3.0.CO;2-W; Stober G, 1996, AM J MED GENET, V67, P523, DOI 10.1002/(SICI)1096-8628(19961122)67:6<523::AID-AJMG3>3.0.CO;2-I; Tournel G, 2001, J CHROMATOGR B, V761, P147, DOI 10.1016/S0378-4347(01)00305-X; Tsapakis E, 2005, EUR NEUROPSYCHOPHARM, V15, pS26, DOI 10.1016/S0924-977X(05)80137-3; Yang L, 2004, J AM ACAD CHILD PSY, V43, P1154, DOI 10.1097/01.chi.0000131134.63368.46; Yoshida K, 2004, AM J PSYCHIAT, V161, P1575, DOI 10.1176/appi.ajp.161.9.1575; YOSHIDA K, 1908, PROG NEUROPSYCHOPHAR, V26, P383; Zanardi R, 2001, BIOL PSYCHIAT, V50, P323, DOI 10.1016/S0006-3223(01)01118-0	54	164	183	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1609	1618		10.1001/jama.296.13.1609	http://dx.doi.org/10.1001/jama.296.13.1609			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	090JS	17018806	Bronze			2022-12-28	WOS:000240948200021
J	Reilly, JJ; Kelly, L; Montgomery, C; Williamson, A; Fisher, A; McColl, JH; Lo Conte, R; Paton, JY; Grant, S				Reilly, John J.; Kelly, Louise; Montgomery, Colette; Williamson, Avril; Fisher, Abigail; McColl, John H.; Lo Conte, Rossella; Paton, James Y.; Grant, Stanley			Physical activity to prevent obesity in young children: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	52nd Annual Meeting of the American-College-of-Sports-Medicine	JUN 01-04, 2005	Nashville, TN	Amer Coll Sports Med			FUNDAMENTAL MOVEMENT SKILLS; INTERVENTIONS; BEHAVIOR	Objective To assess whether a physical activity intervention reduces body mass index in young children. Design Cluster randomised controlled single blinded trial over 12 months. Setting Thirty six nurseries m Glasgow, Scotland. Participants 545 children in their preschool year, mean age 4.2 years (SD 0.2) at baseline. Intervention Enhanced physical activity programme in nursery (three 30 minute sessions a week over 24 weeks) plus home based health education aimed at increasing physical activity through play and reducing sedentary behaviour. Main outcome measure Body mass index, expressed as a standard deviation score relative to UK 1990 reference data. Secondary measures were objectively measured physical activity and sedentary behaviour; fundamental movement skills; and evaluation of tire process. Results Group allocation had no significant effect on the primary outcome measure at six and 12 months or on measures of physical activity and sedentary behaviour by accelerometry. Children in the intervention group had significantly higher performance in movement: Skills tests than control children at six month follow-up (P = 0.0027; 95% confidence interval 0.3 to 1.3) after adjustment for sex and baseline performance. Conclusions Physical activity can significantly improve motor skills but did not reduce body mass index in young children in this trial.	Univ Glasgow, Yorkhill Hosp, Div Dev Med, Glasgow G3 8SJ, Lanark, Scotland; Glasgow City Council, Dept Educ, Glasgow G1 1HL, Lanark, Scotland; Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Reilly, JJ (corresponding author), Univ Glasgow, Yorkhill Hosp, Div Dev Med, Glasgow G3 8SJ, Lanark, Scotland.	jjr2y@clinmed.gla.ac.uk	Grant, Stanley Baugh/AAD-5326-2022	Grant, Stanley Baugh/0000-0001-6221-7211; McColl, John/0000-0002-6008-2349				COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Hardeman W, 2000, INT J OBESITY, V24, P131, DOI 10.1038/sj.ijo.0801100; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; *NHS, 2003, NHS QUAL IMPR IND CH; Okely AD, 2004, RES Q EXERCISE SPORT, V75, P238, DOI 10.1080/02701367.2004.10609157; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2002, ARCH DIS CHILD, V86, P392, DOI 10.1136/adc.86.6.392; Reilly JJ, 2003, P NUTR SOC, V62, P611, DOI 10.1079/PNS2003276; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Sahota P, 2001, BMJ-BRIT MED J, V323, P1029, DOI 10.1136/bmj.323.7320.1029; SUMMERBELL CD, 2006, COCHRANE LIB; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585	15	284	287	2	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1041	1043		10.1136/bmj.38979.623773.55	http://dx.doi.org/10.1136/bmj.38979.623773.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	108HB	17028105	Green Published, Bronze			2022-12-28	WOS:000242229800014
J	Wiesmann, C; Katschke, KJ; Yin, JP; Helmy, KY; Steffek, M; Fairbrother, WJ; McCallum, SA; Embuscado, L; DeForge, L; Hass, PE; Campagne, MV				Wiesmann, Christian; Katschke, Kenneth J., Jr.; Yin, JianPing; Helmy, Karim Y.; Steffek, Micah; Fairbrother, Wayne J.; McCallum, Scott A.; Embuscado, Lizette; DeForge, Laura; Hass, Philip E.; van Lookeren Campagne, Menno			Structure of C3b in complex with CRIg gives insights into regulation of complement activation	NATURE			English	Article							ALTERNATIVE PATHWAY; COMPONENT C3; PUTATIVE THIOESTER; C5 CONVERTASE; FACTOR-H; BINDING; BIOLOGY; CD35; CR-1; C3-CONVERTASE	The complement system is a key part of the innate immune system, and is required for clearance of pathogens from the bloodstream(1). After exposure to pathogens, the third component of the complement system, C3, is cleaved to C3b which, after recruitment of factor B, initiates formation of the alternative pathway convertases(2-4). CRIg, a complement receptor expressed on macrophages, binds to C3b and iC3b mediating phagocytosis of the particles 5, but it is unknown how CRIg selectively recognizes proteolytic C3-fragments and whether binding of CRIg to C3b inhibits convertase activation. Here we present the crystal structure of C3b in complex with CRIg and, using CRIg mutants, provide evidence that CRIg acts as an inhibitor of the alternative pathway of complement. The structure shows that activation of C3 induces major structural rearrangements, including a dramatic movement (>80 angstrom) of the thioester-bond-containing domain through which C3b attaches to pathogen surfaces. We show that CRIg is not only a phagocytic receptor, but also a potent inhibitor of the alternative pathway convertases. The structure provides insights into the complex macromolecular structural rearrangements that occur during complement activation and inhibition. Moreover, our structure - function studies relating the structural basis of complement activation and the means by which CRIg inhibits the convertases provide important clues to the development of therapeutics that target complement.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Assay Technol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wiesmann, C (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way S, San Francisco, CA 94080 USA.	wiesmann.christian@gene.com; menno@gene.com	McCallum, Scott A./K-3769-2018	Wiesmann, Christian/0000-0002-4092-9880				FISHELSON Z, 1983, J BIOL CHEM, V258, P7411; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gadjeva M, 1998, J IMMUNOL, V161, P985; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; JANSSEN BJ, IN PRESS MOL IMMUNOL; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kostavasil I, 1997, J IMMUNOL, V158, P1763; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Lambris JD, 1996, J IMMUNOL, V156, P4821; Langnaese K, 2000, BBA-GENE STRUCT EXPR, V1492, P522, DOI 10.1016/S0167-4781(00)00131-7; Liddington R, 2005, NATURE, V437, P484, DOI 10.1038/437484a; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; VOGT W, 1978, IMMUNOLOGY, V34, P29; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	23	170	189	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					217	220		10.1038/nature05263	http://dx.doi.org/10.1038/nature05263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051150				2022-12-28	WOS:000241867200043
J	Mobius-Winkler, S; Walther, C				Mobius-Winkler, Sven; Morton, Douglas			Cardiac constriction due to a calcified pericardium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Leipzig, Heart Ctr, Leipzig 04289, Germany	Heart Center Leipzig GMBH; Leipzig University	Mobius-Winkler, S (corresponding author), Univ Leipzig, Heart Ctr, Leipzig 04289, Germany.	sven.moes@medizin.uni-leipzig.de							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17							e19	10.1056/NEJMicm041098	http://dx.doi.org/10.1056/NEJMicm041098			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065634				2022-12-28	WOS:000241512500012
J	Yoshino, T; Matsuzaki, T; Yamashita, S; Katsura, T				Yoshino, Takashi; Matsuzaki, Takuya; Yamashita, Shigeru; Katsura, Tomoo			Hydrous olivine unable to account for conductivity anomaly at the top of the asthenosphere	NATURE			English	Article							ELECTRICAL-CONDUCTIVITY; PERIDOTITE KLB-1; PARTIAL-MELT; WATER; MANTLE; SOLUBILITY; WADSLEYITE; DIFFUSION; STORAGE; GPA	The oceanic asthenosphere is observed to have high electrical conductivity, which is highly anisotropic in some locations(1,2). In the directions parallel and normal to the plate motion, the conductivity is of the order of 10(-1) and 10(-2) Sm-1, respectively, which cannot be explained by the conductivity of anhydrous olivine(2). But because hydrogen can be incorporated in olivine at mantle pressures(3-5), this observation has been attributed to olivine hydration, which might cause anisotropically high conductivity by proton migration(1,2,6,7). To examine this hypothesis, here we report the effect of water on electrical conductivity and its anisotropy for hydrogen-doped and undoped olivine at 500 - 1,500 K and 3 GPa. The hydrous olivine has much higher conductivity and lower activation energy than anhydrous olivine in the investigated temperature range. Nevertheless, extrapolation of the experimental results suggests that conductivity of hydrous olivine at the top of the asthenosphere should be nearly isotropic and only of the order of 10(-2) Sm-1. Our data indicate that the hydration of olivine cannot account for the geophysical observations(2), which instead may be explained by the presence of partial melt elongated in the direction of plate motion.	Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	Okayama University	Yoshino, T (corresponding author), Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan.	tyoshino@misasa.okayama-u.ac.jp	YOSHINO, Takashi/B-1899-2011; Katsura, Tomoo/A-7483-2010; Yamashita, Shigeru/AAM-1563-2020; Katsura, Tomoo/ABC-1899-2021	YOSHINO, Takashi/0000-0002-5422-7396; Katsura, Tomoo/0000-0001-7857-5101; Katsura, Tomoo/0000-0001-7857-5101				Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; BAI Q, 1992, NATURE, V357, P672, DOI 10.1038/357672a0; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; Dunn RA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002217; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Hae R, 2006, EARTH PLANET SC LETT, V243, P141, DOI 10.1016/j.epsl.2005.12.035; Hirschmann MM, 2005, EARTH PLANET SC LETT, V236, P167, DOI 10.1016/j.epsl.2005.04.022; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; Kohlstedt DL, 1998, Z PHYS CHEM, V207, P147, DOI 10.1524/zpch.1998.207.Part_1_2.147; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; KUSHIRO I, 1968, J GEOPHYS RES, V73, P6023, DOI 10.1029/JB073i018p06023; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; MACKWELL SJ, 1990, J GEOPHYS RES-SOLID, V95, P5079, DOI 10.1029/JB095iB04p05079; Mott NP, 1948, ELECT PROCESSES IONI; PRESNALL DC, 1972, J GEOPHYS RES, V77, P5665, DOI 10.1029/JB077i029p05665; Roberts JJ, 1999, J GEOPHYS RES-SOL EA, V104, P7055, DOI 10.1029/1998JB900111; SHANKLAND TJ, 1990, GEOPHYS J INT, V103, P25, DOI 10.1111/j.1365-246X.1990.tb01749.x; TAKAHASHI E, 1986, J GEOPHYS RES-SOLID, V91, P9367, DOI 10.1029/JB091iB09p09367; Utada H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016092; WAFF HS, 1979, J GEOPHYS RES, V84, P6109, DOI 10.1029/JB084iB11p06109; WANAMAKER BJ, 1993, J GEOPHYS RES-SOL EA, V98, P489, DOI 10.1029/92JB01584; Wang WY, 2000, J GEOPHYS RES-SOL EA, V105, P2855, DOI 10.1029/1999JB900366; Williams HM, 2004, SCIENCE, V304, P1656, DOI 10.1126/science.1095679; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337; WYLLIE PJ, 1975, NATURE, V257, P297, DOI 10.1038/257297a0; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1	30	223	245	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					973	976		10.1038/nature05223	http://dx.doi.org/10.1038/nature05223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066031				2022-12-28	WOS:000241523400050
J	Al Sheibani, BIM; Hadi, NR; Hasoon, T				Al Sheibani, Bassim Irheim Mohammed; Hadi, Najah R.; Hasoon, Tariq			Iraq lacks facilities and expertise in emergency medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Al Sheibani, BIM (corresponding author), Diwaniyah Coll Med, POB 279, Diwaniyah, Iraq.	jumabassim@yahoo.co.uk	Mohammad, Bassim Irheim/G-3715-2019; Hadi, Najah R/K-4953-2018	Hadi, Najah R/0000-0002-8415-5311				*CTR EXC DIAST MAN, IR HUM ASS REP OV	1	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					847	847		10.1136/bmj.38986.476782.68	http://dx.doi.org/10.1136/bmj.38986.476782.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053243	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000241678500021
J	Al-Taiar, A; Jaffar, S; Assabri, A; Al-Habori, M; Azazy, A; A-Mahdi, N; Ameen, K; Greenwood, BM; Whitty, CJM				Al-Taiar, Abdullah; Jaffar, Shabbar; Assabri, Ali; Al-Habori, Molham; Azazy, Ahmed; A-Mahdi, Nagiba; Ameen, Khaled; Greenwood, Brian M.; Whitty, Christopher J. M.			Severe malaria in children in Yemen: two site observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; AFRICAN CHILDREN; FEATURES; INDICATORS; MORBIDITY; DAKAR; LEVEL; AREAS; AGE	Objectives To assess the burden of malaria on health services, describe the clinical presentation of severe malaria in children, and identify factors associated with mortality by means of a prospective observational study Setting Two public hospitals in Taiz (mountain hinterland) and Hodeidah (coastal plain), Yemen. Participants Children aged 6 months to 10 years. Results Of 12 301 paediatric admissions, 2071 (17%) were for suspected severe malaria. The proportion of such admissions varied according to the season (from 1% to 40%). Falciparum malaria was confirmed in 1332 children; 808 had severe disease as defined by the World Health Organization. Main presentations were respiratory distress (322/808, 40%), severe anaemia (291/800,37%), and cerebral malaria (60/808, 8%). Twenty two of 26 children who died had a neurological presentation. No deaths occurred in children with severe anaemia but no other signs of severity. In multivariate analysis, a Blantyre coma score <= 2. history of fits, female sex, and hyperlactataemia predicted mortality; severe anaemia, respiratory distress, and hyperparasitaemia were not significant predictors of mortality. Conclusions Severe malaria puts a high burden on health services in Yemen. Although presentation is similar to African series, some important differences exist. Case fatality is higher in girls.	Sanaa Univ, Fac Med & Hlth Sci, Sanaa 13078, Yemen; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Yemeni Swedish Hosp, Taizi, Yemen	University of London; London School of Hygiene & Tropical Medicine	Al-Taiar, A (corresponding author), Sanaa Univ, Fac Med & Hlth Sci, POB 13078, Sanaa 13078, Yemen.	a_m_altaiar@yahoo.com	Whitty, Christopher/C-7740-2012	Jaffar, Shabbar/0000-0002-9615-1588; Whitty, Christopher/0000-0002-6076-5027; Al-Taiar, Abdullah/0000-0001-7421-3381	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; English M, 1996, AM J TROP MED HYG, V55, P521, DOI 10.4269/ajtmh.1996.55.521; Imbert P, 2002, T ROY SOC TROP MED H, V96, P278, DOI 10.1016/S0035-9203(02)90099-4; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Maitland K, 2005, BRIT MED J, V331, P337, DOI 10.1136/bmj.331.7512.337; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Newton CRJC, 2005, CLIN INFECT DIS, V41, P948, DOI 10.1086/432941; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Varandas L, 2000, ANN TROP PAEDIATR, V20, P265, DOI 10.1080/1465328002003852; WHO UNICEF, 2005, WORLD MALARIA REPORT; 2006, LANCET, V367, P959	20	35	37	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					827	830A		10.1136/bmj.38959.368819.BE	http://dx.doi.org/10.1136/bmj.38959.368819.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ON	17053235	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000241678500014
J	Richter, K; Buchner, J				Richter, Klaus; Buchner, Johannes			Hsp90: Twist and fold	CELL			English	Editorial Material							CHAPERONE COMPLEX; PROTEINS; ATPASE	Molecular chaperones are cellular machines that facilitate protein folding. The crystal structures of HtpG, the Escherichia coli homolog of hsp90, reported in this issue (Shiau et al., 2006) together with the recently published structures of an hsp90-cochaperone complex (Ali et al., 2006) and an hsp90-client protein complex (Vaughan et al., 2006), reveal exciting insights into the hsp90 reaction cycle.	Tech Univ Munich, Dept Chem, D-8000 Munich, Germany	Technical University of Munich; University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, D-8000 Munich, Germany.	johannes.buchner@ch.tum.de	Buchner, Johannes/A-2651-2010; Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642; Buchner, Johannes/0000-0003-1282-7737				Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; RICHTER K, 2005, PROTEIN FOLDING HD 2, P162; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	9	46	48	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					251	253		10.1016/j.cell.2006.10.004	http://dx.doi.org/10.1016/j.cell.2006.10.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055424	Bronze			2022-12-28	WOS:000241827100010
J	Zhu, SJ; Lin, SW; Kao, CF; Awasaki, T; Chiang, AS; Lee, T				Zhu, Sijun; Lin, Suewei; Kao, Chih-Fei; Awasaki, Takeshi; Chiang, Ann-Shyn; Lee, Tzumin			Gradients of the Drosophila Chinmo BTB-zinc finger protein govern neuronal temporal identity	CELL			English	Article							DEVELOPING NERVOUS-SYSTEM; MUSHROOM BODIES; OLFACTORY MAP; CELL-TYPES; PROGENITORS; NEUROBLAST; FATE; NEUROGENESIS; MELANOGASTER; RESTRICTION	Many neural progenitors, including Drosophila mushroom body (MB) and projection neuron (PN) neuroblasts, sequentially give rise to different subtypes of neurons throughout development. We identified a novel BTB-zinc finger protein, named Chinmo (Chronologically inappropriate morphogenesis), that governs neuronal temporal identity during postembryonic development of the Drosophila brain. In both MB and PN lineages, loss of Chinmo autonomously causes early-born neurons to adopt the fates of late-born neurons from the same lineages. Interestingly, primarily due to a posttranscriptional control, MB neurons born at early developmental stages contain more abundant Chinmo than their later-born siblings. Further, the temporal identity of MB progeny can be transformed toward earlier or later fates by reducing or increasing Chinmo levels, respectively. Taken together, we suggest that a temporal gradient of Chinmo (Chinmo(high) -> Chinmo(low)) helps specify distinct birth order-dependent cell fates in an extended neuronal lineage.	Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Massachusetts, Dept Neurol, Sch Med, Worcester, MA 01605 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Massachusetts System; University of Massachusetts Worcester; National Tsing Hua University	Lee, T (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	tzumin.lee@umassmed.edu	Lin, Suewei/AAA-3962-2021; AWASAKI, Takeshi/AAO-7579-2021	Lin, Suewei/0000-0001-7079-7818; AWASAKI, Takeshi/0000-0003-2662-6389; Chiang, Ann-Shyn/0000-0001-9668-7115	NINDS NIH HHS [NS42049] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Brody T, 2002, DEVELOPMENT, V129, P3763; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Desai AR, 2000, DEVELOPMENT, V127, P2863; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Schmid A, 1999, DEVELOPMENT, V126, P4653; Soula C, 2001, DEVELOPMENT, V128, P1369; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; YANG MY, 1995, NEURON, V15, P45; Zhu SJ, 2005, J NEUROSCI, V25, P4189, DOI 10.1523/JNEUROSCI.0149-05.2005; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	29	162	163	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					409	422		10.1016/j.cell.2006.08.045	http://dx.doi.org/10.1016/j.cell.2006.08.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055440	Bronze			2022-12-28	WOS:000241827100026
J	Rosenthal, VD; Maki, DG; Salomao, R; Alvarez-Moreno, C; Mehta, Y; Higuera, F; Cuellar, LE; Arikan, OA; Abouqal, R; Leblebicioglu, H				Rosenthal, Victor D.; Maki, Dennis G.; Salomao, Reinaldo; Alvarez-Moreno, Carlos; Mehta, Yatin; Higuera, Francisco; Cuellar, Luis E.; Arikan, Ozay Akan; Abouqal, Redouane; Leblebicioglu, Hakan		Int Nosocomial Infection Control C	Device-associated nosocomial infections in 55 intensive care units of 8 developing countries	ANNALS OF INTERNAL MEDICINE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; URINARY-TRACT-INFECTION; ATTRIBUTABLE MORTALITY; PERFORMANCE FEEDBACK; CONTROL PROGRAM; HOSPITAL STAY; RISK-FACTORS; RATES	Background: Health care-associated infections from invasive medical devices in the intensive care unit (ICU) are a major threat to patient safety. Most published studies of ICU-acquired infections have come from industrialized western countries. In a Centers for Disease Control and Prevention (CDC) National Nosocomial Infections Surveillance (NNIS) System report, the U.S. pooled mean rates of central venous catheter (CVC)-related bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections were 4.0 per 1000 CVC days, 5.4 per 1000 mechanical ventilator days, and 3.9 per Foley catheter days, respectively. Objective: To ascertain the incidence of device-associated infections in the ICUs of developing countries. Design: Multicenter, prospective cohort surveillance of device-associated infection by using the CDC NNIS System definitions. Setting: 55 ICUs of 46 hospitals in Argentina, Brazil, Colombia, India, Mexico, Morocco, Peru, and Turkey that are members of the International Nosocomial Infection Control Consortium (INICC). Measurements: Rates of device-associated infection per 100 patients and per 1000 device days. Results: During 2002-2005, 21 069 patients who were hospitalized in ICUs for an aggregate 137 740 days acquired 3095 device-associated infections for an overall rate of 14.7% or 22.5 infections per 1000 ICU days. Ventilator-associated pneumonia posed the greatest risk (41% of all device-associated infections or 24.1 cases [range, 10.0 to 52.7 cases] per 1000 ventilator days), followed by CVC-related bloodstream infections (30% of all device-associated infections or 12.5 cases [range, 7.8 to 18.5 cases] per 1000 catheter days) and catheter-associated urinary tract infections (29% of all device-associated infections or 8.9 cases (range, 1.7 to 12.8 cases) per 1000 catheter days). Notably, 84% of Staphylococcus aureus infections were caused by methicillin-resistant strains, 51% of Enterobacteriaceae isolates were resistant to ceftriaxone, and 59% of Pseudomonas aeruginosa isolates were resistant to fluoro-quinolones. The crude mortality rate for patients with device-associated infections ranged from 35.2% (for CVC-associated bloodstream infection) to 44.9% (for ventilator-associated pneumonia). Limitations: These initial data are not adequate to represent any entire country, and likely variations in the efficiency of surveillance and institutional resources may have affected the rates that were detected. Conclusions: Device-associated infections in the ICUs of these developing countries pose greater threats to patient safety than in U.S. ICUs. Active infection control programs that perform surveillance of infection and implement guidelines for prevention can improve patient safety and must become a priority in every country.	Med Coll Buenos Aires, Buenos Aires, DF, Argentina; Univ Wisconsin, Sch Med, Madison, WI USA; Santa Marcelina Hosp, Sao Paulo, Brazil; Pontificia Javeriana Univ, San Ignacio Hosp, Bogota, Colombia; Escorts Heart Inst & Res Ctr, New Delhi, India; Gen Hosp, Mexico City, DF, Mexico; Inst Neoplast Dis, Lima, Peru; Ankara Univ, Sch Med, Ibni Sina Hosp, TR-06100 Ankara, Turkey; Ibn Sina Hosp, Rabat, Morocco; Ondokuz Mayis Univ, Sch Med, Samsun, Turkey	University of Wisconsin System; University of Wisconsin Madison; Pontificia Universidad Javeriana; Instituto Nacional de Enfermedades Neoplasicas; Ankara University; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Ondokuz Mayis University	Rosenthal, VD (corresponding author), Arengreen 1366, RA-1405 Buenos Aires, DF, Argentina.	victor_rosenthal@inicc.org	Rosenthal, Victor Daniel/HGD-1892-2022; Abouqal, Redouane/C-7952-2011; Unal, Necmettin/AAH-6241-2019; Leblebicioglu, Hakan/A-3960-2016; Abouqal, Redouane/N-3468-2019; Moreno, carlos Arturo alvarez/P-6678-2016; Salomao, Reinaldo/C-6419-2013	Abouqal, Redouane/0000-0002-6117-4341; Unal, Necmettin/0000-0002-9440-7893; Leblebicioglu, Hakan/0000-0002-6033-8543; Abouqal, Redouane/0000-0002-6117-4341; Moreno, carlos Arturo alvarez/0000-0001-5419-4494; Salomao, Reinaldo/0000-0003-1149-4598; ROSENTHAL, VICTOR DANIEL/0000-0001-9138-4801				Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; [Anonymous], 1997, MMWR-MORBID MORTAL W, V46, P1; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; BERG DE, 1995, CLIN INFECT DIS, V21, P588, DOI 10.1093/clinids/21.3.588; Blot S, 2005, INFECT CONT HOSP EP, V26, P352, DOI 10.1086/502551; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chandra PN, 2001, J HOSP INFECT, V47, P218, DOI 10.1053/jhin.2000.0904; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Cooke EM, 2000, J HOSP INFECT, V46, P1, DOI 10.1053/jhin.2000.0801; Diaz Molina C, 1998, Gac Sanit, V12, P23; Diener J R, 1996, Rev Assoc Med Bras (1992), V42, P205; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1994, INFECT CONT HOSP EP, V15, P428; Finkelstein R, 2000, J HOSP INFECT, V44, P200, DOI 10.1053/jhin.1999.0682; FREEMAN R, 1991, J HOSP INFECT, V18, P299, DOI 10.1016/0195-6701(91)90036-8; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; Gastmeier P, 1998, J HOSP INFECT, V38, P51, DOI 10.1016/S0195-6701(98)90174-8; GOMEZ VW, 2005, ANN ED C INT M ASS P; HALEY RW, 1998, HOSP INFECT, P249; Harihara Yasushi, 2002, Nihon Rinsho, V60, P2079; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Higuera F, 2007, INFECT CONTROL HOSP; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; HUGHES JM, 1988, CHEMOTHERAPY, V34, P553, DOI 10.1159/000238624; Hugonnet S, 2004, CURR OPIN INFECT DIS, V17, P329, DOI 10.1097/01.qco.0000136931.83167.d2; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Karabey S, 2002, J HOSP INFECT, V50, P36, DOI 10.1053/jhin.2001.1132; Kurlat I, 1998, J HOSP INFECT, V40, P149, DOI 10.1016/S0195-6701(98)90094-9; Laupland KB, 2005, INTENS CARE MED, V31, P213, DOI 10.1007/s00134-004-2544-6; Lopes JMM, 2002, AM J INFECT CONTROL, V30, P1, DOI 10.1067/mic.2002.117039; Macias AE, 1999, AM J INFECT CONTROL, V27, P285, DOI 10.1053/ic.1999.v27.a92879; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Martinez-Aguilar G, 2001, SALUD PUBLICA MEXICO, V43, P515, DOI 10.1590/S0036-36342001000600001; Merchant M, 1998, J HOSP INFECT, V39, P143, DOI 10.1016/S0195-6701(98)90328-0; Mittal Nalini, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P365; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Grady NP, 2002, AM J INFECT CONTROL, V30, P476, DOI 10.1067/mic.2002.129427; OROPEZA SM, 2005, 15 ANN SCI M SOC HEA; Orrett FA, 1998, INFECT CONT HOSP EP, V19, P136; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; Pittet D, 1996, AM J RESP CRIT CARE, V153, P684, DOI 10.1164/ajrccm.153.2.8564118; Pittet D, 2001, J HOSP INFECT, V48, pS40, DOI 10.1016/S0195-6701(01)90012-X; PITTET D, 1994, SCHWEIZ MED WSCHR, V124, P227; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Barba EJR, 2006, AM J INFECT CONTROL, V34, P244, DOI 10.1016/j.ajic.2005.05/024; Reed CS, 2003, J HOSP INFECT, V54, P267, DOI 10.1016/S0195-6701(03)00148-8; Rezende EM, 1998, INFECT CONT HOSP EP, V19, P872, DOI 10.1086/647751; Richards MJ, 1998, AM J CARDIOL, V82, P789, DOI 10.1016/S0002-9149(98)00450-0; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016/j.ajic.2005.11.002; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P157, DOI 10.1016/j.ajic.2004.08.008; Rosenthal VD, 2004, AM J INFECT CONTROL, V32, P135, DOI 10.1016/j.ajic.2003.12.002; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P47, DOI 10.1086/502291; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P85, DOI 10.1067/mic.2003.63; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; ROSENTHAL VD, 2006, ANN ED C INT M ASS P; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Safdar Nasia, 2001, Curr Infect Dis Rep, V3, P487, DOI 10.1007/s11908-001-0085-5; SALOMAO R, 2005, ANN ED C INT M ASS P; Sodano L, 2002, Ann Ig, V14, P389; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tinoco JC, 1997, SALUD PUBLICA MEXICO, V39, P25, DOI 10.1590/S0036-36341997000100005; Velasco E, 1997, AM J INFECT CONTROL, V25, P458, DOI 10.1016/S0196-6553(97)90067-5; Vicca AF, 1999, J HOSP INFECT, V43, P109, DOI 10.1053/jhin.1999.0246; Wayne P., 1997, M7A4 NAT COMM CLIN L; Zaidi M, 1999, SALUD PUBLICA MEXICO, V41, pS38	76	345	363	0	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					582	591		10.7326/0003-4819-145-8-200610170-00007	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043340				2022-12-28	WOS:000241315700004
J	Andersson, SGE				Andersson, Siv G. E.			The bacterial world gets smaller	SCIENCE			English	Editorial Material							EVOLUTION; GENOME; BUCHNERA; ENDOSYMBIONT		Uppsala Univ, Evolutionary Biol Ctr, Dept Mol Evolut, S-75236 Uppsala, Sweden	Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Mol Evolut, Norbyvagen 18C, S-75236 Uppsala, Sweden.	siv.andersson@ebc.uu.se						Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; PETTERSSON ME, IN PRESS GENETICA; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100	13	18	19	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					259	260		10.1126/science.1133739	http://dx.doi.org/10.1126/science.1133739			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093TV	17038609				2022-12-28	WOS:000241194100026
J	Wing, RR; Tate, DF; Gorin, AA; Raynor, HA; Fava, JL				Wing, Rena R.; Tate, Deborah F.; Gorin, Amy A.; Raynor, Hollie A.; Fava, Joseph L.			A self-regulation program for maintenance of weight loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-STYLE MODIFICATION; LONG-TERM MAINTENANCE; BENEFITS; RISK	BACKGROUND Since many successful dieters regain the weight they lose, programs that teach maintenance skills are needed. We developed a maintenance program based on self-regulation theory and tested the efficacy of delivering the program face to face or over the Internet. METHODS We randomly assigned 314 participants who had lost a mean of 19.3 kg of body weight in the previous 2 years to one of three groups: a control group, which received quarterly newsletters (105 participants), a group that received face-to-face intervention (105), and a group that received Internet-based intervention (104). The content of the programs in the two intervention groups was the same, emphasizing daily self-weighing and self-regulation, as was the frequency of contact with the groups. The primary outcome was weight gain over a period of 18 months. RESULTS The mean (+/-SD) weight gain was 2.5+/-6.7 kg in the face-to-face group, 4.7+/-8.6 kg in the Internet group, and 4.9+/-6.5 kg in the control group, with a significant difference between the face-to-face group and the control group (2.4 kg; 95% confidence interval [CI], 0.002 to 10.8; P=0.05). The proportion of participants who regained 2.3 kg or more over the 18-month period was significantly higher in the control group (72.4%) than in the face-to-face group (45.7%; absolute difference, 27%; 95% CI, 14 to 39; P<0.001) or the Internet group (54.8%; absolute difference, 18%; 95% CI, 5 to 30; P=0.008). Daily self-weighing increased in both intervention groups and was associated with a decreased risk of regaining 2.3 kg or more (P<0.001). CONCLUSIONS As compared with receiving quarterly newsletters, a self-regulation program based on daily weighing improved maintenance of weight loss, particularly when delivered face to face.	Brown Med Sch, Providence, RI USA; Miriam Hosp, Providence, RI 02906 USA; Univ N Carolina, Chapel Hill, NC USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of North Carolina; University of North Carolina Chapel Hill	Wing, RR (corresponding author), Weight Control & Diabet Res Ctr, 196 Richmond St, Providence, RI 02903 USA.	rwing@lifespan.org		Raynor, Hollie/0000-0002-3782-9504; Fava, Joseph/0000-0001-7129-7903	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057413] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57413] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker RC, 1998, HEALTH PSYCHOL, V17, P367, DOI 10.1037/0278-6133.17.4.367; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Harvey-Berino J, 2004, OBES RES, V12, P320, DOI 10.1038/oby.2004.40; KANFER FH, 1975, HELPINGM PEOPLE CHAN; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Linde JA, 2005, ANN BEHAV MED, V30, P210, DOI 10.1207/s15324796abm3003_5; McGuire MT, 1999, J CONSULT CLIN PSYCH, V67, P177, DOI 10.1037/0022-006X.67.2.177; MCGUIRE MT, 1999, J CONSULT CLIN PSYCH, V67, P282; O'Neil PM, 2005, J NUTR EDUC BEHAV, V37, P319, DOI 10.1016/S1499-4046(06)60163-2; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Perri M. G., 2002, Handbook of obesity treatment, P357; Phelan S, 2003, AM J CLIN NUTR, V78, P1079, DOI 10.1093/ajcn/78.6.1079; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Wadden T. A., 2002, Handbook of obesity treatment, P186; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2001, ARCH INTERN MED, V161, P218, DOI 10.1001/archinte.161.2.218; Wing R.R., 2004, HDB OBESITY CLIN APP, P147; WING RR, 1986, PSYCHOL BULL, V99, P78, DOI 10.1037/0033-2909.99.1.78; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	24	554	562	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1563	1571		10.1056/NEJMoa061883	http://dx.doi.org/10.1056/NEJMoa061883			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093HW	17035649	Green Published			2022-12-28	WOS:000241160400007
J	Runyon, JB; Mescher, MC; De Moraes, CM				Runyon, Justin B.; Mescher, Mark C.; De Moraes, Consuelo M.			Volatile chemical cues guide host location and host selection by parasitic plants	SCIENCE			English	Article							INTERPLANT COMMUNICATION; CUSCUTA-CAMPESTRIS; INSECT HERBIVORE; TALKING TREES; SIGNALS; DAMAGE; COMMUNITIES; RESISTANCE; SAGEBRUSH; RESPONSES	The importance of plant volatiles in mediating interactions between plant species is much debated. Here, we demonstrate that the parasitic plant Cuscuta pentagona ( dodder) uses volatile cues for host location. Cuscuta pentagona seedlings exhibit directed growth toward nearby tomato plants ( Lycopersicon esculentum) and toward extracted tomato-plant volatiles presented in the absence of other cues. Impatiens ( Impatiens wallerana) and wheat plants ( Triticum aestivum) also elicit directed growth. Moreover, seedlings can distinguish tomato and wheat volatiles and preferentially grow toward the former. Several individual compounds from tomato and wheat elicit directed growth by C. pentagona, whereas one compound from wheat is repellent. These findings provide compelling evidence that volatiles mediate important ecological interactions among plant species.	Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	De Moraes, CM (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	czd10@psu.edu		Runyon, Justin B./0000-0002-0271-0511				Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; D'Alessandro M, 2006, ANALYST, V131, P24, DOI 10.1039/b507589k; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; De Moraes CM, 2004, P NATL ACAD SCI USA, V101, P8993, DOI 10.1073/pnas.0403248101; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; KABAN R, 1997, INDUCED RESPONSES HE; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R, 2003, OIKOS, V100, P325, DOI 10.1034/j.1600-0706.2003.12075.x; KELLY CK, 1990, ECOLOGY, V71, P1916, DOI 10.2307/1937599; KELLY CK, 1992, P NATL ACAD SCI USA, V89, P12194, DOI 10.1073/pnas.89.24.12194; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Koch AM, 2004, NEW PHYTOL, V162, P147, DOI 10.1046/j.1469-8137.2004.00999.x; Metcalf RL, 1992, PLANT KAIROMONES INS; Nadler-Hassar T, 2003, WEED RES, V43, P341, DOI 10.1046/j.1365-3180.2003.00350.x; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; RHOADES DF, 1983, ACS SYM SER, V208, P55; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0	32	244	264	13	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1964	1967		10.1126/science.1131371	http://dx.doi.org/10.1126/science.1131371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008532				2022-12-28	WOS:000240832200052
J	Kidwingira, F; Strand, JD; Van Harlingen, DJ; Maeno, Y				Kidwingira, Francoise; Strand, J. D.; Van Harlingen, D. J.; Maeno, Yoshiteru			Dynamical superconducting order parameter domains in Sr2RuO4	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; TIME-REVERSAL SYMMETRY; PAIRING STATE; PHASE; DEPENDENCE; GAP	We present direct evidence for complex p-wave order parameter symmetry and the presence of dynamical chiral order parameter domains of the form p(x) +/- ip(y) in the ruthenate superconductor Sr2RuO4. The domain structure creates differences in the magnetic field modulation of the critical current of Josephson junctions fabricated on orthogonal faces of Sr2RuO4 single crystals. Transitions between the chiral states of a domain or the motion of domain walls separating them generates telegraph noise in the critical current as a function of magnetic field or time and is responsible for hysteresis observed in field sweeps of the critical current. The presence of such domains confirms the p-wave triplet spin and complex ( broken time-reversal symmetry) nature of the superconducting pairing state in Sr2RuO4.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Kyoto Univ, Dept Phys, Kyoto 6068502, Japan	University of Illinois System; University of Illinois Urbana-Champaign; Kyoto University	Van Harlingen, DJ (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	dvh@uiuc.edu		Strand, Joel/0000-0002-8454-1191				Bjornsson PG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.012504; Bonalde I, 2000, PHYS REV LETT, V85, P4775, DOI 10.1103/PhysRevLett.85.4775; GESHKENBEIN VB, 1987, PHYS REV B, V36, P235, DOI 10.1103/PhysRevB.36.235; Hilgenkamp H, 2002, REV MOD PHYS, V74, P485, DOI 10.1103/RevModPhys.74.485; Ishida K, 2000, PHYS REV LETT, V84, P5387, DOI 10.1103/PhysRevLett.84.5387; Ishida K, 1998, NATURE, V396, P658, DOI 10.1038/25315; Leggett AJ, 1996, PHILOS MAG B, V74, P509, DOI 10.1080/01418639608240353; Luke GM, 1998, NATURE, V394, P558, DOI 10.1038/29038; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Mao ZQ, 2000, MATER RES BULL, V35, P1813, DOI 10.1016/S0025-5408(00)00378-0; Matsumoto M, 1999, J PHYS SOC JPN, V68, P994, DOI 10.1143/JPSJ.68.994; Mota AC, 1999, PHYSICA B, V259-61, P934, DOI 10.1016/S0921-4526(98)00963-6; Neils WK, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047001; Nelson KD, 2004, SCIENCE, V306, P1151, DOI 10.1126/science.1103881; NishiZaki S, 1999, J LOW TEMP PHYS, V117, P1581, DOI 10.1023/A:1022551313401; RICE TM, 1995, J PHYS-CONDENS MAT, V7, pL643, DOI 10.1088/0953-8984/7/47/002; SIGRIST M, 1989, PHYS REV LETT, V63, P1727, DOI 10.1103/PhysRevLett.63.1727; SIGRIST M, 1991, REV MOD PHYS, V63, P239, DOI 10.1103/RevModPhys.63.239; Sigrist M, 1999, PROG THEOR PHYS, V102, P965, DOI 10.1143/PTP.102.965; Tanatar MR, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.064505; VANHARLINGEN DJ, 1995, REV MOD PHYS, V67, P515, DOI 10.1103/RevModPhys.67.515; Volovik G. E., 1985, Soviet Physics - JETP, V61, P843; VOLOVIK GE, 1984, JETP LETT+, V39, P674; WOLLMAN DA, 1993, PHYS REV LETT, V71, P2134, DOI 10.1103/PhysRevLett.71.2134; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002	27	163	165	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1267	1271		10.1126/science.1133239	http://dx.doi.org/10.1126/science.1133239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17068225				2022-12-28	WOS:000242215800034
J	Chin, JK; Miller, DE; Liu, Y; Stan, C; Setiawan, W; Sanner, C; Xu, K; Ketterle, W				Chin, J. K.; Miller, D. E.; Liu, Y.; Stan, C.; Setiawan, W.; Sanner, C.; Xu, K.; Ketterle, W.			Evidence for superfluidity of ultracold fermions in an optical lattice	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; GAS; ATOMS; INTERFERENCE; PAIRS	The study of superfluid fermion pairs in a periodic potential has important ramifications for understanding superconductivity in crystalline materials. By using cold atomic gases, various models of condensed matter can be studied in a highly controllable environment. Weakly repulsive fermions in an optical lattice could undergo d-wave pairing(1) at low temperatures, a possible mechanism for high temperature superconductivity in the copper oxides(2). The lattice potential could also strongly increase the critical temperature for s-wave superfluidity. Recent experimental advances in bulk atomic gases include the observation of fermion-pair condensates and high-temperature superfluidity(3-8). Experiments with fermions(9-11) and bosonic bound pairs(12,13) in optical lattices have been reported but have not yet addressed superfluid behaviour. Here we report the observation of distinct interference peaks when a condensate of fermionic atom pairs is released from an optical lattice, implying long-range order ( a property of a superfluid). Conceptually, this means that s-wave pairing and coherence of fermion pairs have now been established in a lattice potential, in which the transport of atoms occurs by quantum mechanical tunnelling and not by simple propagation. These observations were made for interactions on both sides of a Feshbach resonance. For larger lattice depths, the coherence was lost in a reversible manner, possibly as a result of a transition from superfluid to insulator. Such strongly interacting fermions in an optical lattice can be used to study a new class of hamiltonians with interband and atom - molecule couplings(14).	MIT, Dept Phys, MIT Harvard Ctr Ultracold Atom, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chin, JK (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atom, Cambridge, MA 02139 USA.	jitkee@mit.edu	Stan, Claudiu/AAV-8091-2021					Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Bartenstein M., 2004, PHYS REV LETT, V94; Duan LM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.243202; GOULD PL, 1986, PHYS REV LETT, V56, P827, DOI 10.1103/PhysRevLett.56.827; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; GUBBELS KB, 2006, UNPUB CONDENSED MATT; Hadzibabic Z, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.160401; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; KOETSIER AO, UNPUB CONDENSED MATT; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Modugno G, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.011601; Moritz H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.210401; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Scalapino D. J., 1995, Physics Reports, V250, P329, DOI 10.1016/0370-1573(94)00086-I; Schori C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240402; SCHUNCK C, 2006, UNPUB CONDENSED MATT; Stan CA, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1935433; Stoferle T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030401; VOLZ T, 2006, UNPUB CONDENSED MATT; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918; Xu K, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043604; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250401	30	312	315	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					961	964		10.1038/nature05224	http://dx.doi.org/10.1038/nature05224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066028	Green Submitted			2022-12-28	WOS:000241523400047
J	Kawane, K; Ohtani, M; Miwa, K; Kizawa, T; Kanbara, Y; Yoshioka, Y; Yoshikawa, H; Nagata, S				Kawane, Kohki; Ohtani, Mayumi; Miwa, Keiko; Kizawa, Takuji; Kanbara, Yoshiyuki; Yoshioka, Yoshichika; Yoshikawa, Hideki; Nagata, Shigekazu			Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; THERAPY; SERUM; EXPRESSION; RECEPTORS; BETA; MICE	A large amount of chromosomal DNA is degraded during programmed cell death and definitive erythropoiesis(1). DNase II is an enzyme that digests the chromosomal DNA of apoptotic cells and nuclei expelled from erythroid precursor cells after macrophages have engulfed them(1,2). Here we show that DNase II-/- IFN-IR-/- mice and mice with an induced deletion of the DNase II gene develop a chronic polyarthritis resembling human rheumatoid arthritis. A set of cytokine genes was strongly activated in the affected joints of these mice, and their serum contained high levels of anti-cyclic citrullinated peptide antibody, rheumatoid factor and matrix metalloproteinase-3. Early in the pathogenesis, expression of the gene encoding tumour necrosis factor (TNF)-alpha was upregulated in the bone marrow, and administration of anti-TNF-alpha antibody prevented the development of arthritis. These results indicate that if macrophages cannot degrade mammalian DNA from erythroid precursors and apoptotic cells, they produce TNF-alpha, which activates synovial cells to produce various cytokines, leading to the development of chronic polyarthritis.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrat Biol Labs, Genet Lab, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; Iwate Med Univ, Adv Med Sci Res Ctr, High Field Magnet Resonance Imaging Res Inst, Takizawa 0200173, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Iwate Medical University	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nagata@genetic.med.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019; Yoshioka, Yoshichika/D-1929-2009	Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483				Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Brennan FM, 1997, BRIT J RHEUMATOL, V36, P643; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; FUJII I, 1990, ANN RHEUM DIS, V49, P497, DOI 10.1136/ard.49.7.497; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; MANICOURT DH, 1995, ARTHRITIS RHEUM, V38, P1031, DOI 10.1002/art.1780380803; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	29	342	353	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					998	1002		10.1038/nature05245	http://dx.doi.org/10.1038/nature05245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066036				2022-12-28	WOS:000241523400056
J	Trivedi, AN; Zaslavsky, AM; Schneider, EC; Ayanian, JZ				Trivedi, Amal N.; Zaslavsky, Alan M.; Schneider, Eric C.; Ayanian, John Z.			Relationship between quality of care and racial disparities in medicare health plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ETHNIC DISPARITIES; BLOOD-PRESSURE; IMPROVEMENT; MANAGEMENT; RISK; HOSPITALS; ENROLLEES; THERAPY; IMPACT	Context Overall quality of care and racial disparities in quality are important and related problems in health care, but their relationship has not been well studied. In the Medicare managed care program, broad improvements in quality have been accompanied by reduced racial gaps in processes of care, but substantial disparities in outcomes have persisted. Objectives To assess variations among Medicare health plans in overall quality and racial disparity in 4 Health Plan Employer and Data Information Set ( HEDIS) outcome measures, to determine whether high-performing plans exhibit smaller racial disparities, and to identify plans with high quality and low disparity. Design, Setting, and Patients We assessed the relationship between quality and racial disparity using multilevel multivariable regression models. The study sample included 431 573 individual-level observations in 151 Medicare health plans from 2002 to 2004. Main Outcome Measures Hemoglobin A(1c) of less than 9.5% or less than 9.0% for enrollees with diabetes; low-density lipoprotein cholesterol level of less than 130 mg/dL for enrollees with diabetes or after a coronary event; and blood pressure of less than 140/90 mm Hg for enrollees with hypertension. Results Clinical performance on HEDIS outcome measures was 6.8% to 14.4% lower for black enrollees than for white enrollees ( P <. 001 for all). For each measure, more than 70% of this disparity was due to different outcomes for black and white individuals enrolled in the same health plan rather than selection of black enrollees into lower-performing plans. Health plans varied substantially in both overall quality and racial disparity on each of the 4 outcome measures. Adjusted correlations between overall quality and racial disparity were small and not statistically significant, ranging from 0.01 ( blood pressure control) to - 0.21 ( cholesterol control in diabetes). Only 1 health plan achieved both high quality and low disparity on more than 1 measure. Conclusions In Medicare health plans, disparities vary widely and are only weakly correlated with the overall quality of care. Therefore, plan-specific performance reports of racial disparities on outcome measures would provide useful information not currently conveyed by standard HEDIS reports.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Schneider, Eric/0000-0002-1132-5084	AHRQ HHS [P01-HS10803, 5 T32 HS000020-20] Funding Source: Medline; PHS HHS [5 T32 HP11001-15] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803, T32HS000020] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HEALTHC RES QU, 2005, CAHPS 3 0 HLTH PLAN; *AM HLTH INS PLAN, COLL RAC ETHN DAT HL; [Anonymous], 2001, INTERSTUDY COMPETITI; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; Ayanian JZ, 2002, ARCH INTERN MED, V162, P1013, DOI 10.1001/archinte.162.9.1013; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Collins R, 2003, LANCET, V361, P2005; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gandhi TK, 2002, MED CARE, V40, P155, DOI 10.1097/00005650-200202000-00010; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; *I MED, 2002, UN TREATM CONFR RAC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Lee TH, 2000, JAMA-J AM MED ASSOC, V283, P94, DOI 10.1001/jama.283.1.94; Lurie N, 2003, AM J MANAG CARE, V9, P502; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; Moy E, 2005, HEALTH AFFAIR, V24, P376, DOI 10.1377/hlthaff.24.2.376; Neal B, 2000, LANCET, V356, P1955; O'Connor PJ, 2005, DIABETES CARE, V28, P1890, DOI 10.2337/diacare.28.8.1890; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Persell SD, 2005, J GEN INTERN MED, V20, P123, DOI 10.1111/j.1525-1497.2005.40155.x; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Schneider EC, 1999, JAMA-J AM MED ASSOC, V282, P1184, DOI 10.1001/jama.282.12.1184; Schneider EC, 2001, MED CARE, V39, P1313, DOI 10.1097/00005650-200112000-00007; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Sequist TD, 2006, HEALTH SERV RES, V41, P1451, DOI 10.1111/j.1475-6773.2006.00549; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US DEP HHS, 3091998 HEDIS US DEP; Virnig BA, 2002, HEALTH AFFAIR, V21, P224, DOI 10.1377/hlthaff.21.6.224; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Zaslavsky AM, 2005, MED CARE, V43, P303, DOI 10.1097/01.mlr.0000159975.43573.8d; Zaslavsky AM, 2002, INQUIRY-J HEALTH CAR, V39, P138, DOI 10.5034/inquiryjrnl_39.2.138; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	48	134	134	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1998	2004		10.1001/jama.296.16.1998	http://dx.doi.org/10.1001/jama.296.16.1998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098BL	17062863	Bronze			2022-12-28	WOS:000241495300022
J	DeJong, J; El-Khoury, G				DeJong, Jocelyn; El-Khoury, Golda			Reproductive health of Arab young people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COUNTRIES		Amer Univ Beirut, Fac Hlth Sci, Beirut 2020, Lebanon; Unicef, Middle E & N Africa Reg, Amman 11821, Jordan	American University of Beirut	DeJong, J (corresponding author), Amer Univ Beirut, Fac Hlth Sci, POB 11-0236,Riad El Solh 1107, Beirut 2020, Lebanon.	jd16@aub.edu.lb						Al Riyami Asya, 2004, Reprod Health Matters, V12, P144, DOI 10.1016/S0968-8080(04)23113-5; Aoyama Atsuko, 2001, REPROD HLTH MIDDLE E; *ATPF, 2003, EV PROJ DOUBL PROT J; *BBC NEWS, 2003, EGYPT TACKL TAB NET; BEAMISH J, 2003, ADOLESCENT REPROD HL; DeJong J, 2005, REPROD HEALTH MATTER, V13, P49, DOI 10.1016/S0968-8080(05)25181-9; *EG MIN HLTH POP, 2002, REP AIDS HOT LIN 1 J; El-Tawila S., 1999, TRANSITIONS ADULTHOO; ELZANATY F, 1996, BEHAV RES AMONG EGYP; Fargues P, 2005, REPROD HEALTH MATTER, V13, P43, DOI 10.1016/S0968-8080(05)25161-3; Fargues P., 2001, MONDE ARABE MAGHREB, V171, P3; Foster AM, 2005, CONTRACEPTION, V72, P130, DOI 10.1016/j.contraception.2005.03.003; Human Rights Watch, 2003, HUMAN RIGHTS WATCH, V15; Johns Hopkins University Center for Communication Programs, 2001, JORD YOUTH SURV KNOW; Khawaja M, 2000, POP STUD-J DEMOG, V54, P331, DOI 10.1080/713779091; *OM NAT AIDS PROGR, 2006, HIV AIDS HOTL REC; *PRINC BASM WOM RE, 2000, QUAL RES REPR HLTH K; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; SHEPARD BL, 2005, BREAKING SILENCE SAV; *UNAIDS, SUMM CAR DRIV FORW H; WHO, 2002, GROW CONF PROGR AD H	21	42	43	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					849	851		10.1136/bmj.38993.460197.68	http://dx.doi.org/10.1136/bmj.38993.460197.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053245	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000241678500023
J	Doe, CQ				Doe, Chris Q.			Chinmo and neuroblast temporal identity	CELL			English	Editorial Material							DROSOPHILA; SPECIFY; COMPETENCE	Although spatial patterning during embryonic development is well characterized, a corresponding framework for temporal patterning has not been established. In this issue, Zhu et al. (2006) identify the Chinmo protein as conferring temporal identity on the neural progeny of Drosophila neuroblasts, revealing appealing parallels with spatial patterning.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu						ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Novotny T, 2002, DEVELOPMENT, V129, P1027; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910	8	7	7	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					254	256		10.1016/j.cell.2006.10.008	http://dx.doi.org/10.1016/j.cell.2006.10.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055425	Bronze			2022-12-28	WOS:000241827100011
J	Li, QX; Ali, MA; Cohen, JI				Li, Qingxue; Ali, Mir A.; Cohen, Jeffrey I.			Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread	CELL			English	Article							AMYLOID BETA-PROTEIN; GLYCOPROTEIN-I; MONOCLONAL-ANTIBODIES; POLIOVIRUS RECEPTOR; MANNOSE 6-PHOSPHATE; HEPARAN-SULFATE; ENTRY; DEGRADATION; GE; FUSION	Varicella-zoster virus (VZV) causes chickenpox and shingles. While varicella is likely spread as cell-free virus to susceptible hosts, the virus is transmitted by cell-to-cell spread in the body and in vitro. Since VZV glycoprotein E (gE) is essential for virus infection, we postulated that gE binds to a cellular receptor. We found that insulin-degrading enzyme (IDE) interacts with gE through its extracellular domain. Downregulation of IDE by siRNA, or blocking of IDE with antibody, with soluble IDE protein extracted from liver, or with bacitracin inhibited VZV infection. Cell-to-cell spread of virus was also impaired by blocking IDE. Transfection of cell lines impaired for VZV infection with a plasmid expressing human IDE resulted in increased entry and enhanced infection with cell-free and cell-associated virus. These studies indicate that IDE is a cellular receptor for both cell-free and cell-associated VZV.	NIH, Med Virol Sect, Lab Clin Infect Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Cohen, JI (corresponding author), NIH, Med Virol Sect, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000430, Z01AI000430] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AKIYAMA H, 1988, BIOCHEM BIOPH RES CO, V155, P914, DOI 10.1016/S0006-291X(88)80583-7; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Arvin A, 2001, FIELDS VIROLOGY, P2731; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; CAI WZ, 1991, J VIROL, V65, P4078, DOI 10.1128/JVI.65.8.4078-4090.1991; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; Cohen JI, 1997, J VIROL, V71, P6913, DOI 10.1128/JVI.71.9.6913-6920.1997; Cohen JI, 1998, J INFECT DIS, V177, P293, DOI 10.1086/514210; Cohen JI, 2001, FIELDS VIROLOGY, P2707; Cole NL, 2003, REV MED VIROL, V13, P207, DOI 10.1002/rmv.377; Collins WJ, 2003, J VIROL, V77, P2686, DOI 10.1128/JVI.77.4.2686-2695.2003; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dingwell KS, 1998, J VIROL, V72, P8933, DOI 10.1128/JVI.72.11.8933-8942.1998; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GABEL CA, 1989, J VIROL, V63, P4264, DOI 10.1128/JVI.63.10.4264-4276.1989; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOLDFINE ID, 1984, DIABETES, V33, P64, DOI 10.2337/diabetes.33.1.64; Hambleton S, 2004, CELL MOL LIFE SCI, V61, P3047, DOI 10.1007/s00018-004-4269-7; Hamel FG, 1997, BBA-PROTEIN STRUCT M, V1338, P207, DOI 10.1016/S0167-4838(96)00202-6; HAMEL FG, 1991, DIABETES, V40, P438; Kimura H, 1997, VIROLOGY, V233, P382, DOI 10.1006/viro.1997.8625; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Kwon H, 2006, J VIROL, V80, P138, DOI 10.1128/JVI.80.1.138-148.2006; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lopez M, 2001, J VIROL, V75, P5684, DOI 10.1128/JVI.75.12.5684-5691.2001; LOWRY PW, 1992, J GEN VIROL, V73, P811, DOI 10.1099/0022-1317-73-4-811; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; MISBIN RI, 1989, DIABETES, V38, P152, DOI 10.2337/diabetes.38.2.152; Mo CJ, 2002, VIROLOGY, V304, P176, DOI 10.1006/viro.2002.1556; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Santos RA, 2000, VIROLOGY, V275, P306, DOI 10.1006/viro.2000.0507; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SMITH TW, 1987, NORC REPORTER, V1, P4; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Wu L, 1997, ARCH VIROL, V142, P349, DOI 10.1007/s007050050081; YASO S, 1987, DIABETOLOGIA, V30, P27, DOI 10.1007/BF01788903; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	50	108	118	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					305	316		10.1016/j.cell.2006.08.046	http://dx.doi.org/10.1016/j.cell.2006.08.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055432	Green Published, Bronze			2022-12-28	WOS:000241827100018
J	Papassotiropoulos, A; Stephan, DA; Huentelman, MJ; Hoerndli, FJ; Craig, DW; Pearson, JV; Huynh, KD; Brunner, F; Corneveaux, J; Osborne, D; Wollmer, MA; Aerni, A; Coluccia, D; Hanggi, J; Mondadori, CRA; Buchmann, A; Reiman, EM; Caselli, RJ; Henke, K; de Quervain, DJF				Papassotiropoulos, Andreas; Stephan, Dietrich A.; Huentelman, Matthew J.; Hoerndli, Frederic J.; Craig, David W.; Pearson, John V.; Huynh, Kim-Dung; Brunner, Fabienne; Corneveaux, Jason; Osborne, David; Wollmer, M. Axel; Aerni, Amanda; Coluccia, Daniel; Haenggi, Juergen; Mondadori, Christian R. A.; Buchmann, Andreas; Reiman, Eric M.; Caselli, Richard J.; Henke, Katharina; de Quervain, Dominique J. -F.			Common KIBRA alleles are associated with human memory performance	SCIENCE			English	Article							PROTEIN-KINASE-C; POPULATION STRATIFICATION; POLYMORPHISM; HIPPOCAMPUS; ACTIVATION; COGNITION	Human memory is a polygenic trait. We performed a genome-wide screen to identify memory-related gene variants. A genomic locus encoding the brain protein KIBRA was significantly associated with memory performance in three independent, cognitively normal cohorts from Switzerland and the United States. Gene expression studies showed that KIBRA was expressed in memory-related brain structures. Functional magnetic resonance imaging detected KIBRA allele dependent differences in hippocampal activations during memory retrieval. Evidence from these experiments suggests a role for KIBRA in human memory.	Univ Zurich, Div Psychiat Res, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Univ Arizona, Dept Psychiat, Phoenix, AZ 85006 USA; Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ 85006 USA; Mayo Clin, Dept Psychol, Scottsdale, AZ 85259 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; University of Arizona; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix	Papassotiropoulos, A (corresponding author), Univ Zurich, Div Psychiat Res, CH-8057 Zurich, Switzerland.	papas@bli.unizh.ch; dstephan@tgen.org	Craig, David Wesley/K-6961-2019; Wollmer, Marc A/B-5038-2009; Pearson, John V/F-2249-2011; Pearson, John/AAT-4211-2020	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Hanggi, Jurgen/0000-0001-8124-6018; , Andreas/0000-0001-6981-9389; de Quervain, Dominique/0000-0001-7131-2464; Papassotiropoulos, Andreas/0000-0002-2210-9651	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01-HL086528-01] Funding Source: Medline; NIA NIH HHS [P30AG19610] Funding Source: Medline; NIMH NIH HHS [R01MH057899] Funding Source: Medline; NINDS NIH HHS [U24NS051872] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Craig DW, 2005, EXPERT REV MOL DIAGN, V5, P159, DOI 10.1586/14737159.5.2.159; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Kelsoe JR, 2004, INT REV PSYCHIATR, V16, P294, DOI 10.1080/09540260400014385; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Milner B, 1972, Clin Neurosurg, V19, P421; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schacter D., 1994, MEMORY SYSTEMS; Schork NJ, 2001, ADV GENET, V42, P299, DOI 10.1016/S0065-2660(01)42030-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921	27	307	329	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					475	478		10.1126/science.1129837	http://dx.doi.org/10.1126/science.1129837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053149	Green Submitted			2022-12-28	WOS:000241382500045
J	Hulzebos, EHJ; Helders, PJM; Favie, NJ; De Bie, RA; de la Riviere, AB; Van Meeteren, NLU				Hulzebos, Erik H. J.; Helders, Paul J. M.; Favie, Nine J.; De Bie, Rob A.; de la Riviere, Aart Brutel; Van Meeteren, Nico L. U.			Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYPASS GRAFT-SURGERY; CARDIAC-SURGERY; MECHANICAL VENTILATION; CARDIOPULMONARY BYPASS; CHEST PHYSIOTHERAPY; PHYSICAL THERAPY; DYSFUNCTION; MORTALITY; OUTCOMES; PUMP	Context Postoperative pulmonary complications (PPCs) after coronary artery bypass graft (CABG) surgery are a major source of morbidity and mortality, and increase length of hospital stay and resource utilization. The prehospitalization period before CABG surgery may be used to improve a patient's pulmonary condition. The efficacy of preoperative inspiratory muscle training (IMT) in reducing the incidence of PPCs in high-risk patients undergoing CABG surgery has not yet been determined. Objective To evaluate the prophylactic efficacy of preoperative IMT on the incidence of PPCs in high-risk patients scheduled for elective CABG surgery. Design, Setting, and Patients A single-blind, randomized clinical trial conducted at the University Medical Center Utrecht, Utrecht, the Netherlands, with enrollment between July 2002 and August 2005. Of 655 patients referred for elective CABG surgery, 299 (45.6%) met criteria for high risk of developing PPCs, of whom 279 were enrolled and followed up until discharge from hospital. Intervention Patients were randomly assigned to receive either preoperative IMT (n = 140) or usual care (n = 139). Both groups received the same postoperative physical therapy. Main Outcome Measures Incidence of PPCs, especially pneumonia, and duration of postoperative hospitalization. Results Both groups were comparable at baseline. After CABG surgery, PPCs were present in 25 (18.0%) of 139 patients in the IMT group and 48 (35.0%) of 137 patients in the usual care group (odds ratio [ OR], 0.52; 95% confidence interval [CI], 0.30-0.92). Pneumonia occurred in 9 (6.5%) of 139 patients in the IMT group and in 22 (16.1%) of 137 patients in the usual care group (OR, 0.40; 95% CI, 0.19-0.84). Median duration of postoperative hospitalization was 7 days (range, 5-41 days) in the IMT group vs 8 days (range, 6-70 days) in the usual care group by Mann-Whitney U statistic (z = -2.42; P =. 02). Conclusion Preoperative IMT reduced the incidence of PPCs and duration of postoperative hospitalization in patients at high risk of developing a pulmonary complication undergoing CABG surgery.	Univ Med Ctr & Childrens Hosp, Dept Pediat Phys Therapy & Exercise Physiol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; Acad Hlth Sci Utrecht, Dept Physiotherapy Res, Utrecht, Netherlands; Univ Utrecht, Utrecht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; Onze Lieve Vrouw Hosp, Dept Cardiopulm Surg, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Maastricht University; Onze Lieve Vrouwe Gasthuis Hospital	Hulzebos, EHJ (corresponding author), Univ Med Ctr & Childrens Hosp, Dept Pediat Phys Therapy & Exercise Physiol, Room KM 02-056,POB 85090, NL-3508 AB Utrecht, Netherlands.	h.hulzebos@umcutrecht.nl						[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Arthur HM, 2000, ANN INTERN MED, V133, P253, DOI 10.7326/0003-4819-133-4-200008150-00007; BLOK H, 2003, TIJDSCHRIFT HYGIENE, V6, P172; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brooks-Brunn J A, 1995, Am J Crit Care, V4, P340; Carli F, 2005, CURR OPIN CLIN NUTR, V8, P23, DOI 10.1097/00075197-200501000-00005; CASTILLO R, 1985, ARCH PHYS MED REHAB, V66, P376; Chumillas S, 1998, ARCH PHYS MED REHAB, V79, P5, DOI 10.1016/S0003-9993(98)90198-8; CLARK RE, 1994, ANN THORAC SURG, V58, P271, DOI 10.1016/0003-4975(94)91127-4; Crowe JM, 1997, PHYS THER, V77, P260, DOI 10.1093/ptj/77.3.260; DALNOGARE AR, 1994, MED CLIN N AM, V78, P1081, DOI 10.1016/S0025-7125(16)30121-3; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Henke PK, 2005, AM J SURG, V190, P333, DOI 10.1016/j.amjsurg.2005.05.036; HOM SD, 2005, ARCH PHYS MED REHAB, V86, pS8; Hulzebos EHJ, 2003, PHYS THER, V83, P8, DOI 10.1093/ptj/83.1.8; Keenan TDL, 2005, CHEST, V128, P363, DOI 10.1378/chest.128.1.363; KROENKE K, 1992, ARCH INTERN MED, V152, P967, DOI 10.1001/archinte.152.5.967; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; Lapin Craig D, 2002, Respir Care, V47, P778; LEE TH, 1988, AM HEART J, V115, P203, DOI 10.1016/0002-8703(88)90545-5; Lotters F, 2002, EUR RESPIR J, V20, P570, DOI 10.1183/09031936.02.00237402; McConnell AK, 2004, SPORTS MED, V34, P117, DOI 10.2165/00007256-200434020-00005; McCool FD, 2006, CHEST, V129, p250S, DOI 10.1378/chest.129.1_suppl.250S; Montes FR, 2004, J CARDIOTHOR VASC AN, V18, P698, DOI 10.1053/j.jvca.2004.08.004; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Ng CSH, 2002, CHEST, V121, P1269, DOI 10.1378/chest.121.4.1269; NOMORI H, 1994, CHEST, V105, P1782, DOI 10.1378/chest.105.6.1782; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Olsen MF, 1997, BRIT J SURG, V84, P1535, DOI 10.1002/bjs.1800841111; Pasquina P, 2003, BMJ-BRIT MED J, V327, P1379, DOI 10.1136/bmj.327.7428.1379; Pryor JA, 1999, EUR RESPIR J, V14, P1418, DOI 10.1183/09031936.99.14614189; Rajendran A J, 1998, Indian Heart J, V50, P531; Scott BH, 2005, J CARDIOTHOR VASC AN, V19, P583, DOI 10.1053/j.jvca.2005.03.030; STILLER KR, 1992, BRIT J SURG, V79, P745, DOI 10.1002/bjs.1800790807; Toumpoulis IK, 2006, J THORAC CARDIOV SUR, V131, P343, DOI 10.1016/j.jtcvs.2005.08.056; van der Tweel I, 2003, J CLIN EPIDEMIOL, V56, P610, DOI 10.1016/S0895-4356(03)00117-3; VRACIU JK, 1977, PHYS THER, V57, P1367, DOI 10.1093/ptj/57.12.1367; WEINER P, 1989, AM REV RESPIR DIS, V140, P392, DOI 10.1164/ajrccm/140.2.392; Weiner P, 1998, WORLD J SURG, V22, P427, DOI 10.1007/s002689900410; Wynne R, 2004, AM J CRIT CARE, V13, P384, DOI 10.4037/ajcc2004.13.5.384; Yende S, 2002, CHEST, V122, P245, DOI 10.1378/chest.122.1.245; Zupancich E, 2005, J THORAC CARDIOV SUR, V130, P378, DOI 10.1016/j.jtcvs.2004.11.061	42	377	408	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1851	1857		10.1001/jama.296.15.1851	http://dx.doi.org/10.1001/jama.296.15.1851			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047215	Bronze			2022-12-28	WOS:000241329300027
J	Stanulla, M; Schunemann, HJ				Stanulla, Martin; Schuenemann, Holger J.			Thioguanine versus mercaptopurine in childhood ALL	LANCET			English	Editorial Material							LYMPHOBLASTIC-LEUKEMIA; TRIALS; 6-THIOGUANINE; BENEFIT		Hannover Med Sch, Dept Paediat Hematol & Oncol, D-30625 Hannover, Germany; Italian Natl Canc Inst Regina Elena, Clin res & Informat Translat Unit, SC Epidemiol, Rome, Italy	Hannover Medical School	Stanulla, M (corresponding author), Hannover Med Sch, Dept Paediat Hematol & Oncol, D-30625 Hannover, Germany.	Stanulla.Martin@MH-Hannover.de	Stanulla, Martin/N-4674-2017; Stanulla, Martin/D-2528-2010	Stanulla, Martin/0000-0002-3834-0727; Schunemann, Holger/0000-0003-3211-8479				BURCHENAL JH, 1953, BLOOD, V8, P965, DOI 10.1182/blood.V8.11.965.965; de Boer NKH, 2006, DIGESTION, V73, P25, DOI 10.1159/000091662; ELION GB, 1952, J AM CHEM SOC, V74, P411, DOI 10.1021/ja01122a037; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Stork LC, 2002, BLOOD, V100, p156A; Vora A, 2006, LANCET, V368, P1339, DOI 10.1016/S0140-6736(06)69558-5	12	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1304	1306		10.1016/S0140-6736(06)69531-7	http://dx.doi.org/10.1016/S0140-6736(06)69531-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046444				2022-12-28	WOS:000241388100005
J	Perez-Brocal, V; Gil, R; Ramos, S; Lamelas, A; Postigo, M; Michelena, JM; Silva, FJ; Moya, A; Latorre, A				Perez-Brocal, Vicente; Gil, Rosario; Ramos, Silvia; Lamelas, Araceli; Postigo, Marina; Manuel Michelena, Jose; Silva, Francisco J.; Moya, Andres; Latorre, Amparo			A small microbial genome: The end of a long symbiotic relationship?	SCIENCE			English	Article							ENDOSYMBIONT BUCHNERA; ACYRTHOSIPHON-PISUM; APHID; EVOLUTION; BACTERIA; SEQUENCE	Intracellular bacteria are characterized by genome reduction. The 422,434 - base pair genome of Buchnera aphidicola BCc, primary endosymbiont of the aphid Cinara cedri, is similar to 200 kilobases smaller than the previously sequenced B. aphidicola genomes. B. aphidicola BCc has lost most metabolic functions, including the ability to synthesize the essential amino acid tryptophan and riboflavin. In addition, most retained genes are evolving rapidly. Possibly, B. aphidicola BCc is losing its symbiotic capacity and is being complemented ( and might be replaced) by the highly abundant coexisting secondary symbiont.	Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46071, Spain; Univ Valencia, Dept Genet, E-46100 Valencia, Spain; CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; Univ Valencia, Dept Zool, E-46100 Valencia, Spain	University of Valencia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Valencia	Latorre, A (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Apartado Postal 22085, Valencia 46071, Spain.	amparo.latorre@uv.es	Lamelas Cabello, Araceli/B-6129-2015; Latorre, Amparo/E-4997-2015; Cabello, Araceli Lamelas/Q-6726-2018; Moya, Andrés/A-8190-2008; Cabello, Araceli Lamelas/AAC-6066-2019; Postigo, Marina/Y-6210-2019; Gil, Rosario/R-6932-2018; Silva, Francisco/ABF-7144-2021; Perez Brocal, Vicente/K-3627-2014	Latorre, Amparo/0000-0002-9146-7284; Cabello, Araceli Lamelas/0000-0002-1939-5642; Moya, Andrés/0000-0002-2867-1119; Cabello, Araceli Lamelas/0000-0002-1939-5642; Gil, Rosario/0000-0002-9397-1003; Silva, Francisco/0000-0002-6911-6541; Perez Brocal, Vicente/0000-0002-1927-9676				Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; FUKATSU T, 1992, J INSECT PHYSIOL, V38, P765, DOI 10.1016/0022-1910(92)90029-D; Gil R, 2006, GENE, V370, P17, DOI 10.1016/j.gene.2005.10.043; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	15	255	410	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					312	313		10.1126/science.1130441	http://dx.doi.org/10.1126/science.1130441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038625				2022-12-28	WOS:000241194100045
J	Hartmann, CW; Rhee, DJ				Hartmann, Christine W.; Rhee, Douglas J.			The patient's journey: glaucoma	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Thomas Jefferson Univ, Jefferson Med Coll, Dept Hlth Policy, Philadelphia, PA 19107 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA	Jefferson University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Hartmann, CW (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Hlth Policy, Philadelphia, PA 19107 USA.	cwhrtmnn@aol.com							0	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					738	739		10.1136/bmj.38975.507188.7C	http://dx.doi.org/10.1136/bmj.38975.507188.7C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	17023466	Green Published			2022-12-28	WOS:000241248600021
J	Raab-Graham, KF; Haddick, PCG; Jan, YN; Jan, LY				Raab-Graham, Kimberly F.; Haddick, Patrick C. G.; Jan, Yuh Nung; Jan, Lily Yeh			Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites	SCIENCE			English	Article							LONG-TERM POTENTIATION; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; EXPRESSION; ACTIVATION; MECHANISMS; DISTINCT; CONTRIBUTES; PLASTICITY	Mammalian target of rapamycin ( mTOR) is implicated in synaptic plasticity and local translation in dendrites. We found that the mTOR inhibitor, rapamycin, increased the Kv1.1 voltage-gated potassium channel protein in hippocampal neurons and promoted Kv1.1 surface expression on dendrites without altering its axonal expression. Moreover, endogenous Kv1.1 mRNA was detected in dendrites. Using Kv1.1 fused to the photoconvertible fluorescence protein Kaede as a reporter for local synthesis, we observed Kv1.1 synthesis in dendrites upon inhibition of mTOR or the N-methyl-D-aspartate (NMDA) glutamate receptor. Thus, synaptic excitation may cause local suppression of dendritic Kv1 channels by reducing their local synthesis.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	lily.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Raab-Graham, Kimberly/0000-0001-6502-057X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334, R01MH065334] Funding Source: NIH RePORTER; NIMH NIH HHS [MH13010, MH65334] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Chen XX, 2006, PFLUG ARCH EUR J PHY, V453, P397, DOI 10.1007/s00424-006-0097-y; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; JAKOI ER, 1995, BRAIN RES, V693, P124, DOI 10.1016/0006-8993(95)00599-L; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328	28	207	213	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					144	148		10.1126/science.1131693	http://dx.doi.org/10.1126/science.1131693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023663				2022-12-28	WOS:000241031200056
J	Zwierlein, MW; Ketterle, W				Zwierlein, Martin W.; Ketterle, Wolfgang			Comment on "Pairing and phase separation in a polarized Fermi gas"	SCIENCE			English	Editorial Material									MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ketterle, W (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ketterle@mit.edu		Hulet, Randall/0000-0001-7045-8947				De Silva TN, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.051602; Haque M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.011602; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; PARTRIDGE GB, CONDMAT0605581, P20403; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Zwierlein MW, 2006, NATURE, V442, P54, DOI 10.1038/nature04936; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318; [No title captured]	8	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796								10.1126/science.1129812	http://dx.doi.org/10.1126/science.1129812			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023636				2022-12-28	WOS:000241031200022
J	Elliott, T; Thomas, A; Jeffcoate, A; Niu, YL				Elliott, Tim; Thomas, Alex; Jeffcoate, Alistair; Niu, Yaoling			Lithium isotope evidence for subduction-enriched mantle in the source of mid-ocean-ridge basalts	NATURE			English	Article							EAST PACIFIC RISE; MARBLE-CAKE MANTLE; RED-SEA MANTLE; ICP-MS; CRUST; LI; FRACTIONATION; ORIGIN; GEOCHEMISTRY; CONSTRAINTS	'Recycled' crustal materials, returned from the Earth's surface to the mantle by subduction, have long been invoked to explain compositional heterogeneity in the upper mantle(1). Yet increasingly, problems have been noted with this model(2,3). The debate can be definitively addressed using stable isotope ratios, which should only significantly vary in primitive, mantle-derived materials as a consequence of recycling. Here we present data showing a notable range in lithium isotope ratios in basalts from the East Pacific Rise, which correlate with traditional indices of mantle heterogeneity (for example, Nd-143/Nd-144 ratios). Such co-variations of stable and radiogenic isotopes in melts from a normal ridge segment provide critical evidence for the importance of recycled material in generating chemical heterogeneity in the upper mantle. Contrary to many models, however, the elevated lithium isotope ratios of the 'enriched' East Pacific Rise lavas imply that subducted ocean crust is not the agent of enrichment. Instead, we suggest that fluid-modified mantle, which is enriched during residency in a subduction zone, is mixed back into the upper mantle to cause compositional variability.	Univ Bristol, Bristol Isotope Grp, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	University of Bristol; University of Oxford; Durham University	Elliott, T (corresponding author), Univ Bristol, Bristol Isotope Grp, Dept Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	tim.elliott@bris.ac.uk	Thomas, Alex/D-1028-2012; Niu, Yaoling/A-5448-2008; Jeffcoate, Alistair/AAN-9753-2020; Niu, Yaoling/GPW-9211-2022	Thomas, Alex/0000-0002-0734-9593; Niu, Yaoling/0000-0001-9488-2304; Elliott, Tim/0000-0002-0984-0191				ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Brooker RA, 2004, CHEM GEOL, V212, P179, DOI 10.1016/j.chemgeo.2004.08.007; BRUECKNER HK, 1988, TECTONOPHYSICS, V150, P163, DOI 10.1016/0040-1951(88)90300-9; Chan LH, 2002, EARTH PLANET SC LETT, V201, P187, DOI 10.1016/S0012-821X(02)00707-0; CHAN LH, 1992, EARTH PLANET SC LETT, V108, P151, DOI 10.1016/0012-821X(92)90067-6; Cooper KM, 2004, EARTH PLANET SC LETT, V220, P297, DOI 10.1016/S0012-821X(04)00058-5; Decitre S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000178; Donnelly KE, 2004, EARTH PLANET SC LETT, V226, P347, DOI 10.1016/j.epsl.2004.07.019; Eiler JM, 2000, NATURE, V403, P530, DOI 10.1038/35000553; Elliott T, 2004, EARTH PLANET SC LETT, V220, P231, DOI 10.1016/S0012-821X(04)00096-2; Gillis KM, 2002, J PETROL, V43, P2075, DOI 10.1093/petrology/43.11.2075; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; Jeffcoate AB, 2004, GEOSTAND GEOANAL RES, V28, P161, DOI 10.1111/j.1751-908X.2004.tb01053.x; JEFFCOATE AB, IN PRESS GEOCHIM COS; Lundstrom CC, 2005, GEOCHIM COSMOCHIM AC, V69, P735, DOI 10.1016/j.gca.2004.08.004; Magna T, 2006, EARTH PLANET SC LETT, V243, P336, DOI 10.1016/j.epsl.2006.01.005; Moriguti T, 1998, EARTH PLANET SC LETT, V163, P167, DOI 10.1016/S0012-821X(98)00184-8; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; Niu YL, 1999, J GEOPHYS RES-SOL EA, V104, P7067, DOI 10.1029/1998JB900037; PRINZHOFER A, 1989, EARTH PLANET SC LETT, V92, P189, DOI 10.1016/0012-821X(89)90046-0; Regelous M, 1999, EARTH PLANET SC LETT, V168, P45, DOI 10.1016/S0012-821X(99)00048-5; Seitz HM, 2004, CHEM GEOL, V212, P163, DOI 10.1016/j.chemgeo.2004.08.009; Stracke A, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000223; Sun S.S., 1989, GEOL SOC SPECIAL PUB, V42, P313; Tomascak PB, 1999, GEOCHIM COSMOCHIM AC, V63, P907, DOI 10.1016/S0016-7037(98)00318-4; Tomascak PB, 2002, EARTH PLANET SC LETT, V196, P227, DOI 10.1016/S0012-821X(01)00614-8; TOMASCAK PB, 1999, EOS, V80, pF1086; Wunder B, 2006, CONTRIB MINERAL PETR, V151, P112, DOI 10.1007/s00410-005-0049-0; Zack T, 2003, EARTH PLANET SC LETT, V208, P279, DOI 10.1016/S0012-821X(03)00035-9; ZINDLER A, 1984, EARTH PLANET SC LETT, V70, P175, DOI 10.1016/0012-821X(84)90004-9	30	171	186	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					565	568		10.1038/nature05144	http://dx.doi.org/10.1038/nature05144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024091				2022-12-28	WOS:000240988200041
J	Rocco, MV; Frankenfield, DL; Hopson, SD; McClellan, WM				Rocco, Michael V.; Frankenfield, Diane L.; Hopson, Sari D.; McClellan, William M.			Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; ESRD PATIENTS; MORTALITY; RISK; DEATH; HYPOALBUMINEMIA; PREDICTORS; SURVIVAL; ALBUMIN; IMPACT	Background: Patients receiving long-term hemodialysis have a yearly mortality rate of 15% to 20%. Objective: To determine whether attaining clinical performance measures for hemodialysis care is associated with favorable 12-month mortality and hospitalization rates. Design: Cohort study. Setting: Outpatient hemodialysis centers in the United States. Patients: 15 287 patients who were selected from a 5% random sample of patients receiving long-term hemodialysis. Measurements: The authors used data from the Centers for Medicare & Medicaid Services End-Stage Renal Disease Clinical Performance Measures Project from 1999 and 2000. The clinical performance measure targets were hemoglobin value of 110 g/L or greater; serum albumin value of 40 g/L or greater or 37 g/L or greater (bromcresol green and bromcresol purple laboratory methods, respectively); use of a fistula for vascular access; and measured single-pool Kt/V urea value of 1.2 or greater. The outcome measures were death or hospitalization during 1-year follow-up. Results: 8364 patients (54.7%) were hospitalized and 3062 (20.0%) died during the 12-month follow-up period. Six percent of patients did not meet any clinical measure targets, 24% met 1 target, 39% met 2 targets, 24% met 3 targets, and 7% met all 4 targets. The unadjusted 12-month hospitalization and mortality rates for these 5 groups were 60%, 60%, 56%, 49%, and 43% (P < 0.001) and 29%, 25%, 21%, 14%, and 7% (P < 0.001), respectively. The risk for death increased for each additional guideline indicator that was not met: Adjusted hazard ratios were 4.6 (95% Cl, 3.3 to 6.4), 3.5 (Cl, 2.6 to 4.7), 2.6 (Cl, 1.9 to 3.5), and 1.9 (CI, 1.4 to 2.6) for 0, 1, 2, or 3 targets met, respectively, compared with meeting 4 targets (referent). Similarly, the risk for hospitalization increased for each additional guideline indicator that was not met: Adjusted hazard ratios were 1.6 (Cl, 1.4 to 1.9), 1.5 (Cl, 1.3 to 1.7), 1.3 (Cl, 1.1 to 1.5), and 1.1 (Cl, 0.98 to 1.3), respectively. Limitations: It was not possible to determine the roles of severity of illness, other patient factors, or suboptimal care in failure to meet performance measures. Conclusions: In patients receiving long-term hemodialysis, meeting multiple clinical measure targets is associated with a decrease in hospitalization and mortality rates.	Wake Forest Univ, Sch Med, Nephrol Sect, Winston Salem, NC 27157 USA; Emory Univ, Atlanta, GA 30322 USA; Ctr Medicare Serv, Baltimore, MD USA; Ctr Medicaid Serv, Baltimore, MD USA	Wake Forest University; Emory University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Rocco, MV (corresponding author), Wake Forest Univ, Sch Med, Nephrol Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA.	mrocco@wfubmc.edu						[Anonymous], 2004, AM J KIDNEY DIS S, V44, pS1; Collins AJ, 2002, KIDNEY INT, V61, pS44, DOI 10.1046/j.1523-1755.61.s80.9.x; Collins AJ, 2002, AM J KIDNEY DIS, V39, P784, DOI 10.1053/ajkd.2002.31999; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; GOLDWASSER P, 1993, J AM SOC NEPHROL, V3, P1613; Iseki K, 1997, KIDNEY INT, V51, P1212, DOI 10.1038/ki.1997.165; Jones M, 2004, KIDNEY INT, V65, P757, DOI 10.1111/j.1523-1755.2004.00450.x; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V37, P564, DOI 10.1053/ajkd.2001.22433; Kaysen GA, 2002, KIDNEY INT, V61, P2240, DOI 10.1046/j.1523-1755.2002.00076.x; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McClellan WM, 2003, HEALTH CARE FINANC R, V24, P89; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Pastan S, 2002, KIDNEY INT, V62, P620, DOI 10.1046/j.1523-1755.2002.00460.x; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; *US REN DAT SYST, USRDS 2003 ANN DAT R; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Wong CS, 2002, KIDNEY INT, V61, P630, DOI 10.1046/j.1523-1755.2002.00169.x; Yang CWS, 1996, AM J KIDNEY DIS, V27, P380, DOI 10.1016/S0272-6386(96)90361-3	18	89	97	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					512	519		10.7326/0003-4819-145-7-200610030-00009	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015869				2022-12-28	WOS:000241093900005
J	Rokas, A				Rokas, Antonis			Genomics and the Tree of Life	SCIENCE			English	Editorial Material									MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Rokas, A (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	arokas@mit.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cracraft J., 2004, ASSEMBLING TREE LIFE; Doolittle WF, 2003, PHILOS T R SOC B, V358, P39, DOI 10.1098/rstb.2002.1185; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Larget B, 2005, MOL PHYLOGENET EVOL, V36, P214, DOI 10.1016/j.ympev.2005.03.026; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; ROSHAN UW, 2004, P 2004 IEEE COMP SYS; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7	12	15	15	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1897	+		10.1126/science.1134490	http://dx.doi.org/10.1126/science.1134490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008515				2022-12-28	WOS:000240832200033
J	Stern, DT; Papadakis, M				Stern, David T.; Papadakis, Maxine			The developing physician - Becoming a professional	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DOCTOR-PATIENT-RELATIONSHIP; MEDICAL-EDUCATION; DISCIPLINARY ACTION; HIDDEN CURRICULA; HUMAN DIMENSIONS; STUDENTS; BEHAVIOR; RESPONSES; SCHOOLS; VALUES		Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Med Educ, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Calif San Francisco, Dept Internal Med, Off Dean, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Stern, DT (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, 300 N Ingalls,Rm 7E02, Ann Arbor, MI 48109 USA.	dstern@umich.edu	Stern, David/E-8678-2016	Stern, David/0000-0001-9278-7303				*ACCR COUNC GRAD M, 2000, ACGME TOOLB ASS METH; Accreditation Council of Graduate Medical Education, 2005, OUTC PROJ; Alexander GC, 2003, ANN INTERN MED, V138, P472, DOI 10.7326/0003-4819-138-6-200303180-00011; [Anonymous], OXFORD ENGLISH DICT; Armstrong EG, 2002, MED TEACH, V24, P130, DOI 10.1080/01421590220120731; Arnold L, 2005, J GEN INTERN MED, V20, P819, DOI 10.1111/j.1525-1497.2005.0162.x; Becker Howard, 1961, BOYS WHITE STUDENT C; BENSON JA, 1983, ANN INTERN MED, V99, P720, DOI 10.7326/0003-4819-99-5-720; Branch WT, 2001, JAMA-J AM MED ASSOC, V286, P1067, DOI 10.1001/jama.286.9.1067; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Burack JH, 1999, J GEN INTERN MED, V14, P49, DOI 10.1046/j.1525-1497.1999.00280.x; Charap M, 2004, ANN INTERN MED, V140, P814, DOI 10.7326/0003-4819-140-10-200405180-00011; Charon R, 2004, NEW ENGL J MED, V350, P862, DOI 10.1056/NEJMp038249; COHEN JJ, 2002, COMMUNICATION   1110; COHEN JJ, 2006, MEASURING MED PROFES; Cote L, 2000, ACAD MED, V75, P1117, DOI 10.1097/00001888-200011000-00020; Davis MH, 1999, PROBLEM BASED LEARNI; Dewey J., 1938, EXPERIENCE ED; DuBois JM, 2002, ACAD MED, V77, P432, DOI 10.1097/00001888-200205000-00019; Eisner E. W., 2002, ED IMAGINATION DESIG, VThird; Elnicki DM, 2002, TEACH LEARN MED, V14, P92, DOI 10.1207/S15328015TLM1402_05; Eva KW, 2004, MED EDUC, V38, P314, DOI 10.1046/j.1365-2923.2004.01776.x; Ginsburg S, 2000, ACAD MED, V75, pS6, DOI 10.1097/00001888-200010001-00003; Gracey CF, 2005, ACAD MED, V80, P21, DOI 10.1097/00001888-200501000-00007; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Haidet P, 2006, J GEN INTERN MED, V21, P405, DOI 10.1111/j.1525-1497.2006.00417.x; Haidet P, 2005, ACAD MED, V80, P44, DOI 10.1097/00001888-200501000-00012; Hammond Kenric W, 2003, AMIA Annu Symp Proc, P269; HENSEL WA, 1992, ACAD MED, V67, P500, DOI 10.1097/00001888-199208000-00003; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Hundert EM, 1996, MED EDUC, V30, P353, DOI 10.1111/j.1365-2923.1996.tb00847.x; *I MED, 2004, AC HLTH CTR LEAD CHA; INUI T, 2003, FLAG WIND; Jackson P., 1990, LIFE CLASSROOMS; *LIAIS COMM MED ED, 2005, ACCR STAND; Merton R. K., 1957, STUDENT PHYS INTRO S; MIZRAHI T, 1985, SOCIOL HEALTH ILL, V7, P214, DOI 10.1111/1467-9566.ep10949079; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; Mutchnick IS, 2003, ACAD MED, V78, pS1, DOI 10.1097/00001888-200310001-00002; Osborn E, 2000, ACAD MED, V75, P241, DOI 10.1097/00001888-200003000-00011; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Papadakis MA, 1998, AM J MED, V104, P605; Schon D.A., 1987, ED REFLECTIVE PRACTI; Self DJ, 1998, ACAD MED, V73, pS91, DOI 10.1097/00001888-199810000-00056; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411; Sobel RK, 2006, NEW ENGL J MED, V354, P1114, DOI 10.1056/NEJMp058089; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Srinivasan M, 2004, ACAD MED, V79, P888, DOI 10.1097/00001888-200409000-00017; STEERN DT, 2006, MEASURING MED PROFES; Stern DT, 2000, HASTINGS CENT REP, V30, pS26, DOI 10.2307/3527661; Stern DT, 1998, AM J MED, V104, P569, DOI 10.1016/S0002-9343(98)00109-0; Stern DT, 1998, ACAD MED, V73, pS28, DOI 10.1097/00001888-199810000-00036; Stern DT, 2005, MED EDUC, V39, P75, DOI 10.1111/j.1365-2929.2004.02035.x; STERN DT, 2003, VIRTUAL MENTOR, V5; Thompson MJ, 2003, ACAD MED, V78, P342, DOI 10.1097/00001888-200303000-00023; *U TX MED BRANCH, 2003, PROF; Wear D, 1998, ANN INTERN MED, V129, P734, DOI 10.7326/0003-4819-129-9-199811010-00010; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112; 2006, AAMC REPORTER    JAN	60	239	246	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1794	1799		10.1056/NEJMra054783	http://dx.doi.org/10.1056/NEJMra054783			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065641				2022-12-28	WOS:000241512500008
J	Horton, R				Horton, Richard			Iraq: time to signal a new era for health in foreign policy	LANCET			English	Editorial Material							MORTALITY		Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							BEAUMONT P, 2006, GUARDIAN        0922, P19; BURNHAM G, 2006, LANCET          1012; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Fidler DP, 2006, B WORLD HEALTH ORGAN, V84, P687, DOI 10.2471/BLT.06-035469; Horton R, 2001, LANCET, V358, P1112, DOI 10.1016/S0140-6736(01)06297-3; Horton R, 2006, LANCET, V368, P1213, DOI 10.1016/S0140-6736(06)69496-8; MOORE S, 2006, SAN FRANCISCO C 1004, pA7; Moore Solomon, 2006, LOS ANGELES TIMES, P1; OPPEL RA, 2006, NY TIMES        0921, pA18; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TYSON AS, 2006, WASHINGTON POST 1007, pA16; WHITE J, 2006, WASH POST       0123, pA3	14	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1395	1397		10.1016/S0140-6736(06)69492-0	http://dx.doi.org/10.1016/S0140-6736(06)69492-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	097PA	17055923	Green Published, Bronze			2022-12-28	WOS:000241459100004
J	Leventhal, A; Ramlawi, A; Belbiesi, A; D Balicer, R				Leventhal, Alex; Ramlawi, Assad; Belbiesi, Adel; D Balicer, Ran			Regional collaboration in the Middle East to deal with H5N1 avian flu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Israel Minist Hlth, Publ Hlth Serv, POB 1176, IL-91010 Jerusalem, Israel; Palestinian Author, Minist Hlth, Ramallah, West Bank, Palestine; Jordan Minist Hlth, Amman, Jordan; Steering Comm Pandem Influenza Preparedness, IL-52392 Ramat Gan, Israel		Leventhal, A (corresponding author), Israel Minist Hlth, Publ Hlth Serv, POB 1176, IL-91010 Jerusalem, Israel.	leventhal_a@yahoo.com						Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; *ISR ORN CTR, MIGR BIRDS KNOW NO B; Leventhal A, 2003, LANCET, V361, P1222, DOI 10.1016/S0140-6736(03)12959-5; Levin A, 1998, J NATL CANCER I, V90, P807, DOI 10.1093/jnci/90.11.807; Ress Paul, 2005, BMJ, V331, P1164, DOI 10.1136/bmj.331.7526.1164-b; Skinner H, 2005, LANCET, V365, P1274, DOI 10.1016/S0140-6736(05)74817-0; TULCHINSKY T, 2002, SEPARATE COOPERATE C; *WHO, 2006, AV INFL SIT EG 20 MA; *WHO, H5N1 AV INFL TIM; *WHO, 2005, WHA58 3 REV INT HLTH	10	19	20	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					856	858		10.1136/bmj.38994.420926.80	http://dx.doi.org/10.1136/bmj.38994.420926.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ON	17053248	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000241678500026
J	Duldig, M				Duldig, Marc			Astronomy: Cosmic rays track the rotation of the milky way	SCIENCE			English	Editorial Material							ANISOTROPIES		Australian Govt, Antarctic Div, Kingston, Tas 7050, Australia	Australian Antarctic Division	Duldig, M (corresponding author), Australian Govt, Antarctic Div, 203 Channel Highway, Kingston, Tas 7050, Australia.	marc.duldig@aad.gov.au						Amenomori M, 2006, SCIENCE, V314, P439, DOI 10.1126/science.1131702; FORMAN MA, 1975, ASTROPHYS SPACE SCI, V32, P77, DOI 10.1007/BF00646218; Hall DL, 1996, SPACE SCI REV, V78, P401, DOI 10.1007/BF00171926; PARKER EN, 1965, PLANET SPACE SCI, V13, P9, DOI 10.1016/0032-0633(65)90131-5; PARKER EN, 1964, PLANET SPACE SCI, V12, P735, DOI 10.1016/0032-0633(64)90054-6	5	2	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					429	430		10.1126/science.1134046	http://dx.doi.org/10.1126/science.1134046			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053136				2022-12-28	WOS:000241382500028
J	Nair, KS; Rizza, RA; O'Brien, P; Dhatariya, K; Short, KR; Nehra, A; Vittone, JL; Klee, GG; Basu, A; Basu, R; Cobelli, C; Toffolo, G; Dalla Man, C; Tindall, DJ; Melton, L; Smith, GE; Khosla, S; Jensen, MD				Nair, K. Sreekumaran; Rizza, Robert A.; O'Brien, Peter; Dhatariya, Ketan; Short, Kevin R.; Nehra, Ajay; Vittone, Janet L.; Klee, George G.; Basu, Ananda; Basu, Rita; Cobelli, Claudio; Toffolo, Gianna; Dalla Man, Chiara; Tindall, Donald J.; Melton, L. Joseph, III; Smith, Glenn E.; Khosla, Sundeep; Jensen, Michael D.			DHEA in elderly women and DHEA or testosterone in elderly men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; DEHYDROEPIANDROSTERONE REPLACEMENT THERAPY; BODY-COMPOSITION; MUSCLE STRENGTH; HEALTHY-MEN; FAT; SULFATE; PERFORMANCE; DECLINE; MASS	BACKGROUND Dehydroepiandrosterone (DHEA) and testosterone are widely promoted as antiaging supplements, but the long-term benefits, as compared with potential harm, are unknown. METHODS We performed a 2-year, placebo-controlled, randomized, double-blind study involving 87 elderly men with low levels of the sulfated form of DHEA and bioavailable testosterone and 57 elderly women with low levels of sulfated DHEA. Among the men, 29 received DHEA, 27 received testosterone, and 31 received placebo. Among the women, 27 received DHEA and 30 received placebo. Outcome measures included physical performance, body composition, bone mineral density (BMD), glucose tolerance, and quality of life. RESULTS As compared with the change from baseline to 24 months in the placebo group, subjects who received DHEA for 2 years had an increase in plasma levels of sulfated DHEA by a median of 3.4 microg per milliliter (9.2 micromol per liter) in men and by 3.8 microg per milliliter (10.3 micromol per liter) in women. Among men who received testosterone, the level of bioavailable testosterone increased by a median of 30.4 ng per deciliter (1.1 nmol per liter), as compared with the change in the placebo group. A separate analysis of men and women showed no significant effect of DHEA on body-composition measurements. Neither hormone altered the peak volume of oxygen consumed per minute, muscle strength, or insulin sensitivity. Men who received testosterone had a slight increase in fat-free mass, and men in both treatment groups had an increase in BMD at the femoral neck. Women who received DHEA had an increase in BMD at the ultradistal radius. Neither treatment improved the quality of life or had major adverse effects. CONCLUSIONS Neither DHEA nor low-dose testosterone replacement in elderly people has physiologically relevant beneficial effects on body composition, physical performance, insulin sensitivity, or quality of life.	Mayo Clin & Mayo Fdn, Div Endocrinol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Psychol, Rochester, MN 55905 USA; Univ Padua, Dept Informat Engn, Padua, Italy	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Padua	Nair, KS (corresponding author), Mayo Clin & Mayo Fdn, Div Endocrinol, 200 1st St SW,5-194 Joseph, Rochester, MN 55905 USA.	nair.ree@mayo.edu	Short, Kevin R/AAC-2553-2020; Khosla, Sundeep/AAE-6170-2020	Short, Kevin R/0000-0001-6704-9587; Khosla, Sundeep/0000-0002-2936-4372; DALLA MAN, CHIARA/0000-0002-4908-0596; Smith, Glenn/0000-0003-1506-9484	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00585] Funding Source: Medline; NIA NIH HHS [P01 AG14283] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1993, HLTH STAT QUEST HSQ; Arlt W, 2001, J CLIN ENDOCR METAB, V86, P4686, DOI 10.1210/jc.86.10.4686; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; Basu R, 2003, DIABETES, V52, P3014; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Clarke BL, 2002, CALCIFIED TISSUE INT, V70, P137, DOI 10.1007/s00223-001-1072-4; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; Dhatariya KK, 2003, MAYO CLIN PROC, V78, P1257, DOI 10.4065/78.10.1257; Diamond P, 1996, J ENDOCRINOL, V150, pS43; Flynn MA, 1999, J CLIN ENDOCR METAB, V84, P1527, DOI 10.1210/jc.84.5.1527; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HELZLSOUER KJ, 1992, CANCER RES, V52, P1; JENSEN MD, 1993, MAYO CLIN PROC, V68, P867, DOI 10.1016/S0025-6196(12)60695-8; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P3498, DOI 10.1210/jc.82.10.3498; Lasco A, 2001, EUR J ENDOCRINOL, V145, P457, DOI 10.1530/eje.0.1450457; Levine JA, 2000, J APPL PHYSIOL, V88, P452, DOI 10.1152/jappl.2000.88.2.452; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x; MORALES AJ, 1995, J CLIN ENDOCR METAB, V80, P2799; MORTOLA JF, 1990, J CLIN ENDOCR METAB, V71, P696, DOI 10.1210/jcem-71-3-696; nap, 2004, BIOLOGICAL CONFINEMENT OF GENETICALLY ENGINEERED ORGANISMS, P1; NESTLER JE, 1988, J CLIN ENDOCR METAB, V66, P57, DOI 10.1210/jcem-66-1-57; NORDIN BEC, 1985, J CLIN ENDOCR METAB, V60, P651, DOI 10.1210/jcem-60-4-651; ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Prestwood KM, 2003, JAMA-J AM MED ASSOC, V290, P1042, DOI 10.1001/jama.290.8.1042; Proctor DN, 1996, J APPL PHYSIOL, V81, P2495, DOI 10.1152/jappl.1996.81.6.2495; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001; SHEPHERD A, 1984, AM J PHYSIOL, V246, pE123, DOI 10.1152/ajpendo.1984.246.2.E123; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Tan KCB, 1998, CLIN ENDOCRINOL, V48, P187, DOI 10.1046/j.1365-2265.1998.3721211.x; TURNER RT, 1990, AM J PHYSIOL, V258, pE673, DOI 10.1152/ajpendo.1990.258.4.E673; VALENTI G, 2002, 84 ANN M END SOC SAN; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243; Wolf OT, 1997, J CLIN ENDOCR METAB, V82, P2363, DOI 10.1210/jc.82.7.2363	45	415	432	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1647	1659		10.1056/NEJMoa054629	http://dx.doi.org/10.1056/NEJMoa054629			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050889				2022-12-28	WOS:000241357300006
J	Niemann, H; Losekann, T; de Beer, D; Elvert, M; Nadalig, T; Knittel, K; Amann, R; Sauter, EJ; Schluter, M; Klages, M; Foucher, JP; Boetius, A				Niemann, Helge; Losekann, Tina; de Beer, Dirk; Elvert, Marcus; Nadalig, Thierry; Knittel, Katrin; Amann, Rudolf; Sauter, Eberhard J.; Schlueter, Michael; Klages, Michael; Foucher, Jean Paul; Boetius, Antje			Novel microbial communities of the Haakon Mosby mud volcano and their role as a methane sink	NATURE			English	Article							SULFATE-REDUCING BACTERIA; ANAEROBIC OXIDATION; CASCADIA MARGIN; HYDRATE RIDGE; WATER COLUMN; SEA; SEDIMENTS; DIVERSITY; ARCHAEA; FLUXES	Mud volcanism is an important natural source of the greenhouse gas methane to the hydrosphere and atmosphere(1,2). Recent investigations show that the number of active submarine mud volcanoes might be much higher than anticipated ( for example, see refs 3 - 5), and that gas emitted from deep-sea seeps might reach the upper mixed ocean(6-8). Unfortunately, global methane emission from active submarine mud volcanoes cannot be quantified because their number and gas release are unknown(9). It is also unclear how efficiently methane-oxidizing microorganisms remove methane. Here we investigate the methane-emitting Haakon Mosby Mud Volcano (HMMV, Barents Sea, 72 degrees N, 14 degrees 44' E; 1,250 m water depth) to provide quantitative estimates of the in situ composition, distribution and activity of methanotrophs in relation to gas emission. The HMMV hosts three key communities: aerobic methanotrophic bacteria (Methylococcales), anaerobic methanotrophic archaea (ANME-2) thriving below siboglinid tubeworms, and a previously undescribed clade of archaea (ANME-3) associated with bacterial mats. We found that the upward flow of sulphate- and oxygen-free mud volcano fluids restricts the availability of these electron acceptors for methane oxidation, and hence the habitat range of methanotrophs. This mechanism limits the capacity of the microbial methane filter at active marine mud volcanoes to <40% of the total flux.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; IFREMER, Ctr Brest, F-29280 Plouzane, France; Int Jacobs Univ Bremen, D-28759 Bremen, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ifremer	Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	aboetius@mpi-bremen.de	Niemann, Helge/C-6630-2014; Lösekann, Tina/J-6358-2014; Boetius, Antje/D-5459-2013; Amann, Rudolf I/C-6534-2014; de Beer, Dirk/L-4840-2013	Niemann, Helge/0000-0002-3468-8304; Boetius, Antje/0000-0003-2117-4176; Amann, Rudolf I/0000-0002-0846-7372; de Beer, Dirk/0000-0001-5274-1781; Elvert, Marcus/0000-0003-3863-0975; Sauter, Eberhard/0000-0001-7954-952X; Schlueter, Michael/0000-0002-4997-3802; Loesekann, Tina/0000-0002-7803-9613				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [DOI 10.1007/978-3-662-05127-6_28, 10.1007/978-3-662-05127-6_28]; Bohrmann G, 2003, GEO-MAR LETT, V23, P239, DOI 10.1007/s00367-003-0157-7; Brown KM, 2005, EARTH PLANET SC LETT, V238, P189, DOI 10.1016/j.epsl.2005.06.055; Damm E, 2003, MAR CHEM, V82, P1, DOI 10.1016/S0304-4203(03)00031-8; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Ginsburg GD, 1999, GEO-MAR LETT, V19, P57, DOI 10.1007/s003670050093; JEROSCH K, UNPUB MAR GEOL; Judd AG, 2002, GEOFLUIDS, V2, P109, DOI 10.1046/j.1468-8123.2002.00027.x; Kaul N, 2006, MAR GEOL, V229, P1, DOI 10.1016/j.margeo.2006.02.004; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Kopf AJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000093; Loncke L, 2004, MAR PETROL GEOL, V21, P669, DOI 10.1016/j.marpetgeo.2004.02.004; Luff R, 2003, GEOCHIM COSMOCHIM AC, V67, P3403, DOI 10.1016/S0016-7037(03)00127-3; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; Milkov AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016358; Milkov AV, 2004, CHEM GEOL, V205, P347, DOI 10.1016/j.chemgeo.2003.12.030; Niemann H, 2005, BIOGEOSCIENCES, V2, P335, DOI 10.5194/bg-2-335-2005; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pinheiro LM, 2003, MAR GEOL, V195, P131, DOI 10.1016/S0025-3227(02)00685-0; REEBURGH WS, 2003, TREATISE GEOCHEMISTR, V4, P65, DOI DOI 10.1016/B0-08-043751-6/04036-6; Rehder G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013966; Sauter EJ, 2006, EARTH PLANET SC LETT, V243, P354, DOI 10.1016/j.epsl.2006.01.041; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Vogt P. R., 1997, EOS T AM GEOPHYS U S, V78, P187; Vogt PR, 1999, GEO-MAR LETT, V19, P2, DOI 10.1007/s003670050088	30	440	487	6	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					854	858		10.1038/nature05227	http://dx.doi.org/10.1038/nature05227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051217	Green Published			2022-12-28	WOS:000241362700051
J	Towbin, JA; Lowe, AM; Colan, SD; Sleeper, LA; Orav, EJ; Clunie, S; Messere, J; Cox, GF; Lurie, PR; Hsu, D; Canter, C; Wilkinson, JD; Lipshultz, SE				Towbin, Jeffrey A.; Lowe, April M.; Colan, Steven D.; Sleeper, Lynn A.; Orav, E. John; Clunie, Sarah; Messere, Jane; Cox, Gerald F.; Lurie, Paul R.; Hsu, Daphne; Canter, Charles; Wilkinson, James D.; Lipshultz, Steven E.			Incidence, causes, and outcomes of dilated cardiomyopathy in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-FAILURE; INTERNATIONAL SOCIETY; EPIDEMIOLOGY; TRANSPLANTATION; MUTATIONS; GENE; CLASSIFICATION; CARDIOLOGY; FREQUENCY; SEVERITY	Context Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and cause of cardiac transplantation in children. However, the epidemiology and clinical course of DCM in children are not well established. Objective To provide a detailed description of the incidence, causes, outcomes, and related risk factors for DCM in children. Design and Setting Longitudinal study based on a population-based, prospective cohort of children diagnosed as having DCM since January 1, 1996, at 89 pediatric cardiac centers and a retrospectively collected cohort of patients seen primarily at large tertiary care centers in North America and who had diagnoses between January 1, 1990, and December 31, 1995, and were enrolled through February 2003. Participants A total of 1426 children from the United States and Canada diagnosed as having DCM at younger than 18 years. Primary DCM was determined by strict echocardiographic and/or pathologic criteria. Patients with disease due to endocrine, immunologic, drug toxicity, and other causes were excluded. Main Outcome Measures Annual incidence per 100 000 children; mortality; cardiac transplantation. Results The annual incidence of DCM in children younger than 18 years was 0.57 cases per 100 000 per year overall. The annual incidence was higher in boys than in girls (0.66 vs 0.47 cases per 100 000; P < .001), in blacks than in whites (0.98 vs 0.46 cases per 100 000; P < .001), and in infants (<1 year) than in children (4.40 vs 0.34 cases per 100 000; P < .001). The majority of children (66%) had idiopathic disease. The most common known causes were myocarditis (46%) and neuromuscular disease (26%). The 1- and 5-year rates of death or transplantation were 31% and 46%, respectively. Independent risk factors at DCM diagnosis for subsequent death or transplantation were older age, congestive heart failure, lower left ventricular fractional shortening Z score, and cause of DCM (P < .001 for all). Conclusions In children, DCMis a diverse disorder with outcomes that depend largely on cause, age, and heart failure status at presentation. Race, sex, and age affect the incidence of disease. Most children do not have a known cause of DCM, which limits the potential for disease-specific therapies.	Baylor Coll Med, Texas Childrens Hosp, Houston, TX 77030 USA; New England Res Inst, Watertown, MA 02172 USA; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Genzyme Corp, Cambridge, MA USA; Albany Med Coll, Albany, NY 12208 USA; Columbia Univ, New York, NY USA; Washington Univ, Sch Med, St Louis, MO USA; Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33152 USA	Baylor College of Medicine; HealthCore, Inc; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Sanofi-Aventis; Genzyme Corporation; Albany Medical College; Columbia University; Washington University (WUSTL); University of Miami	Towbin, JA (corresponding author), Baylor Coll Med, Texas Childrens Hosp, 6621 Fannin St,MC 19345-C, Houston, TX 77030 USA.	jtowbin@bcm.tmc.edu	Hsu, Daphne/C-8913-2017; Colan, Steven/ABB-4580-2020; Towbin, Jeffrey A./J-5595-2019	Hsu, Daphne/0000-0002-2654-0430; Towbin, Jeffrey A./0000-0002-6585-714X; WILKINSON, JAMES/0000-0003-1945-5622	NCI NIH HHS [R01 CA79060, P01 CA68484] Funding Source: Medline; NHLBI NIH HHS [R01 HL78522, R01 HL53392, P01 HL67155, N01 HR96041, R01 HL72705] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR096041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA068484, R01CA079060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072705, R01HL053392, R01HL078522, P01HL067155] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; BILGIC A, 1990, JPN HEART J, V31, P789; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; Connolly D, 2001, J PEDIATR-US, V138, P644, DOI 10.1067/mpd.2001.114020; DiGiorgi PL, 2005, J HEART LUNG TRANSPL, V24, P200, DOI 10.1016/j.healun.2003.11.397; Feng JO, 2002, J AM COLL CARDIOL, V40, P1120, DOI 10.1016/S0735-1097(02)02126-5; FERENCZ C, 1992, PEDIATR CARDIOL, V13, P65, DOI 10.1007/BF00798206; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; GRIFFIN ML, 1988, J AM COLL CARDIOL, V11, P139, DOI 10.1016/0735-1097(88)90179-9; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Harmon WE, 2005, AM J TRANSPLANT, V5, P887, DOI 10.1111/j.1600-6135.2005.00834.x; Ichida F, 2001, CIRCULATION, V103, P1256; KEELING PJ, 1995, BRIT HEART J, V73, P417; KELLY DP, 1994, NEW ENGL J MED, V330, P913; Lipshultz, 2000, Prog Pediatr Cardiol, V12, P1, DOI 10.1016/S1058-9813(00)00076-X; Lipshultz SE, 2005, J APPL PHYSIOL, V99, P386, DOI 10.1152/japplphysiol.00167.2005; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McMahon CJ, 2004, HEART, V90, P908, DOI 10.1136/hrt.2003.020966; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosenthal D, 2004, J HEART LUNG TRANSPL, V23, P1313, DOI 10.1016/j.healun.2004.03.018; ROSS RD, 1992, PEDIATR CARDIOL, V13, P72, DOI 10.1007/BF00798207; Shaddy R E, 2001, Adolesc Med, V12, P35; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Towbin JA, 1999, PEDIATR CLIN N AM, V46, P289, DOI 10.1016/S0031-3955(05)70119-X; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Towbin JA, 1999, CURR OPIN CARDIOL, V14, P250, DOI 10.1097/00001573-199905000-00010; Tsirka AE, 2004, J AM COLL CARDIOL, V44, P391, DOI 10.1016/j.jacc.2004.04.035; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021	35	601	651	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1867	1876		10.1001/jama.296.15.1867	http://dx.doi.org/10.1001/jama.296.15.1867			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047217	Bronze			2022-12-28	WOS:000241329300029
J	van Doorslaer, E; O'Donnell, O; Rannan-Eliya, RP; Somanathan, A; Adhikari, SR; Garg, CC; Harbianto, D; Herrin, AN; Huq, MN; Ibragimova, S; Karan, A; Ng, CW; Pande, BR; Racelis, R; Tao, S; Tin, K; Tisayaticom, K; Trisnantoro, L; Vasavid, C; Zhao, YX				van Doorslaer, Eddy; O'Donnell, Owen; Rannan-Eliya, Ravi P.; Somanathan, Aparnaa; Adhikari, Shiva Raj; Garg, Charu C.; Harbianto, Deni; Herrin, Alejandro N.; Huq, Mohammed Nazmul; Ibragimova, Shamsia; Karan, Anup; Ng, Chiu Wan; Pande, Badri Raj; Racelis, Rachel; Tao, Sihai; Tin, Keith; Tisayaticom, Kanjana; Trisnantoro, Laksono; Vasavid, Chitpranee; Zhao, Yuxin			Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data	LANCET			English	Article								Background Conventional estimates of poverty do not take account of out-of-pocket payments to finance health care. We aimed to reassess measures of poverty in 11 low-to-middle income countries in Asia by calculating total household resources both with and without out-of-pocket payments for health care. Methods We obtained data on payments for health care from nationally representative surveys, and subtracted these payments from total household resources. We then calculated the number of individuals with less than the internationally accepted threshold of absolute poverty (US$1 per head per day) after making health payments. We also assessed the effect of health-care payments on the poverty gap-the amount by which household resources fell short of the $1 poverty line in these countries. Findings Our estimate of the overall prevalence of absolute poverty in these countries was 14% higher than conventional estimates that do not take account of out-of-pocket payments for health care. We calculated that an additional 2.7% of the population under study (78 million people) ended up with less than $1 per day after they had paid for health care. In Bangladesh, China, India, Nepal, and Vietnam, where more than 60% of health-care costs are paid out-of-pocket by households, our estimates of poverty were much higher than conventional figures, ranging from an additional 1.2% of the population in Vietnam to 3.8% in Bangladesh. Interpretation Out-of-pocket health payments exacerbate poverty. Policies to reduce the number of Asians living on less than $1 per day need to include measures to reduce such payments.	Erasmus Univ, Med Ctr, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands; Univ Macedonia, Thessaloniki, Greece; Inst Hlth Policy, Colombo, Sri Lanka; Nepal Hlth Econ Assoc, Kathmandu, Nepal; WHO, CH-1211 Geneva, Switzerland; Gadjah Mada Univ, Yogyakarta, Indonesia; Univ Philippines, Quezon City 1101, Philippines; Jahangirnagar Univ, Dhaka, Bangladesh; Natl Stat Comm, Bishkek, Kyrgyzstan; Inst Human Dev, Delhi, India; Minist Hlth, QUal & Stand Unit, Putrajaya, Malaysia; N China Coal Med Coll, Tangshan City, Peoples R China; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Int Hlth Policy Programme, Nonthaburi, Thailand; Natl Hlth Econ Inst, Beijing, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Macedonia; World Health Organization; Gadjah Mada University; University of the Philippines System; University of the Philippines Diliman; Jahangirnagar University; Kementerian Kesihatan Malaysia; North China University of Science & Technology; University of Hong Kong	van Doorslaer, E (corresponding author), Erasmus Univ, Med Ctr, Dept Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.	e.vandoorslaer@erasmusmc.nl	O'Donnell, Owen A./C-1732-2015; Rannan-Eliya, Ravindra/AAR-2096-2021; NG, CHIU WAN/B-5218-2010; NG, CHIU WAN/B-9222-2010; Karan, Anup/AAK-2060-2020; Tin, Yiu Kei/C-4417-2009	O'Donnell, Owen A./0000-0002-6289-1924; Rannan-Eliya, Ravindra/0000-0002-5013-2816; NG, CHIU WAN/0000-0002-7687-2310; van Doorslaer, Eddy/0000-0003-2692-1433				Abhijit Banerjee, 2004, Economic and Political Weekly, V39, P944; *CENTR BANK SRI LA, 1999, REP CONS FIN SOC SUR; *CENTR BUR STAT, 1996, NEP LIV STAND SURV 1; Chang FR, 2003, HEALTH ECON, V12, P721, DOI 10.1002/hec.841; Chen SH, 2004, WORLD BANK RES OBSER, V19, P141, DOI 10.1093/wbro/lkh020; Chen SH, 2001, REV INCOME WEALTH, P283; *CHIN NAT BUR STAT, 2002, RUR HOUS SURV URB HO; Cirto C., 1995, MEASURING POVERTY NE; COGAN JF, 1995, MEASURING POVERTY NE, P385; Deaton Angus, 2003, ECON POLIT WEEKLY, V38, P322; Gustafsson B, 2004, CHINA ECON REV, V15, P292, DOI 10.1016/j.chieco.2003.07.004; *IND NAT BOARD STA, 2001, NAT SOC EC SURV SUSE; *IND NAT SAMPL SUR, 2001, CONS EXP SURV 55 ROU; Krishna A, 2004, WORLD DEV, V32, P121, DOI 10.1016/j.worlddev.2003.08.002; *KYRG REP NAT STAT, 2002, HOUS BUDG SURV 2000; LUI Y, 2003, J HEALTH POPUL NUTR, V21, P216; *MAL DEP STAT, 2000, REP HOUS EXP SURV MA; McNay K, 2004, BUCKING TREND SRI LA; Mudur G, 1999, BRIT MED J, V318, P556, DOI 10.1136/bmj.318.7183.556b; Narayan D., 2000, VOICES POOR CAN ANYO, V1; *NAT STAT OFF, 2000, ANN POV IND SURV 199; ODONNELL O, 2005, 3 EQUITAP ER U; ODONNELL O, 2005, 5 EQUITAP ER U; Peters D., 2001, BETTER HLTH SYSTEMS; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; RAVAILLON M, 1998, 133 LSMS WORLD BANK; RAVAILLON M, 1996, 1694 WORLD BANK POV; RAVALLION M, 1991, REV INCOME WEALTH, P345; Short K, 2002, MON LABOR REV, V125, P3; SHORT K, 1999, EXPT POVERTY MEASURE, P60; *THAIL NAT STAT OF, 2002, 2002 SOC SURV; Van Doorslaer E, 2005, 2 EQUITAP ER U; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; World Bank, 2001, VIETN LIV STAND SURV; [No title captured]	35	393	393	0	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1357	1364		10.1016/S0140-6736(06)69560-3	http://dx.doi.org/10.1016/S0140-6736(06)69560-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096PA	17046468				2022-12-28	WOS:000241388100032
J	Schietinger, A; Philip, M; Yoshida, BA; Azadi, P; Liu, H; Meredith, SC; Schreiber, H				Schietinger, Andrea; Philip, Mary; Yoshida, Barbara A.; Azadi, Parastoo; Liu, Hui; Meredith, Stephen C.; Schreiber, Hans			A mutant chaperone converts a wild-type protein into a tumor-specific antigen	SCIENCE			English	Article							AGGREGATION-INDUCING FACTOR; O-GLYCAN; HUMAN CANCER; CELL LINE; EXPRESSION; BETA-1,3-GALACTOSYLTRANSFERASE; IDENTIFICATION; KERATINOCYTES; BIOSYNTHESIS; INDUCTION	Monoclonal antibodies have become important therapeutic agents against certain cancers. Many tumor-specific antigens are mutant proteins that are predominantly intracellular and thus not readily accessible to monoclonal antibodies. We found that a wild-type transmembrane protein could be transformed into a tumor-specific antigen. A somatic mutation in the chaperone gene Cosmc abolished function of a glycosyltransferase, disrupting O-glycan Core 1 synthesis and creating a tumor-specific glycopeptidic neo-epitope consisting of a monosaccharide and a specific wild-type protein sequence. This epitope induced a high-affinity, highly specific, syngeneic monoclonal antibody with antitumor activity. Such tumor-specific glycopeptidic neo-epitopes represent potential targets for monoclonal antibody therapy.	Univ Chicago, Dept Pathol, Comm Immunol, Comm Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Chicago; University of Chicago; University of Munich; University System of Georgia; University of Georgia	Schietinger, A (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, Comm Canc Biol, Chicago, IL 60637 USA.	aschieti@uchicago.edu			NCI NIH HHS [R01-CA22677, P01-CA97296, R01-CA37516] Funding Source: Medline; NCRR NIH HHS [P41RR018502-01] Funding Source: Medline; NICHD NIH HHS [HD 07009] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022677, P01CA097296] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Gilboa E, 2001, NAT IMMUNOL, V2, P789, DOI 10.1038/ni0901-789; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HANISCH FG, 1995, CANCER RES, V55, P4036; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Livingston PO, 1995, SEMIN CANCER BIOL, V6, P357, DOI 10.1016/1044-579X(95)90005-5; LLOYD KO, 1987, AM J CLIN PATHOL, V87, P129, DOI 10.1093/ajcp/87.1.129; LLOYD KO, 1990, IMMUNOL ALLERGY CLIN, V10, P765; Lorimer IAJ, 2002, CURR CANCER DRUG TAR, V2, P91, DOI 10.2174/1568009023333926; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; OETTGEN HF, 1990, IMMUNOL ALLERGY CLIN, V10, P607; PILLER V, 1990, J BIOL CHEM, V265, P9264; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Scholl FG, 1999, J CELL SCI, V112, P4601; Schreiber H., 2003, FUNDAMENTAL IMMUNOLO, P1557; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0	28	115	129	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					304	308		10.1126/science.1129200	http://dx.doi.org/10.1126/science.1129200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038624				2022-12-28	WOS:000241194100043
J	Isayama, T; Alexeev, D; Makino, CL; Washington, I; Nakanishi, K; Turro, NJ				Isayama, T.; Alexeev, D.; Makino, C. L.; Washington, I.; Nakanishi, K.; Turro, N. J.			An accessory chromophore in red vision	NATURE			English	Article							DRAGON FISH; CHLOROPHYLL		Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Columbia University	Isayama, T (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; W, I/0000-0002-2238-7918				Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; Douglas RH, 1999, VISION RES, V39, P2817, DOI 10.1016/S0042-6989(98)00332-0; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; KIRSCHFELD K, 1986, VISION RES, V26, P1771, DOI 10.1016/0042-6989(86)90127-6; Washington I, 2004, J AM CHEM SOC, V126, P9892, DOI 10.1021/ja0486317	7	19	21	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					649	649		10.1038/443649a	http://dx.doi.org/10.1038/443649a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035994	Bronze			2022-12-28	WOS:000241160500035
J	Haucke, V				Haucke, Volker			Cargo takes control of endocytosis	CELL			English	Editorial Material							INTERNALIZATION	Clathrin-mediated endocytosis is a major route for diverse cargo to enter the cellular endocytic pathway. New findings by Puthenveedu and von Zastrow (2006) suggest that certain cargo proteins, such as G protein coupled receptors that bind to PDZ domains, regulate their own targeting to a subset of clathrin-coated pits. Thus, cargo proteins may cause functional specialization of vesicle trafficking within the early endocytic pathway.	Free Univ Berlin, Biochim Membranes Lab, Inst Chem & Biochem, D-14195 Berlin, Germany	Free University of Berlin	Haucke, V (corresponding author), Free Univ Berlin, Biochim Membranes Lab, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	vhaucke@chemie.fu-berlin.de		Haucke, Volker/0000-0003-3119-6993				Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; KEYEL PA, 2006, MOL BIOL CELL; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056	7	16	19	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					35	37		10.1016/j.cell.2006.09.012	http://dx.doi.org/10.1016/j.cell.2006.09.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018271	Bronze			2022-12-28	WOS:000241445800008
J	Marshall, CR				Marshall, Charles R.			Fossil record reveals tropics as cradle and museum	SCIENCE			English	Editorial Material							DIVERSITY; DIVERSIFICATION; RADIATION; BIRDS; GENUS		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Marshall, CR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	cmarshal@oeb.harvard.edu						[Anonymous], 1878, TROPICAL NATURE OTHE; FARRELL BD, 1992, BIOSCIENCE, V42, P34, DOI 10.2307/1311626; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 1996, P ROY SOC B-BIOL SCI, V263, P63, DOI 10.1098/rspb.1996.0011; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hawkins BA, 2005, J BIOGEOGR, V32, P1035, DOI 10.1111/j.1365-2699.2004.01238.x; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Latham Roger Earl, 1993, P294; Malcomber ST, 2002, EVOLUTION, V56, P42, DOI 10.1111/j.0014-3820.2002.tb00848.x; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; PRANCE GT, 1974, ACTA AMAZONICA, V3, P5; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Weir JT, 2006, EVOLUTION, V60, P842; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	17	8	10	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					66	67		10.1126/science.1133351	http://dx.doi.org/10.1126/science.1133351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023640				2022-12-28	WOS:000241031200031
J	Spies, C; Trohman, RG				Spies, Christian; Trohman, Richard G.			Electrocution and life-threatening electrical injuries	ANNALS OF INTERNAL MEDICINE			English	Review							LIGHTNING INJURIES; MYOCARDIAL DAMAGE; ACCIDENTAL ELECTROCUTION; LICHTENBERG FIGURES; UNITED-STATES; BURN INJURY; MANAGEMENT; TRAUMA; DEATH; STRIKES	The authors reviewed the mechanisms and pathophysiology of typically encountered electrical injuries by searching English-language publications listed in MEDLINE and reference lists from identified articles. They included relevant retrospective studies, case reports, and review articles published between 1966 and 2005. The authors also searched the Internet for information related to electrocution and life-threatening electrical injuries. They found that familiarity with basic principles of physics elucidates the typical injuries sustained by patients who experience electrical shock. Death due to electrocution occurs frequently. However, patients successfully resuscitated after cardiopulmonary arrest often have a favorable prognosis. Approximately 3000 patients who survive electrical shock are admitted to specialized burn units annually. Patients with serious electrical burns admitted to the intensive care unit are trauma patients and should be treated accordingly. Initial prediction of outcome for patients who have experienced electrical shock is difficult, as the full degree of injury is often not apparent.	Rush Univ, Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60612 USA	Rush University	Trohman, RG (corresponding author), Rush Univ, Med Ctr, Dept Med, Cardiol Sect, 1653 W Congress Pkwy,Suite 983, Chicago, IL 60612 USA.	rtrohman@rush.edu						*AM HEART ASS, 2002, ACLS PROV MAN; AMY BW, 1985, JAMA-J AM MED ASSOC, V253, P243; ARTZ CP, 1974, AM J SURG, V128, P600, DOI 10.1016/S0002-9610(74)80008-5; BAKER MD, 1989, AM J DIS CHILD, V143, P59, DOI 10.1001/archpedi.1989.02150130069017; BAXTER CR, 1970, SURG CLIN N AM, V50, P1401; BAXTER CR, 1988, ANN EMERG MED, V17, P1305, DOI 10.1016/S0196-0644(88)80356-1; BINGHAM H, 1986, CLIN PLAST SURG, V13, P75; Bligh-Glover WZ, 2004, AM J FOREN MED PATH, V25, P255, DOI 10.1097/01.paf.0000136442.17344.b5; Block Thomas A., 1995, Journal of Burn Care and Rehabilitation, V16, P581, DOI 10.1097/00004630-199511000-00004; BROWNE B J, 1992, Emergency Medicine Clinics of North America, V10, P211; BUTLER ED, 1977, AM J SURG, V134, P95, DOI 10.1016/0002-9610(77)90290-2; Cawley JC, 2003, J SAFETY RES, V34, P241, DOI 10.1016/S0022-4375(03)00028-8; Celik A, 2004, J PEDIATR SURG, V39, P1233, DOI 10.1016/j.jpedsurg.2004.04.004; CHANDRA NC, 1990, CRIT CARE MED, V18, P293, DOI 10.1097/00003246-199003000-00010; Cherington M, 2003, NEUROLOGY, V60, P182, DOI 10.1212/01.WNL.0000033801.15204.B5; COOPER MA, 1980, ANN EMERG MED, V9, P134, DOI 10.1016/S0196-0644(80)80268-X; DIVINCENTI FC, 1969, J TRAUM, V9, P497; Domart Y, 2000, NEW ENGL J MED, V343, P1536, DOI 10.1056/NEJM200011233432105; DUCLOS PJ, 1990, INT J EPIDEMIOL, V19, P673, DOI 10.1093/ije/19.3.673; Einarson A, 1997, AM J OBSTET GYNECOL, V176, P678, DOI 10.1016/S0002-9378(97)70569-6; EPPERLY TD, 1989, J FAM PRACTICE, V29, P267; Fatovich Daniel M., 1993, Journal of Emergency Medicine, V11, P175, DOI 10.1016/0736-4679(93)90516-A; FATOVICH DM, 1991, MED J AUSTRALIA, V155, P301, DOI 10.5694/j.1326-5377.1991.tb142285.x; FERNANDO R, 1990, MED SCI LAW, V30, P219, DOI 10.1177/002580249003000309; Ferreiro I, 1998, BURNS, V24, P649, DOI 10.1016/S0305-4179(98)00082-5; GARCIA CT, 1995, ANN EMERG MED, V26, P604, DOI 10.1016/S0196-0644(95)70012-9; Gatewood MO, 2004, EMERG MED CLIN N AM, V22, P369, DOI 10.1016/j.emc.2004.02.002; Graber J, 1996, J TRAUMA, V40, P288, DOI 10.1097/00005373-199602000-00020; HAMMOND J, 1986, SOUTHERN MED J, V79, P414, DOI 10.1097/00007611-198604000-00006; HAZELWOOD RR, 1981, SOC SCI MED-MED PSYC, V15, P129, DOI 10.1016/0271-5384(81)90033-8; HOUSINGER TA, 1985, J TRAUMA, V25, P122, DOI 10.1097/00005373-198502000-00005; Jain S, 1999, CRIT CARE CLIN, V15, P319, DOI 10.1016/S0749-0704(05)70057-9; JAMES TN, 1990, AM HEART J, V120, P143, DOI 10.1016/0002-8703(90)90171-S; JENSEN PJ, 1987, BRIT HEART J, V57, P279; JOHN BA, 2003, AM J IND MED, V43, P237; KINNEY TJ, 1982, ANN EMERG MED, V11, P622, DOI 10.1016/S0196-0644(82)80206-0; KLEINER JP, 1978, JAMA-J AM MED ASSOC, V240, P2757, DOI 10.1001/jama.240.25.2757; KOBERNICK M, 1982, ANN EMERG MED, V11, P633, DOI 10.1016/S0196-0644(82)80211-4; Kopp J, 2004, BURNS, V30, P680, DOI 10.1016/j.burns.2004.05.008; KOSHIMA I, 1991, ANN PLAS SURG, V26, P587, DOI 10.1097/00000637-199106000-00017; KU CS, 1989, AM HEART J, V118, P621, DOI 10.1016/0002-8703(89)90283-4; LAWRENCE RD, 1985, AM J FOREN MED PATH, V6, P276, DOI 10.1097/00000433-198509000-00020; Lee RC, 2000, ANNU REV BIOMED ENG, V2, P477, DOI 10.1146/annurev.bioeng.2.1.477; LEE RC, 1988, J SURG RES, V44, P709, DOI 10.1016/0022-4804(88)90105-9; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; LICHTENBERG R, 1993, J AM COLL CARDIOL, V21, P531, DOI 10.1016/0735-1097(93)90699-2; LOWN B, 1962, AM J CARDIOL, V10, P223, DOI 10.1016/0002-9149(62)90299-0; LUCE EA, 1984, ANN PLAS SURG, V12, P321, DOI 10.1097/00000637-198404000-00003; MCBRIDE JW, 1986, JAMA-J AM MED ASSOC, V255, P764, DOI 10.1001/jama.255.6.764; MONCRIEF JA, 1970, POSTGRAD MED, V48, P189, DOI 10.1080/00325481.1970.11693562; PATTEN BM, 1992, NEUROL CLIN, V10, P1047, DOI 10.1016/S0733-8619(18)30195-6; PURDUE GF, 1986, J TRAUMA, V26, P166, DOI 10.1097/00005373-198602000-00013; Resnik BI, 1996, AM J FOREN MED PATH, V17, P99, DOI 10.1097/00000433-199606000-00002; ROUSE RG, 1978, J TRAUMA, V18, P43, DOI 10.1097/00005373-197801000-00008; Schott JC, 2003, AM J FOREN MED PATH, V24, P92, DOI 10.1097/00000433-200303000-00018; Selvaggi G, 2005, NEUROREHABILITATION, V20, P35; Shields LBE, 2005, AM J FOREN MED PATH, V26, P53, DOI 10.1097/01.paf.0000153995.07817.9f; SKOOG T, 1970, J TRAUM, V10, P816, DOI 10.1097/00005373-197010000-00002; SOLEM L, 1977, J TRAUMA, V17, P487, DOI 10.1097/00005373-197707000-00001; STRASSER EJ, 1977, J TRAUMA, V17, P315, DOI 10.1097/00005373-197704000-00010; Taylor AJ, 2002, OCCUP MED-OXFORD, V52, P102, DOI 10.1093/occmed/52.2.102; TENDUIS HJ, 1985, BURNS, V12, P54, DOI 10.1016/0305-4179(85)90183-4; VEDUNG S, 1990, SCAND J PLAST RECONS, V24, P225, DOI 10.3109/02844319009041283; Whitcomb D, 2002, SOUTHERN MED J, V95, P1331; WRIGHT RK, 1980, J FORENSIC SCI, V25, P514	65	72	76	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					531	537		10.7326/0003-4819-145-7-200610030-00011	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015871				2022-12-28	WOS:000241093900007
J	Reyes, N; Gadsby, DC				Reyes, Nicolas; Gadsby, David C.			Ion permeation through the Na+,K+-ATPase	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; BINDING-SITES; SODIUM-PUMP; XENOPUS-LAEVIS; CATION-BINDING; ALPHA-SUBUNIT; NA,K-ATPASE; MECHANISM; OCCLUSION	P-type ATPase pumps generate concentration gradients of cations across membranes in nearly all cells. They provide a polar transmembrane pathway, to which access is strictly controlled by coupled gates that are constrained to open alternately, thereby enabling thermodynamically uphill ion transport ( for example, see ref. 1). Here we examine the ion pathway through the Na+, K+-ATPase, a representative P-type pump, after uncoupling its extra- and intracellular gates with the marine toxin palytoxin(2). We use small hydrophilic thiol-specific reagents(3) as extracellular probes and we monitor their reactions, and the consequences, with cysteine residues introduced along the anticipated cation pathway through the pump. The distinct effects of differently charged reagents indicate that a wide outer vestibule penetrates deep into the Na+, K+-ATPase, where the pathway narrows and leads to a charge-selectivity filter. Acidic residues in this region, which are conserved to coordinate pumped ions, allow the approach of cations but exclude anions. Reversing the charge at just one of those positions converts the pathway from cation selective to anion selective. Close structural homology among the catalytic subunits of Ca2+-, Na+, K+- and H+, K+-ATPases(4-6) argues that their extracytosolic cation exchange pathways all share these physical characteristics.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA	Rockefeller University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	gadsby@rockefeller.edu		Reyes, Nicolas/0000-0001-6618-8307				Apell HJ, 2004, REV PHYSIOL BIOCH P, V150, P1, DOI 10.1007/s10254-003-0018-9; Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Asano S, 2004, J BIOL CHEM, V279, P13968, DOI 10.1074/jbc.M308934200; GOOD PJ, 1990, P NATL ACAD SCI USA, V87, P9088, DOI 10.1073/pnas.87.23.9088; Grenthe I., 1997, MODELLING AQUEOUS CH, P325; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Horisberger JD, 2004, PHYSIOLOGY, V19, P377, DOI 10.1152/physiol.00013.2004; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lauger P., 1991, ELECTROGENIC ION PUM; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Munson K, 2005, BIOCHEMISTRY-US, V44, P5267, DOI 10.1021/bi047761p; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2003, J BIOL CHEM, V278, P47240, DOI 10.1074/jbc.M308833200; Rakowski RF, 2003, NEWS PHYSIOL SCI, V18, P164, DOI 10.1152/nips.01441.2003; SCHEINERBOBIS G, 1994, MOL PHARMACOL, V45, P1132; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VERREY F, 1989, AM J PHYSIOL, V256, pF1034, DOI 10.1152/ajprenal.1989.256.6.F1034; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	30	65	71	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2006	443	7110					470	474		10.1038/nature05129	http://dx.doi.org/10.1038/nature05129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088FY	17006516				2022-12-28	WOS:000240798800049
J	Hay, EM; Foster, NE; Thomas, E; Peat, G; Phelan, M; Yates, HE; Blenkinsopp, A; Sim, J				Hay, Elaine M.; Foster, Nadine E.; Thomas, Elaine; Peat, George; Phelan, Mike; Yates, Hannah E.; Blenkinsopp, Alison; Sim, Julius			Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial	BRITISH MEDICAL JOURNAL			English	Article							OSTEOARTHRITIS CLINICAL-TRIALS; PRACTICE GUIDELINES; RESPONDER CRITERIA; HOME EXERCISE; OLDER-ADULTS; MANAGEMENT; WOMAC; DISABILITY; ARTHRITIS; VARIABLES	Objectives To evaluate the effectiveness of two primary care strategies for delivering evidence based care to people aged 55 or over with knee pain: enhanced pharmacy review and community physiotherapy. Design Pragmatic multicentre randomised clinical trial. Setting 15 general practices in North Staffordshire. Participants 325 adults aged 55 years or over (mean 68 years) consulting with knee pain; 297 (91%) reached six month follow-up. Interventions Enhanced pharmacy review (pharmacological management in accordance with an algorithm), community physiotherapy (advice about activity and pacing and an individualised exercise programme): control (advice leaflet reinforced by telephone call). Main outcome measure Change in Western Ontario and McMaster Universities osteoarthritis index (WOMAC) at 3, 6, and 12 months. Results Mean baseline WOMAC pain score was 9.1 (SD 3.7) and mean baseline function score was 29.9 (SD 12.8). At three months, the mean reductions in pain scores were 0.41 (SD 2.8) for control, 1.59 (3.2) for pharmacy, mid 1.56 (3.4) for physiotherapy; reductions in function scores were 0.80 (8.5),2.61 (9.8), and 4.79 (10.8). Compared with control, mean differences in change scores for physiotherapy were 1.15 (95% confidence interval 0.2 to 2.1) for pain mid 3.99 (1.2 to 6.8) for function; those for pharmacy were 1.18 (0.3 to 2.1) for pain and 1.80 ( - 0.8 to 4.5) for function. These differences were not sustained to six or 12 months. Significantly fewer participants in the physiotherapy group reported consulting their general practitioner for knee pain in the follow-up period, and use of non-steroidal anti-inflammatory drugs was lower in die physiotherapy and pharmacy groups than in the control group. Conclusions Evidence based care for older adults with knee pain, delivered by primary care physiotherapists and pharmacists, resulted in short term improvements in health outcomes, reduced use of non-steroidal anti-inflammatory drugs, and high patient satisfaction. Physiotherapy seemed to produce a shift in consultation behaviour away from the traditional general practitioner led model of care.	Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England	Keele University	Hay, EM (corresponding author), Univ Keele, Primary Care Musculoskeletal Res Ctr, Keele ST5 5BG, Staffs, England.	e.m.hay@cphc.keele.ac.uk	Peat, George/AAE-5869-2020	Peat, George/0000-0002-9008-0184; Foster, Nadine/0000-0003-4429-9756; Blenkinsopp, Alison/0000-0001-8872-2769	National Institute for Health Research [PC6/CSA04/03] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Altman RD, 1998, OSTEOARTHR CARTILAGE, V6, P22, DOI 10.1016/S1063-4584(98)80007-1; BELLAMY N, 1992, J RHEUMATOL, V19, P153; Bellamy N, 1997, J RHEUMATOL, V24, P768; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bellamy N, 1996, WOMAC OSTEOARTHRITIS; Beney J., 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000336; Bennell K, 2005, CURR OPIN RHEUMATOL, V17, P634, DOI 10.1097/01.bor.0000171214.49876.38; BEURSKENS AJ, 1995, LANCET, V346, P1596, DOI 10.1016/S0140-6736(95)91930-9; Department of Health, 2005, SUPP PEOPL LONG TERM; Deyle GD, 2005, PHYS THER, V85, P1301, DOI 10.1093/ptj/85.12.1301; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fish A, 2002, INT J PHARM PRACT, V10, P225; HART DJ, 1995, BAILLIERE CLIN RHEUM, V9, P407, DOI 10.1016/S1521-6942(06)80011-2; Haynes RB, 1996, LANCET, V348, P383; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HURLEY M, 2002, EVIDENCE BRIEFING, V3; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Lane NE, 1997, AM J MED, V103, P25, DOI 10.1016/S0002-9343(97)90005-X; Mazzuca SA, 1997, ARTHRIT CARE RES, V10, P289, DOI 10.1002/art.1790100503; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Pencharz JN, 2002, ARTHRITIS RES, V4, P36, DOI 10.1186/ar381; Pham T, 2003, J RHEUMATOL, V30, P1648; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; *PRESCR SUPPL ADM, 1999, REV PRESCR SUPPL ADM; *PRIM CAR RHEUM SO, MAN OST GUID 1999; *REV TEAM PRESCR S, 1999, REV PRESCR SUPPL ADM; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Roughead L, 2002, VALUE PHARM PROFESSI; Sun Y, 1997, CLIN RHEUMATOL, V16, P185, DOI 10.1007/BF02247849; Tully MP, 2000, ANN PHARMACOTHER, V34, P1320, DOI 10.1345/aph.19374; van Gool CH, 2005, ARTHRIT RHEUM-ARTHR, V53, P24, DOI 10.1002/art.20902; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	35	119	121	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2006	333	7576					995	998B		10.1136/BMJ.38977.590752.0B	http://dx.doi.org/10.1136/BMJ.38977.590752.0B			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17056608	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000242229400015
J	Ben-Chaim, Y; Chanda, B; Dascal, N; Bezanilla, F; Parnas, I; Parnas, H				Ben-Chaim, Yair; Chanda, Baron; Dascal, Nathan; Bezanilla, Francisco; Parnas, Itzchak; Parnas, Hanna			Movement of 'gating charge' is coupled to ligand binding in a G-protein-coupled receptor	NATURE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; VOLTAGE CONTROL; ACTIVATION; CHANNEL; SELECTIVITY; RELEASE	Activation by agonist binding of G-protein-coupled receptors (GPCRs) controls most signal transduction processes(1). Although these receptors span the cell membrane, they are not considered to be voltage sensitive. Recently it was shown that both the activity of GPCRs(2-5) and their affinity towards agonists(6) are regulated by membrane potential. However, it remains unclear whether GPCRs intrinsically respond to changes in membrane potential. Here we show that two prototypical GPCRs, the m2 and m1 muscarinic receptors (m2R and m1R), display charge-movement-associated currents analogous to 'gating currents' of voltage-gated channels. The gating charge - voltage relationship of m2R correlates well with the voltage dependence of the affinity of the receptor for acetylcholine. The loop that couples m2R and m1R to their G protein has a crucial function in coupling voltage sensing to agonist-binding affinity. Our data strongly indicate that GPCRs serve as sensors for both transmembrane potential and external chemical signals.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Univ Chicago, Inst Mol Pediat Sci, Chicago, IL 60637 USA	Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Tel Aviv University; University of Chicago	Parnas, H (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	hannap@huji.ac.il	Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Chanda, Baron/0000-0003-4954-7034				ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bradley SR, 2000, J NEUROSCI, V20, P3085, DOI 10.1523/JNEUROSCI.20-09-03085.2000; COHEN-ARMON M, 1993, J BIOL CHEM, V268, P9824; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; HAGA K, 1986, J BIOL CHEM, V261, P133; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HULME EC, 1995, LIFE SCI, V56, P891, DOI 10.1016/0024-3205(95)00025-2; Ilouz N, 1999, J BIOL CHEM, V274, P29519, DOI 10.1074/jbc.274.41.29519; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2004, J PHYSIOL-LONDON, V555, P61, DOI 10.1113/jphysiol.2003.056846; MARTY A, 1989, J PHYSIOL-LONDON, V419, P665, DOI 10.1113/jphysiol.1989.sp017892; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Ong BH, 2001, PFLUG ARCH EUR J PHY, V441, P604, DOI 10.1007/s004240000459; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rakowski RF, 1997, ANN NY ACAD SCI, V834, P231, DOI 10.1111/j.1749-6632.1997.tb52254.x; Stefani E, 1998, METHOD ENZYMOL, V293, P300; WESS J, 1990, MOL PHARMACOL, V38, P517; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	30	130	132	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					106	109		10.1038/nature05259	http://dx.doi.org/10.1038/nature05259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17065983				2022-12-28	WOS:000241701500055
J	Assai, M; Siddiqi, S; Watts, S				Assai, M.; Siddiqi, S.; Watts, S.			Tackling social determinants of health through community based initiatives	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EGYPT; IRAN		WHO, Eastern Mediterranean Reg Off, Hlth Policy & Planning Unit, Cairo 11371, Egypt; WHO, Eastern Mediterranean Reg Off, Community Based Iniat Unit, Cairo 11371, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Siddiqi, S (corresponding author), WHO, Eastern Mediterranean Reg Off, Hlth Policy & Planning Unit, Cairo 11371, Egypt.	siddiqis@emro.who.int						[Anonymous], 1996, EGYPT DEMOGRAPHIC HL; [Anonymous], 2005, INN DIG CHANG HARMF; *DEP HLTH GOV SIND, 2006, PC 1 PROF STRENGTH B; El-Gibaly O, 2002, SOC SCI MED, V54, P205, DOI 10.1016/S0277-9536(01)00020-X; Feachem RGA, 2000, B WORLD HEALTH ORGAN, V78, P1; *FED MIN HLTH SUD, 2003, BAS DEV NEEDS PROGR; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; *GLOB FUND FIGHT A, 2003, APPL FORM PROP GLOB; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; *JORD DEP STAT ORC, 2003, JORD POP FAM HLTH SU; *LEAG AR STAT REP, 2005, YEM FAM HLTH SURV PR; Maziak W, 2002, SOC SCI MED, V54, P1419, DOI 10.1016/S0277-9536(01)00123-X; Mohammadi MR, 2005, SUICIDE LIFE-THREAT, V35, P309, DOI 10.1521/suli.2005.35.3.309; *MORR MIN HLTH, 2004, MOR DEM HLTH SURV 20; Mumtaz Z, 2005, SOC SCI MED, V60, P1751, DOI 10.1016/j.socscimed.2004.08.019; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; *WHO, 2005, EV BAS DEV NEEDS PRO; *WHO, 2006, VAL EV COMM BAS IN I; *WHO REG OFF E MED, 2006, SOC HLTH IND COUNTR; Yount KM, 2003, SOC SCI MED, V56, P753, DOI 10.1016/S0277-9536(02)00072-2	20	27	29	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					854	856		10.1136/bmj.38988.607836.68	http://dx.doi.org/10.1136/bmj.38988.607836.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053247	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000241678500025
J	Brun, T; Devetak, I; Hsieh, MH				Brun, Todd; Devetak, Igor; Hsieh, Min-Hsiu			Correcting quantum errors with entanglement	SCIENCE			English	Article							CODES	We show how entanglement shared between encoder and decoder can simplify the theory of quantum error correction. The entanglement-assisted quantum codes we describe do not require the dual-containing constraint necessary for standard quantum error-correcting codes, thus allowing us to "quantize'' all of classical linear coding theory. In particular, efficient modern classical codes that attain the Shannon capacity can be made into entanglement-assisted quantum codes attaining the hashing bound ( closely related to the quantum capacity). For systems without large amounts of shared entanglement, these codes can also be used as catalytic codes, in which a small amount of initial entanglement enables quantum communication.	Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA	University of Southern California	Brun, T (corresponding author), Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	tbrun@usc.edu	Brun, Todd A/C-3943-2008	Brun, Todd/0000-0002-8807-3495; Hsieh, Min-Hsiu/0000-0002-3396-8427				BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Bennett CH, 2002, IEEE T INFORM THEORY, V48, P2637, DOI 10.1109/TIT.2002.802612; BERROU C, 1993, IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS 93 : TECHNICAL PROGRAM, CONFERENCE RECORD, VOLS 1-3, P1064, DOI 10.1109/ICC.1993.397441; Blume-Kohout R, 2002, FOUND PHYS, V32, P1641, DOI 10.1023/A:1021471621587; Bowen G, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052313; Bravyi S, 2006, J MATH PHYS, V47, DOI 10.1063/1.2203431; Calderbank AR, 1998, IEEE T INFORM THEORY, V44, P1369, DOI 10.1109/18.681315; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Calderbank AR, 1997, PHYS REV LETT, V78, P405, DOI 10.1103/PhysRevLett.78.405; Devetak I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.230504; FATTAL D, 2004, ENTANGLEMENT STABILI; Gallager R. G., 1963, THESIS MIT CAMBRIDGE; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; GOTTESMAN D, 1997, THESIS CALTECH PASAD; Josza R., 2003, P ROY SOC LOND A MAT, V459, P2011; MacKay DJC, 2004, IEEE T INFORM THEORY, V50, P2315, DOI 10.1109/TIT.2004.834737; Nielsen Michael A., 2002, QUANTUM COMPUTATION; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793	22	246	251	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					436	439		10.1126/science.1131563	http://dx.doi.org/10.1126/science.1131563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17008489	Green Submitted			2022-12-28	WOS:000241382500033
J	Caughey, B; Baron, GS				Caughey, Byron; Baron, Gerald S.			Prions and their partners in crime	NATURE			English	Review							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; KDA LAMININ RECEPTOR; PROTEASE-RESISTANT STATE; INFECTED NEURONAL CELLS; SCRAPIE-ASSOCIATED FORM; CELLULAR PRION; IN-VITRO; HEPARAN-SULFATE; NEURITE OUTGROWTH; PRPSC PROPAGATION	Prions, the infectious agents of transmissible spongiform encephalopathies ( TSEs), have defied full characterization for decades. The dogma has been that prions lack nucleic acids and are composed of a pathological, self-inducing form of the host's prion protein (PrP). Recent progress in propagating TSE infectivity in cell-free systems has effectively ruled out the involvement of foreign nucleic acids. However, host-derived nucleic acids or other non-PrP molecules seem to be crucial. Interactions between TSE-associated PrP and its normal counterpart are also pathalogically important, so the physiological functions of normal PrP and how they might be corrupted by TSE infections have been the subject of recent research.	NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov; gbaron@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000982, Z01AI000580, ZIAAI000580, ZIAAI000982] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Cashman NR, 2004, NAT REV DRUG DISCOV, V3, P874, DOI 10.1038/nrd1525; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Cordeiro Y, 2005, PROTEIN PEPTIDE LETT, V12, P251, DOI 10.2174/0929866053587138; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fontes P, 2005, INFECT IMMUN, V73, P6229, DOI 10.1128/IAI.73.10.6229-6236.2005; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P759, DOI 10.1128/AAC.50.2.759-761.2006; KOVALCHUK O, 2003, J BIOL CHEM, V278, P40041; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kuczius T, 2004, BIOL CHEM, V385, P739, DOI 10.1515/BC.2004.090; Kunz B, 1999, FEBS LETT, V458, P65, DOI 10.1016/S0014-5793(99)01123-0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Leucht C, 2004, TRANSGENIC RES, V13, P81, DOI 10.1023/B:TRAG.0000017177.35197.89; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marella M, 2005, J BIOL CHEM, V280, P1529, DOI 10.1074/jbc.M410966200; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; McKenzie D, 1998, J BIOL CHEM, V273, P25545, DOI 10.1074/jbc.273.40.25545; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Moya KL, 2005, J NEUROCHEM, V92, P1044, DOI 10.1111/j.1471-4159.2004.02940.x; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nico PBC, 2005, BEHAV BRAIN RES, V162, P173, DOI 10.1016/j.bbr.2005.02.003; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shaked GM, 2001, J BIOL CHEM, V276, P14324, DOI 10.1074/jbc.M007815200; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Silveira JR, 2004, CURR TOP MICROBIOL, V284, P1; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Watarai MH, 2003, J EXP MED, V198, P5, DOI 10.1084/jem.20021980; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	96	229	246	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					803	810		10.1038/nature05294	http://dx.doi.org/10.1038/nature05294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051207				2022-12-28	WOS:000241362700040
J	Reichle, R; Leibfried, D; Knill, E; Britton, J; Blakestad, RB; Jost, JD; Langer, C; Ozeri, R; Seidelin, S; Wineland, DJ				Reichle, R.; Leibfried, D.; Knill, E.; Britton, J.; Blakestad, R. B.; Jost, J. D.; Langer, C.; Ozeri, R.; Seidelin, S.; Wineland, D. J.			Experimental purification of two-atom entanglement	NATURE			English	Article							QUANTUM-STATE; TELEPORTATION; CHANNELS; IONS	Entanglement is a necessary resource for quantum applications entanglement established between quantum systems at different locations enables private communication(1) and quantum teleportation(2), and facilitates quantum information processing(3). Distributed entanglement is established by preparing an entangled pair of quantum particles in one location, and transporting one member of the pair to another location. However, decoherence during transport reduces the quality ( fidelity) of the entanglement. A protocol to achieve entanglement 'purification' has been proposed(4) to improve the fidelity after transport. This protocol uses separate quantum operations at each location and classical communication to distil high-fidelity entangled pairs from lower-fidelity pairs. Proof-of-principle experiments distilling entangled photon pairs have been carried out(5-9). However, these experiments obtained distilled pairs with a low probability of success and required destruction of the entangled pairs, rendering them unavailable for further processing. Here we report efficient and non-destructive entanglement purification(4) with atomic quantum bits. Two noisy entangled pairs were created and distilled into one higher-fidelity pair available for further use. Success probabilities were above 35 per cent. The many applications of entanglement purification make it one of the most important techniques in quantum information processing.	Natl Inst Stand & Technol, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Leibfried, D (corresponding author), Natl Inst Stand & Technol, Boulder, CO 80305 USA.	dil@boulder.nist.gov	Jost, John D/F-4701-2010	Britton, Joe/0000-0001-8103-7347; jost, john/0000-0002-1698-8602				BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Brennen GK, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.050302; Browne DE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010501; Efron B., 1994, MONOGRAPHS STAT APPL; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Kwiat PG, 2001, NATURE, V409, P1014, DOI 10.1038/35059017; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; LVOVSKY AI, 2005, CONTINUOUS VARIABLE; Ozeri R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030403; Pan JW, 2003, NATURE, V423, P417, DOI 10.1038/nature01623; *QUANT INF SCI TEC, 2002, ARDA QUANT INF SCI T; Walther P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.040504; Yamamoto T, 2003, NATURE, V421, P343, DOI 10.1038/nature01358; Zhao Z, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207901	22	113	118	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					838	841		10.1038/nature05146	http://dx.doi.org/10.1038/nature05146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051214				2022-12-28	WOS:000241362700047
J	Gasink, LB; Blumberg, EA; Localio, AR; Desai, SS; Israni, AK; Lautenbach, E				Gasink, Leanne B.; Blumberg, Emily A.; Localio, A. Russell; Desai, Shashank S.; Israni, Ajay K.; Lautenbach, Ebbing			Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPENSITY SCORE; INFECTION	Context Although liberalization of donor criteria could expand the donor pool, the use of certain "marginal donors," such as those who are hepatitis C virus (HCV) positive, is controversial. Little is known about the effect of donor HCV positivity on survival in cardiac transplantation. Objectives To examine the association between donor HCV positivity and survival among heart transplant recipients and to determine the effects of recipient age and recipient HCV status on this association. Design, Setting, and Participants A multicenter cohort study was performed using the US Scientific Registry of Transplant Recipients. Adult heart transplant patients who received their transplants between April 1, 1994, and July 31, 2003, were eligible for inclusion. Main Outcome Measure All-cause mortality. Results Of 10 915 patients meeting entry criteria, 261 received an HCV-positive donor heart. Mortality was higher among recipients of HCV-positive donor hearts at 1 year (16.9% vs 8.2%; P < .001), 5 years (41.8% vs 18.5%; P < .001), and 10 years (50.6% vs 24.3%; P < .001). Using Kaplan-Meier methods, 1-, 5-, and 10-year survival rates were 83%, 53%, and 25%, and 92%, 77%, and 53% for recipients of HCV-positive and HCV-negative donor hearts, respectively (P < .001, log-rank test). Recipients of HCV-positive donor hearts were more likely to die of liver disease and coronary vasculopathy. After propensity matching, the overall hazard ratio (HR) associated with receipt of an HCV-positive donor heart was 2.10 (95% confidence interval [CI], 1.60-2.75). Stratified analyses showed that HRs did not vary by recipient HCV status or by recipient age (for recipients aged 18-39 years: HR, 1.75 [95% CI, 0.70-4.40]; for recipients aged 40-59 years: HR, 2.23 [95% CI, 1.42-3.52]; and for recipients aged 60 years and older: HR, 2.07 [95% CI, 1.32-3.27]; overall P value for interaction, >.10). Conclusions Receipt of a heart from an HCV-positive donor is associated with decreased survival in heart transplant recipients. This association appears to be independent of recipient HCV status and age. Preferential allocation of HCV-positive donors to HCV-positive recipients and/or older recipients is not warranted.	Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Fairfax Hosp, Dept Med, Heart Failure & Transplant Program, Falls Church, VA 22046 USA; Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN 55415 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Inova Fairfax Hospital; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gasink, LB (corresponding author), Univ Penn, Sch Med, Div Infect Dis, 3 Silverstein Pavil,Suite E,3400 Spruce St, Philadelphia, PA 19104 USA.	gasink@uphs.upenn.edu			NIAID NIH HHS [T32 AI055435] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055435] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; [Anonymous], SCI REGISTRY TRANSPL; Carlin JB, 2003, STATA J, V3, P226, DOI 10.1177/1536867X0300300302; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Daily OP, 2004, TRANSPLANTATION, V77, P1309, DOI 10.1097/01.TP.0000120943.94789.E4; HAJL SA, 2004, J HEART LUNG TRANSPL, V23, P277; Hanto DW, 2003, TRANSPLANTATION, V75, P2162, DOI 10.1097/01.TP.0000080273.83998.C4; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ishizaka N, 2002, LANCET, V359, P133, DOI 10.1016/S0140-6736(02)07339-7; Lake KD, 1997, TRANSPL P, V29, P581, DOI 10.1016/S0041-1345(96)00312-0; Marelli D, 2002, AM J TRANSPLANT, V2, P443, DOI 10.1034/j.1600-6143.2002.20508.x; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MICKEY RM, 1989, AM J EPIDEMIOL, V130, P1066; MILFRED SK, 1994, TRANSPLANTATION, V57, P568; Ong JP, 1999, HEPATOLOGY, V30, P1293, DOI 10.1002/hep.510300519; Pfau PR, 2000, J HEART LUNG TRANSPL, V19, P350, DOI 10.1016/S1053-2498(00)00062-0; Renlund DG, 1999, J HEART LUNG TRANSPL, V18, P1065, DOI 10.1016/S1053-2498(99)00075-3; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75; 2004, AM J TRANSPLANT S10, V4, P72	23	101	103	2	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1843	1850		10.1001/jama.296.15.1843	http://dx.doi.org/10.1001/jama.296.15.1843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047214				2022-12-28	WOS:000241329300026
J	Jorgensen, AW; Hilden, J; Gotzsche, PC				Jorgensen, Anders W.; Hilden, Jorgen; Gotzsche, Peter C.			Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; CLINICAL-TRIALS; EFFICACY; QUALITY; ANTIPSYCHOTICS; INTERVENTIONS; TOLERABILITY; VARIABILITY; RISPERIDONE	Objective To compare the methodological quality and conclusions in Cochrane reviews with those in industry supported meta-analyses and other meta-analyses of the same drugs. Design Systematic review comparing pairs of meta-analyses that studied the same two drugs in the same disease and were published within two years of each other. Data sources Cochrane Database of Systematic Reviews (2003, issue 1), PubMed, and Embase. Data extraction Two observers independently extracted data and used a validated scale to judge the methodological quality of the reviews. Results 175 of 1596 Cochrane reviews had a meta-analysis that compared two drugs. Twenty four meta-analyses that matched the Cochrane reviews were found: eight were industry supported, nine had undeclared support, and seven had no support or were supported by non-industry sources. On a 0-7 scale, the median quality score was 7 for Cochrane reviews and 3 for other reviews (P < 0.01). Compared with industry supported reviews and reviews with undeclared support, Cochrane reviews had more often considered the potential for bias in the review-for example, by describing the method of concealment of allocation and describing excluded patients or studies. The seven industry supported reviews that had conclusions recommended the experimental drug without reservations, compared with none of the Cochrane reviews (P = 0.02), although the estimated treatment effect was similar on average (z = 0.46, P = 0.64). Reviews with undeclared support and reviews with not for profit support or no support had conclusions that were similar in cautiousness to the Cochrane reviews. Conclusions Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews.	Rigshosp, Nord Cochrene Ctr, DK-2100 Copenhagen O, Denmark; Univ Copenhagen, Panum Inst, Dept Biostat, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrene Ctr, DK-2100 Copenhagen O, Denmark.	pcg@cochrane.dk						ADAMS N, 2003, COCHRANE LIB; ALDERSON P, 2003, COCHRANE LIB; ALINANY H, 2003, COCHRANE LIB; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; BARBUI C, 2003, COCHRANE LIB; Barnes NC, 1998, RESP MED, V92, P95, DOI 10.1016/S0954-6111(98)90039-7; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; CHALMERS TC, 1987, STAT MED, V6, P733, DOI 10.1002/sim.4780060704; Chien PFW, 1996, BRIT J OBSTET GYNAEC, V103, P1085, DOI 10.1111/j.1471-0528.1996.tb09587.x; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; CLARK N, 2003, COCHRANE LIB; *COCHR COLL, COCHR COLL PRINC; *COCHR COLL, COMM SPONS COCHR COL; Cohen M, 2001, J THROMB THROMBOLYS, V11, P171, DOI 10.1023/A:1011284902244; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Corley DA, 2001, GASTROENTEROLOGY, V120, P946, DOI 10.1053/gast.2001.22451; Davies A, 1998, CLIN THER, V20, P58, DOI 10.1016/S0149-2918(98)80034-9; Davies B, 1998, RESP MED, V92, P256, DOI 10.1016/S0954-6111(98)90105-6; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; DUGGAN L, 2003, COCHRANE LIB; Duley L, 2003, COCHRANE LIB; Einarson TR, 1999, CLIN THER, V21, P296, DOI 10.1016/S0149-2918(00)88287-9; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; GARNER S, 2003, COCHRANE LIB; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; GEDDES JR, 2003, COCHRANE LIB; GOTZSCHE PC, 1994, J INTERN MED, V236, P599, DOI 10.1111/j.1365-2796.1994.tb00853.x; GOTZSCHE PC, 1992, J CLIN EPIDEMIOL, V45, P587, DOI 10.1016/0895-4356(92)90130-F; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hopayian K, 2001, BRIT MED J, V323, P681, DOI 10.1136/bmj.323.7314.681; IOANNOU G, 2003, COCHRANE LIB; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, JAMA-J AM MED ASSOC, V288, P2407; Katerndahl DA, 1999, AM J EPIDEMIOL, V149, P429, DOI 10.1093/oxfordjournals.aje.a009830; KENNEDY E, 2003, COCHRANE LIB; Kim HL, 1999, J NERV MENT DIS, V187, P532, DOI 10.1097/00005053-199909000-00002; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Le Nguyen M T, 2001, J Thromb Thrombolysis, V12, P289, DOI 10.1023/A:1015287311065; Leucht S, 1999, SCHIZOPHR RES, V35, P51, DOI 10.1016/S0920-9964(98)00105-4; Leucht S, 2002, AM J PSYCHIAT, V159, P180, DOI 10.1176/appi.ajp.159.2.180; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Linde K, 2003, J ROY SOC MED, V96, P17, DOI 10.1258/jrsm.96.1.17; Linde K, 2003, COCHRANE LIB; Ludwig M, 2001, Arch Gynecol Obstet, V265, P175, DOI 10.1007/s00404-001-0267-2; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; MAGEE KD, 2003, COCHRANE LIB; Magee LA, 2000, EUR J OBSTET GYN R B, V88, P15, DOI 10.1016/S0301-2115(99)00113-X; MATTICK RP, 2003, COCHRANE LIB; MCINTOSH HM, 2003, COCHRANE LIB; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montgomery SA, 2001, INT CLIN PSYCHOPHARM, V16, P169, DOI 10.1097/00004850-200105000-00006; Mozurkewich EL, 1997, OBSTET GYNECOL, V89, P1035, DOI 10.1016/S0029-7844(97)00094-X; NAKIELNY J, 1993, BRIT MED J, V306, P1125, DOI 10.1136/bmj.306.6885.1125-b; NETO JIS, 2003, COCHRANE LIB; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; Olsen O., 2001, COCHRANE DB SYST REV; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; Pittler MH, 1999, CLIN INFECT DIS, V28, P597, DOI 10.1086/515148; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; SEGAL JB, 2003, COCHRANE LIB; Smith GD, 1998, BMJ-BRIT MED J, V316, P221; SONG FJ, 1993, BMJ-BRIT MED J, V306, P683, DOI 10.1136/bmj.306.6879.683; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; TAN BP, 2003, COCHRANE LIB; Taylor FC, 2001, BMJ-BRIT MED J, V322, P321, DOI 10.1136/bmj.322.7282.321; VANDENBELT AGM, 2003, COCHRANE LIB; WAHLBECK K, 2003, COCHRANE LIB; West SL, 2000, J SUBST ABUSE, V12, P405, DOI 10.1016/S0899-3289(01)00054-2; WILSON AJ, 2003, COCHRANE LIB; YANK V, 2005, 5 INT C PEER REV BIO, P16; [No title captured]	81	294	299	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2006	333	7572					782	785		10.1136/bmj.38973.444699.0B	http://dx.doi.org/10.1136/bmj.38973.444699.0B			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17028106	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000241566000014
J	Chavez, AE; Singer, JH; Diamond, JS				Chavez, Andres E.; Singer, Joshua H.; Diamond, Jeffrey S.			Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors	NATURE			English	Article							MAMMALIAN RIBBON SYNAPSE; ROD BIPOLAR CELLS; AMACRINE CELLS; RAT RETINA; ACCUMULATING NEURONS; RABBIT RETINA; CALCIUM; A17; INHIBITION; TERMINALS	Feedback inhibition at reciprocal synapses between A17 amacrine cells and rod bipolar cells (RBCs) shapes light-evoked responses in the retina(1-3). Glutamate-mediated excitation of A17 cells elicits GABA (gamma-aminobutyric acid)-mediated inhibitory feedback onto RBCs4-6, but the mechanisms that underlie GABA release from the dendrites of A17 cells are unknown. If, as observed at all other synapses studied, voltage-gated calcium channels (VGCCs) couple membrane depolarization to neurotransmitter release(7), feedforward excitatory postsynaptic potentials could spread through A17 dendrites to elicit 'surround' feedback inhibitory transmission at neighbouring synapses. Here we show, however, that GABA release from A17 cells in the rat retina does not depend on VGCCs or membrane depolarization. Instead, calcium-permeable AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors (AMPARs), activated by glutamate released from RBCs, provide the calcium influx necessary to trigger GABA release from A17 cells. The AMPAR-mediated calcium signal is amplified by calcium-induced calcium release (CICR) from intracellular calcium stores. These results describe a fast synapse that operates independently of VGCCs and membrane depolarization and reveal a previously unknown form of feedback inhibition within a neural circuit.	NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Diamond, JS (corresponding author), NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA.	diamondj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS043365, Z01NS003039] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [K22 NS043365] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumgarten H G, 1978, Ann N Y Acad Sci, V305, P3, DOI 10.1111/j.1749-6632.1978.tb31507.x; Bloomfield SA, 2000, J PHYSIOL-LONDON, V523, P771, DOI 10.1111/j.1469-7793.2000.t01-1-00771.x; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Drose S, 1997, J EXP BIOL, V200, P1; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hartveit E, 1996, J NEUROPHYSIOL, V76, P401, DOI 10.1152/jn.1996.76.1.401; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KOLB H, 1981, VISION RES, V21, P1625, DOI 10.1016/0042-6989(81)90046-8; Menger N, 2000, VISUAL NEUROSCI, V17, P769, DOI 10.1017/S0952523800175108; NAKATSUKA K, 1985, INVEST OPHTH VIS SCI, V26, P1109; Nawy S, 2004, J PHYSIOL-LONDON, V558, P137, DOI 10.1113/jphysiol.2004.064980; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; SANDELL JH, 1986, J NEUROSCI, V6, P3331; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Sidach SS, 2002, J NEUROSCI, V22, P2023, DOI 10.1523/JNEUROSCI.22-06-02023.2002; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; STERLING P, 1986, J NEUROSCI, V6, P1314; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Warrier A, 2005, J NEUROPHYSIOL, V94, P4196, DOI 10.1152/jn.00604.2005; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Zhang J, 2002, J NEUROSCI, V22, P10871	30	131	134	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					705	708		10.1038/nature05123	http://dx.doi.org/10.1038/nature05123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036006				2022-12-28	WOS:000241160500049
J	Oeffinger, KC; Mertens, AC; Sklar, CA; Kawashima, T; Hudson, MM; Meadows, AT; Friedman, DL; Marina, N; Hobbie, W; Kadan-Lottick, NS; Schwartz, CL; Leisenring, W; Robison, LL				Oeffinger, Kevin C.; Mertens, Ann C.; Sklar, Charles A.; Kawashima, Toana; Hudson, Melissa M.; Meadows, Anna T.; Friedman, Debra L.; Marina, Neyssa; Hobbie, Wendy; Kadan-Lottick, Nina S.; Schwartz, Cindy L.; Leisenring, Wendy; Robison, Leslie L.		Childhood Canc Survivor Study	Chronic health conditions in adult survivors of childhood cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM SURVIVORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; PSYCHOLOGICAL OUTCOMES; DOXORUBICIN THERAPY; ADOLESCENT CANCER; 5-YEAR SURVIVORS; HODGKINS-DISEASE; RISK; DYSFUNCTION; NEOPLASMS	BACKGROUND Only a few small studies have assessed the long-term morbidity that follows the treatment of childhood cancer. We determined the incidence and severity of chronic health conditions in adult survivors. METHODS The Childhood Cancer Survivor Study is a retrospective cohort study that tracks the health status of adults who received a diagnosis of childhood cancer between 1970 and 1986 and compares the results with those of siblings. We calculated the frequencies of chronic conditions in 10,397 survivors and 3034 siblings. A severity score (grades 1 through 4, ranging from mild to life-threatening or disabling) was assigned to each condition. Cox proportional-hazards models were used to estimate hazard ratios, reported as relative risks and 95% confidence intervals (CIs), for a chronic condition. RESULTS Survivors and siblings had mean ages of 26.6 years (range, 18.0 to 48.0) and 29.2 years (range, 18.0 to 56.0), respectively, at the time of the study. Among 10,397 survivors, 62.3% had at least one chronic condition; 27.5% had a severe or life-threatening condition (grade 3 or 4). The adjusted relative risk of a chronic condition in a survivor, as compared with siblings, was 3.3 (95% CI, 3.0 to 3.5); for a severe or life-threatening condition, the risk was 8.2 (95% CI, 6.9 to 9.7). Among survivors, the cumulative incidence of a chronic health condition reached 73.4% (95% CI, 69.0 to 77.9) 30 years after the cancer diagnosis, with a cumulative incidence of 42.4% (95% CI, 33.7 to 51.2) for severe, disabling, or life-threatening conditions or death due to a chronic condition. CONCLUSIONS Survivors of childhood cancer have a high rate of illness owing to chronic health conditions.	Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Univ Minnesota, Minneapolis, MN USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; Yale Univ, Sch Med, New Haven, CT USA; Brown Med Sch, Providence, RI USA	Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University; Yale University; Brown University	Oeffinger, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	oeffingk@mskcc.org	Robison, Leslie/N-8122-2018; Hudson, Melissa M/N-4441-2018; Kadan-Lottick, Nina Singh/HGE-5850-2022; Schwartz, Cindy L/J-4771-2019; Marina, Neyssa/B-7449-2009	Hudson, Melissa M/0000-0001-6984-2407; Kadan-Lottick, Nina Singh/0000-0002-6857-396X; Marina, Neyssa/0000-0002-7195-8887	NATIONAL CANCER INSTITUTE [U24CA055727] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA055727, U24-CA-55727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Eiser C, 2001, Sarcoma, V5, P189, DOI 10.1080/13577140120099173; Friedman DL, 2002, PEDIATR CLIN N AM, V49, P1083, DOI 10.1016/S0031-3955(02)00032-9; GARRE ML, 1994, AM J PEDIAT HEMATOL, V16, P143; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Hull MC, 2003, JAMA-J AM MED ASSOC, V290, P2831, DOI 10.1001/jama.290.21.2831; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Meadows AT, 2003, CURR PROB CANCER, V27, P110; Melin AE, 1998, EUR J PEDIATR, V157, P703, DOI 10.1007/s004310050918; Mertens AC, 2004, J CLIN EPIDEMIOL, V57, P933, DOI 10.1016/j.jclinepi.2004.01.005; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mulhern RK, 1999, ANN NEUROL, V46, P834, DOI 10.1002/1531-8249(199912)46:6<834::AID-ANA5>3.0.CO;2-M; MULHERN RK, 1992, MED PEDIATR ONCOL, V20, P181, DOI 10.1002/mpo.2950200302; Nagarajan R, 2002, J CLIN ONCOL, V20, P4493, DOI 10.1200/JCO.2002.09.006; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Ness KK, 2005, ANN INTERN MED, V143, P639, DOI 10.7326/0003-4819-143-9-200511010-00007; Ng Andrea K, 2004, Curr Hematol Rep, V3, P27; Oeffinger KC, 2004, CA-CANCER J CLIN, V54, P208, DOI 10.3322/canjclin.54.4.208; Oeffinger KC, 2004, ANN FAM MED, V2, P61, DOI 10.1370/afm.26; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Oeffinger KC, 2000, CANCER-AM CANCER SOC, V88, P1687, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.3.CO;2-D; Ries L., 2005, SEER CANC STAT REV 1; ROBISON LL, 1985, MED PEDIATR ONCOL, V13, P14, DOI 10.1002/mpo.2950130105; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Simone J.V., 2003, CHILDHOOD CANC SURVI; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; Sklar CA, 1999, ACTA PAEDIATR, V88, P1, DOI 10.1111/j.1651-2227.1999.tb14395.x; Stevens MCG, 1998, EUR J CANCER, V34, P694, DOI 10.1016/S0959-8049(98)00012-4; Therneau TM, 2000, MODELING SURVIVAL DA; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; WABER DP, 1995, J CLIN ONCOL, V13, P2490, DOI 10.1200/JCO.1995.13.10.2490; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148; Zebrack BJ, 2002, PEDIATRICS, V110, P42, DOI 10.1542/peds.110.1.42	38	2390	2433	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1572	1582		10.1056/NEJMsa060185	http://dx.doi.org/10.1056/NEJMsa060185			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035650				2022-12-28	WOS:000241160400008
J	de Jong, PTVM				de Jong, Paulus T. V. M.			Mechanisms of disease: Age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMPLEMENT FACTOR-H; RETINAL-PIGMENT EPITHELIUM; APOLIPOPROTEIN-E GENE; BRUCHS MEMBRANE; MORPHOMETRIC-ANALYSIS; CIGARETTE-SMOKING; OXIDATIVE STRESS; AGING CHANGES; LIGHT; RISK		Royal Netherlands Acad Arts & Sci, KNAW, Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1105 BA Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	de Jong, PTVM (corresponding author), Royal Netherlands Acad Arts & Sci, KNAW, Netherlands Inst Neurosci, Dept Ophthalmogenet, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.dejong@nin.knaw.nl						Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; AHMED J, 1993, INVEST OPHTH VIS SCI, V34, P516; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Assink JJM, 2005, OPHTHALMOLOGY, V112, P482, DOI 10.1016/j.ophtha.2004.10.035; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BESHARSE JC, 1998, RETINAL PIGMENT EPIT, P152; BIRD AC, 1986, T OPHTHAL SOC UK, V105, P674; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bok D., 1979, RETINAL PIGMENT EPIT, P148; BONNET M, 1976, ARCH OPHTALMOL-PARIS, V36, P465; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Davies NP, 2004, PROG RETIN EYE RES, V23, P533, DOI 10.1016/j.preteyeres.2004.05.004; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; DeCaprio AP, 1999, CRIT REV TOXICOL, V29, P283, DOI 10.1080/10408449991349221; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Donders FC, 1854, ARCH OPHTHALMOL-CHIC, V1, P106; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; DOSSO AA, 1992, OPHTHALMOLOGICA, V205, P24, DOI 10.1159/000310307; DUVALL J, 1985, ARCH OPHTHALMOL-CHIC, V103, P694, DOI 10.1001/archopht.1985.01050050086024; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eldred GE, 1995, GERONTOLOGY, V41, P15; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Evans JR, 2005, BRIT J OPHTHALMOL, V89, P550, DOI 10.1136/bjo.2004.049726; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FORRESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P64; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GAILLARD ER, 1995, PHOTOCHEM PHOTOBIOL, V61, P448, DOI 10.1111/j.1751-1097.1995.tb02343.x; Gass J D, 1972, Trans Am Ophthalmol Soc, V70, P409; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Guymer R, 1998, RETINAL PIGMENT EPIT, P693; Guymer RH, 2004, INVEST OPHTH VIS SCI, V45, P1660, DOI 10.1167/iovs.03-0913; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hammond BR, 1996, VISION RES, V36, P3003, DOI 10.1016/0042-6989(96)00008-9; HEWITT AT, 1989, INVEST OPHTH VIS SCI, V30, P478; HOGAN MJ, 1967, ARCH OPHTHALMOL-CHIC, V77, P410, DOI 10.1001/archopht.1967.00980020412022; Hogg RE, 2006, PROG RETIN EYE RES, V25, P249, DOI 10.1016/j.preteyeres.2005.11.002; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Hu DN, 2002, INT J TOXICOL, V21, P465, DOI 10.1080/10915810290169891; Hutchinson J., 1874, R LOND OPHTHALMIC HO, V8, P231; Issa PC, 2005, OPHTHALMOLOGE, V102, P1036, DOI 10.1007/s00347-005-1269-4; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; JUNG H, 1994, GRAEF ARCH CLIN EXP, V232, P167, DOI 10.1007/BF00176787; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KLIFFEN M, 1995, LAB INVEST, V73, P267; KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1135; LEYS A, 1991, GRAEF ARCH CLIN EXP, V229, P406, DOI 10.1007/BF00166300; LYDA W, 1957, AM J OPHTHALMOL, V44, P362, DOI 10.1016/0002-9394(57)93133-1; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001; Marshall J., 1998, RETINAL PIGMENT EPIT, P669; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; MELROSE MA, 1985, OPHTHALMIC SURG LAS, V16, P648; MEYERS SM, 1988, ARCH OPHTHALMOL-CHIC, V106, P651; Mitchell P, 1998, OPHTHALMOLOGY, V105, P1359, DOI 10.1016/S0161-6420(98)98013-7; Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; ORGANISCIAK DT, 1994, PROG RETIN EYE RES, V13, P1, DOI 10.1016/1350-9462(94)90003-5; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Penfold PL, 1997, INVEST OPHTH VIS SCI, V38, P2125; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Peto R, 1997, BRIT MED J, V315, P1030, DOI 10.1136/bmj.315.7115.1030; PIGUET B, 1993, BRIT J OPHTHALMOL, V77, P400, DOI 10.1136/bjo.77.7.400; Powell DEB, 1998, BRIT MED J, V316, P1531, DOI 10.1136/bmj.316.7143.1531; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; REINBOTH JJ, 1995, CURR EYE RES, V14, P1001, DOI 10.3109/02713689508998521; Reme C, 2005, INVEST OPHTH VIS SCI, V46, P2672, DOI 10.1167/iovs.04-1095; Reme CE, 1998, RETINAL PIGMENT EPIT, P563; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; RUDNEW A, 1871, ARCH PATHOL ANAT PHY, V53, P455; RUYSCH F, 1722, ASSER PRIMUS THESAUR, P3; SARKS SH, 1973, BRIT J OPHTHALMOL, V57, P951, DOI 10.1136/bjo.57.12.951; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; SARKS SH, 1979, 23RD P INT C OPHTH, V1, P228; Sastry BVR, 1998, J OCUL PHARMACOL TH, V14, P447, DOI 10.1089/jop.1998.14.447; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schachat AP, 2005, OPHTHALMOLOGY, V112, P531, DOI 10.1016/j.ophtha.2005.01.018; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmidt S, 2000, MOL VIS, V6, P287; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Spilsbury K, 2000, AM J PATHOL, V157, P1413; Starita C, 1996, EXP EYE RES, V62, P565, DOI 10.1006/exer.1996.0066; STREETEN BW, 1961, ARCH OPHTHALMOL-CHIC, V66, P391; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; TERMAN M, 1990, PHOTOCHEM PHOTOBIOL, V51, P781, DOI 10.1111/php.1990.51.6.781; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; VANDERSCHAFT TL, 1992, OPHTHALMOLOGY, V99, P278; VANDERSCHAFT TL, 1991, ARCH OPHTHALMOL-CHIC, V109, P420, DOI 10.1001/archopht.1991.01080030122052; Wolfrum M., 1908, Graefes Archiv fuer Ophthalmologie Leipzig, V67; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1971, J ULTRA MOL STRUCT R, V34, P190, DOI 10.1016/S0022-5320(71)90014-1; Yu DY, 2002, COMP BIOCHEM PHYS A, V132, P47, DOI 10.1016/S1095-6433(01)00528-1; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	127	690	726	2	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1474	1485		10.1056/NEJMra062326	http://dx.doi.org/10.1056/NEJMra062326			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021323				2022-12-28	WOS:000240976200009
J	List, A; Dewald, G; Bennett, J; Giagounidis, A; Raza, A; Feldman, E; Powell, B; Greenberg, P; Thomas, D; Stone, R; Reeder, C; Wride, K; Patin, J; Schmidt, M; Zeldis, J; Knight, R				List, Alan; Dewald, Gordon; Bennett, John; Giagounidis, Aristotle; Raza, Azra; Feldman, Eric; Powell, Bayard; Greenberg, Peter; Thomas, Deborah; Stone, Richard; Reeder, Craig; Wride, Kenton; Patin, John; Schmidt, Michele; Zeldis, Jerome; Knight, Robert		Myelodysplastic Syndrome-003	Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG ARM; CLASSIFICATION; PROGNOSIS; CRITERIA; LIFE	Background: Severe, often refractory anemia is characteristic of the myelodysplastic syndrome associated with chromosome 5q31 deletion. We investigated whether lenalidomide (CC5013) could reduce the transfusion requirement and suppress the abnormal 5q31- clone in patients with this disorder. Methods: One hundred forty-eight patients received 10 mg of lenalidomide for 21 days every 4 weeks or daily. Hematologic, bone marrow, and cytogenetic changes were assessed after 24 weeks of treatment by an intention-to-treat analysis. Results: Among the 148 patients, 112 had a reduced need for transfusions (76%; 95% confidence interval [CI], 68 to 82) and 99 patients (67%; 95% CI, 59 to 74) no longer required transfusions, regardless of the karyotype complexity. The response to lenalidomide was rapid (median time to response, 4.6 weeks; range, 1 to 49) and sustained; the median duration of transfusion independence had not been reached after a median of 104 weeks of follow-up. The maximum hemoglobin concentration reached a median of 13.4 g per deciliter (range, 9.2 to 18.6), with a corresponding median rise of 5.4 g per deciliter (range, 1.1 to 11.4), as compared with the baseline nadir value before transfusion. Among 85 patients who could be evaluated, 62 had cytogenetic improvement, and 38 of the 62 had a complete cytogenetic remission. There was complete resolution of cytologic abnormalities in 38 of 106 patients whose serial bone marrow samples could be evaluated. Moderate-to-severe neutropenia (in 55% of patients) and thrombocytopenia (in 44%) were the most common reasons for interrupting treatment or adjusting the dose of lenalidomide. Conclusions: Lenalidomide can reduce transfusion requirements and reverse cytologic and cytogenetic abnormalities in patients who have the myelodysplastic syndrome with the 5q31 deletion. (ClinicalTrials.gov number, NCT00065156.)	Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Div, Tampa, FL 33612 USA; Mayo Clin, Rochester, MN USA; Univ Rochester, Rochester, NY USA; St Johannes Hosp, Duisburg, Germany; Univ Massachusetts, Worcester, MA 01605 USA; Cornell Med Ctr, New York, NY USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Stanford Univ, Stanford, CA 94305 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Mayo Clin, Scottsdale, AZ USA; Celgene Corp, Warren, NJ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic; University of Rochester; St. Johannes Hospital; University of Massachusetts System; University of Massachusetts Worcester; Cornell University; Wake Forest University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; Mayo Clinic Phoenix; Bristol-Myers Squibb; Celgene Corporation	List, A (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Div, SRB-4,12902 Magnolia Dr, Tampa, FL 33612 USA.	heberten@moffitt.usf.edu	Giagounidis, Aristoteles/S-7097-2019; Giagounidis, Aristoteles/ABE-3927-2020	Giagounidis, Aristoteles/0000-0003-4083-4109; LIST, ALAN/0000-0002-1647-2972				BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Bernasconi P, 2005, LEUKEMIA, V19, P1424, DOI 10.1038/sj.leu.2403806; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Cheson BD, 2000, BLOOD, V96, P3671; DEWALD GW, 1985, BLOOD, V66, P189; Giagounidis AAN, 2004, LEUKEMIA, V18, P113, DOI 10.1038/sj.leu.2403189; Greenberg, 1998, BLOOD, V91, P1100; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; LIST AF, 2005, HAEMATOLOGICA, V90, pA307; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; *NIH DIV CANC TREA, 1998, COMM TOX CRIT VERS 2; Oliva EN, 2005, LEUKEMIA RES, V29, P1217, DOI 10.1016/j.leukres.2005.03.004; Pedersen-Bjergaard J, 2002, BLOOD, V99, P1909, DOI 10.1182/blood.V99.6.1909; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199	18	942	978	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1456	1465		10.1056/NEJMoa061292	http://dx.doi.org/10.1056/NEJMoa061292			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021321				2022-12-28	WOS:000240976200007
J	Schilling, MM; Oeser, JK; Boustead, JN; Flemming, BP; O'Brien, RM				Schilling, Marcia M.; Oeser, James K.; Boustead, Jared N.; Flemming, Brian P.; O'Brien, Richard M.			Re-evaluating the FOXO1-PGC-1 alpha connection	NATURE			English	Letter							SUBUNIT GENE PROMOTER; PGC-1; GLUCONEOGENESIS; TRANSCRIPTION; COACTIVATORS		Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Schilling, MM (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.	richard.obrien@vanderbilt.edu						Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200	7	47	51	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2006	443	7111					E10	E11		10.1038/nature05288	http://dx.doi.org/10.1038/nature05288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024043				2022-12-28	WOS:000240988200033
J	Caughey, AB				Caughey, Aaron B.			Obesity, weight loss, and pregnancy outcomes	LANCET			English	Editorial Material							PREPREGNANCY WEIGHT; WOMEN; COHORT; BIRTH; RISK		Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Caughey, AB (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	abcmd@berkeley.edu			NICHD NIH HHS [HD01262] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Kac G, 2004, AM J CLIN NUTR, V79, P487; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Norman RJ, 2004, HUM REPROD UPDATE, V10, P267, DOI 10.1093/humupd/dmh018; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Rosenberg TJ, 2003, OBSTET GYNECOL, V102, P1022, DOI [10.1016/j.obstetgynecol.2003.07.005, 10.1016/S0029-7844(03)00878-0]; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stotland NE, 2004, OBSTET GYNECOL, V104, P671, DOI 10.1097/01.AOG.0000139515.97799.f6; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1136	1138		10.1016/S0140-6736(06)69451-8	http://dx.doi.org/10.1016/S0140-6736(06)69451-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089XU	17011927				2022-12-28	WOS:000240916000008
J	Nakamura, H; Arakawa, K; Itakura, H; Kitabatake, A; Goto, Y; Toyota, T; Nakaya, N; Nishimoto, S; Muranaka, M; Yamamoto, A; Mizuno, K; Ohashi, Y				Nakamura, Haruo; Arakawa, Kikuo; Itakura, Hiroshige; Kitabatake, Akira; Goto, Yoshio; Toyota, Takayoshi; Nakaya, Noriaki; Nishimoto, Shoji; Muranaka, Masaharu; Yamamoto, Akira; Mizuno, Kyoichi; Ohashi, Yasuo		MEGA Study Grp	Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial	LANCET			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; DOSE SIMVASTATIN; EVENTS; ATORVASTATIN; AVERAGE; RISK; STROKE; MEN	Background Evidence-based treatment for hypercholesterolaemia in Japan has been hindered by the lack of direct evidence in this population. Our aim was to assess whether evidence for treatment with statins derived from western populations can be extrapolated to the Japanese population. Methods In this prospective, randomised, open-labelled, blinded study, patients with hypercholesterolaemia (total cholesterol 5.69-6.98 mmol/L) and no history of coronary heart disease or stroke were randomly assigned diet or diet plus 10-20 mg pravastatin daily. The primary endpoint was the first occurrence of coronary heart disease. Statistical analyses were done by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT00211705. Findings 3966 patients were randomly assigned to the diet group and 3866 to the diet plus pravastatin group. Mean follow-up was 5.3 years. At the end of study, 471 and 522 patients had withdrawn, died, or been lost to follow-up in the diet and diet plus pravastatin groups, respectively. Mean total cholesterol was reduced by 2.1% (from 6.27 mmol/L to 6.13 mmol/L) and 11.5% (from 6.27 mmol/L to 5.55 mmol/L) and mean LDL cholesterol by 3.2% (from 4.05 mmol/L to 3.90 mmol/L) and 18.0% (from 4.05 mmol/L to 3.31 mmol/L) in the diet and the diet plus pravastatin groups, respectively. Coronary heart disease was significantly lower in the diet plus pravastatin group than in the diet alone group (66 events vs 101 events; HR 0.67, 95% CI 0.49-0.91; p=0.01). There was no difference in the incidence of malignant neoplasms or other serious adverse events between the two groups. Interpretation Treatment with a low dose of pravastatin reduces the risk of coronary heart disease in Japan by much the same amount as higher doses have shown in Europe and the USA.	Mitsukoshi Hlth & Welf Fdn, Shinjuku Ku, Tokyo 1600023, Japan; Fukuoka Univ, Fukuoka 81401, Japan; Ibaraki Christian Univ, Ibaraki, Japan; Hokkaido Univ, Postgrad Med Sch, Sapporo, Hokkaido, Japan; Tohoku Univ, Sendai, Miyagi 980, Japan; Tohoku Rosai Hosp, Sendai, Miyagi, Japan; Nakaya Clin, Tokyo, Japan; Kyushu Kosei Nenkin Hosp, Kitakyushu, Fukuoka, Japan; Yugawara Koseinenkin Hosp, Kanagawa, Japan; Natl Cardiovasc Ctr, Res Inst, Osaka, Japan; Chiba Hokuso Hosp, Nippon Med Sch, Chiba, Japan; Univ Tokyo, Dept Biostat Epidemiol & Prevent Hlth Sci, Tokyo, Japan	Fukuoka University; Hokkaido University; Tohoku University; National Cerebral & Cardiovascular Center - Japan; Nippon Medical School; University of Tokyo	Nakamura, H (corresponding author), Mitsukoshi Hlth & Welf Fdn, Shinjuku Ku, STEC Jyoho Bldg,1-24-1 Nishishinjuku, Tokyo 1600023, Japan.	nakamura@mhwf.or.jp	Hug, Balthasar L./G-1568-2010; Matsushita, Hiroshi/AFQ-0956-2022					*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; *AM HEART ASS, 2006, HEART STROK STAT 200; [Anonymous], 2000, J Atheroscler Thromb, V7, P110; [Anonymous], INT C HARM TECHN REQ; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2004, LANCET, V363, P757; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; KODAMA K, 1990, JPN CIRC J, V54, P414, DOI 10.1253/jcj.54.414; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Matsuzaki M, 2002, CIRC J, V66, P1087, DOI 10.1253/circj.66.1087; Nakamura H, 2004, CIRC J, V68, P860; *NAT CHOL ED PROGR, 1993, REP EXP PAN DET EV T; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; *WHO, 1996, WORLD HLTH STAT ANN	26	652	693	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1155	1163		10.1016/S0140-6736(06)69472-5	http://dx.doi.org/10.1016/S0140-6736(06)69472-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011942				2022-12-28	WOS:000240916000027
J	Christensen, K; Petersen, I; Skytthe, A; Herskind, AM; Mcgue, M; Bingley, P				Christensen, Kaare; Petersen, Inge; Skytthe, Axel; Herskind, Anne Maria; McGue, Matt; Bingley, Paul			Comparison of academic performance of twins and singletons in adolescence: follow-up study	BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE-ABILITY; BIRTH-WEIGHT; INTELLIGENCE; ACHIEVEMENT	Objectives To determine whether twins in recent cohorts show similar academic performance in adolescence to singletons and to test the effect of birth weight on academic performance in twins and singletons. Design Follow-up study. Setting Denmark. Participants All twins (D = 3411) and a 5% random sample of singletons (n = 7796) born in Denmark during 1986-8. Main outcome measures Test scores in ninth grade (age 15 or 16), birth weight, gestational age at birth, parents' age, and parents' education. Results Ninth grade test scores were normally distributed, with almost identical mean and standard deviations for twins and singletons (8.02 v 8.02 and 1.05 v 1.06) despite the twins weighing on average 908 9 (95% confidence interval 886 to 930 g) less,than the singletons at birth. Controlling for birth weight, gestational age at birth, age at test, and parents' age and education confirmed the similarity of test scores for twins and singletons (difference 0.04, 95% confidence interval - 0.03 to 0.10). A significant, positive association between test score and birth weight was observed in both twins and singletons, but the size of the effect was small: 0.06-0.12 standard deviations for every kilogram increase in birth weight. Conclusions Although older cohorts of twins have been found to have lower mean IQ scores than singletons, twins in recent Danish cohorts show similar academic performance in adolescence to that of singletons. Birth weight has a minimal effect on academic performance in recent cohorts; for twins this effect is best judged relative to what is a normal birth weight for twins and not for singletons.	Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; Odense Univ Hosp, Dept Paediat, Odense, Denmark; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Aarhus Sch Business, Dept Econ, Aarhus, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Aarhus University	Christensen, K (corresponding author), Univ So Denmark, Inst Hlth Sci, DK-5000 Odense C, Denmark.	kchristensen@health.sdu.dk	Christensen, Kaare/C-2360-2009; Skytthe, Axel E/G-4820-2019	Christensen, Kaare/0000-0002-5429-5292; Skytthe, Axel E/0000-0002-8629-4913	ESRC [RES-000-27-0200] Funding Source: UKRI; Economic and Social Research Council [RES-000-27-0200] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andersen TF, 1999, DAN MED BULL, V46, P263; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; BINGLEY P, 2005, SCH RESOURCES CURRIC; *DAN MIN ED, 2000, TESTS ASS TEACH OV E; Deary IJ, 2005, TWIN RES HUM GENET, V8, P376, DOI 10.1375/1832427054936709; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Naglieri JA, 2003, J PSYCHOEDUC ASSESS, V21, P244, DOI 10.1177/073428290302100302; Petersen JK, 2000, 15 U SO DENM DAN CTR; RECORD RG, 1970, ANN HUM GENET, V34, P11, DOI 10.1111/j.1469-1809.1970.tb00215.x; RONALDS GA, 2005, BMJ             1118, DOI DOI 10.1136/BMJ.38633.594387.3A; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Skytthe A, 2002, TWIN RES, V5, P352; WILCOX AJ, 2006, AM J EPIDEMIOL  0824	13	103	103	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 25	2006	333	7578					1095	1097		10.1136/bmj.38959.650903.7C	http://dx.doi.org/10.1136/bmj.38959.650903.7C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112IW	17012267	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000242520200015
J	Bhutta, ZA; Belgaumi, A; Rab, MA; Karrar, Z; Khashaba, M; Mouane, N				Bhutta, Zulfiqar A.; Belgaumi, Asim; Rab, Mohammad Abdur; Karrar, Zein; Khashaba, Mohamed; Mouane, Nezha			Child health and survival in the Eastern Mediterranean region	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONS; DEATHS		Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; King Faisal Specialist Hosp & Res Ctr, Dept Paediat, Sect Leukaemia & Lymphoma, Riyadh 11211, Saudi Arabia; WHO, Res Policy & Cooperat Unit, Eastern Mediterranean Reg, Cairo, Egypt; Sch Med, Dept Paediat, Khartoum, Sudan; Mansoura Childrens Hosp, Mansoura, Egypt; Hop Enfants, Unite Nutr, Serv Pediat 3, Rabat, Morocco	Aga Khan University; King Faisal Specialist Hospital & Research Center; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS72, DOI 10.1038/sj.jp.7211276; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, BRIT MED J, V329, P1151, DOI 10.1136/bmj.329.7475.1151; BHUTTA ZA, 2005, GLOBAL FORUM UPDATE, P107; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; HAINES A, IN PRESS LANCET; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Shadpour K, 2000, East Mediterr Health J, V6, P822; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; *TASK FORC CHILD H, 2005, WHOS GOT POW TRANSF; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNICEF, MON STAT WOM CHILDR; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WHO REG OFF E MED, 2006, COMM BAS IN SUCC STO; World Health Organization, WORLD HLTH REP 2005; WORLD HEALTH ORGANIZATION, 2006, SOCIAL DETERMINANTS; World Health Organization, STATISTICS	20	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					839	842		10.1136/bmj.38979.379641.68	http://dx.doi.org/10.1136/bmj.38979.379641.68			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053238	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000241678500017
J	Campbell, DB; Campbell, BA; Carter, LM; Margot, JL; Stacy, NJS				Campbell, Donald B.; Campbell, Bruce A.; Carter, Lynn M.; Margot, Jean-Luc; Stacy, Nicholas J. S.			No evidence for thick deposits of ice at the lunar south pole	NATURE			English	Article							WATER ICE; RADAR; MERCURY; SATELLITES; REGOLITH; SURFACE; MOON	Shackleton crater at the Moon's south pole has been suggested as a possible site of concentrated deposits of water ice, on the basis of modelling of bi-static radar polarization properties and interpretations of earlier Earth-based radar images(1,2). This suggestion, and parallel assumptions about other topographic cold traps, is a significant element in planning for future lunar landings. Hydrogen enhancements have been identified in the polar regions(3), but these data do not identify the host species or its local distribution. The earlier Earth-based radar data lack the resolution and coverage for detailed studies of the relationship between radar scattering properties, cold traps in permanently shadowed areas, and local terrain features such as the walls and ejecta of small craters. Here we present new 20-m resolution, 13-cm-wavelength radar images that show no evidence for concentrated deposits of water ice in Shackleton crater or elsewhere at the south pole. The polarization properties normally associated with reflections from icy surfaces in the Solar System(4-6) were found at all the observed latitudes and are strongly correlated with the rockstrewn walls and ejecta of young craters, including the inner wall of Shackleton. There is no correlation between the polarization properties and the degree of solar illumination. If the hydrogen enhancement observed by the Lunar Prospector orbiter(3) indicates the presence of water ice, then our data are consistent with the ice being present only as disseminated grains in the lunar regolith.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; Def Sci & Technol Org, Edinburgh, SA 5111, Australia	Cornell University; Smithsonian Institution; Defence Science & Technology	Campbell, DB (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	campbell@astro.cornell.edu	Carter, Lynn/D-2937-2012; Margot, Jean-Luc/A-6154-2012	Carter, Lynn/0000-0002-6245-4142; Margot, Jean-Luc/0000-0001-9798-1797				ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Benner LAM, 1997, ICARUS, V130, P296, DOI 10.1006/icar.1997.5834; Black G., 2004, B AM ASTRON SOC, V36, P1123; CAMPBELL BA, 1993, J GEOPHYS RES-PLANET, V98, P17099, DOI 10.1029/93JE01541; Campbell BA, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002425; Campbell BA, 2006, ICARUS, V180, P1, DOI 10.1016/j.icarus.2005.08.018; Campbell BA, 1999, J GEOPHYS RES-PLANET, V104, P1897, DOI 10.1029/1998JE900022; Campbell BA., 2002, RADAR REMOTE SENSING; CAMPBELL DB, 1978, ICARUS, V34, P254, DOI 10.1016/0019-1035(78)90166-5; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; HAPKE B, 1990, ICARUS, V88, P407, DOI 10.1016/0019-1035(90)90091-M; Harmon JK, 1999, J GEOPHYS RES-PLANET, V104, P14065, DOI 10.1029/1998JE900042; HARMON JK, 1992, SCIENCE, V258, P640, DOI 10.1126/science.258.5082.640; Harmon JK, 2001, ICARUS, V149, P1, DOI 10.1006/icar.2000.6544; Margot JL, 1999, SCIENCE, V284, P1658, DOI 10.1126/science.284.5420.1658; Nelson RM, 1998, ICARUS, V131, P223, DOI 10.1006/icar.1997.5850; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; SLADE MA, 1992, SCIENCE, V258, P635, DOI 10.1126/science.258.5082.635; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; Stacy NJS, 1997, SCIENCE, V276, P1527, DOI 10.1126/science.276.5318.1527; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zuber MT, 2005, SCIENCE, V310, P983, DOI 10.1126/science.1115126	24	110	112	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					835	837		10.1038/nature05167	http://dx.doi.org/10.1038/nature05167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051213				2022-12-28	WOS:000241362700046
J	Chan, DKY				Chan, Danel Kam Yin			Obturator hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bankstown Hosp, Bankstown, NSW 2200, Australia		Chan, DKY (corresponding author), Bankstown Hosp, Bankstown, NSW 2200, Australia.	Daniel.chan@swsahs.nsw.gov.au							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1714	1714		10.1056/NEJMicm050862	http://dx.doi.org/10.1056/NEJMicm050862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050895				2022-12-28	WOS:000241357300012
J	Tagbor, H; Bruce, J; Browne, E; Randal, A; Greenwood, B; Chandramohan, D				Tagbor, Harry; Bruce, Jane; Browne, Edmund; Randal, Anna; Greenwood, Brian; Chandramohan, Daniel			Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial	LANCET			English	Article							INDUCED AGRANULOCYTOSIS; PLASMODIUM-FALCIPARUM; CHLOROQUINE	Background The widespread increase in resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine threatens the use of these drugs for malaria treatment in pregnancy. We aimed to assess the safety and efficacy of amodiaquine alone or in combination with sulphadoxine-pyrimethamine as alternative regimens. Methods Pregnant women with a gestational age of 16 weeks or more who attended antenatal clinics at a district hospital in Ghana were screened for malaria with OptiMAL dipsticks. 900 pregnant women who had a positive test result and P falciparum asexual stage parasitaemia were enrolled and randomly assigned chloroquine, sulphadoxine-pyrimethamine, amodiaquine, or amodiaquine plus sulphadoxine-pyrimethamine. The primary outcome was parasitological failure by day 28 of treatment. Women were seen on days 3, 7, 14, and 28 after the start of treatment to assess the effect of treatment on peripheral parasitaemia, haemoglobin concentration, white-blood-cell count, and liver function. Additionally, reports of adverse effects were solicited and monitored during follow-up visits. Analysis was by intention to treat. This trial is registered with the US National Institute of Health clinical trials database number NCT00131703. Findings PCR-corrected parasitological failure by day 28 was 14%, 11%, 3%, and 0% in the women assigned chloroquine, sulphadoxine-pyrimethamine, amodiaquine, and amodiaquine plus sulphadoxine-pyrimethamine, respectively (p<0.0001). No serious liver toxic effects or white-blood-cell dyscrasias were noted. Minor side-effects were reported more often on day 3 by women receiving amodiaquine (86%) or amodiaquine plus sulphadoxine-pyrimethamine (90%) than those receiving sulphadoxine-pyrimethamine (48%) or no antimalarial drugs (34%; p<0.0001 for every comparison). Interpretation Amodiaquine alone or in combination with sulphadoxine-pyrimethamine, although associated with minor side-effects, is effective when used to treat malaria in pregnancy.	St Theresas Hosp, Nkoranza, BA, Ghana; Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine	Tagbor, H (corresponding author), St Theresas Hosp, POB 30, Nkoranza, BA, Ghana.	Harry.Tagbor@lshtm.ac.uk	Tagbor, Harry/B-9312-2018	Tagbor, Harry/0000-0002-9300-665X				[Anonymous], 2004, STRATEGIC FRAMEWORK; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; GARNER P, 2000, COCHRANE DB SYST REV, V2; HATTON CSR, 1986, LANCET, V1, P411; KOLLARITSCH H, 1988, T ROY SOC TROP MED H, V82, P524, DOI 10.1016/0035-9203(88)90492-0; MARFO C, 2001, GHANA MALARIA BASELI; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Mengesha T, 1999, E AFR MED J, V76, P314; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Muller O, 1996, TROP MED INT HEALTH, V1, P124, DOI 10.1046/j.1365-3156.1996.d01-13.x; NAING T, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P253; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Oduro AR, 2005, TROP MED INT HEALTH, V10, P279, DOI 10.1111/j.1365-3156.2004.01382.x; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; RHODES EGH, 1986, BRIT MED J, V292, P717, DOI 10.1136/bmj.292.6522.717; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; STEKETEE RW, 1987, B WORLD HEALTH ORGAN, V65, P885; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; STURCHLER D, 1987, J TROP MED HYG, V90, P239; Thomas F, 2004, LANCET INFECT DIS, V4, P235, DOI 10.1016/S1473-3099(04)00974-0; World Health Organization, 2003, WHOCDSMAL20031094	24	60	63	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1349	1356		10.1016/S0140-6736(06)69559-7	http://dx.doi.org/10.1016/S0140-6736(06)69559-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046467				2022-12-28	WOS:000241388100031
J	Carpenter, SR; DeFries, R; Dietz, T; Mooney, HA; Polasky, S; Reid, WV; Scholes, RJ				Carpenter, Stephen R.; DeFries, Ruth; Dietz, Thomas; Mooney, Harold A.; Polasky, Stephen; Reid, Walter V.; Scholes, Robert J.			Millennium Ecosystem Assessment: Research needs	SCIENCE			English	Editorial Material							SCIENCE; POLICY		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Maryland, Dept Geog, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; CSIR, ZA-0001 Pretoria, South Africa	Stanford University; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Michigan State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Council for Scientific & Industrial Research (CSIR) - South Africa	Mooney, HA (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	hmooney@stanford.edu	Polasky, Stephen/AAC-5341-2019; Carpenter, Stephen/AAQ-6404-2020	Dietz, Thomas/0000-0001-9399-0784; Scholes, Robert/0000-0001-5537-6935				[Anonymous], 2005, EC HUM WELL BEING SY; CAMPBELL DT, 1969, AM PSYCHOL, V24, P409, DOI 10.1037/h0027982; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; John Heinz H., 2002, STAT NAT EC MEAS LAN; Kinzig AP, 2003, AMBIO, V32, P330, DOI 10.1639/0044-7447(2003)032[0330:CWUACF]2.0.CO;2; McNeely JA, 2005, ECOSYSTEMS HUMAN WEL, V3, P119; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GL; National Research Council, 2004, VAL EC SERV BETT ENV; National Research Council, 2000, EC IND NAT; Ostrom E., 2002, DRAMA COMMONS; Sarewitz D.R., 2000, PREDICTION SCI DECIS; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; SIZER N, 2005, ECOSYSTEMS HUMAN WEL, V3, P257; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068	15	343	373	34	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					257	258		10.1126/science.1131946	http://dx.doi.org/10.1126/science.1131946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093TV	17038608				2022-12-28	WOS:000241194100025
J	Neumann, M; Sampathu, DM; Kwong, LK; Truax, AC; Micsenyi, MC; Chou, TT; Bruce, J; Schuck, T; Grossman, M; Clark, CM; McCluskey, LF; Miller, BL; Masliah, E; Mackenzie, IR; Feldman, H; Feiden, W; Kretzschmar, HA; Trojanowski, JQ; Lee, VMY				Neumann, Manuela; Sampathu, Deepak M.; Kwong, Linda K.; Truax, Adam C.; Micsenyi, Matthew C.; Chou, Thomas T.; Bruce, Jennifer; Schuck, Theresa; Grossman, Murray; Clark, Christopher M.; McCluskey, Leo F.; Miller, Bruce L.; Masliah, Eliezer; Mackenzie, Ian R.; Feldman, Howard; Feiden, Wolfgang; Kretzschmar, Hans A.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis	SCIENCE			English	Article							NUCLEAR FACTOR TDP-43; MOTOR-NEURON DISEASE; DEMENTIA; TAU; CHROMOSOME-17; MUTATIONS; GENE; EXON-9; FAMILY; 17Q21	Ubiquitin-positive, tau- and alpha-synuclein - negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Although the identity of the ubiquitinated protein specific to either disorder was unknown, we showed that TDP-43 is the major disease protein in both disorders. Pathologic TDP-43 was hyperphosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments and was recovered only from affected central nervous system regions, including hippocampus, neocortex, and spinal cord. TDP-43 represents the common pathologic substrate linking these neurodegenerative disorders.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Alzheimers Dis Core Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Univ San Francisco, Dept Neurol, San Francisco, CA 94117 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; Univ Saarland, Inst Neuropathol, D-66421 Homburg, Germany; Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of San Francisco; University of California System; University of California San Diego; University of British Columbia; University of British Columbia; Saarland University; University of Munich	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057; Feldman, Howard/0000-0002-9258-4538	NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG019724, T32AG000255, P01AG017586] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG00255, P01 AG019724, AG17586, AG10124] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; SAMPATHU DM, IN PRESS AM J PATHOL; Shi J, 2005, ACTA NEUROPATHOL, V110, P501, DOI 10.1007/s00401-005-1079-4; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099	27	4235	4359	11	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					130	133		10.1126/science.1134108	http://dx.doi.org/10.1126/science.1134108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023659				2022-12-28	WOS:000241031200052
J	Tsao, D				Tsao, Doris			A dedicated system for processing faces	SCIENCE			English	Editorial Material							NEURONS; MACAQUE; CORTEX; PERCEPTION; AREA		Univ Bremen, Inst Brain Res, D-28359 Bremen, Germany; Univ Bremen, Ctr Adv Imaging, D-28359 Bremen, Germany	University of Bremen; University of Bremen	Tsao, D (corresponding author), Univ Bremen, Inst Brain Res, D-28359 Bremen, Germany.	doris@nmr.mgh.harvard.edu						BAYLIS GC, 1987, J NEUROSCI, V7, P330; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Kanwisher N, 1997, J NEUROSCI, V17, P4302; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111	9	9	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					72	73		10.1126/science.1135163	http://dx.doi.org/10.1126/science.1135163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023644				2022-12-28	WOS:000241031200035
J	Storchova, Z; Breneman, A; Cande, J; Dunn, J; Burbank, K; O'Toole, E; Pellman, D				Storchova, Zuzana; Breneman, Amanda; Cande, Jessica; Dunn, Joshua; Burbank, Kendra; O'Toole, Eileen; Pellman, David			Genome-wide genetic analysis of polyploidy in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BI-ORIENTATION; SISTER CHROMATIDS; MITOTIC SPINDLE; BUDDING YEAST; RECOMBINATION; PROTEIN; EVOLUTION; TENSION; KINASE	Polyploidy, increased sets of chromosomes, occurs during development, cellular stress, disease and evolution. Despite its prevalence, little is known about the physiological alterations that accompany polyploidy. We previously described 'ploidy-specific lethality', where a gene deletion that is not lethal in haploid or diploid budding yeast causes lethality in triploids or tetraploids. Here we report a genome-wide screen to identify ploidy-specific lethal functions. Only 39 out of 3,740 mutations screened exhibited ploidy-specific lethality. Almost all of these mutations affect genomic stability by impairing homologous recombination, sister chromatid cohesion, or mitotic spindle function. We uncovered defects in wild-type tetraploids predicted by the screen, and identified mechanisms by which tetraploidization affects genomic stability. We show that tetraploids have a high incidence of syntelic/monopolar kinetochore attachments to the spindle pole. We suggest that this defect can be explained by mismatches in the ability to scale the size of the spindle pole body, spindle and kinetochores. Thus, geometric constraints may have profound effects on genome stability; the phenomenon described here may be relevant in a variety of biological contexts, including disease states such as cancer.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Dept Phys, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol Oncol, Childrens Hosp, Boston, MA 02115 USA; Univ Colorado, Boulder Lab 3D Elect Microscopy Cells, Boulder, CO 80309 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Boulder	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu		Dunn, Joshua/0000-0003-4476-7257; Storchova, Zuzana/0000-0003-2376-7047				AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Akhmanova A, 2005, GENE DEV, V19, P2501, DOI 10.1101/gad.344505; Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; BYERS B, 1973, COLD SPRING HARB SYM, V38, P123, DOI 10.1101/SQB.1974.038.01.016; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Dong Z, 2003, NUCLEIC ACIDS RES, V31, P2576, DOI 10.1093/nar/gkg352; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; KADYK LC, 1992, GENETICS, V132, P387; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Klein HL, 1997, GENETICS, V147, P1533; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; MAYER VW, 1992, MUTAT RES, V279, P41, DOI 10.1016/0165-1218(92)90264-Z; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Melo JA, 2001, GENE DEV, V15, P2809; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Raderschall E, 2002, CANCER RES, V62, P219; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WHELAN WL, 1979, GENETICS, V91, P35; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655	47	257	266	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					541	547		10.1038/nature05178	http://dx.doi.org/10.1038/nature05178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024086				2022-12-28	WOS:000240988200036
J	Gornall, J				Gornall, Jonathan			Professional regulation - The path to safer patients	BRITISH MEDICAL JOURNAL			English	Editorial Material							GMC; REVALIDATION; EXPEDIENCY; PRINCIPLE; DOCTORS					Jgornall@mac.com						BARKHAM P, 2002, TIMES           0720; *BMA, 2006, HOSP DOCT JUN DOCT H; BOSELEY S, 2006, GUARDIAN        0715; BROWSE N, 1998, SELF REGULATION CLIN; *DEP HLTH, 2006, PROV COST EST REC MA; *DEP HLTH, 2000, GOOD DOCT SAF PAT; DONALDSON LJ, 1994, BRIT MED J, V308, P1277, DOI 10.1136/bmj.308.6939.1277; Flin R, 2005, SAFE THEIR HANDS LIC; Hamilton P, 2006, BRIT MED J, V333, P262, DOI 10.1136/bmj.333.7561.262-b; HARMER M, 2006, ANAESTHESIA NEWS SEP, P8; HAWKES N, 2006, TIMES           0913; Irvine D., 2003, DOCTORS TALE PROFESS; Jackson CA, 2006, OCCUP MED-OXFORD, V56, P263, DOI 10.1093/occmed/kql021; Johnson J, 2005, BRIT MED J, V330, P252, DOI 10.1136/bmj.330.7485.252; LAURANCE J, 2006, INDEPENDENT     0715; Macara AW, 2005, BMJ-BRIT MED J, V330, P252, DOI 10.1136/bmj.330.7485.252-c; *MORI, 2005, ATT MED REG REV DOCT; *PEN MED SCH, GMC PAT COLL QUEST S; Pringle M, 2006, BRIT MED J, V333, P161, DOI 10.1136/bmj.333.7560.161; Rathbone A, 2006, BRIT J GEN PRACT, V56, P719; Smith R, 2005, BRIT MED J, V330, P1, DOI 10.1136/bmj.330.7481.1; Southgate L, 1999, BMJ-BRIT MED J, V319, P1180, DOI 10.1136/bmj.319.7218.1180; Tallis R, 2004, HIPPOCRATIC OATHS ME; TIMMINS N, 2006, FIANNCIAL TIMES 0923; Toynbee P, 2002, BRIT MED J, V325, P718, DOI 10.1136/bmj.325.7366.718; Turner JJ, 2005, BRIT MED J, V330, P252, DOI 10.1136/bmj.330.7485.252-a; *WORK PART ROYAL C, 2005, CLIN MED S1, V5	27	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 28	2006	333	7574					906	911		10.1136/bmj.39008.535162.94	http://dx.doi.org/10.1136/bmj.39008.535162.94			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	101WT	17068037	Green Published			2022-12-28	WOS:000241772600021
J	Chipman, A				Chipman, Andrea			Capital gains	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					897	897		10.1038/443897a	http://dx.doi.org/10.1038/443897a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066002	Bronze			2022-12-28	WOS:000241523400013
J	Robert, F; Chaussidon, M				Robert, Francois; Chaussidon, Marc			A palaeotemperature curve for the Precambrian oceans based on silicon isotopes in cherts	NATURE			English	Article							GEOCHEMISTRY; RATIOS; MICROFOSSILS; TEMPERATURE; SOLUBILITY; EVOLUTION; DIATOMS	The terrestrial sediment record indicates that the Earth's climate varied drastically in the Precambrian era ( before 550 million years ago), ranging from surface temperatures similar to or higher than today's to global glaciation events(1). The most continuous record of sea surface temperatures of that time has been derived from variations in oxygen isotope ratios of cherts (siliceous sediments)(2), but the long-term cooling of the oceans inferred from those data(3-5) has been questioned because the oxygen isotope signature could have been reset through the exchange with hydrothermal fluids after deposition of the sediments(6). Here we show that the silicon isotopic composition of cherts more than 550 million years old shows systematic variations with age that support the earlier conclusion of long-term ocean cooling and exclude post-depositional exchange as the main source of the isotopic variations. In agreement with other lines of evidence(1,7), a model of the silicon cycle in the Precambrian era shows that the observed silicon isotope variations imply seawater temperature changes from about 70 degrees C 3,500 million years ago to about 20 degrees C 800 million years ago.	Museum Natl Hist Nat, CNRS, LEME Nanoanal, UMS 2679, F-75005 Paris, France; Ctr Rech Petrog & Geochim, CRPG, CNRS, F-54501 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Robert, F (corresponding author), Museum Natl Hist Nat, CNRS, LEME Nanoanal, UMS 2679, 57 Rue Cuvier, F-75005 Paris, France.	robert@mnhn.fr; chocho@crpg.cnrs-nancy.fr	Chaussidon, Marc/E-7067-2017					ALLISON CW, 1989, PRECAMBRIAN RES, V43, P253, DOI 10.1016/0301-9268(89)90060-0; [Anonymous], 1996, SILICON ISOTOPE GEOC; [Anonymous], 1962, AAPG B; AWRAMIK SM, 1985, NATURE, V315, P655, DOI 10.1038/315655a0; Basile-Doelsch I, 2005, NATURE, V433, P399, DOI 10.1038/nature03217; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; De la Rocha CL, 2000, GEOCHIM COSMOCHIM AC, V64, P2467, DOI 10.1016/S0016-7037(00)00373-2; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ding T, 2004, GEOCHIM COSMOCHIM AC, V68, P205, DOI 10.1016/S0016-7037(03)00264-3; DOUTHITT CB, 1982, GEOCHIM COSMOCHIM AC, V46, P1449, DOI 10.1016/0016-7037(82)90278-2; Gunnarsson I, 2000, GEOCHIM COSMOCHIM AC, V64, P2295, DOI 10.1016/S0016-7037(99)00426-3; Jiang SY, 1997, CHEM GEOL, V135, P189, DOI 10.1016/S0009-2541(96)00115-5; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; Karpeta W.P., 1989, S AFR J GEOL, V92, P29; Kasting JF, 2005, PRECAMBRIAN RES, V137, P119, DOI 10.1016/j.precamres.2005.03.002; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Knauth LP, 2005, PALAEOGEOGR PALAEOCL, V219, P53, DOI 10.1016/j.palaeo.2004.10.014; KNAUTH LP, 1978, EARTH PLANET SC LETT, V41, P209, DOI 10.1016/0012-821X(78)90011-0; KOLODNY Y, 1976, GEOCHIM COSMOCHIM AC, V40, P1195, DOI 10.1016/0016-7037(76)90155-1; Lowe DR, 2004, GEOLOGY, V32, P493, DOI 10.1130/G20342.1; RIMSTIDT JD, 1980, GEOCHIM COSMOCHIM AC, V44, P1683, DOI 10.1016/0016-7037(80)90220-3; Rollion-Bard C, 2003, EARTH PLANET SC LETT, V215, P275, DOI 10.1016/S0012-821X(03)00391-1; SCHOPF J.W., 1992, PROTEROZOIC BIOSPHER; Schopf JW, 1983, EARTHS EARLIEST BIOS; SIEVER R, 1992, GEOCHIM COSMOCHIM AC, V56, P3265, DOI 10.1016/0016-7037(92)90303-Z; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; VONDAMM KL, 1991, AM J SCI, V291, P977, DOI 10.2475/ajs.291.10.977; Ziegler K, 2005, GEOCHIM COSMOCHIM AC, V69, P4597, DOI 10.1016/j.gca.2005.05.008	30	281	304	6	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					969	972		10.1038/nature05239	http://dx.doi.org/10.1038/nature05239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066030				2022-12-28	WOS:000241523400049
J	Sibai, AM; Sen, K				Sibai, Abla-Mehio; Sen, Kasturi			Can Lebanon conjure a public health phoenix from the ashes?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, Beirut, Lebanon; Int NGO Training & Res Ctr, Oxford OX2 6RZ, England	American University of Beirut	Sibai, AM (corresponding author), Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Fac Hlth Sci, POB 11-0236, Beirut, Lebanon.	ansibai@aub.edu.lb		Sibai, Abla/0000-0002-1851-5606				Ammar W., 2000, LEBANON NATL HLTH AC; Ammar W., 2003, HLTH SYSTEM REFORM L; HARIK J, 1994, PUBLIC SOCIAL SERVIC, V14; KRONFOL N M, 1989, Journal of Public Health Policy, V10, P377, DOI 10.2307/3342798; MECHBEL A, 1997, HLTH CARE REFORM FRO, P120; SIBAI AM, 2004, BMJ MIDDLE E, V11, P6; Van Lerberghe W, 1997, HEALTH POLICY PLANN, V12, P296, DOI 10.1093/heapol/12.4.296	7	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 21	2006	333	7573					848	849		10.1136/bmj.38996.466678.68	http://dx.doi.org/10.1136/bmj.38996.466678.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053244	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000241678500022
J	Dorrello, NV; Peschiaroli, A; Guardavaccaro, D; Colburn, NH; Sherman, NE; Pagano, M				Dorrello, N. Valerio; Peschiaroli, Angelo; Guardavaccaro, Daniele; Colburn, Nancy H.; Sherman, Nicholas E.; Pagano, Michele			S6K1- and beta TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth	SCIENCE			English	Article							INITIATION-FACTOR 4A; SUPPRESSOR PDCD4; TRANSFORMATION; NUTRIENT; BINDING; KINASE; TARGET	The tumor suppressor programmed cell death protein 4 (PDCD4) inhibits the translation initiation factor eIF4A, an RNA helicase that catalyzes the unwinding of secondary structure at the 5' untranslated region (5'UTR) of messenger RNAs (mRNAs). In response to mitogens, PDCD4 was rapidly phosphorylated on Ser(67) by the protein kinase S6K1 and subsequently degraded via the ubiquitin ligase SCF beta TRCP. Expression in cultured cells of a stable PDCD4 mutant that is unable to bind beta TRCP inhibited translation of an mRNA with a structured 5' UTR, resulted in smaller cell size, and slowed down cell cycle progression. We propose that regulated degradation of PDCD4 in response to mitogens allows efficient protein synthesis and consequently cell growth.	NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; NCI, Lab Canc Prevent, Frederick, MD 21702 USA; Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA 22908 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@med.nyu.edu		Sherman, Nicholas/0000-0003-3206-3113; pagano, michele/0000-0003-3210-2442; PESCHIAROLI, ANGELO/0000-0001-6311-2382; Guardavaccaro, Daniele/0000-0002-4517-1765	NATIONAL CANCER INSTITUTE [R01CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA76584] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	16	532	556	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					467	471		10.1126/science.1130276	http://dx.doi.org/10.1126/science.1130276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053147				2022-12-28	WOS:000241382500043
J	Shen, YY; Wang, XF; Wu, FQ; Du, SY; Cao, Z; Shang, Y; Wang, XL; Peng, CC; Yu, XC; Zhu, SY; Fan, RC; Xu, YH; Zhang, DP				Shen, Yuan-Yue; Wang, Xiao-Fang; Wu, Fu-Qing; Du, Shu-Yuan; Cao, Zheng; Shang, Yi; Wang, Xiu-Ling; Peng, Chang-Cao; Yu, Xiang-Chun; Zhu, Sai-Yong; Fan, Ren-Chun; Xu, Yan-Hong; Zhang, Da-Peng			The Mg-chelatase H subunit is an abscisic acid receptor	NATURE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; PROTEIN PHOSPHATASE 2C; BINDING PROTEIN; ARABIDOPSIS; GENE; ENCODES; MUTANT; ABI1; ACCUMULATION; REGULATOR	Abscisic acid (ABA) is a vital phytohormone that regulates mainly stomatal aperture and seed development, but ABA receptors involved in these processes have yet to be determined. We previously identified from broad bean an ABA-binding protein (ABAR) potentially involved in stomatal signalling, the gene for which encodes the H subunit of Mg-chelatase (CHLH), which is a key component in both chlorophyll biosynthesis and plastid-to-nucleus signalling. Here we show that Arabidopsis ABAR/CHLH specifically binds ABA, and mediates ABA signalling as a positive regulator in seed germination, post-germination growth and stomatal movement, showing that ABAR/CHLH is an ABA receptor. We show also that ABAR/CHLH is a ubiquitous protein expressed in both green and non-green tissues, indicating that it might be able to perceive the ABA signal at the whole-plant level.	China Agr Univ, China State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Zhang, DP (corresponding author), China Agr Univ, China State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zhangdp@sohu.net						Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; HORNBERG C, 1984, NATURE, V310, P321, DOI 10.1038/310321a0; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Walker CJ, 1997, BIOCHEM J, V327, P321; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	34	387	466	6	280	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					823	826		10.1038/nature05176	http://dx.doi.org/10.1038/nature05176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051210				2022-12-28	WOS:000241362700043
J	Charo, RA				Charo, R. Alta			Body of research - Ownership and use of human tissue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Andrews L, 2006, J LAW MED ETHICS, V34, P398, DOI 10.1111/j.1748-720X.2006.00046.x; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; Winickoff DE, 2003, NEW ENGL J MED, V349, P1180, DOI 10.1056/NEJMsb030036	3	79	80	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1517	1519		10.1056/NEJMp068192	http://dx.doi.org/10.1056/NEJMp068192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035644				2022-12-28	WOS:000241160400001
J	Tuomilehto, J; Wareham, N				Tuomilehto, Jaakko; Wareham, Nicholas			Glucose lowering and diabetes prevention: are they the same?	LANCET			English	Editorial Material							LIFE-STYLE; TYPE-2; MELLITUS		Elsie Widdowson Lab, MRC, Epidemiol Unit, Cambridge, England; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Helsinki	Tuomilehto, J (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.	jaakko.tuomilehto@ktl.fi						Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *DREAM TRIAL INV, 2006, LANCET          0915, DOI DOI 10.1016/S0140-6736(06)69420-8; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; FOROUHI NG, IN PRESS DIABET MED; HERMAN WH, 2005, ANN INTERN MED, V346, P393; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Muhlhauser I, 2006, DIABETOLOGIA, V49, P1742, DOI 10.1007/s00125-006-0290-8; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	13	23	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1218	1219		10.1016/S0140-6736(06)69421-X	http://dx.doi.org/10.1016/S0140-6736(06)69421-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027710				2022-12-28	WOS:000241058300007
J	Han, TS; Sattar, N; Lean, M				Han, Thang S.; Sattar, Naveed; Lean, Mike			ABC of obesity - Assessment of obesity and its clinical implications	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WAIST CIRCUMFERENCE		UCL Hosp, Dept Endocrinol & Diabet, London, England; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Glasgow	Han, TS (corresponding author), UCL Hosp, Dept Endocrinol & Diabet, London, England.	nsattar@clinmed.gla.ac.uk		Han, Thang/0000-0003-2570-0938				Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Han TS, 1996, BRIT MED J, V312, P1227; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; 2000, PRACT GUID ID EV TRE; WHO, 2004, LANCET, V363, P902; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	8	92	93	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					695	698		10.1136/bmj.333.7570.695	http://dx.doi.org/10.1136/bmj.333.7570.695			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	17008674	Green Published			2022-12-28	WOS:000241068200028
J	Groves, JT				Groves, Jay T.			Unveiling the membrane domains	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY		Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov						Caldwell RL, 2005, MOL CELL PROTEOMICS, V4, P394, DOI 10.1074/mcp.R500006-MCP200; Chaurand P, 2005, TOXICOL PATHOL, V33, P92, DOI 10.1080/01926230590881862; Connell SD, 2006, MOL MEMBR BIOL, V23, P17, DOI 10.1080/09687860500501158; Heeren RMA, 2005, PROTEOMICS, V5, P4316, DOI 10.1002/pmic.200500406; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f; Yeo WS, 2005, ANGEW CHEM INT EDIT, V44, P5480, DOI 10.1002/anie.200501363	8	5	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1901	1902		10.1126/science.1133760	http://dx.doi.org/10.1126/science.1133760			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008517				2022-12-28	WOS:000240832200035
J	Fischbach, MA; Walsh, CT				Fischbach, Michael A.; Walsh, Christopher T.			Biochemistry - Directing biosynthesis	SCIENCE			English	Editorial Material							PEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; ASSEMBLY-LINE		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Fischbach, Michael/0000-0003-3079-8247				Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; Kopp F, 2006, BIOCHEMISTRY-US, V45, P10474, DOI 10.1021/bi0609422; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miao V, 2006, CHEM BIOL, V13, P269, DOI 10.1016/j.chembiol.2005.12.012; Murata M, 2000, NAT PROD REP, V17, P293, DOI 10.1039/a901979k; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; *ROYAL SOC CHEM, 2004, ROYAL SOC CHEM C DIR; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	15	17	18	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					603	605		10.1126/science.1132692	http://dx.doi.org/10.1126/science.1132692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068249				2022-12-28	WOS:000241557800031
J	Chung, RT; Misdraji, J; Sahani, DV; Goldfinger, SE				Chung, Raymond T.; Misdraji, Joseph; Sahani, Dushyant V.; Goldfinger, Stephen E.			A man with diabetes, hypogonadism, cirrhosis, arthralgias, and fatigue - Hereditary hemochromatosis due to a homozygous C282Y mutation in the HFE gene, with hepatic cirrhosis, diabetes, and hypogonadism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IRON OVERLOAD; LIVER; EXPRESSION; MANAGEMENT; HEPCIDIN; DISEASE		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Chung, RT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.		Misdraji, Joseph/AAD-4588-2019; Misdraji, Joseph/AGX-4779-2022					Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Blanc JF, 1999, J HEPATOL, V30, P325, DOI 10.1016/S0168-8278(99)80080-4; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; Brunt EM, 2000, AM J GASTROENTEROL, V95, P1788; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Calonge N, 2006, ANN INTERN MED, V145, P204, DOI 10.7326/0003-4819-145-3-200608010-00008; *CDCP, 2006, IR OV HEM HOM; CUTLER P, 1994, CAN J PSYCHIAT, V39, P8, DOI 10.1177/070674379403900104; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; DEUGNIER YM, 1993, HEPATOLOGY, V18, P1363, DOI 10.1002/hep.1840180613; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; SEARLE J, 2002, PATHOLOGY LIVER, P257; Tavill AS, 2001, HEPATOLOGY, V33, P1321, DOI 10.1053/jhep.2001.24783; Turlin B, 1998, SEMIN DIAGN PATHOL, V15, P237	20	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1812	1819		10.1056/NEJMcpc069024	http://dx.doi.org/10.1056/NEJMcpc069024			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065644				2022-12-28	WOS:000241512500013
J	Puck, JM; Candotti, F				Puck, Jennifer M.; Candotti, Fabio			Lessons from the Wiskott-Aldrich syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Puck, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.			Candotti, Fabio/0000-0001-6399-6042	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000122, ZIAHG000122] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	24	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1759	1761		10.1056/NEJMp068209	http://dx.doi.org/10.1056/NEJMp068209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065636				2022-12-28	WOS:000241512500003
J	Tarchini, B; Duboule, D; Kmita, M				Tarchini, Basile; Duboule, Denis; Kmita, Marie			Regulatory constraints in the evolution of the tetrapod limb anterior-posterior polarity	NATURE			English	Article							POSITIVE FEEDBACK LOOP; SONIC-HEDGEHOG; VERTEBRATE LIMB; HOXD COMPLEX; GENES; ZPA; BUD; EXPRESSION; FORELIMB; GROWTH	The anterior to posterior (A - P) polarity of the tetrapod limb is determined by the confined expression of Sonic hedgehog (Shh) at the posterior margin of developing early limb buds(1,2), under the control of HOX proteins encoded by gene members of both the HoxA and HoxD clusters(3-6). Here, we use a set of partial deletions to show that only the last four Hox paralogy groups can elicit this response: that is, precisely those genes whose expression is excluded from most anterior limb bud cells owing to their collinear transcriptional activation. We propose that the limb A - P polarity is produced as a collateral effect of Hox gene collinearity, a process highly constrained by its crucial importance during trunk development. In this view, the co-option of the trunk collinear mechanism, along with the emergence of limbs, imposed an A - P polarity to these structures as the most parsimonious solution. This in turn further contributed to stabilize the architecture and operational mode of this genetic system.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	denis.duboule@zoo.unige.ch	kmita, marie/AAU-9620-2020	Kmita, Marie/0000-0003-4021-0478; Tarchini, Basile/0000-0003-2708-6273; duboule, denis/0000-0001-9961-2960				Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; COATES MI, 1994, DEVELOPMENT S, V120, P169; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; INOUYE M, 1976, Congenital Anomalies, V16, P171; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2000, GENE DEV, V14, P198; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	27	97	101	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					985	988		10.1038/nature05247	http://dx.doi.org/10.1038/nature05247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066034				2022-12-28	WOS:000241523400053
J	Gottesman, D				Gottesman, Daniel			Physics: Jump-starting quantum error correction with entanglement	SCIENCE			English	Editorial Material							PARITY-CHECK CODES		Perimeter Inst, Waterloo, ON N2L 2Y5, Canada	Perimeter Institute for Theoretical Physics	Gottesman, D (corresponding author), Perimeter Inst, Waterloo, ON N2L 2Y5, Canada.	dgottesman@perimeterinstitute.ca						Brun T, 2006, SCIENCE, V314, P436, DOI 10.1126/science.1131563; Calderbank AR, 1998, IEEE T INFORM THEORY, V44, P1369, DOI 10.1109/18.681315; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; GALLAGER RG, 1962, IRE T INFORM THEOR, V8, P21, DOI 10.1109/tit.1962.1057683	5	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					427	428		10.1126/science.1133797	http://dx.doi.org/10.1126/science.1133797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053134				2022-12-28	WOS:000241382500026
J	Hsu, HH; Chung, KM; Chen, TC; Chang, BY				Hsu, Hsin-Hsien; Chung, Kuei-Min; Chen, Tsung-Ching; Chang, Ban-Yang			RETRACTED: Role of the sigma factor in transcription initiation in the absence of core RNA polymerase (Retracted Article. See vol 128, pg 211, 2007)	CELL			English	Article; Retracted Publication							ESCHERICHIA-COLI SIGMA(70); AROMATIC-AMINO-ACIDS; PROMOTER OPEN COMPLEX; BACILLUS-SUBTILIS; REGION 3; ABORTIVE TRANSCRIPTION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; R PROMOTER; START SITE	Sigma factors (sigma s) are bacterial transcription factors that bind core RNA polymerase (RNAP) and direct transcription initiation at cognate promoter sites. However, most of their functions have been investigated in the context of RNAP. This has made the exact function of a, and the importance of core RNAP in modulating a function, ambiguous. Here we identify a Bacillus subtilis mutant sigma(A) that is independently capable of specific binding and melting of the promoter DNA. Interestingly, specific and independent promoter binding of a is sufficient for the temperature- and Mg2+-independent melting of promoter DNA around the transcription start site, in contrast to the temperature- and Mg2+-dependent melting by RNAP around the promoter -10 element. Thus core RNAP is able to negatively modulate the sigma-initiated melting of the transcription start site and, by sensing the changes in temperature and Mg2+ concentration, to regulate the efficiency of promoter -10 melting.	Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan	National Chung Hsing University	Chang, BY (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	bychang@mail.nchu.edu.tw						Borukhov S, 2002, RES MICROBIOL, V153, P557, DOI 10.1016/S0923-2508(02)01368-2; Brodolin K, 2005, J MOL BIOL, V350, P930, DOI 10.1016/j.jmb.2005.05.048; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Camarero JA, 2002, P NATL ACAD SCI USA, V99, P8536, DOI 10.1073/pnas.132033899; CHANG BY, 1990, J BACTERIOL, V172, P3257, DOI 10.1128/jb.172.6.3257-3263.1990; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DANIELS D, 1990, P NATL ACAD SCI USA, V87, P8075, DOI 10.1073/pnas.87.20.8075; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; Hsu HH, 2004, J BACTERIOL, V186, P2366, DOI 10.1128/JB.186.8.2366-2375.2004; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; JUANG YL, 1995, BIOCHEMISTRY-US, V34, P8465, DOI 10.1021/bi00026a030; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; KAHN D, 1991, MOL MICROBIOL, V5, P987, DOI 10.1111/j.1365-2958.1991.tb00774.x; KEENER J, 1993, P NATL ACAD SCI USA, V90, P1751, DOI 10.1073/pnas.90.5.1751; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Landini P, 1999, J BACTERIOL, V181, P1524, DOI 10.1128/JB.181.5.1524-1529.1999; Liao CT, 1999, MOL MICROBIOL, V33, P377, DOI 10.1046/j.1365-2958.1999.01480.x; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rhodius VA, 2000, J MOL BIOL, V299, P295, DOI 10.1006/jmbi.2000.3736; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; ROE JH, 1985, J MOL BIOL, V184, P441, DOI 10.1016/0022-2836(85)90293-1; RONG JC, 1994, J BACTERIOL, V176, P5218, DOI 10.1128/JB.176.17.5218-5224.1994; Sen R, 1998, J BIOL CHEM, V273, P9872, DOI 10.1074/jbc.273.16.9872; SIEBENLIST U, 1979, NATURE, V279, P651, DOI 10.1038/279651a0; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZUBER P, 1989, J MOL BIOL, V206, P605, DOI 10.1016/0022-2836(89)90569-X	43	5	5	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					317	327		10.1016/j.cell.2006.08.042	http://dx.doi.org/10.1016/j.cell.2006.08.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055433	Bronze			2022-12-28	WOS:000241827100019
J	Lutz, W; Kritzinger, S; Skirbekk, V				Lutz, Wolfgang; Kritzinger, Sylvia; Skirbekk, Vegard			Population: The demography of growing European identity	SCIENCE			English	Editorial Material									Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; Austrian Acad Sci, Vienna Inst Demog, A-1010 Vienna, Austria; Inst Adv Studies, Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences	Lutz, W (corresponding author), Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria.	lutz@iiasa.ac.at		Lutz, Wolfgang/0000-0001-7975-8145; Kritzinger, Sylvia/0000-0003-2765-8200				Cohen-Tanugi L, 2005, FOREIGN AFF, V84, P55, DOI 10.2307/20031776; Easton D, 1965, SYSTEMS ANAL POLITIC; Robinson RV, 2001, SOC SCI RES, V30, P117, DOI 10.1006/ssre.2000.0692; 2005, ECONOMIST       0908, P37	4	36	36	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					425	425		10.1126/science.1128313	http://dx.doi.org/10.1126/science.1128313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	096MW	17053133				2022-12-28	WOS:000241382500025
J	Mas, J; Chatellier, G; Beyssen, B; Branchereau, A; Moulin, T; Becquemin, JP; Larrue, V; Lievre, M; Leys, D; Bonneville, JF; Watelet, J; Pruvo, JP; Albucher, JF; Viguier, A; Piquet, P; Garnier, P; Viader, F; Touze, E; Giroud, M; Hosseini, H; Pillet, JC; Favrole, P; Neau, JP; Ducrocq, X				Mas, Jean-Louis; Chatellier, Gilles; Beyssen, Bernard; Branchereau, Alain; Moulin, Thierry; Becquemin, Jean-Pierre; Larrue, Vincent; Lievre, Michel; Leys, Didier; Bonneville, Jean-Francois; Watelet, Jacques; Pruvo, Jean-Pierre; Albucher, Jean-Francois; Viguier, Alain; Piquet, Philippe; Garnier, Pierre; Viader, Fausto; Touze, Emmanuel; Giroud, Maurice; Hosseini, Hassan; Pillet, Jean-Christophe; Favrole, Pascal; Neau, Jean-Philippe; Ducrocq, Xavier		EVAS-35 Investigators	Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; CEREBRAL PROTECTION; CLINICAL-TRIAL; ANGIOPLASTY; STROKE; RISKS	BACKGROUND Carotid stenting is less invasive than endarterectomy, but it is unclear whether it is as safe in patients with symptomatic carotid-artery stenosis. METHODS We conducted a multicenter, randomized, noninferiority trial to compare stenting with endarterectomy in patients with a symptomatic carotid stenosis of at least 60%. The primary end point was the incidence of any stroke or death within 30 days after treatment. RESULTS The trial was stopped prematurely after the inclusion of 527 patients for reasons of both safety and futility. The 30-day incidence of any stroke or death was 3.9% after endarterectomy (95% confidence interval [CI], 2.0 to 7.2) and 9.6% after stenting (95% CI, 6.4 to 14.0); the relative risk of any stroke or death after stenting as compared with endarterectomy was 2.5 (95% CI, 1.2 to 5.1). The 30-day incidence of disabling stroke or death was 1.5% after endarterectomy (95% CI, 0.5 to 4.2) and 3.4% after stenting (95% CI, 1.7 to 6.7); the relative risk was 2.2 (95% CI, 0.7 to 7.2). At 6 months, the incidence of any stroke or death was 6.1% after endarterectomy and 11.7% after stenting (P=0.02). There were more major local complications after stenting and more systemic complications (mainly pulmonary) after endarterectomy, but the differences were not significant. Cranial-nerve injury was more common after endarterectomy than after stenting. CONCLUSIONS In this study of patients with symptomatic carotid stenosis of 60% or more, the rates of death and stroke at 1 and 6 months were lower with endarterectomy than with stenting.	Univ Paris 05, Hop St Anne, Serv Neurol, F-75674 Paris 14, France; Univ Paris 05, Europeen Georges Pompidou, Paris, France; Univ Mediterranee, Hop Timone, Marseille, France; Univ Mediterranee, Hop St Marguerite, Marseille, France; Univ Franche Comte, Hop Jean Minjoz, F-25030 Besancon, France; Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France; Univ Toulouse 3, Hop Rangueil, F-31062 Toulouse, France; Univ Toulouse 3, Hop Purpan, F-31062 Toulouse, France; Univ Lyon 1, F-69365 Lyon, France; Univ Lille 2, Hop Roger Salengro, Lille, France; Univ Rouen, Hop Charles Nicolle, Rouen, France; Univ St Etienne, Hop Bellevue, St Etienne, France; Univ Caen, Hop Cote Nacre, F-14032 Caen, France; Univ Bourgogne, Hop Gen, Dijon, France; Nouvelles Clin Nantaises, Nantes, France; Dept Denis Diderot, Hop Lariboisiere, Paris, France; Univ Poitiers, Hop La Miletrie, Poitiers, France; Univ Henri Poincare, Hop St Julien, Nancy, France	GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Rouen; Universite de Rouen Normandie; CHU de St Etienne; Universite Jean Monnet; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Dijon Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; CHU de Nancy; Universite de Lorraine	Mas, J (corresponding author), Univ Paris 05, Hop St Anne, Serv Neurol, 1 Rue Cabanis, F-75674 Paris 14, France.	jl.mas@ch-sainte-anne.fr	LEYS, Didier/G-2955-2016	LEYS, Didier/0000-0003-4408-4392; Moulin, thierry/0000-0002-6639-8117; Touze, Emmanuel/0000-0002-7254-2162				Alberts MJ, 2001, STROKE, V32, P325; Albucher JF, 2004, CEREBROVASC DIS, V18, P62, DOI 10.1159/000078751; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Bond R, 2003, STROKE, V34, P2290, DOI 10.1161/01.STR.0000087785.01407.CC; Brooks WH, 2004, NEUROSURGERY, V54, P318, DOI 10.1227/01.NEU.0000103447.30087.D3; Brooks WH, 2001, J AM COLL CARDIOL, V38, P1589, DOI 10.1016/S0735-1097(01)01595-9; Brown MM, 2001, LANCET, V357, P1729; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Featherstone RL, 2004, CEREBROVASC DIS, V18, P69, DOI 10.1159/000078753; Hobson R W 2nd, 2000, Semin Vasc Surg, V13, P139; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Mas JL, 2004, STROKE, V35, pE18, DOI 10.1161/01.STR.0000106913.33940.DD; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; Ringleb PA, 2004, CEREBROVASC DIS, V18, P66, DOI 10.1159/000078752; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 1996, STROKE, V27, P260, DOI 10.1161/01.STR.27.2.260; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wholey MH, 2003, CATHETER CARDIO INTE, V60, P259, DOI 10.1002/ccd.10645; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	24	1128	1222	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1660	1671		10.1056/NEJMoa061752	http://dx.doi.org/10.1056/NEJMoa061752			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050890				2022-12-28	WOS:000241357300007
J	Mozaffarian, D; Rimm, EB				Mozaffarian, Dariush; Rimm, Eric B.			Fish intake, contaminants, and human health - Evaluating the risks and the benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; N-3 FATTY-ACIDS; ALPHA-LINOLENIC ACID; POLYCHLORINATED-BIPHENYLS PCBS; ACUTE MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD MERCURY LEVELS; DIBENZO-P-DIOXINS; PRENATAL EXPOSURE; OIL SUPPLEMENTATION	Context Fish (finfish or shellfish) may have health benefits and also contain contaminants, resulting in confusion over the role of fish consumption in a healthy diet. Evidence Acquisition We searched MEDLINE, governmental reports, and meta-analyses, supplemented by hand reviews of references and direct investigator contacts, to identify reports published through April 2006 evaluating (1) intake of fish or fish oil and cardiovascular risk, (2) effects of methylmercury and fish oil on early neurodevelopment, (3) risks of methylmercury for cardiovascular and neurologic outcomes in adults, and (4) health risks of dioxins and polychlorinated biphenyls in fish. We concentrated on studies evaluating risk in humans, focusing on evidence, when available, from randomized trials and large prospective studies. When possible, meta-analyses were performed to characterize benefits and risks most precisely. Evidence Synthesis Modest consumption of fish (eg, 1-2 servings/wk), especially species higher in the n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), reduces risk of coronary death by 36% (95% confidence interval, 20%-50%; P < .001) and total mortality by 17% (95% confidence interval, 0%-32%; P = .046) and may favorably affect other clinical outcomes. Intake of 250 mg/d of EPA and DHA appears sufficient for primary prevention. DHA appears beneficial for, and low-level methylmercury may adversely affect, early neurodevelopment. Women of childbearing age and nursing mothers should consume 2 seafood servings/wk, limiting intake of selected species. Health effects of low-level methylmercury in adults are not clearly established; methylmercury may modestly decrease the cardiovascular benefits of fish intake. A variety of seafood should be consumed; individuals with very high consumption (>= 5 servings/wk) should limit intake of species highest in mercury levels. Levels of dioxins and polychlorinated biphenyls in fish are low, and potential carcinogenic and other effects are outweighed by potential benefits of fish intake and should have little impact on choices or consumption of seafood (women of childbearing age should consult regional advisories for locally caught freshwater fish). Conclusions For major health outcomes among adults, based on both the strength of the evidence and the potential magnitudes of effect, the benefits of fish intake exceed the potential risks. For women of childbearing age, benefits of modest fish intake, excepting a few selected species, also outweigh risks.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2,Room 315, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Snejdrlova, Michaela/H-7899-2017; Vaclova, Martina/S-9395-2017; Zlatohlavek, Lukas/E-1276-2017; Vrablik, Michal/B-4590-2017	Snejdrlova, Michaela/0000-0003-1087-9795; Vaclova, Martina/0000-0003-4587-6906; Zlatohlavek, Lukas/0000-0001-6550-2587; Vrablik, Michal/0000-0002-7226-1926	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710, K08HL075628] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL-075628, R01 HL085710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; Airas S, 2004, B ENVIRON CONTAM TOX, V73, P276, DOI 10.1007/s00128-004-0424-y; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; ANDERSON RN, NATL VITAL STAT REPO; Angerer P, 2002, CARDIOVASC RES, V54, P183, DOI 10.1016/S0008-6363(02)00229-8; Auger N, 2005, NEUROTOXICOLOGY, V26, P149, DOI 10.1016/j.neuro.2004.12.005; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Balk EM, 2006, ATHEROSCLEROSIS, V184, P237, DOI 10.1016/j.atherosclerosis.2005.06.042; Bang HO, 1980, ADV NUTR RES, P1, DOI [DOI 10.1007/978-1-4757-4448-4_1, 10.1007/978-1-4757-4448-4_1]; Bayarri S, 2001, CHEMOSPHERE, V43, P601, DOI 10.1016/S0045-6535(00)00412-4; Bordajandi LR, 2006, CHEMOSPHERE, V64, P1450, DOI 10.1016/j.chemosphere.2005.12.059; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; BROWN AJ, 1991, AM J CLIN NUTR, V54, P668, DOI 10.1093/ajcn/54.4.668; Brox J, 2001, LIPIDS, V36, P7, DOI 10.1007/s11745-001-0661-4; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; CHARNOCK JS, 1992, MOL CELL BIOCHEM, V116, P19, DOI 10.1007/BF01270564; CHEE KM, 1990, LIPIDS, V25, P523, DOI 10.1007/BF02537158; Chen CY, 2006, ENVIRON HEALTH PERSP, V114, P297, DOI 10.1289/ehp.7861; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; CHIN JPF, 1993, HYPERTENSION, V21, P22, DOI 10.1161/01.HYP.21.1.22; Christensen JH, 2003, DAN MED BULL, V50, P347; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Cohen JT, 2005, AM J PREV MED, V29, P366, DOI 10.1016/j.amepre.2005.06.008; Colombo J, 2004, CHILD DEV, V75, P1254, DOI 10.1111/j.1467-8624.2004.00737.x; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Dallongeville J, 2003, CIRCULATION, V108, P820, DOI 10.1161/01.CIR.0000084542.64687.97; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; Daniels JL, 2003, AM J EPIDEMIOL, V157, P485, DOI 10.1093/aje/kwg010; Davidson PW, 2000, ENVIRON RES, V84, P1, DOI 10.1006/enrs.2000.4084; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; *DIETFACTS COM, HELP YOU CHOOS HLTH; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; *E KAS SEAF, AL WILD SALM; Easton MDL, 2002, CHEMOSPHERE, V46, P1053, DOI 10.1016/S0045-6535(01)00136-9; Eritsland J, 1996, AM J CARDIOL, V77, P31, DOI 10.1016/S0002-9149(97)89130-8; Erkkila AT, 2004, AM J CLIN NUTR, V80, P626; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Fiedler H, 1998, CHEMOSPHERE, V37, P1645, DOI 10.1016/S0045-6535(98)00231-8; Focant JF, 2004, CHEMOSPHERE, V54, P137, DOI 10.1016/S0045-6535(03)00656-8; Folsom AR, 2004, AM J EPIDEMIOL, V160, P1005, DOI 10.1093/aje/kwh307; *FOOD SAF AUTH IR, 2002, SUMM INV DIOX FUR PC; Foran JA, 2005, J NUTR, V135, P2639, DOI 10.1093/jn/135.11.2639; Foran SE, 2003, ARCH PATHOL LAB MED, V127, P1603; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Frost L, 2005, AM J CLIN NUTR, V81, P50; Garcia SM, 2005, PHILOS T R SOC B, V360, P21, DOI 10.1098/rstb.2004.1580; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gochfeld M, 2003, ECOTOX ENVIRON SAFE, V56, P174, DOI 10.1016/S0147-6513(03)00060-5; Gomara B, 2005, J AGR FOOD CHEM, V53, P8406, DOI 10.1021/jf050835z; Grandjean P, 1998, ENVIRON RES, V77, P165, DOI 10.1006/enrs.1997.3804; Grandjean P, 2001, NEUROTOXICOL TERATOL, V23, P305, DOI 10.1016/S0892-0362(01)00155-6; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Gray KA, 2005, AM J EPIDEMIOL, V162, P17, DOI 10.1093/aje/kwi158; *GREAT AL SEAF, FRESH WILD AL SALM; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; Hamilton MC, 2005, ENVIRON SCI TECHNOL, V39, P8622, DOI 10.1021/es050898y; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Hayward DG, 2001, CHEMOSPHERE, V43, P407, DOI 10.1016/S0045-6535(00)00388-X; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Hoyert D, NATL VITAL STAT REPO; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Institute of Medicine Food and Nutrition Board Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Panel on Micronutrients., 2002, DIET REF INT EN CARB; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Jacobs MN, 2002, ENVIRON SCI TECHNOL, V36, P2797, DOI 10.1021/es011287i; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Jensen E, 2001, FOOD ADDIT CONTAM, V18, P395, DOI 10.1080/02652030010024465; Jimenez B, 1996, CHEMOSPHERE, V32, P461, DOI 10.1016/0045-6535(95)00233-2; Johansen O, 1999, J AM COLL CARDIOL, V33, P1619, DOI 10.1016/S0735-1097(99)00054-6; Johansson N, 2002, BIOMETALS, V15, P189, DOI 10.1023/A:1015202301127; Joshi A, 2003, J PUBLIC HEALTH DENT, V63, P52, DOI 10.1111/j.1752-7325.2003.tb03474.x; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; Judd N, 2004, REGUL TOXICOL PHARM, V40, P125, DOI 10.1016/j.yrtph.2004.06.004; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Karl H, 2002, CHEMOSPHERE, V49, P765, DOI 10.1016/S0045-6535(02)00399-5; KAUL U, 1992, INT J CARDIOL, V35, P87, DOI 10.1016/0167-5273(92)90059-C; KENNY D, 1992, AM J CARDIOL, V70, P1347, DOI 10.1016/0002-9149(92)90773-R; Kiviranta H, 2001, FOOD ADDIT CONTAM, V18, P945, DOI 10.1080/02652030110057134; KJELLSTROM T, 1989, PHYS MENTAL DEV CHIL; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Kristensen SD, 2001, LIPIDS, V36, pS79, DOI 10.1007/s11745-001-0671-2; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; LEAF A, 1994, CIRCULATION, V90, P2248, DOI 10.1161/01.CIR.90.5.2248; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lewin G A, 2005, Evid Rep Technol Assess (Summ), P1; Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; McCann JC, 2005, AM J CLIN NUTR, V82, P281, DOI 10.1093/ajcn/82.2.281; McDowell MA, 2004, ENVIRON HEALTH PERSP, V112, P1165, DOI 10.1289/ehp.7046; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Mozaffarian D, 2006, AM J CARDIOL, V97, P216, DOI 10.1016/j.amjcard.2005.08.025; Mozaffarian D, 2005, J AM COLL CARDIOL, V45, P2015, DOI 10.1016/j.jacc.2005.03.038; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2005, ALTERN THER HEALTH M, V11, P24; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Nakamura Y, 2005, AM J MED, V118, P239, DOI 10.1016/j.amjmed.2004.12.016; NAKJIMA S, 2006, ENV HLTH PERSPECT, V114, P773; *NAT MAR FISH SERV, 2005, FISH US 2004; *NAT RES COUNC COM, 2000, TOX EFF METH; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nestel PJ, 2000, AM J CLIN NUTR, V71, p228S, DOI 10.1093/ajcn/71.1.228S; Nilsen DWT, 2001, AM J CLIN NUTR, V74, P50; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Oken E, 2003, OBSTET GYNECOL, V102, P346, DOI 10.1016/S0029-7844(03)00484-8; Oomen CM, 2000, AM J EPIDEMIOL, V151, P999, DOI 10.1093/oxfordjournals.aje.a010144; Osler M, 2003, J CLIN EPIDEMIOL, V56, P274, DOI 10.1016/S0895-4356(02)00600-5; Palumbo DR, 2000, ENVIRON RES, V84, P81, DOI 10.1006/enrs.2000.4095; Patandin S, 1999, J PEDIATR-US, V134, P33, DOI 10.1016/S0022-3476(99)70369-0; Patch CS, 2005, J AM DIET ASSOC, V105, P1918, DOI 10.1016/j.jada.2005.09.001; PAULSSON K, 1989, SCI TOTAL ENVIRON, V87-8, P495, DOI 10.1016/0048-9697(89)90256-8; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Plante M, 2003, NEW ENGL J MED, V348, P2151; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Rawn DFK, 2006, SCI TOTAL ENVIRON, V359, P101, DOI 10.1016/j.scitotenv.2005.04.021; Raymond LJ, 2020, NEUROTOXICOLOGY, V81, P294, DOI 10.1016/j.neuro.2020.09.020; Ribas-Fito N, 2001, J EPIDEMIOL COMMUN H, V55, P537, DOI 10.1136/jech.55.8.537; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; Risher JF, 2004, J ENVIRON HEALTH, V67, P9; Risher JF, 2002, TOXICOL IND HEALTH, V18, P109, DOI 10.1191/0748233702th138oa; *RISK ASS INF SYST, TOX SUMM MERC; Rissanen T, 2000, CIRCULATION, V102, P2677, DOI 10.1161/01.CIR.102.22.2677; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schecter A, 1998, CHEMOSPHERE, V37, P1723, DOI 10.1016/S0045-6535(98)00237-9; Schecter A, 2001, J TOXICOL ENV HEAL A, V63, P1, DOI 10.1080/152873901750128326; Schmitt CJ, 2005, SCI TOTAL ENVIRON, V350, P161, DOI 10.1016/j.scitotenv.2005.01.038; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Seppanen K, 2000, J TRACE ELEM MED BIO, V14, P84, DOI 10.1016/S0946-672X(00)80035-8; Shim SM, 2005, J FOOD PROTECT, V68, P633, DOI 10.4315/0362-028X-68.3.633; SIMMER K, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000376; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Siscovick DS, 2003, CIRCULATION, V107, P2632, DOI 10.1161/01.CIR.0000074779.11379.62; SMITH PL, 1979, AM STAT, V33, P57, DOI 10.2307/2683222; Spurgeon A, 2006, ENVIRON HEALTH PERSP, V114, P307, DOI 10.1289/ehp.7859; Stewart PW, 2003, NEUROTOXICOL TERATOL, V25, P11, DOI 10.1016/S0892-0362(02)00320-3; Storelli MM, 2004, J FOOD PROTECT, V67, P1787, DOI 10.4315/0362-028X-67.8.1787; Suzuki KT, 1998, BBA-PROTEIN STRUCT M, V1429, P102, DOI 10.1016/S0167-4838(98)00221-0; THANNUM J, TRIBALLY SOLD LAKE S; *U MD CTR FOOD NUT, REAL MERC FACTS; U.S. EPA, 1996, PCBS CANC DOS RESP A; U.S. EPA, CONTR POW PLANT EM E; Uauy R, 2003, J PEDIATR-US, V143, pS17, DOI 10.1067/S0022-3476(03)00398-6; Uauy R, 2000, PEDIATR RES, V47, P127, DOI 10.1203/00006450-200001000-00022; United States Department of Agriculture, 2006, USDA NAT NUTR DAT ST; *US DEP HHS, MERC LEV COMM FISH S; US Environmental Protection Agency, MERC STUD REP C; *US EPA, 22967926 US EPA CASR; US EPA, POL BIPH PCBS; *US EPA, 2003, RISK ASS FISH CONS L; *US EPA, GUID ASS CHEM CONT D, V2; *US EPA, WHAT YOU NEED KNOW M; *US EPA, DIOX REL COMP; *US FDA, OM CONS DRUG INF SHE; *US FDA, QUEST ANSW DIOX; *US FDA, FOOD DRUG ADM TOT DI; *US FDA, COMPL POL GUID; *US FDA, SEAF INF RES; *US FISH WILDL SER, TOT MERC METH FRESHW; *US GEOL SURV, MERC ENV; *USDA, DIOX DIOX LIK COMP U; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Vanden Heuvel John P, 2004, Curr Atheroscler Rep, V6, P432, DOI 10.1007/s11883-004-0083-9; Verbeke W, 2005, PUBLIC HEALTH NUTR, V8, P422, DOI 10.1079/PHN2004697; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Warner K, 1999, Adv Exp Med Biol, V459, P67; Watanabe C, 2002, TOHOKU J EXP MED, V196, P71, DOI 10.1620/tjem.196.71; Weil M, 2005, JAMA-J AM MED ASSOC, V293, P1875, DOI 10.1001/jama.293.15.1875; WHO (World Health Organization), 1998, ASS HLTH RISK DIOX R; *WILD PAC SALM, WILD SALM PROD; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Resources Institute, 2005, MILL EC ASS EC HUM W; Yokoo Edna M, 2003, Environ Health, V2, P8, DOI 10.1186/1476-069X-2-8; YOKOYAMA M, 2005, AM HEART ASS SCI SES; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437; Young G, 2005, REPROD NUTR DEV, V45, P1, DOI 10.1051/rnd:2005001; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809	207	1374	1429	16	519	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1885	1899		10.1001/jama.296.15.1885	http://dx.doi.org/10.1001/jama.296.15.1885			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	095ST	17047219				2022-12-28	WOS:000241329300031
J	Ting, HH; Yang, EH; Rihal, CS				Ting, Henry H.; Yang, Eric H.; Rihal, Charanjit S.			Narrative review: Reperfusion strategies for ST-Segment elevation myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; SITE CARDIAC-SURGERY; NO-REFLOW PHENOMENON; PRIMARY ANGIOPLASTY; THROMBOLYTIC THERAPY; FIBRINOLYTIC THERAPY; RANDOMIZED-TRIAL; EMERGENCY-ROOM; PREHOSPITAL FIBRINOLYSIS; IMMEDIATE THROMBOLYSIS	Optimal treatment for ST-segment elevation myocardial infarction depends on early diagnosis and rapid selection of the appropriate reperfusion strategy. Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy at PCI-capable hospitals. For hospitals without PCI capability, there are 2 reperfusion strategies, primary PCI and thrombolytic therapy, which are both supported by clinical evidence and national guidelines. Transferring patients for primary PCI may cause delays and requires established, proven protocols, systems, and networks to achieve minimal door-to-balloon times. The authors review the available data and present a systematic, evidence-based approach in a simple framework to enable noncardiovascular and cardiovascular physicians to select the optimal reperfusion strategy. The framework is based on available data from clinical trials and local circumstances from clinical practice by incorporating duration of symptoms (fixed ischemia time) and anticipated transport delays to a PCI-capable facility (incurred ischemia time).	Mayo Clin, Coll Med, Div Cardiovasc Dis, Cardiac Catheterizat Lab, Rochester, MN 55905 USA	Mayo Clinic	Rihal, CS (corresponding author), Mayo Clin, Coll Med, Div Cardiovasc Dis, Cardiac Catheterizat Lab, 200 1st St SW, Rochester, MN 55905 USA.	rihal@mayo.edu						Akhras F., 1997, Journal of the American College of Cardiology, V29, p235A; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], 1988, LANCET, V2, P349; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Arntz HR, 2003, EUR HEART J, V24, P268, DOI 10.1016/S0195-668X(03)94640-9; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Caputo RP, 2005, CATHETER CARDIO INTE, V64, P428, DOI 10.1002/ccd.20308; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cutlip DE, 2003, AM J CARDIOL, V92, P977, DOI 10.1016/S0002-9149(03)00983-4; Cutlip DE, 2001, AM J CARDIOL, V88, P62, DOI 10.1016/S0002-9149(01)01587-9; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; DeWood MA, 1990, THROMB INT THER AC M; Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1; Gabriel HM, 2003, EUR HEART J, V24, P543, DOI 10.1016/S0195-668X(03)95631-4; Garcia E, 1999, J AM COLL CARDIOL, V33, P605, DOI 10.1016/S0735-1097(98)00644-5; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Giugliano RP, 2003, J AM COLL CARDIOL, V41, P1251, DOI 10.1016/S0735-1097(03)00123-2; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Grinfeld Liliana, 1996, Journal of the American College of Cardiology, V27, p222A; Henry TD, 2005, AM HEART J, V150, P373, DOI 10.1016/j.ahj.2005.01.059; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Karvouni E, 2003, J AM COLL CARDIOL, V41, P26, DOI 10.1016/S0735-1097(02)02666-9; Kastrati A, 2004, JAMA-J AM MED ASSOC, V291, P947, DOI 10.1001/jama.291.8.947; Kastrati A, 2002, LANCET, V359, P920, DOI 10.1016/S0140-6736(02)08022-4; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8; KENNER MD, 1995, AM J CARDIOL, V76, P861, DOI 10.1016/S0002-9149(99)80250-1; Le May MR, 2001, J AM COLL CARDIOL, V37, P985, DOI 10.1016/S0735-1097(00)01213-4; Lee DP, 2003, CIRCULATION, V107, P1497, DOI 10.1161/01.CIR.0000056120.00513.7A; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; McGinn AP, 2005, AM HEART J, V150, P392, DOI 10.1016/j.ahj.2005.03.064; Mehta RH, 2003, J AM COLL CARDIOL, V42, P1739, DOI 10.1016/j.jacc.2003.07.012; Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; Ribeiro EE, 1993, J AM COLL CARDIOL, V22, P376, DOI 10.1016/0735-1097(93)90040-8; Ribichini F, 1998, J AM COLL CARDIOL, V32, P1687, DOI 10.1016/S0735-1097(98)00446-X; Ribichini F, 2002, HEART, V88, P298, DOI 10.1136/heart.88.3.298; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865; Schull MJ, 2005, AM HEART J, V150, P583, DOI 10.1016/j.ahj.2005.03.061; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Ting HH, 2003, AM HEART J, V145, P278, DOI 10.1067/mhj.2003.61; Topol EJ, 2000, CIRCULATION, V101, P2788; Topol EJ, 2001, LANCET, V357, P1905; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Van de Werf F, 2002, CIRCULATION, V105, P2813, DOI 10.1161/01.CIR.0000019762.35104.DA; Van de Werf F, 2001, LANCET, V358, P605; van't Hof AWJ, 2004, EUR HEART J, V25, P837, DOI 10.1016/j.ehj.2004.04.003; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; WEITZ JI, 1995, CHEST, V108, pS471, DOI 10.1378/chest.108.4_Supplement.471S; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Zeymer U, 2005, EUR HEART J, V26, P1971, DOI 10.1093/eurheartj/ehi293; Zijlstra F, 1997, J AM COLL CARDIOL, V29, P908, DOI 10.1016/S0735-1097(97)00018-1; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002; Zorman S, 2002, AM J CARDIOL, V90, P533, DOI 10.1016/S0002-9149(02)02530-4	72	23	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					610	617		10.7326/0003-4819-145-8-200610170-00010	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043342				2022-12-28	WOS:000241315700007
J	Heininger, U; Seward, JF				Heininger, Ulrich; Seward, Jane F.			Varicella	LANCET			English	Review							ZOSTER-VIRUS-INFECTION; LINKED-IMMUNOSORBENT-ASSAY; WILD-TYPE STRAINS; A STREPTOCOCCAL DISEASE; HERPES-ZOSTER; UNITED-STATES; VACCINE EFFECTIVENESS; COST-EFFECTIVENESS; ELEMENTARY-SCHOOL; ANTIBODY-RESPONSE	Varicella-zoster virus, a herpesvirus, causes varicella (chickenpox) and, after endogenous reactivation, herpes zoster (shingles). Varicella, which is recognised by a characteristic vesicular rash, arises mainly in young children, although older individuals can be affected. In immunocompetent patients, symptoms are usually mild to moderate, but an uncomplicated severe case can have more than 1000 lesions and severe constitutional symptoms. Serious complications-including central nervous system involvement, pneumonia, secondary bacterial infections, and death-are sometimes seen. Varicella can be prevented by vaccination. Vaccine is about 80-85% effective against all disease and highly (more than 95%) effective in prevention of severe disease. In the USA, a routine childhood immunisation programme has reduced disease incidence, complications, hospital admissions, and deaths in children and in the general population, indicating strong herd immunity. Similar immunisation programmes have been adopted by some other countries, including Uruguay, Germany, Taiwan, Canada, and Australia, and are expected to be implemented more widely in future.	Univ Childrens Hosp, Div Paediat Infect Dis & Vaccinol, CH-4005 Basel, Switzerland; Ctr Dis Control & Prevent, Viral Vaccine Preventable Dis Branch, Natl Immunizat Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Heininger, U (corresponding author), Univ Childrens Hosp, Div Paediat Infect Dis & Vaccinol, CH-4005 Basel, Switzerland.	Ulrich.Heininger@unibas.ch						*ADV COMM IMM PRAC, PROV REC PREV VAR; Aebi C, 2001, VACCINE, V19, P3097, DOI 10.1016/S0264-410X(01)00035-4; Ampofo K, 2002, CLIN INFECT DIS, V34, P774, DOI 10.1086/338959; [Anonymous], 1993, Pediatrics, V91, P674; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; [Anonymous], VARICELLA ZOSTER VIR; [Anonymous], PROD APPR INF LIC AC; ARBETER AM, 1984, AM J DIS CHILD, V138, P434, DOI 10.1001/archpedi.1984.02140430012004; Argaw T, 2000, J INFECT DIS, V181, P1153, DOI 10.1086/315335; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Arvin AM, 2001, VIROLOGY, V284, P153, DOI 10.1006/viro.2001.0918; ASANO Y, 1977, PEDIATRICS, V59, P3; ASANO Y, 1993, PEDIATRICS, V92, P219; Askalan R, 2001, STROKE, V32, P1257, DOI 10.1161/01.STR.32.6.1257; Barrett-Muir W., 2003, Journal of Medical Virology, V70, pS42, DOI 10.1002/jmv.10319; BERGEN RE, 1991, VIRAL IMMUNOL, V4, P51; BERNSTEIN HH, 1993, PEDIATRICS, V92, P833; Black S, 1999, PEDIATR INFECT DIS J, V18, P1041, DOI 10.1097/00006454-199912000-00003; Boelle PY, 2002, EPIDEMIOL INFECT, V129, P599, DOI 10.1017/S0950268802007720; Bonhoeffer J, 2005, EUR J PEDIATR, V164, P366, DOI 10.1007/s00431-005-1637-8; BRAMLEY JC, 2000, COMMUN DIS PUBLIC HL, V3, P82; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; Carapetis JR, 2004, VACCINE, V23, P755, DOI 10.1016/j.vaccine.2004.07.025; *CDC, 2006, MMWR-MORBID MORTAL W, V55, P209; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Chan ISF, 2002, STAT MED, V21, P3411, DOI 10.1002/sim.1268; Chant KG, 1998, AUST NZ J PUBL HEAL, V22, P413, DOI 10.1111/j.1467-842X.1998.tb01405.x; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; CHEN SH, 1992, PEDIATR HEMAT ONCOL, V9, P347, DOI 10.3109/08880019209016606; CHOO PW, 1995, J INFECT DIS, V172, P706, DOI 10.1093/infdis/172.3.706; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Cohrs RJ, 2003, J VIROL, V77, P11718, DOI 10.1128/JVI.77.21.11718-11732.2003; Coudeville L, 1999, VACCINE, V17, P142, DOI 10.1016/S0264-410X(98)00161-3; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; DAVISON AJ, 1991, J GEN VIROL, V72, P475, DOI 10.1099/0022-1317-72-3-475; Deguen S, 1998, J EPIDEMIOL COMMUN H, V52, p46S; DUELAND AN, 1992, LAB INVEST, V66, P762; DUNKLE LM, 1991, NEW ENGL J MED, V325, P1539, DOI 10.1056/NEJM199111283252203; Duus KM, 1996, J VIROL, V70, P8961, DOI 10.1128/JVI.70.12.8961-8971.1996; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2; Enders G., 2000, VARICELLA ZOSTER VIR, P317; Enright Andrea M, 2003, Herpes, V10, P32; Etzioni A, 2005, J PEDIATR-US, V146, P423, DOI 10.1016/j.jpeds.2004.11.022; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; FELDMAN S, 1975, PEDIATRICS, V56, P388; FINGER R, 1994, PUBLIC HEALTH REP, V109, P750; Gabutti G, 2001, EPIDEMIOL INFECT, V126, P433, DOI 10.1017/S0950268801005398; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, AM J PUBLIC HEALTH, V92, P1248, DOI 10.2105/AJPH.92.8.1248; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gershon AA, 2003, J INFECT DIS, V188, P945, DOI 10.1086/378504; Gershon AA, 2002, NEW ENGL J MED, V347, P1962, DOI 10.1056/NEJMe020138; GERSHON AA, 1975, INFECTIONS FETUS NEW, P79; Gershon AA, 2004, VACCINES, P783; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P544, DOI 10.1111/j.1467-842X.2005.tb00248.x; GILLER RH, 1989, J INFECT DIS, V160, P919, DOI 10.1093/infdis/160.6.919; Girisch M, 1999, KLIN PADIATR, V211, P403, DOI 10.1055/s-2008-1043820; Gomi Y, 2003, J VIROL, V77, P3351, DOI 10.1128/JVI.77.5.3351.2003; GROSE C, 1981, INFECT IMMUN, V31, P1044, DOI 10.1128/IAI.31.3.1044-1053.1981; GROSE C, 1990, ANNU REV MICROBIOL, V44, P59, DOI 10.1146/annurev.mi.44.100190.000423; GUESS HA, 1986, PEDIATRICS, V78, P723; GUESS HA, 1985, PEDIATRICS, V76, P512; Haddad MB, 2005, PEDIATRICS, V115, P1488, DOI 10.1542/peds.2004-1826; HALL CB, 1993, PEDIATRICS, V91, P858; Hanslik T, 2003, VACCINE, V21, P3614, DOI 10.1016/S0264-410X(03)00405-5; HARDY I, 1991, NEW ENGL J MED, V325, P1545, DOI 10.1056/NEJM199111283252204; Harger JH, 2002, OBSTET GYNECOL, V100, P260, DOI 10.1016/S0029-7844(02)02059-8; Heininger U, 2001, PEDIATR INFECT DIS J, V20, P775, DOI 10.1097/00006454-200108000-00011; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; HUNT SM, 1993, FAM PRACT, V10, P19, DOI 10.1093/fampra/10.1.19; HURWITZ ES, 1991, PEDIATRICS, V87, P62; IYUN F, 1986, GEORG MED, V14, P73; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Jaeggi A, 1998, ARCH DIS CHILD, V79, P472, DOI 10.1136/adc.79.6.472; Jerant A F, 1998, J Am Board Fam Pract, V11, P296; Jezek Z, 1978, Indian J Public Health, V22, P120; Jezek Z, 1988, HUMAN MONKEYPOX; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; JUNKER AK, 1994, J MED VIROL, V43, P119, DOI 10.1002/jmv.1890430204; JUNKER AK, 1991, PEDIATR INFECT DIS J, V10, P569, DOI 10.1097/00006454-199108000-00004; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Katz J, 2004, CLIN INFECT DIS, V39, P342, DOI 10.1086/421942; KIDO S, 1991, J CLIN MICROBIOL, V29, P76, DOI 10.1128/JCM.29.1.76-79.1991; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Knuf M, 2006, PEDIATR INFECT DIS J, V25, P12, DOI 10.1097/01.inf.0000195626.35239.58; KOROPCHAK CM, 1991, J INFECT DIS, V163, P1016, DOI 10.1093/infdis/163.5.1016; Krah DL, 1996, INFECT DIS CLIN N AM, V10, P507, DOI 10.1016/S0891-5520(05)70311-1; Kudesia G, 2002, J CLIN PATHOL, V55, P154, DOI 10.1136/jcp.55.2.154; Kumagai T, 1999, J INFECT DIS, V180, P834, DOI 10.1086/314950; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; LAFORET EG, 1947, NEW ENGL J MED, V236, P534, DOI 10.1056/NEJM194704102361504; LaRussa P, 1997, J INFECT DIS, V176, P1072, DOI 10.1086/516514; Laupland KB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e60; Law B, 2000, PEDIATR INFECT DIS J, V19, P1053, DOI 10.1097/00006454-200011000-00005; Law B, 1999, PEDIATRICS, V104, P1, DOI 10.1542/peds.104.1.1; Lee BR, 2004, J INFECT DIS, V190, P477, DOI 10.1086/422041; Lee BW, 1998, TROP MED INT HEALTH, V3, P886; Lesko SM, 2001, PEDIATRICS, V107, P1108, DOI 10.1542/peds.107.5.1108; Leung AKC, 2001, PEDIATR DERMATOL, V18, P378, DOI 10.1046/j.1525-1470.2001.01975.x; LEUNG J, 2005, 43 ANN M INF DIS SOC; Levy O, 2003, J INFECT DIS, V188, P948, DOI 10.1086/378503; Li S, 2002, PEDIATR INFECT DIS J, V21, P337, DOI 10.1097/00006454-200204000-00014; LIEU TA, 1994, JAMA-J AM MED ASSOC, V271, P375, DOI 10.1001/jama.271.5.375; Lin TY, 1997, PEDIATR INFECT DIS J, V16, P1162, DOI 10.1097/00006454-199712000-00012; LONGLEY J, 1987, ARCH DERMATOL, V123, P1335, DOI 10.1001/archderm.123.10.1335; Loparev VN, 2000, J CLIN MICROBIOL, V38, P3156, DOI 10.1128/JCM.38.9.3156-3160.2000; Loparev VN, 2004, J VIROL, V78, P8349, DOI 10.1128/jvi.78.15.8349-8358.2004; Loparev VN, 2000, J CLIN MICROBIOL, V38, P4315, DOI 10.1128/JCM.38.12.4315-4319.2000; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; Mandal BK, 1998, J INFECT DIS, V178, pS52, DOI 10.1086/514262; Marin M, 2005, PEDIATRICS, V115, P900, DOI 10.1542/peds.2004-1162; MARTIN JH, 1982, J MED VIROL, V9, P69, DOI 10.1002/jmv.1890090110; MARTIN KA, 1994, J INFECT DIS, V170, P991, DOI 10.1093/infdis/170.4.991; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; MILLER E, 1989, LANCET, V2, P371; Miron D, 2005, PEDIATR INFECT DIS J, V24, P233, DOI 10.1097/01.inf.0000154323.20387.82; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Oladepo DK, 2000, J VIROL METHODS, V84, P169, DOI 10.1016/S0166-0934(99)00139-1; OOI P-L, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P22; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; PADOVAN D, 1986, LAB ANIM SCI, V36, P7; Passwell JH, 2004, PEDIATR INFECT DIS J, V23, P221, DOI 10.1097/01.inf.0000114906.78716.64; Poulsen A, 2005, PEDIATR INFECT DIS J, V24, P102, DOI 10.1097/01.inf.0000151034.15747.4a; PREBLUD SR, 1986, PEDIATRICS, V78, P728; Quinlivan M, 2005, J MED VIROL, V75, P174, DOI 10.1002/jmv.20253; Ratner AJ, 2002, PEDIATR INFECT DIS J, V21, P927, DOI 10.1097/00006454-200210000-00008; Rawson H, 2001, BRIT MED J, V323, P1091, DOI 10.1136/bmj.323.7321.1091; Ross A M, 2000, Commun Dis Public Health, V3, P213; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; SALISBURY D, 1996, IMMUNISATION INFECT; Salzman MB, 1998, PEDIATR INFECT DIS J, V17, P256, DOI 10.1097/00006454-199803000-00020; SANTOS AM, 2004, J HOSP INFECT, V58, P92; Sauerbrei A, 2004, J VIROL METHODS, V119, P25, DOI 10.1016/j.jviromet.2004.02.012; SAWYER MH, 1992, J INFECT DIS, V166, P885, DOI 10.1093/infdis/166.4.885; Seward JF, 2004, CLIN INFECT DIS, V39, P1477, DOI 10.1086/425500; Seward JF, 2004, JAMA-J AM MED ASSOC, V292, P704, DOI 10.1001/jama.292.6.704; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; SHANLEY J, 1982, J CLIN MICROBIOL, V15, P208, DOI 10.1128/JCM.15.2.208-211.1982; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; Sheffer R, 2005, PEDIATR INFECT DIS J, V24, P434, DOI 10.1097/01.inf.0000160947.89942.30; SHEHAB Z, 1983, J INFECT DIS, V148, P472; SHEPP DH, 1986, NEW ENGL J MED, V314, P208, DOI 10.1056/NEJM198601233140404; Shinefield H, 2005, PEDIATR INFECT DIS J, V24, P665, DOI 10.1097/01.inf.0000172902.25009.a1; SHIRAKI K, 1982, J GEN VIROL, V61, P255, DOI 10.1099/0022-1317-61-2-255; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Socan M, 2001, EPIDEMIOL INFECT, V126, P279, DOI 10.1017/S0950268801005350; Somekh E, 2002, J INFECTION, V45, P233, DOI 10.1053/jinf.2002.1039; STARKO KM, 1980, PEDIATRICS, V66, P859; Suzuki K, 2003, PEDIATR INT, V45, P458, DOI 10.1046/j.1442-200X.2003.01746.x; TAKAHASHI M, 1975, BIKEN J, V18, P25; Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011; TERADA K, 1995, ARCH DIS CHILD, V73, P162, DOI 10.1136/adc.73.2.162; Terada K, 1996, PEDIATR INFECT DIS J, V15, P179, DOI 10.1097/00006454-199602000-00022; Thiry N, 2004, VACCINE, V22, P3546, DOI 10.1016/j.vaccine.2004.03.043; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Tobias M, 1998, NEW ZEAL MED J, V111, P274; TSOLIA M, 1990, J PEDIATR-US, V116, P184, DOI 10.1016/S0022-3476(05)82872-0; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Tyrrell GJ, 2005, CLIN INFECT DIS, V40, P1055, DOI 10.1086/428614; VANLOON AM, 1992, EPIDEMIOL INFECT, V108, P165, DOI 10.1017/S095026880004961X; Varis T, 1996, J INFECT DIS, V174, pS330, DOI 10.1093/infdis/174.Supplement_3.S330; Vazquez M, 2004, PEDIATR INFECT DIS J, V23, P871, DOI 10.1097/01.inf.0000140786.15816.38; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Verstraelen H, 2003, PRENATAL DIAG, V23, P705, DOI 10.1002/pd.669; WASMUTH EH, 1990, J MED VIROL, V32, P189, DOI 10.1002/jmv.1890320310; WATSON BM, 1993, PEDIATRICS, V91, P17; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; Welgama U., 2003, Ceylon Medical Journal, V48, P119; WELLER TH, 1958, J EXP MED, V108, P843, DOI 10.1084/jem.108.6.843; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; *WHO, 1998, WKLY EPIDEMIOL REC, V73, P241; WILLIAMS V, 1974, J INFECT DIS, V130, P669, DOI 10.1093/infdis/130.6.669; Wirrell E, 2004, J PEDIATR-US, V145, P845, DOI 10.1016/j.jpeds.2004.08.005; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; Wutzler P, 2001, VACCINE, V20, P121, DOI 10.1016/S0264-410X(01)00276-6; Yawn BP, 1997, J PEDIATR-US, V130, P759, DOI 10.1016/S0022-3476(97)80019-4; Yih WK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-68; Zerr DM, 1999, PEDIATRICS, V103, P783, DOI 10.1542/peds.103.4.783; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797	189	392	411	2	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1365	1376		10.1016/S0140-6736(06)69561-5	http://dx.doi.org/10.1016/S0140-6736(06)69561-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046469				2022-12-28	WOS:000241388100033
J	Kenter, MJH; Cohen, AF				Kenter, M. J. H.; Cohen, A. F.			Establishing risk of human experimentation with drugs: lessons from TGN1412	LANCET			English	Editorial Material							T-CELLS; APOPTOSIS; BLOCKADE; BINDING; CANCER		CHDR, NL-2333 CL Leiden, Netherlands; Cent Comm Res Invilving Human Subjects, The Hague, Netherlands		Cohen, AF (corresponding author), CHDR, Zernikedreef 10, NL-2333 CL Leiden, Netherlands.	ac@chdr.nl	Cohen, Adam/G-3756-2010					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barr TA, 2006, VACCINE, V24, P3399, DOI 10.1016/j.vaccine.2006.02.022; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Bhogal N, 2006, ATLA-ALTERN LAB ANIM, V34, P225, DOI 10.1177/026119290603400204; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Bouchie A, 2002, NAT BIOTECHNOL, V20, P639, DOI 10.1038/nbt0702-639b; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Carmen IH, 2001, MOL THER, V3, P425, DOI 10.1006/mthe.2001.0305; Carpenter PA, 2000, J IMMUNOL, V165, P6205, DOI 10.4049/jimmunol.165.11.6205; Carpenter PA, 2000, TRANSPLANT P, V32, P1545, DOI 10.1016/S0041-1345(00)01343-9; *COUN INT ORG MED, 1983, SAF REQ 1 US NEW DRU; *DEP HLTH, EXP SCI GROUP PHAS 1; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; LEWIS CE, 1990, IMMUNOLOGY, V69, P402; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; *MED HLTH CAR PROD, 2005, PHARM SAF ASS TGN141; ORME M, 1989, BRIT J CLIN PHARMACO, V27, P125, DOI 10.1111/j.1365-2125.1989.tb05342.x; *PAR INT, 2006, PAR CLIN TRIAL PROT; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Schneider CK, 2006, NAT BIOTECHNOL, V24, P493, DOI 10.1038/nbt0506-493; Smith JA, 1997, CURR OPIN IMMUNOL, V9, P648, DOI 10.1016/S0952-7915(97)80044-1; Steinbrook R, 2002, NEW ENGL J MED, V346, P716, DOI 10.1056/NEJM200202283460924; *TEGENERO AG, 2005, TEG IMM INV BROCH TG; Venuprasad K, 2003, HUM IMMUNOL, V64, P38, DOI 10.1016/S0198-8859(02)00689-4; Venuprasad K, 2001, EUR J IMMUNOL, V31, P1536, DOI 10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8; Wadman M, 2006, NATURE, V440, P388, DOI 10.1038/440388a; ZARAFONETIS CJD, 1978, CLIN PHARMACOL THER, V24, P127	29	112	123	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1387	1391		10.1016/S0140-6736(06)69562-7	http://dx.doi.org/10.1016/S0140-6736(06)69562-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046471				2022-12-28	WOS:000241388100035
J	Mahal, A				Mahal, Ajay			Health spending and poverty	LANCET			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mahal, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	amahal@hsph.harvard.edu						Bhalla S., 2002, IMAGINE THERES NO CO; Cirto C., 1995, MEASURING POVERTY NE; Krishna A, 2004, WORLD DEV, V32, P121, DOI 10.1016/j.worlddev.2003.08.002; LANJOUW J, 1998, DEMYSTIFYING POVERTY; Mahal A., 2006, HLTH EXPENDITURES EL; ORSHANSKY M, 1965, SOC SECUR BULL, V28, P3; Peters D.H., 2002, BETTER HLTH SYSTEMS; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3	8	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1308	1309		10.1016/S0140-6736(06)69533-0	http://dx.doi.org/10.1016/S0140-6736(06)69533-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096PA	17046446				2022-12-28	WOS:000241388100007
J	Karbowski, M; Norris, KL; Cleland, MM; Jeong, SY; Youle, RJ				Karbowski, Mariusz; Norris, Kristi L.; Cleland, Megan M.; Jeong, Seon-Yong; Youle, Richard J.			Role of Bax and Bak in mitochondrial morphogenesis	NATURE			English	Article							CELL-SURVIVAL; APOPTOSIS; FUSION; DYNAMICS; DIVISION; FISSION; DEATH; ACTIVATION; PROTEIN; ABSENCE	Bcl-2 family proteins are potent regulators of programmed cell death. Although their intracellular localization to mitochondria and the endoplasmic reticulum has focused research on these organelles, how they function remains unknown. Two members of the Bcl-2 family, Bax and Bak, change intracellular location early in the promotion of apoptosis to concentrate in focal clusters at sites of mitochondrial division. Here we report that in healthy cells Bax or Bak is required for normal fusion of mitochondria into elongated tubules. Bax seems to induce mitochondrial fusion by activating assembly of the large GTPase Mfn2 and changing its submitochondrial distribution and membrane mobility properties that correlate with different GTP-bound states of Mfn2. Our results show that Bax and Bak regulate mitochondrial dynamics in healthy cells and indicate that Bcl-2 family members may also regulate apoptosis through organelle morphogenesis machineries.	NINCDS, Biochem Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Karbowski, M (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, UMBI Bldg,725 W Lombard St, Baltimore, MD 21201 USA.	karbowsm@ninds.nih.gov; youler@ninds.nih.gov		Harwig, Megan/0000-0003-2140-5739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002859, ZIANS002859] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Poncet D, 2004, J BIOL CHEM, V279, P22605, DOI 10.1074/jbc.M308408200; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; van der Bliek AM, 2000, J CELL BIOL, V151, pF1, DOI 10.1083/jcb.151.2.F1; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	24	506	526	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					658	662		10.1038/nature05111	http://dx.doi.org/10.1038/nature05111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035996				2022-12-28	WOS:000241160500038
J	Moore, DAJ; Evans, CAW; Gilman, RH; Caviedes, L; Coronel, J; Vivar, A; Sanchez, E; Pinedo, Y; Saravia, JC; Salazar, C; Oberhelman, R; Hollm-Delgado, MG; LaChira, D; Escombe, AR; Friedland, JS				Moore, David A. J.; Evans, Carlton A. W.; Gilman, Robert H.; Caviedes, Luz; Coronel, Jorge; Vivar, Aldo; Sanchez, Eduardo; Pinedo, Yvette; Saravia, Juan Carlos; Salazar, Cayo; Oberhelman, Richard; Hollm-Delgado, Maria-Graciela; LaChira, Doris; Escombe, A. Roderick; Friedland, Jon S.			Microscopic-observation drug-susceptibility assay for the diagnosis of TB	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	29th Annual Presidents Conference	JAN 30-FEB 01, 2005	Arlington, VA	ARAMARK Educ, Baker, George K Baum & Co, Guidestone, Holme Roberts & Owen LLP, INTERDESIGN, JENZABAR, JOHNSON CONTROLS, People Management Int, PIONEER, Richard Harrison Baily Agcy, SallieMae, SCANNELL& KURZ INC, Sodexho, THE TROYER GRP			MULTIDRUG-RESISTANT TUBERCULOSIS; ALAMAR BLUE ASSAY; MYCOBACTERIUM-TUBERCULOSIS; MB/BACT SYSTEM; PULMONARY TUBERCULOSIS; TESTING SUSCEPTIBILITY; MULTICENTER EVALUATION; MIC DETERMINATION; AGAR PROPORTION; LIMA	BACKGROUND New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically to detect characteristic growth. METHODS In an operational setting in Peru, we investigated the performance of the MODS assay for culture and drug-susceptibility testing in three target groups: unselected patients with suspected tuberculosis, prescreened patients at high risk for tuberculosis or multidrug-resistant tuberculosis, and unselected hospitalized patients infected with the human immunodeficiency virus. We compared the MODS assay head-to-head with two reference methods: automated mycobacterial culture and culture on Lowenstein-Jensen medium with the proportion method. RESULTS Of 3760 sputum samples, 401 (10.7%) yielded cultures positive for Mycobacterium tuberculosis. Sensitivity of detection was 97.8% for MODS culture, 89.0% for automated mycobacterial culture, and 84.0% for Lowenstein-Jensen culture (P<0.001); the median time to culture positivity was 7 days, 13 days, and 26 days, respectively (P<0.001), and the median time to the results of susceptibility tests was 7 days, 22 days, and 68 days, respectively. The incremental benefit of a second MODS culture was minimal, particularly in patients at high risk for tuberculosis or multidrug-resistant tuberculosis. Agreement between MODS and the reference standard for susceptibility was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid (combined results for multidrug resistance), 95% for ethambutol, and 92% for streptomycin (kappa values, 1.0, 0.89, 0.93, 0.71, and 0.72, respectively). CONCLUSIONS A single MODS culture of a sputum sample offers more rapid and sensitive detection of tuberculosis and multidrug-resistant tuberculosis than the existing gold-standard methods used.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Ctr Clin Trop Med, London W12 0NN, England; Asociac Benefica PRISMA, Lima, Peru; Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; Hosp Nacl Gen Arzobispo Loaya, Lima, Peru; Hosp Nacl Hipolito Unanue, Lima, Peru; Minist Salud, Direcc Salud Lima Norte 3, Lima, Peru; Minist Salud, Direcc Salud Lima Este 4, Lima, Peru; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA	Imperial College London; Imperial College London; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	Moore, DAJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	davidajmoore@msn.com	Hollm-Delgado, Maria-Graciela/I-9277-2017; Evans, Carlton/AAI-1653-2020	Hollm-Delgado, Maria-Graciela/0000-0003-1067-8520; Evans, Carlton/0000-0002-6873-5447; Coronel, Jorge/0000-0002-4580-6716; Friedland, Jonathan S/0000-0001-7789-9649	FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Barreto AMW, 2003, MEM I OSWALDO CRUZ, V98, P827, DOI 10.1590/S0074-02762003000600020; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Bemer P, 2004, J CLIN MICROBIOL, V42, P1030, DOI 10.1128/JCM.42.3.1030-1034.2004; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brunello F, 2000, J CLIN MICROBIOL, V38, P872, DOI 10.1128/JCM.38.2.872-873.2000; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Cole RA, 1996, TUBERCLE LUNG DIS, V77, P363, DOI 10.1016/S0962-8479(96)90103-3; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; DelPortillo P, 1996, J CLIN MICROBIOL, V34, P324, DOI 10.1128/JCM.34.2.324-328.1996; Diaz-Infantes MS, 2000, J CLIN MICROBIOL, V38, P1988; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Kumar M, 2005, INT J TUBERC LUNG D, V9, P939; Madison B, 2002, J CLIN MICROBIOL, V40, P3976, DOI 10.1128/JCM.40.11.3976-3979.2002; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, DIAGN MICR INFEC DIS, V56, P35, DOI 10.1016/j.diagmicrobio.2006.03.009; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; Perkins MD, 2002, B WORLD HEALTH ORGAN, V80, P512; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Pracharktam Roongnapa, 2001, Journal of the Medical Association of Thailand, V84, P1241; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Reis RS, 2004, J CLIN MICROBIOL, V42, P2247, DOI 10.1128/JCM.42.5.2247-2248.2004; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Somi GR, 1999, INT J TUBERC LUNG D, V3, P231; Suffys P, 2000, INT J TUBERC LUNG D, V4, P179; Sungkanuparph Somnuek, 2002, J Med Assoc Thai, V85, P820; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; Tortoli E, 2000, DIAGN MICR INFEC DIS, V38, P83, DOI 10.1016/S0732-8893(00)00176-0; Tsubura E, 1997, Kekkaku, V72, P611; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P355; Walsh A, 2004, INT J TUBERC LUNG D, V8, P609; *WHO, 1998, PUBL WHO; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Yew WW, 2001, DIAGN MICR INFEC DIS, V39, P229, DOI 10.1016/S0732-8893(01)00237-1	41	343	371	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1539	1550		10.1056/NEJMoa055524	http://dx.doi.org/10.1056/NEJMoa055524			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	093HW	17035648	Green Accepted			2022-12-28	WOS:000241160400005
J	Badri, M; D Lawn, S; Wood, R				Badri, Motasim; D Lawn, Stephen; Wood, Robin			Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study	LANCET			English	Article							RESOURCE-POOR SETTINGS; PLASMA VIRAL LOAD; PROGNOSTIC VALUE; GAMBIAN PATIENTS; CELL COUNT; SURVIVAL; MORTALITY; RNA; SEROCONVERSION; PREDICTORS	Background In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to investigate these risks in patients who had no access to ART or who were given zidovudine alone. Methods 6-month risks (%) of death, AIDS, and combined risk of AIDS and death (AIDS/death) were calculated according to CD4-cell count category of less than 200 cells per mu L, 200-350 cells per mu L, or greater than 350 cells per mu L, stratified by WHO clinical stages I and 2 combined, 3, or 4 in untreated patients (n=1399) seeking care in tertiary public-sector HIV clinics before widespread availability of ART in Cape Town, South Africa. Findings Risk of death for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 2.8% for 200-350 cells per mu L, and 1.2% for greater than 350 cells per mu L. The corresponding rates for WHO stage 3 were 10.8%, 4.3%, and 4.9% and for stage 4, 22.2%, 10.3%, and 13.8%. 52% (90) of deaths took place in patients without AIDS. 6-month risk of AIDS for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 1.6% for 200-350 cells per mu L, and zero for greater than 350 cells per mu L. The corresponding rates for those with WHO stage 3 disease were 17.4%, 7.0%, and 2.2%. Interpretation In this study, risk of AIDS in patients with a CD4-cell count of less than 200 cells per mu L or greater than 350 cells per mu L was similar to that previously reported from European cohorts, but was 1.9 times greater for those with CD4-cell counts of between 200 and 350 cells per mu L. The high death rate before development of AIDS and a high risk of AIDS in those with CD4-cell counts of 200-350 cells per mu L indicate that delay in initiation of ART is associated with increased morbidity and mortality. These findings might help to amend criteria for start of ART in resource-limited settings.	Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Badri, M (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	motasim.badri@hiv-research.org.za	Wood, Robin/G-8509-2011; Badri, Motasim/E-1141-2013	Badri, Motasim/0000-0002-5268-6492	Wellcome Trust [074641/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alabi AS, 2003, AIDS, V17, P1513, DOI 10.1097/00002030-200307040-00012; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bodri M, 2006, ANTIVIR THER, V11, P63; Bogaards JA, 2006, JAIDS-J ACQ IMM DEF, V41, P232, DOI 10.1097/01.qai.0000179457.46809.42; *BRIT HIV ASS, 2005, BHIVA GUID TREATM HI; CLEARY S, 2004, COST EFFECTIVENESS A; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; European AIDS Clinical Society, EUR GUID CLIN MAN TR; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lepri AC, 1998, AIDS, V12, P1639, DOI 10.1097/00002030-199813000-00011; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; Malamba SS, 1999, AIDS, V13, P2555, DOI 10.1097/00002030-199912240-00009; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Operskalski EA, 1997, J ACQ IMMUN DEF SYND, V15, P243; Post FA, 2001, S AFR MED J, V91, P583; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Ruiz L, 1996, AIDS, V10, pF39, DOI 10.1097/00002030-199609000-00001; Sabin CA, 1998, AIDS, V12, P1347, DOI 10.1097/00002030-199811000-00017; SCHLUCHTER MD, 1992, STAT MED, V11, P1861, DOI 10.1002/sim.4780111408; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; *US DEP HHS PAN CL, 2005, GUID US ANT AG HIV 1; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; *WHO GUID DEV GROU, 2005, ANT DRUGS TREATM HIV; *WHO UNAIDS, 2005, PRESS REL HIV INF RA; WHO/UNAIDS, 2005, PROGR GLOB ACC HIV A; Wood R, 2005, SAMJ S AFR MED J, V95, P926; World Health Organization, 2003, SCAL ANT THER RES LT	34	81	87	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1254	1259		10.1016/S0140-6736(06)69117-4	http://dx.doi.org/10.1016/S0140-6736(06)69117-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027731				2022-12-28	WOS:000241058300032
J	Naylor, AR				Naylor, A. Ross			SPACE: not the final frontier	LANCET			English	Editorial Material							ENDARTERECTOMY; SELECTION; TRIAL		Leicester Royal Infirm, Dept Vasc Surg, Leicester LE2 7LX, Leics, England	University of Leicester	Naylor, AR (corresponding author), Leicester Royal Infirm, Dept Vasc Surg, Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	ross.naylor@uhl-tr.nhs.uk						Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Hobson RW, 2004, J VASC SURG, V40, P1106, DOI 10.1016/j.jvs.2004.10.022; Mas JL, 2004, STROKE, V35, pE18, DOI 10.1161/01.STR.0000106913.33940.DD; Moore WS, 1996, J VASC SURG, V23, P323, DOI 10.1016/S0741-5214(96)70277-X; Roubin GS, 2006, CIRCULATION, V113, P2021, DOI 10.1161/CIRCULATIONAHA.105.595512; *SPACE COLL GROUP, 2006, LANCET          0810	7	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1215	1216		10.1016/s0140-6736(06)69123-X	http://dx.doi.org/10.1016/s0140-6736(06)69123-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027708				2022-12-28	WOS:000241058300005
J	Segawa, Y; Yamashita, M; Nozaki, K				Segawa, Yasutomo; Yamashita, Makoto; Nozaki, Kyoko			Boryllithium: Isolation, characterization, and reactivity as a boryl anion	SCIENCE			English	Article							CARBENE ANALOGS; BORON; COMPLEXES; PHOTOCHEMISTRY; IRRADIATION; GALLIUM; BORANES	Nucleophilic, anionic boryl compounds are long-sought but elusive species. We report that reductive cleavage of the boron-bromine bond in N,N'-bis(2,6-diisopropylphenyl)-2-bromo-2,3-dihydro-1H-1,3,2-diazaborole by lithium naphthalenide afforded the corresponding boryllithium, which is isoelectronic with an N-heterocyclic carbene. The structure of the boryllithium determined by x-ray crystallography was consistent with sp(2) boron hybridization and revealed a boron-lithium bond length of 2.291 +/- 0.006 angstroms. The structural similarity between this compound and the calculated free boryl anion suggests that the boron atom has an anionic charge. The B-11 nuclear magnetic resonance spectrum also supports the boryl anion character. Moreover, the compound behaves as an efficient base and nucleophile in its reactions with electrophiles such as water, methyl trifluoromethanesulfonate, 1-chlorobutane, and benzaldehyde.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo	Yamashita, M (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	makotoy@chembio.t.u-tokyo.ac.jp; nozaki@chembio.t.u-tokyo.ac.jp	Yamashita, Makoto/E-4607-2010; Liu, Shih/Q-1672-2019; Nozaki, kyoko/E-8779-2010; Heterocycles, BoronNitrogen/Q-1699-2019; Segawa, Yasutomo/F-4889-2010	Yamashita, Makoto/0000-0002-3665-5311; Nozaki, kyoko/0000-0002-0321-5299; Segawa, Yasutomo/0000-0001-6439-8546				Abrams MB, 2000, ORGANOMETALLICS, V19, P4944, DOI 10.1021/om0005351; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P6361, DOI 10.1021/ja00093a041; Arduengo AJ, 1999, TETRAHEDRON, V55, P14523, DOI 10.1016/S0040-4020(99)00927-8; AUTEN RW, 1952, J AM CHEM SOC, V74, P3398, DOI 10.1021/ja01133a053; BLUMENTHAL A, 1993, J ORGANOMET CHEM, V462, P107, DOI 10.1016/0022-328X(93)83347-X; BOYATZIS S, 1990, J ORG CHEM, V55, P4537, DOI 10.1021/jo00302a015; Braunschweig H, 2001, COORDIN CHEM REV, V223, P1, DOI 10.1016/S0010-8545(01)00378-2; BROTHERTON RJ, 1960, J AM CHEM SOC, V82, P6242, DOI 10.1021/ja01509a009; Dembitsky VM, 2004, ADV ORGANOMET CHEM, V51, P193, DOI 10.1016/S0065-3055(03)51005-X; EMSLEY J, 1998, ELEMENTS, P40; Fedushkin IL, 2003, EUR J INORG CHEM, P3336, DOI 10.1002/ejic.200300181; GRAGG BR, 1976, INORG CHEM, V15, P1209, DOI 10.1021/ic50159a047; GUNTER S, 1968, CHEM BER, V101, P2502; IMAMOTO T, 1994, J ORG CHEM, V59, P6753, DOI 10.1021/jo00101a040; Irvine GJ, 1998, CHEM REV, V98, P2685, DOI 10.1021/cr9500085; Katritzky A. R., 1988, ORGANOLITHIUM METHOD; KOSTER R, 1964, ANGEW CHEM INT EDIT, V3, P515, DOI 10.1002/anie.196405151; KOSTER R, 1963, ANGEW CHEM INT EDIT, V2, P219; Laidig KE, 1996, J COMPUT CHEM, V17, P1771; MARDER TB, 2005, PRODUCT SUBCLASS, V3, P117; Metzler-Nolte N, 1998, NEW J CHEM, V22, P793, DOI 10.1039/a803448f; NOTH H, 2005, PRODUCT SUBCLASS, V4, P139; PARSONS TD, 1967, J AM CHEM SOC, V89, P3446, DOI 10.1021/ja00990a015; RATH NP, 1988, J AM CHEM SOC, V110, P5345, DOI 10.1021/ja00224a019; Schmidt ES, 1999, J AM CHEM SOC, V121, P9758, DOI 10.1021/ja9928780; SMITH K, 1976, J CHEM SOC DALTON, P2297, DOI 10.1039/dt9760002297; Sundermann A, 1998, EUR J INORG CHEM, P305, DOI 10.1002/(SICI)1099-0682(199803)1998:3<305::AID-EJIC305>3.0.CO;2-0; Unverzagt M, 1997, ANGEW CHEM INT EDIT, V36, P1469, DOI 10.1002/anie.199714691; WAGNER M, 1995, INORG CHEM, V34, P607, DOI 10.1021/ic00107a013; Wanzlick H.W., 1962, ANGEW CHEM-GER EDIT, V1, P75, DOI DOI 10.1002/(ISSN)1521-3773; Weber L, 1997, CHEM BER-RECL, V130, P705, DOI 10.1002/cber.19971300606; Weber L, 1999, EUR J INORG CHEM, P491; Weber L, 2001, J CHEM SOC DALTON, P3459, DOI 10.1039/b106128n; WILKEY JD, 1987, J ORG CHEM, V52, P2117, DOI 10.1021/jo00387a001; WILLIAMS JL, 1967, J AM CHEM SOC, V89, P5153, DOI 10.1021/ja00996a013	36	395	395	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					113	115		10.1126/science.1131914	http://dx.doi.org/10.1126/science.1131914			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	091LU	17023656				2022-12-28	WOS:000241031200047
J	Schmidt, MW; Vautravers, MJ; Spero, HJ				Schmidt, Matthew W.; Vautravers, Maryline J.; Spero, Howard J.			Rapid subtropical North Atlantic salinity oscillations across Dansgaard-Oeschger cycles	NATURE			English	Article							FRESH-WATER BALANCE; THERMOHALINE CIRCULATION; OXYGEN-ISOTOPE; TRANSPORT; OCEAN	Geochemical and sedimentological evidence suggest that the rapid climate warming oscillations of the last ice age, the Dansgaard - Oeschger cycles(1), were coupled to fluctuations in North Atlantic meridional overturning circulation through its regulation of poleward heat flux(2). The balance between cold meltwater from the north and warm, salty subtropical gyre waters from the south influenced the strength and location of North Atlantic overturning circulation during this period of highly variable climate(3-5). Here we investigate how rapid reorganizations of the ocean atmosphere system across these cycles are linked to salinity changes in the subtropical North Atlantic gyre. We combine Mg/Ca palaeothermometry and oxygen isotope ratio measurements on planktonic foraminifera across four Dansgaard - Oeschger cycles (spanning 45.9 - 59.2 kyr ago) to generate a seawater salinity proxy record from a subtropical gyre deep-sea sediment core. We show that North Atlantic gyre surface salinities oscillated rapidly between saltier stadial conditions and fresher interstadials, covarying with inferred shifts in the Tropical Atlantic hydrologic cycle(6) and North Atlantic overturning circulation. These salinity oscillations suggest a reduction in precipitation into the North Atlantic and/or reduced export of deep salty thermohaline waters during stadials. We hypothesize that increased stadial salinities preconditioned the North Atlantic Ocean for a rapid return to deep overturning circulation and high-latitude warming by contributing to increased North Atlantic surface-water density on interstadial transitions.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Cambridge, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England	University of California System; University of California Davis; University of Cambridge	Schmidt, MW (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	mschmidt@eas.gatech.edu		Mleneck-Vautravers, Maryline/0000-0003-2534-219X; Spero, Howard/0000-0001-5465-8607				Boyle EA, 2000, QUATERNARY SCI REV, V19, P255, DOI 10.1016/S0277-3791(99)00065-7; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; DEUSER WG, 1981, PALAEOGEOGR PALAEOCL, V33, P103, DOI 10.1016/0031-0182(81)90034-1; Hastenrath S, 2002, INT J CLIMATOL, V22, P347, DOI 10.1002/joc.739; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lohmann G, 2003, TELLUS A, V55, P438, DOI 10.1034/j.1600-0870.2003.00028.x; OPPO DW, 1995, PALEOCEANOGRAPHY, V10, P901, DOI 10.1029/95PA02089; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Prange M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015337; Rasmussen TL, 2004, PALAEOGEOGR PALAEOCL, V210, P101, DOI 10.1016/j.palaeo.2004.04.005; Romanova V, 2004, CLIM DYNAM, V22, P527, DOI 10.1007/s00382-004-0395-z; Schmidt G. A., 1999, GLOBAL SEAWATER OXYG; Schmidt MW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000957; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schmittner A, 2000, GEOPHYS RES LETT, V27, P1163, DOI 10.1029/1999GL011048; SCHMITTNER A, 2002, PALEOCEANOGRAPHY, V17, DOI DOI 10.1029/2000PA; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Thunell R, 1999, GEOLOGY, V27, P843, DOI 10.1130/0091-7613(1999)027<0843:SSTAAW>2.3.CO;2; Vautravers MJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000966; Vellinga M, 2004, J CLIMATE, V17, P4498, DOI 10.1175/3219.1; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	30	70	73	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					561	564		10.1038/nature05121	http://dx.doi.org/10.1038/nature05121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024090				2022-12-28	WOS:000240988200040
J	Hayward, RA; Hofer, TP; Vijan, S				Hayward, Rodney A.; Hofer, Timothy P.; Vijan, Sandeep			Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; RANDOMIZED CONTROLLED-TRIALS; ESTROGEN PLUS PROGESTIN; HIGH-DOSE ATORVASTATIN; C-REACTIVE PROTEIN; BETA-CAROTENE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION	Recent national recommendations have proposed that physicians should titrate lipid therapy to achieve low-density lipoprotein (LDL) cholesterol levels less than 1.81 mmol/L (< 70 mg/dL) for patients at very high cardiovascular risk and less than 2.59 mmol/L (< 100 mg/dL) for patients at high cardiovascular risk. To examine the clinical evidence for these recommendations, the authors sought to review all controlled trials, cohort studies, and case-control studies that examined the independent relationship between LDL cholesterol and major cardiovascular outcomes in patients with LDL cholesterol levels less than 3.36 mmol/L (< 130 mg/dL). For those with LDL cholesterol levels less than 3.36 mmol/L (< 130 mg/dL), the authors found no clinical trial subgroup analyses or valid cohort or case-control analyses suggesting that the degree to which LDL cholesterol responds to a statin independently predicts the degree of cardiovascular risk reduction. Published studies had avoidable limitations, such as a reliance on ecological (aggregate) analyses, use of analyses that ignore statins other proposed mechanisms of action, and failure to account for known confounders (especially healthy volunteer effects). Clear, compelling evidence supports near-universal empirical statin therapy in patients at high cardiovascular risk (regardless of their natural LDL cholesterol values), but current clinical evidence does not demonstrate that titrating lipid therapy to achieve proposed low LDL cholesterol levels is beneficial or safe.	Dept Vet Affairs, VA Ctr Practive & Outcomes Res, VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48113 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hayward, RA (corresponding author), Dept Vet Affairs, VA Ctr Practive & Outcomes Res, VA Ann Arbor Healthcare Syst, POB 130170, Ann Arbor, MI 48113 USA.	rhayward@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787	NIDDK NIH HHS [P60 DK-20572] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AITKIN M, 1986, J ROY STAT SOC A STA, V149, P1, DOI 10.2307/2981882; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Barzi F, 2005, ANN EPIDEMIOL, V15, P405, DOI 10.1016/j.annepidem.2005.01.005; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chan PS, 2005, J AM COLL CARDIOL, V45, P1474, DOI 10.1016/j.jacc.2005.01.031; COLLEY CA, 1993, J GEN INTERN MED, V8, P278, DOI 10.1007/BF02600099; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738; HORWITZ RI, 1993, ARCH INTERN MED, V153, P1863, DOI 10.1001/archinte.153.16.1863; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LAW MR, 1994, EUR J CLIN NUTR, V48, P305; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Nakaya N, 2005, CIRC J, V69, P1016, DOI 10.1253/circj.69.1016; Nam BH, 2006, AM J CARDIOL, V97, P372, DOI 10.1016/j.amjcard.2005.08.055; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; SACKETT DL, 2000, EVIDENCE BASED MED H; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Snijders T, 1999, MULTILEVEL ANAL; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Tornwall ME, 2004, EUR HEART J, V25, P1171, DOI 10.1016/j.ehj.2004.05.007; Van De Wiel A, 2002, NETH J MED, V60, P4; Vasan RS, 2005, ANN INTERN MED, V142, P393, DOI 10.7326/0003-4819-142-6-200503150-00005; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Vijan S, 2000, DIABETOLOGIA, V43, P125, DOI 10.1007/s001250050017; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	53	126	130	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					520	530		10.7326/0003-4819-145-7-200610030-00010	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015870				2022-12-28	WOS:000241093900006
J	Rosenfield, A; Maine, D; Freedman, L				Rosenfield, Allan; Maine, Deborah; Freedman, Lynn			Meeting MDG-5: an impossible dream?	LANCET			English	Editorial Material							EMERGENCY OBSTETRIC CARE		Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA	Columbia University; Boston University	Freedman, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	lpf1@columbia.edu						ABOUZAHR C, 2003, BR MED B, V67, P15; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; *GOV IND MIN FAM H, 2005, NAT RUR HLTH MISS FR; *JHPIEGO, 2003, AV MAT DEATH DIS EM; Olsen OE, 2004, INT J GYNECOL OBSTET, V87, P98, DOI 10.1016/j.ijgo.2004.07.002; PADMANATHAN I, 2003, INVESTING MATERNAL H; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Ronsmans C, 2004, BJOG-INT J OBSTET GY, V111, P1027, DOI 10.1111/j.1471-0528.2004.00247.x; ROSENFIELD A, 1985, LANCET, V2, P83; Simwaka BN, 2005, BMJ-BRIT MED J, V331, P708, DOI 10.1136/bmj.331.7519.708; UN Millennium Project, 2005, WHOS GOT POW TRANSF; *UNICEF WHO UN POP, 1997, GUID MON AV US OBST; Wagstaff A, 2004, MILLENNIUM DEV GOALS; WBISPP (Wood Biomass Inventory and Strategic Planning Project), 2004, WOOD BIOM INV STRAT; *WHO UN POP FUND U, 2003, MAN COMPL PREGN CHIL; World Health Organization, 2005, WORLD HLTH REP 2005; 1997, INT J GYNAECOL OBSTE, V59, pS3; 2003, AVERTING MATERNAL DE; 2003, ENGENDERHEALTH AVERT	19	42	44	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1133	1135		10.1016/S0140-6736(06)69386-0	http://dx.doi.org/10.1016/S0140-6736(06)69386-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011925				2022-12-28	WOS:000240916000006
J	Duerr, RH; Taylor, KD; Brant, SR; Rioux, JD; Silverberg, MS; Daly, MJ; Steinhart, AH; Abraham, C; Regueiro, M; Griffiths, A; Dassopoulos, T; Bitton, A; Yang, HY; Targan, S; Datta, LW; Kistner, EO; Schumm, LP; Lee, AT; Gregersen, PK; Barmada, MM; Rotter, JI; Nicolae, DL; Cho, JH				Duerr, Richard H.; Taylor, Kent D.; Brant, Steven R.; Rioux, John D.; Silverberg, Mark S.; Daly, Mark J.; Steinhart, A. Hillary; Abraham, Clara; Regueiro, Miguel; Griffiths, Anne; Dassopoulos, Themistocles; Bitton, Alain; Yang, Huiying; Targan, Stephan; Datta, Lisa Wu; Kistner, Emily O.; Schumm, L. Philip; Lee, Annette T.; Gregersen, Peter K.; Barmada, M. Michael; Rotter, Jerome I.; Nicolae, Dan L.; Cho, Judy H.			A genome-wide association study identifies IL23R as an inflammatory bowel disease gene	SCIENCE			English	Article							ACTIVE CROHNS-DISEASE; AUTOIMMUNE INFLAMMATION; T-CELLS; IL-23; CYTOKINE; IL-12; SUSCEPTIBILITY; EXPRESSION; SUBUNIT; INTERLEUKIN-17	The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c. 1142G> A, p. Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohn's disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease.	Yale Univ, IBD Ctr, Sect Digest Dis, Dept Med, New Haven, CT 06519 USA; Univ Pittsburgh, Med Ctr, Sch Med,Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Div Gastroenterol, IBD Ctr, Los Angeles, CA 90048 USA; Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Montreal, Montreal, PQ H1T 1C8, Canada; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; MIT, Broad Inst, Med & Populat Genet Program, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Feinstein Inst Med Res, Manhasset, NY 11030 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Yale Univ, IBD Ctr, Sect Digest Dis, Dept Genet, New Haven, CT 06519 USA	Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Chicago; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Royal Victoria Hospital; Cedars Sinai Medical Center; University of Chicago; Northwell Health; University of Chicago; Yale University	Cho, JH (corresponding author), Yale Univ, IBD Ctr, Sect Digest Dis, Dept Med, S155A,300 Cedar St, New Haven, CT 06519 USA.	judy.cho@yale.edu	Rioux, John D/A-9599-2015; Rotter, Jerome/AAY-6598-2021; Duerr, Richard H/B-4188-2009; Daly, Mark J/B-2453-2017; Silverberg, Mark/B-4183-2008; Eckhardt, Erik/G-1567-2010	Rioux, John D/0000-0001-7560-8326; Duerr, Richard H/0000-0001-6586-3905; Daly, Mark J/0000-0002-0949-8752; Nicolae, Dan/0000-0002-0918-4630; Schumm, Phil/0000-0002-3050-2429; Barmada, M Michael/0000-0002-3604-6460	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062423, P30DK063491, U01DK062431, U01DK062413, U01DK062429, U01DK062420, U01DK062432, U01DK062422] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK062413, U01 DK062420, U01 DK062423, DK62431, DK62423, DK62413, DK62432, P30 DK063491-049004, DK62429, U01 DK062429, U01 DK062422, P30 DK063491-039004, U01 DK062432, P30 DK063491-019004, P30 DK063491-029004, DK62422, U01 DK062431, P30 DK063491, DK62420] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nadeau JH, 2006, NAT GENET, V38, P1095, DOI 10.1038/ng1006-1095; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang XY, 2006, IMMUNOGENETICS, V57, P934, DOI 10.1007/s00251-005-0067-0	28	2243	2372	4	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1461	1463		10.1126/science.1135245	http://dx.doi.org/10.1126/science.1135245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17068223	Green Accepted			2022-12-28	WOS:000242406100044
J	Cazenave, A				Cazenave, Anny			How fast are the ice sheets melting?	SCIENCE			English	Editorial Material							SEA-LEVEL RISE; MASS-LOSS; GREENLAND; ANTARCTICA; BALANCE		Observ Midi Pyrenees, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cazenave, A (corresponding author), Observ Midi Pyrenees, F-31400 Toulouse, France.	anny.cazenave@cnes.fr						Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; Chen JL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026369; Chen JL, 2006, SCIENCE, V313, P1958, DOI 10.1126/science.1129007; Church JA, 2004, J CLIMATE, V17, P2609, DOI 10.1175/1520-0442(2004)017<2609:EOTRDO>2.0.CO;2; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; DYURGEROV M, 2005, INSTAAR; Holgate SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019626; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; LOMBARD A, IN PRESS OCEAN DYN; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; RAMILLIEN G, IN PRESS GLOBAL PLAN; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007	20	56	58	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1250	1252		10.1126/science.1133325	http://dx.doi.org/10.1126/science.1133325			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17053111				2022-12-28	WOS:000242215800028
J	Luthcke, SB; Zwally, HJ; Abdalati, W; Rowlands, DD; Ray, RD; Nerem, RS; Lemoine, FG; McCarthy, JJ; Chinn, DS				Luthcke, S. B.; Zwally, H. J.; Abdalati, W.; Rowlands, D. D.; Ray, R. D.; Nerem, R. S.; Lemoine, F. G.; McCarthy, J. J.; Chinn, D. S.			Recent Greenland ice mass loss by drainage system from satellite gravity observations	SCIENCE			English	Article							SHEET; SURFACE; BALANCE; VARIABILITY; GRACE; EARTH	Mass changes of the Greenland Ice Sheet resolved by drainage system regions were derived from a local mass concentration analysis of NASA - Deutsches Zentrum fur Luft- und Raumfahrt Gravity Recovery and Climate Experiment ( GRACE mission) observations. From 2003 to 2005, the ice sheet lost 101 +/- 16 gigaton/year, with a gain of 54 gigaton/year above 2000 meters and a loss of 155 gigaton/year at lower elevations. The lower elevations show a large seasonal cycle, with mass losses during summer melting followed by gains from fall through spring. The overall rate of loss reflects a considerable change in trend ( - 113 +/- 17 gigaton/ year) from a near balance during the 1990s but is smaller than some other recent estimates.	NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Cryospher Sci Branch, Greenbelt, MD 20771 USA; Univ Colorado, Dept Aerosp Engn Sci, Cooperat Inst Res Environm Sci, Colorado Ctr Astrodynam Res, Boulder, CO 80309 USA; SGT Inc, Div Sci, Greenbelt, MD 20770 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Colorado System; University of Colorado Boulder; Stinger Ghaffarian Technologies, Inc. (SGT)	Luthcke, SB (corresponding author), NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Code 698, Greenbelt, MD 20771 USA.	Scott.B.Luthcke@nasa.gov	Lemoine, Frank/D-1215-2013; Luthcke, Scott B/D-6283-2012; Ray, Richard/D-1034-2012; Rowlands, David/D-2751-2012	Lemoine, Frank G./0000-0002-3051-1456				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Box JE, 2006, J CLIMATE, V19, P2783, DOI 10.1175/JCLI3738.1; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; Chen JL, 2006, SCIENCE, V313, P1958, DOI 10.1126/science.1129007; Ekstrom G, 2006, SCIENCE, V311, P1756, DOI 10.1126/science.1122112; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Luthcke SB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024846; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; RAMILLIEN G, 2006, J GLOBAL PLANET CHAN, V53, DOI DOI 10.1016/J.GLOPLACHA.2006.06.003; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rowlands DD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021908; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Thomas R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026075; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2000, ANN GLACIOL-SER, V31, P126, DOI 10.3189/172756400781820318	20	280	295	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1286	1289		10.1126/science.1130776	http://dx.doi.org/10.1126/science.1130776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17053112				2022-12-28	WOS:000242215800039
J	Harrington, J; Hansen, BM; Luszcz, SH; Seager, S; Deming, D; Menou, K; Cho, JYK; Richardson, LJ				Harrington, Joseph; Hansen, Brad M.; Luszcz, Statia H.; Seager, Sara; Deming, Drake; Menou, Kristen; Cho, James Y. -K.; Richardson, L. Jeremy			The phase-dependent infrared brightness of the extrasolar planet upsilon Andromedae b	SCIENCE			English	Article							THERMAL EMISSION; TRES-1; STARS	The star upsilon Andromedae is orbited by three known planets, the innermost of which has an orbital period of 4.617 days and a mass at least 0.69 that of Jupiter. This planet is close enough to its host star that the radiation it absorbs overwhelms its internal heat losses. Here, we present the 24-micrometer light curve of this system, obtained with the Spitzer Space Telescope. It shows a variation in phase with the orbital motion of the innermost planet, demonstrating that such planets possess distinct hot substellar ( day) and cold antistellar ( night) faces.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; Columbia Univ, Dept Astron, New York, NY 10027 USA; Univ London, Queen Mary, Sch Math Sci, Astron Unit, London E1 4NS, England; NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Central Florida; Cornell University; University of California System; University of California Berkeley; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of London; Queen Mary University London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Hansen, BM (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	hansen@astro.ucla.edu	Harrington, Joseph/E-6250-2011					Barman TS, 2005, ASTROPHYS J, V632, P1132, DOI 10.1086/444349; Burrows A, 2005, ASTROPHYS J, V625, pL135, DOI 10.1086/431242; Butler RP, 1997, ASTROPHYS J, V474, pL115, DOI 10.1086/310444; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Cho JYK, 2003, ASTROPHYS J, V587, pL117, DOI 10.1086/375016; Cooper CS, 2005, ASTROPHYS J, V629, pL45, DOI 10.1086/444354; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fortney JJ, 2005, ASTROPHYS J, V627, pL69, DOI 10.1086/431952; Henry GW, 2000, ASTROPHYS J, V531, P415, DOI 10.1086/308466; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; RICHARDSON LJ, ASTROPHYS J; Rieke GH, 2004, PROC SPIE, V5487, P50, DOI 10.1117/12.551965; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Shkolnik E, 2005, ASTROPHYS J, V622, P1075, DOI 10.1086/428037	18	177	181	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					623	626		10.1126/science.1133904	http://dx.doi.org/10.1126/science.1133904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17038587	Green Submitted			2022-12-28	WOS:000241557800039
J	May, M; Davis, J; Jeanloz, R				May, Michael; Davis, Jay; Jeanloz, Raymond			Preparing for the worst	NATURE			English	Editorial Material									Stanford Univ, Lawrence Livermore Natl Lab, Stanford, CA 94305 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	May, M (corresponding author), Stanford Univ, Lawrence Livermore Natl Lab, Stanford, CA 94305 USA.							BUNN M, 2005, SECURING BOMB 2005 N; *CISAC NAT AC SCI, 2005, MON NUCL WEAP NUCL E; KRISTO MJ, 2004, UCRLTR202675 LAWR LI; Moody K.J., 2015, NUCL FORENSIC ANAL	4	10	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					907	908		10.1038/443907a	http://dx.doi.org/10.1038/443907a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066010				2022-12-28	WOS:000241523400023
J	Stuessy, TF				Stuessy, Tod F.			Evolutionary biology - Sympatric plant speciation in islands?	NATURE			English	Letter									Univ Vienna, Dept Systemat & Evolutionary Bot, A-1030 Vienna, Austria	University of Vienna	Stuessy, TF (corresponding author), Univ Vienna, Dept Systemat & Evolutionary Bot, Waehringer Guertel 18, A-1030 Vienna, Austria.	tod.stuessy@univie.ac.at						Crawford D. J., 1997, EVOLUTION DIVERSIFIC, P249; Parsons YM, 2001, MOL ECOL, V10, P1765, DOI 10.1046/j.1365-294X.2001.01318.x; Sanders R. W., 1987, OPERA BOT, V92, P195; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Stuessy T.F., 1998, EVOLUTION SPECIATION, P121; STUESSY TF, 1984, SCIENCE, V225, P49, DOI 10.1126/science.225.4657.49; STUESSY TF, 2005, BIOL SKRIFT, V55, P89	7	34	35	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114								10.1038/nature05216	http://dx.doi.org/10.1038/nature05216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17065986	Bronze			2022-12-28	WOS:000241523400042
J	Ranji, SR; Goldman, LE; Simel, DL; Shojania, KG				Ranji, Sumant R.; Goldman, L. Elizabeth; Simel, David L.; Shojania, Kaveh G.			Do opiates affect the clinical evaluation of patients with acute abdominal pain?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-EXAMINATION; ACUTE APPENDICITIS; ACUTE ABDOMEN; NEGATIVE APPENDECTOMY; MEDICINE PHYSICIANS; DIAGNOSTIC-ACCURACY; PERFORATION RATES; RANDOMIZED-TRIAL; EMERGENCY-ROOM; ANALGESIA	Context Clinicians have traditionally withheld opiate analgesia from patients with acute abdominal pain until after evaluation by a surgeon, out of concern that analgesia may alter the physical findings and interfere with diagnosis. Objective To determine the impact of opiate analgesics on the rational clinical examination and operative decision for patients with acute abdominal pain. Data Sources and Study Selection MEDLINE (through May 2006), EMBASE, and hand searches of article bibliographies to identify placebo-controlled randomized trials of opiate analgesia reporting changes in the history, physical examination findings, or diagnostic errors (those resulting in "management errors," defined as the performance of unnecessary surgery or failure to perform necessary surgery in a timely fashion). Data Extraction Two authors independently reviewed each study, abstracted data, and classified study quality. A third reviewer independently resolved discrepancies. Data Synthesis Studies both in adults (9 trials) and in children (3 trials) showed trends toward increased risks of altered findings on the abdominal examination due to opiate administration, with risk ratios for changes in the examination of 1.51 (95% confidence interval [CI], 0.85 to 2.69) and 2.11 (95% CI, 0.60 to 7.35), respectively. When the analysis was restricted to the 8 adult and pediatric trials that reported significantly greater analgesia for patients who received opiates compared with those who received placebo, the risk of physical examination changes became significant (risk ratio, 2.13; 95% CI, 1.14 to 3.98). These trials exhibited significant heterogeneity (I-2 = 68.6%; P =. 002), and only 2 trials distinguished clinically significant changes such as loss of peritoneal signs from all other changes; consequently, we analyzed risk of management errors as a marker for important changes in the physical examination. Opiate administration had no significant association with management errors (+0.3% absolute increase; 95% CI, -4.1% to +4.7%). The 3 pediatric trials showed a nonsignificant absolute decrease in management errors (-0.8%; 95% CI, -8.6% to +6.9%). Across adult and pediatric trials with adequate analgesia, opiate administration was associated with a nonsignificant absolute decrease in the risk of management errors (-0.2%; 95% CI, -4.0% to +3.6%). Conclusions Opiate administration may alter the physical examination findings, but these changes result in no significant increase in management errors. The existing literature does not rule out a small increase in errors, but this error rate reflects a conservative definition in which surgeries labeled as either delayed or unnecessary may have met appropriate standards of care. In published research reports, no patient experienced major morbidity or mortality attributable to opiate administration.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Duke Univ, Dept Med, Durham, NC USA; Durham Vet Affairs Med Ctr, Durham, NC USA; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of California System; University of California San Francisco; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Ranji, SR (corresponding author), Univ Calif San Francisco, Dept Med, 533 Parnassus Ave,Box 0131, San Francisco, CA 94143 USA.	sumantr@medicine.ucsf.edu						Armstrong FD, 2005, PEDIATRICS, V116, P1018, DOI 10.1542/peds.2005-1719; ATTARD AR, 1992, BRIT MED J, V305, P554, DOI 10.1136/bmj.305.6853.554; Aydelotte Jayson D, 2004, Curr Surg, V61, P373, DOI 10.1016/j.cursur.2004.01.008; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; BREWER RJ, 1976, AM J SURG, V131, P219, DOI 10.1016/0002-9610(76)90101-X; Brunicardi FC, 2005, SCHWARTZS PRINCIPLES, V8th; Centers for Disease Control and Prevention Ambulatory and Hospital Care Statistics Branch, NAT HOSP AMB MED CAR; Chong CF, 2004, EMERG MED J, V21, P41, DOI 10.1136/emj.2003.004853; Cope Z., 1987, COPES EARLY DIAGNOSI, V17th, P36; Doherty G., 2006, CURRENT SURG DIAGNOS; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; GARYFALLOU GT, 1997, ACAD EMERG MED, V4, P424; Graber MA, 1999, AM J EMERG MED, V17, P113, DOI 10.1016/S0735-6757(99)90039-6; Green R, 2005, PEDIATRICS, V116, P978, DOI 10.1542/peds.2005-0273; Hale DA, 1997, ANN SURG, V225, P252, DOI 10.1097/00000658-199703000-00003; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; IRVIN TT, 1989, BRIT J SURG, V76, P1121, DOI 10.1002/bjs.1800761105; Kim MK, 2002, ACAD EMERG MED, V9, P281, DOI 10.1111/j.1553-2712.2002.tb01319.x; Kokki H, 2005, ARCH PEDIAT ADOL MED, V159, P320, DOI 10.1001/archpedi.159.4.320; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; Lee JS, 2000, ACAD EMERG MED, V7, P980, DOI 10.1111/j.1553-2712.2000.tb02087.x; Lovecchio Frank, 1997, Journal of Emergency Medicine, V15, P775, DOI 10.1016/S0736-4679(97)00183-2; Mahadevan M, 2000, AM J EMERG MED, V18, P753, DOI 10.1053/ajem.2000.16315; Nelson BP, 2005, J EMERG MED, V28, P409, DOI 10.1016/j.jemermed.2004.12.009; Nissman SA, 2003, AM J SURG, V185, P291, DOI 10.1016/S0002-9610(02)01412-5; Pace S, 1996, ACAD EMERG MED, V3, P1086, DOI 10.1111/j.1553-2712.1996.tb03365.x; Pappagallo M., 2005, NEUROLOGICAL BASIS P; PETERSON MC, 1992, WESTERN J MED, V156, P163; Pines J, 2005, AM J EMERG MED, V23, P483, DOI 10.1016/j.ajem.2004.09.034; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; RICH EC, 1987, ARCH INTERN MED, V147, P1957, DOI 10.1001/archinte.147.11.1957; Roshan M, 2000, J Assoc Physicians India, V48, P771; Shabbir J, 2004, EUR J EMERG MED, V11, P309, DOI 10.1097/00063110-200412000-00002; Tait IS, 1999, J ROY COLL SURG EDIN, V44, P181; Thomas SH, 2003, BRIT J SURG, V90, P5, DOI 10.1002/bjs.4009; Thomas SH, 2003, J AM COLL SURGEONS, V196, P18, DOI 10.1016/S1072-7515(02)01480-1; Townsend CM, 2001, SABISTON TXB SURG, V16th, P1421; Vermeulen B, 1999, RADIOLOGY, V210, P639, DOI 10.1148/radiology.210.3.r99fe54639; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Wolfe JM, 2004, AM J EMERG MED, V22, P280, DOI 10.1016/j.ajem.2004.02.015; Wolfe JM, 2000, AM J EMERG MED, V18, P250, DOI 10.1016/S0735-6757(00)90114-1; ZOLTIE N, 1986, ANN ROY COLL SURG, V68, P209; [No title captured]	43	50	53	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1764	1774		10.1001/jama.296.14.1764	http://dx.doi.org/10.1001/jama.296.14.1764			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032990				2022-12-28	WOS:000241103400025
J	Stenestrand, U; Lindback, J; Wallentin, L				Stenestrand, Ulf; Lindback, Johan; Wallentin, Lars		RIKS-HIA Registry	Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REAL-LIFE PATIENTS; PRIMARY ANGIOPLASTY; FIBRINOLYTIC THERAPY; CLINICAL-TRIALS; TIME-DELAY; MORTALITY; IMPACT; SURVIVAL; SALVAGE; WORLD	Context Whether the superior results of percutaneous coronary intervention (PCI) reported in clinical trials in which patients with ST-segment elevation myocardial infarction (STEMI) received reperfusion treatment can be replicated in daily practice has been questioned, especially whether it is superior to prehospital thrombolysis (PHT). Objective To evaluate the outcome of different reperfusion strategies in consecutive STEMI patients. Design, Setting, and Patients A prospective observational cohort study of 26 205 consecutive STEMI patients in the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA) who received reperfusion therapy within 15 hours of symptom onset. The registry includes more than 95% of all Swedish patients, of all ages, who were treated in a coronary intensive care unit between 1999 and 2004. Interventions Seven thousand eighty-four patients underwent primary PCI; 3078, PHT; and 16 043, in-hospital thrombolysis (IHT). Main Outcome Measures Mortality, reinfarction, and readmissions as reported in the National Health Registries through December 31, 2005. Results After adjusting for younger age and less comorbidity, primary PCI was associated with lower mortality than IHT at 30 days (344 [4.9%] vs 1834 [11.4%]; hazard ratio [HR], 0.61; 95% confidence interval [CI], 0.53-0.71) and at 1 year (541 [7.6%] vs 2555 [15.9%]; HR, 0.68; 95% CI, 0.60-0.76). Also primary PCI correlated with lower mortality than PHT at 30 days (344 [4.9%] vs 234 [7.6%]; HR, 0.70; 95% CI, 0.58-0.85) and 1 year (541 [ 7.6%] vs 317 [10.3%]; HR, 0.81; 95% CI, 0.69-0.94). Prehospital thrombolysis predicted a lower mortality than IHT at 30 days (HR, 0.87; 95% CI, 0.76-1.01) and at 1 year (HR, 0.84; CI 0.74-0.95). Beyond 2 hours' treatment delay, the observed mortality reductions with PHT tended to decrease while the benefits with primary PCI seemed to remain regardless of time delay. Primary PCI was also associated with shorter hospital stay and less reinfarction than either PHT or IHT. Conclusions In unselected patients with STEMI, primary PCI, which compared favorably with IHT and PHT, was associated with reduced duration of hospital stay, readmission, reinfarction, and mortality.	Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden; Uppsala Univ, Uppslaa Clin Res Ctr, Uppsala, Sweden	Uppsala University	Stenestrand, U (corresponding author), Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden.	stenestrand@rlks-hia.se	Lindbäck, Johan/R-2900-2017	Lindbäck, Johan/0000-0002-6473-8798				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Bjorklund E, 2006, EUR HEART J, V27, P1146, DOI 10.1093/eurheartj/ehi886; Bjorklund E, 2005, J ELECTROCARDIOL, V38, P186, DOI 10.1016/j.jelectrocard.2005.06.032; Bjorklund E, 2004, AM HEART J, V148, P566, DOI 10.1016/j.ahj.2004.04.014; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Danchin N, 1999, CIRCULATION, V99, P2639, DOI 10.1161/01.CIR.99.20.2639; Danchin N, 2004, CIRCULATION, V110, P1909, DOI 10.1161/01.CIR.0000143144.82338.36; GERSH BJ, 1993, CIRCULATION, V88, P296, DOI 10.1161/01.CIR.88.1.296; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; Nallamothu BK, 2004, AM J CARDIOL, V94, P772, DOI 10.1016/j.amjcard.2004.05.064; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Schomig A, 2003, CIRCULATION, V108, P1084, DOI 10.1161/01.CIR.0000086346.32856.9C; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stenestrand U, 2005, CIRCULATION, V112, P3225, DOI 10.1161/CIRCULATIONAHA.105.552984; Stenestrand U, 2005, AM HEART J, V149, P82, DOI 10.1016/j.ahj.2004.07.018; Stenestrand U, 2003, ARCH INTERN MED, V163, P965, DOI 10.1001/archinte.163.8.965; Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Widimsky P, 2001, EUR HEART J SUPPL, V3, pC47, DOI 10.1016/S1520-765X(01)90029-X; Zahn R, 2001, AM HEART J, V142, P105, DOI 10.1067/mhj.2001.115585; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	35	201	215	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1749	1756		10.1001/jama.296.14.1749	http://dx.doi.org/10.1001/jama.296.14.1749			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032988	Bronze			2022-12-28	WOS:000241103400023
J	Reeve, J				Reeve, Jonathan			Institutional reviews and innovation in clinical research	LANCET			English	Editorial Material							IMPACT		Addenbrookes Hosp, Univ Dept Med, Bone Div, Cambridge CB2 2QQ, England	Addenbrooke's Hospital; University of Cambridge	Reeve, J (corresponding author), Addenbrookes Hosp, Univ Dept Med, Bone Div, Box 157, Cambridge CB2 2QQ, England.	jonathan.reeve@srl.cam.ac.uk	Reeve, Jonathan/C-7551-2012	Reeve, Jonathan/0000-0002-4364-2682				ABT HA, 1997, NATURE, V395, P756; Academy of Medical Sciences (AMS), 2006, UK EV FOR MED RES AS; Banatvala J, 2005, LANCET, V365, P458; CUTSHALL TJ, 2006, REFORM HIGHER ED RES; GRANT J, 2005, OPTIONS FUTURE MRC R; *HM TREAS DEP ED S, 2006, SCI INV INN FRAM 200; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Peters K, 2004, LANCET, V364, P2142, DOI 10.1016/S0140-6736(04)17556-9; Reeve J, 2006, RHEUMATOLOGY, V45, P646, DOI 10.1093/rheumatology/kel035; Seglen PO, 1997, BRIT MED J, V314, P498	11	0	0	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1223	1224		10.1016/S0140-6736(06)69499-3	http://dx.doi.org/10.1016/S0140-6736(06)69499-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027713				2022-12-28	WOS:000241058300010
J	Ginsburg, GS; Angrist, M; Cook-Deegan, R				Ginsburg, Geoffrey S.; Angrist, Misha; Cook-Deegan, Robert			Genomics and medicine at a crossroads in Chernobyl	SCIENCE			English	Editorial Material							CLEANUP WORKERS; IONIZING-RADIATION; IRRADIATION; ACCIDENT; CELLS		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Ginsburg, GS (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237				BELLABY MD, 2006, ASS PRESS       0422; Braselmann H, 2005, MUTAT RES-FUND MOL M, V578, P124, DOI 10.1016/j.mrfmmm.2005.04.006; *CHERN FOR, 2005, CHERN LEG HLTH ENV S; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; Eged K, 2001, HEALTH PHYS, V80, P137, DOI 10.1097/00004032-200102000-00004; Gluzman D, 2005, HEMATOL J, V5, P565, DOI 10.1038/sj.thj.6200568; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Herodin F, 2005, FOLIA HISTOCHEM CYTO, V43, P223; *ICRP, 2005, OPT RAD PROT; Jacquet P, 2004, J BIOL REG HOMEOS AG, V18, P106; Kellerer AM, 2002, RADIAT ENVIRON BIOPH, V41, P1, DOI 10.1007/s00411-002-0150-y; KRUSHELNYCKY A, 2006, SUNDAY TIMES    0423; Mazurik V K, 2004, Radiats Biol Radioecol, V44, P296; Neronova E, 2003, RADIAT RES, V160, P46, DOI 10.1667/0033-7587(2003)160[0046:CAICWS]2.0.CO;2; Rahu M, 2006, INT J CANCER, V119, P162, DOI 10.1002/ijc.21733; Rahu M, 2003, EUR J CANCER, V39, P295, DOI 10.1016/S0959-8049(02)00764-5; SCHMIEMAN EA, 2006, NUCL ENG INT    0406; Silasi G, 2004, BIOCHEM BIOPH RES CO, V325, P1223, DOI 10.1016/j.bbrc.2004.10.166; Smith MT, 2005, CHEM-BIOL INTERACT, V153, P123, DOI 10.1016/j.cbi.2005.03.017; Stone R, 2006, SCIENCE, V312, P180, DOI 10.1126/science.312.5771.180; Touil N, 2002, MUTAGENESIS, V17, P223, DOI 10.1093/mutage/17.3.223	21	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					62	63		10.1126/science.1130274	http://dx.doi.org/10.1126/science.1130274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023637				2022-12-28	WOS:000241031200028
J	Yang, LQ; Lin, CR; Liu, ZR				Yang, Liuqing; Lin, Chunru; Liu, Zhi-Ren			P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from beta-catenin	CELL			English	Article							SRC FAMILY KINASES; GROWTH-FACTOR-BETA; C-ABL; TYROSINE PHOSPHORYLATION; TUMOR-METASTASIS; DNA-DAMAGE; PROTEIN; EXPRESSION; WNT; DIFFERENTIATION	The nuclear p68 RNA helicase (referred to as p68) is a prototypical member of the DEAD box family of RNA helicases. The protein plays a very important role in early organ development. In the present study, we characterized the tyrosine phosphorylation of p68 under platelet-derived growth factor (PDGF) stimulation. We demonstrated that tyrosine phosphorylation of p68 at Y593 mediated PDGF-stimulated epithelial-mesenchymal transition (EMT). We showed that PDGF treatment led to phosphorylation of p68 at Y593 in the cell nucleus. The Y593-phosphorylated p68 (referred to as phosphor-p68) promotes beta-catenin nuclear translocation via a Wnt-independent pathway. The phosphor-p68 facilitates beta-catenin nuclear translocation by blocking phosphorylation of beta-catenin by GSK-3 beta and displacing Axin from beta-catenin. The beta-catenin nuclear translocation and subsequent interaction with the LEF/TCF was required for the EMT process. These data demonstrated a novel mechanism of phosphor-p68 in mediating the growth factor-induced EMT and uncovered a new pathway to promote beta-catenin nuclear translocation.	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Yang, LQ (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza, Atlanta, GA 30303 USA.	biozrl@langate.gsu.edu	Yang, Liuqing/B-7935-2011		NIGMS NIH HHS [GM063874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; CALUSEVIC M, 2001, ONCOGENE, V20, P7734; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Hirabayashi S, 2004, J NEUROCHEM, V90, P332, DOI 10.1111/j.1471-4159.2004.02497.x; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kahlina K, 2004, J BIOL CHEM, V279, P44872, DOI 10.1074/jbc.M402467200; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu ZR, 1998, MOL CELL BIOL, V18, P6910, DOI 10.1128/MCB.18.12.6910; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; NESON WJ, 2004, SCIENCE, V303, P1483; Nicol SM, 2000, EXP CELL RES, V257, P272, DOI 10.1006/excr.2000.4886; Pagan R, 1999, J HEPATOL, V31, P895, DOI 10.1016/S0168-8278(99)80292-X; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seufert DW, 2000, J EXP ZOOL, V288, P193, DOI 10.1002/1097-010X(20001015)288:3<193::AID-JEZ1>3.0.CO;2-V; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wei Y, 2001, Yi Chuan Xue Bao, V28, P991; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang LQ, 2004, PROTEIN EXPRES PURIF, V35, P327, DOI 10.1016/j.pep.2004.02.004; Yang LQ, 2004, BIOCHEM BIOPH RES CO, V314, P622, DOI 10.1016/j.bbrc.2003.12.129; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	50	228	236	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					139	155		10.1016/j.cell.2006.08.036	http://dx.doi.org/10.1016/j.cell.2006.08.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018282	Bronze			2022-12-28	WOS:000241445800020
J	Maggiorini, M; Brunner-La Rocca, HP; Peth, S; Fischler, M; Bohm, T; Bernheim, A; Kiencke, S; Bloch, KE; Dehnert, C; Naeije, R; Lehmann, T; Bartsch, P; Mairbaurl, H				Maggiorini, Marco; Brunner-La Rocca, Hans-Peter; Peth, Simon; Fischler, Manuel; Boehm, Thomas; Bernheim, Alain; Kiencke, Stefanie; Bloch, Konrad E.; Dehnert, Christoph; Naeije, Robert; Lehmann, Thomas; Baertsch, Peter; Mairbaeurl, Heimo			Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MOUNTAIN-SICKNESS; ALVEOLAR EPITHELIAL SODIUM; EXHALED NITRIC-OXIDE; SYMPATHETIC ACTIVATION; CONTROLLED CROSSOVER; FLUID TRANSPORT; DOUBLE-BLIND; SWISS ALPS; HYPOXIA; ACETAZOLAMIDE	Background: High-altitude pulmonary edema (HAPE) is caused by exaggerated hypoxic pulmonary vasoconstriction associated with decreased bioavailability of nitric oxide in the lungs and by impaired reabsorption of alveolar fluid. Objective: To investigate whether dexamethasone or tadalafil reduces the incidence of HAPE and acute mountain sickness (AAAS) in adults with a history of HAPE. Design: Randomized, double-blind, placebo-controlled study performed in summer 2003. Setting: Ascent from 490 in within 24 hours and stay for 2 nights at 4559 in. Patients: 29 adults with previous HAPE. Intervention: Prophylactic tadalafil (10 mg), dexamethasone (8 mg), or placebo twice daily during ascent and stay at 4559 m. Measurements: Chest radiography was used to diagnose HAPE. A Lake Louise score greater than 4 defined AMS. Systolic pulmonary artery pressure was measured by using Doppler echocardiography, and nasal potentials were measured as a surrogate marker of alveolar sodium transport. Results, Two participants who received tadalafil developed severe AMS on arrival at 4559 m and withdrew from the study; they did not have HAPE at that time. High-altitude pulmonary edema developed in 7 of 9 participants receiving placebo and 1 of the remaining 8 participants receiving tadalafil but in none of the 10 participants receiving dexamethasone (P = 0.007 for tadalafil vs. placebo; P < 0.001 for dexamethasone vs. placebo). Eight of 9 participants receiving placebo, 7 of 10 receiving tadalafil, and 3 of 10 receiving dexamethasone had AMS (P = 1.0 for tadalafil vs. placebo; P = 0.020 for dexamethasone vs. placebo). At high altitude, systolic pulmonary artery pressure increased less in participants receiving dexamethasone (16 mm Hg [95% Cl, 9 to 23 mm Hg]) and tadalafil (13 mm Hg [Cl, 6 to 20 mm Hg]) than in those receiving placebo (28 mm Hg [Cl, 20 to 36 min Hg]) (P = 0.005 for tadalafil vs. placebo; P = 0.012 for dexamethasone vs. placebo). No statistically significant difference between groups was found in change in nasal potentials and expression of leukocyte sodium transport protein messenger RNA. Limitations: The study involved a small sample of adults with a history of HAPE. Conclusions: Both dexamethasone and tadalafil decrease systolic pulmonary artery pressure and may reduce the incidence of HAPE in adults with a history of HAPE. Dexamethasone prophylaxis may also reduce the incidence of AMS in these adults.	Univ Zurich Hosp, Dept Internal Med, Intens Care Unit, CH-8091 Zurich, Switzerland; Univ Basel Hosp, CH-4031 Basel, Switzerland; Kantonsspital Chur, Chur, Switzerland; Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; Heidelberg Univ, Med Clin 7, D-6900 Heidelberg, Germany	University of Zurich; University Zurich Hospital; University of Basel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Ruprecht Karls University Heidelberg	Maggiorini, M (corresponding author), Univ Zurich Hosp, Dept Internal Med, Intens Care Unit, Ramistr 100, CH-8091 Zurich, Switzerland.	klinmax@usz.unizh.ch	Brunner-La Rocca, Hans-Peter/AAF-7330-2021	Maggiorini, Marco/0000-0001-8180-2117				Asoh K, 2000, PEDIATR RES, V48, P91, DOI 10.1203/00006450-200007000-00016; BARTSCH P, 1990, J WILDERNESS MED, V1, P162, DOI 10.1580/0953-9859-1.3.162; Bartsch P, 2003, SWISS MED WKLY, V133, P377; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Berg JT, 2004, WILD ENVIRON MED, V15, P32, DOI 10.1580/1080-6032(2004)015[0032:IOHPVP]2.0.CO;2; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; DAWSON CA, 1984, PHYSIOL REV, V64, P544, DOI 10.1152/physrev.1984.64.2.544; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039; ELLSWORTH AJ, 1987, AM J MED, V83, P1024, DOI 10.1016/0002-9343(87)90937-5; FERRAZZINI G, 1987, BRIT MED J, V294, P1380, DOI 10.1136/bmj.294.6584.1380; FORWAND SA, 1968, NEW ENGL J MED, V279, P839, DOI 10.1056/NEJM196810172791601; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Goth MI, 2003, MICROSC RES TECHNIQ, V60, P98, DOI 10.1002/jemt.10248; GREENE MK, 1981, BRIT MED J, V283, P811, DOI 10.1136/bmj.283.6295.811; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HAYCOOK K, 1993, STATVIEW ULTIMATE IN; HOHENHAUS E, 1994, AM J RESP CRIT CARE, V150, P857, DOI 10.1164/ajrccm.150.3.8087361; Hohne C, 2004, J APPL PHYSIOL, V97, P515, DOI 10.1152/japplphysiol.01217.2003; Hopkins SR, 2005, AM J RESP CRIT CARE, V171, P83, DOI 10.1164/rccm.200406-707OC; JOHNSON TS, 1984, NEW ENGL J MED, V310, P683, DOI 10.1056/NEJM198403153101103; JOHNSON TS, 1988, AVIAT SPACE ENVIR MD, V59, P208; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; LEVINE BD, 1989, NEW ENGL J MED, V321, P1707, DOI 10.1056/NEJM198912213212504; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Maggiorini M, 2001, CIRCULATION, V103, P2078; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; Mairbaurl H, 2006, RESP PHYSIOL NEUROBI, V151, P178, DOI 10.1016/j.resp.2005.11.001; Mairbaurl H, 2003, J APPL PHYSIOL, V95, P1843, DOI 10.1152/japplphysiol.01156.2002; Mairbaurl H, 2003, AM J RESP CRIT CARE, V167, P862, DOI 10.1164/rccm.200208-864OC; Mairbaurl H, 2002, AM J PHYSIOL-LUNG C, V282, pL659, DOI 10.1152/ajplung.00355; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; Murata T, 2004, AM J RESP CRIT CARE, V170, P647, DOI 10.1164/rccm.200309-1311OC; NAEIJE R, 1990, BRIT HEART J, V64, P400; OELZ O, 1989, LANCET, V2, P1241; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; SCHERRER U, 1993, CIRCULATION, V88, P388, DOI 10.1161/01.CIR.88.2.388; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; STELZNER TJ, 1988, J CLIN INVEST, V82, P1840, DOI 10.1172/JCI113800; STENMARK KR, 2000, J APPL PHYSIOL, V98, P715; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; VOCK P, 1989, RADIOLOGY, V170, P661, DOI 10.1148/radiology.170.3.2916019; WEST JB, 1991, J APPL PHYSIOL, V70, P1731, DOI 10.1152/jappl.1991.70.4.1731; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117; Zhou HY, 1996, J APPL PHYSIOL, V80, P390, DOI 10.1152/jappl.1996.80.2.390	50	202	208	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					497	506		10.7326/0003-4819-145-7-200610030-00007	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015867				2022-12-28	WOS:000241093900003
J	Bibring, JP; Squyres, SW; Arvidson, RE				Bibring, Jean-Pierre; Squyres, Steven W.; Arvidson, Raymond E.			Merging views on Mars	SCIENCE			English	Editorial Material							MERIDIANI-PLANUM		Inst Astrophys Spatiale, Orsay, France; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Cornell University; Washington University (WUSTL)	Arvidson, RE (corresponding author), Inst Astrophys Spatiale, Orsay, France.	arvidson@wunder.wustl.edu						Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; 2006, 1 MER OMEGA WORKSH V	8	20	22	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1899	1901		10.1126/science.1132311	http://dx.doi.org/10.1126/science.1132311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008516				2022-12-28	WOS:000240832200034
J	Holland, JN; Okuyama, T; DeAngelis, DL				Holland, J. Nathaniel; Okuyama, Toshinori; DeAngelis, Donald L.			Comment on "Asymmetric coevolutionary networks facilitate biodiversity maintenance''	SCIENCE			English	Editorial Material							STABILITY		Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA; Univ Miami, US Geol Survey, Florida Integrated Sci Ctr, Coral Gables, FL 33124 USA; Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Rice University; United States Department of the Interior; United States Geological Survey; University of Miami; University of Miami	Holland, JN (corresponding author), Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA.	jholland@rice.edu	Holland, Julian Nathaniel/AAD-2116-2021	Holland, Julian Nathaniel/0000-0001-5525-8816; OKUYAMA, TOSHINORI/0000-0002-9893-4797				Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Boucher D.H., 1985, P1; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Gause GF, 1935, AM NAT, V69, P596, DOI 10.1086/280628; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; May R.M., 1973, STABILITY COMPLEXITY; May R. M., 1981, THEOR ECOL-NETH, P78; Ringel MS, 1996, THEOR POPUL BIOL, V50, P281, DOI 10.1006/tpbi.1996.0032; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Tilman D., 1982, Monographs in Population Biology, pi; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x	11	32	33	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1887	1887		10.1126/science.1129547	http://dx.doi.org/10.1126/science.1129547			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008511				2022-12-28	WOS:000240832200024
J	Pearle, MS				Pearle, Margaret S.			Medical therapy for urinary stone passage	LANCET			English	Editorial Material							URETERAL CALCULI; EXPULSIVE THERAPY; MANAGEMENT; NIFEDIPINE; TAMSULOSIN; EFFICACY; SUBTYPES		Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pearle, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75390 USA.	margaret.pearle@utsouthwestern.edu						BORGHI L, 1994, J UROLOGY, V152, P1095, DOI 10.1016/S0022-5347(17)32511-9; Cooper JT, 2000, UROLOGY, V56, P575, DOI 10.1016/S0090-4295(00)00658-0; Dellabella M, 2005, J UROLOGY, V174, P167, DOI 10.1097/01.ju.0000161600.54732.86; Dellabella M, 2003, J UROLOGY, V170, P2202, DOI 10.1097/01.ju.0000096050.22281.a7; Dellabella M, 2005, UROLOGY, V66, P712, DOI 10.1016/j.urology.2005.04.055; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; MAGGI CA, 1995, J AUTON PHARMACOL, V15, P55, DOI 10.1111/j.1474-8673.1995.tb00348.x; MALIN J M JR, 1970, British Journal of Urology, V42, P171, DOI 10.1111/j.1464-410X.1970.tb10018.x; MORITA T, 1987, TOHOKU J EXP MED, V152, P111, DOI 10.1620/tjem.152.111; Porpiglia F, 2000, UROLOGY, V56, P579, DOI 10.1016/S0090-4295(00)00732-9; Porpiglia F, 2004, J UROLOGY, V172, P568, DOI 10.1097/01.ju.0000132390.61756.ff; SAHIN A, 1993, ARCH INT PHYSIOL BIO, V101, P245, DOI 10.3109/13813459309003918; Salman S, 1989, Actas Urol Esp, V13, P150; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; Sigala S, 2005, NEUROUROL URODYNAM, V24, P142, DOI 10.1002/nau.20097	15	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP-OCT	2006	368	9542					1138	1139		10.1016/S0140-6736(06)69452-X	http://dx.doi.org/10.1016/S0140-6736(06)69452-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011928				2022-12-28	WOS:000240916000009
J	Hornung, V; Ellegast, J; Kim, S; Brzozka, K; Jung, A; Kato, H; Poeck, H; Akira, S; Conzelmann, KK; Schlee, M; Endres, S; Hartmann, G				Hornung, Veit; Ellegast, Jana; Kim, Sarah; Brzozka, Krzysztof; Jung, Andreas; Kato, Hiroki; Poeck, Hendrik; Akira, Shizuo; Conzelmann, Karl-Klaus; Schlee, Martin; Endres, Stefan; Hartmann, Gunther			5 '-triphosphate RNA is the ligand for RIG-I	SCIENCE			English	Article							PLASMACYTOID DENDRITIC CELLS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; ACTIVATION; INDUCTION; ACID; POLYADENYLATION; REPLICATION; RECOGNITION; RESPONSES	The structural basis for the distinction of viral RNA from abundant self RNA in the cytoplasm of virally infected cells is largely unknown. We demonstrated that the 5'-triphosphate end of RNA generated by viral polymerases is responsible for retinoic acid - inducible protein I (RIG-I) mediated detection of RNA molecules. Detection of 5'-triphosphate RNA is abrogated by capping of the 5'-triphosphate end or by nucleoside modification of RNA, both occurring during posttranscriptional RNA processing in eukaryotes. Genomic RNA prepared from a negative-strand RNA virus and RNA prepared from virus-infected cells ( but not from noninfected cells) triggered a potent interferon-alpha response in a phosphatase-sensitive manner. 5'-triphosphate RNA directly binds to RIG-I. Thus, uncapped 5'-triphosphate RNA ( now termed 3pRNA) present in viruses known to be recognized by RIG-I, but absent in viruses known to be detected by MDA-5 such as the picornaviruses, serves as the molecular signature for the detection of viral infection by RIG-I.	Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany; Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Univ Munich, Max von Pettenkofer Inst, Dept Virol, D-81377 Munich, Germany; Univ Munich, Gene Ctr, D-81377 Munich, Germany	University of Bonn; University of Munich; Osaka University; University of Munich; University of Munich	Hartmann, G (corresponding author), Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany.	gunther.hartmann@ukb.uni-bonn.de	Hornung, Veit/C-3565-2012; Kim-Hellmuth, Sarah/AAF-4911-2021; Schlee, Martin/AAL-1238-2021; Conzelmann, Karl-Klaus/L-7239-2013; Hartmann, Gunther/P-7492-2017; Akira, Shizuo/C-3134-2009	Hornung, Veit/0000-0002-4150-194X; Kim-Hellmuth, Sarah/0000-0001-8791-5729; Hartmann, Gunther/0000-0003-1021-2018; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Schlee, Martin/0000-0003-3671-7639; Ellegast, Jana/0000-0003-4201-4227; Brzozka, Krzysztof/0000-0001-7563-6482				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; LEE YF, 1977, P NATL ACAD SCI USA, V74, P59, DOI 10.1073/pnas.74.1.59; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	19	1780	1915	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					994	997		10.1126/science.1132505	http://dx.doi.org/10.1126/science.1132505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17038590				2022-12-28	WOS:000241896000054
J	Brown, P				Brown, Phyllida			NIMR awaits the final verdict	CELL			English	Editorial Material								Is translational research enhanced by the proximity of research institutes to hospitals? For scientists at the UK's National Institute of Medical Research, which is facing relocation from London's outskirts to its center, the question is no longer academic.											0	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					235	237		10.1016/j.cell.2006.10.006	http://dx.doi.org/10.1016/j.cell.2006.10.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055419	Bronze			2022-12-28	WOS:000241827100005
J	Shiau, AK; Harris, SF; Southworth, DR; Agard, DA				Shiau, Andrew K.; Harris, Seth F.; Southworth, Daniel R.; Agard, David A.			Structural analysis of E-coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements	CELL			English	Article							CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ATPASE ACTIVITY; PROTEIN; COMPLEX; IDENTIFICATION; INHIBITION; HYDROLYSIS; DISSECTION	In eukaryotes, the ubiquitous and abundant members of the 90 kilodalton heat-shock protein (hsp90) chaperone family facilitate the folding and conformational changes of a broad array of proteins important in cell signaling, proliferation, and survival. Here we describe the effects of nucleotides on the structure of full-length HtpG, the Escherichia coli hsp90 ortho-log. By electron microscopy, the nucleotide-free, AMPPNP bound, and ADP bound states of HtpG adopt completely distinct conformations. Structural characterization of nucleotide-free and ADP bound HtpG was extended to higher resolution by X-ray crystallography. In the absence of nucleotide, HtpG exhibits an "open" conformation in which the three domains of each monomer present hydrophobic elements into the large cleft formed by the dimer. By contrast, AIDP binding drives dramatic conformational changes that allow these hydrophobic elements to converge and shield each other from solvent, suggesting a mechanism by which nucleotides could control client protein binding and release.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Kalypsys Inc, Dept Biol, San Diego, CA 92121 USA; Roche Palo Alto, Palo Alto, CA 94304 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			NIDDK NIH HHS [P01 DK58390] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058390] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Chiosis G, 2003, CURR CANCER DRUG TAR, V3, P371, DOI 10.2174/1568009033481778; Chu FX, 2006, PROTEIN SCI, V15, P1260, DOI 10.1110/ps.052065106; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	37	340	349	2	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					329	340		10.1016/j.cell.2006.09.027	http://dx.doi.org/10.1016/j.cell.2006.09.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055434	Bronze			2022-12-28	WOS:000241827100020
J	Haland, G; Carlsen, KCL; Sandvik, L; Devulapalli, CS; Munthe-Kaas, MC; Pettersen, M; Carlsen, KH				Haland, Geir; Carlsen, Karin C. Lodrup; Sandvik, Leiv; Devulapalli, Chandra Sekhar; Munthe-Kaas, Monica Cheng; Pettersen, Morten; Carlsen, Kai-Hakon		ORAACLE	Reduced lung function at birth and the risk of asthma at 10 years of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPIRATORY FLOW PATTERNS; BRONCHIAL OBSTRUCTION; AIRWAY FUNCTION; EARLY-LIFE; INFANTS; CHILDREN; MECHANICS; EXPOSURE; WHEEZE	BACKGROUND Reduced lung function in early infancy has been associated with later obstructive airway diseases. We assessed whether reduced lung function shortly after birth predicts asthma 10 years later. METHODS We conducted a prospective birth cohort study of healthy infants in which we measured lung function shortly after birth with the use of tidal breathing flow-volume loops (the fraction of expiratory time to peak tidal expiratory flow to total expiratory time [t(sub PTEF)/t(sub E)]) in 802 infants and passive respiratory mechanics, including respiratory-system compliance, in 664 infants. At 10 years of age, 616 children (77%) were reassessed by measuring lung function, exercise-induced bronchoconstriction, and bronchial hyperresponsiveness (by means of a methacholine challenge) and by conducting a structured interview to determine whether there was a history of asthma or current asthma. RESULTS As compared with children whose t(sub PTEF)/t(sub E) shortly after birth was above the median, children whose t(sub PTEF)/t(sub E) was at or below the median were more likely at 10 years of age to have a history of asthma (24.3% vs. 16.2%, P=0.01), to have current asthma (14.6% vs. 7.5%, P=0.005), and to have severe bronchial hyperresponsiveness, defined as a methacholine dose of less than 1.0 micromol causing a 20% fall in the forced expiratory volume in 1 second (FEV(sub 1)) (9.1% vs. 4.9%, P=0.05). As compared with children whose respiratory-system compliance was above the median, children with respiratory compliance at or below the median more often had a history of asthma (27.4% vs. 14.8%; P=0.001) and current asthma (15.0% vs. 7.7%, P=0.009), although this measure was not associated with later measurements of lung function. At 10 years of age, t(sub PTEF)/t(sub E) at birth correlated weakly with the maximal midexpiratory flow rate (r=0.10, P=0.01) but not with FEV(sub 1) or forced vital capacity. CONCLUSIONS Reduced lung function at birth is associated with an increased risk of asthma by 10 years of age.	Rigshosp Radiumhosp Med Ctr, Dept Pediat, Voksentoppen, N-0491 Oslo, Norway; Ullevaal Univ Hosp, Dept Pediat, Div Woman & Child, Oslo, Norway; Ullevaal Univ Hosp, Clin Res Ctr, Oslo, Norway; Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Haland, G (corresponding author), Rigshosp Radiumhosp Med Ctr, Dept Pediat, Voksentoppen, Ullveien 14, N-0491 Oslo, Norway.	haland@medisin.uio.no	Devulapalli, Chandra Sekhar/B-6170-2008	Devulapalli, Chandra Sekhar/0000-0001-5473-9642				BANOVCIN P, 1995, PEDIATR RES, V38, P218, DOI 10.1203/00006450-199508000-00014; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Carlsen KCL, 2006, ALLERGY, V61, P454, DOI 10.1111/j.1398-9995.2005.00938.x; CARLSEN KCL, 1994, EUR RESPIR J, V7, P1660, DOI 10.1183/09031936.94.07091660; CARLSEN KCL, 1997, EUR RESP MON, V5, P27; Carlsen KH, 2000, RESP MED, V94, P750, DOI 10.1053/rmed.2000.0809; Carlsen L, 1999, PEDIATR ALLERGY IMMU, V10, P89, DOI 10.1034/j.1399-3038.1999.00028.x; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; CUTRERA R, 1991, PEDIATR PULM, V10, P6, DOI 10.1002/ppul.1950100103; LESOUEF PN, 1984, AM REV RESPIR DIS, V129, P552; LODRUP KC, 1992, PEDIATR PULM, V12, P99, DOI 10.1002/ppul.1950120208; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1991, AM REV RESPIR DIS, V143, P312, DOI 10.1164/ajrccm/143.2.312; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; MORRIS MJ, 1981, THORAX, V36, P135, DOI 10.1136/thx.36.2.135; Murray CS, 2002, THORAX, V57, P388, DOI 10.1136/thorax.57.5.388; Nystad W, 2001, EUR J EPIDEMIOL, V17, P209, DOI 10.1023/A:1017926403763; Ronmark E, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e37; Seddon PC, 1996, AM J RESP CRIT CARE, V153, P1248, DOI 10.1164/ajrccm.153.4.8616549; TAGER IB, 1993, AM REV RESPIR DIS, V147, P811, DOI 10.1164/ajrccm/147.4.811; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; vanderEnt CK, 1996, AM J RESP CRIT CARE, V153, P1253, DOI 10.1164/ajrccm.153.4.8616550; YOUNG S, 1994, J PEDIATR-US, V124, P681, DOI 10.1016/S0022-3476(05)81355-1; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Yuksel B, 1996, THORAX, V51, P815, DOI 10.1136/thx.51.8.815	25	275	284	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1682	1689		10.1056/NEJMoa052885	http://dx.doi.org/10.1056/NEJMoa052885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050892				2022-12-28	WOS:000241357300009
J	Attaran, A				Attaran, Amir			Finding true north for the Canadian Medical Association Journal	LANCET			English	Editorial Material									Univ Ottawa, Fac Law, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Fac Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Inst Populat Hlth, 1 Stewart St, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						*GOV REV PAN, 2006, CMAJ            0714; Kassirer JP, 2006, CAN MED ASSOC J, V174, P945, DOI 10.1503/cmaj.060290; MCILROY A, 2006, GLOBE MAIL TORO 0401; Steinbrook R, 2006, NEW ENGL J MED, V354, P1661, DOI 10.1056/NEJMp068064	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1309	1311		10.1016/S0140-6736(06)69534-2	http://dx.doi.org/10.1016/S0140-6736(06)69534-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046447				2022-12-28	WOS:000241388100008
J	Rabitz, H				Rabitz, Herschel			Strong-arming molecular dynamics	SCIENCE			English	Editorial Material									Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Rabitz, H (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hrabitz@princeton.edu						Brixner T, 2001, ADV ATOM MOL OPT PHY, V46, P1, DOI 10.1016/S1049-250X(01)80062-8; Daniel C, 2003, SCIENCE, V299, P536, DOI 10.1126/science.1078517; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Pearson BJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.063412; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Rabitz HA, 2004, SCIENCE, V303, P1998, DOI 10.1126/science.1093384; Rice S. A., 2000, OPTICAL CONTROL MOL; Sussman BJ, 2006, SCIENCE, V314, P278, DOI 10.1126/science.1132289	8	27	28	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					264	265		10.1126/science.1134083	http://dx.doi.org/10.1126/science.1134083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038613				2022-12-28	WOS:000241194100030
J	Traynor, J; Mactier, R; Geddes, CC; Fox, JG				Traynor, Jamie; Mactier, Robert; Geddes, Colin C.; Fox, Jonathan G.			How to measure renal function in clinical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GLOMERULAR-FILTRATION-RATE; DIETARY-PROTEIN RESTRICTION; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; SERUM CYSTATIN C; CREATININE CLEARANCE; PLASMA-CLEARANCE; PROGRESSION; GFR; EQUATIONS		Univ Glasgow, Western Infirm, Renal Unit, Glasgow G11 6NT, Lanark, Scotland; Glasgow Royal Infirm, Renal Unit, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow	Traynor, J (corresponding author), Univ Glasgow, Western Infirm, Renal Unit, Glasgow G11 6NT, Lanark, Scotland.	jamie.traynor@northglasgow.scot.nhs.uk						Anandarajah S, 2005, NEPHROL DIAL TRANSPL, V20, P2089, DOI 10.1093/ndt/gfi006; AURELL M, 1994, NEPHROL DIAL TRANSPL, V9, P1222; BJARNADOTTIR M, 1995, SCAND J CLIN LAB INV, V55, P617, DOI 10.3109/00365519509110261; BROCHNERMORTENSEN J, 1976, SCAND J CLIN LAB INV, V36, P35, DOI 10.3109/00365517609068016; BROCHNERMORTENSEN J, 1985, CLIN PHYSIOL, V5, P1, DOI 10.1111/j.1475-097X.1985.tb00742.x; CALLOWAY DH, 1971, J NUTR, V101, P205, DOI 10.1093/jn/101.2.205; CHANTLER C, 1969, CLIN SCI, V37, P169; Chasis H, 1938, J CLIN INVEST, V17, P347, DOI 10.1172/JCI100959; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; COLLE A, 1992, J IMMUNOASSAY, V13, P47, DOI 10.1080/15321819208019824; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Dondi M, 1995, Curr Opin Nephrol Hypertens, V4, P520, DOI 10.1097/00041552-199511000-00012; EDWARDS K. D. G., 1959, AUSTRALASIAN ANN MED, V8, P218; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; HOOGWERF BJ, 1986, AM J CLIN NUTR, V43, P350, DOI 10.1093/ajcn/43.3.350; ISRAELIT AH, 1973, KIDNEY INT, V4, P346, DOI 10.1038/ki.1973.127; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; JELLIFFE RW, 1973, ANN INTERN MED, V79, P604, DOI 10.7326/0003-4819-79-4-604; Kampmann J P, 1971, Ugeskr Laeger, V133, P2369; Keevil BG, 1998, CLIN CHEM, V44, P1535; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kos J, 1998, CLIN CHEM, V44, P2556; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Levey AS, 1996, AM J KIDNEY DIS, V27, P652, DOI 10.1016/S0272-6386(96)90099-2; Levey AS, 1996, J AM SOC NEPHROL, V7, P2616; LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.me.39.020188.002341; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; LUBOWITZ H, 1967, J AMER MED ASSOC, V199, P252, DOI 10.1001/jama.199.4.252; Mahajan S, 2005, J NEPHROL, V18, P257; MITCH WE, 1978, NEPHRON, V21, P248, DOI 10.1159/000181400; MORGAN DB, 1978, POSTGRAD MED J, V54, P302, DOI 10.1136/pgmj.54.631.302; NKF-K/DOQI, 2001, AM J KIDNEY DIS S, V37, pS65; Page MK, 2000, CLIN CHIM ACTA, V297, P67, DOI 10.1016/S0009-8981(00)00234-5; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pierrat A, 2003, KIDNEY INT, V64, P1425, DOI 10.1046/j.1523-1755.2003.00208.x; Poge U, 2005, AM J TRANSPLANT, V5, P1306, DOI 10.1111/j.1600-6143.2005.00861.x; REHLING M, 1984, CLIN SCI, V66, P613, DOI 10.1042/cs0660613; ROSANO TG, 1982, CLIN CHEM, V28, P2330; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Smith H., 1951, KIDNEY, P47; Van Biesen W, 2006, NEPHROL DIAL TRANSPL, V21, P77, DOI 10.1093/ndt/gfi185; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	46	192	202	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					733	737		10.1136/bmj.38975.390370.7C	http://dx.doi.org/10.1136/bmj.38975.390370.7C			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	17023465	Green Published			2022-12-28	WOS:000241248600020
J	Nguyen, H; Rendl, M; Fuchs, E				Nguyen, Hoang; Rendl, Michael; Fuchs, Elaine			Tcf3 governs stem cell features and represses cell fate determination in skin	CELL			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; TRANSIENT ACTIVATION; HAIR-FOLLICLES; PPAR; EXPRESSION; GAMMA; CANCER; MORPHOGENESIS	Many stem cells (SCs) respond to Wnt signaling, but whether beta-catenin's DNA binding partners, the Tcfs, play a role in SCs in the absence of Writs, is unknown. In adult skin, quiescent multipotent progenitors express Tcf3 and commit to a hair cell fate in response to Wnt signaling. We find that embryonic skin progenitors also express Tcf3. Using an inducible system in mice, we show that upon Tcf3 reactivation, committed epidermal cells induce genes associated with an undifferentiated, Wnt-inhibited state and Tcf3 promotes a transcriptional program shared by embryonic and postnatal SCs. Further, Tcf3-repressed genes include transcriptional regulators of the epidermal, sebaceous gland and hair follicle differentiation programs, and correspondingly, all three terminal differentiation pathways are suppressed when Tcf3 is induced postnatally. These data suggest that in the absence of Writ signals, Tcf3 may function in skin SCs to maintain an undifferentiated state and, through Wnt signaling, directs these cells along the hair lineage.	Rockefeller Univ, Dept Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Nguyen, H (corresponding author), Rockefeller Univ, Dept Mammalian Cell Biol & Dev, Howard Hughes Med Inst, 1230 York Ave,Box 300, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Rendl, Michael/0000-0001-6326-620X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR31737] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Di-Poi N, 2004, LIPIDS, V39, P1093, DOI 10.1007/s11745-004-1335-y; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Knott A, 2002, BIOTECHNIQUES, V32, P796, DOI 10.2144/02324st06; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Michalik L, 2002, INT J DEV BIOL, V46, P105; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; SIERRA J, 2000, GENE DEV, V20, P586; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	49	223	239	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					171	183		10.1016/j.cell.2006.07.036	http://dx.doi.org/10.1016/j.cell.2006.07.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018284	Bronze			2022-12-28	WOS:000241445800022
J	Creticos, PS; Schroeder, JT; Hamilton, RG; Balcer-Whaley, SL; Khattignavong, AP; Lindblad, R; Li, H; Coffman, R; Seyfert, V; Eiden, JJ; Broide, D				Creticos, Peter S.; Schroeder, John T.; Hamilton, Robert G.; Balcer-Whaley, Susan L.; Khattignavong, Arouna P.; Lindblad, Robert; Li, Henry; Coffman, Robert; Seyfert, Vicki; Eiden, Joseph J.; Broide, David		Immune Tolerance Network Grp	Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; RAGWEED HAY-FEVER; IMMUNOSTIMULATORY DNA; IGG ANTIBODIES; DOUBLE-BLIND; EFFICACY; EXTRACT; ANTIGEN; CONJUGATION; EXPRESSION	Background: Conjugating immunostimulatory sequences of DNA to specific allergens offers a new approach to allergen immunotherapy that reduces acute allergic responses. Methods: We conducted a randomized, double-blind, placebo-controlled phase 2 trial of a vaccine consisting of Amb a 1, a ragweed-pollen antigen, conjugated to a phosphorothioate oligodeoxyribonucleotide immunostimulatory sequence of DNA (AIC) in 25 adults who were allergic to ragweed. Patients received six weekly injections of the AIC or placebo vaccine before the first ragweed season and were monitored during the next two ragweed seasons. Results: There was no pattern of vaccine-associated systemic reactions or clinically significant laboratory abnormalities. AIC did not alter the primary end point, the vascular permeability response (measured by the albumin level in nasal-lavage fluid) to nasal provocation. During the first ragweed season, the AIC group had better peak-season rhinitis scores on the visual-analogue scale (P=0.006), peak-season daily nasal symptom diary scores (P=0.02), and midseason overall quality-of-life scores (P=0.05) than the placebo group. AIC induced a transient increase in Amb a 1-specific IgG antibody but suppressed the seasonal increase in Amb a 1-specific IgE antibody. A reduction in the number of interleukin-4-positive basophils in AIC-treated patients correlated with lower rhinitis visual-analogue scores (r=0.49, P=0.03). Clinical benefits of AIC were again observed in the subsequent ragweed season, with improvements over placebo in peak-season rhinitis visual-analogue scores (P=0.02) and peak-season daily nasal symptom diary scores (P=0.02). The seasonal specific IgE antibody response was again suppressed, with no significant change in IgE antibody titer during the ragweed season (P=0.19). Conclusions: In this pilot study, a 6-week regimen of the AIC vaccine appeared to offer long-term clinical efficacy in the treatment of ragweed allergic rhinitis. (ClinicalTrials.gov number, NCT00346086.)	Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy, Baltimore, MD 21205 USA; Emmes Corp, Rockville, MD USA; Inst Asthma & Allergy, Wheaton, VA USA; Dynavax Technol, Berkeley, CA USA; Immune Tolerance Network, San Francisco, CA USA; Univ Calif San Diego, Dept Med, Sect Allergy & Immunol, San Diego, CA 92103 USA	Johns Hopkins University; Emmes Corporation; Immune Tolerance Network; University of California System; University of California San Diego	Creticos, PS (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Cir, Baltimore, MD 21224 USA.	pcretic@jhmi.edu		Broide, David/0000-0001-8405-9090				BAUMGARTEN CR, 1985, J CLIN INVEST, V76, P191, DOI 10.1172/JCI111945; Bukantz Samuel C, 2004, Clin Allergy Immunol, V18, P711; CRETICOS PS, 1984, J ALLERGY CLIN IMMUN, V73, P94, DOI 10.1016/0091-6749(84)90490-1; CRETICOS PS, 1992, IMMUNOL ALLERGY CLIN, V12, P13; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; CRETICOS PS, 1992, JAMA-J AM MED ASSOC, V268, P2834, DOI 10.1001/jama.268.20.2834; DUBUSKE LM, 1992, IMMUNOL ALLERGY CLIN, V12, P145; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Eng PA, 2002, ALLERGY, V57, P306, DOI 10.1034/j.1398-9995.2002.1o3264.x; Frew Anthony J., 2003, Journal of Allergy and Clinical Immunology, V111, pS712; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; Hamilton R. G., 1997, MANUAL CLIN LAB IMMU, P881; HEJJAOUI A, 1990, J ALLERGY CLIN IMMUN, V85, P473, DOI 10.1016/0091-6749(90)90157-Y; Juniper EF, 1999, J ALLERGY CLIN IMMUN, V104, P364, DOI 10.1016/S0091-6749(99)70380-5; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LICHTENSTEIN LM, 1966, J CLIN INVEST, V45, P1126, DOI 10.1172/JCI105419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKEY RF, 1987, J ALLERGY CLIN IMMUN, V79, P660, DOI 10.1016/S0091-6749(87)80164-1; LOWELL FC, 1963, J ALLERGY, V34, P165, DOI 10.1016/0021-8707(63)90069-8; LOWELL FC, 1965, NEW ENGL J MED, V273, P675, DOI 10.1056/NEJM196509232731302; LOWER T, 1993, ANN ALLERGY, V70, P480; Marshall JD, 2001, J ALLERGY CLIN IMMUN, V108, P191, DOI 10.1067/mai.2001.116984; NISH WA, 1994, J ALLERGY CLIN IMMUN, V93, P484, DOI 10.1016/0091-6749(94)90358-1; Noon L, 1911, LANCET, V1, P1572; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; PARKER WA, 1989, J ALLERGY CLIN IMMUN, V84, P667, DOI 10.1016/0091-6749(89)90294-7; PIENKOWSKI MM, 1985, J ALLERGY CLIN IMMUN, V76, P729, DOI 10.1016/0091-6749(85)90679-7; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Schroeder JT, 2001, J ALLERGY CLIN IMMUN, V107, P265, DOI 10.1067/mai.2001.112846; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Tighe H, 2000, EUR J IMMUNOL, V30, P1939, DOI 10.1002/1521-4141(200007)30:7<1939::AID-IMMU1939>3.0.CO;2-#; TINKELMAN D, 1995, ANN ALLERG ASTHMA IM, V74, P241; VANMETRE TE, 1982, J ALLERGY CLIN IMMUN, V69, P181, DOI 10.1016/0091-6749(82)90098-7; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; WALKER SM, 1995, ALLERGY, V50, P405, DOI 10.1111/j.1398-9995.1995.tb01170.x; Walker SM, 2001, J ALLERGY CLIN IMMUN, V107, P87, DOI 10.1067/mai.2001.112027	39	449	480	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1445	1455		10.1056/NEJMoa052916	http://dx.doi.org/10.1056/NEJMoa052916			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021320				2022-12-28	WOS:000240976200006
J	Rosenfeld, PJ; Brown, DM; Heier, JS; Boyer, DS; Kaiser, PK; Chung, CY; Kim, RY				Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y.		MARINA Study Grp	Ranibizumab for neovascular age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VERTEPORFIN; EXPRESSION; FAMILY	Background: Ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - has been evaluated for the treatment of neovascular age-related macular degeneration. Methods: In this multicenter, 2-year, double-blind, sham-controlled study, we randomly assigned patients with age-related macular degeneration with either minimally classic or occult (with no classic lesions) choroidal neovascularization to receive 24 monthly intravitreal injections of ranibizumab (either 0.3 mg or 0.5 mg) or sham injections. The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 months. Results: We enrolled 716 patients in the study. At 12 months, 94.5% of the group given 0.3 mg of ranibizumab and 94.6% of those given 0.5 mg lost fewer than 15 letters, as compared with 62.2% of patients receiving sham injections (P < 0.001 for both comparisons). Visual acuity improved by 15 or more letters in 24.8% of the 0.3-mg group and 33.8% of the 0.5-mg group, as compared with 5.0% of the sham-injection group (P < 0.001 for both doses). Mean increases in visual acuity were 6.5 letters in the 0.3-mg group and 7.2 letters in the 0.5-mg group, as compared with a decrease of 10.4 letters in the sham-injection group (P < 0.001 for both comparisons). The benefit in visual acuity was maintained at 24 months. During 24 months, presumed endophthalmitis was identified in five patients (1.0%) and serious uveitis in six patients (1.3%) given ranibizumab. Conclusions: Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimally classic or occult (with no classic lesions) choroidal neovascularization secondary to age-related macular degeneration. (ClinicalTrials.gov number, NCT00056836.)	Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; Methodist Hosp, Vitreoretinal Consultants, Houston, TX 77030 USA; Ophthalm Consultants Boston, Boston, MA USA; Retina Vitreous Associates Med Grp, Los Angeles, CA USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Genentech Inc, San Francisco, CA 94080 USA	Bascom Palmer Eye Institute; University of Miami; The Methodist Hospital System; The Methodist Hospital - Houston; Ophthalmic Consultants of Boston; Retina Vitreous Associates Medical Group; Cleveland Clinic Foundation; Roche Holding; Genentech	Rosenfeld, PJ (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA.	prosenfeld@med.miami.edu	ORTEGA, ANA/D-2408-2017; Liew, Gerald/AAB-6870-2022; Eben-Chaime, Moshe/F-1871-2012; Zhang, Kang/Y-2740-2019	ORTEGA, ANA/0000-0003-1456-2437; Eben-Chaime, Moshe/0000-0001-8759-0549; Zhang, Kang/0000-0002-4549-1697; Kaiser, Peter/0000-0001-5126-045X				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Barbazetto I, 2003, ARCH OPHTHALMOL-CHIC, V121, P1253; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2005, RETINA-J RET VIT DIS, V25, P119; Bressler NM, 2000, ARCH OPHTHALMOL-CHIC, V118, P488; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Heier JS, 2006, OPHTHALMOLOGY, V113, P633, DOI 10.1016/j.ophtha.2005.10.052; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOGAN MJ, 1959, AM J OPHTHALMOL, V47, P155, DOI 10.1016/S0002-9394(14)78239-X; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; NUSSENBLATT RB, 1996, UVEITIS FUNDAMENTALS, P64; Otani A, 2002, MICROVASC RES, V64, P162, DOI 10.1006/mvre.2002.2407; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rosenfeld PJ, 2005, OPHTHALMOLOGY, V112, P1048, DOI 10.1016/j.ophtha.2005.01.043; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027	27	4236	4467	4	282	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1419	1431		10.1056/NEJMoa054481	http://dx.doi.org/10.1056/NEJMoa054481			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021318				2022-12-28	WOS:000240976200004
J	Winters, BD; Pham, J; Pronovost, PJ				Winters, Bradford D.; Pham, Julius; Pronovost, Peter J.			Rapid response teams - Walk, don't run	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL EMERGENCY TEAM; CRITICAL-CARE OUTREACH; INTENSIVE-CARE; CONTROLLED-TRIAL; MORTALITY; ARRESTS; IMPLEMENTATION; SERVICE; SYSTEM; RATES		Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Winters, BD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 600 N Wolfe St, Baltimore, MD 21287 USA.	bwinters@jhmi.edu						Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; [Anonymous], 2005, Jt Comm Perspect, V25, P3; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; BROOK RH, 1994, METHODOLOGY PERSPECT, P59; Buist M, 2004, Crit Care Resusc, V6, P88; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Dorman T, 2001, CRIT CARE CLIN, V17, P293, DOI 10.1016/S0749-0704(05)70168-8; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Gosfield AG, 2005, HEALTH AFFAIR, V24, P1560, DOI 10.1377/hlthaff.24.6.1560; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Kenward G, 2004, RESUSCITATION, V61, P257, DOI 10.1016/j.resuscitation.2004.01.021; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Martin JF, 2004, ADV BIOCHEM ENG BIOT, V88, P91, DOI 10.1007/b1992589; Martinez EA, 2003, CRIT CARE MED, V31, P2302, DOI 10.1097/01.CCM.0000084857.87446.DD; Pittard AJ, 2003, ANAESTHESIA, V58, P882, DOI 10.1046/j.1365-2044.2003.03331.x; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surowiecki J., 2005, WISDOM CROWDS	25	108	125	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1645	1647		10.1001/jama.296.13.1645	http://dx.doi.org/10.1001/jama.296.13.1645			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090JS	17018807				2022-12-28	WOS:000240948200024
J	Hall, WJ				Hall, William J.			Update in geriatrics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVERTING ENZYME-INHIBITORS; ATRIAL-FIBRILLATION; COGNITIVE FUNCTION; OLDER PATIENTS; HOMOCYSTEINE; RISK; ADULTS; CARE; MEDICATIONS; STRENGTH		Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA	University of Rochester	Hall, WJ (corresponding author), Univ Rochester, Sch Med, Dept Med, Box MED,601 Elmwood Ave, Rochester, NY 14642 USA.	william_hall@urmc.rochester.edu						Chung MK, 2005, J AM COLL CARDIOL, V46, P1891, DOI 10.1016/j.jacc.2005.07.040; de Vreede PL, 2005, J AM GERIATR SOC, V53, P2, DOI 10.1111/j.1532-5415.2005.53003.x; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; *FDA PUBL HLHT ADV, 2005, DEATHS ANT ELD PAT B; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Kado DM, 2005, AM J MED, V118, P161, DOI 10.1016/j.amjmed.2004.08.019; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Ravaglia G, 2005, AM J CLIN NUTR, V82, P636, DOI 10.1093/ajcn/82.3.636; Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Schellenbaum GD, 2005, J AM GERIATR SOC, V53, P1996, DOI 10.1111/j.1532-5415.2005.53568.x; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; von Haehling S, 2005, J AM GERIATR SOC, V53, P2030, DOI 10.1111/j.1532-5415.2005.53571.x; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008	18	38	39	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2006	145	7					538	543		10.7326/0003-4819-145-7-200610030-00012	http://dx.doi.org/10.7326/0003-4819-145-7-200610030-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092JX	17015872				2022-12-28	WOS:000241093900008
J	Eggleton, PP; Dearborn, DSP; Lattanzio, JC				Eggleton, Peter P.; Dearborn, David S. P.; Lattanzio, John C.			Deep mixing of He-3: Reconciling big bang and stellar nucleosynthesis	SCIENCE			English	Article							RED GIANT STARS; HORIZONTAL BRANCH; EVOLUTION; ANOMALIES; DJEHUTY	Low-mass stars, similar to 1 to 2 solar masses, near the Main Sequence are efficient at producing the helium isotope He-3, which they mix into the convective envelope on the giant branch and should distribute into the Galaxy by way of envelope loss. This process is so efficient that it is difficult to reconcile the low observed cosmic abundance of He-3 with the predictions of both stellar and Big Bang nucleosynthesis. Here we find, by modeling a red giant with a fully three-dimensional hydrodynamic code and a full nucleosynthetic network, that mixing arises in the supposedly stable and radiative zone between the hydrogen-burning shell and the base of the convective envelope. This mixing is due to Rayleigh-Taylor instability within a zone just above the hydrogen-burning shell, where a nuclear reaction lowers the mean molecular weight slightly. Thus, we are able to remove the threat that He-3 production in low-mass stars poses to the Big Bang nucleosynthesis of He-3.	Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94551 USA; Lawrence Livermore Natl Lab, Phys & Appl Technol Div, Livermore, CA 94551 USA; Monash Univ, Ctr Stellar & Planetary Astrophys, Clayton, Vic 3168, Australia	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Monash University	Eggleton, PP (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, 7000 E Ave, Livermore, CA 94551 USA.	ppe@igpp.ucllnl.org		Lattanzio, John/0000-0003-2952-859X				Balser DS, 1999, ASTROPHYS J, V510, P759, DOI 10.1086/306598; Bazan G, 2003, ASTR SOC P, V293, P1; CHARBONNEL C, 1995, ASTROPHYS J, V453, pL41, DOI 10.1086/309744; Dearborn DSP, 2006, ASTROPHYS J, V639, P405, DOI 10.1086/499263; Dearborn DSP, 1996, ASTROPHYS J, V465, P887, DOI 10.1086/177472; DEARBORN DSP, 1986, ASTROPHYS J, V302, P35, DOI 10.1086/163969; DEARBORN DSP, 1991, SUN TIME; Denissenkov PA, 2000, MON NOT R ASTRON SOC, V316, P395, DOI 10.1046/j.1365-8711.2000.03498.x; Eggleton PP, 2003, ASTR SOC P, V293, P15; EGGLETON PP, 1972, MON NOT R ASTRON SOC, V156, P361, DOI 10.1093/mnras/156.3.361; FAULKNER J, 1972, ASTROPHYS J, V173, P401, DOI 10.1086/151430; FAULKNER J, 1966, ASTROPHYS J, V144, P978, DOI 10.1086/148696; HATA N, 1995, PHYS REV LETT, V75, P3977, DOI 10.1103/PhysRevLett.75.3977; IBEN I, 1967, ASTROPHYS J, V147, P624, DOI 10.1086/149040; KRAFT RP, 1994, PUBL ASTRON SOC PAC, V106, P553, DOI 10.1086/133416; OLIVE KA, 1995, ASTROPHYS J, V444, P680, DOI 10.1086/175640; POLS OR, 1995, MON NOT R ASTRON SOC, V274, P964, DOI 10.1093/mnras/274.3.964; STEIGMAN G, 1986, NATO ASI SERIES C, V163; SUNTZEFF N, 1993, ASTR SOC P, V48, P167; SWEIGART AV, 1979, ASTROPHYS J, V229, P624, DOI 10.1086/156996; Weiss A., 2004, MEM SOC ASTRON ITAL, V75, P347	21	181	181	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1580	1583		10.1126/science.1133065	http://dx.doi.org/10.1126/science.1133065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17068226	Green Submitted			2022-12-28	WOS:000242624600036
J	Miller, SP; Lunzer, M; Dean, AM				Miller, Stephen P.; Lunzer, Mark; Dean, Antony M.			Direct demonstration of an adaptive constraint	SCIENCE			English	Article							3-ISOPROPYLMALATE DEHYDROGENASE; DEVELOPMENTAL CONSTRAINTS; NATURAL-SELECTION; ESCHERICHIA-COLI; EVOLUTION; ISOCITRATE; SPANDRELS; MECHANISM	The role of constraint in adaptive evolution is an open question. Directed evolution of an engineered beta-isopropylmalate dehydrogenase ( IMDH), with coenzyme specificity switched from nicotinamide adenine dinucleotide (NAD) to nicotinamide adenine dinucleotide phosphate ( NADP), always produces mutants with lower affinities for NADP. This result is the correlated response to selection for relief from inhibition by NADPH ( the reduced form of NADP) expected of an adaptive landscape subject to three enzymatic constraints: an upper limit to the rate of maximum turnover (k(cat)), a correlation in NADP and NADPH affinities, and a trade-off between NAD and NADP usage. Two additional constraints, high intracellular NADPH abundance and the cost of compensatory protein synthesis, have ensured the conserved use of NAD by IMDH throughout evolution. Our results show that selective mechanisms and evolutionary constraints are to be understood in terms of underlying adaptive landscapes.	Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dean, AM (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	deanx024@umn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060611] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM060611] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS KJ, 1976, J MOL EVOL, V8, P317, DOI 10.1007/BF01739257; ANTONOVICS J, 1991, TRENDS ECOL EVOL, V6, P166, DOI 10.1016/0169-5347(91)90059-7; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hall BG, 2002, ANTIMICROB AGENTS CH, V46, P3035, DOI 10.1128/AAC.46.9.3035-3038.2002; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; KUCHNER O, 1997, TRENDS BIOTECHNOL, V58, P1; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; PENFOUND T, 1996, CELLULAR MOL BIOL, P721; Pigliucci M, 2000, TRENDS ECOL EVOL, V15, P66, DOI 10.1016/S0169-5347(99)01762-0; Rose M. R., 1996, ADAPTATION; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZAMENHOF S, 1967, NATURE, V216, P456, DOI 10.1038/216456a0; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	28	61	63	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					458	461		10.1126/science.1133479	http://dx.doi.org/10.1126/science.1133479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053145				2022-12-28	WOS:000241382500040
J	Macilwain, C				Macilwain, Colin			A firm response to AIDS	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					738	739		10.1038/443738a	http://dx.doi.org/10.1038/443738a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051178				2022-12-28	WOS:000241362700012
J	Rubinsztein, DC				Rubinsztein, David C.			The roles of intracellular protein-degradation pathways in neurodegeneration	NATURE			English	Review							AGGREGATE-PRONE PROTEINS; PARKINSONS-DISEASE SUSCEPTIBILITY; CHAPERONE-MEDIATED AUTOPHAGY; UBIQUITIN-PROTEASOME SYSTEM; MOTOR-NEURON DISEASE; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; CELL-DEATH; ALPHA-SYNUCLEIN; MOUSE MODEL	Many late-onset neurodegenerative diseases, including Parkinson's disease and Huntington's disease, are associated with the formation of intracellular aggregates by toxic proteins. It is therefore crucial to understand the factors that regulate the steady-state levels of these 'toxins', at both the synthetic and degradation stages. The degradation pathways acting on such aggregate-prone cytosolic proteins include the ubiquitin - proteasome system and macroautophagy. Dysfunction of the ubiquitin - proteasome or macroautophagy pathways might contribute to the pathology of various neurodegenerative conditions. However, enhancing macroautophagy with drugs such as rapamycin could offer a tractable therapeutic strategy for a number of these diseases.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 2XY, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011		MRC [G0000872] Funding Source: UKRI; Medical Research Council [G0000872] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARPER P. S., 1996, HUNTINGTONS DIS; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Healy DG, 2006, ANN NEUROL, V59, P627, DOI 10.1002/ana.20757; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee VWS, 2005, NEPHROLOGY, V10, P606, DOI 10.1111/j.1440-1797.2005.00493.x; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murphy MP, 2001, BBA-BIOENERGETICS, V1504, P1, DOI 10.1016/S0005-2728(00)00234-6; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pangalos MN, 2005, BIOCHEM SOC T, V33, P553, DOI 10.1042/BST0330553; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	76	1264	1332	3	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					780	786		10.1038/nature05291	http://dx.doi.org/10.1038/nature05291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051204				2022-12-28	WOS:000241362700037
J	Oh-I, S; Shimizu, H; Satoh, T; Okada, S; Adachi, S; Inoue, K; Eguchi, H; Yamamoto, M; Imaki, T; Hashimoto, K; Tsuchiya, T; Monden, T; Horiguchi, K; Yamada, M; Mori, M				Oh-, Shinsuke, I; Shimizu, Hiroyuki; Satoh, Tetsurou; Okada, Shuichi; Adachi, Sachika; Inoue, Kinji; Eguchi, Hiroshi; Yamamoto, Masanori; Imaki, Toshihiro; Hashimoto, Koushi; Tsuchiya, Takafumi; Monden, Tsuyoshi; Horiguchi, Kazuhiko; Yamada, Masanobu; Mori, Masatomo			Identification of nesfatin-1 as a satiety molecule in the hypothalamus	NATURE			English	Article							MELANOCORTIN-4 RECEPTOR; LEPTIN RECEPTOR; BINDING PROTEIN; FOOD-INTAKE; NUCLEOBINDIN; NEFA; PATHWAY; OBESITY; CLONING; SYSTEM	The brain hypothalamus contains certain secreted molecules that are important in regulating feeding behaviour(1-3). Here we show that nesfatin, corresponding to NEFA/nucleobindin(2) (NUCB2), a secreted protein of unknown function, is expressed in the appetite-control hypothalamic nuclei in rats. Intracerebroventricular (i.c.v.) injection of NUCB2 reduces feeding. Rat cerebrospinal fluid contains nesfatin-1, an amino-terminal fragment derived from NUCB2, and its expression is decreased in the hypothalamic paraventricular nucleus under starved conditions. I.c.v. injection of nesfatin-1 decreases food intake in a dose-dependent manner, whereas injection of an antibody neutralizing nesfatin-1 stimulates appetite. In contrast, i.c.v. injection of other possible fragments processed from NUCB2 does not promote satiety, and conversion of NUCB2 to nesfatin-1 is necessary to induce feeding suppression. Chronic i.c.v. injection of nesfatin-1 reduces body weight, whereas rats gain body weight after chronic i.c.v. injection of antisense morpholino oligonucleotide against the gene encoding NUCB2. Nesfatin-1-induced anorexia occurs in Zucker rats with a leptin receptor mutation, and an anti-nesfatin-1 antibody does not block leptin-induced anorexia. In contrast, central injection of alpha-melanocyte-stimulating hormone elevates NUCB2 gene expression in the paraventricular nucleus, and satiety by nesfatin-1 is abolished by an antagonist of the melanocortin-3/4 receptor. We identify nesfatin-1 as a satiety molecule that is associated with melanocortin signalling in the hypothalamus.	Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 3718511, Japan; Saitama Univ, Dept Regulat Biol, Shimo Okubo, Saitama 3788570, Japan; Teijin Pharma Ltd, Pharmaceut Discovery Res Lab, Hino, Tokyo 1918512, Japan	Gunma University; Saitama University; Teijin Pharma Limited	Mori, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 3718511, Japan.	mmori@med.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X				BARNIKOLWATANABE S, 1994, BIOL CHEM H-S, V375, P497, DOI 10.1515/bchm3.1994.375.8.497; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Jia DM, 2000, METABOLISM, V49, P1167, DOI 10.1053/meta.2000.8599; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Karabinos A, 1996, MOL BIOL EVOL, V13, P990, DOI 10.1093/oxfordjournals.molbev.a025667; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; OH IS, 2005, CELL METAB, V1, P331; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; SATO F, 1980, TETRAHEDRON LETT, V21, P2171, DOI 10.1016/S0040-4039(00)78989-1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimizu H, 2005, NUTR NEUROSCI, V8, P7, DOI 10.1080/10284150500047245; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	24	773	821	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					709	712		10.1038/nature05162	http://dx.doi.org/10.1038/nature05162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036007				2022-12-28	WOS:000241160500050
J	Quam, L; Smith, R; Yach, D				Quam, Lois; Smith, Richard; Yach, Derek			Rising to the global challenge of the chronic disease epidemic	LANCET			English	Editorial Material							HEALTH		Ovations, Minneapolis, MN 55440 USA; UnitedHlth Europe, London, England		Quam, L (corresponding author), Ovations, Minneapolis, MN 55440 USA.	Lois_E_Quam@uhc.com						Boyle P, 2006, LANCET, V368, P629, DOI 10.1016/S0140-6736(06)69225-8; *CLINT GLOB IN, 2006, CLINT GLOB IN NYC; Fuster V, 2006, NAT CLIN PRACT CARD, V3, P401, DOI 10.1038/ncpcardio0630; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Okie S, 2006, NEW ENGL J MED, V355, P1084, DOI 10.1056/NEJMp068186; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2	7	33	33	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1221	1223		10.1016/s0140-6736(06)69422-1	http://dx.doi.org/10.1016/s0140-6736(06)69422-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091WF	17027712				2022-12-28	WOS:000241058300009
J	Hanna, J; Hathaway, NA; Tone, Y; Crosas, B; Elsasser, S; Kirkpatrick, DS; Leggett, DS; Gygi, SP; King, RW; Finley, D				Hanna, John; Hathaway, Nathaniel A.; Tone, Yoshiko; Crosas, Bernat; Elsasser, Suzanne; Kirkpatrick, Donald S.; Leggett, David S.; Gygi, Steven P.; King, Randall W.; Finley, Daniel			Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation	CELL			English	Article							UBIQUITIN-SPECIFIC PROTEASE; YEAST; INHIBITORS; PROTEINS; DEPLETION; FIDELITY; RPN11; USP14	Ubiquitin chains serve as a recognition motif for the proteasome, a multisubunit protease, which degrades its substrates into polypeptides while releasing ubiquitin for reuse. Yeast proteasomes contain two deubiquitinating enzymes, Ubp6 and Rpn11. Rpn11 promotes protein breakdown through its degradation-coupled activity. In contrast, we show here that Ubp6 has the capacity to delay the degradation of ubiquitinated proteins by the proteasome. However, delay of degradation by Ubp6 does not require its catalytic activity, indicating that Ubp6 has both deubiquitinating activity and proteasome-inhibitory activity. Delay of degradation by Ubp6 appears to provide a time window allowing gradual deubiquitination of the substrate by Ubp6. Rpn11 catalyzes en bloc chain removal, and Ubp6 interferes with degradation at or upstream of this step, so that degradation delay by Ubp6 is accompanied by a switch in the mode of ubiquitin chain processing. We propose that Ubp6 regulates both the nature and magnitude of proteasome activity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CSIC, Inst Mol Biol, ES-08034 Barcelona, Spain	Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Hanna, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu		King, Randall/0000-0001-7882-8180; Kirkpatrick, Donald/0000-0003-3091-2804	NIGMS NIH HHS [GM66492, GM67945, GM65592] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R01GM067945, R56GM066492, R01GM065592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Miura T, 2004, FEMS MICROBIOL LETT, V239, P171, DOI 10.1016/j.femsle.2004.08.035; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	28	267	274	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					99	111		10.1016/j.cell.2006.07.038	http://dx.doi.org/10.1016/j.cell.2006.07.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018280	Bronze			2022-12-28	WOS:000241445800017
J	Kaiser, CM; Chang, HC; Agashe, VR; Lakshmipathy, SK; Etchells, SA; Hayer-Hartl, M; Hartl, FU; Barral, JM				Kaiser, Christian M.; Chang, Hung-Chun; Agashe, Vishwas R.; Lakshmipathy, Sathish K.; Etchells, Stephanie A.; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Barral, Jose M.			Real-time observation of trigger factor function on translating ribosomes	NATURE			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI RIBOSOME; MOLECULAR CHAPERONES; NASCENT POLYPEPTIDE; CRYSTAL-STRUCTURE; AMINO-ACID; IN-VIVO; PROTEINS; BINDING; SRP	The contribution of co-translational chaperone functions to protein folding is poorly understood. Ribosome-associated trigger factor (TF) is the first molecular chaperone encountered by nascent polypeptides in bacteria. Here we show, using fluorescence spectroscopy to monitor TF function and structural rearrangements in real time, that TF interacts with ribosomes and translating polypeptides in a dynamic reaction cycle. Ribosome binding stabilizes TF in an open, activated conformation. Activated TF departs from the ribosome after a mean residence time of similar to 10 s, but may remain associated with the elongating nascent chain for up to 35 s, allowing entry of a new TF molecule at the ribosome docking site. The duration of nascent-chain interaction correlates with the occurrence of hydrophobic motifs in translating polypeptides, reflecting a high aggregation propensity. These findings can explain how TF prevents misfolding events during translation and may provide a paradigm for the regulation of nucleotide-independent chaperones.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	Max Planck Society; University of Texas System; University of Texas Medical Branch Galveston	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; jmbarral@utmb.edu	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bremer H, 1996, ESCHERICHIA COLI SAL; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MICHALSKI CJ, 1973, EUR J BIOCHEM, V33, P481, DOI 10.1111/j.1432-1033.1973.tb02706.x; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schroder GF, 2004, COMPUT PHYS COMMUN, V158, P150, DOI 10.1016/j.cpc.2004.02.001; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	44	173	176	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					455	460		10.1038/nature05225	http://dx.doi.org/10.1038/nature05225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17051157				2022-12-28	WOS:000242215700039
J	Andreasen, R; Sharma, M				Andreasen, Rasmus; Sharma, Mukul			Solar nebula heterogeneity in p-process samarium and neodymium isotopes	SCIENCE			English	Article							DIVERSE SUPERNOVA SOURCES; NEUTRON-CAPTURE; CROSS-SECTIONS; SM; ND; CHONDRITES; ABUNDANCES; SYSTEMATICS; METEORITES; EVOLUTION	Bulk carbonaceous chondrites display a deficit of similar to 100 parts per million (ppm) in Sm-144 with respect to other meteorites and terrestrial standards, leading to a decrease in their Nd-142/Nd-144 ratios by similar to 11 ppm. The data require that samarium and neodymium isotopes produced by the p process associated with photodisintegration reactions in supernovae were heterogeneously distributed in the solar nebula. Other samarium and neodymium isotopes produced by rapid neutron capture (r process) in supernovae and by slow neutron capture (s process) in red giants were homogeneously distributed. The supernovae sources supplying the p- and r-process nuclides to the solar nebula were thus disconnected or only weakly connected.	Dartmouth Coll, Dept Earth Sci, Radiogen Isotope Geochem Lab, Hanover, NH 03755 USA	Dartmouth College	Sharma, M (corresponding author), Dartmouth Coll, Dept Earth Sci, Radiogen Isotope Geochem Lab, 6105 Sherman Fairchild Hall, Hanover, NH 03755 USA.	mukul.sharma@dartmouth.edu	Andreasen, Rasmus/J-8837-2019	Andreasen, Rasmus/0000-0001-9737-1243				Arlandini C, 1999, ASTROPHYS J, V525, P886, DOI 10.1086/307938; Arnould A, 2003, PHYS REP, V384, P1, DOI 10.1016/S0370-1573(03)00242-4; Becker H, 2003, NATURE, V425, P152, DOI 10.1038/nature01975; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Chen JH, 2004, LUNAR PLANET SCI, VXXXV, P1431; Dauphas N, 2002, ASTROPHYS J, V565, P640, DOI 10.1086/324597; Gounelle M, 2006, ASTROPHYS J, V640, P1163, DOI 10.1086/500309; Hayakawa T, 2005, NUCL PHYS A, V758, p525C, DOI 10.1016/j.nuclphysa.2005.05.095; Hidaka H, 1999, EARTH PLANET SC LETT, V173, P41, DOI 10.1016/S0012-821X(99)00221-6; Hidaka H, 2000, EARTH PLANET SC LETT, V180, P29, DOI 10.1016/S0012-821X(00)00148-5; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; JACOBSEN SB, 1984, EARTH PLANET SC LETT, V67, P137, DOI 10.1016/0012-821X(84)90109-2; LAMBERT DL, 1992, ASTRON ASTROPHYS REV, V3, P201, DOI 10.1007/BF00872527; Patchett PJ, 2004, EARTH PLANET SC LETT, V222, P29, DOI 10.1016/j.epsl.2004.02.030; Qian YZ, 2003, ASTROPHYS J, V588, P1099, DOI 10.1086/374271; Qian YZ, 2000, PHYS REP, V333, P77, DOI 10.1016/S0370-1573(00)00017-X; RANEN MC, 2006, LUNAR PLANET SCI C, V37, P1832; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; RUSS GP, 1971, EARTH PLANET SC LETT, V13, P53, DOI 10.1016/0012-821X(71)90104-X; SCHRAMM DN, 1970, ASTROPHYS J, V162, P57, DOI 10.1086/150634; Shukolyukov A, 2000, SPACE SCI REV, V92, P225, DOI 10.1023/A:1005243228503; Somorjai E, 1998, ASTRON ASTROPHYS, V333, P1112; Stewart B, 1996, EARTH PLANET SC LETT, V143, P1, DOI 10.1016/0012-821X(96)00124-0; Wallerstein G, 1997, REV MOD PHYS, V69, P995, DOI 10.1103/RevModPhys.69.995; Wisshak K, 1998, PHYS REV C, V57, P391, DOI 10.1103/PhysRevC.57.391; Yin QZ, 2002, NATURE, V415, P881, DOI 10.1038/415881a; ZINNER E, 1991, ASTROPHYS J, V382, pL47, DOI 10.1086/186210	29	139	141	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					806	809		10.1126/science.1131708	http://dx.doi.org/10.1126/science.1131708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17023612				2022-12-28	WOS:000241729800043
J	Shin, JS; Ebersold, M; Pypaert, M; Delamarre, L; Hartley, A; Mellman, I				Shin, Jeoung-Sook; Ebersold, Melanie; Pypaert, Marc; Delamarre, Lelia; Hartley, Adam; Mellman, Ira			Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination	NATURE			English	Article							RECEPTOR TYROSINE KINASES; INVARIANT CHAIN; DOWN-REGULATION; ANTIGEN PRESENTATION; IN-VIVO; ENDOCYTOSIS; COMPLEX; PROTEIN; DEGRADATION; TRANSPORT	Dendritic cells have a unique function in the immune response owing to their ability to stimulate immunologically naive T lymphocytes(1). In response to microbial and inflammatory stimuli, dendritic cells enhance their capacity for antigen presentation by a process of terminal differentiation, termed maturation(2,3). The conversion of immature to mature dendritic cells is accompanied by a marked cellular reorganization, including the redistribution of major histocompatibility complex class II molecules (MHC II) from late endosomal and lysosomal compartments to the plasma membrane(4-7) and the downregulation of some forms of endocytosis, which has been thought to slow the clearance of MHC II from the surface(8-11). The relative extent to which these or other mechanisms contribute to the regulation of surface MHC II remains unclear, however. Here we find that the MHC II beta-chain cytoplasmic tail is ubiquitinated in mouse immature dendritic cells. Although only partly required for the sequestration of MHC II in multivesicular bodies, this modification is essential for endocytosis. Notably, ubiquitination of MHC II ceased upon maturation, resulting in the accumulation of MHC II at the cell surface. Dendritic cells thus exhibit a unique ability to regulate MHC II surface expression by selectively controlling MHC II ubiquitination.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Immunobiol Sect, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.	ira.mellman@yale.edu	Mellman, Ira/ABG-5896-2020					Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colledge L, 2002, EUR J IMMUNOL, V32, P3246, DOI 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Pathak SS, 2001, J IMMUNOL, V167, P632, DOI 10.4049/jimmunol.167.2.632; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	29	200	227	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					115	118		10.1038/nature05261	http://dx.doi.org/10.1038/nature05261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17051151				2022-12-28	WOS:000241701500057
J	Burnham, G; Lafta, R; Doocy, S; Roberts, L				Burnham, Gilbert; Lafta, Riyadh; Doocy, Shannon; Roberts, Les			Mortality after the 2003 invasion of Iraq: a cross-sectional cluster sample survey	LANCET			English	Article							CHILD-MORTALITY; WAR	Background An excess mortality of nearly 100 000 deaths was reported in Iraq for the period March, 2003-September, 2004, attributed to the invasion of Iraq. Our aim was to update this estimate. Methods Between May and July, 2006, we did a national cross-sectional cluster sample survey of mortality in Iraq. 50 clusters were randomly selected from 16 Governorates, with every cluster consisting of 40 households. Information on deaths from these households was gathered. Findings Three misattributed clusters were excluded from the final analysis; data from 1849 households that contained 12801 individuals in 47 clusters was gathered. 1474 births and 629 deaths were reported during the observation period. Pre-invasion mortality rates were 5.5 per 1000 people per year (95% Cl 4.3-7.1), compared with 13.3 per 1000 people per year (10.9-16.1) in the 40 months post-invasion. We estimate that as of July, 2006, there have been 654965 (392979-942636) excess Iraqi deaths as a consequence of the war, which corresponds to 2.5% of the population in the study area. Of post-invasion deaths, 601027 (426369-793663) were due to violence, the most common cause being gunfire. Interpretation The number of people dying in Iraq has continued to escalate. The proportion of deaths ascribed to coalition forces has diminished in 2006, although the actual numbers have increased every year. Gunfire remains the most common cause of death, although deaths from car bombing have increased.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Al Mustansiriya Univ, Sch Med, Baghdad, Iraq	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mustansiriya University	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	gburnham@jhsph.edu						Allukian M., 2000, WAR PUBLIC HLTH; [Anonymous], 1995, Lancet, V345, P339; Ball Patrick, 1999, STATE VIOLENCE GUATE; *BBC, IR VIOL FACTS FIG; BECKER SR, 1993, INT J EPIDEMIOL, V22, pS56, DOI 10.1093/ije/22.Supplement_1.S56; CALDWELL AA, 2006, WASHINGTON POST 0912; *CNN, US APPR E TIM INV DO; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; *DEP DEF, 2006, MEAS STAB SEC IR; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GLANZ J, 2006, NY TIMES        0209; Hagan J, 2006, SCIENCE, V313, P1578, DOI 10.1126/science.1127397; JANABI A, IRAQI GROUP CIVILIAN; KNICKMEYER E, 2006, WASHINGTON POST 0908; KUZMAN M, 1993, JAMA-J AM MED ASSOC, V270, P626, DOI 10.1001/jama.270.5.626; MALFAIT P, 1993, INT J EPIDEMIOL, V22, P504, DOI 10.1093/ije/22.3.504; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; *NGO COORD COMM IR, 2006, IR EM SIT FIN REP; OHANLON ME, 2006, IRAQ INDEX TRACKING; REGAN T, 2006, CHRISTIAN SCI M 0724; Roberts L, 1999, LANCET, V353, P2249, DOI 10.1016/S0140-6736(05)76308-X; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; ROBERTS L, 2001, MORTALITY E DEMOCRAC; Sapir D. G., 2006, ANGOLA HUMAN IMPACT; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TAVERNISE S, 2005, NY TIMES        1030; TAYLOR WR, 1993, INT J EPIDEMIOL, V22, pS15, DOI 10.1093/ije/22.Supplement_1.S15; The Sphere Project, 2004, HUM CHART MIN STAND; *UN DEV PROGR, 2004, IR LIV COND SURV; *UN DEV PROGR IR M, 2005, IR 2004 LIV COND SUR, V1; *US AG INT HLTH US, 2004, GLOB POP PROF 2002; *US CENS BUR, IDB POP PYR; Zaidi S, 1997, LANCET, V350, P1105, DOI 10.1016/S0140-6736(05)70470-0; CIA 2003 FACTBOOK EN	35	318	321	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1421	1428		10.1016/S0140-6736(06)69491-9	http://dx.doi.org/10.1016/S0140-6736(06)69491-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055943	Green Submitted			2022-12-28	WOS:000241459100029
J	Kim, WY; Sharpless, NE				Kim, William Y.; Sharpless, Norman E.			The regulation of INK4/ARF in cancer and aging	CELL			English	Review							HEMATOPOIETIC STEM-CELLS; ARF TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; SELF-RENEWAL; PREMATURE SENESCENCE; HUMAN FIBROBLASTS; P16(INK4A) EXPRESSION; GERMLINE MUTATION; OXIDATIVE STRESS; CYCLE ARREST	Loss of the INK4a/ARF/INK4b locus on chromosome 9p21 is among the most frequent cytogenetic events in human cancer. The products of the locus-p15(INK4b), p(16INK4a), and ARF-play widespread and independent roles in tumor suppression. Recent data also suggest that expression of p(16INK4a) induces an age-dependent decrease in the proliferative capacity of certain tissue-specific stem cells and unipotent progenitors. Here, we discuss the regulation and role of p(16INK4a), ARF, and p(15INK4b) in cancer and aging.	Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	nes@med.unc.edu		Sharpless, Norman/0000-0001-7078-9455				Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CHEZCESPEDES M, 2006, NATURE, V440, P702; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Esteller M, 2001, CANCER RES, V61, P3225; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; FORBES S, 2006, COSMIC 2005 BR J CAN, V4, P318; Fox CA, 2005, J BIOL CHEM, V280, P8629, DOI 10.1074/jbc.R400033200; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herman JG, 1996, CANCER RES, V56, P722; Hewitt C, 2002, HUM MOL GENET, V11, P1273, DOI 10.1093/hmg/11.11.1273; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Meng AM, 2003, CANCER RES, V63, P5414; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Munro J, 1999, CANCER RES, V59, P2516; Nairn RS, 1996, P NATL ACAD SCI USA, V93, P13042, DOI 10.1073/pnas.93.23.13042; Nielsen GP, 1999, LAB INVEST, V79, P1137; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pavey S, 1999, CANCER RES, V59, P4185; Piepkorn M, 2000, J AM ACAD DERMATOL, V42, P741, DOI 10.1067/mjd.2000.103988; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sherr CJ, 2000, CANCER RES, V60, P3689; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Uchida T, 1997, BLOOD, V90, P1403, DOI 10.1182/blood.V90.4.1403.1403_1403_1409; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	83	738	776	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					265	275		10.1016/j.cell.2006.10.003	http://dx.doi.org/10.1016/j.cell.2006.10.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055429	Bronze, Green Published			2022-12-28	WOS:000241827100015
J	Meeusen, S; Devay, R; Block, J; Cassidy-Stone, A; Wayson, S; McCaffery, JM; Nunnari, J				Meeusen, Shelly; DeVay, Rachel; Block, Jennifer; Cassidy-Stone, Ann; Wayson, Sarah; McCaffery, J. Michael; Nunnari, Jodi			Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1	CELL			English	Article							DOMINANT OPTIC ATROPHY; RHOMBOID PROTEASE; CYTOCHROME-C; OPA1; MORPHOLOGY; APOPTOSIS; MITOFUSIN-2; DIVISION; FISSION; CELLS	Mitochondrial outer- and inner-membrane fusion events are coupled in vivo but separable and mechanistically distinct in vitro, indicating that separate fusion machines exist in each membrane. Outer-membrane fusion requires trans interactions of the dynamin-related GTPase Fzo1, GTP hydrolysis, and an intact inner-membrane proton gradient. Innermembrane fusion also requires GTP hydrolysis but distinctly requires an innermembrane electrical potential. The protein machinery responsible for innermembrane fusion is unknown. Here, we show that the conserved intermembrane-space dynamin-related GTPase Mgm1 is required to tether and fuse mitochondrial inner membranes. We observe an additional role of Mgm1 in innermembrane dynamics, specifically in the maintenance of crista structures. We present evidence that trans Mgm1 interactions on opposing inner membranes function similarly to tether and fuse innermembranes as well as maintain crista structures and propose a model for how the mitochondrial dynamins function to facilitate fusion.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD 21218 USA	University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins University	Nunnari, J (corresponding author), Univ Calif Davis, Inst Pediat Regenerat Med, 2425 Stockton Blvd, Sacramento, CA 95817 USA.	jmnunnari@ucdavis.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NEI NIH HHS [5R01EY15924] Funding Source: Medline; NIGMS NIH HHS [5R01GM062942] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Andresen M, 2004, MOL BIOL CELL, V15, P5616, DOI 10.1091/mbc.E04-06-0454; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Estaquier J, 2006, MOL CELL, V21, P730, DOI 10.1016/j.molcel.2006.03.003; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen SL, 2005, CURR OPIN CELL BIOL, V17, P389, DOI 10.1016/j.ceb.2005.06.014; Misaka T, 2006, NEUROSCI RES, V55, P123, DOI 10.1016/j.neures.2006.02.010; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797	43	332	343	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					383	395		10.1016/j.cell.2006.09.021	http://dx.doi.org/10.1016/j.cell.2006.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055438	Bronze			2022-12-28	WOS:000241827100024
J	Sansone, G; Benedetti, E; Calegari, F; Vozzi, C; Avaldi, L; Flammini, R; Poletto, L; Villoresi, P; Altucci, C; Velotta, R; Stagira, S; De Silvestri, S; Nisoli, M				Sansone, G.; Benedetti, E.; Calegari, F.; Vozzi, C.; Avaldi, L.; Flammini, R.; Poletto, L.; Villoresi, P.; Altucci, C.; Velotta, R.; Stagira, S.; De Silvestri, S.; Nisoli, M.			Isolated single-cycle attosecond pulses	SCIENCE			English	Article							ORDER HARMONIC-GENERATION	We generated single-cycle isolated attosecond pulses around similar to 36 electron volts using phase-stabilized 5-femtosecond driving pulses with a modulated polarization state. Using a complete temporal characterization technique, we demonstrated the compression of the generated pulses for as low as 130 attoseconds, corresponding to less than 1.2 optical cycles. Numerical simulations of the generation process show that the carrier-envelope phase of the attosecond pulses is stable. The availability of single-cycle isolated attosecond pulses opens the way to a new regime in ultrafast physics, in which the strong-field electron dynamics in atoms and molecules is driven by the electric field of the attosecond pulses rather than by their intensity profile.	Politecn Milan, Dept Phys, Ist Nazl Fis Mat, CNR,Natl Lab Ultrafast & Ultraintense Opt Sci, I-20133 Milan, Italy; CNR, Ist Metodol Inorgan & Plasmi, Area Ric Roma 1, I-00016 Monterotondo, Italy; Univ Padua, Dept Informat Engn, INFM, CNR,Lab Ultraviolet & Xray Opt Res, I-35131 Padua, Italy; Univ Naples Federico II, Dipartimento Sci Fis, Consorzio Nazl Interuniv Sci Fis Mat, I-80138 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; University of Naples Federico II	Nisoli, M (corresponding author), Politecn Milan, Dept Phys, Ist Nazl Fis Mat, CNR,Natl Lab Ultrafast & Ultraintense Opt Sci, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	mauro.nisoli@fisi.polimi.it	Flammini, Roberto/AAO-7679-2020; Altucci, Carlo/AAK-1271-2020; Stagira, Salvatore/C-7415-2011; Calegari, Francesca/H-8881-2012; Velotta, Raffaele/I-5298-2012; Altucci, Carlo/J-4223-2012; Vozzi, Caterina/B-5035-2008; Flammini, Roberto/J-4068-2013; Avaldi, Lorenzo/L-8401-2015; Nisoli, Mauro/K-8563-2017	Flammini, Roberto/0000-0002-2297-7221; Altucci, Carlo/0000-0003-2270-9128; Stagira, Salvatore/0000-0002-8457-3185; Calegari, Francesca/0000-0003-3234-7298; Velotta, Raffaele/0000-0003-1077-8353; Vozzi, Caterina/0000-0002-0212-0191; Flammini, Roberto/0000-0002-2297-7221; Avaldi, Lorenzo/0000-0002-2990-7330; Nisoli, Mauro/0000-0003-2309-732X				Altucci C, 1998, PHYS REV A, V58, P3934, DOI 10.1103/PhysRevA.58.3934; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; DeLong KW, 1996, IEEE J QUANTUM ELECT, V32, P1253, DOI 10.1109/3.517026; Gagnon E, 2006, OPT LETT, V31, P1866, DOI 10.1364/OL.31.001866; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Iaconis C, 1998, OPT LETT, V23, P792, DOI 10.1364/OL.23.000792; Kane DJ, 1999, IEEE J QUANTUM ELECT, V35, P421, DOI 10.1109/3.753647; KANE DJ, 1993, IEEE J QUANTUM ELECT, V29, P571, DOI 10.1109/3.199311; Keller U, 2003, NATURE, V424, P831, DOI 10.1038/nature01938; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; Lopez-Martens R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033001; MACKLIN JJ, 1993, PHYS REV LETT, V70, P766, DOI 10.1103/PhysRevLett.70.766; Mairesse Y, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011401; Mairesse Y, 2003, SCIENCE, V302, P1540, DOI 10.1126/science.1090277; Nakajima T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.213001; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; Sansone G, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013411; Sola IJ, 2006, NAT PHYS, V2, P319, DOI 10.1038/nphys281; Tcherbakoff O, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043804; Yudin GL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063002	25	1370	1437	8	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					443	446		10.1126/science.1132838	http://dx.doi.org/10.1126/science.1132838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053142	Green Submitted			2022-12-28	WOS:000241382500035
J	Bussel, JB; Kuter, DJ; George, JN; McMillan, R; Aledort, LM; Conklin, GT; Lichtin, AE; Lyons, RM; Nieva, J; Wasser, JS; Wiznitzer, I; Kelly, R; Chen, CF; Nichol, JL				Bussel, James B.; Kuter, David J.; George, James N.; McMillan, Robert; Aledort, Louis M.; Conklin, George T.; Lichtin, Alan E.; Lyons, Roger M.; Nieva, Jorge; Wasser, Jeffrey S.; Wiznitzer, Israel; Kelly, Reggie; Chen, Chien-Feng; Nichol, Janet L.			AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEGAKARYOCYTE GROWTH; IN-VITRO; PLATELET PRODUCTION; APLASTIC-ANEMIA; CHEMOTHERAPY; DESTRUCTION; ANTIBODIES; MEGAKARYOPOIESIS; AUTOANTIBODIES	BACKGROUND Most current treatments for chronic immune thrombocytopenic purpura (ITP) act by decreasing platelet destruction. In a phase 1-2 study, we administered a thrombopoiesis-stimulating protein, AMG 531, to patients with ITP. METHODS In phase 1, 24 patients who had received at least one treatment for ITP were assigned to escalating-dose cohorts of 4 patients each and given two identical doses of AMG 531 (0.2 to 10 microg per kilogram of body weight). In phase 2, 21 patients were randomly assigned to receive six weekly subcutaneous injections of AMG 531 (1, 3, or 6 microg per kilogram) or placebo. The primary objective was to assess the safety of AMG 531; the secondary objective was to evaluate platelet counts during and after treatment. RESULTS No major adverse events that could be attributed directly to AMG 531 occurred during the treatment period; 4 of 41 patients had transient post-treatment worsening of thrombocytopenia. In phase 1, a platelet count that was within the targeted range (50,000 to 450,000 per cubic millimeter) and at least twice the baseline count was achieved in 4 of 12 patients given 3, 6, or 10 microg of AMG 531 per kilogram. Overall, a platelet count of at least 50,000 per cubic millimeter was achieved in 7 of 12 patients, including 3 with counts exceeding 450,000 per cubic millimeter. Increases in the platelet count were dose-dependent; mean peak counts were 163,000, 309,000, and 746,000 per cubic millimeter with 3, 6, and 10 microg of AMG 531 per cubic millimeter, respectively. In phase 2, the targeted platelet range was achieved in 10 of 16 patients treated with 1 or 3 microg of AMG 531 per kilogram per week for 6 weeks. Mean peak counts were 135,000, 241,000, and 81,000 per cubic millimeter in the groups that received the 1-microg dose, the 3-microg dose, and placebo, respectively. CONCLUSIONS AMG 531 caused no major adverse events and increased platelet counts in patients with ITP.	New York Presbyterian Hosp, New York, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Oklahoma, Med Ctr, Oklahoma City, OK USA; Scripps Canc Ctr, La Jolla, CA USA; Mt Sinai Med Ctr, New York, NY 10029 USA; Diagnost Clin Houston, Houston, TX USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Hematol Oncol Associates S Texas, San Antonio, TX USA; DeQuattro Community Canc Ctr, Manchester, CT USA; Broward Gen Med Ctr, Ft Lauderdale, FL USA; Amgen Inc, Thousand Oaks, CA 91320 USA	NewYork-Presbyterian Hospital; Harvard University; Massachusetts General Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; Amgen	Bussel, JB (corresponding author), Weill Cornell Univ, Div Pediat Hematol, Payson 609,525 E 68th St, New York, NY 10021 USA.	jbussel@med.cornell.edu	Kuter, David/AAS-1123-2020; Nieva, Jorge/AAE-3634-2022	Nieva, Jorge/0000-0003-1605-4719				Aledort LM, 2004, AM J HEMATOL, V76, P205, DOI 10.1002/ajh.20104; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Basser RL, 2002, BLOOD, V99, P2599, DOI 10.1182/blood.V99.7.2599; BOTTIGER LE, 1972, ACTA MED SCAND, V191, P535; Broudy VC, 2004, CYTOKINE, V25, P52, DOI 10.1016/j.cyto.2003.05.001; Bussel JB, 2005, BLOOD, V106, p68A, DOI 10.1182/blood.V106.11.220.220; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Cines DB, 2005, BLOOD, V106, P2244, DOI 10.1182/blood-2004-12-4598; Douglas VK, 2002, AM J CLIN PATHOL, V117, P844; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; GEORGE JN, 1995, WILLIAMS HEMATOLOGY, P1315; Harker LA, 1998, BLOOD, V92, p707A; HEYNS AD, 1986, BLOOD, V67, P86; HEYNS AD, 1982, AM J HEMATOL, V12, P167, DOI 10.1002/ajh.2830120209; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Ichikawa N, 1996, THROMB HAEMOSTASIS, V76, P156; KELTON JG, 1982, SEMIN THROMB HEMOST, V8, P83, DOI 10.1055/s-2007-1005045; KUTER DJ, 1994, P NATL ACAD SCI USA, V91, P11104, DOI 10.1073/pnas.91.23.11104; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Marsh JCW, 1996, BRIT J HAEMATOL, V95, P605, DOI 10.1046/j.1365-2141.1996.d01-1966.x; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; MCMILLAN R, 1981, NEW ENGL J MED, V304, P1135, DOI 10.1056/NEJM198105073041904; NICHOL JL, 1995, J CLIN INVEST, V95, P2973, DOI 10.1172/JCI118005; Nomura S, 2002, BLOOD, V100, P728, DOI 10.1182/blood.V100.2.728; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Rice L, 2001, AM J HEMATOL, V68, P210, DOI 10.1002/ajh.1181; Scheding S, 2002, TRANSFUSION, V42, P321, DOI 10.1046/j.1537-2995.2002.00047.x; Stepan DE, 2005, BLOOD, V106, p361A; Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567; Ulich TR, 1996, BLOOD, V87, P5006, DOI 10.1182/blood.V87.12.5006.bloodjournal87125006; Usuki K, 1996, STEM CELLS, V14, P558, DOI 10.1002/stem.140558; Wang B, 2004, CLIN PHARMACOL THER, V76, P628, DOI 10.1016/j.clpt.2004.08.010; Yanagida M, 1997, BRIT J HAEMATOL, V99, P739, DOI 10.1046/j.1365-2141.1997.4843288.x	34	361	380	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1672	1681		10.1056/NEJMoa054626	http://dx.doi.org/10.1056/NEJMoa054626			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050891	Green Published			2022-12-28	WOS:000241357300008
J	Hsieh, CH; Reiss, CS; Hunter, JR; Beddington, JR; May, RM; Sugihara, G				Hsieh, Chih-hao; Reiss, Christian S.; Hunter, John R.; Beddington, John R.; May, Robert M.; Sugihara, George			Fishing elevates variability in the abundance of exploited species	NATURE			English	Article							NATURAL-POPULATIONS; AGE STRUCTURE; GADUS-MORHUA; LIFE-HISTORY; COD; RECRUITMENT; IMPACTS; FISHES	The separation of the effects of environmental variability from the impacts of fishing has been elusive, but is essential for sound fisheries management(1-7). We distinguish environmental effects from fishing effects by comparing the temporal variability of exploited versus unexploited fish stocks living in the same environments. Using the unique suite of 50-year-long larval fish surveys from the California Cooperative Oceanic Fisheries Investigations(4) we analyse fishing as a treatment effect in a long-term ecological experiment. Here we present evidence from the marine environment that exploited species exhibit higher temporal variability in abundance than unexploited species. This remains true after accounting for life-history effects, abundance, ecological traits and phylogeny. The increased variability of exploited populations is probably caused by fishery-induced truncation of the age structure, which reduces the capacity of populations to buffer environmental events(1,5,8,9). Therefore, to avoid collapse, fisheries must be managed not only to sustain the total viable biomass but also to prevent the significant truncation of age structure(1,5,8,9). The double jeopardy of fishing to potentially deplete stock sizes and, more immediately, to amplify the peaks and valleys of population variability(7), calls for a precautionary management approach(10,11).	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biol, London SW7 2AZ, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; Imperial College London; University of Oxford	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272				Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Cury PA, 2005, ICES J MAR SCI, V62, P307, DOI 10.1016/j.icesjms.2005.02.003; FAO, 2003, FAO TECHN GUID RE S2, P1, DOI DOI 10.1017/CB09781107415324.004; *FAO UN, 2005, REV STAT WORLD MAR F; Finney BP, 2002, NATURE, V416, P729, DOI 10.1038/416729a; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; LAMBERT TC, 1987, MAR ECOL PROG SER, V39, P209, DOI 10.3354/meps039209; Little R. J., 2002, STAT ANAL MISSING DA, VSecond, P164; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; MAY RM, 1978, MATH BIOSCI, V42, P219, DOI 10.1016/0025-5564(78)90097-4; Mertz G, 1996, CAN J FISH AQUAT SCI, V53, P1618, DOI 10.1139/cjfas-53-7-1618; Mertz G., 1994, Fisheries Oceanography, V3, P1, DOI 10.1111/j.1365-2419.1994.tb00043.x; Murawski SA, 2001, ICES J MAR SCI, V58, P1002, DOI 10.1006/jmsc.2001.1097; MURPHY GI, 1967, ECOLOGY, V48, P731, DOI 10.2307/1933730; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; PIMM SL, 1991, BALANCE NATURE ECOLO, P39; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SHEPHERD JG, 1990, PHILOS T ROY SOC B, V330, P151, DOI 10.1098/rstb.1990.0189; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	30	433	452	5	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					859	862		10.1038/nature05232	http://dx.doi.org/10.1038/nature05232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051218				2022-12-28	WOS:000241362700052
J	Russell, JA				Russell, Jarnes A.			Drug therapy: Management of sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; NECROSIS-FACTOR-ALPHA; RESPIRATORY-DISTRESS-SYNDROME; FACTOR PATHWAY INHIBITOR; SEPTIC SHOCK; DOUBLE-BLIND; TISSUE FACTOR; MONOCLONAL-ANTIBODY		Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Russell, JA (corresponding author), Univ British Columbia, St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jrussell@mrl.ubc.ca						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus DC, 2003, CRIT CARE MED, V31, P1, DOI 10.1097/00003246-200301000-00001; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; AYALA A, 1995, SHOCK, V3, P259, DOI 10.1097/00024382-199504000-00003; Bellomo R, 2000, LANCET, V356, P2139; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Carraway MS, 2003, AM J RESP CRIT CARE, V167, P1200, DOI 10.1164/rccm.200204-287OC; Cole L, 2002, CRIT CARE MED, V30, P100, DOI 10.1097/00003246-200201000-00016; Cook D, 1998, NEW ENGL J MED, V338, P791, DOI 10.1056/NEJM199803193381203; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Corwin HL, 1999, CRIT CARE MED, V27, P2346, DOI 10.1097/00003246-199911000-00004; Creasey AA, 2001, CRIT CARE MED, V29, pS126, DOI 10.1097/00003246-200107001-00038; Crouser ED, 2000, AM J RESP CRIT CARE, V161, P1705, DOI 10.1164/ajrccm.161.5.9907043; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Derhaschnig U, 2003, BLOOD, V102, P2093, DOI 10.1182/blood-2003-02-0416; Dhainaut JFO, 2003, THROMB HAEMOSTASIS, V90, P642, DOI 10.1160/TH02-11-0270; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Fein AM, 1997, JAMA-J AM MED ASSOC, V277, P482, DOI 10.1001/jama.277.6.482; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; FULCHER CA, 1984, BLOOD, V63, P486; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; GRINNELL BW, 1994, GLYCOBIOLOGY, V4, P221, DOI 10.1093/glycob/4.2.221; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herbertson MJ, 1996, AM J PHYSIOL-HEART C, V270, pH1979, DOI 10.1152/ajpheart.1996.270.6.H1979; HERBERTSON MJ, 1995, AM J RESP CRIT CARE, V152, P480, DOI 10.1164/ajrccm.152.2.7633696; Holmes CL, 2001, INTENS CARE MED, V27, P1416, DOI 10.1007/s001340101014; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; Leibovici L, 1998, J INTERN MED, V244, P379; Liaw PCY, 2004, BLOOD, V104, P3958, DOI 10.1182/blood-2004-03-1203; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Lyman Gary H, 2005, J Natl Compr Canc Netw, V3, P557; Manns BJ, 2002, NEW ENGL J MED, V347, P993, DOI 10.1056/NEJMsa020969; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; MARIK PE, 2001, CRIT CARE MED, V29, P2387; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MEAKINS JL, 1977, ANN SURG, V186, P241, DOI 10.1097/00000658-197709000-00002; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Mesotten D, 2004, J CLIN ENDOCR METAB, V89, P219, DOI 10.1210/jc.2003-030760; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Murakami K, 1997, AM J PHYSIOL-LUNG C, V272, pL197, DOI 10.1152/ajplung.1997.272.2.L197; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Okamura T, 1999, J HYPERTENS, V17, P673, DOI 10.1097/00004872-199917050-00011; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Opal SM, 2003, CLIN INFECT DIS, V37, P50, DOI 10.1086/375593; Ortiz A, 1997, J INVEST MED, V45, P50; Patel BM, 2002, ANESTHESIOLOGY, V96, P576, DOI 10.1097/00000542-200203000-00011; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Riewald M, 2003, J ENDOTOXIN RES, V9, P317, DOI 10.1179/096805103225002584; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Tamaki T, 1996, KIDNEY INT, V49, P722, DOI 10.1038/ki.1996.101; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van Haren FMP, 2003, CHEST, V124, P2256, DOI 10.1378/chest.124.6.2256; VANHINSBERGH VWM, 1985, BLOOD, V65, P444; Vanhorebeek I, 2005, CURR OPIN CRIT CARE, V11, P304, DOI 10.1097/01.ccx.0000170506.61281.94; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Vincent JL, 2003, CRIT CARE MED, V31, P834, DOI 10.1097/01.CCM.0000051515.56179.E1; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192; Weintraub WS, 2004, CIRCULATION, V110, P472, DOI 10.1161/01.CIR.0000136820.77558.B1; Whiting JF, 2004, AM J TRANSPLANT, V4, P569, DOI 10.1111/j.1600-6143.2004.00373.x; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	113	807	886	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1699	1713		10.1056/NEJMra043632	http://dx.doi.org/10.1056/NEJMra043632			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050894				2022-12-28	WOS:000241357300011
J	Hilton, R				Hilton, Rachel			Acute renal failure	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE-CARE-UNIT; N-ACETYLCYSTEINE; EPIDEMIOLOGY; ADULTS		Guys Hosp, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Hilton, R (corresponding author), Guys Hosp, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England.	rachel.hilton@gstt.nhs.uk		Hilton, Rachel/0000-0001-5118-2017				Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Carmichael P, 2003, ANZ J SURG, V73, P144, DOI 10.1046/j.1445-2197.2003.02640.x; Dupont PJ, 2000, BMJ-BRIT MED J, V321, P1065, DOI 10.1136/bmj.321.7268.1065; FEEST TG, 1993, BMJ-BRIT MED J, V306, P481, DOI 10.1136/bmj.306.6876.481; Firth JD, 2005, OXFORD TXB CLIN NEPH, P1465; GLYNNE PA, 2002, ACUTE RENAL FAILURE; Hegarty J, 2005, QJM-INT J MED, V98, P661, DOI 10.1093/qjmed/hci109; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; KELLUM J, ACUTE RENAL FAILURE; Khan IH, 1997, QJM-MON J ASSOC PHYS, V90, P781; Kulkarni S, 2005, INT J CLIN PRACT, V59, P992, DOI 10.1111/j.1368-5031.2005.00507.x; Kwok MH, 2006, BMJ-BRIT MED J, V333, P420; LAMCIRE H, 2006, NEPHROL DIAL TRANSPL, V21, pI11; Lameire N, 2005, LANCET, V365, P417; Lameire N, 2006, NAT CLIN PRACT NEPHR, V2, P364, DOI 10.1038/ncpneph0218; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; MacDowall P, 1998, LANCET, V352, P13, DOI 10.1016/S0140-6736(97)11060-1; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Metcalfe W, 2002, QJM-INT J MED, V95, P579, DOI 10.1093/qjmed/95.9.579; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; *REN ASS, 2005, 8 REN ASS; Sandhu C, 2006, CARDIOVASC INTER RAD, V29, P344, DOI 10.1007/s00270-005-0127-8; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Stevens PE, 2001, QJM-INT J MED, V94, P533, DOI 10.1093/qjmed/94.10.533; Zacharias M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003590.pub2	27	56	60	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2006	333	7572					786	790		10.1136/bmj.38975.657639.AE	http://dx.doi.org/10.1136/bmj.38975.657639.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038736	Green Published			2022-12-28	WOS:000241566000016
J	Simmons, SF; Brown, KL				Simmons, Stuart F.; Brown, Kevin L.			Gold in magmatic hydrothermal solutions and the rapid formation of a giant ore deposit	SCIENCE			English	Article							PAPUA-NEW-GUINEA; LIHIR ISLAND; MINERALIZATION; TRANSITION; PORPHYRY; SYSTEM; ROCKS	The Ladolam hydrothermal system, on Lihir Island, Papua New Guinea, hosts one of the youngest and largest gold deposits in the world. Several deep ( more than 1 kilometer) geothermal wells were drilled beneath the ore bodies to extract water at >275 degrees C and to facilitate open-pit mining. Using a titanium down-hole sampler, we determined that the deep geothermal brine of magmatic origin contains similar to 15 parts per billion gold. At the current gold flux of 24 kilograms per year, this deposit could have formed within similar to 55,000 years. The combination of sustained metal flux and efficient metal precipitation led to the formation of a giant hydrothermal gold deposit in a short period.	GEOKEM, Swanson 0653, Waitakere, New Zealand		Simmons, SF (corresponding author), Univ Auckland, Dept Geol, Private Bag 92019,Auckland Mail Ctr, Auckland 1142, New Zealand.	sf.simmons@auckland.ac.nz						ALLIS RG, 1988, 67 DEP SCI IND RES G; ANDRES RJ, 1993, GEOL RUNDSCH, V82, P687; Benning LG, 1996, GEOCHIM COSMOCHIM AC, V60, P1849, DOI 10.1016/0016-7037(96)00061-0; BIBBY HM, 1995, J VOLCANOL GEOTH RES, V68, P29, DOI 10.1016/0377-0273(95)00007-H; Brown KL, 2003, GEOTHERMICS, V32, P619, DOI 10.1016/S0375-6505(03)00049-X; BROWN KL, 1986, ECON GEOL, V81, P979, DOI 10.2113/gsecongeo.81.4.979; Carman G.D., 2003, SOC EC GEOLOGISTS SP, P247; Hannington M.D., 2005, EC GEOLOGY 100 ANNIV, P111; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; HEDENQUIST JW, 1993, GEOLOGY, V21, P731, DOI 10.1130/0091-7613(1993)021<0731:WINZVH>2.3.CO;2; Heinrich C, 2005, MINER DEPOSITA, V39, P864, DOI 10.1007/s00126-004-0461-9; Jensen E.P., 2000, GOLD IN 2000, P279; Longo A.A., 2005, THESIS OREGON STATE; McInnes BIA, 2001, EARTH PLANET SC LETT, V188, P169, DOI 10.1016/S0012-821X(01)00306-5; MOYLE AJ, 1990, AUSTRALASIAN I MININ, V14, P1793; Muller D, 2002, MINER DEPOSITA, V37, P61, DOI 10.1007/s00126-001-0230-y; Muller D, 2001, LITHOS, V57, P163, DOI 10.1016/S0024-4937(01)00035-4; Pichler T, 1999, ECON GEOL BULL SOC, V94, P281, DOI 10.2113/gsecongeo.94.2.281; SILLITOE RH, 1994, GEOLOGY, V22, P945, DOI 10.1130/0091-7613(1994)022<0945:EACOVC>2.3.CO;2; Sillitoe RH, 2002, MINER DEPOSITA, V37, P4, DOI 10.1007/s00126-001-0227-6; SILLITOE RH, 2000, GEOL ORE DEPOSIT+, P1; Simmons S.F., 2005, EC GEOLOGY 100 ANNIV, V100, P485, DOI DOI 10.2113/gsecongeo.100.5.1052; Stefansson A, 2004, GEOCHIM COSMOCHIM AC, V68, P4121, DOI 10.1016/j.gca.2004.04.006	23	146	156	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					288	291		10.1126/science.1132866	http://dx.doi.org/10.1126/science.1132866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038619				2022-12-28	WOS:000241194100038
J	Davidoff, F; Trussell, J				Davidoff, Frank; Trussell, James			Plan B and the politics of doubt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMERGENCY CONTRACEPTION; OVARIAN-FUNCTION; YUZPE REGIMEN; LEVONORGESTREL; PREGNANCY; MIFEPRISTONE; MECHANISMS; CYCLE		Inst Healthcare Improvement, Cambridge, MA USA; Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA	Institute for Healthcare Improvement; Princeton University	Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						BEREK JS, 2002, NOVAKS GYNECOLOGY, P249; BOSSOM E, CONTRACEPTION DECEPT; Brito KS, 2005, CONTRACEPTION, V72, P225, DOI 10.1016/j.contraception.2005.04.005; Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007; CROXATTO HB, 2002, IPPF MED B, P36; *DIV REPR UR PROD, MED OFF SAF REV SUPP; Durand M, 2005, CONTRACEPTION, V71, P451, DOI 10.1016/j.contraception.2005.01.003; Durand M, 2001, CONTRACEPTION, V64, P227, DOI 10.1016/S0010-7824(01)00250-5; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Marions L, 2004, CONTRACEPTION, V69, P373, DOI 10.1016/j.contraception.2003.11.018; NOVIKOVA N, IN PRESS CONTRACEPTI; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Raymond EG, 2006, CONTRACEPTION, V73, P376, DOI 10.1016/j.contraception.2005.10.006; Rosenstock L, 2006, JAMA-J AM MED ASSOC, V295, P2407, DOI 10.1001/jama.295.20.2407; SALETAN W, 2006, WASH POST       0806, pB2; SHORTO R, 2006, NY TIMES SUNDAY 0507, P49; Stewart FH, 2000, AM J PREV MED, V19, P228, DOI 10.1016/S0749-3797(00)00243-9; Trussell J, 2003, J FAM PLAN REPROD H, V29, P249, DOI 10.1783/147118903101197944; Trussell J, 2003, CONTRACEPTION, V67, P167, DOI 10.1016/S0010-7824(02)00486-9; *US GOV ACC OFF, GAO06109; Verpoest WMJA, 2000, FERTIL STERIL, V73, P75, DOI 10.1016/S0015-0282(99)00481-1; *WOM CAP CORP, 2003, NONPR DRUGS REPR HLT, P63	24	35	36	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1775	1778		10.1001/jama.296.14.1775	http://dx.doi.org/10.1001/jama.296.14.1775			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092NH	17032991				2022-12-28	WOS:000241103400026
J	Campbell, OMR; Graham, WJ				Campbell, Oona M. R.; Graham, Wendy J.		Lancet Maternal Survival Series	Maternal survival 2 - Strategies for reducing maternal mortality: getting on with what works	LANCET			English	Article							TRADITIONAL BIRTH ATTENDANTS; SAFE MOTHERHOOD; ANTENATAL CARE; RANDOMIZED-TRIAL; OBSTETRIC CARE; HEALTH; PREGNANCY; PROGRAMS; AVAILABILITY; MORBIDITY	The concept of knowing what works in terms of reducing maternal mortality is complicated by a huge diversity of country contexts and of determinants of maternal health. Here we aim to show that, despite this complexity, only a few strategic choices need to be made to reduce maternal mortality. We begin by presenting the logic that informs our strategic choices. This logic suggests that implementation of an effective intrapartum-care strategy is an overwhelming priority. We also discuss the alternative configurations of such a strategy and, using the best available evidence, prioritise one strategy based on delivery in primary-level institutions (health centres), backed up by access to referral-level facilities. We then go on to discuss strategies that complement intrapartum care. We conclude by discussing the inexplicable hesitation in decision-making after nearly 20 years of safe motherhood programming: if the fifth Millennium Development Goal is to be achieved, then what needs to be prioritised is obvious. Further delays in getting on with what works begs questions about the commitment of decision-makers to this goal.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen	Campbell, OMR (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Oona.Campbell@lshtm.ac.uk		Graham, Wendy/0000-0003-1473-5342; Campbell, Oona/0000-0002-9311-0115				*A GUTTM I, 1999, SHAR RESP WOM SOC AB; AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; ALISJAHBANA A, 1995, INT J GYNECOL OBSTET, V48, pS83, DOI 10.1016/0020-7292(95)02323-5; [Anonymous], 1986, WHO CHRON, V40, P175; [Anonymous], 2001, STUDIES HLTH SERVICE, V17, P195; Bale JR, 2003, IMPROVING BIRTH OUTC; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Blum LS, 2006, REPROD HEALTH MATTER, V14, P51, DOI 10.1016/S0968-8080(06)27234-3; CAMPBELL OMR, 2001, SAFE MOTHERHOOD STRA, V17, P415; Carrette L, 2001, FUEL CELLS, V1, P5, DOI 10.1002/1615-6854(200105)1:1<5::AID-FUCE5>3.0.CO;2-G; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Cleland J, 2005, LANCET, V366, P1899, DOI 10.1016/S0140-6736(05)67603-9; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Essien E, 1997, INT J GYNECOL OBSTET, V59, pS237, DOI 10.1016/S0020-7292(97)00171-9; Filippi V, 2004, HEALTH POLICY PLANN, V19, P57, DOI 10.1093/heapol/czh007; Freedman LP, 2001, INT J GYNECOL OBSTET, V75, P51, DOI 10.1016/S0020-7292(01)00473-8; GAY J, 2003, WHAT WORKS POLICY PR; Gozum S, 2005, MIDWIFERY, V21, P371, DOI 10.1016/j.midw.2005.02.005; Graham W, 1998, Plan Parent Chall, P13; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; GRAHAM WJ, 1992, SOC SCI MED, V35, P967, DOI 10.1016/0277-9536(92)90236-J; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; GRAHAM WJ, 2001, LANCET, V353, P1836; GREENWOOD AM, 1987, B WORLD HEALTH ORGAN, V65, P635; Hatcher R, 1997, CHINESE VERSION; Hodnett E, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003766; Jahn A, 2001, SAFE MOTHERHOOD STRA; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; JANOWITZ B, 1985, AM J PUBLIC HEALTH, V75, P745, DOI 10.2105/AJPH.75.7.745; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Khalil K, 2005, BJOG-INT J OBSTET GY, V112, P1270, DOI 10.1111/j.1471-0528.2005.00710.x; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Kunst A. E., 2001, STUDIES HLTH SERV OR, V17, P297; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; Maine D, 1991, SAFE MOTHERHOOD PROG; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McDonagh M, 1996, HEALTH POLICY PLANN, V11, P1, DOI 10.1093/heapol/11.1.1; Miller S, 2003, J MIDWIFERY WOM HEAL, V48, P10, DOI 10.1016/S1526-9523(02)00369-0; Milne L, 2004, J MIDWIFERY WOM HEAL, V49, P338, DOI 10.1016/j.jmwh.2004.04.002; NIRUPAM S, 1995, INT J GYNECOL OBSTET, V50, pS79, DOI 10.1016/0020-7292(95)02492-U; PATHMANATHAN J, 2003, INVESTING MATERNAL H; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Ronsmans C, 1998, STUD FAMILY PLANN, V29, P282, DOI 10.2307/172274; Ross JA, 2005, MATERN CHILD HLTH J, V9, P59, DOI 10.1007/s10995-005-2548-z; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; *SAF MOTH IN, 2004, ANN PARTN SAF MOTH N; SCHIEBER B, 1993, INTERVENTION REDUCE; SEMBA R, 2006, NUTR HLTH DEV COUNTR; SEONE G, 1996, DIAGNOSTICO BARRERAS; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Sibley LM, 2004, J MIDWIFERY WOM HEAL, V49, P298, DOI 10.1016/j.jmwh.2004.03.009; Stanton CK, 2004, EVALUATION REV, V28, P179, DOI 10.1177/0193841X03262577; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TRUSSELL J, 1984, STUD FAMILY PLANN, V15, P267, DOI 10.2307/1966071; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WALT G, 1989, SOC SCI MED, V29, P599, DOI 10.1016/0277-9536(89)90179-2; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; *WHO, 2000, WHO MAN COMPL PREGN; *WHO, REPR HLTH LIB VERS 9; WINIKOFF B, 1987, STUD FAMILY PLANN, V18, P128, DOI 10.2307/1966808; World Health Organization, 2005, WORLD HLTH REP 2005	71	1114	1125	0	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1284	1299		10.1016/S0140-6736(06)69381-1	http://dx.doi.org/10.1016/S0140-6736(06)69381-1			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091WF	17027735				2022-12-28	WOS:000241058300036
J	Gostin, LO				Gostin, Lawrence O.			HIV screening in health care settings - Public health and civil liberties in conflict?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; PERSONS AWARE; TRANSMISSION; PREVENTION; STRATEGIES; UNAWARE; VIRUS; WOMEN		Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1149; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], NO TIM LOS GETT MOR; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Gostin LO, 1997, NEW ENGL J MED, V337, P1162, DOI 10.1056/NEJM199710163371611; GOSTIN LO, 1989, JAMA-J AM MED ASSOC, V261, P1621; *HLTH RES ED TRUST, 2006, MAP HIV TEST LAWS US; HODGE JG, 2004, ADV HIV PREVENTION I; *I MED, 1999, RED ODDS PREV PER TR; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; PECKHAM C, 1995, NEW ENGL J MED, V333, P298, DOI 10.1056/NEJM199508033330507; Rotheram-Borus MJ, 2000, ARCH PEDIAT ADOL MED, V154, P435, DOI 10.1001/archpedi.154.5.435; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055	22	53	53	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					2023	2025		10.1001/jama.296.16.2023	http://dx.doi.org/10.1001/jama.296.16.2023			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098BL	17062866				2022-12-28	WOS:000241495300025
J	Musani, A; Shaikh, I				Musani, Altaf; Shaikh, Irshad			Learning from conflict and disaster in the Eastern Mediterranean region - Preparedness for humanitarian crises needs to be improved	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									WHO, Reg Off Eastern Mediterranean, Cairo 11371, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Musani, A (corresponding author), WHO, Reg Off Eastern Mediterranean, POB 7608, Cairo 11371, Egypt.							ANNAN K, 2004, FACING HUMANITARIAN; Burkle FM, 2006, J POSTGRAD MED, V52, P110; *DIS CONTR PRIOR P, 2006, DIS CONTR PRIOR DEV; EM-DAT, OFDA CRED INT DIS DA; Garfield R. M., 1997, WAR PUBLIC HLTH, P27; Guha-Sapir D., 2005, DARFUR COUNTING DEAT; Noji EK, 2005, EPIDEMIOL REV, V27, P3, DOI 10.1093/epirev/mxi007; *PROV CONS, EXP RES LEARN; RAUTELA P, 2006, DISASTER PREV MANAG, V15, P585; *REL, 2006, LEB CRIS FLASH APP 2; Sengezer B, 2005, DISASTERS, V29, P171, DOI 10.1111/j.0361-3666.2005.00279.x; Shaw R, 2006, DISASTER PREV MANAG, V15, P31, DOI [DOI 10.1108/09653560610654220, 10.1108/09653560610654220]; *UN OCHA, 2005, HUM RESP REV; *UN OFF COORD HUM, 2006, 39 OCHA UN OFF COORD; *WHO, 2006, REP WORKSH TRACK HLT; World Bank, 2006, HAZ NAT RISKS DEV IE	16	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					843	845		10.1136/bmj.38994.548125.94	http://dx.doi.org/10.1136/bmj.38994.548125.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053239	Green Published			2022-12-28	WOS:000241678500018
J	Puska, P				Puska, Pekka			WHO Director-General election: public-health infrastructures	LANCET			English	Editorial Material									Natl Publ Hlth Inst, KTL, FI-00300 Helsinki, Finland	Finland National Institute for Health & Welfare	Puska, P (corresponding author), Natl Publ Hlth Inst, KTL, Mannerheimintie 166, FI-00300 Helsinki, Finland.	pekka.puska@ktl.fi						*INT ASS NAT PUBL, 2006, IANPHI MEMB SURV DAT; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Koplan JP, 2005, B WORLD HEALTH ORGAN, V83, P154; *PAHO, 2002, ESS PUBL HLTH FUNCT; Steinbrook R, 2006, NEW ENGL J MED, V355, P1081, DOI 10.1056/NEJMp068167; *WHO, 2006, ENG HLTH 11 GEN PROG	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2006	368	9545					1401	1403		10.1016/S0140-6736(06)69582-2	http://dx.doi.org/10.1016/S0140-6736(06)69582-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055927				2022-12-28	WOS:000241459100008
J	Call, ME; Schnell, JR; Xu, CQ; Lutz, RA; Chou, JJ; Wucherpfennig, KW				Call, Matthew E.; Schnell, Jason R.; Xu, Chenqi; Lutz, Regina A.; Chou, James J.; Wucherpfennig, Kai W.			The structure of the zeta zeta transmembrane dimer reveals features essential for its assembly with the T cell receptor	CELL			English	Article							ISOTOPICALLY ENRICHED PROTEINS; ANTIGEN RECEPTOR; J-COUPLINGS; CHAIN DIMERIZATION; CHEMICAL-SHIFTS; CD3-ZETA CHAIN; ALPHA-HELICES; CD3 COMPLEX; ASSOCIATION; EXPRESSION	The T cell receptor (TCR) alpha beta heterodimer communicates ligand binding to the cell interior via noncovalently associated CD3 gamma epsilon, CD3 delta epsilon, and xi xi dimers. While structures of extracellular components of the TCR-CD3 complex are known, the transmembrane (TM) domains that mediate assembly have eluded structural characterization. Incorporation of the xi xi signaling module is known to require one basic TCR alpha and two xi xi aspartic acid TM residues. We report the NMR structure of the xi xi(TM) dinner, a left-handed coiled coil with substantial polar contacts. Mutagenesis experiments demonstrate that three polar positions are critical for xi xi dimerization and assembly with TCR. The two aspartic acids create a single structural unit at the a interface stabilized by extensive hydrogen bonding, and there is evidence for a structural water molecule (or molecules) within close proximity. This structural unit, representing only the second transmembrane dinner interface solved to date, serves as a paradigm for the assembly of all modules involved in TCR signaling.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	james_chou@hms.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Xu, Chenqi/0000-0002-4968-6782; Call, Matthew/0000-0001-5846-6469	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054520] Funding Source: Medline; NIBIB NIH HHS [EB002026, P41 EB002026] Funding Source: Medline; PHS HHS [F32] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BAX A, 1994, METHOD ENZYMOL, V239, P79; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Bolliger L, 1999, J IMMUNOL, V163, P3867; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; Exley M, 1991, Semin Immunol, V3, P283; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; GEISLER C, 1989, J IMMUNOL, V143, P4069; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; GRZESIEK S, 1993, J BIOMOL NMR, V3, P487; Hu JS, 1996, J AM CHEM SOC, V118, P8170, DOI 10.1021/ja9616239; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; Ishikawa S, 2004, INT IMMUNOL, V16, P1019, DOI 10.1093/intimm/dxh103; KEARSE KP, 1995, IMMUNITY, V2, P391; KUSTER H, 1990, J BIOL CHEM, V265, P6448; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1996, J BIOMOL NMR, V7, P256; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; VUISTER GW, 1993, J AM CHEM SOC, V115, P5334, DOI 10.1021/ja00065a071; Walters KJ, 1997, J AM CHEM SOC, V119, P5958, DOI 10.1021/ja963309k; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	49	183	189	1	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					355	368		10.1016/j.cell.2006.08.044	http://dx.doi.org/10.1016/j.cell.2006.08.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055436	Green Accepted, Bronze			2022-12-28	WOS:000241827100022
J	Schroder, L; Lowery, TJ; Hilty, C; Wemmer, DE; Pines, A				Schroeder, Leif; Lowery, Thomas J.; Hilty, Christian; Wemmer, David E.; Pines, Alexander			Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor	SCIENCE			English	Article							LASER-POLARIZED XE-129; XENON BIOSENSOR; IN-VIVO; FUNCTIONALIZED XENON; SATURATION-TRANSFER; NMR; DELIVERY; SPECTROSCOPY; EXCHANGE; AGENTS	A magnetic resonance approach is presented that enables high-sensitivity, high-contrast molecular imaging by exploiting xenon biosensors. These sensors link xenon atoms to specific biomolecular targets, coupling the high sensitivity of hyperpolarized nuclei with the specificity of biochemical interactions. We demonstrated spatial resolution of a specific target protein in vitro at micromolar concentration, with a readout scheme that reduces the required acquisition time by >3300-fold relative to direct detection. This technique uses the signal of free hyperpolarized xenon to dramatically amplify the sensor signal via chemical exchange saturation transfer (CEST). Because it is similar to 10,000 times more sensitive than previous CEST methods and other molecular magnetic resonance imaging techniques, it marks a critical step toward the application of xenon biosensors as selective contrast agents in biomedical applications.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wemmer, DE (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dewemmer@lbl.gov; pines@berkeley.edu	Hilty, Christian/C-1892-2015; Schröder, Leif/H-6036-2011	Hilty, Christian/0000-0003-2539-2568; Schröder, Leif/0000-0003-4901-0325				Aime S, 2005, ANGEW CHEM INT EDIT, V44, P1813, DOI 10.1002/anie.200462566; ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Bartik K, 1998, J AM CHEM SOC, V120, P784, DOI 10.1021/ja972377j; Bifone A, 1996, P NATL ACAD SCI USA, V93, P12932, DOI 10.1073/pnas.93.23.12932; Goffeney N, 2001, J AM CHEM SOC, V123, P8628, DOI 10.1021/ja0158455; Goodson BM, 1997, P NATL ACAD SCI USA, V94, P14725, DOI 10.1073/pnas.94.26.14725; Han SI, 2005, ANAL CHEM, V77, P4008, DOI 10.1021/ac0500479; Hilty C, 2006, ANGEW CHEM INT EDIT, V45, P70, DOI 10.1002/anie.200502693; Huber G, 2006, J AM CHEM SOC, V128, P6239, DOI 10.1021/ja060266r; Knagge K, 2004, CHEM PHYS LETT, V397, P11, DOI 10.1016/j.cplett.2004.08.050; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Lowery TJ, 2003, MAGN RESON IMAGING, V21, P1235, DOI 10.1016/j.mri.2003.08.025; MAUDSLEY AA, 1983, J MAGN RESON, V51, P147, DOI 10.1016/0022-2364(83)90113-0; Mugler JP, 1997, MAGN RESON MED, V37, P809, DOI 10.1002/mrm.1910370602; Mynar JL, 2006, J AM CHEM SOC, V128, P6334, DOI 10.1021/ja061735s; Spence MM, 2004, J AM CHEM SOC, V126, P15287, DOI 10.1021/ja0483037; Spence MM, 2001, P NATL ACAD SCI USA, V98, P10654, DOI 10.1073/pnas.191368398; Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.0.CO;2-4; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956	20	360	369	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					446	449		10.1126/science.1131847	http://dx.doi.org/10.1126/science.1131847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053143	Green Submitted			2022-12-28	WOS:000241382500036
J	Lansbury, PT; Lashuel, HA				Lansbury, Peter T.; Lashuel, Hilal A.			A century-old debate on protein aggregation and neurodegeneration enters the clinic	NATURE			English	Review							AMYLOID-BETA-PROTEIN; CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; FIBRIL FORMATION; IN-VIVO; TRANSGENIC MOUSE; INCLUSION FORMATION	The correlation between neurodegenerative disease and protein aggregation in the brain has long been recognized, but a causal relationship has not been unequivocally established, in part because a discrete pathogenic aggregate has not been identified. The complexity of these diseases and the dynamic nature of protein aggregation mean that, despite progress towards understanding aggregation, its relationship to disease is difficult to determine in the laboratory. Nevertheless, drug candidates that inhibit aggregation are now being tested in the clinic. These have the potential to slow the progression of Alzheimer's disease, Parkinson's disease and related disorders and could, if administered presymptomatically, drastically reduce the incidence of these diseases. The clinical trials could also settle the century-old debate about causality.	Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Cambridge, MA 02139 USA; Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroproteom, CH-1015 Lausanne, Switzerland	Harvard University; Harvard University; Brigham & Women's Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lansbury, PT (corresponding author), Link Med, 790 Mem Dr, Cambridge, MA 02139 USA.	lansbury@rics.bwh.harvard.edu	Lashuel, Hilal/M-3500-2017					Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; COHEN E, 2006, SCIENCE         0810, DOI DOI 10.1126/SCIENCE.1124646; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dodart JC, 2002, GENES BRAIN BEHAV, V1, P142, DOI 10.1034/j.1601-183X.2002.10302.x; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; GERVAIS F, 2006, IN PRESS NEUROB 0503, DOI DOI 10.1016/J.NEUROBIOLAGING.2006.02.015; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hand CK, 2001, ANN NEUROL, V49, P267, DOI 10.1002/1531-8249(20010201)49:2<267::AID-ANA51>3.0.CO;2-D; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; HSIAO K, 1991, ALZ DIS ASSOC DIS, V5, P155, DOI 10.1097/00002093-199100530-00001; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruger R, 2001, NEUROLOGY, V56, P1355, DOI 10.1212/WNL.56.10.1355; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LASHUEL HA, 2006, Q REV BIOPHYS   0918, DOI DOI 10.1017/50033583506004422; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mathis CA, 2005, ARCH NEUROL-CHICAGO, V62, P196, DOI 10.1001/archneur.62.2.196; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morihara T, 2002, J NEUROCHEM, V83, P1009, DOI 10.1046/j.1471-4159.2002.01195.x; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Restagno G, 2005, AMYOTROPH LATERAL SC, V6, P45, DOI 10.1080/14660820410021276a; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Roher AE, 1999, METHOD ENZYMOL, V309, P58; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; ROSEN AD, 1978, ARCH NEUROL-CHICAGO, V35, P638, DOI 10.1001/archneur.1978.00500340014003; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Satoh J, 2001, J NEUROL SCI, V189, P113, DOI 10.1016/S0022-510X(01)00555-X; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Yu WK, 2005, J NEUROSCI RES, V80, P114, DOI 10.1002/jnr.20428	91	542	559	4	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					774	779		10.1038/nature05290	http://dx.doi.org/10.1038/nature05290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051203	Green Published			2022-12-28	WOS:000241362700036
J	Hackam, DG; Redelmeier, DA				Hackam, Daniel G.; Redelmeier, Donald A.			Translation of research evidence from animals to humans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto	Hackam, DG (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	Daniel.Hackam@ices.on.ca						Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kaste M, 2005, STROKE, V36, P2323, DOI 10.1161/01.STR.0000179037.82647.48; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; *US DEP HHS FOOD D, 2006, GUID IND NONCL SAF E	5	463	741	0	54	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1731	+		10.1001/jama.296.14.1731	http://dx.doi.org/10.1001/jama.296.14.1731			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032985				2022-12-28	WOS:000241103400020
J	Menzies, D; Nair, A; Williamson, PA; Schembri, S; Al-Khairalla, MZH; Barnes, M; Fardon, TC; McFarlane, L; Magee, GJ; Lipworth, BJ				Menzies, Daniel; Nair, Arun; Williamson, Peter A.; Schembri, Stuart; Al-Khairalla, Mudher Z. H.; Barnes, Martyn; Fardon, Tom C.; McFarlane, Lesley; Magee, Gareth J.; Lipworth, Brian J.			Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; EXHALED NITRIC-OXIDE; SECONDHAND SMOKE; LUNG-FUNCTION; PASSIVE SMOKING; BRONCHIAL RESPONSIVENESS; AIRWAY INFLAMMATION; PARENTAL SMOKING; EXPOSURE; METHACHOLINE	Context Scotland prohibited smoking in confined public places on March 26, 2006. Objective To investigate the association of smoke-free legislation with symptoms, pulmonary function, and markers of inflammation of bar workers. Design, Setting, and Participants This prospective observational study was conducted in Tayside, Scotland from February-June 2006. One hundred five nonasthmatic and asthmatic nonsmoking bar workers were initially enrolled, of whom 77 completed the study per protocol. Main Outcome Measures Respiratory and sensory symptoms, spirometry measurements, serum cotinine levels, peripheral inflammatory cell count, asthma qualityof-life scores, and exhaled nitric oxide levels were evaluated before and after introduction of the smoking ban. Results For the per-protocol analysis, the percentage of bar workers with respiratory and sensory symptoms decreased from 79.2% (n = 61) before the smoke-free policy to 53.2% (n = 41) (total change, -26%; 95% confidence interval [CI], -13.8% to -38.1%; P < .001) and 46.8% (n = 38) (-32.5%; 95% CI, -19.8% to -45.2%; P < .001) 1 and 2 months afterward. Forced expiratory volume in the first second increased from 96.6% predicted to 104.8% (change, 8.2%; 95% CI, 3.9% to 12.4%; P , .001) and then 101.7% (change, 5.1%; 95% CI, 2.1% to 8.0%; P = .002), and serum cotinine levels decreased from 5.15 ng/mL to 3.22 ng/mL (change, -1.93 ng/mL; 95% CI, -2.83 to -1.03 ng/mL; P < .001) and then 2.93 ng/mL (-2.22 ng/mL; 95% CI, -3.10 to -1.34 ng/ mL; P < .001). The total white blood cell and neutrophil count was reduced from 7610 to 6980 cells/mu L at 2 months (-630 cells/mu L; 95% CI, - 1010 to - 260 cells/mu L; P = .002) and from 4440 to 4030 cells/mu L (-410 cells/mu L; 95% CI, - 740 to - 90 cells/mu L; P = .03), respectively. Asthmatic bar workers also had less airway inflammation, with a reduction in exhaled nitric oxide from 34.3 parts per billion (ppb) to 27.4 ppb 1 month after the ban (0.8-fold change; 95% CI, 0.67 to 0.96 ppb; P = .04), and Juniper quality-of-life scores increased from 80.2 to 87.5 points (7.3 points; 95% CI, 0.1 to 14.6 points; P = .049). Conclusions Smoke-free legislation was associated with significant early improvements in symptoms, spirometry measurements, and systemic inflammation of bar workers. Asthmatic bar workers also had reduced airway inflammation and improved quality of life.	Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Med & Therapeut, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Resp Med, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Menzies, D (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dept Med & Therapeut, Dundee DD1 9SY, Scotland.	d.menzies@dundee.ac.uk						Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Alving K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-67; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Berry M, 2005, EUR RESPIR J, V25, P986, DOI 10.1183/09031936.05.00132404; Chaudhuri R, 2006, AM J RESP CRIT CARE, V174, P127, DOI 10.1164/rccm.200510-1589OC; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Crook MA, 2000, EUR J CLIN INVEST, V30, P861, DOI 10.1046/j.1365-2362.2000.00738.x; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Fardon TC, 2004, ANN ALLERG ASTHMA IM, V93, P365, DOI 10.1016/S1081-1206(10)61396-8; Farrelly MC, 2005, TOB CONTROL, V14, P236, DOI 10.1136/tc.2004.008839; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55; Inman MD, 1998, J ALLERGY CLIN IMMUN, V101, P342, DOI 10.1016/S0091-6749(98)70246-5; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; Jones SL, 2002, EUR RESPIR J, V20, P601, DOI 10.1183/09031936.02.00285302; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Office on Smoking and Health, 2006, HLTH CONS INV EXP TO; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Sasco AJ, 2004, LUNG CANCER, V45, pS3, DOI 10.1016/j.lungcan.2004.07.998; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Ward C, 2005, CLIN EXP ALLERGY, V35, P1565, DOI 10.1111/j.1365-2222.2005.02365.x; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Yates DH, 2001, AM J RESP CRIT CARE, V164, P1043, DOI 10.1164/ajrccm.164.6.2005043; [No title captured]	36	205	215	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1742	1748		10.1001/jama.296.14.1742	http://dx.doi.org/10.1001/jama.296.14.1742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032987	Bronze			2022-12-28	WOS:000241103400022
J	Han, XM; Jin, M; Breuker, K; McLafferty, FW				Han, Xuemei; Jin, Mi; Breuker, Kathrin; McLafferty, Fred W.			Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons	SCIENCE			English	Article							ELECTRON-CAPTURE DISSOCIATION; MULTIPLY-CHARGED IONS; LARGE MOLECULES; SEQUENCE INFORMATION; ESCHERICHIA-COLI; IONIZATION; IDENTIFICATION; PROTEOMICS; SECONDARY; KDA	For characterization of sequence and posttranslational modifications, molecular and fragment ion mass data from ionizing and dissociating a protein in the mass spectrometer are far more specific than are masses of peptides from the protein's digestion. We extend the similar to 500-residue, similar to 50-kilodalton (kD) dissociation limitation of this top-down methodology by using electrospray additives, heated vaporization, and separate noncovalent and covalent bond dissociation. This process can cleave 287 interresidue bonds in the termini of a 1314-residue (144-kD) protein, specify previously unidentified disulfide bonds between 8 of 27 cysteines in a 1714-residue (200-kD) protein, and correct sequence predictions in two proteins, one with 2153 residues ( 229 kD).	Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA; Univ Innsbruck, Inst Organ Chem, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria	Cornell University; University of Innsbruck; University of Innsbruck	McLafferty, FW (corresponding author), Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA.	fwm5@cornell.edu		Breuker, Kathrin/0000-0002-4978-0883	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM016609, R01GM016609] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM16609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Breuker K, 2005, ANGEW CHEM INT EDIT, V44, P4911, DOI 10.1002/anie.200500668; Breuker K, 2002, J AM CHEM SOC, V124, P6407, DOI 10.1021/ja012267j; FENG R, 1992, ANAL CHEM, V64, P2090, DOI 10.1021/ac00042a012; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ge Y, 2002, J AM CHEM SOC, V124, P672, DOI 10.1021/ja011335z; Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6; HENRY KD, 1989, P NATL ACAD SCI USA, V86, P9075, DOI 10.1073/pnas.86.23.9075; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Hoaglund-Hyzer CS, 1999, CHEM REV, V99, P3037, DOI 10.1021/cr980139g; Horn DM, 2000, P NATL ACAD SCI USA, V97, P10313, DOI 10.1073/pnas.97.19.10313; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Kelleher NL, 1998, PROTEIN SCI, V7, P1796, DOI 10.1002/pro.5560070815; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; LITTLE DP, 1994, ANAL CHEM, V66, P2809, DOI 10.1021/ac00090a004; LOO JA, 1991, ANAL CHEM, V63, P2488, DOI 10.1021/ac00021a018; LOO JA, 1990, SCIENCE, V248, P201, DOI 10.1126/science.2326633; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; McLafferty FW, 1999, SCIENCE, V284, P1289, DOI 10.1126/science.284.5418.1289; Oh H, 2002, P NATL ACAD SCI USA, V99, P15863, DOI 10.1073/pnas.212643599; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n; SEYA T, 1986, J IMMUNOL, V136, P4152; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhai H, 2005, ANAL CHEM, V77, P5777, DOI 10.1021/ac0580215	27	267	273	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					109	112		10.1126/science.1128868	http://dx.doi.org/10.1126/science.1128868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023655				2022-12-28	WOS:000241031200046
J	Steinbrook, R				Steinbrook, Robert			The price of sight - Ranibizumab, bevacizumab, and the treatment of macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bashshur ZF, 2006, AM J OPHTHALMOL, V142, P1, DOI 10.1016/j.ajo.2006.02.037; MOSHFEGHI AA, IN PRESS OPHTHALMOLO; *OPHTH MUT INS CO, 2006, RISK MAN REC OFFL IN; Rosenfeld PJ, 2006, AM J OPHTHALMOL, V142, P141, DOI 10.1016/j.ajo.2006.03.036; ROSENFELD PJ, CURRENT INSIGHTS, V1	5	176	189	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1409	1412		10.1056/NEJMp068185	http://dx.doi.org/10.1056/NEJMp068185			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021315				2022-12-28	WOS:000240976200001
J	Bax, M; Tydeman, C; Flodmark, O				Bax, Martin; Tydeman, Clare; Flodmark, Olof			Clinical and MRI correlates of cerebral palsy - The European Cerebral Palsy Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICOPATHOLOGICAL CORRELATION; CHILDREN	Context Magnetic resonance imaging (MRI) findings have been reported for specific clinical cerebral palsy (CP) subgroups or lesion types but not in a large population of children with all CP subtypes. Further information about the causes of CP could help identify preventive strategies. Objective To investigate the correlates of CP in a population sample and compare clinical findings with information available from MRI brain studies. Design and Setting Cross-sectional, population-based investigative study conducted in 8 European study centers ( North West London and North East London, England; Edinburgh, Scotland; Lisbon, Portugal; Dublin, Ireland; Stockholm, Sweden; Tubingen, Germany; and Helsinki, Finland). Participants Five hundred eighty-five children with CP were identified who had been born between 1996 and 1999; 431 children were clinically assessed and 351 had a brain MRI scan. Main Outcome Measures Standardized clinical examination results, parental questionnaire responses, MRI results, and obstetric, genetic, and metabolic data from medical records. Results Important findings include the high rate of infections reported by mothers during pregnancy (n= 158 [39.5%]). In addition, 235 children (54%) were born at term while 47 children (10.9%) were very preterm (< 28 weeks). A high rate of twins was found, with 51 children (12%) known to be from a multiple pregnancy. Clinically, 26.2% of children had hemiplegia, 34.4% had diplegia, 18.6% had quadriplegia, 14.4% had dyskinesia, 3.9% had ataxia, and 2.6% had other types of CP. Brain MRI scans showed that white-matter damage of immaturity, including periventricular leukomalacia (PVL), was the most common finding (42.5%), followed by basal ganglia lesions (12.8%), cortical/subcortical lesions (9.4%), malformations (9.1%), focal infarcts (7.4%), and miscellaneous lesions (7.1%). Only 11.7% of these children had normal MRI findings. There were good correlations between the MRI and clinical findings. Conclusions These MRI findings suggest that obstetric mishaps might have occurred in a small proportion of children with CP. A systematic approach to identifying and treating maternal infections needs to be developed. Multiple pregnancies should be monitored closely, and the causes of infant stroke need to be investigated further so preventive strategies can be formulated. All children with CP should have an MRI scan to provide information on the timing and extent of the lesion.	Chelsea & Westminster Hosp, Dept Paediat, Imperial Coll London, London SW10 9NH, England; Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden	Imperial College London; Karolinska Institutet; Karolinska University Hospital	Bax, M (corresponding author), Chelsea & Westminster Hosp, Dept Paediat, Imperial Coll London, 369 Fulham Rd, London SW10 9NH, England.	m.bax@imperial.ac.uk						[Anonymous], 2006, PLACENTA NEURODISABI; BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BAX MC, 1964, DEV MED CHILD NEUROL, V11, P295; Becher JC, 2006, BJOG-INT J OBSTET GY, V113, P310, DOI 10.1111/j.1471-0528.2006.00852.x; Becher JC, 2004, ARCH DIS CHILD-FETAL, V89, pF399, DOI 10.1136/adc.2003.037606; *CHILD GROWTH FDN, 1996, CHILD GROWTH FDN 199; Cioni G, 1999, NEUROPEDIATRICS, V30, P249, DOI 10.1055/s-2007-973499; Crothers B., 1959, NATURAL HIST CEREBRA; DEX S, 2005, CHILDREN 2U CENTURY; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Hashimoto K, 2001, PEDIATR INT, V43, P240, DOI 10.1046/j.1442-200x.2001.01374.x; INGRAM TTS, 1964, PAEDIAT ASPECTS CERE; KRAGELOHMANN I, 1995, DEV MED CHILD NEUROL, V37, P379; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Neufeld Michael D, 2005, J Perinatol, V25, P108, DOI 10.1038/sj.jp.7211219; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677	20	373	390	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2006	296	13					1602	1608		10.1001/jama.296.13.1602	http://dx.doi.org/10.1001/jama.296.13.1602			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090JS	17018805				2022-12-28	WOS:000240948200020
J	Shipley, B; Vile, D; Garnier, E				Shipley, Bill; Vile, Denis; Garnier, Eric			From plant traits to plant communities: A statistical mechanistic approach to biodiversity	SCIENCE			English	Article							LOTKA-VOLTERRA EQUATIONS	We developed a quantitative method, analogous to those used in statistical mechanics, to predict how biodiversity will vary across environments, which plant species from a species pool will be found in which relative abundances in a given environment, and which plant traits determine community assembly. This provides a scaling from plant traits to ecological communities while bypassing the complications of population dynamics. Our method treats community development as a sorting process involving species that are ecologically equivalent except with respect to particular functional traits, which leads to a constrained random assembly of species; the relative abundance of each species adheres to a general exponential distribution as a function of its traits. Using data for eight functional traits of 30 herbaceous species and community-aggregated values of these traits in 12 sites along a 42-year chronosequence of secondary succession, we predicted 94% of the variance in the relative abundances.	Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; CNRS, UMR 5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Shipley, B (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	bill.shipley@usherbrooke.ca	Vile, Denis/A-5637-2008; Shipley, Bill/A-4578-2011; Garnier, Eric/D-1650-2012	Vile, Denis/0000-0002-7948-1462; Shipley, Bill/0000-0002-7026-3880; Garnier, Eric/0000-0002-9392-5154				Alexeyev VL, 1997, B MATH BIOL, V59, P649, DOI 10.1016/S0092-8240(97)00027-X; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; DellaPietra S, 1997, IEEE T PATTERN ANAL, V19, P380, DOI 10.1109/34.588021; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2001, NEW PHYTOL, V152, P69, DOI 10.1046/j.0028-646x.2001.00239.x; Gause G. F., 1934, STRUGGLE EXISTENCE; Grime J. P., 2001, PLANT STRATEGIES VEG; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell Stephen P., 2001, V32, pi; Jaynes E.T., 2003, PROBABILITY THEORY L; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KERNER EH, 1964, GIBBS ENSEMBLE BIOL; Levich AP, 2000, ECOL MODEL, V131, P207, DOI 10.1016/S0304-3800(00)00259-3; LEVICH AP, 1988, LECT THEORETICAL BIO, P121; Lurie D., 1984, THERMODYNAMICS REGUL, P257; MacArthur R.H., 1972, pvii; Maurer BA, 1999, UNTANGLING ECOLOGICA; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Plank M, 1996, NONLINEARITY, V9, P887, DOI 10.1088/0951-7715/9/4/004; PLANK M, 1995, J MATH PHYS, V36, P3520, DOI 10.1063/1.530978; Plank M, 1999, SIAM J APPL MATH, V59, P1540, DOI 10.1137/S0036139997319463; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Shannon C. E., 1949, MATH THEORY COMMUNIC; Tilman D., 1982, Monographs in Population Biology, pi; VANDERMEER JH, 1969, ECOLOGY, V50, P362, DOI 10.2307/1933884; Vile D, 2006, ECOLOGY, V87, P504, DOI 10.1890/05-0822; Volterra V, 1931, LECONS THEORIE MATH; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956	30	441	461	13	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					812	814		10.1126/science.1131344	http://dx.doi.org/10.1126/science.1131344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17023613				2022-12-28	WOS:000241729800045
J	Martin, U; Coleman, JJ				Martin, Una; Coleman, Jamie J.			Cases in primary care laboratory medicine - Monitoring renal function in hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTERY STENOSIS; HEART-FAILURE; SPIRONOLACTONE; HYPERKALEMIA; INHIBITORS; GUIDELINES	Several classes of antihypertensive drugs can cause a fall in glomerular Filtration rate and a rise in serum potassium and creatinine concentrations. Appropriate monitoring during treatment of hypertension allows potentially serious underlying conditions to be identified and adverse events avoided.	Univ Birmingham, Dept Clin Pharmacol, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Martin, U (corresponding author), Univ Birmingham, Dept Clin Pharmacol, Div Med Sci, Birmingham B15 2TH, W Midlands, England.	u.martin@bham.ac.nk		Coleman, Jamie/0000-0002-7512-5153				Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Iglesias JI, 2000, AM J MED, V109, P642, DOI 10.1016/S0002-9343(00)00605-7; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Main J, 2003, CLIN MED, V3, P520, DOI 10.7861/clinmedicine.3-6-520; McMurray J, 2001, EUR J HEART FAIL, V3, P495, DOI 10.1016/S1388-9842(01)00173-8; McMurray JJV, 2004, NEW ENGL J MED, V351, P526, DOI 10.1056/NEJMp048144; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Palmer BF, 2002, NEW ENGL J MED, V347, P1256, DOI 10.1056/NEJMra020676; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Smellie WSA, 2007, J CLIN PATHOL, V60, P225, DOI 10.1136/jcp.2006.040014; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	13	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2006	333	7574					896	899		10.1136/bmj.38987.502512.DE	http://dx.doi.org/10.1136/bmj.38987.502512.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	101WT	17068035	Green Published			2022-12-28	WOS:000241772600017
J	Ambati, BK; Nozaki, M; Singh, N; Takeda, A; Jani, PD; Suthar, T; Albuquerque, RJC; Richter, E; Sakurai, E; Newcomb, MT; Kleinman, ME; Caldwell, RB; Lin, Q; Ogura, Y; Orecchia, A; Samuelson, DA; Agnew, DW; St Leger, J; Green, WR; Mahasreshti, PJ; Curiel, DT; Kwan, D; Marsh, H; Ikeda, S; Leiper, LJ; Collinson, JM; Bogdanovich, S; Khurana, TS; Shibuya, M; Baldwin, ME; Ferrara, N; Gerber, HP; De Falco, S; Witta, J; Baffi, JZ; Raisler, BJ; Ambati, J				Ambati, Balamurali K.; Nozaki, Miho; Singh, Nirbhai; Takeda, Atsunobu; Jani, Pooja D.; Suthar, Tushar; Albuquerque, Romulo J. C.; Richter, Elizabeth; Sakurai, Eiji; Newcomb, Michael T.; Kleinman, Mark E.; Caldwell, Ruth B.; Lin, Qing; Ogura, Yuichiro; Orecchia, Angela; Samuelson, Don A.; Agnew, Dalen W.; St. Leger, Judy; Green, W. Richard; Mahasreshti, Parameshwar J.; Curiel, David T.; Kwan, Donna; Marsh, Helene; Ikeda, Sakae; Leiper, Lucy J.; Collinson, J. Martin; Bogdanovich, Sasha; Khurana, Tejvir S.; Shibuya, Masabumi; Baldwin, Megan E.; Ferrara, Napoleone; Gerber, Hans-Peter; De Falco, Sandro; Witta, Jassir; Baffi, Judit Z.; Raisler, Brian J.; Ambati, Jayakrishna			Corneal avascularity is due to soluble VEGF receptor-1	NATURE			English	Article							GENETIC ABLATION; TYROSINE KINASE; NEOVASCULARIZATION; GROWTH; MICE; FLT-1; ANGIOGENESIS; INHIBITION; ABNORMALITIES; ANIRIDIA	Corneal avascularity - the absence of blood vessels in the cornea is required for optical clarity and optimal vision, and has led to the cornea being widely used for validating pro- and anti-angiogenic therapeutic strategies for many disorders(1-4). But the molecular underpinnings of the avascular phenotype have until now remained obscure(5-10) and are all the more remarkable given the presence in the cornea of vascular endothelial growth factor (VEGF)-A, a potent stimulator of angiogenesis, and the proximity of the cornea to vascularized tissues. Here we show that the cornea expresses soluble VEGF receptor-1 (sVEGFR-1; also known as sflt-1) and that suppression of this endogenous VEGF-A trap(11) by neutralizing antibodies, RNA interference or Cre-lox-mediated gene disruption abolishes corneal avascularity in mice. The spontaneously vascularized corneas of corn1 and Pax6(+/-) mice(12,13) and Pax6(+/-) patients with aniridia(14) are deficient in sflt-1, and recombinant sflt-1 administration restores corneal avascularity in corn1 and Pax6(+/-) mice. Manatees, the only known creatures uniformly to have vascularized corneas(15), do not express sflt-1, whereas the avascular corneas of dugongs, also members of the order Sirenia, elephants, the closest extant terrestrial phylogenetic relatives of manatees, and other marine mammals ( dolphins and whales) contain sflt-1, indicating that it has a crucial, evolutionarily conserved role. The recognition that sflt-1 is essential for preserving the avascular ambit of the cornea can rationally guide its use as a platform for angiogenic modulators, supports its use in treating neovascular diseases, and might provide insight into the immunological privilege of the cornea.	Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30907 USA; Med Coll Georgia, Dept Cell Biol, Augusta, GA 30907 USA; Augusta Vet Affairs Med Ctr, Augusta, GA 30907 USA; Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; Nagoya City Univ, Sch Med, Dept Ophthalmol, Nagoya, Aichi 4678601, Japan; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; IRCCS, IDI, Mol & Cell Biol Lab, I-00167 Rome, Italy; Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; Sea World, Dept Pathol, San Diego, CA 92109 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Wilmer Inst, Eye Pathol Lab, Baltimore, MD 21205 USA; Univ Alabama, Gene Therapy Ctr, Div Human Gene Therapy, Birmingham, AL 35294 USA; James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, Townsville, Qld 4811, Australia; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; Dept Mol Oncol, San Francisco, CA 94080 USA; CNR, Inst Genet & Biophys, I-80131 Naples, Italy	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Kentucky; University of Kentucky; University of Kentucky; Nagoya City University; Vanderbilt University; IRCCS Istituto Dermopatico dell'Immacolata (IDI); State University System of Florida; University of Florida; University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Alabama System; University of Alabama Birmingham; James Cook University; University of Wisconsin System; University of Wisconsin Madison; University of Aberdeen; University of Pennsylvania; University of Pennsylvania; University of Tokyo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Ambati, BK (corresponding author), Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30907 USA.	bambati@mail.mcg.edu; jamba2@uky.edu	Samuelson, Don/GXA-0970-2022; Collinson, Jon Martin/I-9997-2019; St. Leger, Judy/AAD-3565-2019; De Falco, Sandro/P-6724-2015	St. Leger, Judy/0000-0002-6213-3429; Caldwell, Ruth/0000-0003-0168-0354; De Falco, Sandro/0000-0002-6501-1697; Marsh, Helene/0000-0003-3492-4992; Kleinman, Mark/0000-0001-8557-7949	Wellcome Trust [074127] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ambati BK, 2003, CORNEA, V22, P465, DOI 10.1097/00003226-200307000-00013; Ambati BK, 2003, INVEST OPHTH VIS SCI, V44, P590, DOI 10.1167/iovs.02-0685; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P1117, DOI 10.1167/iovs.03-0940; Dana MR, 1996, INVEST OPHTH VIS SCI, V37, P2485; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Graubert MD, 2001, AM J PATHOL, V158, P1399, DOI 10.1016/S0002-9440(10)64091-6; Harper JY, 2005, VET OPHTHALMOL, V8, P89, DOI 10.1111/j.1463-5224.2005.00351.x; Hiratsuka S, 2005, MOL CELL BIOL, V25, P346, DOI 10.1128/MCB.25.1.346-354.2005; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; MAGNUS H, 1999, OPHTHALMOLOGY ANCIEN; MEYER K., 1940, AMER JOUR OPHTHALMOL, V23, P1320; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; SHARMA PV, 2001, SUSRUTA SAMHITA; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; Wiegand S. J., 1884, INVEST OPHTHALMOL VI, V45	30	507	541	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					993	997		10.1038/nature05249	http://dx.doi.org/10.1038/nature05249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17051153	Green Accepted			2022-12-28	WOS:000241523400055
J	Binder, V; Albert, MH; Kabus, M; Bertone, M; Meindl, A; Belohradsky, BH				Binder, Vera; Albert, Michael H.; Kabus, Maria; Bertone, Marko; Meindl, Alfons; Belohradsky, Bernd H.			The genotype of the original Wiskott phenotype	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WASP GENE-MUTATIONS; ALDRICH-SYNDROME; TRANSLATION	The Wiskott-Aldrich syndrome is an X-linked hereditary disorder associated with combined immunodeficiency, thrombocytopenia, small platelets, eczema, and increased susceptibility to autoimmune disorders and cancers. It is caused by mutations in the gene (WAS) for the Wiskott-Aldrich syndrome protein (WASP). We investigated family members of the patients originally described by Wiskott in 1937 and identified a new frame shift mutation in exon 1 of WAS. This mutation is likely to be the hypothesized genotype that caused the severe form of the Wiskott-Aldrich syndrome in the three brothers described by Wiskott.	Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynecol, D-81675 Munich, Germany; Univ Munich, Dr von Haunersches Childrens Hosp, Dept Hematol & Oncol, Munich, Germany; Univ Munich, Dr von Haunersches Childrens Hosp, Dept Immunol & Infect Dis, Munich, Germany; Tech Univ Dresden, Acad Sect, Municipal Hosp Dresden Neustadt, Dept Pediat, D-8027 Dresden, Germany	Technical University of Munich; University of Munich; University of Munich; Technische Universitat Dresden; Municipal Hospital Dresden	Meindl, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynecol, Ismaninger Str 22, D-81675 Munich, Germany.	alfons.meindl@lrz.tu-muenchen.de	Binder, Vera/N-2078-2015					ALDRICH RA, 1954, PEDIATRICS, V13, P133; ANCLIFF PJ, 2001, BLOOD, V98, P439; Belohradsky B H, 1978, Ergeb Inn Med Kinderheilkd, V41, P85; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; *HUM GEN VAR SOC, REC DESCR SEQ VAR; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; IMAI K, 2004, WASPBASE DATABASE PU; Imai K, 2003, CURR OPIN ALLERGY CL, V3, P427, DOI 10.1097/01.all.0000104452.09202.9c; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Notarangelo LD, 2003, CURR OPIN IMMUNOL, V15, P585, DOI 10.1016/S0952-7915(03)00112-2; Ochs Hans D, 2005, Curr Opin Hematol, V12, P284, DOI 10.1097/01.moh.0000168520.98990.19; Ochs HD, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P292; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Schindelhauer D, 1996, HUM GENET, V98, P68, DOI 10.1007/s004390050162; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Thrasher AJ, 2000, CLIN EXP IMMUNOL, V120, P2, DOI 10.1046/j.1365-2249.2000.01193.x; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212	25	18	18	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1790	1793		10.1056/NEJMoa062520	http://dx.doi.org/10.1056/NEJMoa062520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065640	Bronze			2022-12-28	WOS:000241512500007
J	Libuda, DE; Winston, F				Libuda, Diana E.; Winston, Fred			Amplification of histone genes by circular chromosome formation in Saccharomyces cerevisiae	NATURE			English	Article							CHROMATIN-STRUCTURE; TRANSPOSABLE ELEMENTS; MEIOTIC RECOMBINATION; CELL-CYCLE; YEAST; TRANSCRIPTION; H2A; REPLICATION; SEQUENCE; SUBTYPES	Proper histone levels are critical for transcription, chromosome segregation, and other chromatin-mediated processes(1-7). In Saccharomyces cerevisiae, the histones H2A and H2B are encoded by two gene pairs, named HTA1-HTB1 and HTA2-HTB2 (ref. 8). Previous studies have demonstrated that when HTA2-HTB2 is deleted, HTA1-HTB1 dosage compensates at the transcriptional level(4,9). Here we show that a different mechanism of dosage compensation, at the level of gene copy number, can occur when HTA1-HTB1 is deleted. In this case, HTA2-HTB2 amplifies via creation of a new, small, circular chromosome. This duplication, which contains 39 kb of chromosome II, includes HTA2-HTB2, the histone H3-H4 locus HHT1-HHF1, a centromere and origins of replication. Formation of the new chromosome occurs by recombination between two Ty1 retrotransposon elements that flank this region. Following meiosis, recombination between these two particular Ty1 elements occurs at a greatly elevated level in hta1-htb1 Delta mutants, suggesting that a decreased level of histones H2A and H2B specifically stimulates this amplification of histone genes. Our results demonstrate another mechanism by which histone gene dosage is controlled to maintain genomic integrity.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Winston, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	winston@genetics.med.harvard.edu		Libuda, Diana/0000-0002-4944-1814	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032967] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; Ercan S, 2005, MOL CELL BIOL, V25, P7976, DOI 10.1128/MCB.25.18.7976-7987.2005; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; HEREFORD L, 1979, CELL, V18, P1261, DOI 10.1016/0092-8674(79)90237-X; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; KOLODRUBETZ D, 1982, P NATL ACAD SCI-BIOL, V79, P7814, DOI 10.1073/pnas.79.24.7814; KUPIEC M, 1988, GENETICS, V119, P549; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NORRIS D, 1988, SCIENCE, V242, P759, DOI 10.1126/science.2847314; NORRIS D, 1987, MOL CELL BIOL, V7, P3473, DOI 10.1128/MCB.7.10.3473; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROEDER GS, 1983, MOL GEN GENET, V190, P117; RYKOWSKI MC, 1981, CELL, V25, P477, DOI 10.1016/0092-8674(81)90066-0; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8; Zeyl C, 2004, RES MICROBIOL, V155, P217, DOI 10.1016/j.resmic.2003.12.006	26	63	63	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					1003	1007		10.1038/nature05205	http://dx.doi.org/10.1038/nature05205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066037	Green Accepted			2022-12-28	WOS:000241523400057
J	Simini, B				Simini, Bruno			Magnesium sulphate for tetanus	LANCET			English	Editorial Material									Osped Lucca, Serv Sanitario Nazl, I-55100 Lucca, Italy		Simini, B (corresponding author), Osped Lucca, Serv Sanitario Nazl, Reg Toscana, I-55100 Lucca, Italy.	bruno.simini@virgilio.it						BLECK TP, 1995, PRINCIPLES PRACTICE, V2, P2173; Farrar JJ, 2000, J NEUROL NEUROSUR PS, V69, P292, DOI 10.1136/jnnp.69.3.292; Pedalino B, 2002, Euro Surveill, V7, P103; SANFORD JP, 1995, NEW ENGL J MED, V332, P812, DOI 10.1056/NEJM199503233321209; SCARBOROUGH J, 1988, CIVILIZATION ANCIENT, V2, P1227; Thwaites CL, 2003, BMJ-BRIT MED J, V326, P117, DOI 10.1136/bmj.326.7381.117; THWAITES CL, 2006, LANCET          1004	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1398	1399		10.1016/S0140-6736(06)69445-2	http://dx.doi.org/10.1016/S0140-6736(06)69445-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055925				2022-12-28	WOS:000241459100006
J	Downward, J				Downward, Julian			Signal transduction: Prelude to an anniversary for the RAS oncogene	SCIENCE			English	Editorial Material							GERMLINE MUTATIONS; ACTIVATION; KRAS		Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England	Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julian.downward@cancer.org.uk	Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729				Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; 2006, BEATS INT CANC C 24	11	34	37	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					433	434		10.1126/science.1134727	http://dx.doi.org/10.1126/science.1134727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053139				2022-12-28	WOS:000241382500031
J	Roux, I; Safieddine, S; Nouvian, R; Grati, M; Simmler, MC; Bahloul, I; Perfettini, I; Le Gall, M; Rostaing, P; Hamard, G; Triller, A; Avan, P; Moser, T; Petit, C				Roux, Isabelle; Safieddine, Saaid; Nouvian, Regis; Grati, M'hamed; Simmler, Marie-Christine; Bahloul, Isabelle; Perfettini, Isabelle; Le Gall, Morgane; Rostaing, Philippe; Hamard, Ghislaine; Triller, Antoine; Avan, Paul; Moser, Tobias; Petit, Christine			Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse	CELL			English	Article							INNER HAIR-CELLS; AFFERENT SYNAPSE; SYNAPTOTAGMIN-I; MEMBRANE REPAIR; TRANSMITTER RELEASE; MUSCULAR-DYSTROPHY; CALCIUM-DEPENDENCE; FUSION-COMPETENCE; CA(V)1.3 CHANNELS; CA2+ SENSOR	The auditory inner hair cell (IHC) ribbon synapse operates with an exceptional temporal precision and maintains a high level of neurotransmitter release. However, the molecular mechanisms underlying IHC synaptic exocytosis are largely unknown. We studied otoferlin, a predicted C2-domain transmembrane protein, which is defective in a recessive form of human deafness. We show that otoferlin expression in the hair cells correlates with afferent synapto-genesis and find that otoferlin localizes to ribbon-associated synaptic vesicles. Otoferlin binds Ca2+ and displays Ca2+,-dependent interactions with the SNARE proteins syntaxin1 and SNAP25. Otoferlin deficient mice (Otof(-/-)) are profoundly deaf. Exocytosis in Otof(-/-) IHCs is almost completely abolished, despite normal ribbon synapse morphogenesis and Ca2+ current. Thus, otoferlin is essential for a late step of synaptic vesicle exocytosis and may act as the major Ca2+ sensor triggering membrane fusion at the IHC ribbon synapse.	Inst Pasteur, Coll France, INSERM, UMRS587,Unite Genet Deficits Sensoriels, F-75015 Paris, France; Univ Gottingen, Dept Otolaryngol, D-37075 Gottingen, Germany; Univ Gottingen, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; CNRS, UMR 7592, Inst Jacques Monod, F-75005 Paris, France; Inst Cochin, Plate Forme Recombinaison Homol, F-75014 Paris, France; Ecole Normale Super, INSERM, U497, F-75005 Paris, France; Fac Med, Lab Biophys Sensorielle, F-63001 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Gottingen; University of Gottingen; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Petit, C (corresponding author), Inst Pasteur, Coll France, INSERM, UMRS587,Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75015 Paris, France.	cpetit@pasteur.fr	Nouvian, Regis/AAW-4207-2021; Nouvian, Regis/AFQ-8065-2022; Roux, Isabelle/AAC-8120-2020; AVAN, Paul/J-6878-2015; Grati, M'hamed/C-9563-2011; Moser, Tobias/L-5068-2014	Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; AVAN, Paul/0000-0003-1054-1479; Moser, Tobias/0000-0001-7145-0533; Roux, Isabelle/0000-0001-7527-7520; Safieddine, Saaid/0000-0002-6159-0572; Grati, Mhamed/0000-0001-5149-3245; TRILLER, Antoine/0000-0002-7530-1233; BAHLOUL, Amel/0000-0001-7042-4616; Le Gall, Morgane/0000-0002-4935-7065; Grati, M'hamed/0000-0002-4490-1682; Petit, Christine/0000-0002-9069-002X				Achanzar WE, 1997, J CELL SCI, V110, P1073; Agulhon C, 2003, J COMP NEUROL, V462, P71, DOI 10.1002/cne.10712; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Dallos P, 1991, Curr Opin Neurobiol, V1, P215, DOI 10.1016/0959-4388(91)90081-H; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; de Caprona MDC, 2004, BRAIN RES BULL, V64, P289, DOI 10.1016/j.brainresbull.2004.08.004; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Eybalin M, 2002, EUR J NEUROSCI, V15, P1409, DOI 10.1046/j.1460-9568.2002.01978.x; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kee Y, 1996, J NEUROSCI, V16, P1975; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; KIM DO, 1986, HEARING RES, V22, P105, DOI 10.1016/0378-5955(86)90088-2; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Le Calvez S, 1998, HEARING RES, V120, P51, DOI 10.1016/S0378-5955(98)00051-3; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z; Matsubara A, 1996, J NEUROSCI, V16, P4457; MerchanPerez A, 1996, J COMP NEUROL, V371, P208, DOI 10.1002/(SICI)1096-9861(19960722)371:2<208::AID-CNE2>3.0.CO;2-6; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; PUJOL R, 1998, DEV SENSORY NEURAL S; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBERTSON D, 1992, J MICROSC-OXFORD, V168, P85, DOI 10.1111/j.1365-2818.1992.tb03253.x; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rodriguez-Ballesteros M, 2003, HUM MUTAT, V22, P451, DOI 10.1002/humu.10274; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Safieddine S, 2002, MOL CELL NEUROSCI, V20, P343, DOI 10.1006/mcne.2002.1120; Safieddine S, 1997, J NEUROSCI, V17, P7523; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; SOBKOWICZ HM, 1986, J NEUROCYTOL, V15, P693, DOI 10.1007/BF01625188; STEEL KPH, 1992, DEV AUDITORY VESTIBU, P221; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Varga R, 2003, J MED GENET, V40, P45, DOI 10.1136/jmg.40.1.45; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	74	415	459	1	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					277	289		10.1016/j.cell.2006.08.040	http://dx.doi.org/10.1016/j.cell.2006.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055430	Bronze			2022-12-28	WOS:000241827100016
J	van den Heuvel, MM; van Rensburg, JJ				van den Heuvel, Michel M.; van Rensburg, Jacques J.			Rasmussen's aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Stellenbosch, ZA-7505 Cape Town, South Africa	Stellenbosch University	van den Heuvel, MM (corresponding author), Univ Stellenbosch, ZA-7505 Cape Town, South Africa.	heuvel@sun.ac.za	van den Heuvel, Michel M/D-9491-2017	van den Heuvel, Michel M/0000-0002-6372-2153					0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					E17	E17		10.1056/NEJMicm050783	http://dx.doi.org/10.1056/NEJMicm050783			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050883				2022-12-28	WOS:000241357300013
J	Tang, ZY; Zhang, ZL; Wang, Y; Glotzer, SC; Kotov, NA				Tang, Zhiyong; Zhang, Zhenli; Wang, Ying; Glotzer, Sharon C.; Kotov, Nicholas A.			Self-assembly of CdTe nanocrystals into free-floating sheets	SCIENCE			English	Article							PERMANENT DIPOLE-MOMENT; QUANTUM DOTS; MONODISPERSE NANOCRYSTALS; NANOPARTICLES; ORGANIZATION; SUPERLATTICES; MONOLAYERS; NANOWIRES; NANORODS; GROWTH	In their physical dimensions, surface chemistry, and degree of anisotropic interactions in solution, CdTe nanoparticles are similar to proteins. We experimentally observed their spontaneous, template-free organization into free-floating particulate sheets, which resemble the assembly of surface layer (S-layer) proteins. Computer simulation and concurrent experiments demonstrated that the dipole moment, small positive charge, and directional hydrophobic attraction are the driving forces for the self-organization process. The data presented here highlight the analogy of the solution behavior of the two vastly different classes of chemical structures.	Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu; kotov@umich.edu	tang, zhiyong/A-8563-2008; li, zhiyuan/HGD-9581-2022; Kotov, Nicholas/AAZ-4204-2021	tang, zhiyong/0000-0003-0610-0064; Kotov, Nicholas/0000-0002-6864-5804				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; [Anonymous], 1985, INTERMOLECULAR SURFA; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978; COLVIN VL, 1992, J AM CHEM SOC, V114, P5221, DOI 10.1021/ja00039a038; Crooker SA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186802; Flachmann R, 1996, P NATL ACAD SCI USA, V93, P14966, DOI 10.1073/pnas.93.25.14966; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Gavartin JL, 2003, PHILOS T R SOC A, V361, P275, DOI 10.1098/rsta.2002.1128; Jagannathan K, 2002, BIOPHYS J, V83, P1902, DOI 10.1016/S0006-3495(02)73954-4; Kagan CR, 1996, PHYS REV LETT, V76, P1517, DOI 10.1103/PhysRevLett.76.1517; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5; PHILLIES GD, 1974, J CHEM PHYS, V60, P2721, DOI 10.1063/1.1681434; Pileni MP, 2001, J PHYS CHEM B, V105, P3358, DOI 10.1021/jp0039520; Polleux J, 2004, ADV MATER, V16, P436, DOI 10.1002/adma.200306251; Rogach AL, 1996, BER BUNSEN PHYS CHEM, V100, P1772, DOI 10.1002/bbpc.19961001104; Rogach AL, 2002, ADV FUNCT MATER, V12, P653, DOI 10.1002/1616-3028(20021016)12:10<653::AID-ADFM653>3.0.CO;2-V; Shanbhag S, 2006, J PHYS CHEM B, V110, P12211, DOI 10.1021/jp0611119; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Shim M, 1999, J CHEM PHYS, V111, P6955, DOI 10.1063/1.479988; SLEYTR UB, 2004, NANOBIOTECHNOLOGY, P77; Tang ZY, 2005, ADV MATER, V17, P951, DOI 10.1002/adma.200401593; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Thoma SG, 2005, J AM CHEM SOC, V127, P7611, DOI 10.1021/ja050501q; Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c; WERTHEIM MS, 1984, J STAT PHYS, V35, P19, DOI 10.1007/BF01017362; Yaroslavov AA, 2005, J AM CHEM SOC, V127, P7322, DOI 10.1021/ja051095d; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zhang ZL, 2003, NANO LETT, V3, P1341, DOI 10.1021/nl034454g	34	767	778	12	553	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					274	278		10.1126/science.1128045	http://dx.doi.org/10.1126/science.1128045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038616				2022-12-28	WOS:000241194100034
J	Rosoff, PM				Rosoff, Philip M.			Focus on research: The two-edged sword of curling childhood cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVORS		Duke Univ, Hosp Program Clin Eth, Durham, NC USA	Duke University	Rosoff, PM (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.							[Anonymous], 2006, SEER CANC STAT REV 1; Bashore Lisa, 2004, J Pediatr Oncol Nurs, V21, P98, DOI 10.1177/1043454203262754; Langeveld NE, 2004, PEDIATR BLOOD CANCER, V42, P604, DOI 10.1002/pbc.20024; Oeffinger KC, 2000, J FAM PRACTICE, V49, P1133; Stam H, 2005, PSYCHO-ONCOLOGY, V14, P227, DOI 10.1002/pon.839	5	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1522	1523		10.1056/NEJMp068168	http://dx.doi.org/10.1056/NEJMp068168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035646				2022-12-28	WOS:000241160400003
J	Friedman, AL				Friedman, Amy L.			Controversy - Payment for living organ donation should be legalised	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KIDNEY; TRANSPLANTATION; MORTALITY; DEATH		Yale Univ, Sch Med, Sect Organ Transplantat & Immunol, New Haven, CT 06520 USA	Yale University	Friedman, AL (corresponding author), Yale Univ, Sch Med, Sect Organ Transplantat & Immunol, 333 Cedar St, New Haven, CT 06520 USA.	amy.friedman@yale.edu						Axelrod DA, 2004, AM J TRANSPLANT, V4, P920, DOI 10.1111/j.1600-6143.2004.00462.x; Delmonico FL, 2006, KIDNEY INT, V69, P954, DOI 10.1038/sj.ki.5000278; Erin CA, 2003, J MED ETHICS, V29, P137, DOI 10.1136/jme.29.3.137; Goyal M, 2002, JAMA-J AM MED ASSOC, V288, P1589, DOI 10.1001/jama.288.13.1589; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Landry DW, 2006, KIDNEY INT, V69, P957, DOI 10.1038/sj.ki.5000280; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; MASTROIANNI, 2001, AM J BIOETHICS, V1, P28; Matas AJ, 2003, AM J TRANSPLANT, V3, P830, DOI 10.1034/j.1600-6143.2003.00126.x; Monaco AP, 2006, KIDNEY INT, V69, P955, DOI 10.1038/sj.ki.5000281; Pancevski B, 2006, LANCET, V367, P461, DOI 10.1016/S0140-6736(06)68160-9; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Savulescu J, 2002, J MED ETHICS, V28, P3, DOI 10.1136/jme.28.1.3; Spital A, 2005, CAMB Q HEALTHC ETHIC, V14, P107; *UN NETW ORG SHAR, ALL DEC KIDN; Wadman M, 2006, NATURE, V440, P388, DOI 10.1038/440388a; Wolters HH, 2003, TRANSPLANT P, V35, P2091, DOI 10.1016/S0041-1345(03)00675-4; 2006, YALE B CATENDAR, V34	18	24	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2006	333	7571					746	748		10.1136/bmj.38961.475718.68	http://dx.doi.org/10.1136/bmj.38961.475718.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	094OK	17023468	Green Published			2022-12-28	WOS:000241248600023
J	Fernald, RD				Fernald, Russell D.			Casting a genetic light on the evolution of eyes	SCIENCE			English	Review							COLOR-VISION; RETINAL DEVELOPMENT; LENS CRYSTALLINS; GANGLION-CELLS; PHOTOTRANSDUCTION; PHOTORECEPTOR; DROSOPHILA; OPSIN; DISSECTION; MECHANISMS	Light has been exploited for information by organisms through the evolution of photoreceptors and, ultimately, eyes in animals. Only a handful of eye types exist because the physics of light constrains photodetection. In the past few years, genetic tools have revealed several parallel pathways through which light guides behavior and have provided insights into the convergent evolution of eyes. The gene encoding opsin ( the primary phototransduction protein) and some developmental genes had very early origins and were recruited repeatedly during eye evolution. Eye lens proteins arose separately and make up a diverse group, many of which were co-opted from other functions. A major challenge now is understanding how newly discovered pathways for processing light evolved and how they collaborate with eyes to harvest information from light.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Fernald, RD (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	rfernald@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R56NS034950, R01NS034950] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34950] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1861, ORIGIN SPECIES MEANS; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2003, INT J DEV BIOL, V47, P563; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Briscoe AD, 2001, MOL BIOL EVOL, V18, P2270, DOI 10.1093/oxfordjournals.molbev.a003773; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; CHIOU SH, 1991, BIOCHEM J, V273, P295, DOI 10.1042/bj2730295; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dulai KS, 1999, GENOME RES, V9, P629; Fernald RD, 2000, CURR OPIN NEUROBIOL, V10, P444, DOI 10.1016/S0959-4388(00)00114-8; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GOLDSMITH TH, 1977, J GEN PHYSIOL, V70, P453, DOI 10.1085/jgp.70.4.453; GORMAN ALF, 1969, SCIENCE, V165, P309, DOI 10.1126/science.165.3890.309; HISATOMI O, 1994, VISION RES, V34, P3097, DOI 10.1016/0042-6989(94)90075-2; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; LAND MF, 2002, OXFORD ANIMAL BIOL S, P1; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Nilsson DE, 1996, CURR BIOL, V6, P39, DOI 10.1016/S0960-9822(02)00417-7; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Nordstrom K, 2004, GENOMICS, V83, P852, DOI 10.1016/j.ygeno.2003.11.008; Ogura A, 2004, GENOME RES, V14, P1555, DOI 10.1101/gr.2268104; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; Piatigorsky J, 1998, ANN NY ACAD SCI, V842, P7, DOI 10.1111/j.1749-6632.1998.tb09626.x; Rohde K, 1999, INT J PARASITOL, V29, P511, DOI 10.1016/S0020-7519(98)00201-X; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V248, P684, DOI 10.1006/bbrc.1998.8989; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; van Hateren JH, 2006, J COMP PHYSIOL A, V192, P187, DOI 10.1007/s00359-005-0060-y; Williams RW, 1998, SEMIN CELL DEV BIOL, V9, P249, DOI 10.1006/scdb.1998.0236; WISTOW GJ, 1990, GENE, V96, P263, DOI 10.1016/0378-1119(90)90262-P; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Wray GA, 2002, BRAIN BEHAV EVOLUT, V59, P327, DOI 10.1159/000063566	42	95	97	3	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1914	1918		10.1126/science.1127889	http://dx.doi.org/10.1126/science.1127889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008522				2022-12-28	WOS:000240832200039
J	Zheng, JR; Kwak, KW; Xie, J; Fayer, MD				Zheng, Junrong; Kwak, Kyungwon; Xie, Jia; Fayer, M. D.			Ultrafast carbon-carbon single-bond rotational isomerization in room-temperature solution	SCIENCE			English	Article							HYDROGEN-BOND; 2D IR; DYNAMICS; SPECTROSCOPY; KINETICS; EQUILIBRIUM; LIQUIDS; SPECTRA; BUTANE	Generally, rotational isomerization about the carbon-carbon single bond in simple ethane derivatives in room-temperature solution under thermal equilibrium conditions has been too fast to measure. We achieved this goal using two-dimensional infrared vibrational echo spectroscopy to observe isomerization between the gauche and trans conformations of an ethane derivative, 1-fluoro-2-isocyanato-ethane ( 1), in a CCl4 solution at room temperature. The isomerization time constant is 43 picoseconds (ps, 10(-12) s). Based on this value and on density functional theory calculations of the barrier heights of 1, n-butane, and ethane, the time constants for n-butane and ethane internal rotation under the same conditions are similar to 40 and similar to 12 ps, respectively.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Zheng, JR (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.		Kwak, Kyungwon/D-8046-2015; Zheng, Junrong/I-5171-2014; Xie, Jia/P-8359-2016	Zheng, Junrong/0000-0001-7419-5494; Xie, Jia/0000-0002-8731-295X				Asbury JB, 2004, J LUMIN, V107, P271, DOI 10.1016/j.jlumin.2003.12.035; Bickelhaupt FM, 2003, ANGEW CHEM INT EDIT, V42, P4183, DOI 10.1002/anie.200350947; BROWN D, 1990, J CHEM PHYS, V92, P3062, DOI 10.1063/1.457904; CHANDLER D, 1978, J CHEM PHYS, V68, P2959, DOI 10.1063/1.436049; COHEN B, 1983, J PHYS CHEM-US, V87, P3606, DOI 10.1021/j100242a008; EDBERG R, 1987, J CHEM PHYS, V87, P5700, DOI 10.1063/1.453545; Jackman L.M., 1975, DYNAMIC NUCL MAGNETI; Jager C, 1999, J NON-CRYST SOLIDS, V258, P161, DOI 10.1016/S0022-3093(99)00436-6; Khalil M, 2004, J CHEM PHYS, V121, P362, DOI 10.1063/1.1756870; Kim YS, 2005, P NATL ACAD SCI USA, V102, P11185, DOI 10.1073/pnas.0504865102; LEVINE I., 1978, PHYS CHEM; Levinger NE, 2003, J CHEM PHYS, V118, P1312, DOI 10.1063/1.1527926; MACPHAIL RA, 1985, J CHEM PHYS, V82, P1156, DOI 10.1063/1.448964; ORVILLETHOMAS WJ, INTERNAL ROTATION MO; Parr R. G., 1989, DENSITY FUNCTIONAL T; Pophristic V, 2001, NATURE, V411, P565, DOI 10.1038/35079036; Ramirez J, 2001, J CHEM PHYS, V115, P7285, DOI 10.1063/1.1405445; ROSENBERG RO, 1980, CHEM PHYS LETT, V75, P162, DOI 10.1016/0009-2614(80)80487-8; STRAUSS HL, 1992, J AM CHEM SOC, V114, P905, DOI 10.1021/ja00029a017; STREITWIESER A, 1968, PROGR PHYS ORGANIC C, V6; Tan HS, 2005, J OPT SOC AM B, V22, P2009, DOI 10.1364/JOSAB.22.002009; TURNER JJ, 1991, J AM CHEM SOC, V113, P8347, DOI 10.1021/ja00022a022; WEBER TA, 1978, J CHEM PHYS, V69, P2347, DOI 10.1063/1.436863; Zheng JR, 2006, J AM CHEM SOC, V128, P2977, DOI 10.1021/ja0570584; Zheng JR, 2005, SCIENCE, V309, P1338, DOI 10.1126/science.1116213	25	168	170	3	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1951	1955		10.1126/science.1132178	http://dx.doi.org/10.1126/science.1132178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008529				2022-12-28	WOS:000240832200048
J	Hollingsworth, JM; Rogers, MAM; Kaufman, SR; Bradford, TJ; Saint, S; Wei, JT; Hollenbeck, BK				Hollingsworth, John M.; Rogers, Mary A. M.; Kaufman, Samuel R.; Bradford, Timothy J.; Saint, Sanjay; Wei, John T.; Hollenbeck, Brent K.			Medical therapy to facilitate urinary stone passage: a meta-analysis	LANCET			English	Article							SHOCK-WAVE LITHOTRIPSY; DISTAL URETERAL CALCULI; FILE-DRAWER PROBLEM; NATURAL-HISTORY; UNITED-STATES; DOUBLE-BLIND; MANAGEMENT; TAMSULOSIN; URETEROSCOPY; NIFEDIPINE	Background Medical therapies to ease urinary-stone passage have been reported, but are not generally used. If effective, such therapies would increase the options for treatment of urinary stones. To assess efficacy, we sought to identify and summarise all randomised controlled trials in which calcium-channel blockers or a blockers were used to treat urinary stone disease. Methods We searched MEDLINE, Pre-MEDLINE, CINAHL, and EMBASE, as well as scientific meeting abstracts, up to July, 2005. All randomised controlled trials in which calcium-channel blockers or a blockers were used to treat ureteral stones were eligible for inclusion in our analysis. Data from nine trials (number of patients=693) were pooled. The main outcome was the proportion of patients who passed stones. We calculated the summary estimate of effect associated with medical therapy use using random-effects and fixed-effects models. Findings Patients given calcium-channel blockers or a blockers had a 65% (absolute risk reduction=0.31 95% CI 0.25-0.38) greater likelihood of stone passage than those not given such treatment (pooled risk ratio 1.65; 95% CI 1.45-1.88). The pooled risk ratio for alpha blockers was 1.54 (1.29-1.85) and for calcium-channel blockers with steroids was 1.90 (1.51-2.40). The proportion of heterogeneity not explained by chance alone was 28%. The number needed to treat was 4. Interpretation Although a high-quality randomised trial is necessary to confirm its efficacy, our findings suggest that medical therapy is an option for facilitation of urinary-stone passage for patients amenable to conservative management, potentially obviating the need for surgery.	Vet Affairs Univ Michigan Patient Safety Enhancem, Dept Urol, Ann Arbor, MI USA; Dept Urol, Ann Arbor, MI USA; Dept Internal Med, Div Gen Med, Ann Arbor, MI USA; Vet Affairs Univ Michigan Patient Safety Enhancem, Ann Arbor, MI USA; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA		Hollenbeck, BK (corresponding author), 1500 E Med Ctr Dr,TC 3875-0330, Ann Arbor, MI 48109 USA.	bhollen@umich.edu	Wei, John T/E-8967-2012; Saint, Sanjay/AAF-5126-2019	Rogers, Mary/0000-0001-5519-3223	AHRQ HHS [R01 HS015571] Funding Source: Medline; NCI NIH HHS [U01 CA111275, R01 CA095662, P50 CA069568, U01 CA113913] Funding Source: Medline; NICHD NIH HHS [U01 HD041249-01] Funding Source: Medline; NIDDK NIH HHS [T32 DK007758, P50 DK065313, R21 DK067451-01A1, P50 DK065313-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015571] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095662, U01CA113913, U01CA111275, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067451, P50DK065313, T32DK007758] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD M, 1991, JPMA (Journal of the Pakistan Medical Association), V41, P268; ALWAILI NS, 1986, CLIN EXP PHARMACOL P, V13, P195, DOI 10.1111/j.1440-1681.1986.tb00337.x; Bierkens AF, 1998, BRIT J UROL, V81, P31; BORGHI L, 1994, J UROLOGY, V152, P1095, DOI 10.1016/S0022-5347(17)32511-9; Cervenakov I., 2002, International Urology and Nephrology, V34, P25; COE FL, 1977, JAMA-J AM MED ASSOC, V238, P1519, DOI 10.1001/jama.238.14.1519; Cooper JT, 2000, UROLOGY, V56, P575, DOI 10.1016/S0090-4295(00)00658-0; Cordell WH, 1996, ANN EMERG MED, V28, P151, DOI 10.1016/S0196-0644(96)70055-0; CORDELL WH, 1994, ANN EMERG MED, V23, P262, DOI 10.1016/S0196-0644(94)70038-9; DANIELS GF, 1988, J UROLOGY, V139, P710, DOI 10.1016/S0022-5347(17)42607-3; Dellabella M, 2005, J UROLOGY, V174, P167, DOI 10.1097/01.ju.0000161600.54732.86; Dellabella M, 2003, J UROLOGY, V170, P2202, DOI 10.1097/01.ju.0000096050.22281.a7; ELFAQIH SR, 1988, BRIT J UROL, V62, P13, DOI 10.1111/j.1464-410X.1988.tb04257.x; Gerber R, 2005, J UROLOGY, V173, P2013, DOI 10.1097/01.ju.0000158042.41319.c4; Harmon WJ, 1997, J UROLOGY, V157, P28, DOI 10.1016/S0022-5347(01)65272-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIGGINS JPT, 2005, COCHRANE LIB; Hochreiter WW, 2003, J UROLOGY, V169, P878, DOI 10.1097/01.ju.0000051896.15091.0c; HUBNER WA, 1993, EUR UROL, V24, P172; KRAMOLOWSKY EV, 1987, J UROLOGY, V138, P36, DOI 10.1016/S0022-5347(17)42979-X; Kupeli B, 2004, UROLOGY, V64, P1111, DOI 10.1016/j.urology.2004.07.020; LAERUM E, 1995, EUR UROL, V28, P108; Laird JMA, 1997, AM J PHYSIOL-REG I, V272, pR1409, DOI 10.1152/ajpregu.1997.272.5.R1409; LJUNGHALL S, 1977, SCAND J UROL NEPHROL, P4; Lotan Y, 2002, J UROLOGY, V167, P1621, DOI 10.1016/S0022-5347(05)65166-X; MAGGI CA, 1995, J AUTON PHARMACOL, V15, P55, DOI 10.1111/j.1474-8673.1995.tb00348.x; MALIN J M JR, 1970, British Journal of Urology, V42, P171, DOI 10.1111/j.1464-410X.1970.tb10018.x; Miller OF, 1999, J UROLOGY, V162, P688, DOI 10.1097/00005392-199909010-00014; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MORITA T, 1987, TOHOKU J EXP MED, V152, P111, DOI 10.1620/tjem.152.111; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pak CYC, 1997, UROLOGY, V50, P504, DOI 10.1016/S0090-4295(97)00307-5; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Porpiglia F, 2000, UROLOGY, V56, P579, DOI 10.1016/S0090-4295(00)00732-9; Porpiglia F, 2004, J UROLOGY, V172, P568, DOI 10.1097/01.ju.0000132390.61756.ff; PREMINGER GM, 1989, SHOCK WAVE LITHOTRIP, P437; Resim S, 2005, INT J UROL, V12, P615, DOI 10.1111/j.1442-2042.2005.01116.x; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1554/04-602; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; RUBIN JI, 1987, RADIOLOGY, V162, P21, DOI 10.1148/radiology.162.1.3786764; Salehi M., 2005, European Urology Supplements, V4, P25, DOI 10.1016/S1569-9056(05)80102-2; Salman S, 1989, Actas Urol Esp, V13, P150; Schuster TG, 2001, J UROLOGY, V166, P538, DOI 10.1016/S0022-5347(05)65978-2; SIERAKOWSKI R, 1978, INVEST UROL, V15, P438; Sigala S, 2005, NEUROUROL URODYNAM, V24, P142, DOI 10.1002/nau.20097; SIVULA ARTO, 1967, SCAND J URON NEPHROL, V1, P259, DOI 10.3109/00365596709133547; Skrekas T., 2003, European Urology Supplements, V2, P82, DOI 10.1016/S1569-9056(03)80323-8; STAERMAN F, 2005, EUR UROL, V37, P28; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taghavi R., 2005, Journal of Endourology, V19, pA9; Tekin A, 2004, J UROLOGY, V171, P304, DOI 10.1016/S0022-5347(18)38389-7; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tiselius HG, 2003, BJU INT, V91, P758, DOI 10.1046/j.1464-410X.2003.04208.x; UENO A, 1977, Urology, V10, P544, DOI 10.1016/0090-4295(77)90097-8; Yilmaz E, 2005, J UROLOGY, V173, P2010, DOI 10.1097/01.ju.0000158453.60029.0a	55	340	349	2	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1171	1179		10.1016/S0140-6736(06)69474-9	http://dx.doi.org/10.1016/S0140-6736(06)69474-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011944				2022-12-28	WOS:000240916000029
J	Balk, E; Raman, G; Chung, M; Ip, S; Tatsioni, A; Alonso, A; Chew, P; Gilbert, SJ; Lau, J				Balk, Ethan; Raman, Gowri; Chung, Mei; Ip, Stanley; Tatsioni, Athina; Alonso, Alvaro; Chew, Priscilla; Gilbert, Scott J.; Lau, Joseph			Comparative effectiveness of management strategies for renal artery stenosis: A systematic review	ANNALS OF INTERNAL MEDICINE			English	Review							ATHEROSCLEROTIC RENOVASCULAR DISEASE; UNSUCCESSFUL BALLOON ANGIOPLASTY; PERIPHERAL VASCULAR-DISEASE; BLOOD-PRESSURE CONTROL; STENT PLACEMENT; FOLLOW-UP; HYPERTENSIVE PATIENTS; SURGICAL-MANAGEMENT; RANDOMIZED-TRIAL; NATURAL-HISTORY	Background: Atherosclerotic renal artery stenosis is increasingly common in an aging population. Therapeutic options include medical treatment only or revascularization procedures. Purpose: To compare the effects of medical treatment and revascularization on clinically important outcomes in adults with atherosclerotic renal artery stenosis. Data Sources: The MEDLINE database (inception to 6 September 2005) and selected reference lists were searched for English-language articles. Study Selection: The authors selected prospective studies of renal artery revascularization or medical treatment of patients with atherosclerotic renal artery stenosis that reported mortality rates, kidney function, blood pressure, cardiovascular events, or adverse events at 6 months or later after study entry. Data Extraction: A standardized protocol with predefined criteria was used to extract details on study design, interventions, outcomes, study quality, and applicability. The overall body of evidence was then graded as robust, acceptable, or weak. Data Synthesis: No study directly compared aggressive medical therapy with angioplasty and stent placement. Two randomized trials compared angioplasty without stent and medical treatments. Eight other comparative studies and 46 cohort studies met criteria for analysis. Studies generally had poor methodologic quality and limited applicability to current practice. Overall, there was no robust evidence. Weak evidence suggested no large differences in mortality rates or cardiovascular events between medical and revascularization treatments. Acceptable evidence suggested similar kidney-related outcomes but better blood pressure outcomes with angioplasty, particularly in patients with bilateral disease. Improvements in kidney function and cure of hypertension were reported among some patients only in cohort studies of angioplasty. Available evidence did not adequately assess adverse events or baseline characteristics that could predict which intervention would result in better outcomes. Limitations: The evidence from direct comparisons of interventions is sparse and inadequate to draw robust conclusions. Conclusions: Available evidence does not clearly support one treatment approach over another for atherosclerotic renal artery stenosis.	Tufts Univ, New England Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Balk, E (corresponding author), Tufts Univ, New England Med Ctr, Box 63,750 Washington St, Boston, MA 02111 USA.	ebalk@tufts-nemc.org	Tatsioni, Athina/AAQ-5413-2020; Balk, Ethan/AAJ-2547-2020		PHS HHS [290-02-0023] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alhadad A, 2004, EUR J VASC ENDOVASC, V27, P151, DOI 10.1016/j.ejvs.2003.10.009; BALK E, IN PRESS COMP EFFECT; Baumgartner I, 2000, RADIOLOGY, V216, P498, DOI 10.1148/radiology.216.2.r00au06498; Blum U, 1997, NEW ENGL J MED, V336, P459, DOI 10.1056/NEJM199702133360702; Bucek RA, 2003, WIEN KLIN WOCHENSCHR, V115, P788, DOI 10.1007/BF03040504; Caps MT, 1998, KIDNEY INT, V53, P735, DOI 10.1046/j.1523-1755.1998.00805.x; Cherr GS, 2002, J VASC SURG, V35, P236, DOI 10.1067/mva.2002.120376; Cheung CM, 2002, J AM SOC NEPHROL, V13, P149, DOI 10.1681/ASN.V131149; Conlon PJ, 2001, KIDNEY INT, V60, P1490, DOI 10.1046/j.1523-1755.2001.00953.x; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; Dangas G, 2001, J ENDOVASC THER, V8, P238, DOI 10.1583/1545-1550(2001)008<0238:IUGRAS>2.0.CO;2; Dorros G, 2002, CATHETER CARDIO INTE, V55, P182, DOI 10.1002/ccd.3050; ENGLUND R, 1991, J CARDIOVASC SURG, V32, P76; FERGANY A, 1994, J UROLOGY, V151, P10, DOI 10.1016/S0022-5347(17)34859-0; FRANKLIN SS, 1985, AM J MED, V79, P14, DOI 10.1016/0002-9343(85)90075-0; Galaria II, 2005, ANN VASC SURG, V19, P218, DOI 10.1007/s10016-004-0165-8; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Gill KS, 2003, RADIOLOGY, V226, P821, DOI 10.1148/radiol.2263011244; Gill-Leertouwer TC, 2002, J ENDOVASC THER, V9, P495, DOI 10.1583/1545-1550(2002)009<0495:PFCSAO>2.0.CO;2; Gray BH, 2002, VASC MED, V7, P275, DOI 10.1191/1358863x02vm456oa; Gross CM, 1998, CATHETER CARDIO DIAG, V45, P1, DOI 10.1002/(SICI)1097-0304(199809)45:1<1::AID-CCD1>3.0.CO;2-7; Gross CM, 2001, RADIOLOGY, V220, P751, DOI 10.1148/radiol.2203001444; HACKSON B, 1986, AM J NEPHROL, V6, P182; Hanzel G, 2005, AM J CARDIOL, V96, P1322, DOI 10.1016/j.amjcard.2005.06.081; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; Harjai K, 1997, CATHETER CARDIO DIAG, V42, P381, DOI 10.1002/(SICI)1097-0304(199712)42:4<381::AID-CCD5>3.0.CO;2-7; Henry M, 2003, CATHETER CARDIO INTE, V60, P299, DOI 10.1002/ccd.10669; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Houston JG, 2004, NEPHROL DIAL TRANSPL, V19, P1786, DOI 10.1093/ndt/gfh238; HRICIK DE, 1983, NEW ENGL J MED, V308, P373, DOI 10.1056/NEJM198302173080706; Iannone LA, 1996, CATHETER CARDIO DIAG, V37, P243, DOI 10.1002/(SICI)1097-0304(199603)37:3<243::AID-CCD3>3.0.CO;2-C; Iglesias JI, 2000, AM J MED, V109, P642, DOI 10.1016/S0002-9343(00)00605-7; Johansson M, 1999, J HYPERTENS, V17, P1743, DOI 10.1097/00004872-199917120-00012; Kennedy DJ, 2003, AM J KIDNEY DIS, V42, P926, DOI 10.1016/j.ajkd.2003.06.004; Krijnen P, 2004, J HUM HYPERTENS, V18, P91, DOI 10.1038/sj.jhh.1001641; Lederman RJ, 2001, AM HEART J, V142, P314, DOI 10.1067/mhj.2001.116958; MARONE LK, 2004, PERSPECT VASC SURG E, V16, P249; MISSOURIS CG, 1994, AM J MED, V96, P10, DOI 10.1016/0002-9343(94)90109-0; Murphy TP, 2004, AM J ROENTGENOL, V183, P561, DOI 10.2214/ajr.183.3.1830561; OGIHARA T, 1991, AM J HYPERTENS, V4, pS42, DOI 10.1093/ajh/4.1.42S; Pillay WR, 2002, BRIT J SURG, V89, P737, DOI 10.1046/j.1365-2168.2002.02144.x; Pizzolo F, 2004, J VASC SURG, V39, P140, DOI 10.1016/S0741-5214(03)01018-8; Plouin PF, 1998, HYPERTENSION, V31, P823, DOI 10.1161/01.HYP.31.3.823; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Ramos F, 2003, KIDNEY INT, V63, P276, DOI 10.1046/j.1523-1755.2003.00734.x; Rivolta R, 2005, J NEPHROL, V18, P749; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; Rocha-Singh KJ, 1999, CATHETER CARDIO INTE, V47, P167, DOI 10.1002/(SICI)1522-726X(199906)47:2<167::AID-CCD7>3.0.CO;2-R; SAFIAN RD, 2001, NEW ENGL J MED, V344, P341; Spinosa DJ, 2001, AM J ROENTGENOL, V176, P1305, DOI 10.2214/ajr.176.5.1761305; TAKABATAKE T, 1987, ANGIOLOGY, V38, P434, DOI 10.1177/000331978703800602; TAYLOR DC, 1989, J VASC SURG, V9, P410, DOI 10.1067/mva.1989.vs0090410; Tillman D M, 1984, J Hypertens Suppl, V2, pS93; Tuttle KR, 1998, AM J KIDNEY DIS, V32, P611, DOI 10.1016/S0272-6386(98)70025-3; *US DEP HHS, 1997, USRDS 1997 ANN DAT R; Uzu T, 2002, HYPERTENS RES, V25, P537; Uzzo RG, 2002, TRANSPLANT P, V34, P723, DOI 10.1016/S0041-1345(02)02623-4; van de Ven PJG, 1999, LANCET, V353, P282, DOI 10.1016/S0140-6736(98)04432-8; van Jaarsveld BC, 2000, SEMIN NEPHROL, V20, P463; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Webster J, 1998, J HUM HYPERTENS, V12, P329, DOI 10.1038/sj.jhh.1000599; White CJ, 1997, J AM COLL CARDIOL, V30, P1445, DOI 10.1016/S0735-1097(97)00348-3; Zeller T, 2004, J ENDOVASC THER, V11, P95, DOI 10.1583/03-1062.1; Ziakka S, 2002, INT J CLIN PRACT, V56, P649	66	138	146	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2006	145	12					901	912		10.7326/0003-4819-145-12-200612190-00143	http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00143			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120BB	17062633				2022-12-28	WOS:000243057400005
J	Aharonian, F; Akhperjanian, AG; Bazer-Bachi, AR; Beilicke, M; Benbow, W; Berge, D; Bernlohr, K; Boisson, C; Bolz, O; Borrel, V; Braun, I; Brown, AM; Buhler, R; Busching, I; Carrigan, S; Chadwick, PM; Chounet, LM; Coignet, G; Cornils, R; Costamante, L; Degrange, B; Dickinson, HJ; Djannati-Atai, A; Drury, LO; Dubus, G; Egberts, K; Emmanoulopoulos, D; Espigat, P; Feinstein, F; Ferrero, E; Fiasson, A; Fontaine, G; Funk, S; Funk, S; Fussling, M; Gallant, YA; Giebels, B; Glicenstein, JF; Goret, P; Hadjichristidis, C; Hauser, D; Hauser, M; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hoffmann, A; Hofmann, W; Holleran, M; Hoppe, S; Horns, D; Jacholkowska, A; de Jager, OC; Kendziorra, E; Kerschhaggl, M; Khelifi, B; Komin, N; Konopelko, A; Kosack, K; Lamanna, G; Latham, IJ; Le Gallou, R; Lemiere, A; Lemoine-Goumard, M; Lenain, JP; Lohse, T; Martin, JM; Martineau-Huynh, O; Marcowith, A; Masterson, C; Maurin, G; McComb, TJL; Moulin, E; de Naurois, M; Nedbal, D; Nolan, SJ; Noutsos, A; Orford, KJ; Osborne, JL; Ouchrif, M; Panter, M; Pelletier, G; Pita, S; Puhlhofer, G; Punch, M; Ranchon, S; Raubenheimer, BC; Raue, M; Rayner, SM; Reimer, A; Ripken, J; Rob, L; Rolland, L; Rosier-Lees, S; Rowell, G; Sahakian, V; Santangelo, A; Sauge, L; Schlenker, S; Schlickeiser, R; Schroder, R; Schwanke, U; Schwarzburg, S; Schwemmer, S; Shalchi, A; Sol, H; Spangler, D; Spanier, F; Steenkamp, R; Stegmann, C; Superina, G; Tam, PH; Tavernet, JP; Terrier, R; Tluczykont, M; van Eldik, C; Vasileiadis, G; Venter, C; Vialle, JP; Vincent, P; Volk, HJ; Wagner, SJ; Ward, M				Aharonian, F.; Akhperjanian, A. G.; Bazer-Bachi, A. R.; Beilicke, M.; Benbow, W.; Berge, D.; Bernloehr, K.; Boisson, C.; Bolz, O.; Borrel, V.; Braun, I.; Brown, A. M.; Buehler, R.; Buesching, I.; Carrigan, S.; Chadwick, P. M.; Chounet, L. -M.; Coignet, G.; Cornils, R.; Costamante, L.; Degrange, B.; Dickinson, H. J.; Djannati-Atai, A.; Drury, L. O'C.; Dubus, G.; Egberts, K.; Emmanoulopoulos, D.; Espigat, P.; Feinstein, F.; Ferrero, E.; Fiasson, A.; Fontaine, G.; Funk, Seb.; Funk, S.; Fuessling, M.; Gallant, Y. A.; Giebels, B.; Glicenstein, J. F.; Goret, P.; Hadjichristidis, C.; Hauser, D.; Hauser, M.; Heinzelmann, G.; Henri, G.; Hermann, G.; Hinton, J. A.; Hoffmann, A.; Hofmann, W.; Holleran, M.; Hoppe, S.; Horns, D.; Jacholkowska, A.; de Jager, O. C.; Kendziorra, E.; Kerschhaggl, M.; Khelifi, B.; Komin, Nu.; Konopelko, A.; Kosack, K.; Lamanna, G.; Latham, I. J.; Le Gallou, R.; Lemiere, A.; Lemoine-Goumard, M.; Lenain, J. -P.; Lohse, T.; Martin, J. M.; Martineau-Huynh, O.; Marcowith, A.; Masterson, C.; Maurin, G.; McComb, T. J. L.; Moulin, E.; de Naurois, M.; Nedbal, D.; Nolan, S. J.; Noutsos, A.; Orford, K. J.; Osborne, J. L.; Ouchrif, M.; Panter, M.; Pelletier, G.; Pita, S.; Puehlhofer, G.; Punch, M.; Ranchon, S.; Raubenheimer, B. C.; Raue, M.; Rayner, S. M.; Reimer, A.; Ripken, J.; Rob, L.; Rolland, L.; Rosier-Lees, S.; Rowell, G.; Sahakian, V.; Santangelo, A.; Sauge, L.; Schlenker, S.; Schlickeiser, R.; Schroeder, R.; Schwanke, U.; Schwarzburg, S.; Schwemmer, S.; Shalchi, A.; Sol, H.; Spangler, D.; Spanier, F.; Steenkamp, R.; Stegmann, C.; Superina, G.; Tam, P. H.; Tavernet, J. -P.; Terrier, R.; Tluczykont, M.; van Eldik, C.; Vasileiadis, G.; Venter, C.; Vialle, J. P.; Vincent, P.; Voelk, H. J.; Wagner, S. J.; Ward, M.			Fast variability of tera-electron volt gamma rays from the radio galaxy M87	SCIENCE			English	Article							BLACK-HOLE; TEV EMISSION; COSMIC-RAYS; JET; HST-1; M-87; NUCLEUS; KNOT	The detection of fast variations of the tera - electron volt (TeV) (10(12) eV) gamma-ray flux, on time scales of days, from the nearby radio galaxy M87 is reported. These variations are about 10 times as fast as those observed in any other wave band and imply a very compact emission region with a dimension similar to the Schwarzschild radius of the central black hole. We thus can exclude several other sites and processes of the gamma-ray production. The observations confirm that TeV g rays are emitted by extragalactic sources other than blazars, where jets are not relativistically beamed toward the observer.	Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Yerevan Phys Inst, Yerevan 375036, Armenia; UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31029 Toulouse 4, France; Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; Observ Paris, CNRS, UMR 8102, Lab Univers & Theories,Sect Meudon, F-92195 Meudon, France; Univ Durham, Dept Phys, Durham DH1 3LE, England; North West Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; CNRS, IN2P3, Lab Annecy Le Vieux Phys Particules, F-74941 Annecy Le Vieux, France; Univ Paris 07, CNRS, CEA,UMR 7164, Observ Paris, F-75025 Paris 13, France; Dublin Inst Adv Studies, Dublin 2, Ireland; Heidelberg Univ, Landessternwarte Konigstuhl, D-69117 Heidelberg, Germany; Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier 5, France; CE Saclay, CEA, DSM, DAPNIA, F-91191 Gif Sur Yvette, France; Univ Grenoble 1, CNRS, Inst Natl Sci Univers, Lab Astrophys Grenoble, F-38041 Grenoble 9, France; Univ Tubingen, Inst Astron & Astrophys, D-72076 Tubingen, Germany; Univ Paris 06, CNRS, IN2P3, Phys Theor & Hautes Energies Lab, F-75252 Paris 5, France; Univ Paris 07, F-75252 Paris 5, France; Charles Univ Prague, Inst Nucl & Particle Phys, CR-18000 Prague 8, Czech Republic; Ruhr Univ Bochum, Lehrstuhl Weltraum & Astrophys 4, Inst Theoret Phys, D-44780 Bochum, Germany; Univ Namibia, Windhoek, Namibia; Univ Erlangen Nurnberg, Inst Phys, D-91058 Erlangen, Germany	University of Hamburg; Max Planck Society; Yerevan Physics Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Humboldt University of Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Durham University; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Dublin Institute for Advanced Studies; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Charles University Prague; Ruhr University Bochum; University of Namibia; University of Erlangen Nuremberg	Beilicke, M (corresponding author), Univ Hamburg, Inst Expt Phys, Luruper Chaussee 149, D-22761 Hamburg, Germany.	matthias.beilicke@desy.de	Hadjichristidis, Christos/G-7284-2012; Reimer, Anita/K-5822-2015; Horns, Dieter/ABE-9516-2020; White, Richard/AAF-4527-2019; Drury, Luke O'C/B-1916-2017; MAURIN, Guillaume GM/G-7435-2015; Berge, David/P-2179-2017; van Eldik, Christopher/C-3901-2013; Horns, Dieter/C-9727-2011; Funk, Stefan/AAI-1568-2021; Braun, Isabel V/C-9373-2012; Marcowith, Alexandre/ABH-1254-2020; Venter, Christo/E-6884-2011; Fontaine, Gerard/D-6420-2014; Funk, Stefan/B-7629-2015; Djannati-Atai, Arache/ABA-9249-2021; Pühlhofer, Gerd/Q-2336-2018; Komin, Nukri/J-6781-2015	Hadjichristidis, Christos/0000-0002-5933-0755; Reimer, Anita/0000-0001-8604-7077; Horns, Dieter/0000-0003-1945-0119; White, Richard/0000-0002-3356-0763; Drury, Luke O'C/0000-0002-9257-2270; MAURIN, Guillaume GM/0000-0002-2096-0450; Berge, David/0000-0002-2918-1824; van Eldik, Christopher/0000-0001-9669-645X; Funk, Stefan/0000-0002-2012-0080; Braun, Isabel V/0000-0002-9389-0502; Marcowith, Alexandre/0000-0002-3971-0910; Venter, Christo/0000-0002-2666-4812; Fontaine, Gerard/0000-0002-6443-5025; Funk, Stefan/0000-0002-2012-0080; Spanier, Felix/0000-0001-6802-4744; Hermann, German/0000-0002-4595-1032; Funk, Sebastian/0000-0002-2842-3406; Rowell, Gavin/0000-0002-9516-1581; Brown, Anthony/0000-0003-0259-3148; Komin, Nukri/0000-0003-3280-0582; Martineau-Huynh, Olivier/0000-0001-5334-8244; Punch, Michael/0000-0002-4710-2165; Chadwick, Paula/0000-0002-1468-2685				Aharonian F, 2004, ASTROPART PHYS, V22, P109, DOI 10.1016/j.astropartphys.2004.06.006; Aharonian F, 2003, ASTRON ASTROPHYS, V403, pL1, DOI 10.1051/0004-6361:20030372; Aharonian FA, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.023005; Baltz EA, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.023514; BAND DL, 1986, ASTROPHYS J, V308, P576, DOI 10.1086/164528; BEILICKE M, 2004, P TEXAS S REL ASTR S; BENBOW W, 2005, P NETW ATM CHER DET, V7, P163; Bicknell GV, 1996, ASTROPHYS J, V467, P597, DOI 10.1086/177636; Biermann PL, 2000, NUCL PHYS B-PROC SUP, V87, P417, DOI 10.1016/S0920-5632(00)00708-8; Boldt E, 2000, MON NOT R ASTRON SOC, V316, pL29, DOI 10.1046/j.1365-8711.2000.03768.x; DENAUROIS M, 2005, P NETW ATM CHER DET, V7, P149; Forman W, 2005, ASTROPHYS J, V635, P894, DOI 10.1086/429746; Georganopoulos M, 2005, ASTROPHYS J, V634, pL33, DOI 10.1086/498714; HARRIS DB, COMMUNICATION; Harris DE, 2006, ASTROPHYS J, V640, P211, DOI 10.1086/500081; Harris DE, 2003, ASTROPHYS J, V586, pL41, DOI 10.1086/374773; Hofmann W, 2005, PROCEEDINGS OF THE 29TH INTERNATIONAL COSMIC RAY CONFERENCE, VOL 10, P97; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; Le Bohec S, 2004, ASTROPHYS J, V610, P156, DOI 10.1086/421697; Levinson A, 2000, PHYS REV LETT, V85, P912, DOI 10.1103/PhysRevLett.85.912; Ma C, 1998, ASTRON J, V116, P516, DOI 10.1086/300408; Macchetto F, 1997, ASTROPHYS J, V489, P579, DOI 10.1086/304823; Marshall HL, 2002, ASTROPHYS J, V564, P683, DOI 10.1086/324396; OWEN FN, 2000, ASP C SER, V199; Perlman ES, 2005, ASTROPHYS J, V627, P140, DOI 10.1086/430340; Pfrommer C, 2003, ASTRON ASTROPHYS, V407, pL73, DOI 10.1051/0004-6361:20031088; Protheroe RJ, 2003, ASTROPART PHYS, V19, P559, DOI 10.1016/S0927-6505(02)00268-2; Reimer A, 2004, ASTRON ASTROPHYS, V419, P89, DOI 10.1051/0004-6361:20034231; Reynolds CS, 1996, MON NOT R ASTRON SOC, V283, pL111, DOI 10.1093/mnras/283.4.L111; Stawarz L, 2006, MON NOT R ASTRON SOC, V370, P981, DOI 10.1111/j.1365-2966.2006.10525.x; Stawarz X, 2005, ASTROPHYS J, V626, P120, DOI 10.1086/430087	31	272	273	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1424	1427		10.1126/science.1134408	http://dx.doi.org/10.1126/science.1134408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17068224	Green Submitted			2022-12-28	WOS:000242406100032
J	Kelly, JA; Amirkhanian, YA; Kabakchieva, E; Vassileva, S; McAuliffe, TL; DiFranceisco, WJ; Antonova, R; Petrova, E; Vassilev, B; Khoursine, RA; Dimitrov, B				Kelly, Jeffrey A.; Amirkhanian, Yuri A.; Kabakchieva, Elena; Vassileva, Sylvia; McAuliffe, Timothy L.; DiFranceisco, Wayne J.; Antonova, Radostina; Petrova, Elena; Vassilev, Boyan; Khoursine, Roman A.; Dimitrov, Borislav			Prevention of HIV and sexually transmitted diseases in high risk social networks of young Roma (Gypsy) men in Bulgaria: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTORS; BEHAVIOR; RUSSIA; SEX; PATTERNS	Objective To determine the effects of a behavioural intervention for prevention of HIV and sexually transmitted diseases that identified, trained, and engaged leaders of Roma (Gypsy) men's social networks to counsel their own network members. Design A two arm randomised controlled trial. Setting A disadvantaged, impoverished Roma settlement in Bulgaria. Participants 286 Roma men from 52 social networks recruited in the community. Intervention At baseline, all participants were assessed for HIV risk behaviour, tested and treated for sexually transmitted diseases, counselled in risk reduction, and randomised to intervention or control groups. Network leaders learnt how to counsel their social network members on risk prevention. Networks were followed up three and 12 months after the intervention to determine evidence of risk reduction. Main outcome measure Occurrence of unprotected intercourse during the three months before each assessment. Results Reported prevalence of unprotected intercourse in the intervention group fell more than in control group (from 81% and 80%, respectively, at baseline to 65% and 75% at three months and 71% and 86% at 12 months). Changes were more pronounced among men with casual partners. Effects remained strong at long term follow-up, consistent with changes in risk reduction norms in the social network. Other measures of risk reduction corroborated the intervention's effects. Conclusions Endorsement and advice on HIV prevention from the leader of a social network produces well maintained change in the reported sexual practices in members of that network. This model has particular relevance for health interventions in populations such as Roma who may be distrustful of outsiders.	Med Coll Wisconsin, Dept Psychiat & Behav Med, CAIR, Milwaukee, WI 53202 USA; Municipal Hosp Infect Dis, St Petersburg 193167, Russia; Hlth & Social Dev Fdn, Sofia 1606, Bulgaria; Med Univ Sofia, Dept Dermatol & Venereol, Sofia 1606, Bulgaria; Mil Med Acad, Dept Dermatol & Venereol, Sofia 1606, Bulgaria	Medical College of Wisconsin; Medical University Sofia; Military Medical Academy Sofia	Kelly, JA (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, CAIR, 2071 N Summit Ave, Milwaukee, WI 53202 USA.	kdemming@mcw.edu	Amirkhanian, Yuri/AAH-9924-2021	Amirkhanian, Yuri/0000-0002-4983-2954	NIMH NIH HHS [R01-MH64410, P30-MH52776] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064410, P30MH052776] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amirkhanian YA, 2005, AIDS, V19, P1897, DOI 10.1097/01.aids.0000189867.74806.fb; Amirkhanian YA, 2005, AIDS CARE, V17, P58, DOI 10.1080/09540120412331305133; Amirkhanian YA, 2003, AIDS EDUC PREV, V15, P205, DOI 10.1521/aeap.15.4.205.23832; Amirkhanian YA, 2001, AIDS, V15, P407, DOI 10.1097/00002030-200102160-00014; Kabakchieva E, 2002, INT J STD AIDS, V13, P184, DOI 10.1258/0956462021924893; Kabakchieva E, 2006, SEX TRANSM DIS, V33, P485, DOI 10.1097/01.olq.0000204533.20324.56; KADUSHIN C, 1966, AM SOCIOL REV, V31, P786, DOI 10.2307/2091658; Kelly JA, 2004, AIDS CARE, V16, P231, DOI 10.1080/09540120410001641075; *LEDIS GROUP, 2003, SOC PRO COMP PROGR V; LIEGOIS JP, 1994, ROMA CYPSIES TRAVELE; Murray DM, 1998, DESIGN ANAL GROUP RA; *NAT I STAT, 2001, SURV HLTH STAT BULG; Tomova I., 1995, GYPSIES TRANSITION P; *UNAIDS, 2002, FACT SHEET HIV AIDS; UNDP, 2003, NAT HUM DEV REP; UNDP, 2005, FAC POV FAC HOP VULN; *UNDP, 2003, SOC ASS ROM HIV AIDS; *WORLD BANK, 2003, HIV AIDS SE EUR CAS; PATRIN WEB J	19	85	88	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2006	333	7578					1098	1101		10.1136/bmj.38992.478299.55	http://dx.doi.org/10.1136/bmj.38992.478299.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112IW	17040924	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000242520200016
J	Ostro, SJ; Margot, JL; Benner, LAM; Giorgini, JD; Scheeres, DJ; Fahnestock, EG; Broschart, SB; Bellerose, J; Nolan, MC; Magri, C; Pravec, P; Scheirich, P; Rose, R; Jurgens, RF; De Jong, EM; Suzuki, S				Ostro, Steven. J.; Margot, Jean-Luc; Benner, Lance A. M.; Giorgini, Jon D.; Scheeres, Daniel J.; Fahnestock, Eugene G.; Broschart, Stephen B.; Bellerose, Julie; Nolan, Michael C.; Magri, Christopher; Pravec, Petr; Scheirich, Petr; Rose, Randy; Jurgens, Raymond F.; De Jong, Eric M.; Suzuki, Shigeru			Radar Imaging of binary near-Earth asteroid (66391) 1999 KW4	SCIENCE			English	Article							CROSSING ASTEROIDS; POPULATION; DENSITY; MASS	High-resolution radar images reveal near-Earth asteroid ( 66391) 1999 KW4 to be a binary system. The similar to 1.5-kilometer-diameter primary ( Alpha) is an unconsolidated gravitational aggregate with a spin period similar to 2.8 hours, bulk density similar to 2 grams per cubic centimeter, porosity similar to 50%, and an oblate shape dominated by an equatorial ridge at the object's potential-energy minimum. The similar to 0.5-kilometer secondary ( Beta) is elongated and probably is denser than Alpha. Its average orbit about Alpha is circular with a radius similar to 2.5 kilometers and period similar to 17.4 hours, and its average rotation is synchronous with the long axis pointed toward Alpha, but librational departures from that orientation are evident. Exotic physical and dynamical properties may be common among near-Earth binaries.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; Arecibo Observ, Arecibo, PR 00612 USA; Univ Maine, Farmington, ME 04938 USA; Acad Sci Czech Republ, Astron Inst, CZ-25165 Ondrejov, Czech Republic	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); University of Maine System; University of Maine Farmington; University of Maine Orono; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences	Ostro, SJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	ostro@reason.jpl.nasa.gov	Margot, Jean-Luc/A-6154-2012; Nolan, Michael C/H-4980-2012; Scheirich, Peter/H-4331-2014; Pravec, Petr/AAE-2695-2019; Pravec, Petr/G-9037-2014	Margot, Jean-Luc/0000-0001-9798-1797; Nolan, Michael C/0000-0001-8316-0680; Scheirich, Peter/0000-0001-8518-9532; Pravec, Petr/0000-0001-8434-9776; SCHEERES, DANIEL/0000-0003-0558-3842				Abe S, 2006, SCIENCE, V312, P1344, DOI 10.1126/science.1126272; Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Binzel RP, 2004, ICARUS, V170, P259, DOI 10.1016/j.icarus.2004.04.004; Bottke WF, 1996, NATURE, V381, P51, DOI 10.1038/381051a0; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; Consolmagno GJ, 1998, METEORIT PLANET SCI, V33, P1221, DOI 10.1111/j.1945-5100.1998.tb01307.x; FINNEY DJ, 1964, STATISTICAL METHOD B, P24; Gronchi GF, 2001, ICARUS, V152, P58, DOI 10.1006/icar.2001.6610; HUDSON RS, 1993, REMOTE SENSING REV, V8, P195, DOI DOI 10.1080/02757259309532195; MAGRI C, IN PRESS ICARUS; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; MILANI A, 2006, NEAR EARTH OBJECTS D; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; Pravec P, 2006, ICARUS, V181, P63, DOI 10.1016/j.icarus.2005.10.014; Richardson DC, 1998, ICARUS, V134, P47, DOI 10.1006/icar.1998.5954; Richardson DC, 2006, ANNU REV EARTH PL SC, V34, P47, DOI 10.1146/annurev.earth.32.101802.120208; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Scheeres DJ, 2006, SCIENCE, V314, P1280, DOI 10.1126/science.1133599; SCHEERES DJ, 1994, ICARUS, V110, P225, DOI 10.1006/icar.1994.1118; Wasson J.T., 1974, METEORITES, P175; Yeomans DK, 2000, SCIENCE, V289, P2085, DOI 10.1126/science.289.5487.2085; Yeomans DK, 1997, SCIENCE, V278, P2106, DOI 10.1126/science.278.5346.2106	23	214	215	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1276	1280		10.1126/science.1133622	http://dx.doi.org/10.1126/science.1133622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17038586				2022-12-28	WOS:000242215800036
J	Bisset, L; Beller, E; Jull, G; Brooks, P; Darnell, R; Vicenzino, B				Bisset, Leanne; Beller, Elaine; Jull, Gwendolen; Brooks, Peter; Darnell, Ross; Vicenzino, Bill			Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LATERAL EPICONDYLITIS; GRIP STRENGTH; UPPER-LIMB; MUSCULOSKELETAL DISORDERS; PRIMARY-CARE; PHYSIOTHERAPY; PREVALENCE; PAIN; INTERVENTIONS; COMPLAINTS	Objective To investigate the efficacy of physiotherapy compared with a wait and see approach or corticosteroid injections over 52 weeks in tennis elbow. Design Single blind randomised controlled trial. Setting Community setting, Brisbane, Australia. Participants 198 participants aged 18 to 65 years with a clinical diagnosis of tennis elbow of a minimum six weeks' duration, who had not received any other active treatment by a health practitioner in the previous six months. Interventions Eight sessions of physiotherapy; corticosteroid injections; or wait and see. Main outcome measures Global improvement, grip force, and assessor's rating of severity measured at baseline, six weeks, and 52 weeks. Results Corticosteroid injection showed significantly better effects at six weeks but with high recurrence rates thereafter (47/65 of successes subsequently regressed) and significantly poorer outcomes in the long term compared with physiotherapy. Physiotherapy was Superior to wait and see in the short term: no difference was seen at 52 weeks, when most participants in both groups reported a successful outcome. Participants who had physiotherapy Sought less additional treatment, such as non-steroidal anti-inflammatory drugs, than did participants who had wait and see or injections. Conclusion Physiotherapy combining elbow manipulation and exercise has a Superior benefit to wait and see in the first six weeks and to corticosteroid injections after six weeks, providing a reasonable alternative to injections in the mid to long term. The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in die management of tennis elbow.	Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Queensland Clin Trials Ctr, Sch Populat Hlth, St Lucia, Qld 4072, Australia; Univ Queensland, Fac Hlth Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	b.vicenzino@uq.edu.au	Bisset, Leanne/AAS-8947-2021; Jull, Gwendolen/F-4233-2010; Beller, Elaine M/E-1615-2013; Vicenzino, Bill/A-8492-2011; Vicenzino, Guglielmo/F-8744-2010; DARNELL, ROSS E/B-3823-2009	Bisset, Leanne/0000-0001-8807-7093; Jull, Gwendolen/0000-0003-2670-1318; Beller, Elaine M/0000-0002-3241-2611; Vicenzino, Bill/0000-0003-0253-5933; DARNELL, ROSS E/0000-0002-7973-6322				ALLANDER E, 1974, SCAND J RHEUMATOL, V3, P145, DOI 10.3109/03009747409097141; Benjamin SJ, 1999, J ORTHOP SPORT PHYS, V29, P668, DOI 10.2519/jospt.1999.29.11.668; Bisset L, 2005, BRIT J SPORT MED, V39, P411, DOI 10.1136/bjsm.2004.016170; Bot SDM, 2005, ANN RHEUM DIS, V64, P1331, DOI 10.1136/ard.2004.030320; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; CHIANG HC, 1993, SCAND J WORK ENV HEA, V19, P126, DOI 10.5271/sjweh.1496; Drechsler WI, 1997, J SPORT REHABIL, V6, P226, DOI 10.1123/jsr.6.3.226; Haker E, 1993, CRIT REV PHYS REHABI, V5, P129; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; KURPPA K, 1991, SCAND J WORK ENV HEA, V17, P32, DOI 10.5271/sjweh.1737; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; RANNEY D, 1995, ERGONOMICS, V38, P1408, DOI 10.1080/00140139508925198; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Smidt N, 2003, ANN MED, V35, P51, DOI 10.1080/07853890310004138; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2005, ANN RHEUM DIS, V64, P1406, DOI 10.1136/ard.2004.029363; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; STRATFORD P, 1987, Physiotherapy Canada, V39, P250; STRATFORD PW, 1989, PHYS THER, V69, P276, DOI 10.1093/ptj/69.4.276; STRATFORD PW, 1994, CLIN J SPORT MED, V4, P88, DOI DOI 10.1097/00042752-199404000-00004; THURTLE OA, 1984, BRIT J RHEUMATOL, V23, P154; Vicenzino B, 2003, MANUAL THER, V8, P66, DOI 10.1016/S1356-689X(02)00157-1; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535; Yan J., 2002, R NEWS, V2, P12	24	294	299	1	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2006	333	7575					939	941		10.1136/bmj.38961.584653.AE	http://dx.doi.org/10.1136/bmj.38961.584653.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17012266	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000242157900014
J	Dulac, C				Dulac, Catherine			Neuroscience - Charting olfactory maps	SCIENCE			English	Editorial Material							ODORANT RECEPTORS; BULB		Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu		Dulac, Catherine/0000-0001-5024-5418				Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9	6	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					606	607		10.1126/science.1135139	http://dx.doi.org/10.1126/science.1135139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068251				2022-12-28	WOS:000241557800033
J	Poinar, GO; Danforth, BN				Poinar, G. O., Jr.; Danforth, B. N.			A fossil bee from Early Cretaceous Burmese amber	SCIENCE			English	Article									Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Cornell University; Oregon State University	Danforth, BN (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	bnd1@cornell.edu		Danforth, Bryan/0000-0002-6495-428X				Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Cruickshank RD, 2003, J ASIAN EARTH SCI, V21, P441, DOI 10.1016/S1367-9120(02)00044-5; Melo Gabriel A.R., 1999, Scientific Papers Natural History Museum the University of Kansas, V14, P1; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Soltis D, 2005, PHYLOGENY EVOLUTION; THORP RW, 1979, ANN MO BOT GARD, V66, P788, DOI 10.2307/2398919	6	75	87	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					614	614		10.1126/science.1134103	http://dx.doi.org/10.1126/science.1134103			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068254				2022-12-28	WOS:000241557800036
J	McFall-Ngai, M				McFall-Ngai, Margaret			Love the one you're with: Vertebrate guts shape their microbiota	CELL			English	Editorial Material							ZEBRAFISH; MICROORGANISMS	Using germ-free animals, Rawls et al. (2006) reveal that the gut of a given host can be colonized by the microbiota of another vertebrate. Remarkably, the recipient host then shapes the composition of the non-native microbiota to more closely resemble that of its native consortium.	Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	McFall-Ngai, M (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	mjmcfallngai@wisc.edu						Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Webb JF, 2006, INTEGR COMP BIOL, V46, P569, DOI 10.1093/icb/icl017	8	8	9	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					247	249		10.1016/j.cell.2006.10.005	http://dx.doi.org/10.1016/j.cell.2006.10.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055422	Bronze			2022-12-28	WOS:000241827100008
J	Bredesen, DE; Rao, RV; Mehlen, P				Bredesen, Dale E.; Rao, Rammohan V.; Mehlen, Patrick			Cell death in the nervous system	NATURE			English	Review							ENDOPLASMIC-RETICULUM STRESS; CYTOCHROME-C RELEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; APOPTOSIS-INDUCING FACTOR; TRANSGENIC MOUSE MODEL; MITOCHONDRIAL FISSION; HUNTINGTONS-DISEASE; NEURONAL DEATH; NEURODEGENERATIVE DISEASES; CASPASE ACTIVATION	Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease trigger neuronal cell death through endogenous suicide pathways. Surprisingly, although the cell death itself may occur relatively late in the course of the degenerative process, the mediators of the underlying cell-death pathways have shown promise as potential therapeutic targets.	Buck Inst Age Res, Novato, CA 94945 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab, F-69008 Lyon, France	Buck Institute for Research on Aging; University of California System; University of California San Francisco; UNICANCER; Centre Leon Berard	Bredesen, DE (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	dbredesen@buckinstitute.org			NIA NIH HHS [R01 AG012282] Funding Source: Medline; NINDS NIH HHS [R01 NS033376] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Bursch W, 2000, J CELL SCI, V113, P1189; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CUNNINGHAM TJ, 1982, INT REV CYTOL, V74, P163, DOI 10.1016/S0074-7696(08)61172-9; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; FADOK VA, 1992, J IMMUNOL, V148, P2207; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hall IH, 1997, ANTICANCER RES, V17, P1195; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1991, APOPTOSIS MOL BASIS, P321; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kordower JH, 1999, EXP NEUROL, V159, P4, DOI 10.1006/exnr.1999.7156; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; LEVI-MONTALCINI RITA, 1966, HARVEY LECT, V60, P217; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Studnicka FK, 1905, LEHRBUCH VERGLEICHEN, P1; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Yang FS, 1998, AM J PATHOL, V152, P379; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JY, 1999, NAT CELL BIOL, V1, pE44, DOI 10.1038/10037; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	80	436	470	7	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					796	802		10.1038/nature05293	http://dx.doi.org/10.1038/nature05293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051206	Green Accepted			2022-12-28	WOS:000241362700039
J	Rapaport, E				Rapaport, Elliot			Update in cardiology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Rapaport, E (corresponding author), San Francisco Gen Hosp, Div Cardiol, Room 5G1,1001 Potrero St, San Francisco, CA 94110 USA.							Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					618	625		10.7326/0003-4819-145-8-200610170-00011	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043343				2022-12-28	WOS:000241315700008
J	D'Alessandro, U; ter Kuile, FO				D'Alessandro, Umberto; ter Kuile, Feiko O.			Amodiaquine, malaria, pregnancy: the old new drug	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; UNCOMPLICATED MALARIA		Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; US Ctr Dis Control & Prevent, Div Parasit Dis, Malaria Branch, Atlanta, GA USA	Institute of Tropical Medicine (ITM); Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA	D'Alessandro, U (corresponding author), Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium.	udalessandro@itg.be	Kuile, Feiko ter/ABD-6681-2020; D'Alessandro, Umberto/D-3457-2015	Kuile, Feiko ter/0000-0003-3663-5617; D'Alessandro, Umberto/0000-0001-6341-5009				Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; [Anonymous], 2004, STRATEGIC FRAMEWORK; Fanello CI, 2006, TROP MED INT HEALTH, V11, P589, DOI 10.1111/j.1365-3156.2006.01610.x; Hwang J, 2006, TROP MED INT HEALTH, V11, P789, DOI 10.1111/j.1365-3156.2006.01571.x; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7; Thomas F, 2004, LANCET INFECT DIS, V4, P235, DOI 10.1016/S1473-3099(04)00974-0; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35	10	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1306	1307		10.1016/S0140-6736(06)69532-9	http://dx.doi.org/10.1016/S0140-6736(06)69532-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046445				2022-12-28	WOS:000241388100006
J	Demetri, GD; van Oosterom, AT; Garrett, CR; Blackstein, ME; Shah, MH; Verweij, J; McArthur, G; Judson, IR; Heinrich, MC; Morgan, JA; Desai, J; D Fletcher, C; George, S; Bello, CL; Huang, X; Baum, CM; Casali, PG				Demetri, George D.; van Oosterom, Allan T.; Garrett, Christopher R.; Blackstein, Martin E.; Shah, Manisha H.; Verweij, Jaap; McArthur, Grant; Judson, Ian R.; Heinrich, Michael C.; Morgan, Jeffrey A.; Desai, Jayesh; D Fletcher, Christopher; George, Suzanne; Bello, Carlo L.; Huang, Xin; Baum, Charles M.; Casali, Paolo G.			Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial	LANCET			English	Article							TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; ACQUIRED-RESISTANCE; SU11248; KIT; MUTATIONS; PROGRESSION; MANAGEMENT; MESYLATE; THERAPY	Background No effective therapeutic options for patients with unresectable imatinib-resistant gastrointestinal stromal tumour are available. We did a randomised, double-blind, placebo-controlled, multicentre, international trial to assess tolerability and anticancer efficacy of sunitinib, a multitargeted tyrosine kinase inhibitor, in patients with advanced gastrointestinal stromal tumour who were resistant to or intolerant of previous treatment with imatinib. Methods Blinded sunitinib or placebo was given orally once daily at a 50-mg starting dose in 6-week cycles with 4 weeks on and 2 weeks off treatment. The primary endpoint was time to tumour progression. Intention-to-treat, modified intention-to-treat, and per-protocol analyses were done. This study is registered at ClinicalTrials.gov, number NCT00075218. Findings 312 patients were randomised in a 2:1 ratio to receive sunitinib (n=207) or placebo (n=105); the trial was unblinded early when a planned interim analysis showed significantly longer time to tumour progression with sunitinib. Median time to tumour progression was 27.3 weeks (95% CI 16.0-32.1) in patients receiving sunitinib and 6.4 weeks (4.4-10.0) in those on placebo (hazard ratio 0.33; p<0.0001). Therapy was reasonably well tolerated; the most common treatment-related adverse events were fatigue, diarrhoea, skin discolouration, and nausea. Interpretation We noted significant clinical benefit, including disease control and superior survival, with sunitinib compared with placebo in patients with advanced gastrointestinal stromal tumour after failure and discontinuation of imatinab. Tolerability was acceptable.	Dana Farber Canc Inst, Ludwig Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Gen Med Oncol, Leuven Canc Inst, Louvain, Belgium; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; Univ Toronto, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; Univ Melbourne, St Vincents Hosp, Dept Med, Parkville, Vic 3052, Australia; Univ Melbourne, Peter MacCallum Canc Ctr, Parkville, Vic 3052, Australia; Royal Marsden Hosp, Sutton, Surrey, England; Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA; Portland VA Med Ctr, Portland, OR USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, La Jolla, CA USA; Ist Nazl Tumori, I-20133 Milan, Italy	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; KU Leuven; University Hospital Leuven; H Lee Moffitt Cancer Center & Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Erasmus University Rotterdam; Erasmus MC; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Royal Marsden NHS Foundation Trust; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Brigham & Women's Hospital; Pfizer; Fondazione IRCCS Istituto Nazionale Tumori Milan	Demetri, GD (corresponding author), Dana Farber Canc Inst, Ludwig Ctr, Boston, MA 02115 USA.	gdemetri@partners.org	Heinrich, Michael/AAC-6745-2019; casali, Paolo Giovanni/D-1524-2017; ravegnini, gloria/K-1330-2016; Desai, Jayesh/AAV-1237-2021	casali, Paolo Giovanni/0000-0003-4056-8023; ravegnini, gloria/0000-0002-7774-402X; Desai, Jayesh/0000-0003-4246-9344; McArthur, Grant/0000-0001-8908-6071; Heinrich, Michael/0000-0003-3790-0478				Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; DESAI J, 2005, AM SOC CLIN ONC 41 A; Edmonson JH, 2002, CANCER INVEST, V20, P605, DOI 10.1081/CNV-120002485; Heinrich MC, 2006, J CLIN ONCOL, V24, p520S; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2002, LANCET ONCOL, V3, P655, DOI 10.1016/S1470-2045(02)00899-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LECESNE A, 2005, AM SOC CLIN ONC 41 A; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Murray LJ, 2003, CLIN EXP METASTAS, V20, P757, DOI 10.1023/B:CLIN.0000006873.65590.68; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Pierie JPEN, 2001, ARCH SURG-CHICAGO, V136, P383, DOI 10.1001/archsurg.136.4.383; Plaat BEC, 2000, J CLIN ONCOL, V18, P3211, DOI 10.1200/JCO.2000.18.18.3211; Schueneman AJ, 2003, CANCER RES, V63, P4009; SMERAGLIA J, 2005, 6 INT REID BIOAN FOR; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas AL, 2003, SEMIN ONCOL, V30, P32, DOI 10.1016/S0093-7754(03)00123-4; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; von Mehren M, 2005, HEMATOL ONCOL CLIN N, V19, P547, DOI 10.1016/j.hoc.2005.03.010; Wakai T, 2004, BRIT J CANCER, V90, P2059, DOI 10.1038/sj.bjc.6601819; Wardelmann E, 2005, LANCET ONCOL, V6, P249, DOI 10.1016/S1470-2045(05)70097-8; World Health Organisation, 1979, HDB REP RES CANC TRE; Zalcberg JR, 2005, EUR J CANCER, V41, P1751, DOI 10.1016/j.ejca.2005.04.034; Zondor SD, 2004, ANN PHARMACOTHER, V38, P1258, DOI 10.1345/aph.1D470	38	1899	2039	0	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1329	1338		10.1016/S0140-6736(06)69446-4	http://dx.doi.org/10.1016/S0140-6736(06)69446-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046465				2022-12-28	WOS:000241388100029
J	MacDonald, GM; Beilman, DW; Kremenetski, KV; Sheng, YW; Smith, LC; Velichko, AA				MacDonald, Glen M.; Beilman, David W.; Kremenetski, Konstantine V.; Sheng, Yongwei; Smith, Laurence C.; Velichko, Andrei A.			Rapid early development of circumarctic peatlands and atmospheric CH4 and CO2 variations	SCIENCE			English	Article							AGE CALIBRATION; CARBON-CYCLE; TAYLOR-DOME; ICE; METHANE; HOLOCENE; ANTARCTICA; RECORD; EMISSIONS; GREENLAND	An analysis of 1516 radiocarbon dates demonstrates that the development of the current circumarctic peatlands began similar to 16.5 thousand years ago (ka) and expanded explosively between 12 and 8 ka in concert with high summer insolation and increasing temperatures. Their rapid development contributed to the sustained peak in CH4 and modest decline of CO2 during the early Holocene and likely contributed to CH4 and CO2 fluctuations during earlier interglacial and interstadial transitions. Given the decreased tempo of peatland initiation in the late Holocene and the transition of many from fens (which generated high levels of CH4) to ombrotrophic bogs, a neoglacial expansion of northern peatlands cannot explain the increase in atmospheric CH4 that occurred after 6 ka.	Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Russian Acad Sci, Moscow 109017, Russia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Russian Academy of Sciences	MacDonald, GM (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	macdonal@geog.ucla.edu	Smith, Laurence C./E-7785-2012	Smith, Laurence C./0000-0001-6866-5904				Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; ALMQUISTJACOBSON H, 1995, ECOLOGY, V76, P2503, DOI 10.2307/2265824; BARTLETT KB, 1993, CHEMOSPHERE, V26, P261, DOI 10.1016/0045-6535(93)90427-7; Bellisario LM, 1999, GLOBAL BIOGEOCHEM CY, V13, P81, DOI 10.1029/1998GB900021; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; Donner J., 1995, QUATERNARY HIST SCAN; Dyke AS, 2003, 1574 GEOL SURV CAN; Fletcher SEM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002223; Fluckiger J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001417; Gajewski K, 2001, GLOBAL BIOGEOCHEM CY, V15, P297, DOI 10.1029/2000GB001286; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Gualtieri L, 2005, BOREAS, V34, P264, DOI 10.1080/03009480510013097; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; JOOS F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI DOI 10.1029/3003GB002156; Kennett JP, 2003, METHANE HYDRATES QUA; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904	30	273	283	6	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					285	288		10.1126/science.1131722	http://dx.doi.org/10.1126/science.1131722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038618				2022-12-28	WOS:000241194100037
J	Aoki, Y; Endrodi, G; Fodor, Z; Katz, SD; Szabo, KK				Aoki, Y.; Endrodi, G.; Fodor, Z.; Katz, S. D.; Szabo, K. K.			The order of the quantum chromodynamics transition predicted by the standard model of particle physics	NATURE			English	Article							DECONFINING PHASE-TRANSITION; CHIRAL-SYMMETRY RESTORATION; LATTICE GAUGE-THEORY; QCD; TEMPERATURE; POINT; SU(2)	Quantum chromodynamics (QCD) is the theory of the strong interaction, explaining (for example) the binding of three almost massless quarks into a much heavier proton or neutron-and thus most of the mass of the visible Universe. The standard model of particle physics predicts a QCD-related transition that is relevant for the evolution of the early Universe. At low temperatures, the dominant degrees of freedom are colourless bound states of hadrons (such as protons and pions). However, QCD is asymptotically free, meaning that at high energies or temperatures the interaction gets weaker and weaker(1,2), causing hadrons to break up. This behaviour underlies the predicted cosmological transition between the low-temperature hadronic phase and a high-temperature quark-gluon plasma phase (for simplicity, we use the word 'phase' to characterize regions with different dominant degrees of freedom). Despite enormous theoretical effort, the nature of this finite-temperature QCD transition (that is, first-order, second-order or analytic crossover) remains ambiguous. Here we determine the nature of the QCD transition using computationally demanding lattice calculations for physical quark masses. Susceptibilities are extrapolated to vanishing lattice spacing for three physical volumes, the smallest and largest of which differ by a factor of five. This ensures that a true transition should result in a dramatic increase of the susceptibilities. No such behaviour is observed: our finite-size scaling analysis shows that the finite-temperature QCD transition in the hot early Universe was not a real phase transition, but an analytic crossover (involving a rapid change, as opposed to a jump, as the temperature varied). As such, it will be difficult to find experimental evidence of this transition from astronomical observations.	Univ Wuppertal, Dept Phys, D-42097 Wuppertal, Germany; Eotvos Lorand Univ, Inst Theoret Phys, H-1117 Budapest, Hungary	University of Wuppertal; Eotvos Lorand University	Katz, SD (corresponding author), Univ Wuppertal, Dept Phys, D-42097 Wuppertal, Germany.	katz@bodri.elte.hu	Katz, Sandor D/A-4154-2011	Aoki, Yasumichi/0000-0003-4096-8836; Endrodi, Gergely/0000-0002-0786-1159; Katz, Sandor/0000-0001-6524-2965				Aoki Y, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/01/089; APPLEGATE JH, 1985, PHYS REV D, V31, P3037, DOI 10.1103/PhysRevD.31.3037; Berges J, 1999, NUCL PHYS B, V538, P215, DOI 10.1016/S0550-3213(98)00620-8; Bernard C, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.114511; BROWN FR, 1988, PHYS REV LETT, V61, P2058, DOI 10.1103/PhysRevLett.61.2058; BROWN FR, 1990, PHYS REV LETT, V65, P2491, DOI 10.1103/PhysRevLett.65.2491; CELIK T, 1983, PHYS LETT B, V125, P411, DOI 10.1016/0370-2693(83)91314-X; Clark MA, 2004, NUCL PHYS B-PROC SUP, V129, P850, DOI 10.1016/j.nuclphysbps.2003.12.309; d'Avila A, 2002, J INTERV CARD ELECTR, V7, P23, DOI 10.1023/A:1020811915133; Fodor Z, 2003, COMPUT PHYS COMMUN, V152, P121, DOI 10.1016/S0010-4655(02)00776-2; FUKUGITA M, 1989, PHYS REV LETT, V63, P1768, DOI 10.1103/PhysRevLett.63.1768; GOTTLIEB S, 1987, PHYS REV D, V35, P2531, DOI 10.1103/PhysRevD.35.2531; GOTTLIEB SA, 1985, PHYS REV LETT, V55, P1958, DOI 10.1103/PhysRevLett.55.1958; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Halasz MA, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.096007; Herpay T, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.125017; Kajantie K, 1996, PHYS REV LETT, V77, P2887, DOI 10.1103/PhysRevLett.77.2887; KHAN AA, 2001, PHYS REV D, V63, DOI [10.1103/PhysRevD.63.034502, DOI 10.1103/PHYSREVD.63.034502]; KOGUT J, 1983, PHYS REV LETT, V50, P393, DOI 10.1103/PhysRevLett.50.393; PISARSKI RD, 1984, PHYS REV D, V29, P338, DOI 10.1103/PhysRevD.29.338; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Schaefer BJ, 2005, NUCL PHYS A, V757, P479, DOI 10.1016/j.nuclphysa.2005.04.012; Schwarz DJ, 2003, ANN PHYS-BERLIN, V12, P220, DOI 10.1002/andp.200310010; UKAWA A, 1995, P 1993 UEHL SUMM SCH; WITTEN E, 1984, PHYS REV D, V30, P272, DOI 10.1103/PhysRevD.30.272	29	1232	1248	4	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2006	443	7112					675	678		10.1038/nature05120	http://dx.doi.org/10.1038/nature05120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035999	Green Submitted			2022-12-28	WOS:000241160500042
J	Gelfand, JM; Neimann, AL; Shin, DB; Wang, XM; Margolis, DJ; Troxel, AB				Gelfand, Joel M.; Neimann, Andrea L.; Shin, Daniel B.; Wang, Xingmei; Margolis, David J.; Troxel, Andrea B.			Risk of myocardial infarction in patients with psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; CONSENSUS CONFERENCE; POPULATION; SMOKING; DISEASE; EPIDEMIOLOGY; PREVALENCE; SEVERITY; LIFE	Context Psoriasis is the most common T-helper cell type 1 (T(H)1) immunological disease. Evidence has linked T(H)1 diseases to myocardial infarction (MI). Psoriasis has been associated with cardiovascular diseases, but has only been investigated in hospital-based studies that did not control for major cardiovascular risk factors. Objective To determine if within a population-based cohort psoriasis is an independent risk factor for MI when controlling for major cardiovascular risk factors. Design, Setting, and Patients A prospective, population-based cohort study in the United Kingdom of patients with psoriasis aged 20 to 90 years, comparing outcomes among patients with and without a diagnosis of psoriasis. Data were collected by general practitioners as part of the patient's medical record and stored in the General Practice Research Database between 1987 and 2002, with a mean follow-up of 5.4 years. Adjustments were made for hypertension, diabetes, history of myocardial infarction, hyperlipidemia, age, sex, smoking, and body mass index. Patients with psoriasis were classified as severe if they ever received a systemic therapy. Up to 5 controls without psoriasis were randomly selected from the same practices and start dates as the patients with psoriasis. A total of 556 995 control patients and patients with mild (n = 127 139) and severe psoriasis (n = 3837) were identified. Main Outcome Measure Incident MI. Results There were 11 194 MIs (2.0%) within the control population and 2319 (1.8%) and 112 (2.9%) MIs within the mild and severe psoriasis groups, respectively. The incidences per 1000 person-years for control patients and patients with mild and severe psoriasis were 3.58 (95% confidence interval [CI], 3.52-3.65), 4.04 (95% CI, 3.88-4.21), and 5.13 (95% CI, 4.22-6.17), respectively. Patients with psoriasis had an increased adjusted relative risk (RR) for MI that varied by age. For example, for a 30-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.29 (95% CI, 1.14-1.46) and 3.10 (95% CI, 1.98-4.86), respectively. For a 60-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.08 (95% CI, 1.03-1.13) and 1.36 (95% CI, 1.13-1.64), respectively. Conclusions Psoriasis may confer an independent risk of MI. The RR was greatest in young patients with severe psoriasis.	Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Gelfand, JM (corresponding author), Univ Penn, Dept Dermatol, 3600 Spruce St,2 Maloney Bldg, Philadelphia, PA 19104 USA.	joel.gelfand@uphs.upenn.edu		Troxel, Andrea/0000-0002-1393-3075; Gelfand, Joel/0000-0003-3480-2661	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051125] Funding Source: NIH RePORTER; NIAMS NIH HHS [K23 AR051125, K23AR051125-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chodorowska G, 2004, J EUR ACAD DERMATOL, V18, P180, DOI 10.1111/j.1468-3083.2004.00863.x; ENA P, 1985, ACTA CARDIOL, V40, P199; Ford ES, 2000, J CLIN EPIDEMIOL, V53, P95, DOI 10.1016/S0895-4356(99)00143-2; Fortes C, 2005, ARCH DERMATOL, V141, P1580, DOI 10.1001/archderm.141.12.1580; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gelfand JM, 2004, J AM ACAD DERMATOL, V51, P704, DOI 10.1016/j.jaad.2004.04.014; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2005, PHARMACOEPIDEMIOL S, V14, pS23; Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1996, PHARMACOTHERAPY, V16, P321; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Kural BV, 2003, CLIN CHIM ACTA, V332, P23, DOI 10.1016/S0009-8981(03)00082-2; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Lebwohl M, 2001, J AM ACAD DERMATOL, V45, P544, DOI 10.1067/mjd.2001.116347; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; MCDONALD CJ, 1973, JAMA-J AM MED ASSOC, V224, P629; MCDONALD CJ, 1973, NEW ENGL J MED, V288, P912; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rocha-Pereira P, 2004, BRIT J DERMATOL, V150, P917, DOI 10.1111/j.1365-2133.2004.05984.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shbeeb M, 2000, J RHEUMATOL, V27, P1247; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Warrington KJ, 2005, ARTHRITIS RES THER, V7, pR984, DOI 10.1186/ar1775	40	1331	1367	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2006	296	14					1735	1741		10.1001/jama.296.14.1735	http://dx.doi.org/10.1001/jama.296.14.1735			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092NH	17032986				2022-12-28	WOS:000241103400021
J	Avenell, A; Sattar, N; Lean, M				Avenell, Alison; Sattar, Naveed; Lean, Mike			ABC of obesity - Management: Part I - Behaviour change, diets and activity	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Aberdeen, Sch Med, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Aberdeen; University of Glasgow	Avenell, A (corresponding author), Univ Aberdeen, Sch Med, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland.	nsattar@clinmed.gla.ac.uk			Chief Scientist Office [HSRU1] Funding Source: Medline; Chief Scientist Office [CZF//4/2] Funding Source: researchfish	Chief Scientist Office; Chief Scientist Office		Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Costain L, 2005, P NUTR SOC, V64, P89, DOI 10.1079/PNS2004413; Gibbs HD, 2004, J HUM NUTR DIET, V17, P191, DOI 10.1111/j.1365-277X.2004.00517.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; *NAT OB FOR, 2004, MAN OB PRIM CAR; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; *SCOTT INT GUID NE, OB SCOTL INT PREV WE	7	37	38	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 7	2006	333	7571					740	743		10.1136/bmj.333.7571.740	http://dx.doi.org/10.1136/bmj.333.7571.740			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	094OK	17023467	Green Published			2022-12-28	WOS:000241248600022
J	Leonardi, M; Bickenbach, J; Ustun, TB; Kostanjsek, N; Chatterji, S				Leonardi, Matilde; Bickenbach, Jerome; Ustun, Tevfik Bedirhan; Kostanjsek, Nenad; Chatterji, Somnath		MHADIE Consortium	The definition of disability: what is in a name?	LANCET			English	Editorial Material							INTERNATIONAL CLASSIFICATION		Italian Natl Neurol Inst Carlo Besta Fdn, IRCCS, I-20133 Milan, Italy; Queens Univ, Dept Philosophy, Kingston, ON, Canada; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland	IRCCS Istituto Neurologico Besta; Queens University - Canada; World Health Organization	Leonardi, M (corresponding author), Italian Natl Neurol Inst Carlo Besta Fdn, IRCCS, I-20133 Milan, Italy.	leonardi@istituto-besta.it	leonardi, matilde/J-9997-2018; CHATTERJI, Somnath/ABE-6832-2020; Alonso, Jordi/A-5514-2010	leonardi, matilde/0000-0003-0552-8923; Alonso, Jordi/0000-0001-8627-9636				Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9; LEONARDI M, 2006, DEF DIS UN CONV ICF; SCOTCH RK, 1988, J SOC ISSUES, V44, P159, DOI 10.1111/j.1540-4560.1988.tb02055.x; *UN EN, 2006, DRAFT CONV RIGHTS PE; United Nations Enable, 2006, 8 SESS AD HOC COMM C; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; *WHO, 2006, WHA5823 WHO; *WHO, 2006, INT CLASS FUNCT DIS	8	251	257	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1219	1221		10.1016/S0140-6736(06)69498-1	http://dx.doi.org/10.1016/S0140-6736(06)69498-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091WF	17027711				2022-12-28	WOS:000241058300008
J	Mantovani, A; Balkwill, F				Mantovani, Alberto; Balkwill, Frances			RaIB signaling: A bridge between inflammation and cancer	CELL			English	Editorial Material							KAPPA-B; CELLS; PATHWAY	A connection between the genetic events that lead to tumor formation and the signaling pathways of the innate immune response has been established. In this issue, Chien et al. (2006) show that the RaIB GTPase regulates the IKK family member TBK1, providing an unexpected link between the signaling pathways that promote inflammation and cancer. In tumor cells the RaIB/TBK1 pathway inhibits apoptosis and in nontumorigenic cells it stimulates an innate immune response.	Ist Clin Humanitas, I-20089 Rozzano, Italy; Univ Milan, I-20122 Milan, Italy; Barts & London Queen Marys Med Sch, Ctr Translat Oncol, London EC1M 6BQ, England	IRCCS Humanitas Research Hospital; University of Milan; Royal Marsden NHS Foundation Trust; University of London; Queen Mary University London	Mantovani, A (corresponding author), Ist Clin Humanitas, Via Manzoni 56, I-20089 Rozzano, Italy.	alberto.mantovani@humanitas.it	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X; Balkwill, Frances/0000-0002-5587-9759	MRC [G0501974] Funding Source: UKRI; Medical Research Council [G0501974] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848	9	15	16	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 6	2006	127	1					42	44		10.1016/j.cell.2006.09.019	http://dx.doi.org/10.1016/j.cell.2006.09.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018274	Bronze			2022-12-28	WOS:000241445800011
J	Offringa, R				Offringa, Rienk			Cancer immunotherapy is more than a numbers game	SCIENCE			English	Editorial Material							CD8(+) T-CELLS; LYMPHOCYTES; REGRESSION		Leiden Univ, Med Ctr, Tumor Immunol Grp, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Offringa, R (corresponding author), Leiden Univ, Med Ctr, Tumor Immunol Grp, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	r.offringa@lumc.nl						Appay V, 2006, J IMMUNOL, V177, P1670, DOI 10.4049/jimmunol.177.3.1670; Clay TM, 1999, J IMMUNOL, V163, P507; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Kawakami Y, 1997, Int Rev Immunol, V14, P173, DOI 10.3109/08830189709116851; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Melief CJM, 2002, IMMUNOL REV, V188, P177, DOI 10.1034/j.1600-065X.2002.18816.x; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wrzesinski C, 2005, CURR OPIN IMMUNOL, V17, P195, DOI 10.1016/j.coi.2005.02.002	15	21	23	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					68	69		10.1126/science.1133893	http://dx.doi.org/10.1126/science.1133893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023641				2022-12-28	WOS:000241031200032
J	Sutton, MA; Schuman, EM				Sutton, Michael A.; Schuman, Erin M.			Dendritic protein synthesis, synaptic plasticity, and memory	CELL			English	Review							LONG-TERM FACILITATION; METABOTROPIC GLUTAMATE RECEPTORS; KINASE M-ZETA; MESSENGER-RNAS; LATE-PHASE; HETEROSYNAPTIC FACILITATION; TRANSLATIONAL CONTROL; STIMULATION LEADS; CRITICAL PERIOD; AMPA RECEPTORS	Considerable evidence suggests that the formation of long-term memories requires a critical period of new protein synthesis. Recently, the notion that some of these newly synthesized proteins originate through local translation in neuronal dendrites has gained some traction. Here, we review the experimental support for this idea and highlight some of the key questions outstanding in this area.	CALTECH, Howard Hughes Med Inst, Div Biol 114 96, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sutton, MA (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 114 96, Pasadena, CA 91125 USA.	schumane@caltech.edu	Sutton, Michael/C-6264-2011; Schuman, Erin M/D-6204-2011	Sutton, Michael/0000-0002-0692-6459				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; BODIAN D, 1965, P NATL ACAD SCI USA, V53, P418, DOI 10.1073/pnas.53.2.418; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CLARK GA, 1984, P NATL ACAD SCI-BIOL, V81, P2577, DOI 10.1073/pnas.81.8.2577; Cracco JB, 2005, HIPPOCAMPUS, V15, P551, DOI 10.1002/hipo.20078; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FEIG S, 1993, J NEUROSCI, V13, P1010; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Huang YY, 2005, LEARN MEMORY, V12, P587, DOI 10.1101/lm.98905; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Moccia R, 2003, J NEUROSCI, V23, P9409; MONNE L, 1948, ADV ENZYMOL REL S BI, V8, P1; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Osten P, 1996, J NEUROSCI, V16, P2444; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RAO A, 1991, J NEUROSCI, V11, P2881; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Sherff CM, 2004, P NATL ACAD SCI USA, V101, P7463, DOI 10.1073/pnas.0402163101; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; STANTON PK, 1984, J NEUROSCI, V4, P3080; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; TORRE ER, 1992, J NEUROSCI, V12, P762; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; YARMOLINSKY MB, 1959, BIOCHEMISTRY-US, V45, P1721; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	87	607	622	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					49	58		10.1016/j.cell.2006.09.014	http://dx.doi.org/10.1016/j.cell.2006.09.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018276	Bronze			2022-12-28	WOS:000241445800013
J	Brown, DM; Kaiser, PK; Michels, M; Soubrane, G; Heier, JS; Kim, RY; Sy, JP; Schneider, S				Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Jeffrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan		ANCHOR Study Grp	Ranibizumab versus verteporfin for neovascular age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVALENCE	Background: We compared ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration. Methods: During the first year of this 2-year, multicenter, double-blind study, we randomly assigned patients in a 1:1:1 ratio to receive monthly intravitreal injections of ranibizumab (0.3 mg or 0.5 mg) plus sham verteporfin therapy or monthly sham injections plus active verteporfin therapy. The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 months. Results: Of the 423 patients enrolled, 94.3% of those given 0.3 mg of ranibizumab and 96.4% of those given 0.5 mg lost fewer than 15 letters, as compared with 64.3% of those in the verteporfin group (P < 0.001 for each comparison). Visual acuity improved by 15 letters or more in 35.7% of the 0.3-mg group and 40.3% of the 0.5-mg group, as compared with 5.6% of the verteporfin group (P < 0.001 for each comparison). Mean visual acuity increased by 8.5 letters in the 0.3-mg group and 11.3 letters in the 0.5-mg group, as compared with a decrease of 9.5 letters in the verteporfin group (P < 0.001 for each comparison). Among 140 patients treated with 0.5 mg of ranibizumab, presumed endophthalmitis occurred in 2 patients (1.4%) and serious uveitis in 1 (0.7%). Conclusions: Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events. Treatment improved visual acuity on average at 1 year. (ClinicalTrials.gov number, NCT00061594.)	Methodist Hosp, Vitreoretinal Consultants, Houston, TX 77030 USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Retina Care Specialists, Palm Beach Gardens, FL USA; Univ Paris 12, Clin Ophtalmol, Creteil, France; Ophthalm Consultants Boston, Boston, MA USA; Genentech Inc, San Francisco, CA 94080 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cleveland Clinic Foundation; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ophthalmic Consultants of Boston; Roche Holding; Genentech	Brown, DM (corresponding author), Methodist Hosp, Vitreoretinal Consultants, 6560 Fannin St,Suite 750, Houston, TX 77030 USA.	dmbmd@houstonretina.com	Zhang, Kang/Y-2740-2019; Wolf, Sebastian/B-8782-2008	Zhang, Kang/0000-0002-4549-1697; Kaiser, Peter/0000-0001-5126-045X; Wolf, Sebastian/0000-0002-7467-7028				Ali F, 2004, ARCH OPHTHALMOL-CHIC, V122, P710, DOI 10.1001/archopht.122.5.710; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2004, AV; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Augood C, 2004, OPHTHAL EPIDEMIOL, V11, P117, DOI 10.1076/opep.11.2.117.28160; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2005, RETINA-J RET VIT DIS, V25, P119; Bressler NM, 2000, ARCH OPHTHALMOL-CHIC, V118, P488; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; HEIER JS, IN PRESS ARCH OPHTHA; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; *NOV PHARM, 2005, VIS; Pauleikhoff D, 2005, RETINA-J RET VIT DIS, V25, P1065, DOI 10.1097/00006982-200512000-00016; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1242	22	2637	2787	4	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1432	1444		10.1056/NEJMoa062655	http://dx.doi.org/10.1056/NEJMoa062655			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021319				2022-12-28	WOS:000240976200005
J	Mustelin, T				Mustelin, Tomas			Restless T cells sniff and go	SCIENCE			English	Editorial Material							CTLA-4; ASSOCIATION; MOLECULE; KINASES; CD28		Burnham Inst, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst, Program Signal Transduct, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Mustelin, T (corresponding author), Burnham Inst, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	tmustelin@burnham.org		Mustelin, Tomas/0000-0001-5912-8840				Alegre ML, 2006, CURR PHARM DESIGN, V12, P149, DOI 10.2174/138161206775193046; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Dillon TJ, 2005, MOL CELL BIOL, V25, P4117, DOI 10.1128/MCB.25.10.4117-4128.2005; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Martin M, 2001, J EXP MED, V194, P1675, DOI 10.1084/jem.194.11.1675; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	17	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1902	1903		10.1126/science.1133578	http://dx.doi.org/10.1126/science.1133578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008518				2022-12-28	WOS:000240832200036
J	Dewan, A; Liu, MG; Hartman, S; Zhang, SSM; Liu, DTL; Zhao, C; Tam, POS; Chan, WM; Lam, DSC; Snyder, M; Barnstable, C; Pang, CP; Hoh, J				DeWan, Andrew; Liu, Mugen; Hartman, Stephen; Zhang, Samuel Shao-Min; Liu, David T. L.; Zhao, Connie; Tam, Pancy O. S.; Chan, Wai Man; Lam, Dennis S. C.; Snyder, Michael; Barnstable, Colin; Pang, Chi Pui; Hoh, Josephine			HTRA1 promoter polymorphism in wet age-related macular degeneration	SCIENCE			English	Article							COMPLEMENT FACTOR-H; RISK; SUSCEPTIBILITY; GENE; ASSOCIATION; JAPANESE; CHINESE; DISEASE; VARIANT; CFH	Age-related macular degeneration (AMD), the most common cause of irreversible vision loss in individuals aged older than 50 years, is classified as either wet (neovascular) or dry (nonneovascular). Inherited variation in the complement factor H gene is a major risk factor for drusen in dry AMD. Here we report that a single-nucleotide polymorphism in the promoter region of HTRA1, a serine protease gene on chromosome 10q26, is a major genetic risk factor for wet AMD. A whole-genome association mapping strategy was applied to a Chinese population, yielding a P value of < 10(-11). Individuals with the risk-associated genotype were estimated to have a likelihood of developing wet AMD 10 times that of individuals with the wild-type genotype.	Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; Rockefeller Univ, Genom Resource Ctr, New York, NY 10021 USA	Yale University; Yale University; Yale University; Chinese University of Hong Kong; Rockefeller University	Hoh, J (corresponding author), Yale Univ, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	Barnstable, Colin/ABB-4822-2021; Pang, Chi P/I-5388-2014; Barnstable, Colin/GLU-9219-2022; Lam, Dennis/AAL-1211-2020	DeWan, Andrew/0000-0002-7679-8704; Snyder, Michael/0000-0003-0784-7987; Barnstable, Colin/0000-0002-7011-4068				Baum L, 2003, OPHTHALMOLOGICA, V217, P111, DOI 10.1159/000068553; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; Chang TS, 1999, CAN J OPHTHALMOL, V34, P266; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Grassi MA, 2006, HUM MUTAT, V27, P921, DOI 10.1002/humu.20359; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Okamoto H, 2006, MOL VIS, V12, P156; Pang CP, 2000, OPHTHALMOLOGICA, V214, P289, DOI 10.1159/000027506; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sandberg MA, 1998, OPHTHALMOLOGY, V105, P441, DOI 10.1016/S0161-6420(98)93025-1; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YUZAWA M, 1991, JPN J OPHTHALMOL, V35, P87	24	668	729	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					989	992		10.1126/science.1133807	http://dx.doi.org/10.1126/science.1133807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17053108				2022-12-28	WOS:000241896000052
J	Buszewicz, M; Rait, G; Griffin, M; Nazareth, I; Patel, A; Atkinson, A; Barlow, J; Haines, A				Buszewicz, Marta; Rait, Greta; Griffin, Mark; Nazareth, Irwin; Patel, Anita; Atkinson, Angela; Barlow, Julie; Haines, Andy			Self management of arthritis in primary care: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLDER-ADULTS; RELIABILITY; VALIDITY; OUTCOMES; PEOPLE; SF-36	Objective To evaluate clinical effectivcness of a self management programme for arthritis in patients in primary care with osteoarthritis. Design Randomised controlled trial. Setting 74 general practices in the United Kingdom. Participants 812 patients aged 50 and over with osteoarthritis of hips or knees (or both) and pain or disability (or both). Intervention Participants were randomised to six sessions of self management of arthritis and an education booklet (intervention group) or the education booklet alone (control group). Main outcome measures Primary outcome was quality of life, as assessed by the short form health survey (SF-36). Several other physical mid psychosocial secondary outcomes were assessed. Data were collected at baseline, four months, and 12 months. Results Response rates were 80% and 76% at four and 12 months. The two groups showed significant differences at 12 months on die anxiety subscore of the hospital anxiety and depression scale (mean difference - 0.62, 95% confidence interval - 1.08 to. - 0.16). arthritis self efficacy scale for pain (0.98, 0.07 to 1.89), and self efficacy, for other aspects of management (1.58, 0.25 to 2.90). Results were similar for intention to treat and per protocol analyses. No significant difference was seen in number of visits to the general practitioner at 12 months. Conclusions The self management of arthritis programme reduced anxiety and improved participants' perceived self efficacy to manage symptoms, but it had no significant effect on pain, physical functioning, or contact with primary care.	UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London N19 5LW, England; Kings Coll London, Inst Psychiat, Ctr Econ & Mental Hlth, London SE5 8AT, England; Royal Victoria Infirm, Clin Res Facil, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Coventry Univ, Interdisciplinary Res Ctr Hlth, Coventry CV1 5FB, W Midlands, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; University College London; UCL Medical School; University of London; King's College London; Newcastle University - UK; Coventry University; University of London; London School of Hygiene & Tropical Medicine	Buszewicz, M (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London N19 5LW, England.	m.buszewicz@pcps.ucl.ac.uk	Patel, Anita/F-9832-2010; Rait, Greta/C-5577-2009; Griffin, Mark/C-1827-2008	Patel, Anita/0000-0003-0769-1732; Rait, Greta/0000-0002-7216-7294; Nazareth, Irwin/0000-0003-2146-9628; Haines, Andy/0000-0002-8053-4605	Medical Research Council [MC_U122797165] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ARC, FACTF ARTHR GLANC; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P1315; Barlow JH, 1997, BRIT J HEALTH PSYCH, V2, P175, DOI 10.1111/j.2044-8287.1997.tb00533.x; Barlow JH, 1997, PSYCHOL HEALTH MED, V2, P221, DOI DOI 10.1080/13548509708400580; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; DONALDSON L, 2005, COMMUNICATION   0216; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Khaltaev N, 2003, ARTHRITIS RES THE S3, V5, P174; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Little R.J.A., 2002, STAT ANAL MISSING DA; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; LORIG K, 2000, ARTHRITIS HELPBOOK T; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SOLOMON D, 2000, J RHEUMATOL, V29, P362; Sun Y, 1997, CLIN RHEUMATOL, V16, P185, DOI 10.1007/BF02247849; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	136	138	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2006	333	7574					879	882A		10.1136/bmj.38965.375718.80	http://dx.doi.org/10.1136/bmj.38965.375718.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	101WT	17040926	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000241772600013
J	Jefferson, T				Jefferson, Tom			Public health - Influenza vaccination: policy versus evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY; CHILDREN; ILLNESS		Anguillara Sabazia, Cochrane Vaccines Field, I-00061 Rome, Italy		Jefferson, T (corresponding author), Anguillara Sabazia, Cochrane Vaccines Field, I-00061 Rome, Italy.	jefferson.tom@gmail.com						Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P230; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; BHALLA P, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001753; Bueving HJ, 2005, REV MED VIROL, V15, P383, DOI 10.1002/rmv.477; Carman WF, 2000, BRIT MED J, V321, P736, DOI 10.1136/bmj.321.7263.736; CATES CJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000364.PUB2; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; DEMICHELI V, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001269.PUB2.ART; Hak E, 2002, J EPIDEMIOL COMMUN H, V56, P951, DOI 10.1136/jech.56.12.951; Harling R, 2004, BRIT MED J, V329, P663, DOI 10.1136/bmj.38204.674595.AE; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Orr P, 2004, Can Commun Dis Rep, V30, P1; Poole PJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002733.pub2; Rennels MB, 2004, PEDIATRICS, V113, P1441, DOI 10.1542/peds.113.5.1441; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Simonsen L, 2005, LANCET, V366, P2086, DOI 10.1016/S0140-6736(05)67884-1; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Smith S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub2; Thomas RE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub2; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0	23	88	90	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2006	333	7574					912	915		10.1136/bmj.38995.531701.80	http://dx.doi.org/10.1136/bmj.38995.531701.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	101WT	17068038	Green Published			2022-12-28	WOS:000241772600022
J	Hyde, JS; Linn, MC				Shibley Hyde, Janet; Linn, Marcia C.			Diversity - Gender similarities in mathematics and science	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; ACHIEVEMENT; AGGRESSION; BELIEFS		Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Hyde, JS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jshyde@wisc.edu						[Anonymous], NATIONS REPORT CARD; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bergmann B., 1996, DEFENSE AFFIRMATIVE; CERAULO S, 1999, J CHEM EDUC, V76, P615; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; EAGLY AH, 1995, PSYCHOL BULL, V117, P125, DOI 10.1037/0033-2909.117.1.125; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; EATON WO, 1986, PSYCHOL BULL, V100, P19, DOI 10.1037/0033-2909.100.1.19; Gurian M., 2003, BOYS GIRLS LEARN DIF; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; HYDE JS, 1984, DEV PSYCHOL, V20, P722, DOI 10.1037/0012-1649.20.4.722; Hyde JS, 1986, PSYCHOL GENDER ADV M; LINN MC, 1998, ED RES, V27, P15; LUMMIS M, 1990, DEV PSYCHOL, V26, P254, DOI 10.1037/0012-1649.26.2.254; National Science Foundation, 2004, WOM MIN PERS DIS SCI; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Seymour E., 1997, TALKING LEAVING WHY; STEVENSON HW, 1993, SCIENCE, V259, P53, DOI 10.1126/science.8418494; Streitmatter J. L., 1999, GIRLS ONLY MAKING CA; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690; Walters AE, 1998, ORGAN BEHAV HUM DEC, V76, P1, DOI 10.1006/obhd.1998.2797; Warrington M, 2001, OXFORD REV EDUC, V27, P339, DOI 10.1080/03054980120067393; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594	27	141	143	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					599	600		10.1126/science.1132154	http://dx.doi.org/10.1126/science.1132154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098XT	17068246				2022-12-28	WOS:000241557800028
J	Rawls, JF; Mahowald, MA; Ley, RE; Gordon, JI				Rawls, John F.; Mahowald, Michael A.; Ley, Ruth E.; Gordon, Jeffrey I.			Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection	CELL			English	Article							HUMAN INTESTINE; DIVERSITY; COMMUNITY; POPULATIONS; ECOLOGY; SOILS; FLORA	The gut microbiotas of zebrafish and mice share six bacterial divisions, although the specific bacteria within these divisions differ. To test how factors specific to host gut habitat shape microbial community structure, we performed reciprocal transplantations of these microbiotas into germ-free zebrafish and mouse recipients. The results reveal that communities are assembled in predictable ways. The transplanted community resembles its community of origin in terms of the lineages present, but the relative abundance of the lineages changes to resemble the normal gut microbial community composition of the recipient host. Thus, differences in community structure between zebrafish and mice arise in part from distinct selective pressures imposed within the gut habitat of each host. Nonetheless, vertebrate responses to microbial colonization of the gut are ancient: Functional genomic studies disclosed shared host responses to their compositionally distinct microbial communities and distinct microbial species that elicit conserved responses.	Washington Univ, Sch Med, Ctr Gen Sci, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.	jgordon@wustl.edu	Rawls, John F/C-9169-2009; Ley, Ruth E/M-8542-2014	Rawls, John F/0000-0002-5976-5206; Ley, Ruth E/0000-0002-9087-1672	NIDDK NIH HHS [DK073695, DK30292, K01 DK073695-01, F32 DK062675-03, R01 DK030292, DK62675, F32 DK062675-02, R37 DK030292, K01 DK073695, F32 DK062675] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, K01DK073695, R37DK030292, F32DK062675] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Axelrood PE, 2002, CAN J MICROBIOL, V48, P655, DOI [10.1139/w02-059, 10.1139/W02-059]; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bala A, 2003, MOL ECOL, V12, P917, DOI 10.1046/j.1365-294X.2003.01754.x; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Colwell RK, 2013, ESTIMATES STAT ESTIM; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, METHOD MICROBIOL, V31, P559, DOI 10.1016/S0580-9517(02)31030-4; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Swofford D.L., 2003, PAUP VERSION 40 B10; WOSTMANN BS, 1981, ANNU REV NUTR, V1, P257, DOI 10.1146/annurev.nu.01.070181.001353; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	33	645	677	5	142	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					423	433		10.1016/j.cell.2006.08.043	http://dx.doi.org/10.1016/j.cell.2006.08.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055441	Green Accepted, Bronze			2022-12-28	WOS:000241827100027
J	St-Pierre, J; Drori, S; Uldry, M; Silvaggi, JM; Rhee, J; Jager, S; Handschin, C; Zheng, KN; Lin, JD; Yang, WL; Simon, DK; Bachoo, R; Spiegelman, BM				St-Pierre, Julie; Drori, Stavit; Uldry, Marc; Silvaggi, Jessica M.; Rhee, James; Jager, Sibylle; Handschin, Christoph; Zheng, Kangni; Lin, Jiandie; Yang, Wenli; Simon, David K.; Bachoo, Robert; Spiegelman, Bruce M.			Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators	CELL			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; HEPATIC GLUCONEOGENESIS; ENDOTHELIAL-CELLS; REDOX REGULATION; PGC-1-ALPHA; MUSCLE; MPTP; DISRUPTION; EXPRESSION; INDUCTION	PPAR gamma coactivator 1 alpha (PGC-1 alpha) is a potent stimulator of mitochondrial biogenesis and respiration. Since the mitochondrial electron transport chain is the main producer of reactive oxygen species (ROS) in most cells, we examined the effect of PGC-1 alpha on the metabolism of ROS. PGC-1 alpha is coinduced with several key ROS-detoxifying enzymes upon treatment of cells with an oxidative stressor; studies with RNAi or null cells indicate that PGC-1 alpha is required for the induction of many ROS-detoxifying enzymes, including GPx1 and SOD2. PGC-1 alpha null mice are much more sensitive to the neurodegenerative effects of MPTP and kainic acid, oxidative stressors affecting the substantia. nigra and hippocampus, respectively. Increasing PGC-1 alpha levels dramatically protects neural cells in culture from oxidative-stressor-mediated death. These studies reveal that PGC-1 alpha is a broad and powerful regulator of ROS metabolism, providing a potential target for the therapeutic manipulation of these important endogenous toxins.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Spiegelman, BM (corresponding author), Univ Montreal, Inst Rech Immunol & Canc, Pavill Marcelle Coutu,2950 Chem Polytech, Montreal, PQ H3T 1J4, Canada.	bruce_spiegelman@dfci.harvard.edu	St-Pierre, Julie/AGB-3651-2022; Handschin, Christoph/E-6886-2015; Rhee, James/V-9973-2019	St-Pierre, Julie/0000-0002-2815-7099; Handschin, Christoph/0000-0003-0603-1097; Jager, Sibylle/0000-0001-8102-7149	NIDDK NIH HHS [P30 DK040561, P30 DK040561-11, DK54477] Funding Source: Medline; NINDS NIH HHS [K02 NS4311] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054477, R01DK054477, P30DK040561] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brown GC, 2001, IUBMB LIFE, V52, P189, DOI 10.1080/15216540152845993; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7; SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	42	1686	1731	5	145	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					397	408		10.1016/j.cell.2006.09.024	http://dx.doi.org/10.1016/j.cell.2006.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055439	Bronze			2022-12-28	WOS:000241827100025
J	Peterman, TA; Tian, LH; Metcalf, CA; Satterwhite, CL; Malotte, CK; DeAugustine, N; Paul, SM; Cross, H; Rietmeijer, CA; Douglas, JM				Peterman, Thomas A.; Tian, Lin H.; Metcalf, Carol A.; Satterwhite, Catherine L.; Malotte, C. Kevin; DeAugustine, Nettie; Paul, Sindy M.; Cross, Helene; Rietmeijer, Cornelis A.; Douglas, John M., Jr.		RESPECT 2 Study Grp	High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: A case for rescreening	ANNALS OF INTERNAL MEDICINE			English	Article							CHLAMYDIA-TRACHOMATIS; LONGITUDINAL DATA; GONORRHEA; PREVENTION; RECURRENT; DISEASE; WOMEN; DETERMINANTS; REINFECTION; PERSISTENT	Background: Studies show 11% to 15% of women treated for Chlamydia trachomatis are reinfected 3 to 4 months after treatment, suggesting the need for rescreening. There is little information on infections among men, infections with Neisseria gonorrhoeae or Trichomonas vaginalis, or long-term follow-up. Objective: To determine the incidence of new sexually transmitted infections during the year after a visit to a sexually transmitted disease (STD) clinic and associated risk factors. Design: Secondary analysis of data from a randomized, controlled trial (RESPECT-2). Setting: 3 urban STD clinics. Patients: Sexually active patients enrolled in an HIV prevention counseling trial. Measurements: Patient characteristics at the initial visit; behaviors during follow-up; and new infections with C. trachomatis, N. gonorrhoeae, or T. vaginalis (women only) detected during 4 scheduled return visits and any other interim visits. Results: 2419 persons had 8129 three-month follow-up intervals. Among 1236 women, 25.8% had 1 or more new infections (11.9% acquired C. trachomatis, 6.3% acquired N. gonorrhoeae, and 12.8% acquired T. vaginalis); among 1183 men, 14.7% had 1 or more new infections (9.4% acquired C trachomatis, and 7.1% acquired N. gonorrhoeae). Black persons and those with sexually transmitted infections at baseline were at highest risk for recurrent infection (adjusted odds ratio, 2.5 and 2.4, respectively). For persons infected at baseline, the risk for infection was high at 3 and 6 months (16.3 per 100 three-month intervals) and remained high at 9 and 12 months (12.0 per 100 three-month intervals). Most (67.2%) infections were diagnosed during study-related visits, and 66.2% of these patients reported no symptoms. Limitations: Because patients were recruited from STD clinics, results may not be generalizable. Conclusions: Men and women who receive diagnoses of C trachomatis, N. gonorrhoeae, or T vaginalis infections should return in 3 months for rescreening because they are at high risk for new asymptomatic sexually transmitted infections. Although single-dose therapy may adequately treat the infection, it often does not adequately treat the patient.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Human Sci Res Council, Pretoria, South Africa; Calif State Univ Long Beach, Long Beach, CA 90840 USA; Long Beach Dept Hlth & Human Serv, Long Beach, CA USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; Denver Publ Hlth Dept, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA	Centers for Disease Control & Prevention - USA; Human Sciences Research Council-South Africa; California State University System; California State University Long Beach; New Jersey Department of Health & Senior Services; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Peterman, TA (corresponding author), Ctr Dis Control & Prevent, Mailstop E-02,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	cpeterman@cdc.gov						ABBOTT LCX, 1996, CHLAMYDIA TRACHOMATI; ABBOTT LCX, 1996, NEISSERIA GONORRHOES; AMPLICOR CT, 2003, NEISSERIA GONORRHOEA; AMPLICOR CT, 2003, CHLAMYDIA TRACHOMATI; *BD PROBETEC ET, 2005, CHLAM TRACH NEISS GO; Bloomfield PJ, 2002, SEX TRANSM DIS, V29, P294, DOI 10.1097/00007435-200205000-00008; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; Gunn RA, 2000, SEX TRANSM DIS, V27, P343, DOI 10.1097/00007435-200007000-00008; Hillis SD, 1998, SEX TRANSM DIS, V25, P5, DOI 10.1097/00007435-199801000-00002; Hu D, 2004, ANN INTERN MED, V141, P501, DOI 10.7326/0003-4819-141-7-200410050-00006; KAMB ML, 2000, JOINT M AM SEX TRANS; Kissinger P, 1998, SEX TRANSM INFECT, V74, P331, DOI 10.1136/sti.74.5.331; Levi MW, 1997, J CLIN MICROBIOL, V35, P3308, DOI 10.1128/JCM.35.12.3308-3310.1997; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Malotte CK, 2004, SEX TRANSM DIS, V31, P637, DOI 10.1097/01.olq.0000143083.38684.9d; Martin DH, 2004, J CLIN MICROBIOL, V42, P4749, DOI 10.1128/JCM.42.10.4749-4758.2004; Mehta SD, 2003, SEX TRANSM INFECT, V79, P124, DOI 10.1136/sti.79.2.124; Metcalf CA, 2005, SEX TRANSM DIS, V32, P130, DOI 10.1097/01.olq.0000151421.97004.c0; PEPE MS, 1994, COMMUN STAT SIMULAT, V23, P939, DOI 10.1080/03610919408813210; POTTERAT JJ, 2002, MMWR RECOMM REP, V51, P1; Richey CM, 1999, SEX TRANSM DIS, V26, P4, DOI 10.1097/00007435-199901000-00002; Rietmeijer CA, 2002, SEX TRANSM DIS, V29, P65, DOI 10.1097/00007435-200202000-00001; Schiller JH, 2003, SEMIN ONCOL, V30, P49, DOI [10.1053/sonc.2003.50032, 10.1097/00007435-200301000-00011]; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Sparks R, 2004, SEX TRANSM DIS, V31, P113, DOI 10.1097/01.OLQ.0000109512.95959.ED; Stokes ME, 2000, CATEGORICAL DATA ANA; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; 1989, MMWR MORB MORTAL S8, V38, P1; 1985, MMWR MORB MORTAL WKL, V4, pS75	34	120	129	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					564	572		10.7326/0003-4819-145-8-200610170-00005	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095NX	17043338				2022-12-28	WOS:000241315700002
J	Puthenveedu, MA; von Zastrow, M				Puthenveedu, Manojkumar A.; von Zastrow, Mark			Cargo regulates clathrin-coated pit dynamics	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; MEDIATED ENDOCYTOSIS; RECRUITMENT; ACTIN; INTERNALIZATION; BINDING; ADAPTER; DOMAIN; DESENSITIZATION; INVAGINATION	Clathrin-coated pits (CCPs) are generally considered a uniform population of endocytic machines containing mixed constitutive and regulated membrane cargo. Contrary to this view, we show that regulated endocytosis of G protein-coupled receptors (GPCRs) occurs preferentially through a subset of CCPs. Significantly, GPCR-containing CCPs are also functionally distinct, as their surface residence time is regulated locally by GPCR cargo via PDZ-dependent linkage to the actin cytoskeleton. Such cargo-regulated CCPs show delayed recruitment of dynamin and can undergo an abortive event in which clathrin coats separate from the plasma membrane without concomitant receptor endocytosis. Segregation of cargo into CCP subsets, combined with cargo-dependent control of CCP dynamics, suggests a simple kinetic mechanism to generate functional specialization early in the endocytic pathway and reduce competition between diverse endocytic cargo.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Puthenveedu, MA (corresponding author), Univ Calif San Francisco, Dept Psychiat, 600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231				Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; WARREN RA, 2006, J BIOL CHEM, V103, P1295; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	195	198	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					113	124		10.1016/j.cell.2006.08.035	http://dx.doi.org/10.1016/j.cell.2006.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018281	Bronze			2022-12-28	WOS:000241445800018
J	Tabin, CJ				Tabin, Clifford J.			The key to left-right asymmetry	CELL			English	Editorial Material							LEFT-RIGHT AXIS; MOUSE EMBRYO; NODAL FLOW; SPECIFICATION; GENERATION; INHIBITION; PROTEINS	Establishment of left-right asymmetry in vertebrates involves cilia as essential components in the breaking of symmetry, an asymmetric signaling cascade, and a midline barrier that helps to maintain asymmetry. A new study suggests that a reaction-diffusion mechanism also plays a key role.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu						Brueckner M, 2001, AM J MED GENET, V101, P339, DOI 10.1002/1096-8628(20010715)101:4<339::AID-AJMG1442>3.0.CO;2-P; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Danos MC, 1996, DEV BIOL, V177, P96, DOI 10.1006/dbio.1996.0148; DUBOC V, 2006, IN PRESS J EXP ZOO B; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1996, NATURE, V384, P321, DOI 10.1038/384321a0; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Qiu DY, 2005, DEV DYNAM, V234, P176, DOI 10.1002/dvdy.20509; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tabin C, 2005, J MOL HISTOL, V36, P317, DOI 10.1007/s10735-005-9000-y; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	21	78	82	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					27	32		10.1016/j.cell.2006.09.018	http://dx.doi.org/10.1016/j.cell.2006.09.018			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018270	Bronze			2022-12-28	WOS:000241445800007
J	Galon, J; Costes, A; Sanchez-Cabo, F; Kirilovsky, A; Mlecnik, B; Lagorce-Pages, C; Tosolini, M; Camus, M; Berger, A; Wind, P; Zinzindohoue, F; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Pages, F				Galon, Jerom; Costes, Anne; Sanchez-Cabo, Fatima; Kirilovsky, Amos; Mlecnik, Bernhard; Lagorce-Pages, Christine; Tosolini, Marie; Camus, Matthieu; Berger, Anne; Wind, Philippe; Zinzindohoue, Franck; Bruneval, Patrick; Cugnenc, Paul-Henri; Trajanoski, Zlatko; Fridman, Wolf-Herman; Pages, Franck			Type, density, and location of immune cells within human colorectal tumors predict clinical outcome	SCIENCE			English	Article							INFILTRATING LYMPHOCYTES; T-CELLS; PROGNOSTIC-FACTOR; OPTIMAL CUTPOINT; OVARIAN-CANCER; INFLAMMATION; SURVIVAL; ANTIGEN; MEMORY; PROGRESSION	The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data ( the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.	INSERM, U255, F-75006 Paris, France; Univ Paris 05, Fac Med, F-75006 Paris, France; Univ Paris 06, Inst Cordeliers, F-75006 Paris, France; Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; Avicenne Hosp, Dept Digest Surg, F-93017 Bobigny, France; Georges Pompidou European Hosp, AP HP, Dept Gen & Digest Surg, F-75015 Paris, France; Georges Pompidou European Hosp, AP HP, Dept Pathol, F-75015 Paris, France; Georges Pompidou European Hosp, AP HP, Dept Immunol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Graz University of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Galon, J (corresponding author), INSERM, U255, F-75006 Paris, France.	jerome.galon@u255.bhdc.jussieu.fr	Galon, Jerome/G-9838-2019; Sanchez-Cabo, Fatima/AAC-5563-2020; Tosolini, Marie/A-6653-2009; mlecnik, bernhard/AAT-7467-2021; COLENO-COSTES, Anne/K-3176-2015; Sanchez-Cabo, Fatima/N-5030-2014; Tosolini, Marie/AAL-5941-2020; Trajanoski, Zlatko/AAT-6703-2021; costes, anne/A-1564-2010	Galon, Jerome/0000-0001-9635-1339; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Tosolini, Marie/0000-0001-5278-5952; COLENO-COSTES, Anne/0000-0002-1775-682X; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Tosolini, Marie/0000-0001-5278-5952; fridman, wolf herman/0000-0002-1332-0973				ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Baier PK, 1998, TUMOR BIOL, V19, P205, DOI 10.1159/000030008; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Faraggi D, 1996, STAT MED, V15, P2203, DOI 10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.3.CO;2-7; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hollander N, 2004, STAT MED, V23, P1701, DOI 10.1002/sim.1611; Naito Y, 1998, CANCER RES, V58, P3491; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2005, BLOOD, V105, P1632, DOI 10.1182/blood-2004-08-3196; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pardoll D, 2001, NATURE, V411, P1010, DOI 10.1038/35082676; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sobin, 2009, UICC TNM CLASSIFICAT; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Xiang R, 1999, J IMMUNOL, V163, P3676; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhou G, 2004, J EXP MED, V200, P1581, DOI 10.1084/jem.20041240	30	4352	4526	20	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1960	1964		10.1126/science.1129139	http://dx.doi.org/10.1126/science.1129139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008531				2022-12-28	WOS:000240832200051
J	van Heekhuizen, HJ; Unkels, R; Mmuni, NS; Kaiser, M				van Heekhuizen, Heleen J.; Unkels, Regine; Mmuni, Nicholaus S.; Kaiser, Miriam			Complications of obstructed labour: pressure necrosis of neonatal scalp and vesicovaginal fistula	LANCET			English	Editorial Material									Sokoine Reg Hosp, Lindi, Tanzania; Mnero Diocesan Hosp, Nachingwea, Tanzania		van Heekhuizen, HJ (corresponding author), Sokoine Reg Hosp, POB 1011, Lindi, Tanzania.	lindi@airpost.net	Unkels, Regine/AAC-5682-2022	Unkels, Regine/0000-0001-6348-1620				Donnay F, 2004, LANCET, V363, P71, DOI 10.1016/S0140-6736(03)15177-X; HUDSON CN, 2001, MATERNITY CARE DEV C, P201; Waaldijk K, 2004, AM J OBSTET GYNECOL, V191, P795, DOI 10.1016/j.ajog.2004.02.020; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; World Health Organization, 2005, WORLD HLTH REP 2005	5	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1210	1210		10.1016/S0140-6736(06)69477-4	http://dx.doi.org/10.1016/S0140-6736(06)69477-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011948				2022-12-28	WOS:000240916000033
J	Valiullin, R; Naumov, S; Galvosas, P; Karger, J; Woo, HJ; Porcheron, F; Monson, PA				Valiullin, Rustem; Naumov, Sergej; Galvosas, Petrik; Kaerger, Joerg; Woo, Hyung-June; Porcheron, Fabien; Monson, Peter A.			Exploration of molecular dynamics during transient sorption of fluids in mesoporous materials	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; DEPENDENT SELF-DIFFUSION; SMALL-ANGLE SCATTERING; FIELD ISING SYSTEMS; CAPILLARY CONDENSATION; ADSORPTION-DESORPTION; POROUS-GLASS; MICROSTRUCTURE; RECONSTRUCTION; HYSTERESIS	In recent years, considerable progress has been made in the development of novel porous materials with controlled architectures and pore sizes in the mesoporous range(1-4). An important feature of these materials is the phenomenon of adsorption hysteresis: for certain ranges of applied pressure, the amount of a molecular species adsorbed by the mesoporous host is higher on desorption than on adsorption, indicating a failure of the system to equilibrate. Although this phenomenon has been known for over a century, the underlying internal dynamics responsible for the hysteresis remain poorly understood(5-9). Here we present a combined experimental and theoretical study in which microscopic and macroscopic aspects of the relaxation dynamics associated with hysteresis are quantified by direct measurement and computer simulations of molecular models. Using nuclear magnetic resonance techniques(10-14) and Vycor porous glass(15,16) as a model mesoporous system, we have explored the relationship between molecular self-diffusion and global uptake dynamics. For states outside the hysteresis region, the relaxation process is found to be essentially diffusive in character; within the hysteresis region, the dynamics slow down dramatically and, at long times, are dominated by activated rearrangement of the adsorbate density within the host material.	Univ Leipzig, Fak Phys & Geowissensch, Abt Granzflachenphys, D-04103 Leipzig, Germany; Univ Nevada, Dept Chem, Reno, NV 89557 USA; Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA	Leipzig University; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Massachusetts System; University of Massachusetts Amherst	Valiullin, R (corresponding author), Univ Leipzig, Fak Phys & Geowissensch, Abt Granzflachenphys, D-04103 Leipzig, Germany.	valiullin@uni-leipzig.de	Valiullin, Rustem/F-6432-2011; Monson, Peter A/G-5662-2017	Valiullin, Rustem/0000-0001-5028-7642; Monson, Peter A/0000-0002-7458-3443; Karger, Jorg/0000-0002-4046-7698; Galvosas, Petrik/0000-0001-8660-4005				Barton TJ, 1999, CHEM MATER, V11, P2633, DOI 10.1021/cm9805929; Beyea SD, 2003, J APPL PHYS, V94, P935, DOI 10.1063/1.1581348; Bocquet L, 1998, NATURE, V396, P735, DOI 10.1038/25492; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Carslaw H.S., 1947, SFPE HDB FIRE PROTEC; DIERKER SB, 1987, PHYS REV LETT, V58, P1865, DOI 10.1103/PhysRevLett.58.1865; EVANS R, 1990, J PHYS-CONDENS MAT, V2, P8989, DOI 10.1088/0953-8984/2/46/001; FISHER DS, 1986, PHYS REV LETT, V56, P416, DOI 10.1103/PhysRevLett.56.416; Gelb LD, 1999, REP PROG PHYS, V62, P1573, DOI 10.1088/0034-4885/62/12/201; HUSE DA, 1987, PHYS REV B, V36, P5383, DOI 10.1103/PhysRevB.36.5383; Karger J., 1988, ADV MAGN RESON, V12, P2; Karger J., 1992, DIFFUSION ZEOLITES O; Kierlik E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055701; Kikkinides ES, 2000, J CHEM PHYS, V112, P9881, DOI 10.1063/1.481625; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lee JW, 2004, MICROPOR MESOPOR MAT, V73, P109, DOI 10.1016/j.micromeso.2004.04.020; Levitz P, 1998, ADV COLLOID INTERFAC, V76, P71, DOI 10.1016/S0001-8686(98)00042-6; LEVITZ P, 1991, J CHEM PHYS, V95, P6151, DOI 10.1063/1.461583; Newman M., 1999, MONTE CARLO METHODS; OGIELSKI AT, 1986, PHYS REV LETT, V56, P1298, DOI 10.1103/PhysRevLett.56.1298; Rajniak P, 1999, AICHE J, V45, P735, DOI 10.1002/aic.690450409; Schuath F., 2002, HDB POROUS SOLIDS; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; SING KSW, 1999, ADSORPTION POWDERS S; Smarsly B, 2003, LANGMUIR, V19, P7295, DOI 10.1021/la034798m; Valiullin R, 2005, MAGN RESON IMAGING, V23, P209, DOI 10.1016/j.mri.2004.11.013; Valiullin R, 2004, J CHEM PHYS, V120, P11804, DOI 10.1063/1.1753572; Wallacher D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.195704; Woo HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041207; Woo HJ, 2001, LANGMUIR, V17, P7472, DOI 10.1021/la015532n	30	203	203	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					965	968		10.1038/nature05183	http://dx.doi.org/10.1038/nature05183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066029				2022-12-28	WOS:000241523400048
J	Hambidge, SJ; Glanz, JM; France, EK; McClure, D; Xu, S; Yamasaki, K; Jackson, L; Mullooly, JP; Zangwill, KM; Marcy, SM; Black, SB; Lewis, EM; Shinefield, HR; Belongia, E; Nordin, J; Chen, RT; Shay, DK; Davis, RL; DeStefano, F				Hambidge, Simon J.; Glanz, Jason M.; France, Eric K.; McClure, David; Xu, Stanley; Yamasaki, Kristi; Jackson, Lisa; Mullooly, John P.; Zangwill, Kenneth M.; Marcy, S. Michael; Black, Steven B.; Lewis, Edwin M.; Shinefield, Henry R.; Belongia, Edward; Nordin, James; Chen, Robert T.; Shay, David K.; Davis, Robert L.; DeStefano, Frank		Vaccine Safety Datalink Team	Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISEASE; CLINICAL REACTIONS; CONTROLLED-TRIAL; ADVERSE EVENTS; YOUNG-CHILDREN; CASE SERIES; INFANTS; MEASLES; MUMPS; RISK	Context Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations. Objective To screen for medically attended events in the clinic, emergency department, or hospital after administration of trivalent inactivated influenza vaccine in children 6 to 23 months old. Design, Setting, and Participants Retrospective cohort using self-control analysis, with chart review of significant medically attended events at 8 managed care organizations in the United States that comprise the Vaccine Safety Datalink. Participants were all children in the Vaccine Safety Datalink cohort 6 to 23 months old who received trivalent inactivated influenza vaccine between January 1, 1991, and May 31, 2003 ( 45 356 children with 69 359 vaccinations). Main Outcome Measure Any medically attended event significantly associated with trivalent inactivated influenza vaccine in risk windows 0 to 3 days, 1 to 14 days ( primary analysis), 1 to 42 days, or 15 to 42 days after vaccination, compared with 2 control periods, one before vaccination and the second after the risk window. All individual ICD-9 codes as well as predefined aggregate codes were examined. Results Before chart review, only 1 diagnosis, gastritis/duodenitis, was more likely to occur in the 14 days after trivalent inactivated influenza vaccine ( matched odds ratio [ OR], 5.50; 95% confidence interval [CI], 1.22-24.81 for control period 1, and matched OR, 4.33; 95% CI, 1.23-15.21 for control period 2). Thirteen medically attended events were less likely to occur after trivalent inactivated influenza vaccine, including acute upper respiratory tract infection, asthma, bronchiolitis, and otitis media. After chart review, gastritis/duodenitis was not significantly associated with trivalent inactivated influenza vaccine ( matched OR, 4.00; 95% CI, 0.85-18.84 for control period 1; matched OR, 3.34; 95% CI, 0.92-12.11 for control period 2). Conclusions In the largest population-based study to date of the safety of trivalent inactivated influenza vaccine in young children, there were very few medically attended events, none of which were serious, significantly associated with the vaccine. This study provides additional evidence supporting the safety of universally immunizing all children 6 to 23 months old with influenza vaccine.	Kaiser Permanente Colorado, Clin Res Unit, Denver, CO 80237 USA; Denver Hlth, Community Hlth Serv, Denver, CO USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; Univ Colorado, Sch Med, Dept Prevent Med & Biostat, Denver, CO USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; NW Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; Univ Calif Los Angeles, Ctr Vaccine Res, Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA 90024 USA; So Calif Kaiser Permanente, Panorama City, CA USA; No Calif Kaiser Permanente, Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Marshfield Clin Res Fdn, Marshfield, WI USA; Hlth Partners Res Fdn, Minneapolis, MN USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Kaiser Permanente; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Group Health Cooperative; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Hambidge, SJ (corresponding author), Kaiser Permanente Colorado, Clin Res Unit, POB 378066, Denver, CO 80237 USA.	simon.hambidge@dhha.org	Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367; Hambidge, Simon/0000-0002-7535-0668; Nordin, James/0000-0002-3359-5843; Belongia, Edward/0000-0001-7478-0415; Shay, David/0000-0001-9619-4820	PHS HHS [200-2002-00732] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; Castro M, 2001, NEW ENGL J MED, V345, P1529, DOI 10.1056/NEJMoa011961; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Euler G. L., 2005, Morbidity and Mortality Weekly Report, V54, P304; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Fine PEM, 2004, BMJ-BRIT MED J, V329, P1297, DOI 10.1136/bmj.329.7478.1297; Finkelstein Jonathan A., 2001, Pediatrics, V108, P1, DOI 10.1542/peds.108.1.1; France EK, 2004, ARCH PEDIAT ADOL MED, V158, P1031, DOI 10.1001/archpedi.158.11.1031; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Goodman MJ, 2006, PEDIATRICS, V117, pE821, DOI 10.1542/peds.2005-2234; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; GROOTHUIS JR, 1991, PEDIATRICS, V87, P823; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kramarz P, 2001, J PEDIATR-US, V138, P306, DOI 10.1067/mpd.2001.112168; LIANG KY, 1987, BIOMETRICS, V43, P289, DOI 10.2307/2531813; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McMahon AW, 2005, PEDIATRICS, V115, P453, DOI 10.1542/peds.2004-1519; Mullooly JP, 2006, VACCINE, V24, P2256, DOI 10.1016/j.vaccine.2005.11.038; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Orr P, 2002, Can Commun Dis Rep, V28, P1; PELTOLA H, 1986, LANCET, V1, P939; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; PIEDRA PA, 1993, VACCINE, V11, P718, DOI 10.1016/0264-410X(93)90255-V; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rennels MB, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e80; Ropper AH, 1998, NEW ENGL J MED, V339, P1845, DOI 10.1056/NEJM199812173392509; Scheifele DW, 2003, CLIN INFECT DIS, V36, P850, DOI 10.1086/368189; Skowronski DM, 2006, PEDIATRICS, V117, P1963, DOI 10.1542/peds.2005-2607; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; Virtanen M, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e62; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; WRIGHT PF, 1976, J PEDIATR-US, V88, P31, DOI 10.1016/S0022-3476(76)80722-6; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	40	101	110	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1990	1997		10.1001/jama.296.16.1990	http://dx.doi.org/10.1001/jama.296.16.1990			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062862	Bronze			2022-12-28	WOS:000241495300021
J	Moore, J				Moore, Jason			Amniotic fluid embolism: on the trail of an elusive diagnosis	LANCET			English	Editorial Material							PLASMA		Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Moore, J (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA.	moorje@ccm.upmc.edu						Benson MD, 2001, OBSTET GYNECOL, V97, P510, DOI 10.1016/S0029-7844(00)01213-8; CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1158, DOI 10.1016/0002-9378(95)91474-9; Dib N, 1996, CATHETER CARDIO DIAG, V39, P177, DOI 10.1002/(SICI)1097-0304(199610)39:2<177::AID-CCD15>3.0.CO;2-E; Gilbert WM, 1999, OBSTET GYNECOL, V93, P973, DOI 10.1016/S0029-7844(99)00004-6; HANKINS GDV, 1993, AM J OBSTET GYNECOL, V168, P1113, DOI 10.1016/0002-9378(93)90355-M; KANAYAMA N, 1992, CLIN CHEM, V38, P526; KOEGLER A, 1994, INTENS CARE MED, V20, P45, DOI 10.1007/BF02425055; Kramer MS, 2006, LANCET, V368, P1444, DOI 10.1016/S0140-6736(06)69607-4; Moore Jason, 2005, Crit Care Med, V33, pS279, DOI 10.1097/01.CCM.0000183158.71311.28; Nishio H, 2002, FORENSIC SCI INT, V126, P53, DOI 10.1016/S0379-0738(02)00034-8; Oi H, 1998, SEMIN THROMB HEMOST, V24, P479, DOI 10.1055/s-2007-996043; Stanten RD, 2003, OBSTET GYNECOL, V102, P496, DOI 10.1016/S0029-7844(03)00161-3; Tuffnell DJ, 2003, CURR OPIN OBSTET GYN, V15, P119, DOI 10.1097/00001703-200304000-00006; Uszynski M, 2001, EUR J OBSTET GYN R B, V95, P163, DOI 10.1016/S0301-2115(00)00448-6; VANHAEFTEN TW, 1989, NETH J MED, V35, P317	15	5	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1399	1401		10.1016/S0140-6736(06)69581-0	http://dx.doi.org/10.1016/S0140-6736(06)69581-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055926				2022-12-28	WOS:000241459100007
J	James, TY; Kauff, F; Schoch, CL; Matheny, PB; Hofstetter, V; Cox, CJ; Celio, G; Gueidan, C; Fraker, E; Miadlikowska, J; Lumbsch, HT; Rauhut, A; Reeb, V; Arnold, AE; Amtoft, A; Stajich, JE; Hosaka, K; Sung, GH; Johnson, D; O'Rourke, B; Crockett, M; Binder, M; Curtis, JM; Slot, JC; Wang, Z; Wilson, AW; Schussler, A; Longcore, JE; O'Donnell, K; Mozley-Standridge, S; Porter, D; Letcher, PM; Powell, MJ; Taylor, JW; White, MM; Griffith, GW; Davies, DR; Humber, RA; Morton, JB; Sugiyama, J; Rossman, AY; Rogers, JD; Pfister, DH; Hewitt, D; Hansen, K; Hambleton, S; Shoemaker, RA; Kohlmeyer, J; Volkmann-Kohlmeyer, B; Spotts, RA; Serdani, M; Crous, PW; Hughes, KW; Matsuura, K; Langer, E; Langer, G; Untereiner, WA; Lucking, R; Budel, B; Geiser, DM; Aptroot, A; Diederich, P; Schmitt, I; Schultz, M; Yahr, R; Hibbett, DS; Lutzoni, F; McLaughlin, DJ; Spatafora, JW; Vilgalys, R				James, Timothy Y.; Kauff, Frank; Schoch, Conrad L.; Matheny, P. Brandon; Hofstetter, Valerie; Cox, Cymon J.; Celio, Gail; Gueidan, Cecile; Fraker, Emily; Miadlikowska, Jolanta; Lumbsch, H. Thorsten; Rauhut, Alexandra; Reeb, Valerie; Arnold, A. Elizabeth; Amtoft, Anja; Stajich, Jason E.; Hosaka, Kentaro; Sung, Gi-Ho; Johnson, Desiree; O'Rourke, Ben; Crockett, Michael; Binder, Manfred; Curtis, Judd M.; Slot, Jason C.; Wang, Zheng; Wilson, Andrew W.; Schuessler, Arthur; Longcore, Joyce E.; O'Donnell, Kerry; Mozley-Standridge, Sharon; Porter, David; Letcher, Peter M.; Powell, Martha J.; Taylor, John W.; White, Merlin M.; Griffith, Gareth W.; Davies, David R.; Humber, Richard A.; Morton, Joseph B.; Sugiyama, Junta; Rossman, Amy Y.; Rogers, Jack D.; Pfister, Don H.; Hewitt, David; Hansen, Karen; Hambleton, Sarah; Shoemaker, Robert A.; Kohlmeyer, Jan; Volkmann-Kohlmeyer, Brigitte; Spotts, Robert A.; Serdani, Maryna; Crous, Pedro W.; Hughes, Karen W.; Matsuura, Kenji; Langer, Ewald; Langer, Gitta; Untereiner, Wendy A.; Lucking, Robert; Buedel, Burkhard; Geiser, David M.; Aptroot, Andre; Diederich, Paul; Schmitt, Imke; Schultz, Matthias; Yahr, Rebecca; Hibbett, David S.; Lutzoni, Francois; McLaughlin, David J.; Spatafora, Joseph W.; Vilgalys, Rytas			Reconstructing the early evolution of Fungi using a six-gene phylogeny	NATURE			English	Article							MOLECULAR PHYLOGENY; TREE; GLOMEROMYCOTA; MICROSPORIDIA; SEQUENCES; RELATIVES; ANIMALS; TUBULIN; ROZELLA; UTILITY	The ancestors of fungi are believed to be simple aquatic forms with flagellated spores, similar to members of the extant phylum Chytridiomycota (chytrids). Current classifications assume that chytrids form an early-diverging clade within the kingdom Fungi and imply a single loss of the spore flagellum, leading to the diversification of terrestrial fungi. Here we develop phylogenetic hypotheses for Fungi using data from six gene regions and nearly 200 species. Our results indicate that there may have been at least four independent losses of the flagellum in the kingdom Fungi. These losses of swimming spores coincided with the evolution of new mechanisms of spore dispersal, such as aerial dispersal in mycelial groups and polar tube eversion in the microsporidia ( unicellular forms that lack mitochondria). The enigmatic microsporidia seem to be derived from an endoparasitic chytrid ancestor similar to Rozella allomycis, on the earliest diverging branch of the fungal phylogenetic tree.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Clark Univ, Dept Biol, Worcester, MA 01610 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Fachbereich Biol, Abt Pflanzenokol & Systemat, D-67653 Kaiserslautern, Germany; New York Bot Garden, Inst Systemat Bot, Bronx, NY 10458 USA; Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA; Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA; USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30605 USA; Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales; ARS, US Plant Soil & Nutr Lab, USDA, Plant Protect Res Unit, Ithaca, NY 14853 USA; W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; TechnoSuruga, Chiyoda Ku, Tokyo 1010052, Japan; ARS, Systemat Bot & Mycol Lab, USDA, Beltsville, MD 20705 USA; Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; Harvard Univ Hebaria, Cambridge, MA 02138 USA; Agr & Agri Food Canada, Biodivers Mycol & Bot, Ottawa, ON K1A 0C6, Canada; Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Oregon State Univ, Mid Columbia Agr Res & Extens Ctr, Hood River, OR 97031 USA; Cent Bur Schimmelcultures, Fungal Biodivers Ctr, NL-3508 AD Utrecht, Netherlands; Univ Tennessee, Dept Bot, Knoxville, TN 37996 USA; Okayama Univ, Fac Agr, Okayama 7008530, Japan; Univ Kassel, Inst Biol, D-34132 Kassel, Germany; Brandon Univ, Dept Bot, Brandon, MB R7A 6A9, Canada; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; Adviesbur Bryol Lichenol, NL-3762 XK Soest, Netherlands; Museum Natl Hist Nat, L-2160 Luxembourg, Luxembourg; Univ Hamburg, Biozentrum Klein Flottbek & Bot Garten, D-22609 Hamburg, Germany	Duke University; Oregon State University; Clark University; University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago); New York Botanical Garden; Duke University; Technical University of Darmstadt; University of Maine System; University of Maine Orono; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Berkeley; University of Kansas; Aberystwyth University; Aberystwyth University; United States Department of Agriculture (USDA); West Virginia University; United States Department of Agriculture (USDA); Washington State University; Harvard University; Agriculture & Agri Food Canada; University of North Carolina; University of North Carolina Chapel Hill; Oregon State University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Tennessee System; University of Tennessee Knoxville; Okayama University; Universitat Kassel; Brandon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hamburg	James, TY (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	tyj2@duke.edu; fungi@duke.edu	Geiser, David/J-9950-2013; Cox, Cymon/D-1303-2012; Schüßler, Arthur/F-1681-2011; Crous, Pedro W/H-1489-2012; Gueidan, Cecile/C-8803-2014; Matsuura, Kenji/H-8364-2019; Griffith, Gareth W./A-1970-2009; Lumbsch, Thorsten/K-3573-2012; Binder, Manfred/C-8571-2013; Wang, Zheng/A-2318-2011; Slot, Jason/L-5500-2018; Schoch, Conrad L./J-4825-2012; Schoch, Conrad/HCH-2412-2022; Wynns, Anja/E-5434-2012; Slot, Jason/E-4802-2011; Stajich, Jason Eric/C-7297-2008; Langer, Ewald JG/D-8479-2012; Hewitt, David/AAA-9160-2021	Cox, Cymon/0000-0002-4927-979X; Crous, Pedro W/0000-0001-9085-8825; Gueidan, Cecile/0000-0001-9295-9996; Matsuura, Kenji/0000-0002-9099-6694; Griffith, Gareth W./0000-0001-6914-3745; Lumbsch, Thorsten/0000-0003-1512-835X; Wang, Zheng/0000-0002-8849-8549; Schoch, Conrad L./0000-0003-1839-5322; Schoch, Conrad/0000-0003-1839-5322; Stajich, Jason Eric/0000-0002-7591-0020; Hewitt, David/0000-0003-3789-9534; Aptroot, Andre/0000-0001-7949-2594; Lucking, Robert/0000-0002-3431-4636; Vilgalys, Rytas/0000-0001-8299-3605; Amtoft Wynns, Anja/0000-0002-6013-9456; Yahr, Rebecca/0000-0003-1518-9451				BARR DJS, 1992, MYCOLOGIA, V84, P1, DOI 10.2307/3760397; Berbee ML, 2001, MYCOTA, V7, P229; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; BLACKWELL M, 1989, MYCOLOGIA, V81, P735, DOI 10.2307/3759878; Cavalier-Smith T, 2001, MYCOTA, V7, P3; CAVALIERSMITH T, 1995, P ROY SOC B-BIOL SCI, V261, P1, DOI 10.1098/rspb.1995.0108; Corradi N, 2004, FUNGAL GENET BIOL, V41, P1037, DOI 10.1016/j.fgb.2004.08.005; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HELD AA, 1981, BOT REV, V47, P451, DOI 10.1007/BF02860539; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; KEELING PJ, 2005, INSECT FUNGAL ASS EC, P97; KIRK PM, 2001, AINSWORTH BISBYS DIC, V60; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maddison DR, 2002, MACCLADE VERSION 4 0; Maddison W.P., 2003, MESQUITE MODULAR SYS; MCKERRACHER LJ, 1985, MYCOLOGIA, V77, P412, DOI 10.2307/3793197; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; NAGAHAMA T, 1995, MYCOLOGIA, V87, P203, DOI 10.2307/3760906; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; POWELL MJ, 1984, MYCOLOGIA, V76, P1039, DOI 10.2307/3793019; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2002, PLANT SOIL, V244, P75, DOI 10.1023/A:1020238728910; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Ustinova I, 2000, PROTIST, V151, P253, DOI 10.1078/1434-4610-00023; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA	41	1248	1334	6	393	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					818	822		10.1038/nature05110	http://dx.doi.org/10.1038/nature05110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051209				2022-12-28	WOS:000241362700042
J	Kalil, T				Kalil, Thomas			Planning for US science policy in 2009	NATURE			English	Editorial Material									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kalil, T (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.								0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					751	752		10.1038/443751a	http://dx.doi.org/10.1038/443751a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	096FJ	17051190				2022-12-28	WOS:000241362700024
J	Shen, YQ; Joachimiak, A; Rosner, MR; Tang, WJ				Shen, Yuequan; Joachimiak, Andrzej; Rosner, Marsha Rich; Tang, Wei-Jen			Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism	NATURE			English	Article							AMYLOID BETA-PROTEIN; MITOCHONDRIAL PROCESSING PEPTIDASE; BUD-SITE SELECTION; ALZHEIMERS-DISEASE; IN-VIVO; DEGRADATION; DOMAIN; INSULYSIN; GLUCAGON; AMYLIN	Insulin-degrading enzyme (IDE), a Zn2+-metalloprotease, is involved in the clearance of insulin and amyloid-beta (refs 1 - 3). Loss-of-function mutations of IDE in rodents cause glucose intolerance and cerebral accumulation of amyloid-beta, whereas enhanced IDE activity effectively reduces brain amyloid-beta ( refs 4 - 7). Here we report structures of human IDE in complex with four substrates ( insulin B chain, amyloid-beta peptide ( 1 - 40), amylin and glucagon). The amino- and carboxy-terminal domains of IDE (IDE-N and IDE-C, respectively) form an enclosed cage just large enough to encapsulate insulin. Extensive contacts between IDE-N and IDE-C keep the degradation chamber of IDE inaccessible to substrates. Repositioning of the IDE domains enables substrate access to the catalytic cavity. IDE uses size and charge distribution of the substrate-binding cavity selectively to entrap structurally diverse polypeptides. The enclosed substrate undergoes conformational changes to form beta-sheets with two discrete regions of IDE for its degradation. Consistent with this model, mutations disrupting the contacts between IDE-N and IDE-C increase IDE catalytic activity 40-fold. The molecular basis for substrate recognition and allosteric regulation of IDE could aid in designing IDE-based therapies to control cerebral amyloid-beta and blood sugar concentrations(1,8,9).	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Tang, WJ (corresponding author), Univ Chicago, Ben May Inst Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM074942-01, U54 GM074942] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMES N, 1995, SCIENCE, V270, P464, DOI 10.1126/science.270.5235.464; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; Mascioni A, 2003, BIOPOLYMERS, V69, P29, DOI 10.1002/bip.10305; MASKOS K, 2004, HDB METALLOPROTEINS, P190; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; PERLMAN RK, 1994, J BIOL CHEM, V269, P33140; SASAKI K, 1975, NATURE, V257, P751, DOI 10.1038/257751a0; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9	30	277	293	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					870	874		10.1038/nature05143	http://dx.doi.org/10.1038/nature05143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051221	Green Accepted			2022-12-28	WOS:000241362700055
J	Noda, S				Noda, Susumu			Seeking the ultimate nanolaser	SCIENCE			English	Editorial Material							2-DIMENSIONAL PHOTONIC-CRYSTAL; SPONTANEOUS EMISSION; QUANTUM DOTS; LIGHT-EMISSION; NANOCAVITY; LASER		Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan	Kyoto University	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	snoda@kuee.kyoto-u.ac.jp						Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; Asano T, 2006, OPT EXPRESS, V14, P1996, DOI 10.1364/OE.14.001996; Badolato A, 2005, SCIENCE, V308, P1158, DOI 10.1126/science.1109815; Englund D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013904; Fujita M, 2005, SCIENCE, V308, P1296, DOI 10.1126/science.1110417; Kounoike K, 2005, ELECTRON LETT, V41, P1402, DOI 10.1049/el:20053011; Kuramochi E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2167801; Lodahl P, 2004, NATURE, V430, P654, DOI 10.1038/nature02772; Ogawa SP, 2004, SCIENCE, V305, P227, DOI 10.1126/science.1097968; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Park HG, 2004, SCIENCE, V305, P1444, DOI 10.1126/science.1100968; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	15	185	191	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					260	261		10.1126/science.1131322	http://dx.doi.org/10.1126/science.1131322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038610				2022-12-28	WOS:000241194100027
J	Hoppin, AG; Katz, ES; Kaplan, LM; Lauwers, GY				Hoppin, Alison G.; Katz, Eliot S.; Kaplan, Lee M.; Lauwers, Gregory Y.			A 15-year-old girl with severe obesity - Severe childhood obesity with obstructive sleep apnea, hypertension, impaired glucose tolerance progressing to type 2 diabetes mellitus, the polycystic ovary syndrome, and nonalcoholic steatohepatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NUTRITION EXAMINATION; INSULIN-RESISTANCE; DAYTIME SLEEPINESS; METABOLIC SYNDROME; NATIONAL-HEALTH; RISK-FACTORS; WEIGHT-LOSS; CHILDREN; PREVALENCE; POLYSOMNOGRAPHY		Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Hoppin, AG (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							ALI NJ, 1993, ARCH DIS CHILD, V68, P360, DOI 10.1136/adc.68.3.360; American Academy of Pediatrics. Committee on Nutrition, 1998, Pediatrics, V101, P141; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Apovian CM, 2005, OBES RES, V13, P274, DOI 10.1038/oby.2005.37; Balcer LJ, 1999, NEUROLOGY, V52, P870, DOI 10.1212/WNL.52.4.870; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Buchwald H, 2005, JAMA-J AM MED ASSOC, V293, P1728; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chay OM, 2000, PEDIATR PULM, V29, P284, DOI 10.1002/(SICI)1099-0496(200004)29:4<284::AID-PPUL8>3.0.CO;2-D; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; COOK SD, 1983, J PEDIATR ORTHOPED, V3, P449, DOI 10.1097/01241398-198309000-00006; Dixon JB, 2005, INT J OBESITY, V29, P1048, DOI 10.1038/sj.ijo.0802960; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; DUNAIF A, 1995, AM J MED, V98, pS33, DOI 10.1016/S0002-9343(99)80057-6; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Franzese A, 1997, DIGEST DIS SCI, V42, P1428, DOI 10.1023/A:1018850223495; GISLASON T, 1995, CHEST, V107, P963, DOI 10.1378/chest.107.4.963; Gozal D, 2001, PEDIATRICS, V108, P693, DOI 10.1542/peds.108.3.693; Gozal D, 2001, PEDIATRICS, V107, P1394, DOI 10.1542/peds.107.6.1394; Ibanez L, 2004, J PEDIATR-US, V144, P23, DOI 10.1016/j.jpeds.2003.08.015; Inge TH, 2005, J PEDIATR-US, V147, P10, DOI 10.1016/j.jpeds.2005.03.021; Jerre R, 1996, ACTA ORTHOP SCAND, V67, P53, DOI 10.3109/17453679608995609; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; Marcus CL, 1996, PEDIATR PULM, V21, P176; MARCUS CL, 1995, J PEDIATR-US, V127, P88, DOI 10.1016/S0022-3476(95)70262-8; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Palmert MR, 2002, J CLIN ENDOCR METAB, V87, P1017, DOI 10.1210/jc.87.3.1017; Prentice AM, 2005, PHYSIOL BEHAV, V86, P640, DOI 10.1016/j.physbeh.2005.08.055; Redline S, 1999, AM J RESP CRIT CARE, V159, P1527, DOI 10.1164/ajrccm.159.5.9809079; Rosenbaum M, 1998, NEW ENGL J MED, V338, P555; SILVESTRI JM, 1993, PEDIATR PULM, V16, P124, DOI 10.1002/ppul.1950160208; Sinha R, 2002, NEW ENGL J MED, V346, P1756; Strauss RS, 2000, J PEDIATR-US, V136, P727, DOI 10.1016/S0022-3476(00)24645-3; Towbin A, 2004, J PEDIATR-US, V145, P263, DOI 10.1016/j.jpeds.2004.04.051; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wiet GJ, 1997, INT J PEDIATR OTORHI, V41, P133, DOI 10.1016/S0165-5876(97)00065-7; Williams DE, 2005, PEDIATRICS, V116, P1122, DOI 10.1542/peds.2004-2001; 2004, N ENGL J MED, V351, P696	47	11	11	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1593	1602		10.1056/NEJMcpc069023	http://dx.doi.org/10.1056/NEJMcpc069023			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035653				2022-12-28	WOS:000241160400012
J	Schneider, LS; Tariot, PN; Dagerman, KS; Davis, SM; Hsiao, JK; Ismail, MS; Lebowitz, BD; Lyketsos, CG; Ryan, JM; Stroup, TS; Sultzer, DL; Weintraub, D; Lieberman, JA				Schneider, Lon S.; Tariot, Pierre N.; Dagerman, Karen S.; Davis, Sonia M.; Hsiao, John K.; Ismail, M. Saleem; Lebowitz, Barry D.; Lyketsos, Constantine G.; Ryan, J. Michael; Stroup, T. Scott; Sultzer, David L.; Weintraub, Daniel; Lieberman, Jeffrey A.		CATIE-AD Study Grp	Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIALS; DIAGNOSTIC-CRITERIA; INTERNATIONAL WORKSHOP; CEREBROVASCULAR EVENTS; NEUROLEPTIC TREATMENT; DEMENTIA TRIALS; METAANALYSIS; DEPRESSION; PSYCHOSIS; RISK	BACKGROUND Second-generation (atypical) antipsychotic drugs are widely used to treat psychosis, aggression, and agitation in patients with Alzheimer's disease, but their benefits are uncertain and concerns about safety have emerged. We assessed the effectiveness of atypical antipsychotic drugs in outpatients with Alzheimer's disease. METHODS In this 42-site, double-blind, placebo-controlled trial, 421 outpatients with Alzheimer's disease and psychosis, aggression, or agitation were randomly assigned to receive olanzapine (mean dose, 5.5 mg per day), quetiapine (mean dose, 56.5 mg per day), risperidone (mean dose, 1.0 mg per day), or placebo. Doses were adjusted as needed, and patients were followed for up to 36 weeks. The main outcomes were the time from initial treatment to the discontinuation of treatment for any reason and the number of patients with at least minimal improvement on the Clinical Global Impression of Change (CGIC) scale at 12 weeks. RESULTS There were no significant differences among treatments with regard to the time to the discontinuation of treatment for any reason: olanzapine (median, 8.1 weeks), quetiapine (median, 5.3 weeks), risperidone (median, 7.4 weeks), and placebo (median, 8.0 weeks) (P=0.52). The median time to the discontinuation of treatment due to a lack of efficacy favored olanzapine (22.1 weeks) and risperidone (26.7 weeks) as compared with quetiapine (9.1 weeks) and placebo (9.0 weeks) (P=0.002). The time to the discontinuation of treatment due to adverse events or intolerability favored placebo. Overall, 24% of patients who received olanzapine, 16% of patients who received quetiapine, 18% of patients who received risperidone, and 5% of patients who received placebo discontinued their assigned treatment owing to intolerability (P=0.009). No significant differences were noted among the groups with regard to improvement on the CGIC scale. Improvement was observed in 32% of patients assigned to olanzapine, 26% of patients assigned to quetiapine, 29% of patients assigned to risperidone, and 21% of patients assigned to placebo (P=0.22). CONCLUSIONS Adverse effects offset advantages in the efficacy of atypical antipsychotic drugs for the treatment of psychosis, aggression, or agitation in patients with Alzheimer's disease.	Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; Banner Alzheimers Inst, Phoenix, AZ USA; Quintiles, Res Triangle Pk, NC USA; NIMH, NIH, Bethesda, MD 20892 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; Johns Hopkins Univ, Johns Hopkins Bayview, Dept Psychiat, Baltimore, MD USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Univ Calif Los Angeles, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Coll Phys & Surg, New York, NY USA	University of Southern California; Banner Research; Banner Health; Banner Alzheimer's Institute; IQVIA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Rochester; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Pennsylvania	Schneider, LS (corresponding author), Univ So Calif, Keck Sch Med, 1510 San Pablo St,HCC 600, Los Angeles, CA 90033 USA.	lschneid@usc.edu	Stroup, Thomas/AAB-7780-2019; Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020; Lieberman, Jeffrey/AAY-8239-2020; Stroup, Thomas S/F-9188-2014	Stroup, Thomas/0000-0002-3123-0672; Weintraub, Daniel/0000-0003-0633-7168; Stroup, Thomas S/0000-0002-3123-0672; Hsiao, John/0000-0003-3471-7539; Lebowitz, Barry/0000-0002-6467-646X; Adler, Lawrence/0000-0002-6619-2493; Thomas, Sonia/0000-0003-1362-5627				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P154; [Anonymous], 1998, Postgrad Med, VSpec No, P1; BELLER SA, 1984, J GERONTOL, V39, P194, DOI 10.1093/geronj/39.2.194; COX DR, 1972, J R STAT SOC B, V34, P187; *CTR DRUG EV RES, 2005, FDA PUBL HLTH ADV PA; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis KL, 1997, INT J GERIATR PSYCH, V12, P978, DOI 10.1002/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1; Devanand DP, 1997, ARCH GEN PSYCHIAT, V54, P257; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; ISMAIL MS, IN PRESS CURR ALZHEI; Jeste DV, 2000, AM J GERIAT PSYCHIAT, V8, P29, DOI 10.1097/00019442-200002000-00004; Jeste DV, 1999, J AM GERIATR SOC, V47, P716, DOI 10.1111/j.1532-5415.1999.tb01595.x; Koch GG, 1998, STAT MED, V17, P1863, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1863::AID-SIM989>3.0.CO;2-M; Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MITTELMAN MS, 2000, GUIDING ALZHEIMERS C; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P129, DOI 10.1176/appi.ajgp.10.2.129; Paulsen JS, 2000, NEUROLOGY, V54, P1965, DOI 10.1212/WNL.54.10.1965; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; RACOOSIN JA, 2004, 17 ANN M AM ASS GER; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schneider LS, 2001, AM J GERIAT PSYCHIAT, V9, P346, DOI 10.1176/appi.ajgp.9.4.346; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; TARIOT PN, 1995, J GERIATR PSYCH NEUR, V8, pS28, DOI 10.1177/089198879500800105; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539	33	782	797	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2006	355	15					1525	1538		10.1056/NEJMoa061240	http://dx.doi.org/10.1056/NEJMoa061240			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093HW	17035647	Green Published, Bronze			2022-12-28	WOS:000241160400004
J	Sueyoshi, E; Sakamoto, I; Mizowaki, T; Uetani, M; Yano, K				Sueyoshi, Eijun; Sakamoto, Ichiro; Mizowaki, Takashi; Uetani, Masataka; Yano, Katsusuke			Persistent left superior vena cava into left atrium	LANCET			English	Editorial Material									Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 8528501, Japan; Nagasaki Univ, Sch Med, Dept Cardiovasc Med, Nagasaki 8528501, Japan	Nagasaki University; Nagasaki University	Sueyoshi, E (corresponding author), Nagasaki Univ, Sch Med, Dept Radiol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	EijunSueyoshi@aol.com	Uetani, Masataka/ABF-7525-2021						0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 7	2006	368	9543					1270	1270		10.1016/S0140-6736(06)69524-X	http://dx.doi.org/10.1016/S0140-6736(06)69524-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027733				2022-12-28	WOS:000241058300034
J	Pagel, M; Venditti, C; Meade, A				Pagel, Mark; Venditti, Chris; Meade, Andrew			Large punctuational contribution of speciation to evolutionary divergence at the molecular level	SCIENCE			English	Article							RAPID EVOLUTION; SUBSTITUTIONS; EQUILIBRIUM; POPULATIONS; PHYLOGENIES; GRADUALISM; SEQUENCE; DYNAMICS; TEMPO; MODEL	A long-standing debate in evolutionary biology concerns whether species diverge gradually through time or by punctuational episodes at the time of speciation. We found that approximately 22% of substitutional changes at the DNA level can be attributed to punctuational evolution, and the remainder accumulates from background gradual divergence. Punctuational effects occur at more than twice the rate in plants and fungi than in animals, but the proportion of total divergence attributable to punctuational change does not vary among these groups. Punctuational changes cause departures from a clock-like tempo of evolution, suggesting that they should be accounted for in deriving dates from phylogenies. Punctuational episodes of evolution may play a larger role in promoting evolutionary divergence than has previously been appreciated.	Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.	m.pagel@rdg.ac.uk			Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Coyne J.A., 2004, SPECIATION; Culotta E, 2005, SCIENCE, V310, P1878, DOI 10.1126/science.310.5756.1878; Draper N.R., 1998, APPL REGRESSION ANAL, P79; ELDREDGE N, 1971, EVOLUTION, V25, P156, DOI 10.1111/j.1558-5646.1971.tb01868.x; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Eldredge N., 1972, P82; FITCH WM, 1990, MOL BIOL EVOL, V7, P438; FITCH WM, 1987, MOL BIOL EVOL, V4, P381; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; GOULD S J, 1977, Paleobiology, V3, P115; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; HECHT M K, 1986, Oxford Surveys in Evolutionary Biology, P1; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; Kay KM, 2005, AM J BOT, V92, P1899, DOI 10.3732/ajb.92.11.1899; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MALMGREN BA, 1984, SCIENCE, V225, P317, DOI 10.1126/science.225.4659.317; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RHODES FHT, 1983, NATURE, V305, P269, DOI 10.1038/305269a0; Ricklefs RE, 2006, SYST BIOL, V55, P151, DOI 10.1080/10635150500431205; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202	34	161	166	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2006	314	5796					119	121		10.1126/science.1129647	http://dx.doi.org/10.1126/science.1129647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023657				2022-12-28	WOS:000241031200049
J	Sardi, SP; Murtie, J; Koirala, S; Patten, BA; Corfas, G				Sardi, S. Pablo; Murtie, Joshua; Koirala, Samir; Patten, Brooke A.; Corfas, Gabriel			Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; GABAERGIC INTERNEURONS; TRANSGENIC MICE; KNOCKOUT MICE; RECEPTORS; ACTIVATION; EXPRESSION; CLEAVAGE; ADULT	Embryonic multipotent neural precursors are exposed to extracellular signals instructing them to adopt different fates, neuronal or glial. However, the mechanisms by which precursors integrate these signals to make timely fate choices remained undefined. Here we show that direct nuclear signaling by a receptor tyrosine kinase inhibits the responses of precursors to astrocyte differentiation factors while maintaining their neurogenic potential. Upon neuregulin-induced activation and presenilin-dependent cleavage of ErbB4, the receptor's intracellular domain forms a complex with TAB2 and the corepressor N-CoR. This complex undergoes nuclear translocation and binds promoters of astrocytic genes, repressing their expression. Consistent with this observation, astrogenesis occurs precociously in ErbB4 knockout mice. Our studies define how presenilin-dependent nuclear signaling by a receptor tyrosine kinase directly regulates gene transcription and cell fate. This pathway could be of importance for neural stem cell biology and for understanding the pathogenesis of Alzheimer's disease.	Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sardi, SP (corresponding author), Childrens Hosp, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884, T32NS007484] Funding Source: NIH RePORTER; NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; NINDS NIH HHS [R01 NS035884, T32 NS007484-06, R01 NS35884] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Craft JM, 2005, GLIA, V51, P209, DOI 10.1002/glia.20194; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; FINLEY RL, 1996, DNA CLONING EXPRESSI, P169; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	42	275	284	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 6	2006	127	1					185	197		10.1016/j.cell.2006.07.037	http://dx.doi.org/10.1016/j.cell.2006.07.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	097KJ	17018285	Bronze			2022-12-28	WOS:000241445800023
J	Potts, M; Prata, N; Walsh, J; Grossman, A				Potts, Malcolm; Prata, Ndola; Walsh, Julia; Grossman, Amy			Controversy - Parachute approach to evidence based medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MALE CIRCUMCISION; INTRAVENOUS REHYDRATION; HIV-INFECTION; TRIAL; RISK; CANCER		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Prata, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 314 Warren Hall, Berkeley, CA 94720 USA.	ndola@berkeley.edu						ALSAMARRAI AYI, 1988, SURG GYNECOL OBSTET, V167, P341; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVERY ME, 1990, NEW ENGL J MED, V323, P891, DOI 10.1056/NEJM199009273231307; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Coplan PM, 2004, SCIENCE, V304, P1911, DOI 10.1126/science.1100441; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; GULMEZOGLU A, 2001, LANCET, V366, P726; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; MACKENZIE A, 1991, BRIT MED J, V303, P393, DOI 10.1136/bmj.303.6799.393; POTTS M, 1991, LANCET, V338, P608, DOI 10.1016/0140-6736(91)90614-U; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; RAHAMAN MM, 1979, LANCET, V2, P809; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Tseng HF, 2001, CANCER CAUSE CONTROL, V12, P267, DOI 10.1023/A:1011266405062; USAID/AIDSMark, 2003, MAL CIRC CURR EP FIE; VESIKARI T, 1987, ACTA PAEDIATR SCAND, V76, P300, DOI 10.1111/j.1651-2227.1987.tb10464.x; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Walraven G, 2005, BJOG-INT J OBSTET GY, V112, P1277, DOI 10.1111/j.1471-0528.2005.00711.x; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WHO, 2005, MAK EV MOTH CHILD CO; WILES M, 2001, ANN INTERN MED, V135, P149	25	62	63	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					701	703		10.1136/bmj.333.7570.701	http://dx.doi.org/10.1136/bmj.333.7570.701			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	17008675	Green Published			2022-12-28	WOS:000241068200029
J	Trouwborst, RE; Clement, BG; Tebo, BM; Glazer, BT; Luther, GW				Trouwborst, Robert E.; Clement, Brian G.; Tebo, Bradley M.; Glazer, Brian T.; Luther, George W., III			Soluble Mn(III) in suboxic zones	SCIENCE			English	Article							NATURAL ORGANIC-LIGANDS; MICROBIAL OXIDATION; MANGANESE; COMPLEXATION; SULFIDE; MECHANISMS; IRON(III); ATLANTIC; MN	Soluble manganese( III) [ Mn( III)] has been thought to disproportionate to soluble Mn(II) and particulate (MnO2)-O-IV in natural waters, although it persists as complexes in laboratory solutions. We report that, in the Black Sea, soluble Mn( III) concentrations were as high as 5 micromolar and constituted up to 100% of the total dissolved Mn pool. Depth profiles indicated that soluble Mn( III) was produced at the top of the suboxic zone by Mn( II) oxidation and at the bottom of the suboxic zone by (MnO2)-O-IV reduction, then stabilized in each case by unknown natural ligands. We also found micromolar concentrations of dissolved Mn( III) in the Chesapeake Bay. Dissolved Mn( III) can maintain the existence of suboxic zones because it can act as either an electron acceptor or donor. Our data indicate that Mn( III) should be ubiquitous at all water column and sediment oxic/anoxic interfaces in the environment.	Univ Delaware, Coll Marine & Earth Studies, Lewes, DE 19958 USA; Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Beaverton, OR 97006 USA	University of Delaware; University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon Health & Science University	Luther, GW (corresponding author), Univ Delaware, Coll Marine & Earth Studies, Lewes, DE 19958 USA.	luther@udel.edu	Luther, George/A-6384-2008; Glazer, Brian/C-2248-2011; Tebo, Bradley M/A-8432-2017	Luther, George/0000-0002-0780-885X; Tebo, Bradley M/0000-0002-6301-4325				BRENDEL PJ, 1995, ENVIRON SCI TECHNOL, V29, P751, DOI 10.1021/es00003a024; BREWER PG, 1971, LIMNOL OCEANOGR, V16, P107, DOI 10.4319/lo.1971.16.1.0107; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; Duckworth OW, 2005, ENVIRON SCI TECHNOL, V39, P6037, DOI 10.1021/es050275k; FAULKNER KM, 1994, ARCH BIOCHEM BIOPHYS, V310, P341, DOI 10.1006/abbi.1994.1176; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Gregg MC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021580; Klewicki JK, 1998, ENVIRON SCI TECHNOL, V32, P2916, DOI 10.1021/es980308e; Konovalov SK, 2003, LIMNOL OCEANOGR, V48, P2369, DOI 10.4319/lo.2003.48.6.2369; KOSTKA JE, 1995, GEOCHIM COSMOCHIM AC, V59, P885; KRUMBEIN WE, 1973, HELGOLAND WISS MEER, V25, P347, DOI 10.1007/BF01611203; Luther GW, 1997, GEOCHIM COSMOCHIM AC, V61, P4043, DOI 10.1016/S0016-7037(97)00239-1; Luther GW, 2005, GEOMICROBIOL J, V22, P195, DOI 10.1080/01490450590946022; LUTHER GW, 1991, DEEP-SEA RES, V38, pS1121, DOI 10.1016/S0198-0149(10)80027-5; MILLERO FJ, 1991, DEEP-SEA RES, V38, pS1139, DOI 10.1016/S0198-0149(10)80028-7; MURRAY JW, 1995, ADV CHEM SER, V244, P157, DOI 10.1021/ba-1995-0244.ch007; NEALSON KH, 1988, ADV APPL MICROBIOL, V33, P279, DOI 10.1016/S0065-2164(08)70209-0; Nico PS, 2001, ENVIRON SCI TECHNOL, V35, P3338, DOI 10.1021/es001848q; Parker DL, 2004, GEOCHIM COSMOCHIM AC, V68, P4809, DOI 10.1016/j.gca.2004.05.038; PEREZBENITO JF, 1989, INORG CHEM, V28, P390, DOI 10.1021/ic00302a002; Rozan TF, 2000, ANAL CHIM ACTA, V415, P175, DOI 10.1016/S0003-2670(00)00844-8; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Summers JS, 2005, INORG CHEM, V44, P3405, DOI 10.1021/ic048618n; SUNDA WG, 1987, LIMNOL OCEANOGR, V32, P552, DOI 10.4319/lo.1987.32.3.0552; SUNDA WG, 1990, LIMNOL OCEANOGR, V35, P325, DOI 10.4319/lo.1990.35.2.0325; TEBO BM, 1991, NATO ADV SCI I C-MAT, V351, P173; TEBO BM, 1991, DEEP-SEA RES, V38, pS883, DOI 10.1016/S0198-0149(10)80015-9; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Webb SM, 2005, P NATL ACAD SCI USA, V102, P5558, DOI 10.1073/pnas.0409119102; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; YAO WS, 1993, GEOCHIM COSMOCHIM AC, V57, P3359, DOI 10.1016/0016-7037(93)90544-7	32	221	228	7	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2006	313	5795					1955	1957		10.1126/science.1132876	http://dx.doi.org/10.1126/science.1132876			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008530				2022-12-28	WOS:000240832200049
J	Malterud, K				Malterud, Kirsti			Women's wisdom - a source of knowledge for medicine	LANCET			English	Editorial Material							PERCEPTIONS		Univ Bergen, Dept Publ Hlth & Primary Care, N-5020 Bergen, Norway; Univ Copenhagen, Dept Gen Practice, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Res Unit, DK-1168 Copenhagen, Denmark	University of Bergen; University of Copenhagen; University of Copenhagen	Malterud, K (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Care, N-5020 Bergen, Norway.	Kirsti.malterud@isf.uib.no						Frich JC, 2006, ANN FAM MED, V4, P198, DOI 10.1370/afm.529; Haraway D., 1991, MANIFESTLY HARAWAY; Kvale S., 2007, INTERVIEWS INTRO QUA; Malterud K, 2000, FAM MED, V32, P603; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; MAYS N, 2005, J HEALTH SERV RES PO, V10, P6, DOI DOI 10.1258/1355819054308576; Raine R, 2004, BMJ-BRIT MED J, V328, P1354, DOI 10.1136/bmj.38078.503819.EE; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; THESEN J, 1999, DOING QUALITATIVE RE, P269	9	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2006	368	9542					1139	1140		10.1016/S0140-6736(06)69453-1	http://dx.doi.org/10.1016/S0140-6736(06)69453-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089XU	17011929				2022-12-28	WOS:000240916000010
J	Schurig, D; Mock, JJ; Justice, BJ; Cummer, SA; Pendry, JB; Starr, AF; Smith, DR				Schurig, D.; Mock, J. J.; Justice, B. J.; Cummer, S. A.; Pendry, J. B.; Starr, A. F.; Smith, D. R.			Metamaterial electromagnetic cloak at microwave frequencies	SCIENCE			English	Article							FIELDS; INDEX	A recently published theory has suggested that a cloak of invisibility is in principle possible, at least over a narrow frequency band. We describe here the first practical realization of such a cloak; in our demonstration, a copper cylinder was "hidden" inside a cloak constructed according to the previous theoretical prescription. The cloak was constructed with the use of artificially structured metamaterials, designed for operation over a band of microwave frequencies. The cloak decreased scattering from the hidden object while at the same time reducing its shadow, so that the cloak and object combined began to resemble empty space.	Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England; SensorMetrix, San Diego, CA 92121 USA	Duke University; Imperial College London	Smith, DR (corresponding author), Duke Univ, Dept Elect & Comp Engn, Box 90291, Durham, NC 27708 USA.	drsmith@ee.duke.edu	Cummer, Steven/AAJ-6761-2020; Smith, David R/E-4710-2012; Schurig, David A/A-3647-2008; Cummer, Steven A/A-6118-2008	Cummer, Steven A/0000-0002-0002-0613; Pendry, John/0000-0001-5145-5441				Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Cummer SA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036621; Driscoll T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174088; Gbur G, 2003, PROG OPTICS, V45, P273, DOI 10.1016/S0079-6638(03)80007-0; Greegor RB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037202; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Greenleaf A, 2003, PHYSIOL MEAS, V24, P413, DOI 10.1088/0967-3334/24/2/353; Justice BJ, 2006, OPT EXPRESS, V14, P8694, DOI 10.1364/OE.14.008694; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/247; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Marques R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144440; MILTON GW, 2006, P ROY SOC LOND A MAT, V462, P1364; NACHMAN AI, 1988, ANN MATH, V128, P531, DOI 10.2307/1971435; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Schurig D, 2006, OPT EXPRESS, V14, P9794, DOI 10.1364/OE.14.009794; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Ward AJ, 1996, J MOD OPTIC, V43, P773, DOI 10.1080/09500349608232782	20	5634	5889	124	2117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					977	980		10.1126/science.1133628	http://dx.doi.org/10.1126/science.1133628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17053110				2022-12-28	WOS:000241896000048
J	Long, JA; Young, GC; Holland, T; Senden, TJ; Fitzgerald, EMG				Long, John A.; Young, Gavin C.; Holland, Tim; Senden, Tim J.; Fitzgerald, Erich M. G.			An exceptional Devonian fish from Australia sheds light on tetrapod origins	NATURE			English	Article							PALEONTOLOGY	The transition from fishes to tetrapods was one of the most dramatic events in the evolution of vertebrates, but many pivotal fossils are incomplete, resulting in gaps in the data that are used for phylogenetic reconstruction. Here we present new observations from the most complete, acid-prepared Devonian tetrapodomorph fish yet discovered, Gogonasus(1,2), which was previously placed just crownward of Kenichthys and rhizodontids(3,4), the most primitive taxa on the tetrapod lineage. Unexpectedly, Gogonasus shows a mosaic of plesiomorphic and derived tetrapod-like features. Whereas the braincase and dermal cranial skeleton exhibit generalized morphologies with respect to Eusthenopteron(5) or Panderichthys(6), taxa that are traditionally considered to be phyletically close to tetrapods(7,8), the presence of a deeply invaginated, wide spiracle, advanced internal spiracular architecture and near-horizontal hyomandibula are specialized features that are absent from Eusthenopteron(9). Furthermore, the pectoral fin skeleton of Gogonasus shares several features with that of Tiktaalik, the most tetrapod-like fish(10). A new phylogenetic analysis places Gogonasus crownward of Eusthenopteron as the sister taxon to the Elpistostegalia. Aspects of the basic tetrapod limb skeleton and middle ear architecture can now be traced further back within the tetrapodomorph radiation.	Museum Victoria, Melbourne, Vic 3001, Australia; Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia; Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; Australian Natl Univ, Res Sch Phys Sci, Dept Appl Math, Canberra, ACT 0200, Australia	Museum Victoria; Australian National University; Monash University; Australian National University	Long, JA (corresponding author), Museum Victoria, POB 666, Melbourne, Vic 3001, Australia.	jlong@museum.vic.gov.au	Senden, Tim J/A-7319-2008; Holland, Timothy/S-8199-2019	Senden, Tim J/0000-0001-6808-7219; Long, John/0000-0001-8012-0114				AHLBERG P, 1989, NATURE, V337, P511, DOI 10.1038/337511a0; AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Andrews S. M., 2006, T ROY SOC EDINBURGH, V96, P197, DOI DOI 10.1017/S0263593300001309; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; CHAN V, 1993, PEDIATR PULM, V15, P183, DOI 10.1002/ppul.1950150310; Chang Mee-Mann, 1997, American Museum Novitates, V3189, P1; Clack J.A., 2002, GAINING GROUND ORIGI, P1; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; HOLLAND T, IN PRESS J VERT PALE; Janvier P., 1996, EARLY VERTEBRATES, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johanson Z, 2001, T ROY SOC EDIN-EARTH, V92, P43, DOI 10.1017/S0263593300000043; LONG J A, 1985, Records of the Western Australian Museum, V12, P361; LONG JA, 1997, RECORDS W AUSTR MU S, V57, P1; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Vorobyeva E., 1991, P68; WARREN JW, 1972, NATURE, V238, P469, DOI 10.1038/238469a0; Young GC, 2005, GEOL MAG, V142, P173, DOI 10.1017/S0016756805000464; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	24	85	88	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					199	202		10.1038/nature05243	http://dx.doi.org/10.1038/nature05243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051154				2022-12-28	WOS:000241867200039
J	Jackson, A; Mavoori, J; Fetz, EE				Jackson, Andrew; Mavoori, Jaideep; Fetz, Eberhard E.			Long-term motor cortex plasticity induced by an electronic neural implant	NATURE			English	Article							CORTICAL PLASTICITY; MOVEMENT REPRESENTATIONS; DEPENDENT PLASTICITY; POTENTIATION; STIMULATION; ACTIVATION; INDUCTION; RECOVERY	It has been proposed that the efficacy of neuronal connections is strengthened when there is a persistent causal relationship between presynaptic and postsynaptic activity. Such activity-dependent plasticity may underlie the reorganization of cortical representations during learning, although direct in vivo evidence is lacking. Here we show that stable reorganization of motor output can be induced by an artificial connection between two sites in the motor cortex of freely behaving primates. An autonomously operating electronic implant used action potentials recorded on one electrode to trigger electrical stimuli delivered at another location. Over one or more days of continuous operation, the output evoked from the recording site shifted to resemble the output from the corresponding stimulation site, in a manner consistent with the potentiation of synaptic connections between the artificially synchronized populations of neurons. Changes persisted in some cases for more than one week, whereas the output from sites not incorporated in the connection was unaffected. This method for inducing functional reorganization in vivo by using physiologically derived stimulus trains may have practical application in neurorehabilitation after injury.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fetz, EE (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	fetz@u.washington.edu		Jackson, Andrew/0000-0001-8701-6387				AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; BARANYI A, 1981, NATURE, V290, P413, DOI 10.1038/290413a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; FETZ E, 1991, CEREB CORTEX, V9, P1; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Huang YY, 2004, P NATL ACAD SCI USA, V101, P859, DOI 10.1073/pnas.2237201100; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jackson A, 2003, NEURON, V38, P115, DOI 10.1016/S0896-6273(03)00162-4; JACKSON A, IN PRESS J NEUROPHYS; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mavoori J, 2005, J NEUROSCI METH, V148, P71, DOI 10.1016/j.jneumeth.2005.04.017; Maynard EM, 1999, J NEUROSCI, V19, P8083; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Prochazka A, 2001, J PHYSIOL-LONDON, V533, P99, DOI 10.1111/j.1469-7793.2001.0099b.x; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Stickgold R, 2005, SLEEP, V28, P1225, DOI 10.1093/sleep/28.10.1225	34	311	325	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					56	60		10.1038/nature05226	http://dx.doi.org/10.1038/nature05226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17057705				2022-12-28	WOS:000241701500043
J	Behbehani, K				Behbehani, Kazem			WHO director-general election: a more connected WHO	LANCET			English	Editorial Material									Genthod, CH-1294 Geneva, Switzerland		Behbehani, K (corresponding author), Genthod, CH-1294 Geneva, Switzerland.	Kazem.behbehani@gmail.com						Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; World Health Organization, 2005, INT HLTH REG 2005 AD; World Health Organization [WHO], 2005, 58 WORLD HLTH ASS MA; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1403	1405		10.1016/S0140-6736(06)69583-4	http://dx.doi.org/10.1016/S0140-6736(06)69583-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055928				2022-12-28	WOS:000241459100009
J	Jabbour, S; El-Zein, A; Nuwayhid, I; Giacaman, R				Jabbour, Samer; El-Zein, Abbas; Nuwayhid, Iman; Giacaman, Rita			Can action on health achieve political and social reform?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSITION; COMMUNITY		Univ Sydney, Dept Civil Engn, Sydney, NSW 2006, Australia; Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon	University of Sydney; American University of Beirut	Jabbour, S (corresponding author), POB 9633, Aleppo, Syria.	sjabbour@post.harvard.edu	El-Zein, Abbas H/E-5811-2011; Jabbour, Samer/Y-6860-2018	El-Zein, Abbas H/0000-0003-4935-3299; Jabbour, Samer/0000-0002-7150-6856				Akala FA, 2006, LANCET, V367, P961, DOI 10.1016/S0140-6736(06)68402-X; Ammar W., 2003, HLTH SYSTEM REFORM L; Barghouti Mustafa., 1990, INTIFADA PALESTINE C, P73; Fouad FM, 2004, AN NAHAR DAILY  0613; Giacaman G, 1998, OSLO NEW REALITIES O, P1; Giacaman R, 2001, DISABIL REHABIL, V23, P639, DOI 10.1080/09638280110036544; *HAR FDN DIR HLTH, HARRIMED; Jabbour S, 2003, BRIT MED J, V326, P1141, DOI 10.1136/bmj.326.7399.1141; Joseph S, 1996, Gend Dev, V4, P14, DOI 10.1080/741922010; Khalil K, 2005, BJOG-INT J OBSTET GY, V112, P1270, DOI 10.1111/j.1471-0528.2005.00710.x; McKee M, 2004, BRIT MED J, V329, P1428, DOI 10.1136/bmj.329.7480.1428; *MIN HLTH, HLTH VILL PROGR SYR; Ncayiyana DJ, 2004, BMJ-BRIT MED J, V329, P1425, DOI 10.1136/bmj.329.7480.1425; *REPR HLTH WORK GR, WHAT IS REPR HLTH WO; Riska E, 2001, SOC SCI MED, V52, P179, DOI 10.1016/S0277-9536(00)00218-5; *UN DEV PROGR AR F, 2005, AR HUM DEV REP 2004; *WHO E MED REG OFF, COUNTR PROF; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZUBUR S, 2003, ARAB STUD Q, V25, P17	19	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					837	839		10.1136/bmj.38980.664074.94	http://dx.doi.org/10.1136/bmj.38980.664074.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ON	17053237	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000241678500016
J	Palop, JJ; Chin, J; Mucke, L				Palop, Jorge J.; Chin, Jeannie; Mucke, Lennart			A network dysfunction perspective on neurodegenerative diseases	NATURE			English	Review							MILD COGNITIVE IMPAIRMENT; AMYLOID BETA-PEPTIDE; CYCLIN-DEPENDENT KINASE-5; PROTEIN TRANSGENIC MICE; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; LEWY BODIES; MOUSE MODEL	Patients with Alzheimer's disease or other neurodegenerative disorders show remarkable fluctuations in neurological functions, even during the same day. These fluctuations cannot be caused by sudden loss or gain of nerve cells. Instead, it is likely that they reflect variations in the activity of neural networks and, perhaps, chronic intoxication by abnormal proteins that the brain is temporarily able to overcome. These ideas have far-reaching therapeutic implications.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Palop, Jorge/AAH-9014-2020; Palop, Jorge J./D-8128-2011	Chin, Jeannie/0000-0001-9902-3744; Mucke, Lennart/0000-0001-6256-9559; Palop, Jorge/0000-0001-6086-1070				Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Blanchet PJ, 2003, CAN J NEUROL SCI, V30, pS101, DOI 10.1017/S0317167100003309; Bradshaw J, 2004, J NEUROL NEUROSUR PS, V75, P382, DOI 10.1136/jnnp.2002.002576; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Cotman CW, 1998, PROG NEUROBIOL, V55, P659, DOI 10.1016/S0301-0082(98)00025-2; Cowan WM, 2001, JAMA-J AM MED ASSOC, V285, P594, DOI 10.1001/jama.285.5.594; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Drzezga A, 2005, PLOS MED, V2, P986, DOI 10.1371/journal.pmed.0020288; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Giese KP, 2005, NEUROREPORT, V16, P1725, DOI 10.1097/01.wnr.0000185019.67434.d2; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Graf RA, 1998, BRAIN RES, V786, P115, DOI 10.1016/S0006-8993(97)01451-0; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Gsell W, 2004, CURR PHARM DESIGN, V10, P265, DOI 10.2174/1381612043386473; Haddad JJ, 2004, PROG NEUROBIOL, V73, P359, DOI 10.1016/j.pneurobio.2004.06.002; Handley OJ, 2006, CLIN SCI, V110, P73, DOI 10.1042/CS20050148; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Iaria G, 2003, J NEUROSCI, V23, P5945; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kelly BL, 2005, J BIOL CHEM, V280, P31746, DOI 10.1074/jbc.M503259200; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee G, 2005, BBA-MOL BASIS DIS, V1739, P323, DOI 10.1016/j.bbadis.2004.09.002; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; LEWIN R, 1980, SCIENCE, V210, P1232, DOI 10.1126/science.7434023; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARK RJ, 1995, NEUROBIOL AGING, V16, P187, DOI 10.1016/0197-4580(94)00150-2; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Martino D, 2004, CURR OPIN NEUROL, V17, P425, DOI 10.1097/01.wco.0000137532.76491.19; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakanishi S, 2005, TRENDS NEUROSCI, V28, P93, DOI 10.1016/j.tins.2004.12.004; Nance MA, 2001, MENT RETARD DEV D R, V7, P153, DOI 10.1002/mrdd.1022; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pariente J, 2005, ANN NEUROL, V58, P870, DOI 10.1002/ana.20653; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Robertsson B, 1998, INT J GERIATR PSYCH, V13, P49, DOI 10.1002/(SICI)1099-1166(199801)13:1<49::AID-GPS733>3.0.CO;2-4; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schapira AHV, 2005, J NEUROL NEUROSUR PS, V76, P1472, DOI 10.1136/jnnp.2004.035980; Schmitt HP, 2005, PSYCHOPHARMACOLOGY, V179, P151, DOI 10.1007/s00213-004-2110-5; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Small DH, 2004, TRENDS NEUROSCI, V27, P245, DOI 10.1016/j.tins.2004.03.006; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thompson PJ, 2005, EPILEPSIA, V46, P1780, DOI 10.1111/j.1528-1167.2005.00279.x; van Dellen A, 2005, CLIN EXP PHARMACOL P, V32, P1007, DOI 10.1111/j.1440-1681.2005.04313.x; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Walker MP, 2000, NEUROLOGY, V54, P1616, DOI 10.1212/WNL.54.8.1616; Walker MP, 2000, BRIT J PSYCHIAT, V177, P252, DOI 10.1192/bjp.177.3.252; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Weiner MF, 2003, J GERIATR PSYCH NEUR, V16, P245, DOI 10.1177/0891988703258671; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xie CW, 2004, NEUROMOL MED, V6, P53, DOI 10.1385/NMM:6:1:053; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	100	462	485	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					768	773		10.1038/nature05289	http://dx.doi.org/10.1038/nature05289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051202				2022-12-28	WOS:000241362700035
J	Hagadorn, JW; Xiao, SH; Donoghue, PCJ; Bengtson, S; Gostling, NJ; Pawlowska, M; Raff, EC; Raff, RA; Turner, FR; Chongyu, Y; Zhou, C; Yuan, X; McFeely, MB; Stampanoni, M; Nealson, KH				Hagadorn, James W.; Xiao, Shuhai; Donoghue, Philip C. J.; Bengtson, Stefan; Gostling, Neil J.; Pawlowska, Maria; Raff, Elizabeth C.; Raff, Rudolf A.; Turner, F. Rudolf; Chongyu, Yin; Zhou, Chuanming; Yuan, Xunlai; McFeely, Matthew B.; Stampanoni, Marco; Nealson, Kenneth H.			Cellular and subcellular structure of neoproterozoic animal embryos	SCIENCE			English	Article							DOUSHANTUO FORMATION; TAPHONOMY; ALGAE	Stereoblastic embryos from the Doushantuo Formation of China exhibit occasional asynchronous cell division, with diminishing blastomere volume as cleavage proceeded. Asynchronous cell division is common in modern embryos, implying that sophisticated mechanisms for differential cell division timing and embryonic cell lineage differentiation evolved before 551 million years ago. Subcellular structures akin to organelles, coated yolk granules, or lipid vesicles occur in these embryos. Paired reniform structures within embryo cells may represent fossil evidence of cells about to undergo division. Embryos exhibit no evidence of epithelial organization, even in embryos composed of similar to 1000 cells. Many of these features are compatible with metazoans, but the absence of epithelialization is consistent only with a stem-metazoan affinity for Doushantuo embryos.	Amherst Coll, Dept Geol, Amherst, MA 01002 USA; Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden; Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Paleobiol & Strat, Nanjing 210008, Peoples R China; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Amherst College; Virginia Polytechnic Institute & State University; University of Bristol; Swedish Museum of Natural History; Indiana University System; Indiana University Bloomington; University of Sydney; Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southern California	Hagadorn, JW (corresponding author), Amherst Coll, Dept Geol, Amherst, MA 01002 USA.	jwhagadorn@amherst.edu	Stampanoni, Marco/GRR-9695-2022; Donoghue, Philip/A-3873-2008; Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/AAZ-3033-2021; Xiao, Shuhai/A-2190-2009; Zhou, Chuanming/E-5313-2010	Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Xiao, Shuhai/0000-0003-4655-2663; Gostling, Neil J./0000-0002-5960-7769; Bengtson, Stefan/0000-0003-0206-5791	Natural Environment Research Council [NE/C511256/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baer v., 1828, ENTWICKLUNGSGESCHICH; Bartley JK, 1996, PALAIOS, V11, P571, DOI 10.2307/3515192; Bengston S., 2003, P289; Bengtson S, 2004, SCIENCE, V306; Campbell R.D., 1974, P133; Chen J, 2005, DAWN ANIMAL WORLD; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JY, 2006, SCIENCE, V312, P1644, DOI 10.1126/science.1125964; Chen JY, 2004, SCIENCE, V306; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; CHIEN P, 2001, PALEOBIOS S, V21, P41; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Dornbos SQ, 2006, PALAIOS, V21, P3, DOI 10.2110/palo.2004.p04-37; Fell P.E., 1974, pUnpaginated; Fell Paul E., 1997, P39; HAGADORN JW, 2001, PALEOBIOS, V21, P60; HAGADORN JW, 2002, GEOLOGICAL SOC AM AB, V34, P169; KNOLL AH, 1975, SCIENCE, V190, P52, DOI 10.1126/science.190.4209.52; KUME K, 1988, INVERTEBRATE EMBRYOL; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; Morris SC, 1998, CURR OPIN GENET DEV, V8, P662, DOI 10.1016/S0959-437X(98)80034-8; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; SCHOPF J W, 1968, Journal of Paleontology, V42, P651; SPERLING EA, IN PRESS J GEOL SOC; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2	30	135	157	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					291	294		10.1126/science.1133129	http://dx.doi.org/10.1126/science.1133129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038620				2022-12-28	WOS:000241194100039
J	Ringleb, PA; Allenberg, J; Berger, J; Bruckmann, H; Eckstein, HH; Fraedrich, G; Hartmann, M; Hennerici, M; Jansen, O; Klein, G; Kunze, A; Marx, P; Niederkorn, K; Schmiedt, W; Solymosi, L; Stingele, R; Zeumer, H; Hacke, W; Hacke, W; Allenberg, JR; Eckstein, HH; Hennerici, M; Jansen, O; Maurer, PC; Zeumer, H; Poeck, K; Marx, P; Solymosi, L; Schweiger, H; von Sommoggy, S; Ringelstein, B; Hennerici, M; Diener, HC; Eckstein, HH; Balzer, K; Steiger, HJ; Ziemer, G; Kniemeyer, HW; Sunder-Plassmann, L; Bruckmann, H; Berger, H; Brassel, F; Kachel, R; Koch, C; Link, J; Mathias, K; Freiberger, A; Kison, H; Berger, J; Lubcke, P; Ringleb, PA; Kunze, A; Rubestahl, C; Hacke, W; Harrer-Haag, J; Stoveken, HJ; Mull, M; Pfadenhauer, K; Bruijnen, H; Hauser, H; Klein, M; Hinrichs, A; Ninnemann, T; Wilaschek, M; Claus, D; Huppert, P; Petermann, C; Dittmar, G; Neumann, G; Mathias, K; Gahn, G; Ockert, DM; von Kummer, R; Nacimiento, W; Brassel, F; Berg-Dammer, E; Betzler, M; Kuhne, D; Kastrup, O; Omlor, G; Bongers, VR; Hetzel, A; Spillner, G; Schuhmacher, M; Michels, P; Kortmann, H; Welger, D; Bruning, R; Pohlmann, C; Arning, C; Rieper, J; Breuer, P; Rother, J; Kucinski, TA; Zeumer, H; Hacke, W; Ringleb, P; Kulkens, S; Allenberg, J; Hartmann, M; Muller, M; Langenscheidt, P; Reith, W; Fetter, M; Huber, R; Pockler-Schoniger, C; Stingele, R; Borsch, K; Walluscheck, K; Jansen, O; Schabet, M; Gahlen, J; Brunk, W; Grau, A; Schultz, H; Zahn, R; Seidel, G; Wulff, B; Koch, C; Eicke, BM; Nedelmann, M; Schmiedt, W; Neufang, A; Ringel, KG; Pitton, MB; Daffertshofer, M; Rewerk, S; Groden, C; Deckerts-Schmitz, M; Heiss-Bogner, J; Muhling, H; Sander, D; Eckstein, HH; Berger, H; Dichgans, M; Steiger, HJ; Mayer, T; Walther, F; Kneist, W; Schuchard, UM; Schmid, E; Hupp, T; Gustorf-Aeckerle, R; Hamann, G; Kilic, M; Berkefeld, J; Mullges, W; Fein, M; Solymosi, L; Niederkorn, K; Fruhwirth, J; Klein, G; Schmidauer, C; Fraedrich, G; Waldenberger, P; Haring, H; Pogady, P; Trenkler, J; Lang, W; Polterauer, P; Ahmadi, R; Arnold, M; Barth, A; Schroth, G; Tettenborn, B; Nagel, W; Link, J				Ringleb, P. A.; Allenberg, J.; Berger, J.; Brueckmann, H.; Eckstein, H-H; Fraedrich, G.; Hartmann, M.; Hennerici, M.; Jansen, O.; Klein, G.; Kunze, A.; Marx, P.; Niederkorn, K.; Schmiedt, W.; Solymosi, L.; Stingele, R.; Zeumer, H.; Hacke, W.; Hacke, W.; Allenberg, Jens R.; Eckstein, H-H; Hennerici, M.; Jansen, O.; Maurer, P. C.; Zeumer, H.; Poeck, K.; Marx, P.; Solymosi, L.; Schweiger, H.; von Sommoggy, S.; Ringelstein, B.; Hennerici, M.; Diener, H. C.; Eckstein, H-H; Balzer, K.; Steiger, H. J.; Ziemer, G.; Kniemeyer, H. W.; Sunder-Plassmann, L.; Brueckmann, H.; Berger, H.; Brassel, F.; Kachel, R.; Koch, C.; Link, J.; Mathias, K.; Freiberger, A.; Kison, H.; Berger, J.; Luebcke, P.; Ringleb, P. A.; Kunze, A.; Ruebestahl, C.; Hacke, W.; Harrer-Haag, J.; Stoeveken, H. J.; Mull, M.; Pfadenhauer, K.; Bruijnen, H.; Haeuser, H.; Klein, M.; Hinrichs, A.; Ninnemann, Th; Wilaschek, M.; Claus, D.; Huppert, P.; Petermann, Ch; Dittmar, G.; Neumann, G.; Mathias, K.; Gahn, G.; Ockert, D. M.; von Kummer, R.; Nacimiento, W.; Brassel, F.; Berg-Dammer, E.; Betzler, M.; Kuehne, D.; Kastrup, O.; Omlor, G.; Bongers, V. R.; Hetzel, A.; Spillner, G.; Schuhmacher, M.; Michels, P.; Kortmann, H.; Welger, D.; Bruening, R.; Pohlmann, C.; Arning, Ch; Rieper, J.; Breuer, P.; Roether, J.; Kucinski, T. A.; Zeumer, H.; Hacke, W.; Ringleb, P.; Kuelkens, S.; Allenberg, J.; Hartmann, M.; Mueller, M.; Langenscheidt, P.; Reith, W.; Fetter, M.; Huber, R.; Poeckler-Schoeniger, Ch; Stingele, R.; Boersch, K.; Walluscheck, K.; Jansen, O.; Schabet, M.; Gahlen, J.; Brunk, W.; Grau, A.; Schultz, H.; Zahn, R.; Seidel, G.; Wulff, B.; Koch, Ch; Eicke, B. M.; Nedelmann, M.; Schmiedt, W.; Neufang, A.; Ringel, K. G.; Pitton, M. B.; Daffertshofer, M.; Rewerk, St; Groden, C.; Deckerts-Schmitz, M.; Heiss-Bogner, J.; Muehling, H.; Sander, D.; Eckstein, H. H.; Berger, H.; Dichgans, M.; Steiger, H. J.; Mayer, T.; Walther, F.; Kneist, W.; Schuchard, U. M.; Schmid, E.; Hupp, T.; Gustorf-Aeckerle, R.; Hamann, G.; Kilic, M.; Berkefeld, J.; Muellges, W.; Fein, M.; Solymosi, L.; Niederkorn, K.; Fruhwirth, J.; Klein, G.; Schmidauer, Ch; Fraedrich, G.; Waldenberger, P.; Haring, H.; Pogady, P.; Trenkler, J.; Lang, W.; Polterauer, P.; Ahmadi, R.; Arnold, M.; Barth, A.; Schroth, G.; Tettenborn, B.; Nagel, W.; Link, J.		SPACE Collaborative Grp	30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial	LANCET			English	Article							ARTERY STENOSIS; STROKE	Background Carotid endarterectomy is effective in stroke prevention for patients with severe symptomatic carotid-artery stenosis, and carotid-artery stenting has been widely used as alternative treatment. Since equivalence or superiority has not been convincingly shown for either treatment, we aimed to compare the two. Methods 1200 patients with symptomatic carotid-artery stenosis were randomly assigned within 180 days of transient ischaemic attack or moderate stroke (modified Rankin scale score of :53) carotid-artery stenting (n=605) or carotid endarterectomy (n=595). The primary endpoint of this hospital-based study was ipsilateral ischaemic stroke or death from time of randomisation to 30 days after the procedure. The non-inferiority margin was defined as less than 2.5% on the basis of an expected event rate of 5%. Analyses were on an intention-to-treat basis. This trial is registered at Current Controlled Trials with the international standard randomised controlled trial number ISRCTN57874028. Findings 1183 patients were included in the analysis. The rate of death or ipsilateral ischaemic stroke from randomisation to 30 days after the procedure was 6.84% with carotid-artery stenting and 6.34% with carotid endarterectomy (absolute difference 0.51%, 90% CI -1.89% to 2.91%). The one-sided p value for non-inferiority is 0.09. Interpretation SPACE failed to prove non-inferiority of carotid-artery stenting compared with carotid endarterectomy for the periprocedural complication rate. The results of this trial do not justify the widespread use in the short-term of carotid-artery stenting for treatment of carotid-artery stenoses. Results at 6-24 months are awaited.	Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hacke, W (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	Neurologie@med.uni-heidelberg.de	Michael, Pitton B/N-1888-2013; Dichgans, Martin/HCH-3247-2022; Diener, Hans-Christoph/AAF-7275-2019; Pitton, Michael B/F-8279-2010; Zeumer, Hermann/AAO-3524-2020; von Kummer, Rüdiger/AAA-4478-2019; Steiger, Hans-Jakob/AAN-8307-2021; Hacke, Werner/ABE-8661-2020; Lima, Thaísa/AAG-6483-2021; Trenkler, Johannes/AAL-4353-2020; Pitton, Michael B/B-2837-2014; Solymosi, László/E-6449-2018; Eckstein, Hans-Henning/AAF-9200-2022; Jansen, Olav/D-2547-2010; Eckstein, Hans-Henning/AFK-1881-2022	Dichgans, Martin/0000-0002-0654-387X; von Kummer, Rüdiger/0000-0003-0119-4604; Steiger, Hans-Jakob/0000-0002-8249-2998; Trenkler, Johannes/0000-0001-6060-4234; Solymosi, László/0000-0001-9647-8647; Zeumer, Hermann/0000-0003-4511-1225				Al-Mubarak N, 1999, AM J CARDIOL, V83, P1411, DOI 10.1016/S0002-9149(99)00110-1; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; Brown MM, 2001, LANCET, V357, P1729; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Featherstone RL, 2004, CEREBROVASC DIS, V18, P69, DOI 10.1159/000078753; Ferguson GG, 1999, STROKE, V30, P1751, DOI 10.1161/01.STR.30.9.1751; Forsting M, 2004, STROKE, V35, pE20, DOI 10.1161/01.STR.0000110686.67987.3D; GRAY WA, ARCHER TRIALS FINAL; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; HENNERICI MG, 2006, VASCULAR DIAGNOSIS U, V1; Hobson R W 2nd, 2000, Semin Vasc Surg, V13, P139; Hobson RW, 2004, J VASC SURG, V40, P1106, DOI 10.1016/j.jvs.2004.10.022; *ISRCTN, STENTPR PERC ANG CAR; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Malek AM, 2000, STROKE, V31, P3029, DOI 10.1161/01.STR.31.12.3029; MARKUS HS, 1994, STROKE, V25, P2403, DOI 10.1161/01.STR.25.12.2403; Mas JL, 2004, STROKE, V35, pE18, DOI 10.1161/01.STR.0000106913.33940.DD; MAS JL, 2004, CEREBROVASC DIS, V18, P62; Qureshi AI, 2005, NEUROSURGERY, V56, P1171, DOI 10.1227/01.NEU.0000159638.45389.C2; Ringleb P, 2003, NERVENARZT, V74, P482, DOI 10.1007/s00115-003-1507-4; Ringleb PA, 2004, CEREBROVASC DIS, V18, P66, DOI 10.1159/000078752; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Teitelbaum GP, 1998, SURG NEUROL, V50, P300, DOI 10.1016/S0090-3019(98)00038-X; Waigand J, 1998, EUR HEART J, V19, P1365, DOI 10.1053/euhj.1998.1048; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	27	1050	1088	1	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2006	368	9543					1239	1247		10.1016/S0140-6736(06)69122-8	http://dx.doi.org/10.1016/S0140-6736(06)69122-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091WF	17027729				2022-12-28	WOS:000241058300030
J	Mathiason, CK; Powers, JG; Dahmes, SJ; Osborn, DA; Miller, KV; Warren, RJ; Mason, GL; Hays, SA; Hayes-Klug, J; Seelig, DM; Wild, MA; Wolfe, LL; Spraker, TR; Miller, MW; Sigurdson, CJ; Telling, GC; Hoover, EA				Mathiason, Candace K.; Powers, Jenny G.; Dahmes, Sallie J.; Osborn, David A.; Miller, Karl V.; Warren, Robert J.; Mason, Gary L.; Hays, Sheila A.; Hayes-Klug, Jeanette; Seelig, Davis M.; Wild, Margaret A.; Wolfe, Lisa L.; Spraker, Terry R.; Miller, Michael W.; Sigurdson, Christina J.; Telling, Glenn C.; Hoover, Edward A.			Infectious prions in the saliva and blood of deer with chronic wasting disease	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE VIRUS-INFECTION; ROCKY-MOUNTAIN ELK; WHITE-TAILED DEER; SPONGIFORM ENCEPHALOPATHY; MULE DEER; TRANSMISSION; TRANSFUSION; PROTEIN; SHEEP	A critical concern in the transmission of prion diseases, including chronic wasting disease (CWD) of cervids, is the potential presence of prions in body fluids. To address this issue directly, we exposed cohorts of CWD-naive deer to saliva, blood, or urine and feces from CWD-positive deer. We found infectious prions capable of transmitting CWD in saliva ( by the oral route) and in blood ( by transfusion). The results help to explain the facile transmission of CWD among cervids and prompt caution concerning contact with body fluids in prion infections.	Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; Colorado State Univ, Coll Vet Med & Biol Sci, Vet Diagnost Lab, Ft Collins, CO 80523 USA; Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO 80525 USA; Wildlife Artist Supply Co, Monroe, GA 30655 USA; Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30609 USA; Colorado Div Wildlife, Wildlife Res Ctr, Ft Collins, CO 80526 USA; Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA	Colorado State University; Colorado State University; United States Department of the Interior; University System of Georgia; University of Georgia; University of Kentucky	Hoover, EA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu	Mathiason, Candace/H-9769-2017; Telling, Glenn C/G-1217-2019; Mathiason, Candace K/E-7843-2017	Mathiason, Candace/0000-0002-5920-4556; Telling, Glenn C/0000-0002-6294-1805; Mathiason, Candace K/0000-0002-5920-4556	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-25491] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; CLARKE MC, 1967, VET REC, V80, P504, DOI 10.1136/vr.80.16.504; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; PERROTT MP, 2005, MOL MECH TRANSM SPON; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	25	366	374	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2006	314	5796					133	136		10.1126/science.1132661	http://dx.doi.org/10.1126/science.1132661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	091LU	17023660				2022-12-28	WOS:000241031200053
J	Fye, WB				Fye, W. Bruce			Tracing atrial fibrillation - 100 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Coll Med, Mayo Clin Ctr Hist Med, Rochester, MN 55905 USA	Mayo Clinic	Fye, WB (corresponding author), Mayo Clin, Coll Med, Mayo Clin Ctr Hist Med, Rochester, MN 55905 USA.							Cushny AR, 1906, STUDIES PATHOLOGY, P95; Einthoven W., 1906, ARCH INT PHYSIOL, V4, P132; FYE WB, 1993, AM J CARDIOL, V72, P1055, DOI 10.1016/0002-9149(93)90862-7; FYE WB, 1994, AM J CARDIOL, V73, P937, DOI 10.1016/0002-9149(94)90135-X; Lewis T, 1909, Br Med J, V2, P1528	5	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1412	1414		10.1056/NEJMp068059	http://dx.doi.org/10.1056/NEJMp068059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021316				2022-12-28	WOS:000240976200002
J	Gardner, P				Gardner, Pierce			Prevention of meningococcal disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONJUGATE VACCINATION; HUMAN IMMUNITY; CARRIAGE; REVACCINATION; IMMUNIZATION; CHILDREN	A previously healthy 18-year-old college freshman presented to an emergency department with acute onset of fever and headache. He was listless and in distress. His temperature was 40.0 degrees C, his pulse was 140 per minute, his blood pressure was 70/40 mm Hg, and his respirations were 35 per minute. Petechiae were noted over his thorax. Meningococcal septicemia was suspected ( and subsequently confirmed by the growth of Neisseria meningitidis serogroup C isolated from blood). Despite the prompt administration of antibiotics and other support, the patient's illness was fulminant and he died 12 hours after the onset of the symptoms. Should he have previously received meningococcal vaccine, and what measures should be taken to protect his close contacts and his community?	SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; SUNY Stony Brook, Sch Med, Grad Program Publ Hlth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gardner, P (corresponding author), SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA.							Borrow R, 2000, VACCINE, V19, P1129, DOI 10.1016/S0264-410X(00)00317-0; Burstein GR, 2002, CLIN INFECT DIS, V35, pS191, DOI 10.1086/342107; *CDCP, 2005, HLTH INF INT TRAV 20; *DEP DEF, 2000, MED SURVEILL MON REP, V6, P2; EDWARDS EA, 1977, SCAND J INFECT DIS, V9, P105, DOI 10.3109/inf.1977.9.issue-2.09; Girgis N, 1998, PEDIATR INFECT DIS J, V17, P816, DOI 10.1097/00006454-199809000-00013; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GREENFIELD S, 1971, J INFECT DIS, V123, P67, DOI 10.1093/infdis/123.1.67; [Guidelines for the management of airline passengers exposed to meningo-coccal disease Centers for Diseases Control and Prevention], 2000, GUID MAN AIRL PASS E; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8; LEPOW ML, 1977, PEDIATRICS, V60, P673; MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5; MacLennan J, 2001, J INFECT DIS, V183, P97, DOI 10.1086/317667; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; *MED EC, 1999, 1999 DRUG TOP RED BO; MOORE PS, 1988, JAMA-J AM MED ASSOC, V260, P2686, DOI 10.1001/jama.260.18.2686; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; REINGOLD AL, 1985, LANCET, V2, P114; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Zangwill KM, 1997, JAMA-J AM MED ASSOC, V277, P389, DOI 10.1001/jama.277.5.389; 2006, MMWR MORB MORTAL WKL, V55, P364	24	66	73	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2006	355	14					1466	1473		10.1056/NEJMcp063561	http://dx.doi.org/10.1056/NEJMcp063561			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	090UA	17021322				2022-12-28	WOS:000240976200008
J	Hart, CA; Thomson, APJ				Hart, C. Anthony; Thomson, Alistair P. J.			Meningococcal disease and its management in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PARENTERAL PENICILLIN; MENINGITIS; ADMISSION; CARRIAGE		Univ Liverpool, Dept Med Microbiol, Liverpool L69 3GA, Merseyside, England; Royal Liverpool Childrens Hosp Alder Hey, Liverpool L12 2AP, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Hart, CA (corresponding author), Univ Liverpool, Dept Med Microbiol, Liverpool L69 3GA, Merseyside, England.	cahmm@liv.ac.uk						Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Carrol ED, 2001, EXPERT OPIN INV DRUG, V10, P1487, DOI 10.1517/13543784.10.8.1487; CARTWRIGHT K, 1992, BRIT MED J, V305, P774, DOI 10.1136/bmj.305.6856.774; *CHIEF MED OFF, 1999, MEN INF; CORRCIA JB, 2004, CLIN EVID, V12, P1164; *DEP HLTH, 1999, MEN C VACC MEN C FAC; Derkx B, 1999, CLIN INFECT DIS, V28, P770, DOI 10.1086/515184; Fellick JM, 2001, ARCH DIS CHILD, V85, P6, DOI 10.1136/adc.85.1.6; Goldacre MJ, 2003, BRIT MED J, V327, P596, DOI 10.1136/bmj.327.7415.596; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hackett SJ, 2002, ARCH DIS CHILD, V86, P449, DOI 10.1136/adc.86.6.449; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hackett SJ, 2001, J MED MICROBIOL, V50, P847, DOI 10.1099/0022-1317-50-10-847; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; *HLTH PROT AG, 2005, CDR WKLY ONLINE, V15; *HLTHPROT AG, 2005, CDR WKLY ONLINE, V15; Keeley D, 2006, BMJ-BRIT MED J, V332, P1283, DOI 10.1136/bmj.332.7553.1283; Kvalsvig AJ, 2003, J CLIN PATHOL, V56, P417, DOI 10.1136/jcp.56.6.417; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Maiden MCJ, 2004, ADV EXP MED BIOL, V549, P23; Makwana N, 2005, CURR OPIN CRIT CARE, V11, P418, DOI 10.1097/01.ccx.0000176699.51456.13; MARZOUK O, 1991, ARCH DIS CHILD, V66, P485, DOI 10.1136/adc.66.4.485; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Oliver KJ, 2002, INFECT IMMUN, V70, P3621, DOI 10.1128/IAI.70.7.3621-3626.2002; Pathan N, 2002, CRIT CARE MED, V30, P2191, DOI 10.1097/00003246-200210000-00003; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Richards C, 2001, ARCH DIS CHILD, V85, P172; Riordan FAI, 1996, BRIT MED J, V313, P1255, DOI 10.1136/bmj.313.7067.1255; Riordan FAI, 2002, EUR J PEDIATR, V161, P531, DOI 10.1007/s00431-002-1024-7; Texereau J, 2004, CRIT CARE MED, V32, pS313, DOI 10.1097/01.CCM.0000126363.46191.DC; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; THOMSON APJ, 2000, CURR PAEDIAT, V10, P104; Thornhill J, 2000, BJU INT, V85, P382; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	36	29	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					685	690A		10.1136/bmj.38968.683958.AE	http://dx.doi.org/10.1136/bmj.38968.683958.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	17008668	Green Published			2022-12-28	WOS:000241068200019
J	Johnson, KS				Johnson, Kenneth S.			Manganese redox chemistry revisited	SCIENCE			English	Editorial Material							BLACK-SEA; OXIDATION; OCEAN		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Johnson, KS (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	johnson@mbari.org	Johnson, Kenneth S/F-9742-2011	Johnson, Kenneth S/0000-0001-5513-5584				DeLong EF, 2000, NATURE, V407, P577, DOI 10.1038/35036677; Hulth S, 1999, GEOCHIM COSMOCHIM AC, V63, P49, DOI 10.1016/S0016-7037(98)00285-3; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Oguz T, 2001, DEEP-SEA RES PT I, V48, P761, DOI 10.1016/S0967-0637(00)00054-6; Schippers A, 2005, GEOCHIM COSMOCHIM AC, V69, P2241, DOI 10.1016/j.gca.2004.10.016; Statham PJ, 1998, MAR CHEM, V61, P55, DOI 10.1016/S0304-4203(98)00007-3; Trouwborst RE, 2006, SCIENCE, V313, P1955, DOI 10.1126/science.1132876; Webb SM, 2005, P NATL ACAD SCI USA, V102, P5558, DOI 10.1073/pnas.0409119102	8	34	34	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1896	1897		10.1126/science.1133496	http://dx.doi.org/10.1126/science.1133496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088SU	17008514				2022-12-28	WOS:000240832200032
J	Garly, ML; Bale, C; Martins, CL; Whittle, HC; Nielsen, J; Lisse, IM; Aaby, P				Garly, May-Lill; Bale, Carlitos; Martins, Cesario Lourenco; Whittle, Hilton C.; Nielsen, Jens; Lisse, Ida M.; Aaby, Peter			Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; VACCINATION; EXPERIENCE; EPIDEMIC; AGE	Objective 16 investigate whether prophylactic antibiotics can prevent complications of measles. Design Community based, randomised, double blind, placebo controlled trial. Setting Bandim Health Project stud), area in Bissau, Guinea-Bissau, west Africa. Participants 84 patients with measles during a measles epidemic in Bissau in 1998 (fewer than originally planned owing to interruption by war). Interventions Sulfamethoxazole-trimethoprim (co-trimoxazole) or placebo for seven days. Main outcome measures Pneumonia and admission to hospital. Also weight change during the first month of infection, diarrhoea, severe fever, oral thrush, stomatitis, conjunctivitis, and otitis media. Results The median age of the patients with measles was 5.4 (range 0.49-24.8) years. One of 46 participants who received co-trimoxazole developed pneumonia, in contrast to six of 38 participants who received placebo (odds ratio 0.08 (95% confidence interval 0 to 0.56), adjusted for age group). The number needed to treat was 7 (4 to 48). All three participants admitted to hospital had received placebo (P = 0.09). The weight gain during the first month after inclusion was 15 (2-29) g/day in the placebo group and 32 (23-42) g/day in the co-trimoxazole group (P = 0.04, adjusted for age group, weight for age at inclusion, measles vaccination status, and duration of disease). Significantly less conjunctivitis occurred among recipients of co-trimoxazole than placebo, as well as a non-significant tendency to less diarrhoea, severe fever, oral thrush, and stomatitis. Complications of otitis media were the same in the two groups. Conclusions The group that received prophylactic antibiotics had less pneumonia and conjunctivitis and had significantly higher weight gains in the month after inclusion. The results indicate that prophylactic antibiotics may have an important role in the management of measles infection in low income countries.	Projecto Saude Bandim, Bissau, Guinea Bissau; MRC Labs, Fajara, Gambia	MRC Laboratory Molecular Biology	Garly, ML (corresponding author), Statens Serum Inst, Div Epidemiol, Bandim Hlth Project, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	mlg@ssi.dk		Aaby, Peter/0000-0001-8331-1389				AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Chalmers I, 2002, PEDIATRICS, V109, P312, DOI 10.1542/peds.109.2.312; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; Klugman KP, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.suppl_A.133; LOENING WEK, 1983, LANCET, V2, P324; Morley DC, 1997, BRIT MED J, V314, P1692, DOI 10.1136/bmj.314.7095.1692; Nur YA, 1999, J CLIN VIROL, V12, P21, DOI 10.1016/S1386-6532(98)00002-X; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; PERRY RT, 2004, J INFECT DIS S1, V18, P4; Qazi SA, 1999, CLIN INFECT DIS, V28, P214, DOI 10.1086/515124; Quiambao BP, 1998, PEDIATR INFECT DIS J, V17, P89, DOI 10.1097/00006454-199802000-00002; SAMB B, 1995, PEDIATR INFECT DIS J, V14, P695, DOI 10.1097/00006454-199508000-00009; SAMB B, 1993, T ROY SOC TROP MED H, V87, P697, DOI 10.1016/0035-9203(93)90301-6; Shann F, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001477.pub2; Shann F, 1997, BRIT MED J, V314, P334, DOI 10.1136/bmj.314.7077.334; Van Den Hof S, 2002, PEDIATR INFECT DIS J, V21, P1146, DOI 10.1097/00006454-200212000-00012; WHITTLE HC, 1988, LANCET, V1, P963; *WHO, 1995, WHOCDR9515; *WHO, 2004, INT MAN CHILDH; 1996, J ANTIMICROB CHEM SA, V38, P133; 2006, WKLY EPIDEMIOL REC, V10, P99; 2002, WKLY EPIDEMIOL REC, V77, P59	26	27	27	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2006	333	7581					1245	1247		10.1136/bmj.38989.684178.AE	http://dx.doi.org/10.1136/bmj.38989.684178.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122AB	17060336	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000243197000016
J	Bao, SD; Wu, QL; McLendon, RE; Hao, YL; Shi, Q; Hjelmeland, AB; Dewhirst, MW; Bigner, DD; Rich, JN				Bao, Shideng; Wu, Qiulian; McLendon, Roger E.; Hao, Yueling; Shi, Qing; Hjelmeland, Anita B.; Dewhirst, Mark W.; Bigner, Darell D.; Rich, Jeremy N.			Glioma stem cells promote radioresistance by preferential activation of the DNA damage response	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-TUMORS; IN-VITRO; CHECKPOINTS; IDENTIFICATION; CANCER; REPAIR; UNIQUE; ATM	Ionizing radiation represents the most effective therapy for glioblastoma ( World Health Organization grade IV glioma), one of the most lethal human malignancies(1), but radiotherapy remains only palliative(2) because of radioresistance. The mechanisms underlying tumour radioresistance have remained elusive. Here we show that cancer stem cells contribute to glioma radioresistance through preferential activation of the DNA damage checkpoint response and an increase in DNA repair capacity. The fraction of tumour cells expressing CD133 (Prominin-1), a marker for both neural stem cells and brain cancer stem cells(3-6), is enriched after radiation in gliomas. In both cell culture and the brains of immunocompromised mice, CD133-expressing glioma cells survive ionizing radiation in increased proportions relative to most tumour cells, which lack CD133. CD133-expressing tumour cells isolated from both human glioma xenografts and primary patient glioblastoma specimens preferentially activate the DNA damage checkpoint in response to radiation, and repair radiation-induced DNA damage more effectively than CD133-negative tumour cells. In addition, the radioresistance of CD133-positive glioma stem cells can be reversed with a specific inhibitor of the Chk1 and Chk2 checkpoint kinases. Our results suggest that CD133-positive tumour cells represent the cellular population that confers glioma radioresistance and could be the source of tumour recurrence after radiation. Targeting DNA damage checkpoint response in cancer stem cells may overcome this radioresistance and provide a therapeutic model for malignant brain cancers.	Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Rich, JN (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	rich0001@mc.duke.edu	Dewhirst, Mark/Q-1302-2019; Rich, Jeremy/AAM-1445-2021	Dewhirst, Mark/0000-0003-3459-6546; 				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GARDEN AS, 1991, RADIOTHER ONCOL, V20, P99, DOI 10.1016/0167-8140(91)90143-5; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; IZANT JG, 1983, J CELL BIOL, V96, P424, DOI 10.1083/jcb.96.2.424; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Marin L, 2003, CYTOM PART A, V51A, P107, DOI 10.1002/cyto.a.10007; Oostendorp RAJ, 1999, LEUKEMIA, V13, P499, DOI 10.1038/sj.leu.2401373; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	27	4506	4749	23	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					756	760		10.1038/nature05236	http://dx.doi.org/10.1038/nature05236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17051156				2022-12-28	WOS:000242581100060
J	Tang, C; Iwahara, J; Clore, GM				Tang, Chun; Iwahara, Junji; Clore, G. Marius			Visualization of transient encounter complexes in protein-protein association	NATURE			English	Article							PHOSPHORYL TRANSFER COMPLEX; NMR STRUCTURES; ENHANCEMENT; BINDING; DNA; BARNASE; DOMAIN	Kinetic data on a number of protein - protein associations have provided evidence for the initial formation of a pre- equilibrium encounter complex that subsequently relaxes to the final stereospecific complex (1). Site- directed mutagenesis(2 - 4) and brownian dynamics simulations(5 - 7) have suggested that the rate of association can be modulated by perturbations in charge distribution outside the direct interaction surfaces. Furthermore, rate enhancement through non- specific binding may occur by either a reduction in dimensionality(8) or the presence of a short- range, non- specific attractive potential(9). Here, using paramagnetic relaxation enhancement, we directly demonstrate the existence and visualize the distribution of an ensemble of transient, non- specific encounter complexes under equilibrium conditions for a relatively weak protein - protein complex between the amino- terminal domain of enzyme I and the phosphocarrier protein HPr. Neither the stereospecific complex(10) alone nor any single alternative conformation can account fully for the intermolecular paramagnetic relaxation enhancement data. Restrained rigid- body simulated annealing refinement against the paramagnetic relaxation enhancement data enables us to obtain an atomic probability distribution map of the non- specific encounter complex ensemble that qualitatively correlates with the electrostatic surface potentials on the interacting proteins. Qualitatively similar results are presented for two other protein - protein complexes.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008; Tang, Chun/P-4060-2019	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Iwahara, Junji/0000-0003-4732-2173; Tang, Chun/0000-0001-6477-6500	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029043] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam G., 1968, STRUCTURAL CHEM MOL, P198; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DeLano W.L, PYMOL MOL GRAPHICS S; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; EBRIGHT YW, 1992, BIOCHEMISTRY-US, V31, P10664, DOI 10.1021/bi00159a004; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	28	334	344	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					383	386		10.1038/nature05201	http://dx.doi.org/10.1038/nature05201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17051159				2022-12-28	WOS:000242018300052
J	Saecker, RM; Davis, CA; Record, MT				Saecker, Ruth M.; Davis, Caroline A.; Record, M. T., Jr.			Do sigma factors need help with a meltdown?	CELL			English	Editorial Material							ESCHERICHIA-COLI SIGMA(70); RNA-POLYMERASE HOLOENZYME; CONFORMATIONAL-CHANGES; PROMOTER; NUCLEATION; PROTEIN; SITE	In this issue of Cell, Hsu et al. (2006) report on the binding activity of a variant of the bacterial transcriptional specificity factor sigma (sigma) to promoter DNA. This study demonstrates that the a variant induces a large distortion in the transcriptional start site in the absence of core RNA polymerase, raising intriguing new questions about the roles of sigma and core RNA polymerase in transcription initiation.	Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Saecker, RM (corresponding author), Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.	rmsaecker@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023467, R37GM023467] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23467] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bochkarev A, 1998, J MOL BIOL, V284, P1273, DOI 10.1006/jmbi.1998.2247; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Heyduk E, 2006, J BIOL CHEM, V281, P12362, DOI 10.1074/jbc.M601364200; Kontur WS, 2006, BIOCHEMISTRY-US, V45, P2161, DOI 10.1021/bi051835v; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462	10	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					256	258		10.1016/j.cell.2006.10.009	http://dx.doi.org/10.1016/j.cell.2006.10.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055426	Bronze			2022-12-28	WOS:000241827100012
J	Sonenberg, N; Pause, A				Sonenberg, Nahum; Pause, Arnim			Signal trnasduction: Protein synthesis and oncogenesis meet again	SCIENCE			English	Editorial Material							TRANSLATION; PHOSPHORYLATION; BINDING; GROWTH		McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	nahum.sonenberg@mcgill.ca; arnim.pause@mcgill.ca						Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	11	34	35	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					428	429		10.1126/science.1134031	http://dx.doi.org/10.1126/science.1134031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053135	Green Published			2022-12-28	WOS:000241382500027
J	Hunten, DM				Hunten, D. M.			The sequestration of ethane on Titan in smog particles	NATURE			English	Article							PROBE MASS-SPECTROMETER; ATMOSPHERE	Saturn's largest satellite, Titan, has a dense atmosphere of nitrogen with a few per cent of methane(1). At visible wavelengths its surface is hidden by dense orange-brown smog, which is produced in the stratosphere by photochemical reactions following the dissociation of methane by solar ultraviolet light. The most abundant of the products of these reactions is ethane, and enough of it should have been generated over the life of the Solar System to form a satellite-wide ocean one kilometre deep(2). Radar observations(3) have found specular reflections in 75 per cent of the surface spots observed, but optical searches for a sun-glint off an ocean have been negative(4). Here I explain the mysterious absence or rarity of liquid ethane: it condenses onto the smog particles, instead of into liquid drops, at the cold temperatures in Titan's atmosphere. This dusty combination of smog and ethane, forming deposits several kilometres thick on the surface, including the observed dunes and dark areas, could be named 'smust'. This satellite-wide deposit replaces the ocean long thought to be an important feature of Titan.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Hunten, DM (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	dhunten@lpl.arizona.edu						Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; Fouchet T, 2000, ASTRON ASTROPHYS, V355, pL13; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Niemann HB, 1998, J GEOPHYS RES-PLANET, V103, P22831, DOI 10.1029/98JE01050; Niemann HB, 1996, SCIENCE, V272, P846, DOI 10.1126/science.272.5263.846; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; West RA, 2005, NATURE, V436, P670, DOI 10.1038/nature03824; YUNG YL, 1999, PHOTOCHEMISTRY PLANE, pCH5	12	29	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					669	670		10.1038/nature05157	http://dx.doi.org/10.1038/nature05157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17035997				2022-12-28	WOS:000241160500040
J	Sahu, KC; Casertano, S; Bond, HE; Valenti, J; Smith, TE; Minniti, D; Zoccali, M; Livio, M; Panagia, N; Piskunov, N; Brown, TM; Brown, T; Renzini, A; Rich, RM; Clarkson, W; Lubow, S				Sahu, Kailash C.; Casertano, Stefano; Bond, Howard E.; Valenti, Jeff; Smith, T. Ed; Minniti, Dante; Zoccali, Manuela; Livio, Mario; Panagia, Nino; Piskunov, Nikolai; Brown, Thomas M.; Brown, Timothy; Renzini, Alvio; Rich, R. Michael; Clarkson, Will; Lubow, Stephen			Transiting extrasolar planetary candidates in the Galactic bulge	NATURE			English	Article							GRAVITATIONAL LENSING EXPERIMENT; DOPPLER FOLLOW-UP; GIANT PLANETS; PROPER MOTIONS; BAADES WINDOW; M-DWARF; MASS; METALLICITY; SEARCH; RADIUS	More than 200 extrasolar planets have been discovered around relatively nearby stars, primarily through the Doppler line shifts owing to reflex motions of their host stars, and more recently through transits of some planets across the faces of the host stars. The detection of planets with the shortest known periods, 1.2 - 2.5 days, has mainly resulted from transit surveys which have generally targeted stars more massive than 0.75 M-., where M-. is the mass of the Sun. Here we report the results from a planetary transit search performed in a rich stellar field towards the Galactic bulge. We discovered 16 candidates with orbital periods between 0.4 and 4.2 days, five of which orbit stars of masses in the range 0.44 - 0.75 M-.. In two cases, radial-velocity measurements support the planetary nature of the companions. Five candidates have orbital periods below 1.0 day, constituting a new class of ultra-short-period planets, which occur only around stars of less than 0.88 M-.. This indicates that those orbiting very close to more-luminous stars might be evaporatively destroyed or that jovian planets around stars of lower mass might migrate to smaller radii.	Space Telescope Sci Inst, Baltimore, MD 21218 USA; Pontificia Univ Catolica Chile, Santiago 22, Chile; Uppsala Univ, S-75120 Uppsala, Sweden; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; Osserv Astron Padova, INAF, I-35122 Padua, Italy; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Space Telescope Science Institute; Pontificia Universidad Catolica de Chile; Uppsala University; National Center Atmospheric Research (NCAR) - USA; Istituto Nazionale Astrofisica (INAF); University of Padua; University of California System; University of California Los Angeles	Sahu, KC (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	ksahu@stsci.edu	Piskunov, Nikolai/U-3831-2019; Minniti, Dante/AAD-7251-2021	Piskunov, Nikolai/0000-0001-5742-7767; Sahu, Kailash/0000-0001-6008-1955; Clarkson, William/0000-0002-2577-8885; Renzini, Alvio/0000-0002-7093-7355; Minniti, Dante/0000-0002-7064-099X; Valenti, Jeff/0000-0003-3305-6281				Albrow MD, 2001, ASTROPHYS J, V559, P1060, DOI 10.1086/322353; Alonso R, 2004, ASTROPHYS J, V613, pL153, DOI 10.1086/425256; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Baraffe I, 2004, ASTRON ASTROPHYS, V419, pL13, DOI 10.1051/0004-6361:20040129; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Bonfils X, 2005, ASTRON ASTROPHYS, V443, pL15, DOI 10.1051/0004-6361:200500193; BORUCKI WJ, 1984, ICARUS, V58, P121, DOI 10.1016/0019-1035(84)90102-7; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Bouchy F, 2005, ASTRON ASTROPHYS, V431, P1105, DOI 10.1051/0004-6361:20041723; Bouchy F, 2004, ASTRON ASTROPHYS, V421, pL13, DOI 10.1051/0004-6361:20040170; Brown TM, 2005, ASTRON J, V130, P1693, DOI 10.1086/444542; Brown TM, 2003, ASTROPHYS J, V593, pL125, DOI 10.1086/378310; Burrows A, 2004, ASTROPHYS J, V610, pL53, DOI 10.1086/423173; Butler RP, 2004, ASTROPHYS J, V617, P580, DOI 10.1086/425173; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; des Etangs AL, 2004, ASTRON ASTROPHYS, V418, pL1, DOI 10.1051/0004-6361:20040106; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fulbright JP, 2006, ASTROPHYS J, V636, P821, DOI 10.1086/498205; Gilliland RL, 1999, ASTROPHYS J, V521, P30, DOI 10.1086/307549; GRAUER AD, 1983, ASTROPHYS J, V271, P259, DOI 10.1086/161192; HENRY GW, 2000, APJ, V529, P41; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Kovacs G, 2002, ASTRON ASTROPHYS, V391, P369, DOI 10.1051/0004-6361:20020802; Kuijken K, 2002, ASTRON J, V124, P2054, DOI 10.1086/342540; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Marcy G, 2005, PROG THEOR PHYS SUPP, P24, DOI 10.1143/PTPS.158.24; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; MCCULLOUGH P, 2006, IN PRESS ASTROPHYS J; Moutou C, 2004, ASTRON ASTROPHYS, V424, pL31, DOI 10.1051/0004-6361:200400048; Pont F, 2006, ASTRON ASTROPHYS, V447, P1035, DOI 10.1051/0004-6361:20053692; Pont F, 2005, ASTRON ASTROPHYS, V438, P1123, DOI 10.1051/0004-6361:20052771; Pont F, 2005, ASTRON ASTROPHYS, V433, pL21, DOI 10.1051/0004-6361:200500025; Pont F, 2004, ASTRON ASTROPHYS, V426, pL15, DOI 10.1051/0004-6361:200400066; Rich RM, 2005, ASTROPHYS J, V634, P1293, DOI 10.1086/432592; Sato B, 2005, ASTROPHYS J, V633, P465, DOI 10.1086/449306; SCHNEIDER J, EXTRASOLAR PLANETS E; STETSON PB, 1992, ASTR SOC P, V25, P297; Sumi T, 2004, MON NOT R ASTRON SOC, V348, P1439, DOI 10.1111/j.1365-2966.2004.07457.x; Trilling DE, 1998, ASTROPHYS J, V500, P428, DOI 10.1086/305711; Udalski A, 2003, ACTA ASTRONOM, V53, P133; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; VandenBerg DA, 2006, ASTROPHYS J SUPPL S, V162, P375, DOI 10.1086/498451; VARDAVAS IM, 1951, MON NOT R ASTRON SOC, V363, pL5105; Zoccali M, 2000, ASTROPHYS J, V530, P418, DOI 10.1086/308359; Zoccali M, 2003, ASTRON ASTROPHYS, V399, P931, DOI 10.1051/0004-6361:20021604; [No title captured]	50	97	97	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2006	443	7111					534	540		10.1038/nature05158	http://dx.doi.org/10.1038/nature05158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	090XO	17024085				2022-12-28	WOS:000240988200035
J	Sivakumar, R; Pavulari, S; Ellis, S				Sivakumar, R.; Pavulari, S.; Ellis, S.			Interactive case report - Fever of unknown origin: case outcome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Lister Hosp, Stevenage SG1 4AB, Herts, England	Lister Hospital	Sivakumar, R (corresponding author), Lister Hosp, Stevenage SG1 4AB, Herts, England.	sivasiva51@hotmail.com							0	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2006	333	7570					691	691		10.1136/bmj.38950.395868.68	http://dx.doi.org/10.1136/bmj.38950.395868.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092AA	17008669	Green Published			2022-12-28	WOS:000241068200023
J	Lillard, A; Else-Quest, N				Lillard, Angeline; Else-Quest, Nicole			The early years: Evaluating Montessori education	SCIENCE			English	Editorial Material							MIND		Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53202 USA	University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Lillard, A (corresponding author), Univ Virginia, Dept Psychol, POB 400400, Charlottesville, VA 22904 USA.	lillard@virginia.edu		Else-Quest, Nicole/0000-0002-4177-2395; Lillard, Angeline S./0000-0001-9697-6611	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036808] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD036808] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amsterlaw J, 2006, J COGN DEV, V7, P139, DOI 10.1207/s15327647jcd0702_1; Belsky J, 2004, HARVARD EDUC REV, V74, P1; Borman GD, 2005, AM EDUC RES J, V42, P673, DOI 10.3102/00028312042004673; Cronbach L. J., 1980, REFORM PROGRAM EVALU; Cunningham AE, 1997, DEV PSYCHOL, V33, P934, DOI 10.1037/0012-1649.33.6.934; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Hart B., 1995, MEANINGFUL DIFFERENC; Lillard A.S., 2016, MONTESSORI SCI GENIU, V3rd Edn; Lipsey MW, 2003, ANN AM ACAD POLIT SS, V587, P69, DOI 10.1177/0002716202250791; MCGREW KS, 2001, WOODCOCKJOHNSON 3 TE; Montessori M., 1964, MONTESSORI METHOD; NICHD, 2005, AM EDUC RES J, V42, P537; RUBIN KH, 1988, SOCIAL PROBLEM SOLVI; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zimmer C, 2003, SCIENCE, V300, P1079, DOI 10.1126/science.300.5622.1079	15	203	205	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2006	313	5795					1893	1894		10.1126/science.1132362	http://dx.doi.org/10.1126/science.1132362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088SU	17008512	Green Submitted			2022-12-28	WOS:000240832200030
